
<html lang="en"     class="pb-page"  data-request-id="3e9e4a13-1cf1-4550-9d64-7d0a78a22c51"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-1;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c00533"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Development and Therapeutic Potential of NUAKs Inhibitors" /></meta><meta name="dc.Creator" content="Muhammad  Faisal" /></meta><meta name="dc.Creator" content="Jae Ho  Kim" /></meta><meta name="dc.Creator" content="Kyung Ho  Yoo" /></meta><meta name="dc.Creator" content="Eun Joo  Roh" /></meta><meta name="dc.Creator" content="Soon Sun  Hong" /></meta><meta name="dc.Creator" content="So Ha  Lee" /></meta><meta name="dc.Description" content="NUAK isoforms, NUAK1 (ARK5) and NUAK2 (SNARK), are important members of the AMPK family of protein kinases. They are involved in a broad spectrum of physiological and cellular events, and sometimes..." /></meta><meta name="Description" content="NUAK isoforms, NUAK1 (ARK5) and NUAK2 (SNARK), are important members of the AMPK family of protein kinases. They are involved in a broad spectrum of physiological and cellular events, and sometimes..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 24, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00533" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00533" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00533" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00533" /></link>
        
    
    

<title>Development and Therapeutic Potential of NUAKs Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00533" /></meta><meta property="og:title" content="Development and Therapeutic Potential of NUAKs Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0016.jpeg" /></meta><meta property="og:description" content="NUAK isoforms, NUAK1 (ARK5) and NUAK2 (SNARK), are important members of the AMPK family of protein kinases. They are involved in a broad spectrum of physiological and cellular events, and sometimes their biological roles overlap. NUAK isoform dysregulation is associated with numerous pathological disorders, including neurodegeneration, metastatic cancer, and diabetes. Therefore, they are promising therapeutic targets in metabolic diseases and cancers; consequently, various NUAK-targeted inhibitors have been disclosed. The first part of this review comprises a brief discussion of the homology, expression, structure, and characteristics of NUAK isoforms. The second part focuses on NUAK isoforms’ involvement in crucial biological operations, including mechanistic findings, highlighting how their abnormal functioning contributes to disease progression and quality of life. The third part summarizes the key findings and applications of targeting NUAK isoforms for treating multiple cancers and neurodegenerative disorders. The final part systematically presents a critical review and analysis of the literature on NUAK isoform inhibitions through small molecules." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="NUAK isoforms, NUAK1 (ARK5) and NUAK2 (SNARK), are important members of the AMPK family of protein kinases. They are involved in a broad spectrum of physiological and cellular events, and sometimes their biological roles overlap. NUAK isoform dysregulation is associated with numerous pathological disorders, including neurodegeneration, metastatic cancer, and diabetes. Therefore, they are promising therapeutic targets in metabolic diseases and cancers; consequently, various NUAK-targeted inhibitors have been disclosed. The first part of this review comprises a brief discussion of the homology, expression, structure, and characteristics of NUAK isoforms. The second part focuses on NUAK isoforms’ involvement in crucial biological operations, including mechanistic findings, highlighting how their abnormal functioning contributes to disease progression and quality of life. The third part summarizes the key findings and applications of targeting NUAK isoforms for treating multiple cancers and neurodegenerative disorders. The final part systematically presents a critical review and analysis of the literature on NUAK isoform inhibitions through small molecules." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0016.jpeg" /></meta><meta name="twitter:title" content="Development and Therapeutic Potential of NUAKs Inhibitors" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00533"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00533">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00533&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00533&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00533&amp;href=/doi/10.1021/acs.jmedchem.0c00533" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 2-25</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c02220" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c00931" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development and Therapeutic Potential of NUAKs Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Muhammad Faisal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Muhammad Faisal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Bio-Medical Science & Technology, KIST School, University of Science and Technology (UST), Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Muhammad++Faisal">Muhammad Faisal</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9181-9262" title="Orcid link">http://orcid.org/0000-0001-9181-9262</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jae Ho Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jae Ho Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Kinomics Research Center, Korea Institute of Science and Technology, Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jae+Ho++Kim">Jae Ho Kim</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kyung Ho Yoo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kyung Ho Yoo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Kinomics Research Center, Korea Institute of Science and Technology, Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kyung+Ho++Yoo">Kyung Ho Yoo</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eun Joo Roh</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eun Joo Roh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Bio-Medical Science & Technology, KIST School, University of Science and Technology (UST), Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Republic of Korea</div><div class="loa-info-affiliations-info">Chemical Kinomics Research Center, Korea Institute of Science and Technology, Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Republic of Korea</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#9defa5abaeabddf6f4eee9b3eff8b3f6ef"><span class="__cf_email__" data-cfemail="57256f616461173c3e2423792532793c25">[email protected]</span></a>. Phone: +82-2-958-6779.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eun+Joo++Roh">Eun Joo Roh</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Soon Sun Hong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Soon Sun Hong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biomedical Sciences, College of Medicine, and Program in Biomedical Science & Engineering, Inha University, Incheon 22212, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Soon+Sun++Hong">Soon Sun Hong</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">So Ha Lee</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">So Ha Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Kinomics Research Center, Korea Institute of Science and Technology, Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Republic of Korea</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#703c233846424141301b1903045e02155e1b02"><span class="__cf_email__" data-cfemail="8ac6d9c2bcb8bbbbcae1e3f9fea4f8efa4e1f8">[email protected]</span></a>. Phone: +82-2-958-6834.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=So+Ha++Lee">So Ha Lee</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7125-9568" title="Orcid link">http://orcid.org/0000-0002-7125-9568</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00533&amp;href=/doi/10.1021%2Facs.jmedchem.0c00533" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 2–25</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 24, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 April 2020</li><li><span class="item_label"><b>Published</b> online</span>24 December 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 January 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00533" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00533</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2%26pageCount%3D24%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMuhammad%2BFaisal%252C%2BJae%2BHo%2BKim%252C%2BKyung%2BHo%2BYoo%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D1%26contentID%3Dacs.jmedchem.0c00533%26title%3DDevelopment%2Band%2BTherapeutic%2BPotential%2Bof%2BNUAKs%2BInhibitors%26numPages%3D24%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D25%26publicationDate%3DJanuary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00533"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1351</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00533" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development and Therapeutic Potential of NUAKs Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Muhammad&quot;,&quot;last_name&quot;:&quot;Faisal&quot;},{&quot;first_name&quot;:&quot;Jae&quot;,&quot;last_name&quot;:&quot;Ho Kim&quot;},{&quot;first_name&quot;:&quot;Kyung&quot;,&quot;last_name&quot;:&quot;Ho Yoo&quot;},{&quot;first_name&quot;:&quot;Eun&quot;,&quot;last_name&quot;:&quot;Joo Roh&quot;},{&quot;first_name&quot;:&quot;Soon&quot;,&quot;last_name&quot;:&quot;Sun Hong&quot;},{&quot;first_name&quot;:&quot;So&quot;,&quot;last_name&quot;:&quot;Ha Lee&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;2-25&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00533&quot;},&quot;abstract&quot;:&quot;NUAK isoforms, NUAK1 (ARK5) and NUAK2 (SNARK), are important members of the AMPK family of protein kinases. They are involved in a broad spectrum of physiological and cellular events, and sometimes their biological roles overlap. NUAK isoform dysregulation is associated with numerous pathological disorders, including neurodegeneration, metastatic cancer, and diabetes. Therefore, they are promising therapeutic targets in metabolic diseases and cancers; consequently, various NUAK-targeted inhibitors have been disclosed. The first part of this review comprises a brief discussion of the homology, expression, structure, and characteristics of NUAK isoforms. The second part focuses on NUAK isoforms’ involvement in crucial biological operations, including mechanistic findings, highlighting how their abnormal functioning contributes to disease progression and quality of life. The third part summarizes the key findings and applications of targeting NUAK isoforms for treating multiple cancers and neurodegenerative diso&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00533&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00533" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00533&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00533" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00533&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00533" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00533&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00533&amp;href=/doi/10.1021/acs.jmedchem.0c00533" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00533" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00533" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00533%26sid%3Dliteratum%253Aachs%26pmid%3D33356242%26genre%3Darticle%26aulast%3DFaisal%26date%3D2021%26atitle%3DDevelopment%2Band%2BTherapeutic%2BPotential%2Bof%2BNUAKs%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D1%26spage%3D2%26epage%3D25%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291305" title="Cell physiology">Cell physiology</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/1" title="Go to Volume 64, Issue 1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/jmcmar.2021.64.issue-1/20210114/jmcmar.2021.64.issue-1.largecover.jpg" alt="Go to Volume 64, Issue 1"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">NUAK isoforms, NUAK1 (ARK5) and NUAK2 (SNARK), are important members of the AMPK family of protein kinases. They are involved in a broad spectrum of physiological and cellular events, and sometimes their biological roles overlap. NUAK isoform dysregulation is associated with numerous pathological disorders, including neurodegeneration, metastatic cancer, and diabetes. Therefore, they are promising therapeutic targets in metabolic diseases and cancers; consequently, various NUAK-targeted inhibitors have been disclosed. The first part of this review comprises a brief discussion of the homology, expression, structure, and characteristics of NUAK isoforms. The second part focuses on NUAK isoforms’ involvement in crucial biological operations, including mechanistic findings, highlighting how their abnormal functioning contributes to disease progression and quality of life. The third part summarizes the key findings and applications of targeting NUAK isoforms for treating multiple cancers and neurodegenerative disorders. The final part systematically presents a critical review and analysis of the literature on NUAK isoform inhibitions through small molecules.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34613" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34613" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Protein kinases catalyze the reversible hydroxyl-phosphorylation reaction of Thr, Ser, or Tyr residues of protein substrates. Generally, they themselves are substrates of upstream protein kinases or have the ability to autophosphorylate, which plays a critical role in a signaling cascade. More precisely, they act as sensors that play a crucial role in signaling pathways and show stimulus to stress conditions, osmolarity, nutrient availability, temperature, and light.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Most kinase signaling pathways are very complex as they control numerous cellular operations, for instance, differentiation, cell growth, immune responses, and gene transcription.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Therefore, elucidating kinase signaling pathways in health and diseases has become a key area in cell biology research.</div><div class="NLM_p">On the basis of the catalytic domain, protein kinases have been categorized as tyrosine kinases (90 kinases) and serine/threonine (Ser/Thr) kinases (388 kinases).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The catalytic kinase domain bears 12 conserved subdomains that fold into a common catalytic core skeleton. The AMP-activated protein kinase (AMPK) subfamily has 12 members: MARK1, MARK2, MARK3, MARK4, MELK, QIK, QSK, salt-inducible kinase (SIK), BRSK1, BRSK2, NUAK1, and NUAK2.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The AMPKs perform important biological operations such as resolution of the immune system,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> regulating gene transcription,<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> controlling cell polarity (MARKs and BRSKs),<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> and maintaining cellular energy levels (AMPKα).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">The NUAK1 [<i>aka</i>. OMPHK1 or ARK5] and closely related NUAK2 [<i>aka.</i> OMPHK2 or SNARK], which are phosphorylated and activated by the LKB1 (liver kinase B1; <i>aka</i>. STK11) tumor suppressor protein kinase, are Ser/Thr kinases that are important in cancer progression, cell adhesion, cell proliferation, and metastasis, as well as carbohydrate metabolism.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Previous investigations have shown that NUAK isoforms (aka. NUAKs) participate in a number of significant functions such as neuronal polarity and axon branching,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> senescence,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> cell adhesion,<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> and controlling embryonic development.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> NUAKs also function as a survival factor in MYC-driven tumors,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> promote cancer cell invasion,<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18−20)</a> and control cell division via their ability to stimulate proliferation.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Owing to their key functions in cellular signaling, their dysregulation has been found to be associated with numerous serious disorders such as infectious disorders and cancers.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Therefore, NUAKs have presented a very promising prospect for targeted treatment using inhibitors.</div><div class="NLM_p last">This review discusses the specific characteristics of NUAKs and recent advances made to understand their signaling connections in tumor cells. It also covers the intricate biological operations of NUAKs in cell migration, invasion, adhesion, proliferation, metabolism, senescence, apoptosis, and survival. In addition, the review highlights genetic mouse models that have been employed to elucidate the roles of NUAKs in metabolic homeostasis, tumorigenesis, actin stress fiber remodeling, muscle-specific knockout, global knockout, and omphalocele as well as to elucidate how the dysregulation of NUAKs is strongly linked with a diverse range of diseases. Further, it discusses the value of NUAKs as potential, interesting, and novel therapeutic targets to tackle cancers and neurodegenerative diseases and summarizes the results of NUAKs inhibitors that have been successfully developed and utilized for the treatment of diseases. Finally, the application of pyrimidine, indole, staurosporinone, thiazole, pyrazole, and imidazole derivatives as small-molecule inhibitors of NUAKs has been reviewed by comparing their inhibitory potencies with each other.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Homology, Expression, Structure, and Specific Characteristics of NUAK Isoforms</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17887" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17887" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1.  NUAK1 (ARK5)</h3><div class="NLM_p">NUAK1 is of particular interest as various reports in the literature have shown its involvement in a broad spectrum of processes.<a onclick="showRef(event, 'ref12 ref19 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref12 ref19 ref23 ref24">(12,19,23,24)</a> NUAK1 belongs to a group of 12 protein kinases closely related to the energy sensor AMPK subunits α1 and α2. These protein kinases have been generally grouped as AMPK-related kinases or AMPK subfamily and employ two different mechanisms to recognize their physiological substrates: (i) proximal mode, where the active site of the protein kinase recognizes the consensus phosphorylation sequence in the protein substrate; (ii) distal mode, a domain on substrate protein is recognized by a recognition/cognate domain on kinase molecules.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a></div><div class="NLM_p">With regard to amino acid units, human NUAK1 has 661 (MW ≈ 76 kDa), whereas mouse NUAK1 has 658. Further, kinase domains of human and mouse NUAK1 are 100% identical at the amino-acid sequence level (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> NUAK1 also has the highest homology to NUAK2; i.e., human NUAK1 amino acid sequence shows 58% homology to NUAK2 as a whole and 82% in the kinase domain.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Like all AMPK-related kinases, NUAK1 has a highly conserved T-loop and a critical threonine residue in the catalytic domain. STK11, an upstream serine-threonine kinase, strongly activates the AMPK subfamily, with the exemption of MELK, <i>in vitro</i> by phosphorylating their conserved T-loop threonine residue (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> For full activation of STK11 kinase potency and subsequent substrate activation, a complex to stabilize and localize STK11 in the cytoplasm must be developed using MO25-like protein and a pseudokinase STRAD (sterile-20-related adaptor).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Endogenous efficacy of the AMPK subfamily is dramatically reduced in cells that do not express STK11 or where STK11 was previously depleted, revealing that STK11 is a limiting factor in AMPK subfamily activation, at least <i>in vitro</i>.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> Other studies have indicated that protein kinase B (PKB; <i>aka</i>. AKT) activates NUAK1 by phosphorylating it at serine 600.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Currently, it is uncertain whether, like AMPK, NUAK1 requires partner proteins or dimerization for activity. However, recent evidence about the structure and activation of members of the PAR/MARK class has indicated that they have the ability of autoactivation,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and this might be true for other associated kinases. Another AMPK-related kinase, <i>viz</i>. MELK, has intrinsic potency and is able to autophosphorylate without activation by STK11.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Homology of NUAK1 in several species and ARKs sequence homology of the kinase domain. (A) Schematic representation of NUAK1 gene products in each animal. Red designates Ser/Thr kinase domain conserved throughout NUAK1 gene products (number shows the amino acid identity with the domain in mouse NUAK1). The Ser/Thr kinase domain is highly conserved among human, mouse and zebrafish NUAK1 genes. (B) Alignment and dendogram of the T-loop sequences of the AMPK-related kinases. Conserved residues are marked in yellow, whereas identical residues are marked in red. An asterisk indicates the Ser and Thr phosphorylation sites of STK11. S, N, G, and A indicate preferences for Ser, Asn, Gly, and Ala, respectively; ϕ represents a large hydrophobic residue; and X stands for any amino acid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">AMPK is a component of the stress response system of cells. As its yeast homologue sucrose nonfermenting 1 (SNF1), AMPK expression is induced by diverse cell stresses such as glucose deprivation, hypoxia, or an increased intracellular AMP/ATP ratio.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> AMPK induction by cellular stresses and further activation by STK11 phosphorylation trigger a signaling cascade that works through inactivation of mTOR to switch off cellular anabolic pathways and prepare the cell for energy storage restoration via catabolic metabolism.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p last">In an investigation to assess the global NUAK1 mouse knockout, expression was assessed by <i>in situ</i> hybridization to observe mRNA levels and by <i>βgal</i> insertion into the NUAK1 gene.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The two approaches correlated well and revealed that mRNA levels should be a precise indicator of protein expression in adult tissues. On embryonic day 9.5, expression of <i>βgal</i> was observed throughout the undifferentiated neuroectoderm, and it mostly occurred in the epidermis; having said that, it was greatly expressed in the ventral body wall (VBW). On E18.5 and E14.5, expression of <i>βgal</i> was only noticed in differentiated areas of the cortex but not in other brain parts, and it was maintained in the epidermis of the entire body. An early investigation on NUAK1 activation in rat skeletal muscle reported the expression profile in adult tissues and observed mRNA present in skeletal muscle, liver, brain, kidney, and heart.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.2.  NUAK2 (SNARK)</h3><div class="NLM_p">NUAK2 is a serine/threonine-protein kinase comprising 661 amino acid units (MW ≈ 76 kDa) in human protein. It was initially observed in 2001 as a UV-induced gene in rat keratinocytes.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Within the AMPK-related kinases, NUAK2 is most closely related with NUAK1. These two kinases differ from the rest in the AMPK subfamily in that they lack an ubiquitin-associated (UBA) protein domain after the C-terminus of the kinase domain.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Despite the fact that mammals have two distinct genes, <i>Caenorhabditis elegans</i> has a unique ortholog, UNC-82,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> which reveals that NUAK1 and NUAK2 are likely to be derived from a common ancestor gene, and hence, they could still share interaction partners and cellular functions.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p last">It has been observed that NUAK2 is the only AMPK subfamily that responds to several cellular stresses.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Its expression in several cell lines is induced by nutrient deprivation, such as hypoxia conditions, glutamine, or glucose deficiency, or increased reactive oxygen molecules.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> However, numerous investigations have highlighted the fact that unlike AMPK, its response to cellular stress seems to be highly cell context and cell type dependent.<a onclick="showRef(event, 'ref27 ref34 ref37'); return false;" href="javascript:void(0);" class="ref ref27 ref34 ref37">(27,34,37)</a> In human myocyte cultures, its expression is induced by palmitate and TNFα, which are two stress substances involved in the acquisition of insulin resistance by skeletal muscle cells.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Although it was observed that this insulin resistance was independent of NUAK2 status, there is available information that indicates that NUAK2 participates in skeletal muscle metabolism homeostasis, and that it mediates part of the exercise-stimulated glucose transport.<a onclick="showRef(event, 'ref26 ref39'); return false;" href="javascript:void(0);" class="ref ref26 ref39">(26,39)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">3.  NUAK Isoforms’ Biological Operations, Mechanistic Findings, and Association with Diseases</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35138" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35138" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3.1.  Cell Invasion and Migration</h3><div class="NLM_p">An initial investigation that highlights NUAK1’s involvement in cell migration was performed in human pancreatic cancer cell lines (PANC-1). NUAK1 overexpression in PANC-1 cell lines considerably increases their invasive capability, which is attenuated by PKB inhibition and promoted by IGF-1 stimulation, indicating a PKB/IGF regulatory mode. The mechanism by which NUAK1 contributes in cell invasion is found to include enhanced potency of matrixin-9 and matrixin-2 (MMP-9 and MMP-2), as a greater affinity of these two matrixins is observed in NUAK1 overexpressing PANC-1 cell lines. Additionally, the enhanced cell invasion upon NUAK1 overexpression has also been verified <i>in vivo</i>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Subcutaneous tumors that originated from transplantation of PANC-1 cell lines stably overexpressing NUAK1 highly invade muscularis propria, and metastases at multiple organs is also noticed at the initial stages, compared with PANC-1 cell lines expressing endogenous levels of NUAK1.<a onclick="showRef(event, 'ref20 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref20 ref40 ref41 ref42">(20,40−42)</a></div><div class="NLM_p last">Transforming growth factor-β (TGF-β) signaling through suppressor of mothers against decapentaplegic (SMAD) proteins and protein kinase pathways is observed to down- or up-regulate the expression of various genes and, therefore, influences physiological functions, such as invasion, migration, apoptosis, cell cycle arrest, and differentiation.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a><i>NUAK isoforms</i> are identified to be two TGF-β target genes. That is to say, transcriptional induction of NUAK isoforms by TGF-β produces signaling loops in such a way that NUAK2 promotes, while NUAK1 inhibits, biological actions mediated by TGF-β signaling. Thus, the balance between the apparently opposite functions of both isoforms of NUAK on TGF-β signaling can perform significant processes in mesenchymal and epithelial cell physiology.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">3.2.  Cell Adhesion</h3><div class="NLM_p">A proteomic analysis performed on immune-precipitated NUAK1 has identified interactors belonging to the myosin light-chain phosphatase complex (<i>aka</i>. MYPT1-PP1β-NUAK1 complex and PP1β<sup>MYPT1</sup> myosin phosphatase complex), which are accountable for catalyzing dephosphorylation (removal of a phosphate species from protein) of proteins, for example, PLK1 (polo-like kinase-1) and MLC2 (myosin light chain 2), which in turn regulates many processes including cell adhesion and smooth muscle contraction.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The PP1β<sup>MYPT1</sup> myosin phosphatase complex is formed using catalytic species denoted by protein phosphatase type 1β (PP1β), and two regulatory subunits: (i) M20, having an unknown function, and (ii) myosin phosphatase target subunit 1 (MYPT1). NUAK1 interacts with the complex formed by MYPT1 and PP1β, and phosphorylates the former at three distinct sites (Ser<sup>910</sup>, Ser<sup>472</sup>, and Ser<sup>445</sup>) to enhance binding between MYPT1 and 14-3-3 protein, leading to the inhibition of the PP1β<sup>MYPT1</sup> myosin phosphatase complex.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Since MYPT1 phosphorylation is decreased in cell lines with STK11 deletion, the described role of NUAK1 was investigated to be influenced by the upstream kinase STK11. Furthermore, inhibition of the PP1β<sup>MYPT1</sup> myosin phosphatase complex followed by activation of the STK11/NUAK1 axis results in greater levels of MLC2 phosphorylation, promoting cell detachment (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Additionally, the investigation also identified the existence of a GILK (Gly-Ile-Leu-Lys) unit in the NUAK1 sequence, which mediates direct binding to a regulatory pocket on the surface of PP1β. Noteworthy, NUAK2 is also described to have the GILK unit and to cooperate with the PP1β-MYPT1, sharing similar phosphorylation sites with NUAK1 on MYPT1, thus supporting previous research studies that indicate MYPT1 phosphorylation by NUAK2.<a onclick="showRef(event, 'ref14 ref45'); return false;" href="javascript:void(0);" class="ref ref14 ref45">(14,45)</a> The recent investigation of Zagórska and co-workers has also shown that NUAKs are the only kinases of the class, which are able to interact with PP1β-MYPT1.<a onclick="showRef(event, 'ref42 ref46'); return false;" href="javascript:void(0);" class="ref ref42 ref46">(42,46)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic illustration of NUAK1 mechanism in controlling cell adhesion. After activation and phosphorylation by STK11, NUAK1 forms a complex with MYPT1 and PP1β. Subsequently, NUAK1 phosphorylates MYPT1 at Ser<sup>910</sup>, Ser<sup>472</sup>, and Ser<sup>445</sup> to enhance binding between MYPT1 and 14-3-3 protein and to inhibit the phosphatase capacity of PP1β. The overall result demonstrated in the figure illustrates that increased MLC2 phosphorylation enhances cell detachment and myosin II activation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">3.3.  Glucose Transport and Metabolism</h3><div class="NLM_p">Skeletal muscle has a fundamentally significant part in the maintaining normal glucose homeostasis and in controlling whole-body carbohydrate metabolism. Glucose generally delivers energy sources for tissues of the body. Exercise and insulin are the chief stimulators of glucose transport in muscle cells.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> It is widely known that in situations of insulin resistance such as adult-onset diabetes, involving reduced insulin-stimulated glucose transport, exercise is extremely valuable because it enhances glucose uptake and transport in SkMC, in addition to insulin sensitivity and fatty acid oxidation.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Exercise and insulin stimulation of glucose transport act via distinct signaling pathways; however, their signaling converge at the PKB substrates paralogs, AS160 (<i>aka</i>. TBC1D4) and TBC1D1, enhancing their phosphorylation and assisting to increase the translocation of the glucose transporter type 4 (GLUT4) from vesicles to the cytoplasmic membrane.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p">Investigations using muscle-specific STK11 knockout mice have analyzed STK11 as a significant molecular regulator of contraction-stimulated glucose transport. In mice, STK11 depletion in SkMC has reduced fatty acid oxidation during treadmill exercise and reduced contraction-stimulated glucose transport.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Also, these mice have decreased AMPK-α2 (the predominant AMPK component in muscle) and lower phosphorylation of TBC1D1 and AS160.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Despite the fact that AMPK-α2 is significantly decreased, and is believed to be the exclusive substrate of STK11 involved in glucose metabolism, further investigations using mice lacking AMPK-α2 have revealed that AMPK cannot be the sole substrate of STK11 involved in contraction-stimulated glucose transport. Mice lacking AMPK-α2 only have partially reduced fatty acid oxidation and little or no change in exercise-dependent glucose uptake and transport stimulation.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a> These outcomes have revealed that in muscle cells, STK11 regulation of glucose homeostasis probably involves more than one member of the AMPK-related kinases besides AMPK-α2.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p">It is interesting to note that NUAK2 heterozygous knockout mice display premature onset of obesity and diabetes mellitus (DM) along with enhanced hyperinsulinemia, hyperglycemia, and fat mass: all classic features of glucose intolerance (GI) and adult-onset diabetes.<a onclick="showRef(event, 'ref39 ref53'); return false;" href="javascript:void(0);" class="ref ref39 ref53">(39,53)</a> Furthermore, these mice display decreased contraction-stimulated glucose transport when investigated for treadmill exercise, and myocytes (i.e., muscle cells) derived from these mice have reduced TBC1D1 phosphorylation.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> On the same note, mice expressing a dominant negative mutant NUAK2 have impaired contraction-stimulated glucose transport in SkMC. NUAK2 is a specific STK11 substrate that controls contraction-stimulated glucose transport.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Along with these reports, obese patients also have enhanced NUAK2 levels in muscle cells, and when human myocyte cell cultures are exposed to palmitate and TNFα (agents that induce insulin resistance), NUAK2 strongly increases.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Attainment of insulin resistance is independent of NUAK2 levels, because reduction of NUAK2 does not revert insulin resistance, revealing that NUAK2 induction in obese humans is highly expected to be a response to counterbalance insulin resistance effects by enhancing exercise-dependent glucose uptake and transport.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p last">In adult tissues, it is not possible to evaluate the physiological functions of the kinase attributed to the embryonic lethality of NUAK1 global knockout mice; therefore, investigations have been accompanied by the use of conditional tissue-specific gene deletions.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> To date, only one study has disclosed a skeletal muscle-specific NUAK1 knockout (MNUAK1KO) by deletion of the kinase using crerecombinase under the control of the muscle phosphocreatine kinase promoter.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> No basal-like phenotype was noticed, revealing that deleting NUAK1 in muscle has no important developmental effect. However, on a high fat diet, MNUAK1KO mice has a higher concentration of muscle glycogen, higher insulin sensitivity, greater glucose tolerance, and lower fasting blood glucose level than control mice.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Furthermore, phosphorylation of insulin receptor substrate 1 (IRS-1) at Ser-1097 is significantly reduced in NUAK1-deficient muscle, and insulin signaling is improved in the soleus muscle of MNUAK1KO mice, suggesting that a physiological function of NUAK1 is to suppress glucose uptake through negative regulation of insulin signaling in oxidative muscle, possibly via the phosphorylation of IRS1.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">3.4.  Cell Senescence and Proliferation</h3><div class="NLM_p">NUAK1 has been engaged in controlling senescence and cell ploidy.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> It has been observed that down-regulation of NUAK1 enhances the replicative potential of senescent cells. Further study reveals that NUAK1-induced senescence is related to its function in the control of cell ploidy. Particularly, NUAK1 is observed to cause aneuploidy through the negative regulation of the large tumor suppressor kinase 1 (LATS1) protein levels, known to promote cytokinesis.<a onclick="showRef(event, 'ref12 ref42'); return false;" href="javascript:void(0);" class="ref ref12 ref42">(12,42)</a></div><div class="NLM_p">Although NUAK1 has been indicated to have contradictory biological roles of an inhibitor or promoter of cell division progression, it has been identified to participate in controlling cell proliferation.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> That is to say, it has been observed to interact with and phosphorylate p53 at Ser<sup>392</sup> and Ser<sup>15</sup>, which causes p21 induction (<i>aka</i>. WAF1 and CAP20) and cell division cycle arrests at the G1/S checkpoint.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In contrast, Alessi and co-workers suggest that NUAK1 is a positive regulator of cell cycle.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> In their investigation, inhibiting NUAK1 potency using HTH-01-015 <b>5</b>, a selective and potent NUAK1 inhibitor, reduced the proportion of cells in the S-phase of the cell division cycle and restricted the development of the mitotic phase. A more detailed examination of the mechanism reveals a remarkable interplay between NUAK1, SCF<sup>βTrCP</sup> (Skp, Cullin and F-box<sup>βTrCP</sup>) E3 ubiquitin ligase complex, Polo like kinase 1 (PLK1) and cyclin-dependent kinase (CDK). That is to say, inhibiting the phosphatase potency of the MYPT1-PP1β complex upon induction of NUAK1 increases potency to conduct G2/M transition and PLK1 phosphorylation. Moreover, active PLK1 phosphorylates NUAK1 at two conserved noncatalytic serine residues (Ser<sup>480</sup> and Ser<sup>476</sup>). This induces binding of NUAK1 to βTrCP, the substrate-recognition subunit of the SCF<sup>βTrCP</sup> E3 ligase, leading to ubiquitylation and degradation of NUAK1 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). Therefore, during the different phases of cell cycle, reciprocal modulation of NUAK1 and PLK1 levels is indicated to orchestrate cell-division cycle progression.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Further investigation indicates a positive function of NUAK1 in the regulation of cell cycle as its down-regulation results in cell cycle arrest,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and its overexpression has been demonstrated to increase proliferation.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic illustration of ubiquitylation and degradation of NUAK1 and mechanisms of PTEN-NUAK1 and PTEN-STK11 synthetic sickness/lethality. (A) NUAK1 binds and phosphorylates PP1β<sup>MYPT1</sup> myosin phosphatase complex at Ser<sup>472</sup> and Ser<sup>445</sup>, promoting 14-3-3 binding. In the S/G<sub>2</sub>-phase of the cell cycle, MYPT1 and NUAK1 are primed by CDKs, which in turn creates a docking site for PLK. PLK1 binds with MYPT1 at Ser<sup>473</sup>, leading to inactivation of PLK1 upon PP1β<sup>MYPT1</sup>-based dephosphorylation of Thr<sup>210</sup> at the PLK1 activation loop. PLK docking on to NUAK1 at Ser<sup>445</sup> results in phosphorylation of NUAK1 at Ser<sup>480</sup> and Ser<sup>476</sup>. This would in turn assists SCF<sup>βTrCP</sup> binding and therefore leads to ubiquitylation and degradation of NUAK1. (B) Effects of losing function of NUAK1 and STK11 on progression of cell cycle (top models) and DNA damage repair (bottom models) in PTEN-cells. (i) Function of selected genes in PTEN+cells for comparing. (ii) PKB signaling is not inactivated by PTEN in PTEN-cells, resulting in enhanced NUAK1 activation, and improved progression of cell cycle. The PTEN participation to DNA damage repair is suppressed. (iii) Progression of cell cycle is furthermore accelerated in PTEN-cells without STK11, attributed to absence of STK11-NUAK1 inhibition. DNA damage repair is more suppressed as compared to PTEN-cells with STK11 potency attributed to absence of NUAK1activation by STK11. (iv) Progression of cell cycle is arrested in PTEN cells without NUAK1. Owing to loss of NUAK activity, DNA damage repair is lost as compared to PTEN-cells having NUAK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a recent interesting study, STK11 and NUAK1 are observed to have phosphatase and tensin homologue-synthetic sick/lethal (PTEN-SSL) patterns of activity in the PTEN-deficient cancer cells. Moreover, in PTEN-deficient cancers, NUAK1 and STK11 are selectively fundamental for the progression of the cell cycle and repairing damaged DNA (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> PTEN-deficient cancer cell lines have impaired DNA damage repair and also have enhanced cell proliferation via accelerated progression of cell cycle. In these cells, losing STK11 function would decrease its NUAK1 phosphorylation at Thr211 and therefore deactivate the p53-regulated brake on progression of cell cycle. However, Ser600 phosphorylation by the PKB(AKT)/PTEN pathway would continue to assist progression of the cell cycle via an STK11-independent mechanism (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B, upper model in (iii)). Hence, in these cells, the net effect of losing STK11 would be further cell cycle acceleration. Meanwhile, loss of STK11 would suppress the DNA damage repair (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B, lower model in (iii)). Hypothetically, this combination of phenomena (increased DNA damage or accelerated cell cycle progression) would result in senescence or cell death.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div><div class="NLM_p">The understanding that ARK5 can activate and phosphorylate large tumor suppressor kinase 1 (LATS1) associates it to a highly conserved growth regulating signaling pathway, <i>viz</i>. Hippo, which is shown to be involved in organ size control.<a onclick="showRef(event, 'ref32 ref58'); return false;" href="javascript:void(0);" class="ref ref32 ref58">(32,58)</a> Also, Hippo signaling exerts a significant role in controlling cell proliferation and contributes to the progression of numerous disorders including tumor. The transcriptional coactivator with PDZ-binding motif (TAZ) and transcriptional coactivators Yes-associated protein (YAP) is the main end target of the Hippo pathway, which in turn maintains the expression of genes number (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). YAP overexpression is capable of mimicking the loss of Hippo signaling and creating enormously oversized organs. When overexpressed in mouse liver, it also leads to HCC.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> NUAK isoforms are observed to be able to directly phosphorylate LATS1 resulting in degradation of LATS1,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> which is investigated to result in enhanced activity of YAP/TAZ, thereby causing an increase in organ size and proliferation.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> This implies that the existence of NUAK isoforms would be pro-proliferative.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> However, other data in human cell lines have reflected that LATS1 down-regulation produces irreversible cell cycle arrest in normal human cells, revealing an antiproliferative role for NUAK1.<a onclick="showRef(event, 'ref12 ref61'); return false;" href="javascript:void(0);" class="ref ref12 ref61">(12,61)</a> In the support of primary findings that NUAK1 activity assists proliferation, various other studies have been performed in the past few years, at least in certain cancer models including HCC,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> nonsmall cell lung cancer (NSCLC),<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> glioma,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and breast.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Moreover, in an interesting study, NUAK1 is reported to be able to direct phosphorylate and regulate p53, resulting in cell cycle arrest.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> However, no such mechanism has since been documented in spite of several other validated upstream kinases of p53 and various publications investigating its function in cell proliferation.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> NUAK1 may contribute to maintain the balance between metastasis and tumor growth, and can control adhesion in melanoma cells and, but it is not clear if it has a anti- or pro-proliferative effect.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hippo pathway. The Hippo pathway is a growth regulating signaling pathway. Dashed lines designate possible interactions recognized by the homology from the Drosophila pathway. Solid lines indicate known direct interactions. Proteins in direct contact with each other also show known direct interactions. Phosphorylating the transcriptional activators TAZ and YAP by LATS1/2 results in cytosolic sequestration, thus suppressing TEAD-target gene transcription. LATS1 and LATS2 are negatively regulated by NUAK isoforms but activated directly by AMPK and indirectly by MARK1 and MARK1 kinases, downstream of STK11. AMPK directly phosphorylates YAP, which prevents its interaction with TEAD transcription parameters.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the flip side, MARK1/4 are indicated to assist activation of LATS1.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Adding complexity to this model (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), in response to energetic stress, AMPK has been recently shown by three independent moieties to suppress YAP activity.<a onclick="showRef(event, 'ref66 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref66 ref67 ref68">(66−68)</a> An earlier report described STK11-dependent regulation of YAP, independent of either LATS or AMPK, indicating that additional ARKs contribute in the regulation of this pathway.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Undoubtedly, the Hippo pathway is intersected by the STK11 pathway at multiple levels, and it will be interesting to investigate how this regulation is coordinated and certainly if it is bidirectional.</div><div class="NLM_p last">Very recently, NUAK2 is identified as a positive regulator of YAP/TAZ activity that directly inhibits LATS-based YAP/TAZ phosphorylation. Induction of NUAK2 by AP-1 and YAP/TAZ is needed for vigorous YAP/TAZ signaling.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Moreover, pharmacological NUAK2 inactivation, blocking expression with RNAi (RNA interference) or knocking out NUAK2 with CRISPR inhibits YAP/TAZ transcriptional potency, reduces tumor growth, drives cytoplasmic localization of YAP/TAZ, and decreases the growth of diverse cancer cell lines, altogether identifying a positive feed-forward loop in the Hippo pathway and demonstrating a key function for NUAK2 in enhancing YAP/TAZ oncogenic function (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). In a related study, NUAK2 has been investigated as a crucial mediator of YAP-driven hepatomegaly and liver tumorigenesis.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> It is selectively demanded for YAP-driven growth and contributes in a feedback loop to maximize potency of YAP through promoting activity of myosins and actin polymerization. In addition, pharmacological NUAK2 inactivation suppresses YAP-dependent liver overgrowth and cancer cell proliferation. Therefore, NUAK2 illustrates an actionable moiety within the pathway that could be amenable to target Hippo/YAP signaling.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">3.5.  Cell Survival and Apoptosis</h3><div class="NLM_p">NUAK2 is observed to aid in maintaining skeletal muscle mass.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Adult mice and humans have shown enhanced expression of NUAK2 in response to metabolic stress and aging skeletal muscle. Noteworthy, the loss of NUAK2 has enhanced the sensitivity of myocyte cell cultures to palmitate-induced apoptosis.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Furthermore, mice bearing a muscle-specific NUAK2 dominant negative mutant kinase (SDN) have severe muscle fiber atrophy. Interestingly, Lessard and co-workers have shown that these mice have impaired Rho signaling because they have reduced expression of downstream Rho signaling targets and reduced MYPT1 phosphorylation at the Rho kinase Thr696 phosphorylation site, revealing that defective Rho signaling might have participated in the apoptosis of phenotypes upon NUAK2 loss.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Using <i>in vitro</i> profiling, primary myocytes cell cultures obtained from SDN mice also presented the same data. Exposing myocytes to palmitate enhances MYPT1 phosphorylation, and this effect is lost when NUAK2 is depleted from the cells.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> It is widely identified that Rho/ROCK (Rho-associated kinase) signaling participates in apoptosis since it is demanded for cell detachment and development of apoptotic bodies.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Constitutive ROCK activation is performed by cysteine aspartases which cut the regulatory domain at the C-terminus of the kinase. ROCK overactivation enhances bud formation (characteristic of apoptotic cells) and cell contraction, along with cell detachment. ROCK inhibitors have been utilized as tumor therapy drugs as tumor cells utilize ROCK overactivation to rearrange their cytoskeleton and obtain metastatic and invasion cell properties.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> NUAK2 can serve as a connecting protein between actin SFs remodeling and apoptosis cascade.</div><div class="NLM_p last">The protective function of NUAK2 in cell survival has been analyzed in tumor cells resistant to Fas (CD95)-induced apoptosis.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Tumor cells resistant to Fas-induced apoptosis have also exhibited enhanced motility and invasiveness via activation of NFκB genes. NUAK2 is seen as one of the Fas-induced up-regulated genes, and its overexpression has protected cells from Fas-induced apoptosis in an NF-κB dependent fashion. Tumor cells lacking NUAK2 are more responsive to Fas apoptosis, and have displayed a reduced invasiveness capability and motility.<a onclick="showRef(event, 'ref26 ref74'); return false;" href="javascript:void(0);" class="ref ref26 ref74">(26,74)</a></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">3.6.  Maintaining Metabolic Homeostasis and Spliceosome Activity</h3><div class="NLM_p">Along with biological roles in cell senescence, proliferation, adhesion, invasion, and migration, NUAK1 promotes the survival of MYC-overexpressing cells and regulates metabolic homeostasis.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Particularly, NUAK1 is found in a synthetic lethality screening performed to search for genes for which the loss of function is lethal only in the existence of MYC-overexpression. Apart from the interesting finding that NUAK1 depletion results in cell death of MYC-overexpressing cells, the investigation confirms several past studies; for example, a cell cycle arrest in the synthesis phase (S-phase) upon NUAK1 depletion; however, most significantly, it reveals new roles in maintaining metabolic homeostasis. To be more precise, NUAK1 participates in controlling ATP levels via two main mechanisms: (i) inhibiting the mTOR complex 1 (mTORC1) pathway. Briefly, activating MYC enhances AMPK induction and reduces mTOR complex 1 activity. NUAK1 depletion, however, ablates the enhancement in AMPK potency, leading to an improvement of overall protein synthesis, perhaps attributed to the incapability of AMPK to restrain mTOR complex 1. Treatment with sirolimus (<i>aka</i>. Rapamycin, an acute inhibitor of mTOR complex 1) can prevent cell death by providing relief from metabolic stress caused by NUAK1 depletion, thus confirming that NUAK1 participates in cell survival by restraining mTOR complex 1 potency; (ii) promoting the expression of components of the mitochondrial respiratory chain (MRC). That is to say, NUAK1 sustains metabolic homeostasis by maintaining the MRC, as NUAK1 depletion significantly reduces the expression of multiple components of the ETC (electron transport chain). Moreover, a study of a tumor model involving the transplantation of HCC cells expressing MYC showed that the down-regulation of NUAK1 not only reduces the occurrence of tumor development but also increases mice survival compared with that of the NUAK1 wild-type (WT) counterpart.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Hence, the overall investigation suggests significant implications of NUAK1 in metabolism and proposes NUAK1 inhibition as a promising therapeutic and diagnostic target to treat cancer patients.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><div class="NLM_p">In a recent interesting study, the synthetic lethal interaction between MYC and NUAK1, and the role of Ca<sup>2+</sup> in supporting tumor cell viability have been investigated.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> More precisely, in cancer cells lacking STK11, NUAK1 potency is regulated by an alternate approach that involves Ca<sup>2+</sup>-dependent PKCα activation (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). Ca<sup>2+</sup>/PKCα-dependent activation of NUAK1 assists engagement of the TORC1-AMPK metabolic checkpoint, thus shielding tumor cells from MYC-based cell death, and indeed, MYC selects for increased Ca<sup>2+</sup> signaling in part by transcriptional regulation of ITPR and PKCα. Notably, calcium-dependent activation of the mTORC1-AMPK metabolic checkpoint demands both NUAK1 and PKCα, and hence, suppression of either drives pronounced HeLa cell apoptosis, thus revealing a positive function for this pathway in maintaining tumor.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Schematic illustration of calcium signaling relations MYC to NUAK1 and model depicting pre-mRNA splicing machinery. (A) Despite the lack of STK11, NUAK1 is active in HeLa cells. Like AMPK, basal activity of NUAK1 is regulated via tonic calcium signaling and activity enhances as a result of calcium mobilization. Opposite to AMPK, CamKK2 does not appear to regulate NUAK1, but rather PKCα participates in activation of NUAK1 in response to calcium signaling. Calcium-mediated activation of the mTORC1-AMPK metabolic checkpoint demands both NUAK1 and PKCα, and suppression of either leads to MYC-dependent cell death, suggesting a positive function for this pathway in maintaining tumor. (B) NUAK1 binds with PP1 and phosphorylates its targeting subunit PNUTS. Consequently, PNUTS, PP1, and NUAK1 develop a trimer that is associated with the splicing machinery. Inhibiting NUAK1 decreases activity of spliceosome and synthesis of nascent RNA. Inhibition of NUAK1 traps RNAPII at the exon–intron boundary when MYC is deregulated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Very recently, NUAK1 has been observed to be associated with the splicing machinery.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> That is to say, phosphatase 1 nuclear targeting subunit (PNUTS), a regulatory subunit of PP1, binds chromatin in part through its interaction with nascent RNA. Consequently, PNUTS comes under the contact of chromatin-linked NUAK1, and its interaction with nascent RNA is stabilized via NUAK1-based phosphorylation. This stabilization locally incapacitates PP1 potency toward spliceosomal proteins and permits activation of spliceosome (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). NUAK1 inhibition eliminates chromatin interaction of PNUTS, decreases activity of spliceosome, and suppresses synthesis of nascent RNA. Activating MYC does not circumvent the requirement for NUAK1 for activity of spliceosome but considerably attenuates transcription termination. As consequence, inhibition of NUAK1 in cells expressing high MYC levels induces global accumulation of RNA polymerase II (RNAPII) both at the first exon-intron boundary and at the pause site but does not enhance synthesis of mRNA, suggesting that inhibiting NUAK1 in the existence of deregulated MYC traps nonproductive RNAPII on account of the lack of properly gathered spliceosomes.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">3.7.  Actin Stress Fibers Remodeling</h3><div class="NLM_p">There are currently only two known proteins that physically interact with NUAK2. These proteins regulate the MLC phosphorylation cycle at the actin stress fibers (SFs) of smooth muscle cells. Alterations in the ATPase potency of MLC remodels the actin SFs changing contractility and motility of cells.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Enhanced MLC phosphorylation leads to high contraction of the actin bundles, followed by cell detachment and enhanced motility of cells.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> This phosphorylation is typically regulated by Rho kinases, which are serine/threonine-protein kinases that are activated by an upstream small GTPase, RhoA.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Myosin light-chain phosphatase (MLCP), which consist of a phosphatase catalytic subunit (PP1) and a phosphatase regulatory subunit (MYPT1), desphosphorylates MLC. The RhoA and MLCP are recruited to actin SFs by the myosin phosphatase Rho-interacting protein (MRIP).<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div><div class="NLM_p">MRIP also recruits NUAK2 to the same position.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> This interaction is demanded for NUAK2 to inhibit the function of the phosphatase regulatory subunit (MYPT1). The fact that existence of NUAK2 at the actin SFs, which prevents MLC dephosphorylation, is believed to be somewhat kinase-independent, as an inactive kinase mutant, NUAK2 has succeeded to inhibit the action of phosphatase.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Nonetheless, an independent investigation has also displayed that NUAK2 can directly bind and phosphorylate MYPT1,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> implying that NUAK2 may also inhibit the phosphatase in a kinase-dependent fashion. In a related study, the closely related NUAK1 has also been shown to physically interact with the catalytic subunit PP1 of the MLCP complex, where it inactivates the phosphatase by directly phosphorylating the Ser<sup>910</sup>, Ser<sup>472</sup>, and Ser<sup>445</sup> residues of MYPT1, and all distinct sites other than those commonly phosphorylated by ROCK (Thr<sup>853</sup> and Thr<sup>696</sup>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> MYPT1 phosphorylation recruits the phosphatase to scaffold 14-3-3 proteins which traps and keeps the phosphatase away from the actin SFs, and hence, avoids MLC dephosphorylation.<a onclick="showRef(event, 'ref14 ref79'); return false;" href="javascript:void(0);" class="ref ref14 ref79">(14,79)</a> These somewhat different models reveal that NUAKs may collaborate or have redundant functions at the actin SFs. In both cases, the existence of NUAKs at the actin SFs enhances cell motility, cell detachment, and turnover by keeping phosphorylated the MLC (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A).<a onclick="showRef(event, 'ref13 ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref13 ref79 ref80">(13,79,80)</a> On the same note, another investigation has displayed that NUAK2 overexpression in a human cancer cell line leads to acute cell–cell detachment when the cells are exposed to a glucose-free environment.<a onclick="showRef(event, 'ref26 ref81'); return false;" href="javascript:void(0);" class="ref ref26 ref81">(26,81)</a> Moreover, in a recent interesting study, it is shown that YAP/TAZ-based transcription is demanded to modulate cytoskeletal tension generation and enable persistent cell motility (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). This pathway is defined as a negative feedback system through which Rho-ROCK-myosin II activate TAZ and YAP, limiting activation of myosin II via expression of NUAK2.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Model of NUAK2 mechanism in the development of actin stress fibers and of the transcriptional negative feedback system that modulates intracellular tension. (A) Dotted arrows show phosphorylation occasion. Myosin heads are shown in light green, whereas actin filaments are shown in dark pink (MLC in dark green). NUAKs enhance the assembly of actin stress fibers by inhibiting MLC phosphatase complex composed of PP1 and MYPT1 subunits. NUAK2 inhibits the MLC phosphatase complex by direct MYPT1 phosphorylation, which is likely to be negative allosteric modulation for MRIP binding (designated by blunted arrow). Also, NUAK1 directly interacts with phosphorylate MYPT1 and PP1 species. MYPT1 phosphorylation by ROCK kinases or by NUAKs recruits 14-3-3 proteins, which keep the myosin phosphatase away from actin stress fibers, enhancing the formation of stress fibers. MRIP and MYPT1 are currently the only two identified protein–protein interactions with NUAK2. (B) ROCK activation of myosin II increases cytoskeletal tension, which causes TAZ and YAP localization. Active TAZ and YAP inhibit ROCK-based MLC phosphorylation through transcriptional control of NUAK2 and ARHGAP 29 and 28 expression, which in turn prevent overactivation of myosin II.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">3.8.  Axon Branching and Cortical Development</h3><div class="NLM_p last">Very recent data has emerged displaying that NUAK1 can have other roles in different tissues,for example, controlling axon branching by interfering with mitochondrial transport. In axons, the NUAK1-STK11 pathway maintains mitochondria immobilization, and NUAK1 and STK11 are essential and enough to immobilize the mitochondria, especially at sites of nascent presynaptic.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Furthermore, an interesting study indicated that NUAK1 is haplo-insufficient in mice with regard to its biological operation in the formation of cortical connectivity, and that loss-of-function mutations in NUAK1 contributes to the etiology of neurodevelopmental diseases.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> That is to say, it has been observed that inactivating one allele of the NUAK1 gene leads to a complex phenotype such as reduced terminal axon branching of cortico-cortical projections, defective axonal mitochondria trafficking, and growth retardation. Most importantly, NUAK1 heterozygosity reduces the prepulse inhibition of the acoustic startle reflex, modifies the preference for social novelty without influencing conspecific social preference, and results in disruption of numerous cognitive courses. Hence, NUAK1 haploinsufficiency results in defects in the formation of cortical connectivity and in a complex range of behavioral deficits.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">3.9.  Functions of NUAKs with Starvin/BAG3 in Autophagic Protein Turnover</h3><div class="NLM_p">In postmitotic cells, the inability to remove protein aggregates such as neurons or muscles is a cellular hallmark of aging cells and is a crucial element in the initiation and progression of protein-misfolding diseases. In a recent interesting study, a novel role of NUAKs with the Stv-Hsc70-4 complex in the autophagic protein clearance in muscle tissue has been reported. To be more precise, loss of NUAKs causes cellular degeneration attributed to the abnormal accumulation of certain proteins, including CryAB and filamin (Fil). NUAKs genetically and biochemically interact with <i>Drosophila</i> Starvin (Stv), the ortholog of mammalian Bcl-2-associated athanogene 3 (BAG3). Consistent with a known role for the cochaperone BAG3 and the heat shock cognate 71 kDa (Hsc70; <i>aka</i>. HSPA8) ATPase in the autophagic clearance of proteins, RNAi of <i>Drosophila</i> Stv, Hsc70-4, or autophagy-related 8a (Atg8a) all exhibit muscle degeneration and muscle contraction defects that phenocopy NUAK mutants (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Furthermore, Fil is a target of NUAKs kinase activity and abnormally accumulates upon loss of the BAG3-Hsc70-4 complex.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> Additionally, Atg8a, ref(2)p/p62, and ubiquitin (Ub) are enhanced in regions of protein aggregation, consistent with a block in autophagy upon knocking out NUAKs.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Model showing NUAKs as a key regulator of protein degradation. (A) Autophagic protein clearance of filamin (Fil) in <i>WT</i> muscle tissue. NUAK phosphorylates Fil either for incorporation into the Z-disc (i) or/and upon protein damage owing to unfolding and folding of the protein (ii). CryAB (alpha B-crystallin) is generally bound to Fil at the Z-disc and the Stv-Hsc70-4 protein complex detects damaged Fil protein. The addition of lysine-63 (K63)-linked polyubiquitin chains on Fil recruits sequestosome 1 (SQSTM1; <i>aka</i>. p62) and autophagy-related 8a (Atg8a) for autophagosome biogenesis. Autophagosomes fuse with lysosomes to form the autolyosome for eventual protein degradation. (B) Fil phosphorylation is lost in <i>NUAK–/–</i>. Unincorporated and/or damaged Fil protein at the Z-disc bound to CryAB. Atg8a, p62, and PolyUb proteins are still recruited to CryAB-Fil complexes. The absence of lysosomes in regions of protein accumulation prevents autophagic protein clearance.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">4.  Clinical Applications of Inhibiting NUAK Isoforms and Further Discussion on the Association of NUAK Isoforms with Diseases</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02782" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02782" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">NUAK isoforms (<i>aka</i>. NUAKs) control numerous processes such as embryonic development,<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> cell adhesion,<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> cell division,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> cell proliferation, replicative senescence and ploidy,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> cell migration and invasion,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> neuronal polarity and axon branching,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> actin SFs remodeling, metabolic homeostasis, survival of MYC-overexpressing cells,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> muscle growth and myosin organization,<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> glycogen synthesis and carbohydrate metabolism,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and TAU stability.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Therefore, abnormal functioning of NUAKs has been causally linked to numerous disorders. Summarily, NUAK isoforms have been connected with tumor cell survival, metastasis, and invasion, and poor prognosis in numerous tumors, including NSCLC,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> melanoma,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> breast, glioma,<a onclick="showRef(event, 'ref20 ref40'); return false;" href="javascript:void(0);" class="ref ref20 ref40">(20,40)</a> and hepatocellular carcinoma (HCC).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> In human cancer, NUAK1 gene alteration frequency is comparatively less than most AMPK subunits.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> More precisely, in 164 investigations (45709 samples) conducted, its highest alteration frequency was 18% in neuroendocrine prostate cancer (NEPC). According to <a href="http://cbioportal.org" class="extLink">cbioportal.org</a>, its alteration frequency was less than 7% in all other cancers. Nonetheless, compared with that of the nontumor tissue, immunohistochemistry (IHC) of the human tissue displayed high levels of NUAK1 expression in HCC (66% of patient samples), pancreatic cancer (57%), and colon cancer (38%).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> It has been observed that NUAK1 expression is much higher in liver metastasis and enlarged in more advanced cases of colorectal cancer (CRC).<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Further, NUAK1 has been associated with numerous tumorigenic functions; for example, promotion of tumor cell invasion and metastasis by enhancing the expression of matrixins (MT1-MMP, MMP-9, and MMP-2) downstream of protein kinase B (PKB).<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Matrixins perform a crucial part in degrading the basement membrane and extracellular matrix (ECM), and therefore, enhance angiogenesis and metastasis in various cancer types.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Accordingly, fixing NUAKs can result in treatment of numerous diseases, which is discussed in detail in this section.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">4.1.  Alzheimer’s Disease and Dementia</h3><div class="NLM_p last">Common neurodegenerative disorders, such as dementia, Alzheimer’s, and Parkinson’s, partially result from unusual accumulation of various proteins in the brain. When certain proteins accumulate in the brain, they become toxic, making the brain susceptible to degeneration. TAU is a protein associated with dementia and Alzheimer’s disease. Hence, taking a drug that stops TAU collection in the brain can assist in delaying or preventing Alzheimer’s. To reduce or prevent TAU collection in the brain, Zoghbi and co-workers inhibited about 600 kinases, one after another.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> An investigation reveals that inhibiting NUAK1 reduces TAU levels. That is to say, NUAK1 stabilizes TAU through phosphorylation, precisely at Ser<sup>356</sup>. In fruit flies, NUAK1 inhibition suppresses neurodegeneration in TAU-expressing <i>Drosophila melanogaster</i>, and the phenotypes of a tauopathy mouse model are haploinsufficiency rescued by NUAK1. Overall, reducing the total TAU levels is an effective approach for mitigating TAU-mediated neurodegeneration, and it reveals NUAK1 as a unique target for treating neurodegenerative diseases.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">4.2.  Ovarian Cancer</h3><div class="NLM_p last">Ovarian cancer, which is common in older women, occurs when an uncontrollable increase in abnormal cells produces a tumor in the female’s reproductive system that forms an ovum. Wang and co-workers investigated NUAK1’s function in ovarian cancer and adjacent normal tissues and observed that it is up-regulated in ovarian cancer tissues compared with that in normal matched tissues.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> It promotes epithelial-mesenchymal transition (EMT) and inhibits microRNA 1181 expression in ovarian cancer cells. Further, in ovarian cancer cells, microRNA 1181 promotes mesenchymal-epithelial transition (MET) and degrades homeobox A10 via targeting its three prime untranslated region (3′-UTR). Therefore, homeobox A10 promotes EMT in ovarian cancer cells, and activation of the NUAK1/microRNA 1181/homeobox A10 axis can be connected with EMT in ovarian cancer. Similarly, Kusakai and co-workers investigated NUAK1’s function in ovarian cancer progression, invasion, and metastasis by using human colon cancer cell lines (SW480, LoVo, SW620, HCT-15, DLD-1, and WiDr) and samples of clinical colon cancers.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> High NUAK1 expression was detected, and a considerable high expression was identified in the liver metastasis. Additionally, in tumor cells, <i>in situ</i> hybridization examination displayed NUAK1 overexpression. Therefore, the PKB-NUAK1 pathway plays a crucial role in ovarian cancer development.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">4.3.  Lung Cancer</h3><div class="NLM_p last">Lung cancer causes controllable multiplication of cells in the lungs. Chen and co-workers investigated NUAK1’s function in the invasion and migration of human NSCLC cell lines.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The study revealed that NUAK1 expression is associated with the stage and differentiation of the carcinoma, along with lymph node metastases. That is to say, inhibiting NUAK1 expression through small interfering RNA (siRNA) severely impairs invasion and migration in A549 cell lines. In addition, NUAK1 knock-down suppresses the expression of MMP-9 and MMP-2 and the activation of nuclear factor kappa B (NF-κB), which can control the transcription of MMP-9 and MMP-2. Accordingly, in a xenograft mouse model of NSCLCs, NUAK1 knock-down decreases lung metastasis, suggesting that NUAK1 plays a vital function in NSCLC cell invasion and migration. Likewise, Li and co-workers studied NUAK1’s function in NSCLC cells and observed that A549 cell lines, which demonstrate small NUAK1 expression levels, are more sensitive to cisplatin than NCI-H1229 cell lines, which demonstrate large NUAK1 expression levels.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Further, NUAK1 knock-down increases the sensitivity of NSCLC cells to cisplatin, and NUAK1 assists EMT in NSCLC cells. Therefore, NUAK1 activation can be clearly linked with EMT in NSCLC cells, revealing that NUAK1 is a promising drug target for regulating EMT in NSCLC cells and combating drug resistance. Similarly, B. Zhang and co-workers observed that NUAK1 is extremely expressed in NSCLC cells and performs a significant role in NSCLC invasion.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Moreover, in NSCLC, the miR204 serves as a tumor suppressor by inhibiting NUAK1 expression. Therefore, both miR204 and NUAK1 can act as promising targets for NSCLC treatment.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">4.4.  HCC</h3><div class="NLM_p">In adults, the most common kind of primary liver cancer is HCC. Xu and co-worker proved that NUAKs are an independent prognostic aspect for overall survival in HCC patients.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> That is to say, both NUAK1 and mRNA protein expression levels in HCC tissues are considerably greater than those in noncancerous (benign) tissues, and the higher NUAK1 expression in HCC is linked with tumor stage, histological differentiation, and tumor size. Further, a higher NUAK1 expression in HCC results in a considerably poor prognosis of patients with HCC. Therefore, NUAK1 can be employed as a unique biomarker and a promising therapeutic target for HCC. Similarly, Liang and co-workers showed that NUAK1 performs a key function in doxorubicin <b>1</b> resistance in HCC patient under both hypoxia and normoxia conditions, thus revealing that NUAK1 can be employed as a unique target for resolving HCC chemo-resistance (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Chemical structures of doxorubicin and ON-123300.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">4.5.  Glioma</h3><div class="NLM_p last">A glioma is a kind of tumor that begins in the spine or the neuroglia (<i>aka</i>. glial cells or glia) of the brain. Zhang and co-workers have disclosed that NUAKs are overexpressed in glioma cell lines and stimulate invasion of glioma cells by regulating matrix metalloproteinase activation and cytoskeleton rearrangement.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In a glioma xenograft mouse model, NUAK1 knock-down was observed to diminish brain invasion, suggesting that NUAK1 has a unique role in bridging two key pathways, viz., LIMK/cofilin and PKB, in glioma tumor cell invasion, as well as in the regulation of cytoskeleton rearrangement. Hence, NUAK1 can be employed as a molecular target for the formation of potent glioma invasion therapy, and as a useful and novel prognostic marker for gliomas.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">4.6.  Melanoma</h3><div class="NLM_p last">One important type of skin cancer is melanoma (<i>aka.</i> malignant melanoma) which starts in the cells (melanocytes) that regulate skin pigment. Levy and co-workers studied the function of miRNA-211 in the treatment of melanoma invasion by disruption of cell–cell adhesion.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The investigation revealed that miRNA-211 contributes to melanoma adhesion by directly targeting NUAK1. Inhibiting miRNA-211 decreases melanoma adhesion and enhances NUAK1 expression, while up-regulating miRNA-211 restores melanoma adhesion via repression of NUAK1. Hence, miRNA-211 has a vital function in the microphthalmos-related transcription factor (MITF)-based phenotypic plasticity of malignant melanoma, and NUAK1 is a promising target for melanoma treatment.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">4.7.  Breast Cancer</h3><div class="NLM_p last">Breast cancer is a disorder in which cells in the breast multiply in an uncontrolled fashion. Chang and co-workers used human breast cancer cell lines to study NUAK1’s function in the metastasis and invasion of cancer.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The investigation revealed that NUAK1 enhances the metastatic and invasive potential of MDA-MB-231 cell lines under PKB regulation. The enhancement is linked with growing MT1-MMP, MMP-9, and MMP-2 expression. Moreover, an <i>in vivo</i> investigation revealed that NUAK1-transfected breast cancer cells grow faster and have higher pulmonary metastasis than its parental counterparts.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24">4.8.  Pancreatic Cancer</h3><div class="NLM_p last">Pancreatic cancer involves the development of malignant (cancerous) cells in the pancreas tissues. Huang and co-workers described that NUAK1 expression is particularly up-regulated in pancreatic cancer, and that it stimulates the invasion, migration, and proliferation of MIA-Pa-Ca-2 pancreatic cancer cell lines by directly targeting NUAK1.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> NUAK1 also stimulates the tumorigenesis, metastasis, and invasion, and suppresses the necrosis of PANC-1 human pancreatic cancer cell lines.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Therefore, NUAK1, as an oncogene, can be a useful target therapy for pancreatic cancer treatment.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">4.9.  Intrahepatic Cholangiocarcinoma</h3><div class="NLM_p last">Intrahepatic cholangiocarcinoma (ICC) originates in the cells inside the bile ducts; both outside and inside the liver. Cheng and co-workers examined NUAK1’s function by assessing microRNA-145 in ICC.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> The Investigation revealed that the level of microRNA-145 is considerably reduced in ICC cell lines and tissue, which is linked with an increment in NUAK1 expression. Precisely, NUAK1 is observed to be a direct target of microRNA-145 regulation, and accordingly, the overexpression of microRNA-145 in ICC cells inhibits invasion, growth, and proliferation via suppressing NUAK1 expression, which is directly linked with a decrease in matrix metalloproteinase (MMP) protein expression and PKB signaling. Further, microRNA-145 behaves as a tumor suppressor by directly controlling NUAK1 expression, which modulates MMP expression as well as PKB/FOXO1 signaling, thus inhibiting progression of ICC. Overall, microRNA-145 can be valuable for targeted therapy and clinical diagnosis of ICC.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26">4.10.  Head and Neck Squamous Cell Carcinoma</h3><div class="NLM_p last">Head and neck squamous cell carcinoma (HNSCC) is a collection of tumors arising in the larynx, oropharynx, and oral cavity, respectively. It has a large capability for invasion. Obayashi and co-workers studied the function of microRNA-203 in invasion and EMT induction in HNSCC.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> It was revealed that microRNA-203 is down-regulated during EMT induction, and ectopic overexpression of microRNA-203 suppresses the invasion and induces MET in HNSCC cell lines. Interestingly, NUAK1 was found to be a potent target gene of microRNA-203 by cyclopedic examination using antiargonaute-2 antibody. Enlarged NUAK1 expression is found during EMT induction, whereas the ectopic expression of microRNA-203 delays EMT induction by suppressing NUAK1 expression. Furthermore, NUAK1 overexpression promotes the invasion of HNSCC cell lines. Notably, NUAK1 expression is strongly associated with lymph node metastasis, poor differentiation, and aggressive invasion patterns. Briefly, microRNA-203 has a tumor-suppressing function in invasion and EMT induction by targeting NUAK1 in HNSCC, thus revealing microRNA-203 as a promising therapeutic and diagnostic target for treating HNSCC patients.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27">4.11.  Multiple Myeloma</h3><div class="NLM_p last">Multiple myeloma (MM), <i>aka</i>. plasma cell myeloma, is a tumor of plasma cells, a kind of white blood cell which generally forms antibodies. Parekh and co-workers disclosed a novel regulatory mechanism for regulating MM with immediate translational relevance by employing small organic NUAK1 inhibitor.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> That is to say, selective NUAK1 inhibition is observed to be a useful approach to target cellular proliferation in MM. In other words, ON-123300 <b>2</b>, a dual NUAK1/CDK4 inhibitor, is found to have specific and potent antimyeloma activity, whose inhibiting NUAK1 potency is lethal in MM cell lines <i>in vivo</i> and <i>in vitro</i>, whereas sparing normal healthy B-cell lines (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). Also, NUAK1-specific siRNAs or ON-123300-based NUAK1 inhibition results in up-regulation of the AMPK kinase cascade and inhibition of the mTOR/S6K pathway. AMPK up-regulation results in destabilization of steady-state MYC protein and enhanced SIRT1 levels.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28">4.12.  Nasopharyngeal Carcinoma</h3><div class="NLM_p last">Nasopharyngeal carcinoma (NPC), commonly known as nasopharyngeal cancer, is a tumor in which malignant (cancerous) cells develop in the tissues of the nasopharynx. Liu and Lan investigated how lncRNA SNHG1 (long noncoding RNA small nucleolar RNA host gene 1) affects the aggressiveness of NPC cell lines.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> The investigation revealed that SNHG1 increases NUAK1 expression, negatively regulates microRNA-145–5p expression, and promotes NPC cell migration and invasion, thus revealing that the SNHG1/microRNA-145-5p/NUAK1 axis plays a vital part in nasopharyngeal cancer, and therefore, can act as a significant target for NPC therapy. Likewise, Xu and co-workers also found excessively high NUAK1 expression in NPC tissues at mRNA levels.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Statistical examination reveals that NUAK1 expression is associated with WHO histological type and maximum neck lymph node diameter. Further, there is clinical correlation between NUAK1 up-regulation in NPC and DFS. Also, the NUAK1 expression is highly correlated with DFS and OS in patients with late-stage tumor.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29">4.13.  Bladder Cancer (BC)</h3><div class="NLM_p last">BC is a cancer arising from the tissues of the urinary bladder. Wang and co-workers disclosed that SNHG-6 overexpression induces EMT and promotes the invasion and migration abilities of BC cell lines.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Alternatively, SNHG-6 induces EMT of BC cell lines by up-regulating Snail1/2 expression levels, and it regulates BC cell invasion and migration via tumor suppressive human hsa-miR-125b-5p and its target gene NUAK1. Furthermore, SNHG-6 is negatively associated with human hsa-miR-125b-5p expression and positively associated with Snail1/2 expression in BC specimens. Briefly, SNHG-6 promotes BC cell invasion and migration partly via the human hsa-miR-125b-5p/Snail1/2/NUAK1 pathway. Hence, SNHG-6 can be a promising biomarker in BC, and targeting human hsa-miR-125b-5p/Snail1/2/NUAK1 axis can be a potential therapeutic method for patients with BC.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30">4.14.  Gastric Cancer</h3><div class="NLM_p last">Gastric cancer (GC), <i>aka</i>. stomach cancer, is cancer that begins from the lining of the stomach. Liu and co-workers explored the involvement of NUAK1 in GC metastasis and invasion, using nude mice, human GC cell lines, and clinical samples of patients.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> The study revealed that NUAK1 expression is enhanced and positively associated with poor prognosis in GC patients, EMT-related markers, and metastasis. Precisely, knock-down of NUAK1 expression highly suppresses GC cells metastasis and invasion by controlling EMT, instead of proliferation <i>in vivo</i> and <i>in vitro</i>. Knock-down of NUAK1 expression in GC cell lines leads to down-regulation of the mTOR/phospho-p70S6K signals, SIP1, and Slug. In the same context, Ye and co-workers investigated the prognostic value of NUAK1 protein in GC and found that the up-regulated expression of NUAK1 protein is an interpreter of various aggressive tumor behaviors; for example, postoperational recurrence and advanced clinical stage in patients with stomach cancer.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> Consequently, large NUAK1 expression identifies patients at high risk. Therefore, NUAK1 can be promising therapeutic target for patients with GC.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31">4.15.  Colorectal Cancer</h3><div class="NLM_p last">Colorectal cancer (CRC), i.e., colon cancer, bowel cancer, or rectal cancer, involves cancer formation in the rectum or colon. Port and co-workers showed that NUAK1 is overexpressed in human CRC and that high expression of NUAK1 is associated with decreased overall survival.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Further, NUAK1 is desired for both maintenance and initiation of autochthonous colorectal tumors, and it assists nuclear translocation of the antioxidant master regulator nuclear factor erythroid 2-type factor-2 (NRF2). Thus, inhibition or depletion of NUAK1 renders human CRC cell lines and murine CR tumors susceptible to oxidative stress-induced cell death, thus suggesting that transient NUAK1 inhibition can deliver an effective and safe means to cure human CRC via disruption of intrinsic antioxidant defenses. Kusakai and co-workers also studied NUAK1’s function in the metastasis, invasion, and progression of CRC by using human CRC cell lines (SW480, LoVo, SW620, HCT-15, DLD-1, and WiDr) and samples of clinical CRC and their metastasis. They revealed that the PKB-NUAK1 pathway performs significant roles in the progression of CRC.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32">4.16.  Omphalocele (Exomphalos)</h3><div class="NLM_p last">Efforts to recognize novel genes involved in mouse brain development resulted in the formation of a global NUAK1 knockout, which was then named omphalocele kinase 1 (OMPHK1), owing to the phenotype generated by the gene deletion.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The main phenotype is in the ventral body wall (VBW), in spite of the interest in the gene attributed to its expression in the brain. The knockout was produced by introducing the <i>lacZ</i> gene after the translation initiation site to examine the expression by <i>βgal</i> staining, and it was verified by RT-PCR. No live NUAK1 knockout embryos were born, and the embryos displayed an exomphalos phenotype by embryonic day (ED) 14.5, displaying it far more noticeably by day 18.5.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> NUAK1 was expressed in both abdominal and sternal bands; however, the former failed to fuse appropriately across the central abdomen. Before embryonic day 12.5, the knockout embryos were normal, and the region taken by the primary body wall expresses NUAK1.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Pathways involved in mediating this phenotype were not investigated, and numerous screening analysis previously showed that other kinases are expressed in the VBW.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> An exomphalos phenotype is a defect in the abdominal wall, in which a defect in the closure of the abdominal wall causes several internal organs to remain outside the abdomen, covered by a membrane. These types of malformations are one of the foremost kinds of physical birth defects in human and exist in almost one in every 4000–2000 live births.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Humans have a high percentage of mortality (i.e., around 25%) and usually other related pathologies; for example, neural tube defects. Chromosomal abnormalities have been noticed in a small number of human cases; however, the precise pathways involved in this phenotype are unclear.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Certain cases have been associated with trisomy 13<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> and trisomy 18.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> NUAK1 is situated on human chromosome 12, and hence, it is unlikely that the exomphalos phenotype has the similar underlying reason that generates the effect in NUAK1 knockout mouse. Recent studies on mouse knockouts have also presented certain evidence about the pathways involved, as the following transgenic models all show VBW defects: ROCK-I/ROCK-II double knockout,<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Mab21l2,<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Tgfβ2/β3 double mutant,<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Hoxb2/b4 double mutant,<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> and AP-2α.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Some recent reports have also outlined that mouse global knockout of NUAK1 and NUAK2 shows the same embryonic lethality attributed to spina bifida, facial clefting, and exencephaly, as well as failure of the VBW to close. The investigation has shown an alternation in the accumulation of several cytoskeletal components, including phosphorylated F-actin, MLC, and cortactin in the forming neural plate, demonstrating possible downstream targets.<a onclick="showRef(event, 'ref16 ref32'); return false;" href="javascript:void(0);" class="ref ref16 ref32">(16,32)</a></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">5.  Inhibiting NUAK Isoforms</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47002" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47002" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34">5.1.  NUAK Isoforms in Disease and Importance of NUAK Isoform Inhibition</h3><div class="NLM_p">Alterations in NUAK isoforms have been causally connected to diverse pathological disorders, especially infectious disorders, Alzheimer’s disease, and tumors and multiple cancers, including HCC,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> glioma, breast,<a onclick="showRef(event, 'ref20 ref40'); return false;" href="javascript:void(0);" class="ref ref20 ref40">(20,40)</a> melanoma,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> colorectal,<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> ovarian,<a onclick="showRef(event, 'ref110 ref111 ref112'); return false;" href="javascript:void(0);" class="ref ref110 ref111 ref112">(110−112)</a> and NSCLC,<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> among others.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Therefore, NUAK isoforms have shown very promising prospects for targeted treatment using inhibitors. Furthermore, in many ways, NUAK isoforms are ideal targets for cancer drug development. They have a well-defined ATP-binding pocket where small molecules can tightly bind and are amenable for crystal structures with bound inhibitors, which makes inhibition/binding assays relatively easy to perform. For these reasons and others, most therapeutic kinase inhibitors have been developed using target-based approaches.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> However, developing NUAK inhibitor-based cancer drugs with target-based screening has its own challenges and limitations. First, the biochemical assays of a target may not accurately model the target’s behavior in the cell, where the presence of cofactors or post-translational modifications can affect inhibitor binding.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> In addition, many of these biochemical assays only use a single domain of multidomain complexes owing to the difficulty involved in purifying many full-length proteins. In the case of kinase biochemical assays, usually, only the kinase domain is used despite the fact that many kinases possess autoregulatory domains.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> However, in recent years, numerous breakthroughs have been achieved in the discovery of small molecules as highly potent inhibitors of NUAK isoforms (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). This section will highlight the recent progress in the formation of NUAKs inhibitors.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitors Showing NUAK1 (ARK5) and NUAK2 (SNARK) Activities</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">inhibitor name</th><th class="colsep0 rowsep0" align="center">primary targets</th><th class="colsep0 rowsep0" align="center">major off-target effects</th><th class="colsep0 rowsep0" align="center">string value IC<sub>50</sub><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ON-123300 <b>2</b><a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NUAK1 and CDK4</td><td class="colsep0 rowsep0" align="left">CDK6, FLT3, and FYN</td><td class="colsep0 rowsep0" align="left">4.95 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref55 ref124'); return false;" href="javascript:void(0);" class="ref ref55 ref124">(55,124)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">XMD-1842 <b>3</b><a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NUAK1</td><td class="colsep0 rowsep0" align="left">Aurora A/B and NUAK2</td><td class="colsep0 rowsep0" align="left">30 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref10 ref116'); return false;" href="javascript:void(0);" class="ref ref10 ref116">(10,116)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">XMD-1883 <b>4</b><a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NUAK1</td><td class="colsep0 rowsep0" align="left">ABL, DDR2, Lck, CLK2, Src, and JAK2</td><td class="colsep0 rowsep0" align="left">17 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HTH-010015 <b>5</b><a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NUAK1 and NUAK2</td><td class="colsep0 rowsep0" align="left">no major off-targets found</td><td class="colsep0 rowsep0" align="left">100 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LRRK2in1 <b>6</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">LRRK2</td><td class="colsep0 rowsep0" align="left">CHEK2 and NUAK1</td><td class="colsep0 rowsep0" align="left">47% at 10 μM conc.<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a>; 3.67 μM<a class="ref internalNav" href="#t1fn10" aria-label="j">j</a>; 5 μM<a class="ref internalNav" href="#t1fn11" aria-label="k">k</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JWE-071 <b>7</b><a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NUAK1</td><td class="colsep0 rowsep0" align="left">ABL, Aurora A, Src, JAK2 and amidst</td><td class="colsep0 rowsep0" align="left">6 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">XMD-17-51 <b>8</b><a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NUAK1</td><td class="colsep0 rowsep0" align="left">Aurora A & B, Src, JAK2 and ABL</td><td class="colsep0 rowsep0" align="left">1.5 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DLW-01-125-01 <b>9</b><a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NUAK1</td><td class="colsep0 rowsep0" align="left">Aurora A & B, FGFR and Src, ABL</td><td class="colsep0 rowsep0" align="left">7 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DLW-01-122-01 <b>10</b><a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NUAK1 and Aurora A & B</td><td class="colsep0 rowsep0" align="left">NUAK2</td><td class="colsep0 rowsep0" align="left">15 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT199665 <b>11</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">SIK isoforms</td><td class="colsep0 rowsep0" align="left">NUAK and MARK isoforms</td><td class="colsep0 rowsep0" align="left">3 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a>, 120 nM<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">WZ4074 <b>12</b><a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NUAK1</td><td class="colsep0 rowsep0" align="left">BTK, HER4, and MLK isoforms</td><td class="colsep0 rowsep0" align="left">33 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TPX-0005 (<i>aka</i>. Repotrectinib) <b>13</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">ROS1, RTKA, TRKB, TRKC, and JAK2</td><td class="colsep0 rowsep0" align="left">ALK and NUAK1</td><td class="colsep0 rowsep0" align="left">3.70 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BAY-880 <b>14</b><a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NUAK1</td><td class="colsep0 rowsep0" align="left">no off-targets reported</td><td class="colsep0 rowsep0" align="left">96% at 1 μM conc.<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRX6313 (<i>aka</i>. UNC2025) <b>15</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">MER and FLT3</td><td class="colsep0 rowsep0" align="left">TYRO3, AXL, TRKA, NUAK1, TRKC, QIK, and SIK</td><td class="colsep0 rowsep0" align="left">7.97 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BI-885578 <b>16</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">IGF-1R and InsR</td><td class="colsep0 rowsep0" align="left">CLK2, FER, IRAK1, PRKCN, FES, PTK2, and NUAK1</td><td class="colsep0 rowsep0" align="left">0.411 μM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HTH-02-006 <b>17</b><a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NUAK2</td><td class="colsep0 rowsep0" align="left">NUAK1</td><td class="colsep0 rowsep0" align="left">126 nM<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">WZ4003 <b>18</b><a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NUAK1 and NUAK2</td><td class="colsep0 rowsep0" align="left">no major off-targets found</td><td class="colsep0 rowsep0" align="left">20 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a>, 100 nM<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HMSL10085 <b>19</b><a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NUAK1</td><td class="colsep0 rowsep0" align="left">IGFR, BTK, and HER4. HMSL10085</td><td class="colsep0 rowsep0" align="left">25 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BAY-1000394 <b>20</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">CDKs</td><td class="colsep0 rowsep0" align="left">FLT4, NUAK1, Mst2, MLK1, JAK2, ARK1, and CDK4</td><td class="colsep0 rowsep0" align="left"><10 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BX-795 <b>21</b><a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NUAK1</td><td class="colsep0 rowsep0" align="left">MARK isoforms, JAK2, GCK and CDK2</td><td class="colsep0 rowsep0" align="left">5 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT67307 <b>22</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">IKKε and TBK1, ULK1, and ULK2</td><td class="colsep0 rowsep0" align="left">MARK, NUAK, and SIK isoforms</td><td class="colsep0 rowsep0" align="left">230 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a>, 2600 nM<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SJB4-115 <b>23</b><a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NUAK1</td><td class="colsep0 rowsep0" align="left">JAK2, SIK2, ULK1, Lck, Src, TrkA, and ERK8</td><td class="colsep0 rowsep0" align="left">67 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Fedratinib (<i>aka</i>. SAR302503, TG101348) <b>24</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">JAK2, FLT3, and RET</td><td class="colsep0 rowsep0" align="left">TSF1, DAPK3, ACV-R1, FGF-R1 V561M, MUSK, FAK, ACK1, and NUAK1</td><td class="colsep0 rowsep0" align="left">50%<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a> and 53%<a class="ref internalNav" href="#t1fn12" aria-label="l">l</a> at 1 μM conc.</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cerdulatinib <b>25</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">JAK, SYK, and TYK2</td><td class="colsep0 rowsep0" align="left">NUAK1 and MST1</td><td class="colsep0 rowsep0" align="left">4.00 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref129 ref130">(129,130)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NVP-TAE684 <b>26</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">NPM-ALK</td><td class="colsep0 rowsep0" align="left">PLK4, BMPR1B, NUAK isoforms, PYK2, and FER</td><td class="colsep0 rowsep0" align="left">13 nM<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a>, 1.2 nM<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CEP-28122 <b>27</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">ALK</td><td class="colsep0 rowsep0" align="left">NUAK1, Rsk2, Rsk3, and Rsk4</td><td class="colsep0 rowsep0" align="left">26 ± 3.00 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Brigatinib (<i>AP26113</i>) <b>28</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">ALK, EGFR, FLT3, IGF-1R, and ROS1</td><td class="colsep0 rowsep0" align="left">FER, FLT3, FES, FAK, BRK, CHK2, and NUAK1</td><td class="colsep0 rowsep0" align="left">47 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">indolinone <b>29</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">MELK</td><td class="colsep0 rowsep0" align="left">AMPK, NUAK1, CHK1, CAMKK2, and ERK2</td><td class="colsep0 rowsep0" align="left">8.60 ± 1.60 nM<a class="ref internalNav" href="#t1fn13" aria-label="m">m</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">indolinone <b>30</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">MELK</td><td class="colsep0 rowsep0" align="left">AMPK, NUAK1, CHK1, CAMKK2, and ERK2</td><td class="colsep0 rowsep0" align="left">11 ± 0.860 nM<a class="ref internalNav" href="#t1fn13" aria-label="m">m</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">indolinone <b>31</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">MELK</td><td class="colsep0 rowsep0" align="left">AMPK, NUAK1, CHK1, CAMKK2, and ERK2</td><td class="colsep0 rowsep0" align="left">1.70 ± 0.170 nM<a class="ref internalNav" href="#t1fn13" aria-label="m">m</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Sunitinib <b>32</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">RTKs</td><td class="colsep0 rowsep0" align="left">FLT3, FLT3-ITD, FLT3-Asp835, and NUAK1</td><td class="colsep0 rowsep0" align="left">48 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref115 ref136'); return false;" href="javascript:void(0);" class="ref ref115 ref136">(115,136)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">indole <b>33</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">Aurora B</td><td class="colsep0 rowsep0" align="left">NUAK1, TrKA, TAK1, and Gck</td><td class="colsep0 rowsep0" align="left">1.40 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TAK-901 <b>34</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">Aurora A/B, JAK3 and c-SRC</td><td class="colsep0 rowsep0" align="left">CLK2, FGR, LRRK2, FLT3, FYN, ARG, AXL, HCK, and NUAK1</td><td class="colsep0 rowsep0" align="left">9.1 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">benzo[e]pyridoindolone <b>35</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">AURKs</td><td class="colsep0 rowsep0" align="left">NUAK1, SIK2 and MELK</td><td class="colsep0 rowsep0" align="left">4.80 ± 0.4 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A7 <b>36</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">CK2 and CDK2</td><td class="colsep0 rowsep0" align="left">Aurora A, Rock II and NUAK1</td><td class="colsep0 rowsep0" align="left">27%<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a><sup>,</sup><a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A22 <b>37</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">MKK1, HIPK isoforms, CDK isoforms, and PDK1</td><td class="colsep0 rowsep0" align="left">MKK1, GSK3b, and NUAK1</td><td class="colsep0 rowsep0" align="left">16%<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a><sup>,</sup><a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A27 <b>38</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">Nek2A and NUAK1</td><td class="colsep0 rowsep0" align="left">not reported</td><td class="colsep0 rowsep0" align="left">49%<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a><sup>,</sup><a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A26 <b>39</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">CDK2 and NUAK1</td><td class="colsep0 rowsep0" align="left">not reported</td><td class="colsep0 rowsep0" align="left">24%<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a><sup>,</sup><a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">prexasertib <b>40</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">CHK1 and CHK2</td><td class="colsep0 rowsep0" align="left">RSK1, MELK, SIK, BRSK2 and NUAK1</td><td class="colsep0 rowsep0" align="left">64 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AZ-SHN-722 <b>41</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">TrkA</td><td class="colsep0 rowsep0" align="left">MST2, NUAK1, and Aurora A</td><td class="colsep0 rowsep0" align="left">34.9 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AZ960 <b>42</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">JAK2</td><td class="colsep0 rowsep0" align="left">TrkA, Aurora-A, and NUAK1</td><td class="colsep0 rowsep0" align="left">35% at 0.01 μm conc.<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">imidazole <b>43</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">JAK isoforms and Tyk2</td><td class="colsep0 rowsep0" align="left">NUAK1 and BRSK1</td><td class="colsep0 rowsep0" align="left">2.00 nM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSK461364 <b>44</b><a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">PLK1</td><td class="colsep0 rowsep0" align="left">NUAK2 and LOK</td><td class="colsep0 rowsep0" align="left">23 nM<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> for NUAK1.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last"><i>K</i><sub>d</sub> for NUAK1.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> for NUAK2.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last"><i>K</i><sub>d</sub> for NUAK2.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Based on <i>in vitro</i> and/or <i>in vivo</i> phosphorylation data.</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">Percentage of residual kinase activity of NUAK1 at a specific concentration relative to control.</p></div><div class="footnote" id="t1fn7"><sup><sup>g</sup></sup><p class="last">According to original publication, the % value of around 50 corresponds to an IC<sub>50</sub> of 10 μM.</p></div><div class="footnote" id="t1fn8"><sup><sup>h</sup></sup><p class="last">The compound being described is found in a screen against the NUAKs.</p></div><div class="footnote" id="t1fn9"><sup><sup>i</sup></sup><p class="last">The compound being described is found to inhibit the NUAKs as off targets from a different kinase inhibitor.</p></div><div class="footnote" id="t1fn10"><sup><sup>j</sup></sup><p class="last">Biochemical NUAK1 assay IC<sub>50</sub> (Invitrogen).</p></div><div class="footnote" id="t1fn11"><sup><sup>k</sup></sup><p class="last">Biochemical NUAK1 assay IC<sub>50</sub> (Dundee).</p></div><div class="footnote" id="t1fn12"><sup><sup>l</sup></sup><p class="last">Percentage of residual kinase activity of NUAK2.</p></div><div class="footnote" id="t1fn13"><sup><sup>m</sup></sup><p class="last"><i>K</i><sub>i</sub> for NUAK1.</p></div></div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36">5.2.  Small Molecules as Inhibitors of NUAK Isoforms</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37">5.2.1.  Seven-Membered Ring Fused Pyrimidine Derivatives as Inhibitors of NUAK Isoforms</h4><div class="NLM_p">XMD-1842 <b>3</b> exhibits high activity for NUAK1 <i>in vitro</i> with an IC<sub>50</sub> value of 30 nM, whereas NUAK1 [A195T] mutant is 50-fold more resistant toward it. Further, in HEK293 cells, it is found to inhibit Ser<sup>445</sup> phosphorylation on MYPT1 with an IC<sub>50</sub> value of 10 μM.<a onclick="showRef(event, 'ref10 ref116'); return false;" href="javascript:void(0);" class="ref ref10 ref116">(10,116)</a> The kinase specificity panel for XMD-1842 <b>3</b> shows that it also potentially inhibits Aurora B (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). Moreover, IC<sub>50</sub> examination of <b>3</b> for the Aurora kinases revealed that the compound strongly inhibited Aurora C with an IC<sub>50</sub> of 120 nM and Aurora B with an IC<sub>50</sub> of 54 nM. In related development, XMD-1843 <b>4</b> is a less specific NUAK1 inhibitor (IC<sub>50</sub> value of 17 nM) with off-target inhibition of JAK2, Src, CLK2, Lck, DDR2, and ABL.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Interestingly, HTH-01-015 <b>5</b>, a hybrid of XMD-1843 <b>4</b> and XMD-1842 <b>3</b>, is a highly potent NUAK1 inhibitor with IC<sub>50</sub> value of 100 nM and >100 times selectivity over NUAK2.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> This compound shows high specificity and does not considerably inhibit the potency of other 139 kinases, including the AMPK class members. In contrast, LRRK2in1 <b>6</b> is a strong and extremely selective LRRK2 inhibitor (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) that has off-target effects on NUAK1. LRRK2in1 <b>6</b> inhibits NUAK1 <i>in vitro</i> by about 47% with a concentration of 10 μM.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> In terms of kinome selectivity, JWE-071 <b>7</b> is a relatively better NUAK1 inhibitor than LRRK2in1 <b>6</b>, XMD-1842 <b>3</b>, and XMD-1843 <b>4</b>, and it also has potent NUAK1 inhibitory activity with IC<sub>50</sub> value of 6 nM.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> The main off-targets of <b>7</b> are Src, ABL, JAK2, and Aurora A. Italso displays some inhibitory potency on BRSK1, AMPK, and certain MARK family members. Together with <b>7</b>, the closely related compound XMD-17-51 <b>8</b> also has a higher affinity for NUAK1, with an IC<sub>50</sub> value of 1.5 nM, and inhibits the phosphorylation of Ser<sup>445</sup> on MYPT1 with 10-μM concentration in HEK293 cell lines.<a onclick="showRef(event, 'ref10 ref116'); return false;" href="javascript:void(0);" class="ref ref10 ref116">(10,116)</a> The off-target effects of <b>8</b> are similar to those of <b>7</b> suppressing ABL, JAK2, Src, and Aurora A and B. Amidst the AMPK class kinases, <b>8</b> has reasonable activity on BRSK1, AMPK, and certain MARK family members. DLW-01-125-01 <b>9</b> has a potency similar to that of XMD-17-51 <b>8</b> and JWE-071 <b>7</b> toward NUAK1, with an IC<sub>50</sub> of 7 nM, and NUAK1 [A195T] in turn offers over 200-fold more resistance.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> In comparison with XMD-17-51 <b>8</b> and JWE-071 <b>7</b>, DLW-01-125-01 <b>9</b> has relatively low off-target effects on inhibiting Aurora B and Aurora A and displays reasonable inhibition of ABL, Src, and FGFR (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). By far, DLW-01-122-01 <b>10</b> is the most selective of all the seven-membered ring fused pyrimidine derivatives series. Its only disadvantage is that it inhibits Aurora B and Aurora A with the same capacity as NUAK1 (IC<sub>50</sub> value of 15 nM, with NUAK1 [A195T] IC<sub>50</sub> value of 2 μM).<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structure of seven-membered ring fused pyrimidine inhibitors of NUAK isoforms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38">5.2.2.  Five- and Six-Membered Ring Fused Pyrimidines as Inhibitors of NUAK Isoforms</h4><div class="NLM_p">In the series of five-membered ring fused pyrimidines, MRT199665 <b>11</b> is a potent pan-SIK inhibitor, with IC<sub>50</sub> values of 43 nM, 12 nM, and 110 nM for SIK3, SIK2, and SIK1, respectively (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>). Apart from its potent SIKs inhibiting activities, it is also a relatively good inhibitor of NUAKs, with an IC<sub>50</sub> value of 3 nM for NUAK1 and IC<sub>50</sub> value of 120 nM for NUAK2; however, its selectivity is far less.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In the same line, WZ4074 <b>12</b> potently inhibits NUAK1 with an IC<sub>50</sub> of 33 nM but has several off-targets including HER4, BTK, and some MLK family members.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Furthermore, in series, TPX-0005 <b>13</b>, <i>aka</i>. repotrectinib, is a TRK/ROS1/ALK inhibitor with IC<sub>50</sub> values of 1.08 nM for ALK (L1196M), 1.26 nM for ALK (G1202R), and 1.01 nM for WT ALK. It is also a good inhibitor of NUAK1 (IC<sub>50</sub> = 3.70 nM).<a onclick="showRef(event, 'ref117 ref119'); return false;" href="javascript:void(0);" class="ref ref117 ref119">(117,119)</a> Very recently, BAY-880 <b>14</b> is reported as a potent NUAK1 inhibitor that inhibits 96% of its kinase activity at concentration of 1 μM. Investigating BAY-880 <b>14</b> against a series of 274 kinases displayed that its best target is NUAK1 and showed a tiny number of other kinases that is inhibited by this derivative.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Lastly, MRX6313 <b>15</b>, a dual Mer/FLT3 TK inhibitor, inhibits NUAK1 with an IC<sub>50</sub> of 7.97 nM.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structure of five- and six-membered ring fused pyrimidine inhibitors of NUAK isoforms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">There are two members in the series of six-membered ring fused pyrimidine derivatives, <i>viz</i>. ON-123300 <b>2</b> (<i>aka</i>.7x), and BI-885578 <b>16</b>.<a onclick="showRef(event, 'ref121 ref122'); return false;" href="javascript:void(0);" class="ref ref121 ref122">(121,122)</a> Biochemical assays indicated that ON-123300 <b>2</b> is a strong inhibitor of CDK4 (IC<sub>50</sub> = 3.9 nM) and NUAK1 (IC<sub>50</sub> = 5 nM) and also displays considerable inhibitory activity against FYN (IC<sub>50</sub> = 11 nM), RET (IC<sub>50</sub> = 9.2 nM), FGFR1 (IC<sub>50</sub> = 26 nM), and PDGFRb (IC<sub>50</sub> = 26 nM) (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Although tumor development in ON-123300-treated xenograft nude mouse models is inhibited over an 18-day period, mice treated with ON-123300 <b>2</b> did not exhibit signs of toxicity.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> On the same note, BI-885578 <b>16</b> is an effective, selective, ATP-competitive IGF-1R/InsR tyrosine kinase inhibitor (TKI) with a <i>K</i><sub>d</sub> of 9 nM/12 nM and an IC<sub>50</sub> of 1 nM/1 nM, respectively (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>). Recent investigation has revealed that it also exhibits potency against NUAK1 with an IC<sub>50</sub> of 0.411 μM but exhibits numerous off-target influences.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In general, this series has many inhibitors with excellent potency, but selectivity is not desirable, except for ON-123300 <b>2</b> and BAY-880 <b>14</b>, which showed outstanding activity as well as selectivity.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39">5.2.3.  Substituted <i>n</i>-Phenylpyrimidin-2-amine Inhibitors of NUAK Isoforms</h4><div class="NLM_p">Very recently, a novel semispecific inhibitor of NUAK2, namely, HTH-02–006 <b>17</b> (NUAK2 IC<sub>50</sub> = 126 nM), has been disclosed, which is observed to show excellent selectivity.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> WZ4003 <b>18</b> is one of most well-known NUAK inhibitors, which inhibits both NUAK family members. For NUAK1, it exhibits an IC<sub>50</sub> of 20 nM and for NUAK2, the IC<sub>50</sub> is 100 nM.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> This compound shows a high level of selectivity, and besides NUAK1 and NUAK2, it does not considerably inhibit the potency of the other 139 kinases, including members of AMPK-related kinases. In the same context, HMSL10085 <b>19</b> is an NUAK1 inhibitor with off-target inhibition of HER4, BTK, and IGFR. That is to say, HMSL10085 <b>19</b> has a comparable NUAK1 IC<sub>50</sub> of 25 nM; however, it is less selective.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> In a related investigation, BAY-1000394 <b>20</b>, a novel cyclin-dependent kinase inhibitor for CDK9/7/4/3/2/1 (IC<sub>50</sub> = 5–25 nM) that has potent antitumor activity, is found to target NUAK1 with an IC<sub>50</sub> < 10 nM.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). In conclusion, BAY-1000394 <b>20</b> is extremely less selective than HTH-02-006 <b>17</b>, WZ4003 <b>18</b> and HMSL10085 <b>19</b>.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structure of inhibitors of <i>N</i>-phenylpyrimidin-2-amine series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40">5.2.4.  Substituted Diaminopyrimidine Inhibitors of NUAK Isoforms</h4><div class="NLM_p">BX-795 <b>21</b> is an effective and comparatively specific inhibitor of NUAK isoforms,<a onclick="showRef(event, 'ref14 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref17">(14,17)</a> which has been primarily described as a PDK1 inhibitor<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> and later as a strong IKKε/TBK1 inhibitor.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> It has an NUAK1 IC<sub>50</sub> of 5 nM and inhibits most of the AMPK subfamily members including some members of MARK class with nanomolar IC<sub>50</sub> values.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Along the previous, the closely related inhibitor MRT67307 <b>22</b> also exhibits kinase inhibitory activity (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). It inhibits TBK1, MARK1-4, IKKε, NUAK1, and NUAK2. For NUAK1 and NUAK2, the IC<sub>50</sub> values are 230 nM and 2600 nM, respectively.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> SJB4-115 <b>23</b>, similar to BX-795 <b>21</b> and MRT67307 <b>22</b>, potently inhibits NUAK1 using <i>in vitro</i> profiling, with an IC<sub>50</sub> of 67 nM (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). However, compared with HMSL10085 <b>19</b>, SJB4-115 <b>23</b> is far less selective for NUAK1, demonstrating off-target effects on Src, SIK2, ULK1, Lck, TRKA, ERK8, and JAK2.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Fedratinib <b>24</b> shows excellent selectivity for JAK2 with an IC<sub>50</sub> of 3 nM in cell-free assays, 334 and 35 times more selective for JAK2 versus JAK3 and JAK1. In an interesting study, fedratinib <b>24</b> showed inhibition potency toward AMPK family members, including NUAK1 with a percentage kinase activity of 50% (NUAK1) and 53% (NUAk2) at 1 μM concentration.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> In a similar fashion, cerdulatinib <b>25</b>, a small molecule which is a dual JAK and SYK inhibitor,<a onclick="showRef(event, 'ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref129 ref130">(129,130)</a> is also a multikinase inhibitor with effective inhibitory potency against NUAK1 kinase with IC<sub>50</sub> of 4.00 nM in ATP and radioactivity assay.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Likewise, NVP-TAE684 <b>26</b> is an extremely powerful and selective ALK inhibitor with an IC<sub>50</sub> value of 3 nM, and it also inhibits NUAK1 and NUAK2 with a <i>K</i><sub>d</sub> value equals to 13 nM and 1.2 nM, respectively.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Apart from fedratinib <b>24</b> and cerdulatinib <b>25</b>, some other commercial drugs also show activity toward NUAK1 (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). For example, CEP-28122 <b>27</b>, an extremely selective and potent orally active inhibitor of ALK tyrosine kinase receptor with antitumor potency, presents efficient NUAK1-inhibitory activity with an IC<sub>50</sub> of 26 ± 3.00 nM.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Furthermore, brigatinib <b>28</b> is a tyrosine kinase receptor inhibitor and an antineoplastic agent used in selected forms of advanced NSCLC. Reportedly, this drug targets and inhibits NUAK1 (IC<sub>50</sub> = 47 nM).<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Thus, it can be concluded that fedratinib <b>24</b>, cerdulatinib <b>25</b>, NVP-TAE684 <b>26</b>, CEP-28122 <b>27</b>, and brigatinib <b>28</b> are not as selective as the BX-795 <b>21</b> and SJB4-115 <b>23</b> members of this series. In the case of NUAK2, the inhibitory efficiency of pyrimidine inhibitors toward NUAK2 is high in many cases such as WZ4003 <b>18</b> and NVP-TAE684 <b>26</b>; however, with the exception of <b>17</b> and <b>18</b>, all other members are less selective.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures of highly functionalized pyrimidine-2,4-diamine NUAKs inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41">5.2.5.  Indole Derivatives as Inhibitors of NUAK Isoforms</h4><div class="NLM_p">In this series, indolinone derivatives <b>29</b>, <b>30</b>, and <b>31</b> have been shown to inhibit NUAK1 potency <i>in vitro</i> with nanomolar <i>K</i><sub>i</sub> values (8.60 ± 1.60 nM, 11 ± 0.860 nM, and 1.70 ± 0.170 nM, respectively), and these derivatives have off-target effects on other AMPK family members.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Along the others, the closely related receptor TKIs, <i>viz</i>. sunitinib <b>32</b> has been reported to inhibit NUAK1 with a nanomolar IC<sub>50</sub> value (48 nM) (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>).<a onclick="showRef(event, 'ref115 ref136'); return false;" href="javascript:void(0);" class="ref ref115 ref136">(115,136)</a> Subsequently, biochemical assays indicate that the indole derivative (namely, C14) <b>33</b> is a strong inhibitor of NUAK1 (IC<sub>50</sub> = 1.40 nM).<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> TAK-901 <b>34</b>, a multitargeted Aurora inhibitor, targets NUAK1 with IC<sub>50</sub> of 9.1 nM as per ATP assay.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Along the same line, benzo[e]pyridoindolone derivative <b>35</b> is a potent inhibitor of AMPKs, including NUAK1 with an IC<sub>50</sub> of 4.80 ± 0.400 nM, as determined using cell-free assays.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Overall, there are many indole-based inhibitors of NUAK1 with excellent potency; however, none of them are appropriate in terms of selectivity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structure of highly functionalized indole-based inhibitors of NUAK isoforms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42">5.2.6.  Thiazole-Cored Inhibitors of NUAK Isoforms</h4><div class="NLM_p">Thiazole derivatives were developed to possess better specificity but still inhibit other AMPK family members. To be more precise, A7 <b>36</b> is a NUAK1 inhibitor with 27% residual kinase activity, while A22 <b>37</b> has very less% residual activity (16%). Both inhibitors also have many off-target activities. On the same note, the NUAK1 percentage residual activity of A27 <b>38</b> is 49% and of A26 <b>39</b> is 24% (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>). According to original publication, a % value of around 50 corresponds to an IC<sub>50</sub> of 10 μM.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> In summary, this class has less selectivity especially in the case of <b>36</b> and <b>37</b> but a good IC<sub>50</sub> value.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structure of thiazole-cored inhibitors of NUAK isoforms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43">5.2.7.  Inhibitory Activity of Pyrazole- and Imidazole-Containing Compounds</h4><div class="NLM_p">In the series of pyrazole-cored inhibitors, there are three members, <i>viz</i>. prexasertib <b>40</b>, SHN-722 <b>41</b>, and AZ960 <b>42</b>. In detail, prexasertib <b>40</b>, a potent, selective, and ATP-competitive CHK1 inhibitor, has a relatively moderate NUAK1 IC<sub>50</sub> value (64 nM) with off-target effects on other AMPK-related kinase family members (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>).<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> Likewise, AZ-SHN-722 <b>41</b> strongly inhibits NUAK1 with an IC<sub>50</sub> = 34.9 nM but exhibits several off-target effects on other family members of AMPK-related kinases.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> Further, AZ960 <b>42</b> is an effective JAK2 inhibitor with off-target effects mainly against TrkA, Aurora-A, NUAK1 and ALK. For NUAK1, percentage of residual kinase activity of NUAK1 is 35%, 6%, and 3% at a concentration 0.01, 0.10, and 1.0 μm.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structure of pyrazole- and imidazole-containing inhibitors of NUAK isoforms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In the library of imidazole-cored inhibitors, derivative <b>43</b> has an excellent NUAK1 IC<sub>50</sub> of 2.00 nM, but it is less selective.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Furthermore, GSK461364 <b>44</b> is a selective, potent, and reversible ATP-competitive Plk1 inhibitor (<i>K</i><sub>i</sub> = 2.2 nM) with a good potency to target NUAK2 (<i>K</i><sub>d</sub> = 23 nM).<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Summarily, in this series, the IC<sub>50</sub> values are in the region of 2–64 nM, but all the members are less selective (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>). It can be noted that there is no selective NUAK2 inhibitor in this family, and this family has lower IC<sub>50</sub> values of NUAK2 inhibition than the class of pyrimidine-based NUAK2 inhibitors.</div></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">6.  Conclusions and Future Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17435" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17435" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Over the past decade, research on NUAK subtypes (NUAK1 and NUAK2) has received extensive attention because they are involved in a wide range of important cell manipulation areas, controlling and promoting various biological processes, including embryonic development, cell adhesion, cell division, replicative senescence and ploidy, cell migration and invasion, neuronal polarity and axon branching, actin SFs remodeling, metabolic homeostasis, cell proliferation, survival of MYC-overexpressing cells, maintaining skeletal muscle mass and muscle growth, glycogen synthesis and carbohydrate metabolism, and TAU stability. Consequently, these processes become abnormal and lead to a large number of disorders when NUAK1 and NUAK2 function abnormally. Therefore, NUAK isoforms are potential interesting therapeutic targets to treat the following diseases: (i) neurodegenerative disorders like Alzheimer’s, dementia, and tauopathy; (ii) tumors and multiple cancers, such as HCC, NSCLC, ovarian cancer, glioma, metastatic melanoma, breast cancer, pancreatic cancer, intrahepatic cholangiocarcinoma, MM, neck and head squamous cell carcinoma, nasopharyngeal carcinoma, bladder cancer, GC (stomach cancer), and colorectal cancer; and (iii) ALM, DM, and obesity together with increased hyperglycemia, fat mass, and hyperinsulinemia. Also, NUAK1 and NUAK2 are frequent targets of multiple microRNAs which are commonly lost during the progression to metastatic disorder. Moreover, in recent years, numerous breakthroughs have been realized in the formation of small molecules as highly potent NUAKs inhibitors for regulating NUAKs and treating various disorders. NUAKs inhibitors are also significant as reagents to assist us in understanding more about the physiological functions of NUAK isoforms. Regarding NUAK1, the inhibitors with relatively high IC<sub>50</sub> values are ON-123300 <b>2</b> (4.95 nM), XMD-17-51 <b>8</b> (1.5 nM), MRT199665 <b>11</b> (3 nM), BX-795 <b>21</b> (5 nM), cerdulatinib <b>25</b> (4 nM), and imidazole <b>43</b> (2.00 nM), whereas the inhibitor with appropriate potency and specificity is HTH-01-015 <b>5</b> (100 nM), WZ4003 <b>18</b> (20 nM) and Bay-880 <b>14</b> (96% at 1 μM conc.). With NUAK2, the inhibitors with relatively outstanding IC<sub>50</sub> and <i>K</i><sub>d</sub> values are WZ4003 <b>18</b> (100 nM) and NVP-TAE684 <b>26</b> (1.2 nM), whereas the inhibitor with good potency and selectivity is HTH-02-006 <b>17</b> (126 nM) andWZ4003 <b>18</b> (100 nM). Nevertheless, there is no selective NUAK2 inhibitor, which inhibits NUAK2 without inhibiting NUAK1. Furthermore, WZ4003 <b>18</b>, BX-795 derivative termed MRT67307 <b>22</b>, MRT199665 <b>11</b>, NVP-TAE684 <b>26</b> and fedratinib <b>24</b> are inhibitors of both NUAK isoforms. However, regarding specificity, WZ4003 <b>18</b> is the only extremely novel NUAKs inhibitor with an IC<sub>50</sub> value of 100 nM and 20 nM for NUAK2 and NUAK1 in cell-base assays, respectively, without any important inhibition of other 139 kinases. Noteworthy, the class of inhibitors based on fused pyrimidine derivatives is more potent than the other classes of inhibitors. Additionally, inhibitors substituted by piperidine and cyano groups have shown IC<sub>50</sub> values greater than others.</div><div class="NLM_p">To obtain higher IC<sub>50</sub> values, enhanced solubility, reduced cytotoxicity, improved selectivity and increased pharmacology, there are some suggestions: (i) furan-, thiophene-, piperidine-, pyrrole-, oxadiazole-, thiane-, and thiadiazole-based derivatives of HTH-01-015 <b>5</b> and WZ4003 <b>18</b> are needed to be synthesized to investigate their inhibitory potency; (ii) derivatization of WZ4003 <b>18</b> and indolinone <b>31</b> with biologically active molecules, such as flavonoids, saponins, and coumarins, should be done and investigated; (iii) dimers of HTH-01-015 <b>5</b> and WZ4003 <b>18</b> must be formed and investigated; (iv) investigation on coupling of staurosporinewith HTH-01-015 <b>5</b> and WZ4003 <b>18</b> is recommended; (v) the role of purine, adenine, guanine, cytosine, floxurdine, and lopinavir in targeting NUAKs must be investigated; (vi) molecular symmetry, conformation, chirality, and coordination modes should be taken into account; (vii) advanced methodologies including high throughput screening, computational modeling and bioinformatics should be employed for designing NUAKs inhibitors; (viii) developing and understanding the structure–activity relation and mechanism of inhibition is required; (ix) enhancing the overall kinome selectivity of small-molecule NUAKs inhibitors are demanded. This approach has diverse benefits, such as (a) advancements in therapeutic and tolerability profiles, as well as allowing (b) assessment of mechanisms of action, (c) validation of novel targets and molecular dependencies of tumors, and (d) the formation of drug combination regimens; and (x) the mechanistic basis of unexpected toxicities analyzed during the preclinical and clinical stages of drug formation require to be investigated more thoroughly. Improved publications of NUAK inhibitor metabolites, specificities, and identified toxicities would offer a useful database to understand whether there are particular kinases of which inhibition needs to be avoided or specific substructures that lead to problematic metabolites.</div><div class="NLM_p">In spite of the data that NUAKs contribute to numerous disorders, the signal transduction context of NUAK isoforms remains poorly defined. Indeed, presently only a limited number of NUAKs substrates and upstream regulators are well investigated, whereas a more in-depth understanding of NUAKs network is lacking. Therefore, further investigation is demanded to explain the functions and regulatory mechanisms of NUAK isoforms. Moreover, most investigations have indicated that NUAKs function in metastasis and invasion. However, to date, no genetically modified mouse or genetically engineered mouse model (GEMM) has been utilized to elucidate the biological operations of NUAKs in the late and early phases of tumor progression. Indeed, by giving a variety of described biological functions, its biological operations in cancer may not be incomplete to the metastatic process. Furthermore, the master upstream protein kinase STK11 has been determined as a significant tumor suppressor in lung carcinogenesis; hence, it cannot be ignored that NUAKs may have some tumor suppressive role in specific types of cancer, for instance, lung cancer. Consequently, GEMM can enhance the knowledge of NUAKs biological operations in cancer and propose novel therapeutic methods.</div><div class="NLM_p">One crucial aspect of regulation of NUAKs is the lack of understanding around the protein phosphatases which are accountable for dephosphorylating the kinases <i>in vivo.</i> With regard to NUAK1, this aspect is of high importance as it  identified NUAK1 to be capable of binding with species of the protein phosphatase system (for example, myosin phosphatase target subunit 1), which in turn raises the possibility that it may affect its own phosphorylation in a negative feedback loop via activating and targeting PP1 complexes. There is potential for investigating this mechanism in other model organisms, for instance, <i>Caenorhabditis elegans</i>, in which preliminary data already reveal that the NUAK1 orthologue can control myosin organization. Clearly, cytoskeletal organization is a multifactorial and complex process, and NUAK1 may influence a small portion of this, but investigating the precise interactions will be significant for modulating the pathways. Furthermore, provided that the aged liver-specific NUAK1 knockout mice display an important metabolic phenotype, it may be of great value to investigate this system biochemically to find out what changes have taken place and what pathways are affected. This evidence may also deliver insight into possible pathologies that might be associated with human variation in NUAK1 expression or activity. More predictive models of tumor and improved methods to analyze target inhibition in humans in a minimally invasive manner are also demanded. As only a tiny proportion of the carcinogenesis that appears in humans can be recapitulated in animal models and cell culture systems, better abilities are required to analyze the formation of tumors in humans. This would include minimally invasive approaches to discover and monitor biomarkers for evaluation of tumors in humans. One can imagine the implementation of novel imaging modalities in combination with proteomic methods to study changes in metabolites and signaling proteins. The formation of early recognition tools may permit us to diagnose and exterminate tumors before their acquisition of survival efficacies that empower them with resistance to therapy. Additionally, as NUAK signaling cascades involve a complex array of interconnected systems, more sophisticated modeling of how they are reprogrammed as a result of oncogenic events and in the presence of inhibitors is needed. That data will be useful to more rationally utilize combinations of NUAKs inhibitors.</div><div class="NLM_p">Significant considerations when selecting kinase profiling assays is the concentration of ATP at which the reaction will be performed and the mode in which the profiling will be carried out. We recommend that the IC<sub>50</sub> mode needs to be the primary choice when investigating a small number of inhibitors because this technique yields more reliable and useful data. Conversely, in the case of investigating a large panel of inhibitors, scientists should prefer to employ a single dose (replicate) approach in order to manage profiling costs. When considering the concentration of ATP at which kinase profiling work is performed, it is significant to remember that assays carried out at the <i>K</i><sub>m</sub> value of ATP for a given kinase or a fixed ATP value can both provide a valid result of the biological profile of a library of compounds. The analysis of data attained using various concentrations of ATP will demand information on the inhibition mode of a given family of inhibitors, however. For instance, frequently investigated ATP-competitive inhibitors have an IC<sub>50</sub> value equivalent to <i>K</i><sub>i</sub> (1 + [S]/<i>K</i><sub>m</sub>). Accordingly, the IC<sub>50</sub> value will rise with enhancing concentration of ATP; the <i>K</i><sub>i</sub> value, however, should not change. Information about the mode of inhibition of tested inhibitors together with the employment of such mathematical equations makes it straightforward to analyze the data of inhibition attained from profiling carried out at any concentration of ATP. In cells, the concentration of ATP is in the low millimolar (mM) range; yet, most kinases assays are carried out in the low micromolar range for investigating inhibitors. Generally, a relatively low concentration of ATP is suggested when investigating a new potential target for some known molecules or when “casting a large net” to detect unwanted off-targets. On the contrary, a comparatively high concentration of ATP would be utilized when seeking to evaluate the specificity of a given inhibitor toward a more focused group of targets. Ligand binding-mediated assays may not be influenced by concentrations of ATP; however, it must be noted that IC<sub>50</sub> values obtained from functional mediated assays and the data of binding affinity obtained from binding assays may be distinct from each other attributed to the nature of the assay platforms.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Hence, the IC<sub>50</sub> values and <i>K</i><sub>d</sub> values using these methodologies need not to be compared directly without considering the conditions of reaction in each assay.</div><div class="NLM_p last">The main purpose of the collection, compilation, and summarization of the literature on NUAKs is to discuss the link between diseases and NUAKs and disclose the value of NUAKs inhibitors. Hopefully, this review will be beneficial for the medical research community to identify and analyze critical issues, barriers, and opportunities, which will help in conducting future research and develop new ideas in the quest for rational designs of more promising NUAKs inhibitors with excellent potency and selectivity. In addition, the review can also help recognize appropriate NUAKs inhibitors for further research and enlarge the complexity and diversity of a class of pyrimidine derivatives.</div></div><div class="NLM_back"><div class="NLM_notes" id="notes1"><p class="first last">The authors declare no competing financial interest.</p></div><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00533" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12022" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12022" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eun Joo Roh</span> - <span class="hlFld-Affiliation affiliation">Division
of Bio-Medical Science & Technology, KIST School, University of Science and Technology (UST), Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Republic
of Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Chemical
Kinomics Research Center, Korea Institute
of Science and Technology, Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Republic
of Korea</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#215319171217614a4852550f53440f4a53"><span class="__cf_email__" data-cfemail="0e7c36383d384e65677d7a207c6b20657c">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">So Ha Lee</span> - <span class="hlFld-Affiliation affiliation">Chemical
Kinomics Research Center, Korea Institute
of Science and Technology, Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Republic
of Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7125-9568" title="Orcid link">http://orcid.org/0000-0002-7125-9568</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6529362d53575454250e0c16114b17004b0e17"><span class="__cf_email__" data-cfemail="68243b205e5a59592803011b1c461a0d46031a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Muhammad Faisal</span> - <span class="hlFld-Affiliation affiliation">Division
of Bio-Medical Science & Technology, KIST School, University of Science and Technology (UST), Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Republic
of Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9181-9262" title="Orcid link">http://orcid.org/0000-0001-9181-9262</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jae Ho Kim</span> - <span class="hlFld-Affiliation affiliation">Chemical
Kinomics Research Center, Korea Institute
of Science and Technology, Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Republic
of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyung Ho Yoo</span> - <span class="hlFld-Affiliation affiliation">Chemical
Kinomics Research Center, Korea Institute
of Science and Technology, Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Republic
of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Soon Sun Hong</span> - <span class="hlFld-Affiliation affiliation">Department
of Biomedical Sciences, College of Medicine, and Program in Biomedical
Science & Engineering, Inha University, Incheon 22212, Republic of Korea</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28740" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28740" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Muhammad Faisal</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=BIO-d7e4019-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Muhammad Faisal</b> is a synthetic chemist with expertise in material, medicinal, and organic chemistry. He is adept at developing novel products and applications, providing technical solutions and generating intellectual properties. He obtained his M.Sc. and M.Phil. degrees in organic chemistry from University of Wah, Pakistan, in 2014 and Quaid-i-Azam University, Pakistan, in 2017, respectively. During his M.Phil., he was awarded with the Best Researcher Award. Currently, he is a research assistant at KIST, Korea, and his project is focused on developing pyrimidine-mediated NUAK1 inhibitors for cancer.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Jae Ho Kim</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=BIO-d7e4024-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jae Ho Kim</b> received his Master degree from Korea University in 2020 for his thesis on the synthesis of novel pyrimidine derivatives as NUAK1 kinase inhibitors. From 2017 to 2020, he worked at the Korea Institute of Science and Technology as a Master course student. His research interests include the synthesis of biologically active the novel kinase drugs.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Kyung Ho Yoo</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=BIO-d7e4029-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Kyung Ho Yoo</b> received his Ph.D. degree in organic chemistry from Korea Advanced Institute of Science and Technology, Republic of Korea, in 1992. Subsequently, he did postdoctoral work at The Johns Hopkins University. Currently, he is working as a principal researcher at Korea Institute of Science and Technology, Republic of Korea. His research interests focused on the development of novel therapeutic agents for the treatment of cancer and neurodegenerative diseases.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Eun Joo Roh</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=BIO-d7e4034-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Eun Joo Roh</b> received her Ph.D. from Seoul National University in 2002 and did her post doctoral research at NIH, NIDDK from 2003 to 2004 as a visiting fellow. She has been research scientist, senior, and principal researcher in Korea Institute of Science and Technology from 1993 to the present. Her research interests are synthesis and discovery of small molecule compound using medicinal chemistry approach for anticancer and CNS (AD and PD) active properties.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Soon Sun Hong</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=BIO-d7e4039-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Soon-Sun Hong</b> got his Ph.D. from Seoul National University in 2001 on effect of CCl<sub>4</sub>-induced hepatic failure on hepatobiliary transport of organic cations, supervised by Professor Chang Koo Shim. He worked as a fellow in Yale University School of Medicine from 2001 to 2003. Since 2007, he has worked as a professor for College of Medicine, Inha University, Korea. His research interests include the development of new anticancer drug and target drugs using preclinical study and mechanism analysis.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="21" class="article__inlineFigure"><h2 class="fig-label">So Ha Lee</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=BIO-d7e4047-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>So Ha Lee</b> received his Ph.D. from Korea University in 1999 for work on the synthesis of bisoxazine ligands and 3-substituted piperidine ligands, and their enantioselective reactions, supervised by Professor Bong Young Chung. From 1991 to the present, he has been based at the Korea Institute of Science and Technology. His research interests include the synthesis of biologically active the novel drugs utilizing chemical synthesis and natural product.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27576" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27576" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by the Korea Institute of Science and Technology (2E30240).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">3′-UTR</td><td class="NLM_def"><p class="first last">three prime untranslated region</p></td></tr><tr><td class="NLM_term">ABL</td><td class="NLM_def"><p class="first last">abelson murine leukemia viral oncogene homologue</p></td></tr><tr><td class="NLM_term">AKT</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">ALM</td><td class="NLM_def"><p class="first last">acral lentiginous melanoma</p></td></tr><tr><td class="NLM_term">AMPK</td><td class="NLM_def"><p class="first last">AMP-activated protein kinase</p></td></tr><tr><td class="NLM_term">AP-2α</td><td class="NLM_def"><p class="first last">activator protein 2α</p></td></tr><tr><td class="NLM_term">ARK1</td><td class="NLM_def"><p class="first last">aurora A</p></td></tr><tr><td class="NLM_term">ARK5</td><td class="NLM_def"><p class="first last">AMPK-related protein kinase 5</p></td></tr><tr><td class="NLM_term">AS160</td><td class="NLM_def"><p class="first last">AKT substrate of 160 kda</p></td></tr><tr><td class="NLM_term">BC</td><td class="NLM_def"><p class="first last">bladder cancer</p></td></tr><tr><td class="NLM_term">BDNF</td><td class="NLM_def"><p class="first last">brain-derived neurotrophic factor</p></td></tr><tr><td class="NLM_term">BRSK</td><td class="NLM_def"><p class="first last">brain-selective kinase</p></td></tr><tr><td class="NLM_term">CAM kinase</td><td class="NLM_def"><p class="first last">calcium/calmodulin-dependent protein kinase</p></td></tr><tr><td class="NLM_term">CAMKL family</td><td class="NLM_def"><p class="first last">calcium/calmodulin-dependent kinase like family</p></td></tr><tr><td class="NLM_term">CAP20</td><td class="NLM_def"><p class="first last">cdk2-associated protein-20</p></td></tr><tr><td class="NLM_term">CGH</td><td class="NLM_def"><p class="first last">comparative genome hybridization</p></td></tr><tr><td class="NLM_term">CRC</td><td class="NLM_def"><p class="first last">colorectal cancer</p></td></tr><tr><td class="NLM_term">DFS</td><td class="NLM_def"><p class="first last">disease-free survival</p></td></tr><tr><td class="NLM_term">DM</td><td class="NLM_def"><p class="first last">diabetes mellitus</p></td></tr><tr><td class="NLM_term">ECM</td><td class="NLM_def"><p class="first last">extracellular matrix</p></td></tr><tr><td class="NLM_term">ED</td><td class="NLM_def"><p class="first last">embryonic day</p></td></tr><tr><td class="NLM_term">EMT</td><td class="NLM_def"><p class="first last">epithelial-mesenchymal transition</p></td></tr><tr><td class="NLM_term">ETC</td><td class="NLM_def"><p class="first last">electron transport chain</p></td></tr><tr><td class="NLM_term">FGFR</td><td class="NLM_def"><p class="first last">fibroblast growth factor receptor</p></td></tr><tr><td class="NLM_term">FLT4</td><td class="NLM_def"><p class="first last">Fms-related tyrosine kinase</p></td></tr><tr><td class="NLM_term">GC</td><td class="NLM_def"><p class="first last">gastric cancer</p></td></tr><tr><td class="NLM_term">GI</td><td class="NLM_def"><p class="first last">glucose intolerance</p></td></tr><tr><td class="NLM_term">GI tract</td><td class="NLM_def"><p class="first last">gastrointestinal tract</p></td></tr><tr><td class="NLM_term">GILK</td><td class="NLM_def"><p class="first last">Gly-ile-leu-lys</p></td></tr><tr><td class="NLM_term">GLUT4</td><td class="NLM_def"><p class="first last">glucose transporter type 4</p></td></tr><tr><td class="NLM_term">GTPase</td><td class="NLM_def"><p class="first last">guanosine triphosphate</p></td></tr><tr><td class="NLM_term">HCC</td><td class="NLM_def"><p class="first last">hepatocellular carcinoma</p></td></tr><tr><td class="NLM_term">HEK293</td><td class="NLM_def"><p class="first last">human embryonic kidney 293 cells</p></td></tr><tr><td class="NLM_term">HNSCC</td><td class="NLM_def"><p class="first last">head and neck squamous cell carcinoma</p></td></tr><tr><td class="NLM_term">ICC</td><td class="NLM_def"><p class="first last">intrahepatic cholangiocarcinoma</p></td></tr><tr><td class="NLM_term">IGF-1R</td><td class="NLM_def"><p class="first last">insulin-like growth factor 1 receptor</p></td></tr><tr><td class="NLM_term">IKKε</td><td class="NLM_def"><p class="first last">I-kappa-B-kinase-epsilon</p></td></tr><tr><td class="NLM_term">InsR</td><td class="NLM_def"><p class="first last">insulin receptor</p></td></tr><tr><td class="NLM_term">IRS1</td><td class="NLM_def"><p class="first last">insulin receptor substrate 1</p></td></tr><tr><td class="NLM_term">ITPR</td><td class="NLM_def"><p class="first last">inositol 1,4,5-trisphosphate receptor</p></td></tr><tr><td class="NLM_term">JAK2</td><td class="NLM_def"><p class="first last">janus kinase 2</p></td></tr><tr><td class="NLM_term"><i>lacZ</i> gene</td><td class="NLM_def"><p class="first last">lactose operon gene Z (encodes β-galactosidase)</p></td></tr><tr><td class="NLM_term">LATS1</td><td class="NLM_def"><p class="first last">large tumor suppressor kinase 1</p></td></tr><tr><td class="NLM_term">Lck</td><td class="NLM_def"><p class="first last">lymphocyte-specific protein tyrosine kinase</p></td></tr><tr><td class="NLM_term">LIMK</td><td class="NLM_def"><p class="first last">LIM motif-containing protein kinase 1</p></td></tr><tr><td class="NLM_term">LKB1</td><td class="NLM_def"><p class="first last">liver kinase B1</p></td></tr><tr><td class="NLM_term">lncRNA SNHG1</td><td class="NLM_def"><p class="first last">long noncoding RNA small nucleolar RNA host gene 1</p></td></tr><tr><td class="NLM_term">Lyn</td><td class="NLM_def"><p class="first last">tyrosine-protein kinase</p></td></tr><tr><td class="NLM_term">M20</td><td class="NLM_def"><p class="first last">20-kda subunit</p></td></tr><tr><td class="NLM_term">Mab21l2</td><td class="NLM_def"><p class="first last">mab-21-like 2 (<i>C. Elegans</i>)</p></td></tr><tr><td class="NLM_term">MARK</td><td class="NLM_def"><p class="first last">microtubule affinity regulating kinase</p></td></tr><tr><td class="NLM_term">MDA-MB-231</td><td class="NLM_def"><p class="first last">M.D. Anderson-metastasis breast cancer-231</p></td></tr><tr><td class="NLM_term">MELK</td><td class="NLM_def"><p class="first last">maternal embryonic leucine zipper kinase</p></td></tr><tr><td class="NLM_term">MET</td><td class="NLM_def"><p class="first last">mesenchymal-epithelial transition</p></td></tr><tr><td class="NLM_term">miRNA</td><td class="NLM_def"><p class="first last">micro ribonucleic acid</p></td></tr><tr><td class="NLM_term">MITF</td><td class="NLM_def"><p class="first last">microphthalmos-related transcription factor</p></td></tr><tr><td class="NLM_term">MLC2</td><td class="NLM_def"><p class="first last">myosin light chain 2</p></td></tr><tr><td class="NLM_term">MLCP</td><td class="NLM_def"><p class="first last">myosin light-chain phosphatase</p></td></tr><tr><td class="NLM_term">MM</td><td class="NLM_def"><p class="first last">multiple myeloma</p></td></tr><tr><td class="NLM_term">MO25</td><td class="NLM_def"><p class="first last">mouse protein 25</p></td></tr><tr><td class="NLM_term">MRIP</td><td class="NLM_def"><p class="first last">myosin phosphatase-rhoa interacting protein</p></td></tr><tr><td class="NLM_term">MT1-MMP</td><td class="NLM_def"><p class="first last">membrane-type matrix metalloproteinase-1</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">mTORC1</td><td class="NLM_def"><p class="first last">mTOR complex 1</p></td></tr><tr><td class="NLM_term">MYC</td><td class="NLM_def"><p class="first last">myelocytom</p></td></tr><tr><td class="NLM_term">MYPT1</td><td class="NLM_def"><p class="first last">myosin phosphatase target subunit 1</p></td></tr><tr><td class="NLM_term">NEPC</td><td class="NLM_def"><p class="first last">neuroendocrine prostate cancer</p></td></tr><tr><td class="NLM_term">NPC</td><td class="NLM_def"><p class="first last">nasopharyngeal carcinoma</p></td></tr><tr><td class="NLM_term">NPM-ALK</td><td class="NLM_def"><p class="first last">nucleophosmin-anaplastic lymphoma kinase</p></td></tr><tr><td class="NLM_term">NRF2</td><td class="NLM_def"><p class="first last">nuclear factor erythroid 2-type factor-2</p></td></tr><tr><td class="NLM_term">NTRK2</td><td class="NLM_def"><p class="first last">neurotrophic tyrosine kinase receptor type 2</p></td></tr><tr><td class="NLM_term">NTRK2</td><td class="NLM_def"><p class="first last">neurotrophic tyrosine kinase receptor type 2</p></td></tr><tr><td class="NLM_term">NUAK</td><td class="NLM_def"><p class="first last">Nua (novel) kinase</p></td></tr><tr><td class="NLM_term">NF-κb</td><td class="NLM_def"><p class="first last">nuclear factor kappa B</p></td></tr><tr><td class="NLM_term">OMPHK</td><td class="NLM_def"><p class="first last">omphalocele kinase 1</p></td></tr><tr><td class="NLM_term">OS</td><td class="NLM_def"><p class="first last">overall survival</p></td></tr><tr><td class="NLM_term">PANC-1</td><td class="NLM_def"><p class="first last">human pancreatic carcinoma</p></td></tr><tr><td class="NLM_term">PDGFR</td><td class="NLM_def"><p class="first last">platelet-derived growth factor receptor</p></td></tr><tr><td class="NLM_term">PDK 1</td><td class="NLM_def"><p class="first last">phosphoinositide-dependent kinase 1</p></td></tr><tr><td class="NLM_term">PJS</td><td class="NLM_def"><p class="first last">peuth jeghers syndrome</p></td></tr><tr><td class="NLM_term">PLK1</td><td class="NLM_def"><p class="first last">polo-like kinase-1</p></td></tr><tr><td class="NLM_term">PP1</td><td class="NLM_def"><p class="first last">protein phosphatase 1</p></td></tr><tr><td class="NLM_term">STRAD</td><td class="NLM_def"><p class="first last">sterile-20-related adaptor</p></td></tr><tr><td class="NLM_term">QIK</td><td class="NLM_def"><p class="first last">qin-induced kinase</p></td></tr><tr><td class="NLM_term">RhoA</td><td class="NLM_def"><p class="first last">Ras homologue family member A</p></td></tr><tr><td class="NLM_term">ROCK</td><td class="NLM_def"><p class="first last">rho-associated protein kinase</p></td></tr><tr><td class="NLM_term">ROS1</td><td class="NLM_def"><p class="first last">receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">RT-PCR</td><td class="NLM_def"><p class="first last">reverse transcription polymerase chain reaction</p></td></tr><tr><td class="NLM_term">SCF</td><td class="NLM_def"><p class="first last">skp1-Cullin1-F-box protein</p></td></tr><tr><td class="NLM_term">SDN</td><td class="NLM_def"><p class="first last">small RNA degrading nuclease</p></td></tr><tr><td class="NLM_term">SFs</td><td class="NLM_def"><p class="first last">stress fibers</p></td></tr><tr><td class="NLM_term">SIK</td><td class="NLM_def"><p class="first last">salt-inducible kinase</p></td></tr><tr><td class="NLM_term">SIP1</td><td class="NLM_def"><p class="first last">smad-interacting protein 1</p></td></tr><tr><td class="NLM_term">siRNA</td><td class="NLM_def"><p class="first last">small interfering RNA</p></td></tr><tr><td class="NLM_term">SkMCs</td><td class="NLM_def"><p class="first last">skeletal muscle cells</p></td></tr><tr><td class="NLM_term">SNARK</td><td class="NLM_def"><p class="first last">sucrose-nonfermenting AMPK-related kinase</p></td></tr><tr><td class="NLM_term">SNF1</td><td class="NLM_def"><p class="first last">sucrose nonfermenting 1</p></td></tr><tr><td class="NLM_term">SNHG-6</td><td class="NLM_def"><p class="first last">small nucleolar RNA host gene 6</p></td></tr><tr><td class="NLM_term">STK11</td><td class="NLM_def"><p class="first last">serine/threonine kinase 11</p></td></tr><tr><td class="NLM_term">SYK</td><td class="NLM_def"><p class="first last">spleen tyrosine kinase</p></td></tr><tr><td class="NLM_term">TANK</td><td class="NLM_def"><p class="first last">TRAF (TNF (tumor necrosis factor) receptor-associated factor)</p></td></tr><tr><td class="NLM_term">TAU</td><td class="NLM_def"><p class="first last">tubulin-associated unit</p></td></tr><tr><td class="NLM_term">TBC1D1</td><td class="NLM_def"><p class="first last">Tre-2/BUB2/cdc 1 domain family</p></td></tr><tr><td class="NLM_term">TBK1</td><td class="NLM_def"><p class="first last">TANK-binding kinase 1</p></td></tr><tr><td class="NLM_term">Tgfβ2/β3</td><td class="NLM_def"><p class="first last">transforming growth factor β2/β3</p></td></tr><tr><td class="NLM_term">TRK</td><td class="NLM_def"><p class="first last">tropomyosin receptor kinase</p></td></tr><tr><td class="NLM_term">Tyk2</td><td class="NLM_def"><p class="first last">tyrosine kinase 2</p></td></tr><tr><td class="NLM_term">UBA protein</td><td class="NLM_def"><p class="first last">ubiquitin-associated protein</p></td></tr><tr><td class="NLM_term">ULK1</td><td class="NLM_def"><p class="first last">Unc-51-like kinase 1 (<i>C. elegans</i>)</p></td></tr><tr><td class="NLM_term">ULK2</td><td class="NLM_def"><p class="first last">Unc-51-like kinase 2 (<i>C. elegans</i>)</p></td></tr><tr><td class="NLM_term">VBW</td><td class="NLM_def"><p class="first last">ventral body wall</p></td></tr><tr><td class="NLM_term">WAF1</td><td class="NLM_def"><p class="first last">wild-type p53 activated fragment 1</p></td></tr><tr><td class="NLM_term">YAP</td><td class="NLM_def"><p class="first last">Yes-associated protein</p></td></tr><tr><td class="NLM_term">βgal</td><td class="NLM_def"><p class="first last">beta-galactosidase</p></td></tr><tr><td class="NLM_term">β-TrCP</td><td class="NLM_def"><p class="first last">beta-transducin repeat-containing protein</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 148 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krupa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, N.</span></span> <span> </span><span class="NLM_article-title">The Repertoire of Protein Kinases Encoded in the Draft Version of the Human Genome: Atypical Variations and Uncommon Domain Combinations</span>. <i>Genome Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">research0066–1</span> <span class="refDoi"> DOI: 10.1186/gb-2002-3-12-research0066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1186%2Fgb-2002-3-12-research0066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&author=A.+Krupaauthor=N.+Srinivasan&title=The+Repertoire+of+Protein+Kinases+Encoded+in+the+Draft+Version+of+the+Human+Genome%3A+Atypical+Variations+and+Uncommon+Domain+Combinations&doi=10.1186%2Fgb-2002-3-12-research0066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1186%2Fgb-2002-3-12-research0066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2002-3-12-research0066%26sid%3Dliteratum%253Aachs%26aulast%3DKrupa%26aufirst%3DA.%26aulast%3DSrinivasan%26aufirst%3DN.%26atitle%3DThe%2520Repertoire%2520of%2520Protein%2520Kinases%2520Encoded%2520in%2520the%2520Draft%2520Version%2520of%2520the%2520Human%2520Genome%253A%2520Atypical%2520Variations%2520and%2520Uncommon%2520Domain%2520Combinations%26jtitle%3DGenome%2520Biol.%26date%3D2002%26volume%3D3%26doi%3D10.1186%2Fgb-2002-3-12-research0066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kennelly, P. J.</span></span> <span> </span><span class="NLM_article-title">Protein Kinases and Protein Phosphatases in Prokaryotes: A Genomic Perspective</span>. <i>FEMS Microbiol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>206</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1111/j.1574-6968.2002.tb10978.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1111%2Fj.1574-6968.2002.tb10978.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=11786249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFaisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2002&pages=1-8&author=P.+J.+Kennelly&title=Protein+Kinases+and+Protein+Phosphatases+in+Prokaryotes%3A+A+Genomic+Perspective&doi=10.1111%2Fj.1574-6968.2002.tb10978.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinases and protein phosphatases in prokaryotes: a genomic perspective</span></div><div class="casAuthors">Kennelly, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">FEMS Microbiology Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">FMLED7</span>;
        ISSN:<span class="NLM_cas:issn">0378-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  For many years, the regulation of protein structure and function by phosphorylation and dephosphorylation was considered a relatively recent invention that arose independently in each phylogenetic domain.  Over time, however, incidents of apparent domain trespass involving the presence of 'eukaryotic' protein kinases or protein phosphatases in prokaryotic organisms were reported with increasing frequency.  Today, genomics has provided the means to examine the phylogenetic distribution of 'eukaryotic' protein kinases and protein phosphatases in a comprehensive and systematic manner.  The results of these genome searches challenge previous conceptions concerning the origins and evolution of this versatile regulatory mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSlBclTsrsGrVg90H21EOLACvtfcHk0lihy2YA1TuU-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFaisw%253D%253D&md5=2587d78ea9f0a5541752791c8fa94374</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1574-6968.2002.tb10978.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1574-6968.2002.tb10978.x%26sid%3Dliteratum%253Aachs%26aulast%3DKennelly%26aufirst%3DP.%2BJ.%26atitle%3DProtein%2520Kinases%2520and%2520Protein%2520Phosphatases%2520in%2520Prokaryotes%253A%2520A%2520Genomic%2520Perspective%26jtitle%3DFEMS%2520Microbiol.%2520Lett.%26date%3D2002%26volume%3D206%26spage%3D1%26epage%3D8%26doi%3D10.1111%2Fj.1574-6968.2002.tb10978.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moustakas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardali, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heldin, C.-H.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of TGF-β Signaling in Regulation of Cell Growth and Differentiation</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/S0165-2478(02)00023-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2FS0165-2478%2802%2900023-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=12008039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsVSqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=85-91&author=A.+Moustakasauthor=K.+Pardaliauthor=A.+Gaalauthor=C.-H.+Heldin&title=Mechanisms+of+TGF-%CE%B2+Signaling+in+Regulation+of+Cell+Growth+and+Differentiation&doi=10.1016%2FS0165-2478%2802%2900023-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of TGF-β signaling in regulation of cell growth and differentiation</span></div><div class="casAuthors">Moustakas, Aristidis; Pardali, Katerina; Gaal, Annamaria; Heldin, Carl-Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">85-91</span>CODEN:
                <span class="NLM_cas:coden">IMLED6</span>;
        ISSN:<span class="NLM_cas:issn">0165-2478</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Transforming growth factor β (TGF-β) is a secreted protein that regulates proliferation, differentiation, and death of various cell types.  All immune cell lineages, including B, T, and dendritic cells as well as macrophages, secrete TGF-β, which neg. regulates their proliferation, differentiation, and activation by other cytokines.  Thus, TGF-β is a potent immunosuppressant and perturbation of TGF-β signaling is linked to autoimmunity, inflammation, and cancer.  Here, the authors summarize their work on the growth inhibitory pathway downstream of TGF-β, which is triggered by receptor serine/threonine kinases at the cell surface and downstream effectors of the Smad family.  Activated Smads regulate transcription of target genes, including cell cycle inhibitors such as p21, which mediate the anti-proliferative response and partially explain the tumor suppressive action of the TGF-β pathway.  The authors have described a mol. mechanism of regulation of the p21 gene by Smads and transcription factor Sp1.  At late stages of tumor progression, TGF-β promotes tumorigenesis via suppression of the immune system and changes in cell differentiation of epithelial tumor cells, a phenomenon termed epithelial to mesenchymal transdifferentiation (EMT).  The authors review their work on the role of the Smad pathway in controlling EMT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqwoFaLN0-TrVg90H21EOLACvtfcHk0ljXYRHdOF5_tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsVSqu7w%253D&md5=cd931827d83c97836e320c31a96e258f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0165-2478%2802%2900023-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-2478%252802%252900023-8%26sid%3Dliteratum%253Aachs%26aulast%3DMoustakas%26aufirst%3DA.%26aulast%3DPardali%26aufirst%3DK.%26aulast%3DGaal%26aufirst%3DA.%26aulast%3DHeldin%26aufirst%3DC.-H.%26atitle%3DMechanisms%2520of%2520TGF-%25CE%25B2%2520Signaling%2520in%2520Regulation%2520of%2520Cell%2520Growth%2520and%2520Differentiation%26jtitle%3DImmunol.%2520Lett.%26date%3D2002%26volume%3D82%26spage%3D85%26epage%3D91%26doi%3D10.1016%2FS0165-2478%2802%2900023-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanks, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span> <span> </span><span class="NLM_article-title">The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>241</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1126/science.3291115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1126%2Fscience.3291115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=3291115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADyaL1cXlt1Cqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=1988&pages=42-52&author=S.+K.+Hanksauthor=A.+M.+Quinnauthor=T.+Hunter&title=The+Protein+Kinase+Family%3A+Conserved+Features+and+Deduced+Phylogeny+of+the+Catalytic+Domains&doi=10.1126%2Fscience.3291115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The protein kinase family:  conserved features and deduced phylogeny of the catalytic domains</span></div><div class="casAuthors">Hanks, Steven K.; Quinn, Anne Marie; Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue">4861</span>),
    <span class="NLM_cas:pages">42-52</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">An alignment of catalytic domain amino acid sequences from 65 different members of the protein kinase family, including many putative protein kinase sequences recently deduced from nucleotide sequence data, is presented.  Based on this alignment, conserved features of the catalytic domains are identified and discussed, and a visual display of the various intersequence relations is provided through construction of a catalytic domain phylogenetic tree.  Catalytic domains from protein kinases having similar modes of regulation or substrate specificities cluster together within the tree.  Clustering appears predictive of the properties and function of novel protein kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2wvmHwUOA1rVg90H21EOLACvtfcHk0ljXYRHdOF5_tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXlt1Cqtbw%253D&md5=5130b76aafb7e479ebf7ac83ec7ca701</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.3291115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.3291115%26sid%3Dliteratum%253Aachs%26aulast%3DHanks%26aufirst%3DS.%2BK.%26aulast%3DQuinn%26aufirst%3DA.%2BM.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DThe%2520Protein%2520Kinase%2520Family%253A%2520Conserved%2520Features%2520and%2520Deduced%2520Phylogeny%2520of%2520the%2520Catalytic%2520Domains%26jtitle%3DScience%26date%3D1988%26volume%3D241%26spage%3D42%26epage%3D52%26doi%3D10.1126%2Fscience.3291115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petkevicius, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristariyanto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peggie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plater, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedrioli, P. G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIver, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of CRTC3 by the Salt-Inducible Kinases Controls the Interconversion of Classically Activated and Regulatory Macrophages</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">16986</span>– <span class="NLM_lpage">16991</span>, <span class="refDoi"> DOI: 10.1073/pnas.1215450109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1073%2Fpnas.1215450109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23033494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1WksLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=16986-16991&author=K.+Clarkauthor=K.+F.+MacKenzieauthor=K.+Petkeviciusauthor=Y.+Kristariyantoauthor=J.+Zhangauthor=H.+G.+Choiauthor=M.+Peggieauthor=L.+Platerauthor=P.+G.+A.+Pedrioliauthor=E.+McIverauthor=N.+S.+Grayauthor=J.+S.+C.+Arthurauthor=P.+Cohen&title=Phosphorylation+of+CRTC3+by+the+Salt-Inducible+Kinases+Controls+the+Interconversion+of+Classically+Activated+and+Regulatory+Macrophages&doi=10.1073%2Fpnas.1215450109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages</span></div><div class="casAuthors">Clark, Kristopher; MacKenzie, Kirsty F.; Petkevicius, Kasparas; Kristariyanto, Yosua; Zhang, Jiazhen; Choi, Hwan Geun; Peggie, Mark; Plater, Lorna; Pedrioli, Patrick G. A.; McIver, Ed; Gray, Nathanael S.; Arthur, J. Simon C.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">16986-16991, S16986/1-S16986/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Macrophages acquire strikingly different properties that enable them to play key roles during the initiation, propagation, and resoln. of inflammation.  Classically activated (M1) macrophages produce proinflammatory mediators to combat invading pathogens and respond to tissue damage in the host, whereas regulatory macrophages (M2b) produce high levels of anti-inflammatory mols., such as IL-10, and low levels of proinflammatory cytokines, like IL-12, and are important for the resoln. of inflammatory responses.  A central problem in this area is to understand how the formation of regulatory macrophages can be promoted at sites of inflammation to prevent and/or alleviate chronic inflammatory and autoimmune diseases.  Here, we demonstrate that the salt-inducible kinases (SIKs) restrict the formation of regulatory macrophages and that their inhibition induces striking increases in many of the characteristic markers of regulatory macrophages, greatly stimulating the prodn. of IL-10 and other anti-inflammatory mols.  We show that SIK inhibitors elevate IL-10 prodn. by inducing the dephosphorylation of cAMP response element-binding protein (CREB)-regulated transcriptional coactivator (CRTC) 3, its dissocn. from 14-3-3 proteins and its translocation to the nucleus where it enhances a gene transcription program controlled by CREB.  Importantly, the effects of SIK inhibitors on IL-10 prodn. are lost in macrophages that express a drug-resistant mutant of SIK2.  These findings identify SIKs as a key mol. switch whose inhibition reprograms macrophages to an anti-inflammatory phenotype.  The remarkable effects of SIK inhibitors on macrophage function suggest that drugs that target these protein kinases may have therapeutic potential for the treatment of inflammatory and autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ5CpfkhhodrVg90H21EOLACvtfcHk0ljXYRHdOF5_tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1WksLzE&md5=cd6fcd9a04957488d2d37bf912621a63</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1215450109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1215450109%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DK.%26aulast%3DMacKenzie%26aufirst%3DK.%2BF.%26aulast%3DPetkevicius%26aufirst%3DK.%26aulast%3DKristariyanto%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DPeggie%26aufirst%3DM.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DPedrioli%26aufirst%3DP.%2BG.%2BA.%26aulast%3DMcIver%26aufirst%3DE.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DPhosphorylation%2520of%2520CRTC3%2520by%2520the%2520Salt-Inducible%2520Kinases%2520Controls%2520the%2520Interconversion%2520of%2520Classically%2520Activated%2520and%2520Regulatory%2520Macrophages%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D16986%26epage%3D16991%26doi%3D10.1073%2Fpnas.1215450109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Screaton, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conkright, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Best, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canettieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffries, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takemori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montminy, M.</span></span> <span> </span><span class="NLM_article-title">The CREB Coactivator TORC2 Functions as a Calcium- and CAMP-Sensitive Coincidence Detector</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2004.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.cell.2004.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15454081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlyqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2004&pages=61-74&author=R.+A.+Screatonauthor=M.+D.+Conkrightauthor=Y.+Katohauthor=J.+L.+Bestauthor=G.+Canettieriauthor=S.+Jeffriesauthor=E.+Guzmanauthor=S.+Niessenauthor=J.+R.+Yatesauthor=H.+Takemoriauthor=M.+Okamotoauthor=M.+Montminy&title=The+CREB+Coactivator+TORC2+Functions+as+a+Calcium-+and+CAMP-Sensitive+Coincidence+Detector&doi=10.1016%2Fj.cell.2004.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector</span></div><div class="casAuthors">Screaton, Robert A.; Conkright, Michael D.; Katoh, Yoshiko; Best, Jennifer L.; Canettieri, Gianluca; Jeffries, Shawn; Guzman, Ernesto; Niessen, Sherry; Yates, John R., III; Takemori, Hiroshi; Okamoto, Mitsuhiro; Montminy, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-74</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Elevations in circulating glucose and gut hormones during feeding promote pancreatic islet cell viability in part via the calcium- and cAMP-dependent activation of the transcription factor CREB.  Here, we describe a signaling module that mediates the synergistic effects of these pathways on cellular gene expression by stimulating the dephosphorylation and nuclear entry of TORC2, a CREB coactivator.  This module consists of the calcium-regulated phosphatase calcineurin and the Ser/Thr kinase SIK2, both of which assoc. with TORC2.  Under resting conditions, TORC2 is sequestered in the cytoplasm via a phosphorylation-dependent interaction with 14-3-3 proteins.  Triggering of the calcium and cAMP second messenger pathways by glucose and gut hormones disrupts TORC2:14-3-3 complexes via complementary effects on TORC2 dephosphorylation; calcium influx increases calcineurin activity, whereas cAMP inhibits SIK2 kinase activity.  Our results illustrate how a phosphatase/kinase module connects two signaling pathways in response to nutrient and hormonal cues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2vwAHAe13oLVg90H21EOLACvtfcHk0ljyL2Pjni80bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlyqu74%253D&md5=18b3093acf60cb2d7480db191e2c14e4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2004.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2004.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DScreaton%26aufirst%3DR.%2BA.%26aulast%3DConkright%26aufirst%3DM.%2BD.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DBest%26aufirst%3DJ.%2BL.%26aulast%3DCanettieri%26aufirst%3DG.%26aulast%3DJeffries%26aufirst%3DS.%26aulast%3DGuzman%26aufirst%3DE.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DYates%26aufirst%3DJ.%2BR.%26aulast%3DTakemori%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DM.%26aulast%3DMontminy%26aufirst%3DM.%26atitle%3DThe%2520CREB%2520Coactivator%2520TORC2%2520Functions%2520as%2520a%2520Calcium-%2520and%2520CAMP-Sensitive%2520Coincidence%2520Detector%26jtitle%3DCell%26date%3D2004%26volume%3D119%26spage%3D61%26epage%3D74%26doi%3D10.1016%2Fj.cell.2004.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matenia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E. M.</span></span> <span> </span><span class="NLM_article-title">The Tau of MARK: A Polarized View of the Cytoskeleton</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">342</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2009.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.tibs.2009.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=19559622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVylsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=332-342&author=D.+Mateniaauthor=E.+M.+Mandelkow&title=The+Tau+of+MARK%3A+A+Polarized+View+of+the+Cytoskeleton&doi=10.1016%2Fj.tibs.2009.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The tau of MARK: a polarized view of the cytoskeleton</span></div><div class="casAuthors">Matenia, Dorthe; Mandelkow, Eva-Maria</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">332-342</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Microtubule-affinity regulating kinases (MARKs) were originally discovered by their ability to phosphorylate tau protein and related microtubule-assocd. proteins (MAPs), and thereby to regulate microtubule dynamics in neurons.  Members of the MARK (also known as partition-defective [Par]-1 kinase) family were subsequently found to be highly conserved and to have key roles in cell processes such as detn. of polarity, cell-cycle control, intracellular signal transduction, transport, and cytoskeleton.  This is important for neuronal differentiation, but is also prominent in neurodegenerative 'tauopathies' such as Alzheimer's disease.  The identified functions of MARK/Par-1 are diverse and require accurate regulation.  Recent discoveries including the x-ray structure of human MARKs have contributed to an increased understanding of the mechanisms that control the kinase activity and, thus, the actin and microtubule cytoskeleton.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwzIeIjkyHRLVg90H21EOLACvtfcHk0ljyL2Pjni80bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVylsrk%253D&md5=e752082afc70186927284aeb7f872648</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2009.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2009.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DMatenia%26aufirst%3DD.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26atitle%3DThe%2520Tau%2520of%2520MARK%253A%2520A%2520Polarized%2520View%2520of%2520the%2520Cytoskeleton%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2009%26volume%3D34%26spage%3D332%26epage%3D342%26doi%3D10.1016%2Fj.tibs.2009.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crump, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanes, J. R.</span></span> <span> </span><span class="NLM_article-title">Mammalian SAD Kinases Are Required for Neuronal Polarization</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1126/science.1107403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1126%2Fscience.1107403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15705853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2005&pages=929-932&author=M.+Kishiauthor=Y.+A.+Panauthor=J.+G.+Crumpauthor=J.+R.+Sanes&title=Mammalian+SAD+Kinases+Are+Required+for+Neuronal+Polarization&doi=10.1126%2Fscience.1107403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian SAD Kinases Are Required for Neuronal Polarization</span></div><div class="casAuthors">Kishi, Masashi; Pan, Y. Albert; Crump, Justin Gage; Sanes, Joshua R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">5711</span>),
    <span class="NLM_cas:pages">929-932</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Elec. activity in neurons is generally initiated in dendritic processes then propagated along axons to synapses, where it is passed to other neurons.  Major structural features of neurons-their dendrites and axons-are thus related to their fundamental functions: the receipt and transmission of information.  The acquisition of these distinct properties by dendrites and axons, called polarization, is a crit. step in neuronal differentiation.  We show here that SAD-A and SAD-B, mammalian orthologs of a kinase needed for presynaptic differentiation in Caenorhabditis elegans, are required for neuronal polarization.  These kinases will provide entry points for unraveling signaling mechanisms that polarize neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqefz9PBjkY5bVg90H21EOLACvtfcHk0ljyL2Pjni80bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWms7c%253D&md5=ce57d6d8dba8c417ce1bf6826e70252d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1107403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1107403%26sid%3Dliteratum%253Aachs%26aulast%3DKishi%26aufirst%3DM.%26aulast%3DPan%26aufirst%3DY.%2BA.%26aulast%3DCrump%26aufirst%3DJ.%2BG.%26aulast%3DSanes%26aufirst%3DJ.%2BR.%26atitle%3DMammalian%2520SAD%2520Kinases%2520Are%2520Required%2520for%2520Neuronal%2520Polarization%26jtitle%3DScience%26date%3D2005%26volume%3D307%26spage%3D929%26epage%3D932%26doi%3D10.1126%2Fscience.1107403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardie, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawley, S. A.</span></span> <span> </span><span class="NLM_article-title">AMPK: A Nutrient and Energy Sensor That Maintains Energy Homeostasis</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1038/nrm3311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fnrm3311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22436748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVenu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=251-262&author=D.+G.+Hardieauthor=F.+A.+Rossauthor=S.+A.+Hawley&title=AMPK%3A+A+Nutrient+and+Energy+Sensor+That+Maintains+Energy+Homeostasis&doi=10.1038%2Fnrm3311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK: A nutrient and energy sensor that maintains energy homeostasis</span></div><div class="casAuthors">Hardie, D. Grahame; Ross, Fiona A.; Hawley, Simon A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">251-262</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  AMP-activated protein kinase (AMPK) is a crucial cellular energy sensor.  Once activated by falling energy status, it promotes ATP prodn. by increasing the activity or expression of proteins involved in catabolism while conserving ATP by switching off biosynthetic pathways.  AMPK also regulates metabolic energy balance at the whole-body level.  For example, it mediates the effects of agents acting on the hypothalamus that promote feeding and entrains circadian rhythms of metab. and feeding behavior.  Finally, recent studies reveal that AMPK conserves ATP levels through the regulation of processes other than metab., such as the cell cycle and neuronal membrane excitability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEnrOEhtMBFbVg90H21EOLACvtfcHk0ljRgwMo-eLcww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVenu7w%253D&md5=1f5378d191c69af099e70c4c8bf3229e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrm3311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3311%26sid%3Dliteratum%253Aachs%26aulast%3DHardie%26aufirst%3DD.%2BG.%26aulast%3DRoss%26aufirst%3DF.%2BA.%26aulast%3DHawley%26aufirst%3DS.%2BA.%26atitle%3DAMPK%253A%2520A%2520Nutrient%2520and%2520Energy%2520Sensor%2520That%2520Maintains%2520Energy%2520Homeostasis%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2012%26volume%3D13%26spage%3D251%26epage%3D262%26doi%3D10.1038%2Fnrm3311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhrlage, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prescott, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Characterization of WZ4003 and HTH-01–015 as Selective Inhibitors of the LKB1-Tumour-Suppressor-Activated NUAK Kinases</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>457</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1042/BJ20131152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1042%2FBJ20131152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=24171924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSlur7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2014&pages=215-225&author=S.+Banerjeeauthor=S.+J.+Buhrlageauthor=H.+T.+Huangauthor=X.+Dengauthor=W.+Zhouauthor=J.+Wangauthor=R.+Traynorauthor=A.+R.+Prescottauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+WZ4003+and+HTH-01%E2%80%93015+as+Selective+Inhibitors+of+the+LKB1-Tumour-Suppressor-Activated+NUAK+Kinases&doi=10.1042%2FBJ20131152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of WZ4003 and HTH-01-015 as selective inhibitors of the LKB1-tumour-suppressor-activated NUAK kinases</span></div><div class="casAuthors">Banerjee, Sourav; Buhrlage, Sara J.; Huang, Hai-Tsang; Deng, Xianming; Zhou, Wenjun; Wang, Jinhua; Traynor, Ryan; Prescott, Alan R.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">457</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">215-225</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The related NUAK1 and NUAK2 are members of the AMPK (AMP-activated protein kinase) family of protein kinases that are activated by the LKB1 (liver kinase B1) tumor suppressor kinase.  Recent work suggests they play important roles in regulating key biol. processes including Myc-driven tumorigenesis, senescence, cell adhesion and neuronal polarity.  In the present paper we describe the first highly specific protein kinase inhibitors of NUAK kinases namely WZ4003 and HTH-01-015.  WZ4003 inhibits both NUAK isoforms (IC50 for NUAK1 is 20 nM and for NUAK2 is 100 nM), whereas HTH-01-015 inhibits only NUAK1 (IC50 is 100 nM).  These compds. display extreme selectivity and do not significantly inhibit the activity of 139 other kinases that were tested including ten AMPK family members.  In all cell lines tested, WZ4003 and HTH-01-015 inhibit the phosphorylation of the only well-characterized substrate, MYPT1 (myosin phosphate-targeting subunit 1) that is phosphorylated by NUAK1 at Ser445.  We also identify a mutation (A195T) that does not affect basal NUAK1 activity, but renders it ~ 50-fold resistant to both WZ4003 and HTH-01-015.  Consistent with NUAK1 mediating the phosphorylation of MYPT1 we find that in cells overexpressing drug-resistant NUAK1[A195T], but not wild-type NUAK1, phosphorylation of MYPT1 at Ser445 is no longer suppressed by WZ4003 or HTH-01-015.  We also demonstrate that administration of WZ4003 and HTH-01-015 to MEFs (mouse embryonic fibroblasts) significantly inhibits migration in a wound-healing assay to a similar extent as NUAK1-knockout.  WZ4003 and HTH-01-015 also inhibit proliferation of MEFs to the same extent as NUAK1 knockout and U2OS cells to the same extent as NUAK1 shRNA knockdown.  We find that WZ4003 and HTH-01-015 impaired the invasive potential of U2OS cells in a 3D cell invasion assay to the same extent as NUAK1 knockdown.  The results of the present study indicate that WZ4003 and HTH-01-015 will serve as useful chem. probes to delineate the biol. roles of the NUAK kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Au6CwHtFALVg90H21EOLACvtfcHk0ljRgwMo-eLcww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSlur7K&md5=feab58d16169f39a2d136016328cc0f6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1042%2FBJ20131152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20131152%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DHuang%26aufirst%3DH.%2BT.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTraynor%26aufirst%3DR.%26aulast%3DPrescott%26aufirst%3DA.%2BR.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520WZ4003%2520and%2520HTH-01%25E2%2580%2593015%2520as%2520Selective%2520Inhibitors%2520of%2520the%2520LKB1-Tumour-Suppressor-Activated%2520NUAK%2520Kinases%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D457%26spage%3D215%26epage%3D225%26doi%3D10.1042%2FBJ20131152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Courchet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courchet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polleux, F.</span></span> <span> </span><span class="NLM_article-title">XTerminal Axon Branching Is Regulated by the LKB1-NUAK1 Kinase Pathway via Presynaptic Mitochondrial Capture</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">1510</span>– <span class="NLM_lpage">1525</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2013.05.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.cell.2013.05.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23791179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVWnsrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2013&pages=1510-1525&author=J.+Courchetauthor=T.+L.+Lewisauthor=S.+Leeauthor=V.+Courchetauthor=D.+Y.+Liouauthor=S.+Aizawaauthor=F.+Polleux&title=XTerminal+Axon+Branching+Is+Regulated+by+the+LKB1-NUAK1+Kinase+Pathway+via+Presynaptic+Mitochondrial+Capture&doi=10.1016%2Fj.cell.2013.05.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Terminal Axon Branching Is Regulated by the LKB1-NUAK1 Kinase Pathway via Presynaptic Mitochondrial Capture</span></div><div class="casAuthors">Courchet, Julien; Lewis, Tommy L., Jr.; Lee, Sohyon; Courchet, Virginie; Liou, Deng-Yuan; Aizawa, Shinichi; Polleux, Franck</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1510-1525</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mol. mechanisms underlying the axon arborization of mammalian neurons are poorly understood but are crit. for the establishment of functional neural circuits.  We identified a pathway defined by two kinases, LKB1 and NUAK1, required for cortical axon branching in vivo.  Conditional deletion of LKB1 after axon specification or knockdown of NUAK1 drastically reduced axon branching in vivo, whereas their overexpression was sufficient to increase axon branching.  The LKB1-NUAK1 pathway controls mitochondria immobilization in axons.  Using manipulation of Syntaphilin, a protein necessary and sufficient to arrest mitochondrial transport specifically in the axon, we demonstrate that the LKB1-NUAK1 kinase pathway regulates axon branching by promoting mitochondria immobilization.  Finally, we show that LKB1 and NUAK1 are necessary and sufficient to immobilize mitochondria specifically at nascent presynaptic sites.  Our results unravel a link between presynaptic mitochondrial capture and axon branching.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxc7_I338GRrVg90H21EOLACvtfcHk0lhGPIEMOqdREA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVWnsrvO&md5=ccc07f566665c4cc691361347f23e05c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2013.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2013.05.021%26sid%3Dliteratum%253Aachs%26aulast%3DCourchet%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DT.%2BL.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DCourchet%26aufirst%3DV.%26aulast%3DLiou%26aufirst%3DD.%2BY.%26aulast%3DAizawa%26aufirst%3DS.%26aulast%3DPolleux%26aufirst%3DF.%26atitle%3DXTerminal%2520Axon%2520Branching%2520Is%2520Regulated%2520by%2520the%2520LKB1-NUAK1%2520Kinase%2520Pathway%2520via%2520Presynaptic%2520Mitochondrial%2520Capture%26jtitle%3DCell%26date%3D2013%26volume%3D153%26spage%3D1510%26epage%3D1525%26doi%3D10.1016%2Fj.cell.2013.05.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Humbert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navaratnam, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Costa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martien, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbadie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Launoit, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, D.</span></span> <span> </span><span class="NLM_article-title">Regulation of Ploidy and Senescence by the AMPK-Related Kinase NUAK1</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">376</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1038/emboj.2009.342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Femboj.2009.342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=19927127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSmu7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=376-386&author=N.+Humbertauthor=N.+Navaratnamauthor=A.+Augertauthor=M.+Da+Costaauthor=S.+Martienauthor=J.+Wangauthor=D.+Martinezauthor=C.+Abbadieauthor=D.+Carlingauthor=Y.+de+Launoitauthor=J.+Gilauthor=D.+Bernard&title=Regulation+of+Ploidy+and+Senescence+by+the+AMPK-Related+Kinase+NUAK1&doi=10.1038%2Femboj.2009.342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of ploidy and senescence by the AMPK-related kinase NUAK1</span></div><div class="casAuthors">Humbert, Nicolas; Navaratnam, Naveenan; Augert, Arnaud; Da Costa, Marco; Martien, Sebastien; Wang, Jing; Martinez, Dolores; Abbadie, Corinne; Carling, David; de Launoit, Yvan; Gil, Jesus; Bernard, David</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">376-386</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Senescence is an irreversible cell-cycle arrest that is elicited by a wide range of factors, including replicative exhaustion.  Emerging evidences suggest that cellular senescence contributes to aging and acts as a tumor suppressor mechanism.  To identify novel genes regulating senescence, we performed a loss-of-function screen on normal human diploid fibroblasts.  Downregulation of the AMPK-related protein kinase 5 (ARK5 or NUAK1) results in extension of the cellular replicative lifespan.  Interestingly, the levels of NUAK1 are upregulated during senescence whereas its ectopic expression triggers a premature senescence.  Cells that constitutively express NUAK1 suffer gross aneuploidies and show diminished expression of the genomic stability regulator LATS1, whereas depletion of NUAK1 with shRNA exerts opposite effects.  Interestingly, a dominant-neg. form of LATS1 phenocopies NUAK1 effects.  Moreover, we show that NUAK1 phosphorylates LATS1 at S464 and this has a role in controlling its stability.  In summary, our work highlights a novel role for NUAK1 in the control of cellular senescence and cellular ploidy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS28reOUWITLVg90H21EOLACvtfcHk0lhGPIEMOqdREA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSmu7rO&md5=b11a0a6a81ae940636af2a38dd6d609c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Femboj.2009.342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2009.342%26sid%3Dliteratum%253Aachs%26aulast%3DHumbert%26aufirst%3DN.%26aulast%3DNavaratnam%26aufirst%3DN.%26aulast%3DAugert%26aufirst%3DA.%26aulast%3DDa%2BCosta%26aufirst%3DM.%26aulast%3DMartien%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DD.%26aulast%3DAbbadie%26aufirst%3DC.%26aulast%3DCarling%26aufirst%3DD.%26aulast%3Dde%2BLaunoit%26aufirst%3DY.%26aulast%3DGil%26aufirst%3DJ.%26aulast%3DBernard%26aufirst%3DD.%26atitle%3DRegulation%2520of%2520Ploidy%2520and%2520Senescence%2520by%2520the%2520AMPK-Related%2520Kinase%2520NUAK1%26jtitle%3DEMBO%2520J.%26date%3D2010%26volume%3D29%26spage%3D376%26epage%3D386%26doi%3D10.1038%2Femboj.2009.342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vallenius, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaahtomeri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovac, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osiceanu, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viljanen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mäkelä, T. P.</span></span> <span> </span><span class="NLM_article-title">An Association between NUAK2 and MRIP Reveals a Novel Mechanism for Regulation of Actin Stress Fibers</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">384</span>– <span class="NLM_lpage">393</span>, <span class="refDoi"> DOI: 10.1242/jcs.072660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1242%2Fjcs.072660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=21242312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFOqu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2011&pages=384-393&author=T.+Valleniusauthor=K.+Vaahtomeriauthor=B.+Kovacauthor=A.+M.+Osiceanuauthor=M.+Viljanenauthor=T.+P.+M%C3%A4kel%C3%A4&title=An+Association+between+NUAK2+and+MRIP+Reveals+a+Novel+Mechanism+for+Regulation+of+Actin+Stress+Fibers&doi=10.1242%2Fjcs.072660"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">An association between NUAK2 and MRIP reveals a novel mechanism for regulation of actin stress fibers</span></div><div class="casAuthors">Vallenius, Tea; Vaahtomeri, Kari; Kovac, Bianca; Osiceanu, Ana-Maria; Viljanen, Martta; Makela, Tomi P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">384-393</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Actin stress fiber assembly and contractility in nonmuscle motile cells requires phosphorylation of myosin regulatory light chain (MLC).  Dephosphorylation and disassembly are mediated by MLC phosphatase, which is targeted to actin fibers by the assocn. of its regulatory subunit MYPT1 with myosin phosphatase Rho-interacting protein (MRIP).  In the present study, we identify the kinase NUAK2 as a second protein targeted by MRIP to actin fibers.  Assocn. of NUAK2 with MRIP increases MLC phosphorylation and promotes formation of stress fibers.  This activity does not require the kinase activity of NUAK2 but is dependent on both MRIP and MYPT1, indicating that the NUAK2-MRIP assocn. inhibits fiber disassembly and MYPT1-mediated MLC dephosphorylation.  NUAK2 levels are strongly induced by stimuli increasing actomyosin fiber formation, and NUAK2 is required for fiber maintenance in exponentially growing cells, implicating NUAK2 in a pos.-feedback loop regulating actin stress fibers independently of the MLC kinase Rho-assocd. protein kinase (ROCK).  The identified MRIP-NUAK2 assocn. reveals a novel mechanism for the maintenance of actin stress fibers through counteracting MYPT1 and, together with recent results, implicates the NUAK proteins as important regulators of the MLC phosphatase acting in both a kinase-dependent and kinase-independent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1NEleHDviObVg90H21EOLACvtfcHk0lhGPIEMOqdREA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFOqu7Y%253D&md5=4796fab6b93cf7b28dadd26292c245a6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1242%2Fjcs.072660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.072660%26sid%3Dliteratum%253Aachs%26aulast%3DVallenius%26aufirst%3DT.%26aulast%3DVaahtomeri%26aufirst%3DK.%26aulast%3DKovac%26aufirst%3DB.%26aulast%3DOsiceanu%26aufirst%3DA.%2BM.%26aulast%3DViljanen%26aufirst%3DM.%26aulast%3DM%25C3%25A4kel%25C3%25A4%26aufirst%3DT.%2BP.%26atitle%3DAn%2520Association%2520between%2520NUAK2%2520and%2520MRIP%2520Reveals%2520a%2520Novel%2520Mechanism%2520for%2520Regulation%2520of%2520Actin%2520Stress%2520Fibers%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2011%26volume%3D124%26spage%3D384%26epage%3D393%26doi%3D10.1242%2Fjcs.072660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zagórska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prescott, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span> <span> </span><span class="NLM_article-title">New Roles for the LKB1-NUAK Pathway in Controlling Myosin Phosphatase Complexes and Cell Adhesion</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">ra25</span> <span class="refDoi"> DOI: 10.1126/scisignal.2000616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1126%2Fscisignal.2000616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=20354225" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&author=A.+Zag%C3%B3rskaauthor=M.+Deakauthor=D.+G.+Campbellauthor=S.+Banerjeeauthor=M.+Hiranoauthor=S.+Aizawaauthor=A.+R.+Prescottauthor=D.+R.+Alessi&title=New+Roles+for+the+LKB1-NUAK+Pathway+in+Controlling+Myosin+Phosphatase+Complexes+and+Cell+Adhesion&doi=10.1126%2Fscisignal.2000616"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2000616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2000616%26sid%3Dliteratum%253Aachs%26aulast%3DZag%25C3%25B3rska%26aufirst%3DA.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DD.%2BG.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DHirano%26aufirst%3DM.%26aulast%3DAizawa%26aufirst%3DS.%26aulast%3DPrescott%26aufirst%3DA.%2BR.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DNew%2520Roles%2520for%2520the%2520LKB1-NUAK%2520Pathway%2520in%2520Controlling%2520Myosin%2520Phosphatase%2520Complexes%2520and%2520Cell%2520Adhesion%26jtitle%3DSci.%2520Signaling%26date%3D2010%26volume%3D3%26doi%3D10.1126%2Fscisignal.2000616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyonari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furushima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizawa, S.</span></span> <span> </span><span class="NLM_article-title">A New Serine/Threonine Protein Kinase, Omphk1, Essential to Ventral Body Wall Formation</span>. <i>Dev. Dyn.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>235</i></span>,  <span class="NLM_fpage">2229</span>– <span class="NLM_lpage">2237</span>, <span class="refDoi"> DOI: 10.1002/dvdy.20823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1002%2Fdvdy.20823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=16715502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVeisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=2006&pages=2229-2237&author=M.+Hiranoauthor=H.+Kiyonariauthor=A.+Inoueauthor=K.+Furushimaauthor=T.+Murataauthor=Y.+Sudaauthor=S.+Aizawa&title=A+New+Serine%2FThreonine+Protein+Kinase%2C+Omphk1%2C+Essential+to+Ventral+Body+Wall+Formation&doi=10.1002%2Fdvdy.20823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A new serine/threonine protein kinase, Omphk1, essential to ventral body wall formation</span></div><div class="casAuthors">Hirano, Mariko; Kiyonari, Hiroshi; Inoue, Ai; Furushima, Kenryo; Murata, Takuya; Suda, Yoko; Aizawa, Schinichi</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Dynamics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">235</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2229-2237</span>CODEN:
                <span class="NLM_cas:coden">DEDYEI</span>;
        ISSN:<span class="NLM_cas:issn">1058-8388</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Here, we report a new serine/threonine protein kinase of the SNF1 subfamily Omphk1.  Two Omphk homologues exist in each vertebrate species, and one homolog exists in Drosophila and Caenorhabditis elegans; the kinase domain is highly conserved among these homologues, and several domains are conserved among vertebrate Omphk.  Omphk1 expression dynamically changes in the developing central nervous system, is found ubiquitously in epidermis, and is present uniquely in several other tissues.  Its expression is also found in each tissue assocd. with the ventral body wall closure: the primary body wall composed of primitive ectoderm and each component of the secondary body wall.  Concomitantly, its null mutant exhibits omphalocele with a failure in closure of the secondary body wall.  There are no apparent gross morphol. defects in brain, however, despite the unique Omphk1 expression in this tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZHWRrkcxnS7Vg90H21EOLACvtfcHk0lhbqkDOR4Lldw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVeisbg%253D&md5=87f08700859e6049a3919a93e170271b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fdvdy.20823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdvdy.20823%26sid%3Dliteratum%253Aachs%26aulast%3DHirano%26aufirst%3DM.%26aulast%3DKiyonari%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DFurushima%26aufirst%3DK.%26aulast%3DMurata%26aufirst%3DT.%26aulast%3DSuda%26aufirst%3DY.%26aulast%3DAizawa%26aufirst%3DS.%26atitle%3DA%2520New%2520Serine%252FThreonine%2520Protein%2520Kinase%252C%2520Omphk1%252C%2520Essential%2520to%2520Ventral%2520Body%2520Wall%2520Formation%26jtitle%3DDev.%2520Dyn.%26date%3D2006%26volume%3D235%26spage%3D2229%26epage%3D2237%26doi%3D10.1002%2Fdvdy.20823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohmura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shioi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizawa, S.</span></span> <span> </span><span class="NLM_article-title">Neural Tube Defects by NUAK1 and NUAK2 Double Mutation</span>. <i>Dev. Dyn.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>241</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1364</span>, <span class="refDoi"> DOI: 10.1002/dvdy.23816</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1002%2Fdvdy.23816" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22689267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVCjs7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=2012&pages=1350-1364&author=T.+Ohmuraauthor=G.+Shioiauthor=M.+Hiranoauthor=S.+Aizawa&title=Neural+Tube+Defects+by+NUAK1+and+NUAK2+Double+Mutation&doi=10.1002%2Fdvdy.23816"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Neural tube defects by NUAK1 and NUAK2 double mutation</span></div><div class="casAuthors">Ohmura, Tomomi; Shioi, Go; Hirano, Mariko; Aizawa, Shinichi</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Dynamics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1350-1364</span>CODEN:
                <span class="NLM_cas:coden">DEDYEI</span>;
        ISSN:<span class="NLM_cas:issn">1058-8388</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Background: NUAK1 and NUAK2, members of the AMP-activated protein kinase family of serine/threonine kinases, are prominently expressed in neuroectoderm, but their functions in neurulation have not been elucidated.  Results: NUAK1 and NUAK2 double mutants exhibited exencephaly, facial clefting, and spina bifida.  Median hinge point was formed, but dorsolateral hinge point formation was not apparent in cranial neural plate; neither apical constriction nor apico-basal elongation took place efficiently in the double mutants during the 5-10-somite stages.  Concomitantly, the apical concn. of phosphorylated myosin light chain 2, F-actin, and cortactin was insignificant, and development of acetylated α-tubulin-pos. microtubules was poor.  However, the distribution of F-actin, cortactin, Shroom3, Rho, myosin heavy chain IIB, phosphorylated myosin light chain 2, α-tubulin, γ-tubulin, or acetylated α-tubulin was apparently normal in the double mutant neuroepithelia at the 5-somite stage.  Conclusions: NUAK1 and NUAK2 complementarily function in the apical constriction and apico-basal elongation that assoc. with the dorsolateral hinge point formation in cephalic neural plate during the 5- to 10-somite stages.  In the double mutant neural plate, phosphorylated myosin light chain 2, F-actin, and cortactin did not conc. efficiently in apical surfaces, and acetylated α-tubulin-pos. microtubules did not develop significantly.  Developmental Dynamics 241:1350-1364, 2012. © 2012 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYQ8OxUKQi9bVg90H21EOLACvtfcHk0lhbqkDOR4Lldw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVCjs7nI&md5=13fb6332eab4620fd4f2325f23af8221</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fdvdy.23816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdvdy.23816%26sid%3Dliteratum%253Aachs%26aulast%3DOhmura%26aufirst%3DT.%26aulast%3DShioi%26aufirst%3DG.%26aulast%3DHirano%26aufirst%3DM.%26aulast%3DAizawa%26aufirst%3DS.%26atitle%3DNeural%2520Tube%2520Defects%2520by%2520NUAK1%2520and%2520NUAK2%2520Double%2520Mutation%26jtitle%3DDev.%2520Dyn.%26date%3D2012%26volume%3D241%26spage%3D1350%26epage%3D1364%26doi%3D10.1002%2Fdvdy.23816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulbrich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wustefeld, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aeberhard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kress, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthalagu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rycak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudalska, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zender, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D. J.</span></span> <span> </span><span class="NLM_article-title">Deregulated MYC Expression Induces Dependence upon AMPK-Related Kinase 5</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>483</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">612</span>, <span class="refDoi"> DOI: 10.1038/nature10927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fnature10927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22460906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtVertbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=608-612&author=L.+Liuauthor=J.+Ulbrichauthor=J.+Mullerauthor=T.+Wustefeldauthor=L.+Aeberhardauthor=T.+R.+Kressauthor=N.+Muthalaguauthor=L.+Rycakauthor=R.+Rudalskaauthor=R.+Mollauthor=S.+Kempaauthor=L.+Zenderauthor=M.+Eilersauthor=D.+J.+Murphy&title=Deregulated+MYC+Expression+Induces+Dependence+upon+AMPK-Related+Kinase+5&doi=10.1038%2Fnature10927"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Deregulated MYC expression induces dependence upon AMPK-related kinase 5</span></div><div class="casAuthors">Liu, Lidan; Ulbrich, Jannes; Mueller, Judith; Wuestefeld, Torsten; Aeberhard, Lukas; Kress, Theresia R.; Muthalagu, Nathiya; Rycak, Lukas; Rudalska, Ramona; Moll, Roland; Kempa, Stefan; Zender, Lars; Eilers, Martin; Murphy, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">7391</span>),
    <span class="NLM_cas:pages">608-612</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deregulated expression of the MYC oncoprotein contributes to the genesis of many human tumors, yet strategies to exploit this for a rational tumor therapy are scarce.  MYC promotes cell growth and proliferation, and alters cellular metab. to enhance the provision of precursors for phospholipids and cellular macromols.  Here we show in human and murine cell lines that oncogenic levels of MYC establish a dependence on AMPK-related kinase 5 (ARK5; also known as NUAK1) for maintaining metabolic homeostasis and for cell survival.  ARK5 is an upstream regulator of AMPK and limits protein synthesis via inhibition of the mammalian target of rapamycin 1 (mTORC1) signaling pathway.  ARK5 also maintains expression of mitochondrial respiratory chain complexes and respiratory capacity, which is required for efficient glutamine metab.  Inhibition of ARK5 leads to a collapse of cellular ATP levels in cells expressing deregulated MYC, inducing multiple pro-apoptotic responses as a secondary consequence.  Depletion of ARK5 prolongs survival in MYC-driven mouse models of hepatocellular carcinoma, demonstrating that targeting cellular energy homeostasis is a valid therapeutic strategy to eliminate tumor cells that express deregulated MYC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWeNMQX50Id7Vg90H21EOLACvtfcHk0lhbqkDOR4Lldw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtVertbk%253D&md5=ca6d9a40456878557f1c4a9cfb5e85f4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature10927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10927%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DUlbrich%26aufirst%3DJ.%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DWustefeld%26aufirst%3DT.%26aulast%3DAeberhard%26aufirst%3DL.%26aulast%3DKress%26aufirst%3DT.%2BR.%26aulast%3DMuthalagu%26aufirst%3DN.%26aulast%3DRycak%26aufirst%3DL.%26aulast%3DRudalska%26aufirst%3DR.%26aulast%3DMoll%26aufirst%3DR.%26aulast%3DKempa%26aufirst%3DS.%26aulast%3DZender%26aufirst%3DL.%26aulast%3DEilers%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DD.%2BJ.%26atitle%3DDeregulated%2520MYC%2520Expression%2520Induces%2520Dependence%2520upon%2520AMPK-Related%2520Kinase%25205%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D608%26epage%3D612%26doi%3D10.1038%2Fnature10927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaled, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netanely, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buxbaum, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janas, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postolsky, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, C.</span></span> <span> </span><span class="NLM_article-title">Transcription Factor/MicroRNA Axis Blocks Melanoma Invasion Program by MiR-211 Targeting NUAK1</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1038/jid.2013.340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fjid.2013.340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23934065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOns7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2014&pages=441-451&author=R.+E.+Bellauthor=M.+Khaledauthor=D.+Netanelyauthor=S.+Schubertauthor=T.+Golanauthor=A.+Buxbaumauthor=M.+M.+Janasauthor=B.+Postolskyauthor=M.+S.+Goldbergauthor=R.+Shamirauthor=C.+Levy&title=Transcription+Factor%2FMicroRNA+Axis+Blocks+Melanoma+Invasion+Program+by+MiR-211+Targeting+NUAK1&doi=10.1038%2Fjid.2013.340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Transcription Factor/microRNA Axis Blocks Melanoma Invasion Program by miR-211 Targeting NUAK1</span></div><div class="casAuthors">Bell, Rachel E.; Khaled, Mehdi; Netanely, Dvir; Schubert, Steffen; Golan, Tamar; Buxbaum, Amir; Janas, Maja M.; Postolsky, Benny; Goldberg, Michael S.; Shamir, Ron; Levy, Carmit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441-451</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanoma is one of the deadliest human cancers, responsible for approx. 80% of skin cancer mortalities.  The aggressiveness of melanoma is due to its capacity to proliferate and rapidly invade surrounding tissues, leading to metastases.  A recent model suggests melanoma progresses by reversibly switching between proliferation and invasion transcriptional signatures.  Recent studies show that cancer cells are more sensitive to microRNA (miRNA) perturbation than are non-cancer cells; however, the roles of miRNAs in melanoma plasticity remain unexplored.  Here, we use the gene expression profiles of melanoma and normal melanocytes to characterize the transcription factor-miRNA relationship that modulates the proliferative and invasive programs of melanoma.  We identified two sets of miRNAs that likely regulate these programs.  Interestingly, one of the miRNAs involved in melanoma invasion is miR-211, a known target of the master regulator microphthalmia-assocd. transcription factor (MITF).  We demonstrate that miR-211 contributes to melanoma adhesion by directly targeting a gene, NUAK1.  Inhibition of miR-211 increases NUAK1 expression and decreases melanoma adhesion, whereas upregulation of miR-211 restores adhesion through NUAK1 repression.  This study defines the MITF/miR-211 axis that inhibits the invasive program by blocking adhesion.  Furthermore, we have identified NUAK1 as a potential target for the treatment of metastatic melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWuaHHq7d3f7Vg90H21EOLACvtfcHk0lgqF7hx2u0epQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOns7nL&md5=02bc20bb2808c189cf5bcb6d10d83319</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fjid.2013.340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjid.2013.340%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DR.%2BE.%26aulast%3DKhaled%26aufirst%3DM.%26aulast%3DNetanely%26aufirst%3DD.%26aulast%3DSchubert%26aufirst%3DS.%26aulast%3DGolan%26aufirst%3DT.%26aulast%3DBuxbaum%26aufirst%3DA.%26aulast%3DJanas%26aufirst%3DM.%2BM.%26aulast%3DPostolsky%26aufirst%3DB.%26aulast%3DGoldberg%26aufirst%3DM.%2BS.%26aulast%3DShamir%26aufirst%3DR.%26aulast%3DLevy%26aufirst%3DC.%26atitle%3DTranscription%2520Factor%252FMicroRNA%2520Axis%2520Blocks%2520Melanoma%2520Invasion%2520Program%2520by%2520MiR-211%2520Targeting%2520NUAK1%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2014%26volume%3D134%26spage%3D441%26epage%3D451%26doi%3D10.1038%2Fjid.2013.340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kusakai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">Strong Association of ARK5 with Tumor Invasion and Metastasis</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15354411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXms1Kjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=263-268&author=G.+Kusakaiauthor=A.+Suzukiauthor=T.+Oguraauthor=M.+Kaminishiauthor=H.+Esumi&title=Strong+Association+of+ARK5+with+Tumor+Invasion+and+Metastasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Strong association of ARK5 with tumor invasion and metastasis</span></div><div class="casAuthors">Kusakai, G.; Suzuki, A.; Ogura, T.; Kaminishi, M.; Esumi, H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">263-268</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">0392-9078</span>.
    
            (<span class="NLM_cas:orgname">Regina Elena Institute for Cancer Research</span>)
        </div><div class="casAbstract">The authors recently identified a novel human AMPK family member, ARK5, and discovered that it is a major factor in Akt-dependent cancer cell survival and migration activity through activation of MT1-MMPs in vitro.  The mRNA expression of other AMPK family members and ARK5 was measured using RT-PCR in human colorectal carcinoma cell lines DLD-1, WiDr, HCT-15, SW620, LoVo, SW480, and mRNA expression of AMPK-α1, SNARK, MELK and ARK5, but not AMPK-α2, was detected in every line.  Quant.-PCR (Q-PCR) to est. the amt. of ARK5 mRNA expression in the cell lines showed that there is a variety of ARK5 expressions among the cell lines and high expression was obsd. in a cell line derived from the metastatic lesion, LoVo.  To det. the effect of ARK5 overexpression on metastasis in vivo, the authors established human pancreas cancer cell line PANC-1 stably transfected with ARK5 full-length expression vector (P/ARK) and DLD-1 stably transfected with the same vector (D/ARK).  Migration assay showed a remarkable increase in the activity both in P/ARK and D/ARK, and an in vivo metastasis assay showed a marked increase of P/ARK in liver metastasis.  Based on these observations, it is suggested that ARK5 expression is involved in cancer invasion and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjb82P4k4HYrVg90H21EOLACvtfcHk0lgqF7hx2u0epQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXms1Kjtbk%253D&md5=398d15306b52cfdb1e68016240821743</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKusakai%26aufirst%3DG.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DKaminishi%26aufirst%3DM.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DStrong%2520Association%2520of%2520ARK5%2520with%2520Tumor%2520Invasion%2520and%2520Metastasis%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D23%26spage%3D263%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span> <span> </span><span class="NLM_article-title">ARK5 Promotes Glioma Cell Invasion, and Its Elevated Expression Is Correlated with Poor Clinical Outcome</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">752</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2012.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.ejca.2012.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23063350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFSntbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=752-763&author=S.+Luauthor=N.+Niuauthor=H.+Guoauthor=J.+Tangauthor=W.+Guoauthor=Z.+Liuauthor=L.+Shiauthor=T.+Sunauthor=F.+Zhouauthor=H.+Liauthor=J.+Zhangauthor=B.+Zhang&title=ARK5+Promotes+Glioma+Cell+Invasion%2C+and+Its+Elevated+Expression+Is+Correlated+with+Poor+Clinical+Outcome&doi=10.1016%2Fj.ejca.2012.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">ARK5 promotes glioma cell invasion, and its elevated expression is correlated with poor clinical outcome</span></div><div class="casAuthors">Lu, Shijun; Niu, Na; Guo, Hua; Tang, Jinbao; Guo, Wenjun; Liu, Zhijun; Shi, Lihong; Sun, Tongyi; Zhou, Fenghua; Li, Hongli; Zhang, Jin; Zhang, Baogang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">752-763</span>CODEN:
                <span class="NLM_cas:coden">EJCAEL</span>;
        ISSN:<span class="NLM_cas:issn">0959-8049</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Poor prognosis of malignant gliomas is primarily attributed to their highly invasive nature.  Despite the identification of new biomarkers and mol. targets for the improvement of the diagnosis, prognosis and treatment of glioma, the overall prognosis of the disease remains poor.  This study is the first to show the significant upregulation of ARK5 paraffin-embedded archival glioma biopsies compared with those in adjacent non-cancerous brain tissues.  Statistical anal. suggests that the upregulation of ARK5 correlates with the World Health Organization grade of glioma (P < 0.001) and that patients with a high ARK5 level exhibit shorter survival time (P < 0.01).  In addn., ARK5 can promote glioma cell invasion by regulating cytoskeleton rearrangement and matrix metalloproteinase activation.  ARK5 knockdown was found to reduce brain invasion in a glioma xenograft mouse model.  Our results strongly suggest that ARK5 represents a novel and valuable biomarker to aid in the prediction of patient prognosis and is a potential therapeutic target against glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5qpZul5r0vrVg90H21EOLACvtfcHk0lgqF7hx2u0epQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFSntbfM&md5=4c925e50ea022837261e763553ca1fd5</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2012.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2012.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DS.%26aulast%3DNiu%26aufirst%3DN.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DB.%26atitle%3DARK5%2520Promotes%2520Glioma%2520Cell%2520Invasion%252C%2520and%2520Its%2520Elevated%2520Expression%2520Is%2520Correlated%2520with%2520Poor%2520Clinical%2520Outcome%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2013%26volume%3D49%26spage%3D752%26epage%3D763%26doi%3D10.1016%2Fj.ejca.2012.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z. Y.</span></span> <span> </span><span class="NLM_article-title">A New Role of NUAK1: Directly Phosphorylating P53 and Regulating Cell Proliferation</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2933</span>– <span class="NLM_lpage">2942</span>, <span class="refDoi"> DOI: 10.1038/onc.2011.19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fonc.2011.19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=21317932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVGjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=2933-2942&author=X.+Houauthor=J.+E.+Liuauthor=W.+Liuauthor=C.+Y.+Liuauthor=Z.+Y.+Liuauthor=Z.+Y.+Sun&title=A+New+Role+of+NUAK1%3A+Directly+Phosphorylating+P53+and+Regulating+Cell+Proliferation&doi=10.1038%2Fonc.2011.19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A new role of NUAK1: Directly phosphorylating p53 and regulating cell proliferation</span></div><div class="casAuthors">Hou, X.; Liu, J.-E.; Liu, W.; Liu, C.-Y.; Liu, Z.-Y.; Sun, Z.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2933-2942</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">It has been suggested that adenosine monophosphate-activated protein kinase (AMPK) and 12 AMPK-related kinases (ARK), including novel (nua) kinase family 1 (NUAK1), are activated by master kinase LKB1, a major tumor suppressor.  Apart from evidence to suggest that NUAK1 participates in induction of tumor survival, invasion and p53-independent cellular senescence, its detailed biol. functions remain unclear.  Here we showed that in the presence of wild-type LKB1, NUAK1 directly interacts with and phosphorylates p53 in vitro and in vivo.  The phosphorylation of p53 induced by LKB1 required the kinase activity of NUAK1 and phosphorylation of NUAK1 at Thr211 by LKB1 was essential for its kinase activity, which leads to the conclusion that LKB1 activates NUAK1 and regulates phosphorylation of p53 through the NUAK1 kinase, at least partially.  LKB1/NUAK1 activation leads to cell cycle arrest at the G1/S border by inducing expression of p21/WAF1.  Under the regulation of LKB1, NUAK1 interacts with p53 in the nucleus and binds to the p53-responsive element of p21/WAF1 promoter.  These findings have highlighted a novel role for NUAK1 in LKB1-related signaling pathways; NUAK1 can regulate cell proliferation and exert tumor suppression through direct interaction with p53.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKoSQTxnlahbVg90H21EOLACvtfcHk0lgPsOLb_mQxyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVGjsbk%253D&md5=b10697d03763efb757233f54b8b5a85b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fonc.2011.19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2011.19%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%2BE.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DC.%2BY.%26aulast%3DLiu%26aufirst%3DZ.%2BY.%26aulast%3DSun%26aufirst%3DZ.%2BY.%26atitle%3DA%2520New%2520Role%2520of%2520NUAK1%253A%2520Directly%2520Phosphorylating%2520P53%2520and%2520Regulating%2520Cell%2520Proliferation%26jtitle%3DOncogene%26date%3D2011%26volume%3D30%26spage%3D2933%26epage%3D2942%26doi%3D10.1038%2Fonc.2011.19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kläger, S.</span></span> <i>Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors</i>. Ph.D. Thesis, <span class="NLM_publisher-name">Technische Universität München</span>, <span class="NLM_publisher-loc">Germany</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=S.+Kl%C3%A4ger&title=Chemical+Proteomics+Reveals+the+Target+Landscape+of+Clinical+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKl%25C3%25A4ger%26aufirst%3DS.%26jtitle%3DChemical%2520Proteomics%2520Reveals%2520the%2520Target%2520Landscape%2520of%2520Clinical%2520Kinase%2520Inhibitors%26pub%3DTechnische%2520Universit%25C3%25A4t%2520M%25C3%25BCnchen%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishimoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavin, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">Identification of a Novel Protein Kinase Mediating Akt Survival Signaling to the ATM Protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1074/jbc.M206025200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M206025200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=12409306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD38XpvVWgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=48-53&author=A.+Suzukiauthor=G.+Kusakaiauthor=A.+Kishimotoauthor=J.+Luauthor=T.+Oguraauthor=M.+F.+Lavinauthor=H.+Esumi&title=Identification+of+a+Novel+Protein+Kinase+Mediating+Akt+Survival+Signaling+to+the+ATM+Protein&doi=10.1074%2Fjbc.M206025200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Protein Kinase Mediating Akt Survival Signaling to the ATM Protein</span></div><div class="casAuthors">Suzuki, Atsushi; Kusakai, Gen-ichi; Kishimoto, Atsuhiro; Lu, Jie; Ogura, Tsutomu; Lavin, Martin F.; Esumi, Hiroyasu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-53</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">We identified a novel human AMP-activated protein kinase (AMPK) family member, designated ARK5, encoding 661 amino acids with an estd. mol. mass of 74 kDa.  The putative amino acid sequence reveals 47, 45.8, 42.4, and 55% homol. to AMPK-α1, AMPK-α2, MELK, and SNARK, resp., suggesting that it is a new member of the AMPK family.  It has a putative Akt phosphorylation motif at amino acids 595-600, and Ser600 was found to be phosphorylated by active Akt resulting in the activation of kinase activity toward the SAMS peptide, a consensus AMPK substrate.  During nutrient starvation, ARK5 supported the survival of cells in an Akt-dependent manner.  In addn., we also demonstrated that ARK5, when activated by Akt, phosphorylated the ATM protein that is mutated in the human genetic disorder ataxia-telangiectasia and also induced the phosphorylation of p53.  On the basis of our current findings, we propose that a novel AMPK family member, ARK5, is the tumor cell survival factor activated by Akt and acts as an ATM kinase under the conditions of nutrient starvation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuT-kNwBTkPbVg90H21EOLACvtfcHk0lgPsOLb_mQxyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpvVWgu70%253D&md5=a52ad90eac8f2a45b62d8c25545338d9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M206025200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M206025200%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DKusakai%26aufirst%3DG.%26aulast%3DKishimoto%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DLavin%26aufirst%3DM.%2BF.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520a%2520Novel%2520Protein%2520Kinase%2520Mediating%2520Akt%2520Survival%2520Signaling%2520to%2520the%2520ATM%2520Protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D48%26epage%3D53%26doi%3D10.1074%2Fjbc.M206025200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishimoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">ARK5 Suppresses the Cell Death Induced by Nutrient Starvation and Death Receptors via Inhibition of Caspase 8 Activation, but Not by Chemotherapeutic Agents or UV Irradiation</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">6177</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1206899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fsj.onc.1206899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=13679856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlWhtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=6177&author=A.+Suzukiauthor=G.+Kusakaiauthor=A.+Kishimotoauthor=J.+Luauthor=T.+Oguraauthor=H.+Esumi&title=ARK5+Suppresses+the+Cell+Death+Induced+by+Nutrient+Starvation+and+Death+Receptors+via+Inhibition+of+Caspase+8+Activation%2C+but+Not+by+Chemotherapeutic+Agents+or+UV+Irradiation&doi=10.1038%2Fsj.onc.1206899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiation</span></div><div class="casAuthors">Suzuki, Atsushi; Kusakai, Gen-ichi; Kishimoto, Atsuhiro; Lu, Jie; Ogura, Tsutomu; Esumi, Hiroyasu</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">6177-6182</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">AMPK is a serine/threonine protein kinase family and we recently identified a novel member, ARK5.  The activation of ARK5 is triggered by Akt, and ARK5 induces tumor cell survival during nutrient starvation.  In the current study, we investigated the mechanisms of induction of cell survival by ARK5.  Human hepatoma HepG2 cells undergo necrotic cell death within 24 h after the start of glucose starvation, and the cell death signaling has been mediated by death-receptor-independent activation of caspase 8.  When HepG2 cells were transfected with ARK5 expression vector and subjected to several cell death stimuli, ARK5 was found to suppress cell death by glucose starvation, TRAIL, and TNF-α, but not by UV irradn., camptothecin, or doxorubicin.  Western blotting anal. revealed that both TRAIL and glucose starvation induced Bid cleavage and FLIP degrdn. following caspase 8 activation in a time-dependent manner, and ARK5 overexpression clearly delayed Bid cleavage, FLIP degrdn., and caspase 8 activation.  On the basis of the results of this study, we report that cell survival induced by ARK5 is, at least in part, due to inhibition of caspase 8 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon5dK8QZhTcrVg90H21EOLACvtfcHk0lgPsOLb_mQxyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlWhtbs%253D&md5=b575aaf1f9ce19b969f54f72fa62bcf9</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1206899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1206899%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DKusakai%26aufirst%3DG.%26aulast%3DKishimoto%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DARK5%2520Suppresses%2520the%2520Cell%2520Death%2520Induced%2520by%2520Nutrient%2520Starvation%2520and%2520Death%2520Receptors%2520via%2520Inhibition%2520of%2520Caspase%25208%2520Activation%252C%2520but%2520Not%2520by%2520Chemotherapeutic%2520Agents%2520or%2520UV%2520Irradiation%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D6177%26doi%3D10.1038%2Fsj.onc.1206899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paudel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H. J.</span></span> <span> </span><span class="NLM_article-title">Regulation and Function of Protein Kinases and Phosphatases</span>. <i>Enzyme Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2011</i></span>,  <span class="NLM_fpage">794089</span>, <span class="refDoi"> DOI: 10.4061/2011/794089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.4061%2F2011%2F794089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22195276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BC38%252Fps1ynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=794089&author=H.+C.+Chengauthor=R.+Z.+Qiauthor=H.+Paudelauthor=H.+J.+Zhu&title=Regulation+and+Function+of+Protein+Kinases+and+Phosphatases&doi=10.4061%2F2011%2F794089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation and function of protein kinases and phosphatases</span></div><div class="casAuthors">Cheng Heung-Chin; Qi Robert Z; Paudel Hemant; Zhu Hong-Jian</div><div class="citationInfo"><span class="NLM_cas:title">Enzyme research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">794089</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4A6JSV6MuoP6xYuD7tu2XfW6udTcc2ebNBzWoN11Aebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252Fps1ynsg%253D%253D&md5=54e052a7549da369d492bfac0e0d25ce</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.4061%2F2011%2F794089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4061%252F2011%252F794089%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%2BC.%26aulast%3DQi%26aufirst%3DR.%2BZ.%26aulast%3DPaudel%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DH.%2BJ.%26atitle%3DRegulation%2520and%2520Function%2520of%2520Protein%2520Kinases%2520and%2520Phosphatases%26jtitle%3DEnzyme%2520Res.%26date%3D2011%26volume%3D2011%26spage%3D794089%26doi%3D10.4061%2F2011%2F794089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Domenech Moreno, E.</span></span> <i>Identification of New Protein-Protein Interactions with NUAK2 by Proximity-Dependent Biotin Labeling</i>, Master’s Thesis, <span class="NLM_publisher-name">Helsingin yliopisto</span>, <span class="NLM_publisher-loc">Finland</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=E.+Domenech+Moreno&title=Identification+of+New+Protein-Protein+Interactions+with+NUAK2+by+Proximity-Dependent+Biotin+Labeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDomenech%2BMoreno%26aufirst%3DE.%26jtitle%3DIdentification%2520of%2520New%2520Protein-Protein%2520Interactions%2520with%2520NUAK2%2520by%2520Proximity-Dependent%2520Biotin%2520Labeling%26pub%3DHelsingin%2520yliopisto%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lizcano, J. M</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goransson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrice, N. A</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boudeau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawley, S. A</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udd, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makela, T. P</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardie, D G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R</span></span> <span> </span><span class="NLM_article-title">LKB1 Is a Master Kinase That Activates 13 Kinases of the AMPK Subfamily, Including MARK/PAR-1</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">843</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7600110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fsj.emboj.7600110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=14976552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFCjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=833-843&author=J.+M+Lizcanoauthor=O.+Goranssonauthor=R.+Tothauthor=M.+Deakauthor=N.+A+Morriceauthor=J.+Boudeauauthor=S.+A+Hawleyauthor=L.+Uddauthor=T.+P+Makelaauthor=D+G.+Hardieauthor=D.+R+Alessi&title=LKB1+Is+a+Master+Kinase+That+Activates+13+Kinases+of+the+AMPK+Subfamily%2C+Including+MARK%2FPAR-1&doi=10.1038%2Fsj.emboj.7600110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1</span></div><div class="casAuthors">Lizcano, Jose M.; Goeransson, Olga; Toth, Rachel; Deak, Maria; Morrice, Nick A.; Boudeau, Jerome; Hawley, Simon A.; Udd, Lina; Maekelae, Tomi P.; Hardie, D. Grahame; Alessi, Dario R.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">833-843</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We recently demonstrated that the LKB1 tumor suppressor kinase, in complex with the pseudokinase STRAD and the scaffolding protein MO25, phosphorylates and activates AMP-activated protein kinase (AMPK).  A total of 12 human kinases (NUAK1, NUAK2, BRSK1, BRSK2, QIK, QSK, SIK, MARK1, MARK2, MARK3, MARK4 and MELK) are related to AMPK.  Here we demonstrate that LKB1 can phosphorylate the T-loop of all the members of this subfamily, apart from MELK, increasing their activity >50-fold.  LKB1 catalytic activity and the presence of MO25 and STRAD are required for activation.  Mutation of the T-loop Thr phosphorylated by LKB1 to Ala prevented activation, while mutation to glutamate produced active forms of many of the AMPK-related kinases.  Activities of endogenous NUAK2, QIK, QSK, SIK, MARK1, MARK2/3 and MARK4 were markedly reduced in LKB1-deficient cells.  Neither LKB1 activity nor that of AMPK-related kinases was stimulated by phenformin or AICAR, which activate AMPK.  Our results show that LKB1 functions as a master upstream protein kinase, regulating AMPK-related kinases as well as AMPK.  Between them, these kinases may mediate the physiol. effects of LKB1, including its tumor suppressor function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzr93XYu3yFbVg90H21EOLACvtfcHk0ljzXTvryn8kBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFCjtbs%253D&md5=1aab7e4182fae41b3597b73baa5f0b7d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7600110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7600110%26sid%3Dliteratum%253Aachs%26aulast%3DLizcano%26aufirst%3DJ.%2BM%26aulast%3DGoransson%26aufirst%3DO.%26aulast%3DToth%26aufirst%3DR.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DMorrice%26aufirst%3DN.%2BA%26aulast%3DBoudeau%26aufirst%3DJ.%26aulast%3DHawley%26aufirst%3DS.%2BA%26aulast%3DUdd%26aufirst%3DL.%26aulast%3DMakela%26aufirst%3DT.%2BP%26aulast%3DHardie%26aufirst%3DD%2BG.%26aulast%3DAlessi%26aufirst%3DD.%2BR%26atitle%3DLKB1%2520Is%2520a%2520Master%2520Kinase%2520That%2520Activates%252013%2520Kinases%2520of%2520the%2520AMPK%2520Subfamily%252C%2520Including%2520MARK%252FPAR-1%26jtitle%3DEMBO%2520J.%26date%3D2004%26volume%3D23%26spage%3D833%26epage%3D843%26doi%3D10.1038%2Fsj.emboj.7600110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakai, G. -i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishimoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">ARK5 Is a Tumor Invasion-Associated Factor Downstream of Akt Signaling</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3526</span>– <span class="NLM_lpage">3535</span>, <span class="refDoi"> DOI: 10.1128/MCB.24.8.3526-3535.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1128%2FMCB.24.8.3526-3535.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15060171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFKjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=3526-3535&author=A.+Suzukiauthor=J.+Luauthor=G.+-i.+Kusakaiauthor=A.+Kishimotoauthor=T.+Oguraauthor=H.+Esumi&title=ARK5+Is+a+Tumor+Invasion-Associated+Factor+Downstream+of+Akt+Signaling&doi=10.1128%2FMCB.24.8.3526-3535.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">ARK5 is a tumor invasion-associated factor downstream of Akt signaling</span></div><div class="casAuthors">Suzuki, Atsushi; Lu, Jie; Kusakai, Gen-ichi; Kishimoto, Atsuhiro; Ogura, Tsutomu; Esumi, Hiroyasu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3526-3535</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">AMP-activated protein kinases (AMPKs) are a class of serine/threonine protein kinases that are activated by an increase in intracellular AMP concn.  They are a sensitive indicator of cellular energy status and have been found to promote tumor cell survival during nutrient starvation.  We recently identified a novel AMPK catalytic subunit family member, ARK5, whose activation is directly regulated by Akt, which, in turn, has been reported to be a key player in tumor malignancy.  In this study, we attempted to det. whether ARK5 is involved in tumor malignancy under regulation by Akt.  Matrigel invasion assays demonstrated that both overexpressed and endogenous ARK5 showed strong activity dependent on Akt.  In addn., ARK5 expression induced activation of matrix metalloproteinase 2 (MMP-2) and MMP-9 following new expression of membrane type 1 MMP (MT1-MMP), and the MT1-MMP expression induced by ARK5 was initiated by rapamycin-sensitive signaling.  In nude mice, ARK5 expression was assocd. with a significant increase in tumor growth and significant suppression of necrosis in tumor tissue.  Interestingly, only the ARK5-overexpressing PANC-1 cell line (P/ARK) tumor showed invasion and metastasis in nude mice, although Akt was activated in tumors derived from both P/ARK and its parental cell line.  We report that a novel AMPK catalytic subunit family member, ARK5, plays a key role in tumor malignancy downstream of Akt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp2pQK3k2_uLVg90H21EOLACvtfcHk0ljzXTvryn8kBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFKjtLk%253D&md5=cf805bd959892c2da70eebd31559ce3b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.8.3526-3535.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.8.3526-3535.2004%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DKusakai%26aufirst%3DG.%2B-i.%26aulast%3DKishimoto%26aufirst%3DA.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DARK5%2520Is%2520a%2520Tumor%2520Invasion-Associated%2520Factor%2520Downstream%2520of%2520Akt%2520Signaling%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D3526%26epage%3D3535%26doi%3D10.1128%2FMCB.24.8.3526-3535.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marx, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugoor, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panneerselvam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of Polarity-Inducing Kinase Family MARK/Par-1 within the Branch of AMPK/Snf1-Related Kinases</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1637</span>– <span class="NLM_lpage">1648</span>, <span class="refDoi"> DOI: 10.1096/fj.09-148064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1096%2Ffj.09-148064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=20071654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnt1Ojtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=1637-1648&author=A.+Marxauthor=C.+Nugoorauthor=S.+Panneerselvamauthor=E.+Mandelkow&title=Structure+and+Function+of+Polarity-Inducing+Kinase+Family+MARK%2FPar-1+within+the+Branch+of+AMPK%2FSnf1-Related+Kinases&doi=10.1096%2Ffj.09-148064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of polarity-inducing kinase family MARK/Par-1 within the branch of AMPK/Snf1-related kinases</span></div><div class="casAuthors">Marx, A.; Nugoor, C.; Panneerselvam, S.; Mandelkow, E.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1637-1648, 10.1096/fj.09-148064</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review.  Kinases of the MARK/Par-1 family of S/T protein kinases are regulators of diverse cellular processes in Caenorhabditis elegans, Drosophila, yeast, and mammalian cells.  They are involved in nematode embryogenesis, epithelial cell polarization, cell signaling, and neuronal differentiation.  MARK phosphorylates microtubule-assocd. proteins such as tau and is a key regulator of microtubule-based intracellular transport.  Hyperphosphorylation of tau causes defects in neuronal transport and may induce abnormal aggregation of tau in Alzheimer disease and other tauopathies.  Recent high-resoln. structure anal. of MARK fragments covering the kinase domain and accessory regulatory domains has revealed important details regarding the autoregulation of MARK, but their interpretation has remained controversial.  Here, the authors focus on the structural aspects of MARK activity and autoregulation.  Comparison of the available MARK structures with related kinases of the AMPK family and with new structures of MARK isoforms (MARK2 and MARK3) reveals unexpected structural similarities between these kinases that may help to resolve the existing controversies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGEBJF7HxdZ7Vg90H21EOLACvtfcHk0lj9gpteFYDFBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnt1Ojtbs%253D&md5=ab8f0ca6a38b55ee99e7b74f265e08c1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1096%2Ffj.09-148064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.09-148064%26sid%3Dliteratum%253Aachs%26aulast%3DMarx%26aufirst%3DA.%26aulast%3DNugoor%26aufirst%3DC.%26aulast%3DPanneerselvam%26aufirst%3DS.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DStructure%2520and%2520Function%2520of%2520Polarity-Inducing%2520Kinase%2520Family%2520MARK%252FPar-1%2520within%2520the%2520Branch%2520of%2520AMPK%252FSnf1-Related%2520Kinases%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26spage%3D1637%26epage%3D1648%26doi%3D10.1096%2Ffj.09-148064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardie, D. G.</span></span> <span> </span><span class="NLM_article-title">AMP-Activated/SNF1 Protein Kinases: Conserved Guardians of Cellular Energy</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">774</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1038/nrm2249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fnrm2249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=17712357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKmt7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=774-785&author=D.+G.+Hardie&title=AMP-Activated%2FSNF1+Protein+Kinases%3A+Conserved+Guardians+of+Cellular+Energy&doi=10.1038%2Fnrm2249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy</span></div><div class="casAuthors">Hardie, D. Grahame</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">774-785</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The SNF1/AMP-activated protein kinase (AMPK) family maintains the balance between ATP prodn. and consumption in all eukaryotic cells.  The kinases are heterotrimers that comprise a catalytic subunit and regulatory subunits that sense cellular energy levels.  When energy status is compromised, the system activates catabolic pathways and switches off protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation.  Surprisingly, recent results indicate that the AMPK system is also important in functions that go beyond the regulation of energy homeostasis, such as the maintenance of cell polarity in epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpQCBXuVk2N7Vg90H21EOLACvtfcHk0lj9gpteFYDFBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKmt7vP&md5=ebf155462b8d49227514227561cf90a9</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrm2249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2249%26sid%3Dliteratum%253Aachs%26aulast%3DHardie%26aufirst%3DD.%2BG.%26atitle%3DAMP-Activated%252FSNF1%2520Protein%2520Kinases%253A%2520Conserved%2520Guardians%2520of%2520Cellular%2520Energy%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D774%26epage%3D785%26doi%3D10.1038%2Fnrm2249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. H.</span></span> <span> </span><span class="NLM_article-title">Cross-Talk between AMPK and MTOR in Regulating Energy Balance</span>. <i>Crit. Rev. Food Sci. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1080/10408398.2010.500245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1080%2F10408398.2010.500245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22369257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms1WgtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=373-381&author=J.+Xuauthor=J.+Jiauthor=X.+H.+Yan&title=Cross-Talk+between+AMPK+and+MTOR+in+Regulating+Energy+Balance&doi=10.1080%2F10408398.2010.500245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-Talk between AMPK and mTOR in Regulating Energy Balance</span></div><div class="casAuthors">Xu, Jia; Ji, Jian; Yan, Xiang-Hua</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Food Science and Nutrition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">373-381</span>CODEN:
                <span class="NLM_cas:coden">CRFND6</span>;
        ISSN:<span class="NLM_cas:issn">1040-8398</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  Energy balance is maintained by a complex homeostatic system involving some signaling pathways and "nutrient sensors" in multiple tissues and organs.  Any defect assocd. with the pathways can lead to metabolic disorders including obesity, type 2 diabetes, and the metabolic syndrome.  The 5'-adenosine monophosphate-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) appear to play a significant role in the intermediary metab. of these diseases.  AMPK is involved in the fundamental regulation of energy balance at the whole body level by responding to hormonal and nutrient signals in the central nervous system and peripheral tissues that modulate food intake and energy expenditure.  Mammalian target of rapamycin (mTOR),is one of the downstream targets of AMPK functions as an intracellular nutrient sensor to control protein synthesis, cell growth, and metab.  Recent research demonstrated the possible interplay between mTOR and AMPK signaling pathways.  In this review, we will present current knowledge of AMPK and mTOR pathways in regulating energy balance and demonstrate the convergence between these two pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnS4N5k5NH6LVg90H21EOLACvtfcHk0lj9gpteFYDFBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms1WgtLw%253D&md5=0232b59ccadfd284f612a5089c9e0ed3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1080%2F10408398.2010.500245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408398.2010.500245%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DX.%2BH.%26atitle%3DCross-Talk%2520between%2520AMPK%2520and%2520MTOR%2520in%2520Regulating%2520Energy%2520Balance%26jtitle%3DCrit.%2520Rev.%2520Food%2520Sci.%2520Nutr.%26date%3D2012%26volume%3D52%26spage%3D373%26epage%3D381%26doi%3D10.1080%2F10408398.2010.500245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bull, D.</span></span> <i>Investigating the Role and Regulation of the AMPK-Related Kinase NUAK1</i>, Ph.D. Thesis, <span class="NLM_publisher-name">Imperial College London</span>, <span class="NLM_publisher-loc">United Kingdom</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=D.+Bull&title=Investigating+the+Role+and+Regulation+of+the+AMPK-Related+Kinase+NUAK1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBull%26aufirst%3DD.%26jtitle%3DInvestigating%2520the%2520Role%2520and%2520Regulation%2520of%2520the%2520AMPK-Related%2520Kinase%2520NUAK1%26pub%3DImperial%2520College%2520London%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppelt, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">Muscle Contractions, AICAR, and Insulin Cause Phosphorylation of an AMPK-Related Kinase</span>. <i>Am. J. Physiol. - Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">E986</span>– <span class="NLM_lpage">E992</span>, <span class="refDoi"> DOI: 10.1152/ajpendo.00335.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1152%2Fajpendo.00335.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=16030062" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2005&pages=E986-E992&author=J.+S.+Fisherauthor=J.+S.+Juauthor=P.+J.+Oppeltauthor=J.+L.+Smithauthor=A.+Suzukiauthor=H.+Esumi&title=Muscle+Contractions%2C+AICAR%2C+and+Insulin+Cause+Phosphorylation+of+an+AMPK-Related+Kinase&doi=10.1152%2Fajpendo.00335.2004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.00335.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.00335.2004%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DJ.%2BS.%26aulast%3DJu%26aufirst%3DJ.%2BS.%26aulast%3DOppelt%26aufirst%3DP.%2BJ.%26aulast%3DSmith%26aufirst%3DJ.%2BL.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DMuscle%2520Contractions%252C%2520AICAR%252C%2520and%2520Insulin%2520Cause%2520Phosphorylation%2520of%2520an%2520AMPK-Related%2520Kinase%26jtitle%3DAm.%2520J.%2520Physiol.%2520-%2520Endocrinol.%2520Metab.%26date%3D2005%26volume%3D289%26spage%3DE986%26epage%3DE992%26doi%3D10.1152%2Fajpendo.00335.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lefebvre, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahmolky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drucker, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, C. F.</span></span> <span> </span><span class="NLM_article-title">Identification and Characterization of a Novel Sucrose-Non-Fermenting Protein Kinase/AMP-Activated Protein Kinase-Related Protein Kinase, SNARK</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1042/0264-6021:3550297</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1042%2Fbj3550297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=11284715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsValur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2001&pages=297-305&author=D.+L.+Lefebvreauthor=Y.+Baiauthor=N.+Shahmolkyauthor=M.+Sharmaauthor=R.+Poonauthor=D.+J.+Druckerauthor=C.+F.+Rosen&title=Identification+and+Characterization+of+a+Novel+Sucrose-Non-Fermenting+Protein+Kinase%2FAMP-Activated+Protein+Kinase-Related+Protein+Kinase%2C+SNARK&doi=10.1042%2F0264-6021%3A3550297"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of a novel sucrose-non-fermenting protein kinase/AMP-activated protein kinase-related protein kinase, SNARK</span></div><div class="casAuthors">Lefebvre, Diana L.; Bai, Yahong; Shahmolky, Nazanin; Sharma, Monika; Poon, Raymond; Drucker, Daniel J.; Rosen, Cheryl F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">297-305</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Subtraction hybridization after the exposure of keratinocytes to UV radiation identified a differentially expressed cDNA that encodes a protein of 630 amino acid residues possessing significant similarity to the catalytic domain of the sucrose-non-fermenting protein kinase (SNF1)/AMP-activated protein kinase (AMPK) family of serine/threonine protein kinases.  Northern blotting and reverse-transcriptase-mediated PCR demonstrated that mRNA transcripts for the SNF1/AMPK-related kinase (SNARK) were widely expressed in rodent tissues.  The SNARK gene was localized to human chromosome 1q32 by fluorescent in situ hybridization.  SNARK was translated in vitro to yield a single protein band of approx. 76 kDa; Western anal. of transfected baby hamster kidney (BHK) cells detected two SNARK-immunoreactive bands of approx. 76-80 kDa.  SNARK was capable of autophosphorylation in vitro; immunopptd. SNARK exhibited phosphotransferase activity with the synthetic peptide substrate HMRSAMSGLHLVKRR (SAMS) as a kinase substrate.  SNARK activity was significantly increased by AMP and 5-amino-4-imidazolecarboxamide riboside (AICAriboside) in rat keratinocyte cells, implying that SNARK might be activated by an AMPK kinase-dependent pathway.  Furthermore, glucose deprivation increased SNARK activity 3-fold in BHK fibroblasts.  These findings identify SNARK as a glucose- and AICAriboside-regulated member of the AMPK-related gene family that represents a new candidate mediator of the cellular response to metabolic stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquvJv0tlxC17Vg90H21EOLACvtfcHk0lhcPx3NnPulNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsValur8%253D&md5=c3d75be60fe8b24fcf5c5f0589b1fc36</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1042%2Fbj3550297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3550297%26sid%3Dliteratum%253Aachs%26aulast%3DLefebvre%26aufirst%3DD.%2BL.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DShahmolky%26aufirst%3DN.%26aulast%3DSharma%26aufirst%3DM.%26aulast%3DPoon%26aufirst%3DR.%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26aulast%3DRosen%26aufirst%3DC.%2BF.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520a%2520Novel%2520Sucrose-Non-Fermenting%2520Protein%2520Kinase%252FAMP-Activated%2520Protein%2520Kinase-Related%2520Protein%2520Kinase%252C%2520SNARK%26jtitle%3DBiochem.%2520J.%26date%3D2001%26volume%3D355%26spage%3D297%26epage%3D305%26doi%3D10.1042%2F0264-6021%3A3550297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katajisto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallenius, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaahtomeri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udd, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiainen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mäkelä, T. P.</span></span> <span> </span><span class="NLM_article-title">The LKB1 Tumor Suppressor Kinase in Human Disease</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1775</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.bbcan.2006.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.bbcan.2006.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=17010524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlaltr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1775&publication_year=2007&pages=63-75&author=P.+Katajistoauthor=T.+Valleniusauthor=K.+Vaahtomeriauthor=N.+Ekmanauthor=L.+Uddauthor=M.+Tiainenauthor=T.+P.+M%C3%A4kel%C3%A4&title=The+LKB1+Tumor+Suppressor+Kinase+in+Human+Disease&doi=10.1016%2Fj.bbcan.2006.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The LKB1 tumor suppressor kinase in human disease</span></div><div class="casAuthors">Katajisto, Pekka; Vallenius, Tea; Vaahtomeri, Kari; Ekman, Niklas; Udd, Lina; Tiainen, Marianne; Maekelae, Tomi P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1775</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-75</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Inactivating germline mutations in the LKB1 gene underlie Peutz-Jeghers syndrome characterized by hamartomatous polyps and an elevated risk for cancer.  Recent studies suggest the involvement of LKB1 also in more common human disorders including diabetes and in a significant fraction of lung adenocarcinomas.  These observations have increased the interest towards signaling pathways of this tumor suppressor kinase.  The recent breakthroughs in understanding the mol. functions of the LKB1 indicate its contribution as a regulator of cell polarity, energy metab. and cell proliferation.  Here we review how the substrates and cellular functions of LKB1 may be linked to Peutz-Jeghers syndrome and other diseases, and discuss how some of the mol. changes assocd. with altered LKB1 signaling might be used in therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgGAfGU1gOV7Vg90H21EOLACvtfcHk0lhcPx3NnPulNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlaltr%252FI&md5=936e91dd7e160b0b01db7253d9141763</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2006.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2006.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DKatajisto%26aufirst%3DP.%26aulast%3DVallenius%26aufirst%3DT.%26aulast%3DVaahtomeri%26aufirst%3DK.%26aulast%3DEkman%26aufirst%3DN.%26aulast%3DUdd%26aufirst%3DL.%26aulast%3DTiainen%26aufirst%3DM.%26aulast%3DM%25C3%25A4kel%25C3%25A4%26aufirst%3DT.%2BP.%26atitle%3DThe%2520LKB1%2520Tumor%2520Suppressor%2520Kinase%2520in%2520Human%2520Disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2007%26volume%3D1775%26spage%3D63%26epage%3D75%26doi%3D10.1016%2Fj.bbcan.2006.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoppe, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reedy, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schriefer, L. A.</span></span> <span> </span><span class="NLM_article-title">Caenorhabditis Elegans Unc-82 Encodes a Serine/Threonine Kinase Important for Myosin Filament Organization in Muscle during Growth</span>. <i>Genetics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1534/genetics.109.110189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1534%2Fgenetics.109.110189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=19901071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOntbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2010&pages=79-90&author=P.+E.+Hoppeauthor=J.+Chauauthor=K.+A.+Flanaganauthor=A.+R.+Reedyauthor=L.+A.+Schriefer&title=Caenorhabditis+Elegans+Unc-82+Encodes+a+Serine%2FThreonine+Kinase+Important+for+Myosin+Filament+Organization+in+Muscle+during+Growth&doi=10.1534%2Fgenetics.109.110189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Caenorhabditis elegans unc-82 encodes a serine/threonine kinase important for myosin filament organization in muscle during growth</span></div><div class="casAuthors">Hoppe, Pamela E.; Chau, Johnnie; Flanagan, Kelly A.; Reedy, April R.; Schriefer, Lawrence A.</div><div class="citationInfo"><span class="NLM_cas:title">Genetics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-90</span>CODEN:
                <span class="NLM_cas:coden">GENTAE</span>;
        ISSN:<span class="NLM_cas:issn">0016-6731</span>.
    
            (<span class="NLM_cas:orgname">Genetics Society of America</span>)
        </div><div class="casAbstract">Mutations in the unc-82 locus of Caenorhabditis elegans were previously identified by screening for disrupted muscle cytoskeleton in otherwise apparently normal mutagenized animals.  Here we demonstrate that the locus encodes a serine/threonine kinase orthologous to human ARK5/SNARK (NUAK1/NUAK2) and related to the PAR-1 and SNF1/AMP-Activated kinase (AMPK) families.  The predicted 1600-amino-acid polypeptide contains an N-terminal catalytic domain and noncomplex repetitive sequence in the remainder of the mol.  Phenotypic analyses indicate that unc-82 is required for maintaining the organization of myosin filaments and internal components of the M-line during cell-shape changes.  Mutants exhibit normal patterning of cytoskeletal elements during early embryogenesis.  Defects in localization of thick filament and M-line components arise during embryonic elongation and become progressively more severe as development proceeds.  The phenotype is independent of contractile activity, consistent with unc-82 mutations preventing proper cytoskeletal reorganization during growth, rather than undermining structural integrity of the M-line.  This is the first report establishing a role for the UNC-82/ARK5/SNARK kinases in normal development.  We propose that activation of UNC-82 kinase during cell elongation regulates thick filament attachment or growth, perhaps through phosphorylation of myosin and paramyosin.  We speculate that regulation of myosin is an ancestral characteristic of kinases in this region of the kinome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppMaV_9tMnq7Vg90H21EOLACvtfcHk0lhcPx3NnPulNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOntbfF&md5=4755cc0e022e9581b08b16fc98dd1c93</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1534%2Fgenetics.109.110189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1534%252Fgenetics.109.110189%26sid%3Dliteratum%253Aachs%26aulast%3DHoppe%26aufirst%3DP.%2BE.%26aulast%3DChau%26aufirst%3DJ.%26aulast%3DFlanagan%26aufirst%3DK.%2BA.%26aulast%3DReedy%26aufirst%3DA.%2BR.%26aulast%3DSchriefer%26aufirst%3DL.%2BA.%26atitle%3DCaenorhabditis%2520Elegans%2520Unc-82%2520Encodes%2520a%2520Serine%252FThreonine%2520Kinase%2520Important%2520for%2520Myosin%2520Filament%2520Organization%2520in%2520Muscle%2520during%2520Growth%26jtitle%3DGenetics%26date%3D2010%26volume%3D184%26spage%3D79%26epage%3D90%26doi%3D10.1534%2Fgenetics.109.110189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lefebvre, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, C. F.</span></span> <span> </span><span class="NLM_article-title">Regulation of SNARK Activity in Response to Cellular Stresses</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1724</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2005.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.bbagen.2005.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFGisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1724&publication_year=2005&pages=71-85&author=D.+L.+Lefebvreauthor=C.+F.+Rosen&title=Regulation+of+SNARK+Activity+in+Response+to+Cellular+Stresses&doi=10.1016%2Fj.bbagen.2005.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of SNARK activity in response to cellular stresses</span></div><div class="casAuthors">Lefebvre, Diana L.; Rosen, Cheryl F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1724</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">71-85</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">SNARK is a member of the AMPK subfamily of serine/threonine protein kinases.  In this study, we examd. the regulation of SNARK activity in kidney (BHK, HEK293), pancreatic β-cell insulinoma (INS-1), hepatocarcinoma (H4IIE) and keratinocyte (NRKC)-derived cell lines in response to diverse cellular stresses.  We show that SNARK activity is regulated by glucose- or glutamine-deprivation, induction of endoplasmic reticulum stress by homocysteine or DTT, elevation of cellular AMP and/or depletion of ATP, hyperosmotic stress, salt stress, UV B radiation and oxidative stress caused by hydrogen peroxide.  Moreover, the regulation of SNARK activity in response to cellular stresses depends greatly upon cell type.  Furthermore, SNARK activity is downregulated by metformin in a dose- and time-dependent manner in H4IIE cells.  These observations support a role for SNARK as a mol. component of the cellular stress response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZKW01TW42ArVg90H21EOLACvtfcHk0lggAKckRViyug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFGisb8%253D&md5=800ac654b9fc04021efe53bcf97c2e31</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2005.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2005.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DLefebvre%26aufirst%3DD.%2BL.%26aulast%3DRosen%26aufirst%3DC.%2BF.%26atitle%3DRegulation%2520of%2520SNARK%2520Activity%2520in%2520Response%2520to%2520Cellular%2520Stresses%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2005%26volume%3D1724%26spage%3D71%26epage%3D85%26doi%3D10.1016%2Fj.bbagen.2005.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rune, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osler, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zierath, J. R.</span></span> <span> </span><span class="NLM_article-title">Regulation of Skeletal Muscle Sucrose, Non-Fermenting 1/AMP-Activated Protein Kinase-Related Kinase (SNARK) by Metabolic Stress and Diabetes</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2182</span>– <span class="NLM_lpage">2189</span>, <span class="refDoi"> DOI: 10.1007/s00125-009-1465-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1007%2Fs00125-009-1465-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=19652946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVygtLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2182-2189&author=A.+Runeauthor=M.+E.+Oslerauthor=T.+Fritzauthor=J.+R.+Zierath&title=Regulation+of+Skeletal+Muscle+Sucrose%2C+Non-Fermenting+1%2FAMP-Activated+Protein+Kinase-Related+Kinase+%28SNARK%29+by+Metabolic+Stress+and+Diabetes&doi=10.1007%2Fs00125-009-1465-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of skeletal muscle sucrose, non-fermenting 1/AMP-activated protein kinase-related kinase (SNARK) by metabolic stress and diabetes</span></div><div class="casAuthors">Rune, A.; Osler, M. E.; Fritz, T.; Zierath, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2182-2189</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aims/hypothesis: Sucrose, non-fermenting 1/AMP-activated protein kinase-related kinase (SNARK) is involved in cellular stress responses linked to obesity and type 2 diabetes.  We detd. the role of SNARK in response to metabolic stress and insulin action on glucose and lipid metab. in skeletal muscle.  Methods: Vastus lateralis skeletal muscle biopsies were obtained from normal glucose tolerant (n = 35) and type 2 diabetic (n = 31) men and women for SNARK expression studies.  Primary myotube cultures were derived from biopsies obtained from normal glucose tolerant individuals for metabolic studies.  Results: SNARK (also known as NUAK2) mRNA expression was unaltered between normal glucose tolerant individuals and type 2 diabetic patients.  SNARK expression was increased in skeletal muscle from obese (BMI >31 kg/m2) normal glucose tolerant individuals and type 2 diabetic patients (1.4- and 1.4-fold, resp., p < 0.05) vs overweight (BMI <28 kg/m2) normal glucose tolerant individuals and type 2 diabetic patients.  SNARK mRNA was increased in myotubes exposed to palmitate (12-fold; p < 0.01), or TNF-α (25-fold, p < 0.05), but not to oleate, glucose or IL-6, whereas expression of the AMP-activated protein kinase α2 subunit was unaltered.  Small interfering (si)RNA against SNARK reduced mRNA and protein in myotubes by 61% and 60%, resp. (p < 0.05).  SNARK siRNA was without effect on basal or insulin-stimulated glucose uptake or lipid oxidn., and insufficient to rescue TNF-α- or palmitate-induced insulin resistance.  Conclusions/interpretation: Skeletal muscle SNARK expression is increased in human obesity, and in response to metabolic stressors, but not type 2 diabetes.  Partial SNARK depletion failed to modify either glucose or lipid metab., or protect against TNF-α- or palmitate-induced insulin resistance in primary human myotubes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXp2SjR73Ad7Vg90H21EOLACvtfcHk0lggAKckRViyug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVygtLbN&md5=022f689d4333704ad2819014bf4e13e5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs00125-009-1465-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-009-1465-x%26sid%3Dliteratum%253Aachs%26aulast%3DRune%26aufirst%3DA.%26aulast%3DOsler%26aufirst%3DM.%2BE.%26aulast%3DFritz%26aufirst%3DT.%26aulast%3DZierath%26aufirst%3DJ.%2BR.%26atitle%3DRegulation%2520of%2520Skeletal%2520Muscle%2520Sucrose%252C%2520Non-Fermenting%25201%252FAMP-Activated%2520Protein%2520Kinase-Related%2520Kinase%2520%2528SNARK%2529%2520by%2520Metabolic%2520Stress%2520and%2520Diabetes%26jtitle%3DDiabetologia%26date%3D2009%26volume%3D52%26spage%3D2182%26epage%3D2189%26doi%3D10.1007%2Fs00125-009-1465-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koh, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathod, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middelbeek, R. J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessard, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treebak, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtaszewski, J. F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirshman, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodyear, L. J.</span></span> <span> </span><span class="NLM_article-title">Sucrose Nonfermenting AMPK-Related Kinase (SNARK) Mediates Contraction-Stimulated Glucose Transport in Mouse Skeletal Muscle</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">15541</span>– <span class="NLM_lpage">15546</span>, <span class="refDoi"> DOI: 10.1073/pnas.1008131107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1073%2Fpnas.1008131107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=20713714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaqu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=15541-15546&author=H.-J.+Kohauthor=T.+Toyodaauthor=N.+Fujiiauthor=M.+M.+Jungauthor=A.+Rathodauthor=R.+J.-W.+Middelbeekauthor=S.+J.+Lessardauthor=J.+T.+Treebakauthor=K.+Tsuchiharaauthor=H.+Esumiauthor=E.+A.+Richterauthor=J.+F.+P.+Wojtaszewskiauthor=M.+F.+Hirshmanauthor=L.+J.+Goodyear&title=Sucrose+Nonfermenting+AMPK-Related+Kinase+%28SNARK%29+Mediates+Contraction-Stimulated+Glucose+Transport+in+Mouse+Skeletal+Muscle&doi=10.1073%2Fpnas.1008131107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Sucrose nonfermenting AMPK-related kinase (SNARK) mediates contraction-stimulated glucose transport in mouse skeletal muscle</span></div><div class="casAuthors">Koh, Ho-Jin; Toyoda, Taro; Fujii, Nobuharu; Jung, Michelle M.; Rathod, Amee; Middelbeek, R. Jan-Willem; Lessard, Sarah J.; Treebak, Jonas T.; Tsuchihara, Katsuya; Esumi, Hiroyasu; Richter, Erik A.; Wojtaszewski, Jorgen F. P.; Hirshman, Michael F.; Goodyear, Laurie J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">15541-15546, S15541/1-S15541/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The signaling mechanisms that mediate the important effects of contraction to increase glucose transport in skeletal muscle are not well understood, but are known to occur through an insulin-independent mechanism.  Muscle-specific knockout of LKB1, an upstream kinase for AMPK and AMPK-related protein kinases, significantly inhibited contraction-stimulated glucose transport.  This finding, in conjunction with previous studies of ablated AMPKα2 activity showing no effect on contraction-stimulated glucose transport, suggests that one or more AMPK-related protein kinases are important for this process.  Muscle contraction increased sucrose nonfermenting AMPK-related kinase (SNARK) activity, an effect blunted in the muscle-specific LKB1 knockout mice.  Expression of a mutant SNARK in mouse tibialis anterior muscle impaired contraction-stimulated, but not insulin-stimulated, glucose transport.  Whole-body SNARK heterozygotic knockout mice also had impaired contraction-stimulated glucose transport in skeletal muscle, and knockdown of SNARK in C2C12 muscle cells impaired sorbitol-stimulated glucose transport.  SNARK is activated by muscle contraction and is a unique mediator of contraction-stimulated glucose transport in skeletal muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-xuJlbFtRuLVg90H21EOLACvtfcHk0lggAKckRViyug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaqu7%252FO&md5=719969b715141ae60f4664438b55534d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1008131107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1008131107%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DH.-J.%26aulast%3DToyoda%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DJung%26aufirst%3DM.%2BM.%26aulast%3DRathod%26aufirst%3DA.%26aulast%3DMiddelbeek%26aufirst%3DR.%2BJ.-W.%26aulast%3DLessard%26aufirst%3DS.%2BJ.%26aulast%3DTreebak%26aufirst%3DJ.%2BT.%26aulast%3DTsuchihara%26aufirst%3DK.%26aulast%3DEsumi%26aufirst%3DH.%26aulast%3DRichter%26aufirst%3DE.%2BA.%26aulast%3DWojtaszewski%26aufirst%3DJ.%2BF.%2BP.%26aulast%3DHirshman%26aufirst%3DM.%2BF.%26aulast%3DGoodyear%26aufirst%3DL.%2BJ.%26atitle%3DSucrose%2520Nonfermenting%2520AMPK-Related%2520Kinase%2520%2528SNARK%2529%2520Mediates%2520Contraction-Stimulated%2520Glucose%2520Transport%2520in%2520Mouse%2520Skeletal%2520Muscle%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D15541%26epage%3D15546%26doi%3D10.1073%2Fpnas.1008131107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X. C.</span></span> <span> </span><span class="NLM_article-title">ARK5 Is Associated with the Invasive and Metastatic Potential of Human Breast Cancer Cells</span>. <i>J. Cancer Res. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1007/s00432-011-1102-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1007%2Fs00432-011-1102-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22105900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XpslOlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2012&pages=247-254&author=X.+Z.+Changauthor=J.+Yuauthor=H.+Y.+Liuauthor=R.+H.+Dongauthor=X.+C.+Cao&title=ARK5+Is+Associated+with+the+Invasive+and+Metastatic+Potential+of+Human+Breast+Cancer+Cells&doi=10.1007%2Fs00432-011-1102-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">ARK5 is associated with the invasive and metastatic potential of human breast cancer cells</span></div><div class="casAuthors">Chang, Xin-Zhong; Yu, Jie; Liu, Hai-Yin; Dong, Rui-Hua; Cao, Xu-Chen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Research and Clinical Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-254</span>CODEN:
                <span class="NLM_cas:coden">JCROD7</span>;
        ISSN:<span class="NLM_cas:issn">0171-5216</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The aim was to investigate the effects of Akt/ARK5 pathways on the metastatic potential of human breast cancer cells.  The human ARK5 gene was transfected into MDA-MB-231 cells.  Effects of ARK5 on MDA-MB-231 cells were investigated in vitro.  The tumorigenicity and spontaneously metastatic capability regulated by ARK5 were detd. using an orthotopic xenograft tumor model.  ARK5 enhanced the invasive and metastatic potential of MDA-MB-231 cells under regulation by Akt.  The enhancement was assocd. with increasing MMP-2, MMP-9, and MT1-MMP expression.  The results were further demonstrated by RNA interference expt.  In an in vivo study, we also demonstrated that ARK5-transfected breast cancer cells grew faster and had more pulmonary metastases than its parental counterparts.  ARK5 led to a more invasive phenotype and metastatic potential in human breast cancer dependent on Akt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWDPURHxop5bVg90H21EOLACvtfcHk0lh1G4Fk1iR-4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpslOlsw%253D%253D&md5=7cb1b5e0f6d5ae13656f76d81f3df423</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2Fs00432-011-1102-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00432-011-1102-1%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DX.%2BZ.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.%2BY.%26aulast%3DDong%26aufirst%3DR.%2BH.%26aulast%3DCao%26aufirst%3DX.%2BC.%26atitle%3DARK5%2520Is%2520Associated%2520with%2520the%2520Invasive%2520and%2520Metastatic%2520Potential%2520of%2520Human%2520Breast%2520Cancer%2520Cells%26jtitle%3DJ.%2520Cancer%2520Res.%2520Clin.%2520Oncol.%26date%3D2012%26volume%3D138%26spage%3D247%26epage%3D254%26doi%3D10.1007%2Fs00432-011-1102-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span> <span> </span><span class="NLM_article-title">MiR-204 Inhibits Human NSCLC Metastasis through Suppression of NUAK1</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">2316</span>, <span class="refDoi"> DOI: 10.1038/bjc.2014.580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fbjc.2014.580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=25412236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGltL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=2316&author=L.+Shiauthor=B.+Zhangauthor=X.+Sunauthor=S.+Luauthor=Z.+Liuauthor=Y.+Liuauthor=H.+Liauthor=L.+Wangauthor=X.+Wangauthor=C.+Zhao&title=MiR-204+Inhibits+Human+NSCLC+Metastasis+through+Suppression+of+NUAK1&doi=10.1038%2Fbjc.2014.580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1</span></div><div class="casAuthors">Shi, L.; Zhang, B.; Sun, X.; Lu, S.; Liu, Z.; Liu, Y.; Li, H.; Wang, L.; Wang, X.; Zhao, C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2316-2327</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Lung cancer is a leading cause of cancer-related mortality worldwide and non-small-cell lung carcinoma (NSCLC) is responsible for almost 80% of lung cancer-related deaths.  Identifying novel mols. that can repress the invasiveness and metastasis of lung cancer will facilitate the development of new antilung cancer strategies.  The aim of this study is to det. the roles of NUAK1 (a downstream of Akt) and miR-204 in the invasiveness and metastasis of NSCLC and to reveal the correlation between NUAK1 and miR-204.  Methods: The expression of NUAK1 in primary human NSCLC tissues was evaluated by immunohistochem.  Real-time PCR was employed to measure the expression level of miR-204.  The effect of NUAK1 and miR204 on the prognosis of NSCLC patients was evaluated by log-rank test.  The siRNA transfection was used to manipulate the expression levels of NUAK1 and miR204 in cancer cells.  Chemotaxis assay, Scratch assay, and Matrigel invasion assay were performed to evaluate the migration and invasion of cells.  Cellular F-actin measurement was used to measure F-actin polymn. in lung cancer cells.  Western blot was used to detect the expression levels of corresponding proteins.  The Luciferase assay and RNA immunopptn. were used to confirm the actual binding site of miR-204 to 3'UTR of NUAK1.  Results: Increased expression of NUAK1 is correlated with the invasiveness and metastasis of human NSCLC.  Knockdown of NUAK1 inhibited cell migration and invasion.  In addn., this study showed that NUAK1 influenced mTOR phosphorylation and induced the phosphorylation of p70S6K1 and eukaryotic initiation factor 4E-binding protein1 (4E-BP1), two downstream targets of mTOR in NSCLC cells.  At the same time, decreased expression of miR-204 promoted NSCLC progression and, contrarily, manipulated upregulation of miR-204-inhibited cell migration and invasion.  There is clin. relevance between miR-204 downregulation and NUAK1 upregulation in human NSCLC.  Furthermore, we found that miR-204 inhibited NSCLC tumor invasion by directly targeting and downregulating NUAK1 expression.  Finally, our data suggested that the downregulation of miR-204 was due to hypermethylation of its promoter region.  Conclusions: Our results indicate that NUAK1 is excessively expressed in NSCLC and plays important roles in NSCLC invasion.  The miR-204 acts as a tumor suppressor by inhibiting NUAK1 expression in NSCLC.  Both NUAK1 and miR-204 may serve as potential targets of NSCLC therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_HXqvYexXfrVg90H21EOLACvtfcHk0lh1G4Fk1iR-4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGltL7P&md5=497c30171ec912fac145c81b6b1c7942</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2014.580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2014.580%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DC.%26atitle%3DMiR-204%2520Inhibits%2520Human%2520NSCLC%2520Metastasis%2520through%2520Suppression%2520of%2520NUAK1%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2014%26volume%3D111%26spage%3D2316%26doi%3D10.1038%2Fbjc.2014.580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monteverde, T.</span></span> <i>Investigating the Function and Regulation of NUAK1 and Its Role in Non-Small Cell Lung Cancer</i>. Ph.D. Thesis, <span class="NLM_publisher-name">University of Glasgow</span>, <span class="NLM_publisher-loc">United Kingdom</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=T.+Monteverde&title=Investigating+the+Function+and+Regulation+of+NUAK1+and+Its+Role+in+Non-Small+Cell+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonteverde%26aufirst%3DT.%26jtitle%3DInvestigating%2520the%2520Function%2520and%2520Regulation%2520of%2520NUAK1%2520and%2520Its%2520Role%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%26pub%3DUniversity%2520of%2520Glasgow%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, J.</span></span> <span> </span><span class="NLM_article-title">TGF-β Signaling: A Complex Role in Tumorigenesis (Review)</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">704</span>, <span class="refDoi"> DOI: 10.3892/mmr.2017.7970</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.3892%2Fmmr.2017.7970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=29115550" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=699-704&author=S.+Liuauthor=S.+Chenauthor=J.+Zeng&title=TGF-%CE%B2+Signaling%3A+A+Complex+Role+in+Tumorigenesis+%28Review%29&doi=10.3892%2Fmmr.2017.7970"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2017.7970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2017.7970%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZeng%26aufirst%3DJ.%26atitle%3DTGF-%25CE%25B2%2520Signaling%253A%2520A%2520Complex%2520Role%2520in%2520Tumorigenesis%2520%2528Review%2529%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2017%26volume%3D17%26spage%3D699%26epage%3D704%26doi%3D10.3892%2Fmmr.2017.7970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolliopoulos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raja, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Razmara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heldin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heldin, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moustakas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Heide, L. P.</span></span> <span> </span><span class="NLM_article-title">Transforming Growth Factor (TGF) Induces NUAK Kinase Expression to Fine-Tune Its Signaling Output</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">4119</span>– <span class="NLM_lpage">4136</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA118.004984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.RA118.004984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=30622137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvFSmsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=4119-4136&author=C.+Kolliopoulosauthor=E.+Rajaauthor=M.+Razmaraauthor=P.+Heldinauthor=C.+H.+Heldinauthor=A.+Moustakasauthor=L.+P.+Van+Der+Heide&title=Transforming+Growth+Factor+%28TGF%29+Induces+NUAK+Kinase+Expression+to+Fine-Tune+Its+Signaling+Output&doi=10.1074%2Fjbc.RA118.004984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Transforming growth factor β (TGFβ) induces NUAK kinase expression to fine-tune its signaling output</span></div><div class="casAuthors">Kolliopoulos, Constantinos; Raja, Erna; Razmara, Masoud; Heldin, Paraskevi; Heldin, Carl-Henrik; Moustakas, Aristidis; van der Heide, Lars P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4119-4136</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">TGFβ signaling via SMAD proteins and protein kinase pathways up- or down-regulates the expression of many genes and thus affects physiol. processes, such as differentiation, migration, cell cycle arrest, and apoptosis, during developmental or adult tissue homeostasis.  We here report that NUAK family kinase 1 (NUAK1) and NUAK2 are two TGFβ target genes.  NUAK1/2 belong to the AMP-activated protein kinase (AMPK) family, whose members control central and protein metab., polarity, and overall cellular homeostasis.  We found that TGFβ-mediated transcriptional induction of NUAK1 and NUAK2 requires SMAD family members 2, 3, and 4 (SMAD2/3/4) and mitogen-activated protein kinase (MAPK) activities, which provided immediate and early signals for the transient expression of these two kinases.  Genomic mapping identified an enhancer element within the first intron of the NUAK2 gene that can recruit SMAD proteins, which, when cloned, could confer induction by TGFβ.  Furthermore, NUAK2 formed protein complexes with SMAD3 and the TGFβ type I receptor.  Functionally, NUAK1 suppressed and NUAK2 induced TGFβ signaling.  This was evident during TGFβ-induced epithelial cytostasis, mesenchymal differentiation, and myofibroblast contractility, in which NUAK1 or NUAK2 silencing enhanced or inhibited these responses, resp.  In conclusion, we have identified a bifurcating loop during TGFβ signaling, whereby transcriptional induction of NUAK1 serves as a neg. checkpoint and NUAK2 induction pos. contributes to signaling and terminal differentiation responses to TGFβ activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomkmMV7cd_V7Vg90H21EOLACvtfcHk0lh1G4Fk1iR-4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvFSmsb8%253D&md5=7cede483273b178a0354350fcbf42a46</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA118.004984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA118.004984%26sid%3Dliteratum%253Aachs%26aulast%3DKolliopoulos%26aufirst%3DC.%26aulast%3DRaja%26aufirst%3DE.%26aulast%3DRazmara%26aufirst%3DM.%26aulast%3DHeldin%26aufirst%3DP.%26aulast%3DHeldin%26aufirst%3DC.%2BH.%26aulast%3DMoustakas%26aufirst%3DA.%26aulast%3DVan%2BDer%2BHeide%26aufirst%3DL.%2BP.%26atitle%3DTransforming%2520Growth%2520Factor%2520%2528TGF%2529%2520Induces%2520NUAK%2520Kinase%2520Expression%2520to%2520Fine-Tune%2520Its%2520Signaling%2520Output%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D4119%26epage%3D4136%26doi%3D10.1074%2Fjbc.RA118.004984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shintani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seguchi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minamino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitakaze, M.</span></span> <span> </span><span class="NLM_article-title">Identification of a Novel Substrate for TNFα-Induced Kinase NUAK2</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2007.11.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.bbrc.2007.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=18023418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlyrsbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2008&pages=541-547&author=H.+Yamamotoauthor=S.+Takashimaauthor=Y.+Shintaniauthor=S.+Yamazakiauthor=O.+Seguchiauthor=A.+Nakanoauthor=S.+Higoauthor=H.+Katoauthor=Y.+Liaoauthor=Y.+Asanoauthor=T.+Minaminoauthor=Y.+Matsumuraauthor=H.+Takedaauthor=M.+Kitakaze&title=Identification+of+a+Novel+Substrate+for+TNF%CE%B1-Induced+Kinase+NUAK2&doi=10.1016%2Fj.bbrc.2007.11.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel substrate for TNFα-induced kinase NUAK2</span></div><div class="casAuthors">Yamamoto, Hiroyuki; Takashima, Seiji; Shintani, Yasunori; Yamazaki, Satoru; Seguchi, Osamu; Nakano, Atsushi; Higo, Shuichiro; Kato, Hisakazu; Liao, Yulin; Asano, Yoshihiro; Minamino, Tetsuo; Matsumura, Yasushi; Takeda, Hiroshi; Kitakaze, Masafumi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">541-547</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">TNFα has multiple important cellular functions both in normal cells and in tumor cells.  To explore the role of TNFα, we identified NUAK family, SNF1-like kinase 2 (NUAK2), as a TNFα-induced kinase by gene chip anal.  NUAK2 is known to be induced by various cellular stresses and involved in cell mortality, however, its substrate has never been identified.  We developed original protocol of de novo screening for kinase substrates using an in vitro kinase assay and high performance liq. chromatog. (HPLC).  Using this procedure, we identified myosin phosphatase target subunit 1 (MYPT1) as a specific substrate for NUAK2.  MYPT1 was phosphorylated at another site(s) by NUAK2, other than known Rho-kinase phosphorylation sites (Thr696 or Thr853) responsible for inhibition of myosin phosphatase activity.  These data suggest different phosphorylation and regulation of MYPT1 activity by NUAK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj-LLt2R1BPbVg90H21EOLACvtfcHk0lhHaP-g3iP3vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlyrsbjI&md5=d823034d0a75749d87579f17893d9063</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2007.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2007.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DTakashima%26aufirst%3DS.%26aulast%3DShintani%26aufirst%3DY.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DSeguchi%26aufirst%3DO.%26aulast%3DNakano%26aufirst%3DA.%26aulast%3DHigo%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DH.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DAsano%26aufirst%3DY.%26aulast%3DMinamino%26aufirst%3DT.%26aulast%3DMatsumura%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DH.%26aulast%3DKitakaze%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520a%2520Novel%2520Substrate%2520for%2520TNF%25CE%25B1-Induced%2520Kinase%2520NUAK2%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D365%26spage%3D541%26epage%3D547%26doi%3D10.1016%2Fj.bbrc.2007.11.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagórska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prescott, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span> <span> </span><span class="NLM_article-title">Interplay between Polo Kinase, LKB1-Activated NUAK1 Kinase, PP1βMYPT1 Phosphatase Complex and the SCβTrCP E3 Ubiquitin Ligase</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1042/BJ20140408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1042%2FBJ20140408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=24785407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVGhtbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2014&pages=233-245&author=S.+Banerjeeauthor=A.+Zag%C3%B3rskaauthor=M.+Deakauthor=D.+G.+Campbellauthor=A.+R.+Prescottauthor=D.+R.+Alessi&title=Interplay+between+Polo+Kinase%2C+LKB1-Activated+NUAK1+Kinase%2C+PP1%CE%B2MYPT1+Phosphatase+Complex+and+the+SC%CE%B2TrCP+E3+Ubiquitin+Ligase&doi=10.1042%2FBJ20140408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Interplay between Polo kinase, LKB1-activated NUAK1 kinase, PP1βMYPT1 phosphatase complex and the SCFβTrCP E3 ubiquitin ligase</span></div><div class="casAuthors">Banerjee, Sourav; Zagorska, Anna; Deak, Maria; Campbell, David G.; Prescott, Alan R.; Alessi, Dario R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-245</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">NUAK1 (NUAK family SnF1-like kinase-1) and NUAK2 protein kinases are activated by the LKB1 tumor suppressor and have been implicated in regulating multiple processes such as cell survival, senescence, adhesion and polarity.  In the present paper we present evidence that expression of NUAK1 is controlled by CDK (cyclin-dependent kinase), PLK (Polo kinase) and the SCFβTrCP (Skp, Cullin and F-boxβTrCP) E3 ubiquitin ligase complex.  Our data indicate that CDK phosphorylates NUAK1 at Ser445, triggering binding to PLK, which subsequently phosphorylates NUAK1 at two conserved non-catalytic serine residues (Ser476 and Ser480).  This induces binding of NUAK1 to βTrCP, the substrate-recognition subunit of the SCFβTrCP E3 ligase, resulting in NUAK1 becoming ubiquitylated and degraded.  We also show that NUAK1 and PLK1 are reciprocally controlled in the cell cycle.  In G2-M-phase, when PLK1 is most active, NUAK1 levels are low and vice versa in S-phase, when PLK1 expression is low, NUAK1 is more highly expressed.  Moreover, NUAK1 inhibitors (WZ4003 or HTH-01-015) suppress proliferation by reducing the population of cells in S-phase and mitosis, an effect that can be rescued by overexpression of a NUAK1 mutant in which Ser476 and Ser480 are mutated to alanine.  Finally, previous work has suggested that NUAK1 phosphorylates and inhibits PP1βMYPT1 (where PP1 is protein phosphatase 1) and that a major role for the PP1βMYPT1 complex is to inhibit PLK1 by dephosphorylating its T-loop (Thr210).  We demonstrate that activation of NUAK1 leads to a striking increase in phosphorylation of PLK1 at Thr210, an effect that is suppressed by NUAK1 inhibitors.  Our data link NUAK1 to important cell-cycle signalling components (CDK, PLK and SCFβTrCP) and suggest that NUAK1 plays a role in stimulating S-phase, as well as PLK1 activity via its ability to regulate the PP1βMYPT1 phosphatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraMe19to0IkLVg90H21EOLACvtfcHk0lhHaP-g3iP3vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVGhtbrK&md5=44c41ed44716228341c8d3d97a99283a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1042%2FBJ20140408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20140408%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DZag%25C3%25B3rska%26aufirst%3DA.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DD.%2BG.%26aulast%3DPrescott%26aufirst%3DA.%2BR.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DInterplay%2520between%2520Polo%2520Kinase%252C%2520LKB1-Activated%2520NUAK1%2520Kinase%252C%2520PP1%25CE%25B2MYPT1%2520Phosphatase%2520Complex%2520and%2520the%2520SC%25CE%25B2TrCP%2520E3%2520Ubiquitin%2520Ligase%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D461%26spage%3D233%26epage%3D245%26doi%3D10.1042%2FBJ20140408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanford, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodyear, L. J.</span></span> <span> </span><span class="NLM_article-title">Exercise and Type 2 Diabetes: Molecular Mechanisms Regulating Glucose Uptake in Skeletal Muscle</span>. <i>Adv. Physiol. Educ.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1152/advan.00080.2014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1152%2Fadvan.00080.2014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=25434013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BC2MzhvVarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=308-314&author=K.+I.+Stanfordauthor=L.+J.+Goodyear&title=Exercise+and+Type+2+Diabetes%3A+Molecular+Mechanisms+Regulating+Glucose+Uptake+in+Skeletal+Muscle&doi=10.1152%2Fadvan.00080.2014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal muscle</span></div><div class="casAuthors">Stanford Kristin I; Goodyear Laurie J</div><div class="citationInfo"><span class="NLM_cas:title">Advances in physiology education</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">308-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Exercise is a well-established tool to prevent and combat type 2 diabetes.  Exercise improves whole body metabolic health in people with type 2 diabetes, and adaptations to skeletal muscle are essential for this improvement.  An acute bout of exercise increases skeletal muscle glucose uptake, while chronic exercise training improves mitochondrial function, increases mitochondrial biogenesis, and increases the expression of glucose transporter proteins and numerous metabolic genes.  This review focuses on the molecular mechanisms that mediate the effects of exercise to increase glucose uptake in skeletal muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQEqKsXbBpWjfcsfMJQC1ZdfW6udTcc2ebTr8lOE4-eSLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzhvVarsw%253D%253D&md5=b345c6129113e1472e77f1fac850169d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1152%2Fadvan.00080.2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fadvan.00080.2014%26sid%3Dliteratum%253Aachs%26aulast%3DStanford%26aufirst%3DK.%2BI.%26aulast%3DGoodyear%26aufirst%3DL.%2BJ.%26atitle%3DExercise%2520and%2520Type%25202%2520Diabetes%253A%2520Molecular%2520Mechanisms%2520Regulating%2520Glucose%2520Uptake%2520in%2520Skeletal%2520Muscle%26jtitle%3DAdv.%2520Physiol.%2520Educ.%26date%3D2014%26volume%3D38%26spage%3D308%26epage%3D314%26doi%3D10.1152%2Fadvan.00080.2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodyear, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, B. B.</span></span> <span> </span><span class="NLM_article-title">Exercise, Glucose Transport, and Insulin Sensitivity</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1146/annurev.med.49.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1146%2Fannurev.med.49.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=9509261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADyaK1cXhtFKqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1998&pages=235-261&author=L.+J.+Goodyearauthor=B.+B.+Kahn&title=Exercise%2C+Glucose+Transport%2C+and+Insulin+Sensitivity&doi=10.1146%2Fannurev.med.49.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Exercise, glucose transport, and insulin sensitivity</span></div><div class="casAuthors">Goodyear, Laurie J.; Kahn, Barbara B.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">235-261</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review, with 168 refs.  Phys. exercise can be an important adjunct in the treatment of both non-insulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus.  Over the past several years, considerable progress has been made in understanding the mol. basis for these clin. important effects of phys. exercise.  Similarly to insulin, a single bout of exercise increases the rate of glucose uptake into the contracting skeletal muscles, a process that is regulated by the translocation of GLUT4 glucose transporters to the plasma membrane and transverse tubules.  Exercise and insulin utilize different signaling pathways, both of which lead to the activation of glucose transport, which perhaps explains why humans with insulin resistance can increase muscle glucose transport in response to an acute bout of exercise.  Exercise training in humans results in numerous beneficial adaptations in skeletal muscles, including an increase in GLUT4 expression.  The increase in muscle GLUT4 in trained individuals contributes to an increase in the responsiveness of muscle glucose uptake to insulin, although not all studies show that exercise training in patients with diabetes improves overall glucose control.  However, there is now extensive epidemiol. evidence demonstrating that long-term regular phys. exercise can significantly reduce the risk of developing non-insulin-dependent diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSKuS8WPmVjbVg90H21EOLACvtfcHk0lhtdFcBCiAGzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtFKqs74%253D&md5=316cb103463a5112abfa56712bc73d8e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1146%2Fannurev.med.49.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.med.49.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DGoodyear%26aufirst%3DL.%2BJ.%26aulast%3DKahn%26aufirst%3DB.%2BB.%26atitle%3DExercise%252C%2520Glucose%2520Transport%252C%2520and%2520Insulin%2520Sensitivity%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D1998%26volume%3D49%26spage%3D235%26epage%3D261%26doi%3D10.1146%2Fannurev.med.49.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koh, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnolds, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liew, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirshman, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodyear, L. J.</span></span> <span> </span><span class="NLM_article-title">Skeletal Muscle-Selective Knockout of LKB1 Increases Insulin Sensitivity, Improves Glucose Homeostasis, and Decreases TRB3</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">8217</span>– <span class="NLM_lpage">8227</span>, <span class="refDoi"> DOI: 10.1128/MCB.00979-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1128%2FMCB.00979-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=16966378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1aksbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=8217-8227&author=H.-J.+Kohauthor=D.+E.+Arnoldsauthor=N.+Fujiiauthor=T.+T.+Tranauthor=M.+J.+Rogersauthor=N.+Jessenauthor=Y.+Liauthor=C.+W.+Liewauthor=R.+C.+Hoauthor=M.+F.+Hirshmanauthor=R.+N.+Kulkarniauthor=C.+R.+Kahnauthor=L.+J.+Goodyear&title=Skeletal+Muscle-Selective+Knockout+of+LKB1+Increases+Insulin+Sensitivity%2C+Improves+Glucose+Homeostasis%2C+and+Decreases+TRB3&doi=10.1128%2FMCB.00979-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3</span></div><div class="casAuthors">Koh, Ho-Jin; Arnolds, David E.; Fujii, Nobuharu; Tran, Thien T.; Rogers, Marc J.; Jessen, Niels; Li, Yangfeng; Liew, Chong Wee; Ho, Richard C.; Hirshman, Michael F.; Kulkarni, Rohit N.; Kahn, C. Ronald; Goodyear, Laurie J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8217-8227</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">LKB1 is a tumor suppressor that may also be fundamental to cell metab., since LKB1 phosphorylates and activates the energy sensing enzyme AMPK.  We generated muscle-specific LKB1 knockout (MLKB1KO) mice, and surprisingly, found that a lack of LKB1 in skeletal muscle enhanced insulin sensitivity, as evidenced by decreased fasting glucose and insulin concns., improved glucose tolerance, increased muscle glucose uptake in vivo, and increased glucose utilization during a hyperinsulinemic-euglycemic clamp.  MLKB1KO mice had increased insulin-stimulated Akt phosphorylation and a >80% decrease in muscle expression of TRB3, a recently identified Akt inhibitor.  Akt/TRB3 binding was present in skeletal muscle, and overexpression of TRB3 in C2C12 myoblasts significantly reduced Akt phosphorylation.  These results demonstrate that skeletal muscle LKB1 is a neg. regulator of insulin sensitivity and glucose homeostasis.  LKB1-mediated TRB3 expression provides a novel link between LKB1 and Akt, crit. kinases involved in both tumor genesis and cell metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSp_xYvILbV7Vg90H21EOLACvtfcHk0lhtdFcBCiAGzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1aksbfJ&md5=b568eb6b6a1c8a5243b2645b270f3de6</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1128%2FMCB.00979-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00979-06%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DH.-J.%26aulast%3DArnolds%26aufirst%3DD.%2BE.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DTran%26aufirst%3DT.%2BT.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26aulast%3DJessen%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiew%26aufirst%3DC.%2BW.%26aulast%3DHo%26aufirst%3DR.%2BC.%26aulast%3DHirshman%26aufirst%3DM.%2BF.%26aulast%3DKulkarni%26aufirst%3DR.%2BN.%26aulast%3DKahn%26aufirst%3DC.%2BR.%26aulast%3DGoodyear%26aufirst%3DL.%2BJ.%26atitle%3DSkeletal%2520Muscle-Selective%2520Knockout%2520of%2520LKB1%2520Increases%2520Insulin%2520Sensitivity%252C%2520Improves%2520Glucose%2520Homeostasis%252C%2520and%2520Decreases%2520TRB3%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D8217%26epage%3D8227%26doi%3D10.1128%2FMCB.00979-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeppesen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maarbjerg, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordy, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritzen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pehmoller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sylow, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serup, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prats, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qvortrup, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyck, J. R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schjerling, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtaszewski, J. F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiens, B.</span></span> <span> </span><span class="NLM_article-title">LKB1 Regulates Lipid Oxidation during Exercise Independently of AMPK</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1490</span>– <span class="NLM_lpage">1499</span>, <span class="refDoi"> DOI: 10.2337/db12-1160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.2337%2Fdb12-1160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23349504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVSnurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=1490-1499&author=J.+Jeppesenauthor=S.+J.+Maarbjergauthor=A.+B.+Jordyauthor=A.+M.+Fritzenauthor=C.+Pehmollerauthor=L.+Sylowauthor=A.+K.+Serupauthor=N.+Jessenauthor=K.+Thorsenauthor=C.+Pratsauthor=K.+Qvortrupauthor=J.+R.+B.+Dyckauthor=R.+W.+Hunterauthor=K.+Sakamotoauthor=D.+M.+Thomsonauthor=P.+Schjerlingauthor=J.+F.+P.+Wojtaszewskiauthor=E.+A.+Richterauthor=B.+Kiens&title=LKB1+Regulates+Lipid+Oxidation+during+Exercise+Independently+of+AMPK&doi=10.2337%2Fdb12-1160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">LKB1 regulates lipid oxidation during exercise independently of AMPK</span></div><div class="casAuthors">Jeppesen, Jacob; Maarbjerg, Stine J.; Jordy, Andreas B.; Fritzen, Andreas M.; Pehmoeller, Christian; Sylow, Lykke; Serup, Annette Karen; Jessen, Niels; Thorsen, Kasper; Prats, Clara; Qvortrup, Klaus; Dyck, Jason R. B.; Hunter, Roger W.; Sakamoto, Kei; Thomson, David M.; Schjerling, Peter; Wojtaszewski, Joergen F. P.; Richter, Erik A.; Kiens, Bente</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1490-1499</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Lipid metab. is important for health and insulin action, yet the fundamental process of regulating lipid metab. during muscle contraction is incompletely understood.  Here, we show that liver kinase B1 (LKB1) muscle-specific knockout (LKB1 MKO) mice display decreased fatty acid (FA) oxidn. during treadmill exercise.  LKB1 MKO mice also show decreased muscle SIK3 activity, increased histone deacetylase 4 expression, decreased NAD+ concn. and SIRT1 activity, and decreased expression of genes involved in FA oxidn.  In AMP-activated protein kinase (AMPK)α2 KO mice, substrate use was similar to that in WT mice, which excluded that decreased FA oxidn. in LKB1 MKO mice was due to decreased AMPKα2 activity.  Addnl., LKB1 MKO muscle demonstrated decreased FA oxidn. in vitro.  A markedly decreased phosphorylation of TBC1D1, a proposed regulator of FA transport, and a low CoA content could contribute to the low FA oxidn. in LKB1 MKO.  LKB1 deficiency did not reduce muscle glucose uptake or oxidn. during exercise in vivo, excluding a general impairment of substrate use during exercise in LKB1 MKO mice.  Our findings demonstrate that LKB1 is a novel mol. regulator of major importance for FA oxidn. but not glucose uptake in muscle during exercise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB3p2JmgcFkbVg90H21EOLACvtfcHk0lhtdFcBCiAGzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVSnurnO&md5=67c373632edf4610dda4fb35e80ea3d2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.2337%2Fdb12-1160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb12-1160%26sid%3Dliteratum%253Aachs%26aulast%3DJeppesen%26aufirst%3DJ.%26aulast%3DMaarbjerg%26aufirst%3DS.%2BJ.%26aulast%3DJordy%26aufirst%3DA.%2BB.%26aulast%3DFritzen%26aufirst%3DA.%2BM.%26aulast%3DPehmoller%26aufirst%3DC.%26aulast%3DSylow%26aufirst%3DL.%26aulast%3DSerup%26aufirst%3DA.%2BK.%26aulast%3DJessen%26aufirst%3DN.%26aulast%3DThorsen%26aufirst%3DK.%26aulast%3DPrats%26aufirst%3DC.%26aulast%3DQvortrup%26aufirst%3DK.%26aulast%3DDyck%26aufirst%3DJ.%2BR.%2BB.%26aulast%3DHunter%26aufirst%3DR.%2BW.%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DThomson%26aufirst%3DD.%2BM.%26aulast%3DSchjerling%26aufirst%3DP.%26aulast%3DWojtaszewski%26aufirst%3DJ.%2BF.%2BP.%26aulast%3DRichter%26aufirst%3DE.%2BA.%26aulast%3DKiens%26aufirst%3DB.%26atitle%3DLKB1%2520Regulates%2520Lipid%2520Oxidation%2520during%2520Exercise%2520Independently%2520of%2520AMPK%26jtitle%3DDiabetes%26date%3D2013%26volume%3D62%26spage%3D1490%26epage%3D1499%26doi%3D10.2337%2Fdb12-1160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jørgensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viollet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frøsig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birk, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schjerling, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaulont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtaszewski, J. F. P.</span></span> <span> </span><span class="NLM_article-title">Knockout of the A2 but Not A1 5′-AMP-Activated Protein Kinase Isoform Abolishes 5-Aminoimidazole-4-Carboxamide-1-β-4-Ribofuranosidebut Not Contraction-Induced Glucose Uptake in Skeletal Muscle</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">1070</span>– <span class="NLM_lpage">1079</span>, <span class="refDoi"> DOI: 10.1074/jbc.M306205200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M306205200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=14573616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVyltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=1070-1079&author=S.+B.+J%C3%B8rgensenauthor=B.+Violletauthor=F.+Andreelliauthor=C.+Fr%C3%B8sigauthor=J.+B.+Birkauthor=P.+Schjerlingauthor=S.+Vaulontauthor=E.+A.+Richterauthor=J.+F.+P.+Wojtaszewski&title=Knockout+of+the+A2+but+Not+A1+5%E2%80%B2-AMP-Activated+Protein+Kinase+Isoform+Abolishes+5-Aminoimidazole-4-Carboxamide-1-%CE%B2-4-Ribofuranosidebut+Not+Contraction-Induced+Glucose+Uptake+in+Skeletal+Muscle&doi=10.1074%2Fjbc.M306205200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Knockout of the α2 but Not α1 5'-AMP-activated Protein Kinase Isoform Abolishes 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranoside- but Not Contraction-induced Glucose Uptake in Skeletal Muscle</span></div><div class="casAuthors">Jorgensen, Sebastian B.; Viollet, Benoit; Andreelli, Fabrizio; Frosig, Christian; Birk, Jesper B.; Schjerling, Peter; Vaulont, Sophie; Richter, Erik A.; Wojtaszewski, Jorgen F. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1070-1079</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">We investigated the importance of the two catalytic α-isoforms of the 5'-AMP-activated protein kinase (AMPK) in 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) and contraction-induced glucose uptake in skeletal muscle.  Incubated soleus and EDL muscle from whole-body α2- or α1-AMPK knockout (KO) and wild type (WT) mice were incubated with 2.0 mM AICAR or elec. stimulated to contraction.  Both AICAR and contraction increased 2DG uptake in WT muscles.  KO of α2, but not α1, abolished AICAR-induced glucose uptake, whereas neither KO affected contraction-induced glucose uptake.  AICAR and contraction increased α2- and α1-AMPK activity in wild type (WT) muscles.  During AICAR stimulation, the remaining AMPK activity in KO muscles increased to the same level as in WT.  During contraction, the remaining AMPK activity in α2-KO muscles was elevated by 100% probably explained by a 2-3-fold increase in α1-protein.  In α1-KO muscles, α2-AMPK activity increased to similar levels as in WT.  Both interventions increased total AMPK activity, as expressed by AMPK-P and ACCβ-P, in WT muscles.  During AICAR stimulation, this was dramatically reduced in α2-KO but not in α1-KO, whereas during contraction, both measurements were essentially similar to WT in both KO-muscles.  The results show that α2-AMPK is the main donor of basal and AICAR-stimulated AMPK activity and is responsible for AICAR-induced glucose uptake.  In contrast, during contraction, the two α-isoforms seem to substitute for each other in terms of activity, which may explain the normal glucose uptake despite the lack of either α2- or α1-AMPK.  Alternatively, neither α-isoform of AMPK is involved in contraction-induced muscle glucose uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtl68JqWYfMLVg90H21EOLACvtfcHk0lhzx1zjgFv6Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVyltw%253D%253D&md5=21a703c390363be00bca0f94f502a093</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M306205200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M306205200%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DS.%2BB.%26aulast%3DViollet%26aufirst%3DB.%26aulast%3DAndreelli%26aufirst%3DF.%26aulast%3DFr%25C3%25B8sig%26aufirst%3DC.%26aulast%3DBirk%26aufirst%3DJ.%2BB.%26aulast%3DSchjerling%26aufirst%3DP.%26aulast%3DVaulont%26aufirst%3DS.%26aulast%3DRichter%26aufirst%3DE.%2BA.%26aulast%3DWojtaszewski%26aufirst%3DJ.%2BF.%2BP.%26atitle%3DKnockout%2520of%2520the%2520A2%2520but%2520Not%2520A1%25205%25E2%2580%25B2-AMP-Activated%2520Protein%2520Kinase%2520Isoform%2520Abolishes%25205-Aminoimidazole-4-Carboxamide-1-%25CE%25B2-4-Ribofuranosidebut%2520Not%2520Contraction-Induced%2520Glucose%2520Uptake%2520in%2520Skeletal%2520Muscle%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D1070%26epage%3D1079%26doi%3D10.1074%2Fjbc.M306205200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirshman, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kane, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodyear, L. J.</span></span> <span> </span><span class="NLM_article-title">AMP-Activated Protein Kinase A2 Activity Is Not Essential for Contraction-and Hyperosmolarity-Induced Glucose Transport in Skeletal Muscle</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">39033</span>– <span class="NLM_lpage">39041</span>, <span class="refDoi"> DOI: 10.1074/jbc.M504208200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M504208200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=16186119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1emsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=39033-39041&author=N.+Fujiiauthor=M.+F.+Hirshmanauthor=E.+M.+Kaneauthor=R.+C.+Hoauthor=L.+E.+Peterauthor=M.+M.+Seifertauthor=L.+J.+Goodyear&title=AMP-Activated+Protein+Kinase+A2+Activity+Is+Not+Essential+for+Contraction-and+Hyperosmolarity-Induced+Glucose+Transport+in+Skeletal+Muscle&doi=10.1074%2Fjbc.M504208200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">AMP-activated Protein Kinase α2 Activity Is Not Essential for Contraction- and Hyperosmolarity-induced Glucose Transport in Skeletal Muscle</span></div><div class="casAuthors">Fujii, Nobuharu; Hirshman, Michael F.; Kane, Erin M.; Ho, Richard C.; Peter, Lauren E.; Seifert, Matthew M.; Goodyear, Laurie J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">39033-39041</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">To examine the role of AMP-activated protein kinase (AMPK) in muscle glucose transport, we generated muscle-specific transgenic mice (TG) carrying cDNAs of inactive α2 (α2i TG) and α1 (α1i TG) catalytic subunits.  Extensor digitorum longus (EDL) muscles from wild type and TG mice were isolated and subjected to a series of in vitro incubation expts.  In α2i TG mice basal α2 activity was barely detectable, whereas basal α1 activity was only partially reduced.  Known AMPK stimuli including 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR), rotenone (a Complex I inhibitor), dinitrophenol (a mitochondrial uncoupler), muscle contraction, and sorbitol (producing hyperosmolar shock) did not increase AMPK α2 activity in α2i TG mice, whereas α1 activation was attenuated by only 30-50%.  Glucose transport was measured in vitro using isolated EDL muscles from α2i TG mice.  AICAR- and rotenone-stimulated glucose transport was fully inhibited in α2i TG mice; however, the lack of AMPK α2 activity had no effect on contraction- or sorbitol-induced glucose transport.  Similar to these observations in vitro, contraction-stimulated glucose transport, assessed in vivo by 2-deoxy-D-[3H]glucose incorporation into EDL, tibialis anterior, and gastrocnemius muscles, was normal in α2i TG mice.  Thus, AMPK α2 activation is essential for some, but not all, insulin-independent glucose transport.  Muscle contraction- and hyperosmolarity-induced glucose transport may be regulated by a redundant mechanism in which AMPK α2 is one of multiple signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWy5Ns2U3E2rVg90H21EOLACvtfcHk0lhzx1zjgFv6Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1emsrrL&md5=8f280e5c01adabf5a3531f069572f795</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M504208200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M504208200%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DHirshman%26aufirst%3DM.%2BF.%26aulast%3DKane%26aufirst%3DE.%2BM.%26aulast%3DHo%26aufirst%3DR.%2BC.%26aulast%3DPeter%26aufirst%3DL.%2BE.%26aulast%3DSeifert%26aufirst%3DM.%2BM.%26aulast%3DGoodyear%26aufirst%3DL.%2BJ.%26atitle%3DAMP-Activated%2520Protein%2520Kinase%2520A2%2520Activity%2520Is%2520Not%2520Essential%2520for%2520Contraction-and%2520Hyperosmolarity-Induced%2520Glucose%2520Transport%2520in%2520Skeletal%2520Muscle%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D39033%26epage%3D39041%26doi%3D10.1074%2Fjbc.M504208200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujioka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuga, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">Susceptibility of Snark-deficient Mice to Azoxymethane-induced Colorectal Tumorigenesis and the Formation of Aberrant Crypt Foci</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">682</span>, <span class="refDoi"> DOI: 10.1111/j.1349-7006.2008.00734.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1111%2Fj.1349-7006.2008.00734.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=18307533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsFGqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=677-682&author=K.+Tsuchiharaauthor=T.+Oguraauthor=R.+Fujiokaauthor=S.+Fujiiauthor=W.+Kugaauthor=M.+Saitoauthor=T.+Ochiyaauthor=A.+Ochiaiauthor=H.+Esumi&title=Susceptibility+of+Snark-deficient+Mice+to+Azoxymethane-induced+Colorectal+Tumorigenesis+and+the+Formation+of+Aberrant+Crypt+Foci&doi=10.1111%2Fj.1349-7006.2008.00734.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Susceptibility of Snark-deficient mice to azoxymethane-induced colorectal tumorigenesis and the formation of aberrant crypt foci</span></div><div class="casAuthors">Tsuchihara, Katsuya; Ogura, Tsutomu; Fujioka, Rumi; Fujii, Satoshi; Kuga, Wataru; Saito, Marie; Ochiya, Takahiro; Ochiai, Atsushi; Esumi, Hiroyasu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">677-682</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">SNF-1/5'-AMP-activated kinase (AMPK)-related kinase (SNARK) is a member of the AMPK-related kinases.  Snark+/- mice exhibited mature-onset obesity and related metabolic disorders.  Obesity is regarded as a risk factor for colorectal cancer.  To investigate whether Snark deficiency is involved in tumorigenesis in the large intestine, obese Snark+/- mice were treated with a chem. carcinogen, azoxymethane (AOM).  The incidences of both adenomas and aberrant crypt foci (ACF) were significantly higher in Snark+/- mice than in their wild-type counterparts 28 wk after the completion of AOM treatment (10 mg/kg/wk for 8 wk).  Furthermore, ACF formation was enhanced in Snark+/- mice treated with AOM for 2 wk, suggesting that Snark deficiency contributed to the early phase of tumorigenesis.  The total no. of ACF was correlated with bodyweight in Snark+/- and Snark+/+ mice, suggesting that obesity was a risk factor for colorectal tumorigenesis in this model.  However, the correlation coeff. was higher in Snark+/- mice.  Moreover, AOM-induced ACF formation was also enhanced in preobese Snark+/- mice.  Together, these findings suggest that AOM-induced tumorigenesis in Snark+/- mice was enhanced via obesity-dependent and -independent mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNomKK31XXT7Vg90H21EOLACvtfcHk0lgMuy8BiojZUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsFGqt78%253D&md5=b9b95c566fd8f1d5e0a7534c216cbf4d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2008.00734.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2008.00734.x%26sid%3Dliteratum%253Aachs%26aulast%3DTsuchihara%26aufirst%3DK.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DFujioka%26aufirst%3DR.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DKuga%26aufirst%3DW.%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DOchiya%26aufirst%3DT.%26aulast%3DOchiai%26aufirst%3DA.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DSusceptibility%2520of%2520Snark-deficient%2520Mice%2520to%2520Azoxymethane-induced%2520Colorectal%2520Tumorigenesis%2520and%2520the%2520Formation%2520of%2520Aberrant%2520Crypt%2520Foci%26jtitle%3DCancer%2520Sci.%26date%3D2008%26volume%3D99%26spage%3D677%26epage%3D682%26doi%3D10.1111%2Fj.1349-7006.2008.00734.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inazuka, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shioi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">Muscle-Specific Knock-out of NUAK Family SNF1-like Kinase 1 (NUAK1) Prevents High Fat Diet-Induced Glucose Intolerance</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">16379</span>– <span class="NLM_lpage">16389</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.302687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M111.302687" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22418434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvVKgtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=16379-16389&author=F.+Inazukaauthor=N.+Sugiyamaauthor=M.+Tomitaauthor=T.+Abeauthor=G.+Shioiauthor=H.+Esumi&title=Muscle-Specific+Knock-out+of+NUAK+Family+SNF1-like+Kinase+1+%28NUAK1%29+Prevents+High+Fat+Diet-Induced+Glucose+Intolerance&doi=10.1074%2Fjbc.M111.302687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Muscle-specific Knock-out of NUAK Family SNF1-like Kinase 1 (NUAK1) Prevents High Fat Diet-induced Glucose Intolerance</span></div><div class="casAuthors">Inazuka, Fumika; Sugiyama, Naoyuki; Tomita, Masaru; Abe, Takaya; Shioi, Go; Esumi, Hiroyasu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">16379-16389</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">NUAK1 is a member of the AMP-activated protein kinase-related kinase family.  Recent studies have shown that NUAK1 is involved in cellular senescence and motility in epithelial cells and fibroblasts.  However, the physiol. roles of NUAK1 are poorly understood because of embryonic lethality in NUAK1 null mice.  The purpose of this study was to elucidate the roles of NUAK1 in adult tissues.  We detd. the tissue distribution of NUAK1 and generated muscle-specific NUAK1 knock-out (MNUAK1KO) mice.  For phenotypic anal., whole body glucose homeostasis and muscle glucose metab. were examd.  Quant. phosphoproteome anal. of soleus muscle was performed to understand the mol. mechanisms underlying the knock-out phenotype.  Nuak1 mRNA was preferentially expressed in highly oxidative tissues such as brain, heart, and soleus muscle.  On a high fat diet, MNUAK1KO mice had a lower fasting blood glucose level, greater glucose tolerance, higher insulin sensitivity, and higher concn. of muscle glycogen than control mice.  Phosphoproteome anal. revealed that phosphorylation of IRS1 Ser-1097 was markedly decreased in NUAK1-deficient muscle.  Consistent with this, insulin signaling was enhanced in the soleus muscle of MNUAK1KO mice, as evidenced by increased phosphorylation of IRS1 Tyr-608, AKT Thr-308, and TBC1D4 Thr-649.  These observations suggest that a physiol. role of NUAK1 is to suppress glucose uptake through neg. regulation of insulin signaling in oxidative muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6cPulwikhIrVg90H21EOLACvtfcHk0lgMuy8BiojZUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvVKgtL8%253D&md5=bdbbf947d37653c83b09c8197e4a4bc0</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.302687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.302687%26sid%3Dliteratum%253Aachs%26aulast%3DInazuka%26aufirst%3DF.%26aulast%3DSugiyama%26aufirst%3DN.%26aulast%3DTomita%26aufirst%3DM.%26aulast%3DAbe%26aufirst%3DT.%26aulast%3DShioi%26aufirst%3DG.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DMuscle-Specific%2520Knock-out%2520of%2520NUAK%2520Family%2520SNF1-like%2520Kinase%25201%2520%2528NUAK1%2529%2520Prevents%2520High%2520Fat%2520Diet-Induced%2520Glucose%2520Intolerance%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D16379%26epage%3D16389%26doi%3D10.1074%2Fjbc.M111.302687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perumal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leshchenko, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Divakar, S. K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brody, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M. V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagannath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parekh, S.</span></span> <span> </span><span class="NLM_article-title">Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1236</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-2934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1158%2F0008-5472.CAN-15-2934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26873845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslCltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=1225-1236&author=D.+Perumalauthor=P.-Y.+Kuoauthor=V.+V.+Leshchenkoauthor=Z.+Jiangauthor=S.+K.+A.+Divakarauthor=H.+J.+Choauthor=A.+Chariauthor=J.+Brodyauthor=M.+V.+R.+Reddyauthor=W.+Zhangauthor=E.+P.+Reddyauthor=S.+Jagannathauthor=S.+Parekh&title=Dual+Targeting+of+CDK4+and+ARK5+Using+a+Novel+Kinase+Inhibitor+ON123300+Exerts+Potent+Anticancer+Activity+against+Multiple+Myeloma&doi=10.1158%2F0008-5472.CAN-15-2934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma</span></div><div class="casAuthors">Perumal, Deepak; Kuo, Pei-Yu; Leshchenko, Violetta V.; Jiang, Zewei; Divakar, Sai Krishna Athaluri; Cho, Hearn Jay; Chari, Ajai; Brody, Joshua; Reddy, M. V. Ramana; Zhang, Weijia; Reddy, E. Premkumar; Jagannath, Sundar; Parekh, Samir</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1225-1236</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Multiple myeloma is a fatal plasma cell neoplasm accounting for over 10,000 deaths in the United States each year.  Despite new therapies, multiple myeloma remains incurable, and patients ultimately develop drug resistance and succumb to the disease.  The response to selective CDK4/6 inhibitors has been modest in multiple myeloma, potentially because of incomplete targeting of other crit. myeloma oncogenic kinases.  As a substantial no. of multiple myeloma cell lines and primary samples were found to express AMPK-related protein kinase 5(ARK5), a member of the AMPK family assocd. with tumor growth and invasion, we examd. whether dual inhibition of CDK4 and ARK5 kinases using ON123300 results in a better therapeutic outcome.  Treatment of multiple myeloma cell lines and primary samples with ON123300 in vitro resulted in rapid induction of cell-cycle arrest followed by apoptosis.  ON123300-mediated ARK5 inhibition or ARK5-specific siRNAs resulted in the inhibition of the mTOR/S6K pathway and upregulation of the AMPK kinase cascade.  AMPK upregulation resulted in increased SIRT1 levels and destabilization of steady-state MYC protein.  Furthermore, ON123300 was very effective in inhibiting tumor growth in mouse xenograft assays.  In addn., multiple myeloma cells sensitive to ON123300 were found to have a unique genomic signature that can guide the clin. development of ON123300.  Our study provides preclin. evidence that ON123300 is unique in simultaneously inhibiting key oncogenic pathways in multiple myeloma and supports further development of ARK5 inhibition as a therapeutic approach in multiple myeloma.  Cancer Res; 76(5); 1225-36. 2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtWO_AVb9ttrVg90H21EOLACvtfcHk0lgMuy8BiojZUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslCltbc%253D&md5=82a0f15235151765215f18d43506c6c3</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-2934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-2934%26sid%3Dliteratum%253Aachs%26aulast%3DPerumal%26aufirst%3DD.%26aulast%3DKuo%26aufirst%3DP.-Y.%26aulast%3DLeshchenko%26aufirst%3DV.%2BV.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DDivakar%26aufirst%3DS.%2BK.%2BA.%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DChari%26aufirst%3DA.%26aulast%3DBrody%26aufirst%3DJ.%26aulast%3DReddy%26aufirst%3DM.%2BV.%2BR.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DParekh%26aufirst%3DS.%26atitle%3DDual%2520Targeting%2520of%2520CDK4%2520and%2520ARK5%2520Using%2520a%2520Novel%2520Kinase%2520Inhibitor%2520ON123300%2520Exerts%2520Potent%2520Anticancer%2520Activity%2520against%2520Multiple%2520Myeloma%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D1225%26epage%3D1236%26doi%3D10.1158%2F0008-5472.CAN-15-2934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, D. L.</span></span> <span> </span><span class="NLM_article-title">MiR-96 Functions as a Tumor Suppressor Gene by Targeting NUAK1 in Pancreatic Cancer</span>. <i>Int. J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1599</span>– <span class="NLM_lpage">1605</span>, <span class="refDoi"> DOI: 10.3892/ijmm.2014.1940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.3892%2Fijmm.2014.1940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=25242509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislCksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=1599-1605&author=X.+Huangauthor=W.+Lvauthor=J.+H.+Zhangauthor=D.+L.+Lu&title=MiR-96+Functions+as+a+Tumor+Suppressor+Gene+by+Targeting+NUAK1+in+Pancreatic+Cancer&doi=10.3892%2Fijmm.2014.1940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">miR-96 functions as a tumor suppressor gene by targeting NUAK1 in pancreatic cancer</span></div><div class="casAuthors">Huang, Xuan; Lv, Wei; Zhang, Jian-Hua; Lu, Da-Lin</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1599-1605</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">MicroRNA-96 (miR-96) is known to be down-regulated in pancreatic cancer.  The overexpression of miR-96 in MIA PaCa-2 pancreatic cancer cells has been shown to inhibit cell proliferation, migration and invasion; however, the mechanisms involved have not yet been fully elucidated.  Novel (nua) kinase family 1 (NUAK1) functions as an oncogene in non-small cell lung cancer (NSCLC), melanoma, glioma, breast cancer, hepatocellular carcinoma and pancreatic cancer.  In this study, firstly, we demonstrate that NUAK1 expression is specifically upregulated in pancreatic cancer and that it promotes the proliferation, migration and invasion of MIA PaCa-2 pancreatic cancer cells.  Secondly, we performed an anal. of potential microRNA (miRNA) target sites using three commonly used prediction algorithms: miRanda, TargetScan and PicTar.  All three algorithms predicted that miR-96 targets the 3' untranslated region (3' UTR) of NUAK1.  Further expts. confirmed this prediction, namely that miR-96 suppresses the expression of NUAK1 by targeting its 3' UTR.  Finally, we demonstrate that the introduction of NUAK1 cDNA lacking predicted sites of the 3' UTR abrogates miR-96 cellular function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuwd_IWfG51bVg90H21EOLACvtfcHk0ljjEnZe_Ogr5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislCksA%253D%253D&md5=bab2232a47e5154c220541146d23a32b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.3892%2Fijmm.2014.1940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.2014.1940%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%2BH.%26aulast%3DLu%26aufirst%3DD.%2BL.%26atitle%3DMiR-96%2520Functions%2520as%2520a%2520Tumor%2520Suppressor%2520Gene%2520by%2520Targeting%2520NUAK1%2520in%2520Pancreatic%2520Cancer%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2014%26volume%3D34%26spage%3D1599%26epage%3D1605%26doi%3D10.3892%2Fijmm.2014.1940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A. W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, G. Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teh, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozen, S. G.</span></span> <span> </span><span class="NLM_article-title">Functional Genomics Identifies Specific Vulnerabilities in PTEN-Deficient Breast Cancer</span>. <i>Breast Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1186/s13058-018-0949-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1186%2Fs13058-018-0949-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=29291743" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=1-16&author=Y.+C.+Tangauthor=S.+C.+Hoauthor=E.+Tanauthor=A.+W.+T.+Ngauthor=J.+R.+McPhersonauthor=G.+Y.+L.+Gohauthor=B.+T.+Tehauthor=F.+Bardauthor=S.+G.+Rozen&title=Functional+Genomics+Identifies+Specific+Vulnerabilities+in+PTEN-Deficient+Breast+Cancer&doi=10.1186%2Fs13058-018-0949-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1186%2Fs13058-018-0949-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13058-018-0949-3%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DY.%2BC.%26aulast%3DHo%26aufirst%3DS.%2BC.%26aulast%3DTan%26aufirst%3DE.%26aulast%3DNg%26aufirst%3DA.%2BW.%2BT.%26aulast%3DMcPherson%26aufirst%3DJ.%2BR.%26aulast%3DGoh%26aufirst%3DG.%2BY.%2BL.%26aulast%3DTeh%26aufirst%3DB.%2BT.%26aulast%3DBard%26aufirst%3DF.%26aulast%3DRozen%26aufirst%3DS.%2BG.%26atitle%3DFunctional%2520Genomics%2520Identifies%2520Specific%2520Vulnerabilities%2520in%2520PTEN-Deficient%2520Breast%2520Cancer%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2018%26volume%3D20%26spage%3D1%26epage%3D16%26doi%3D10.1186%2Fs13058-018-0949-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, D.</span></span> <span> </span><span class="NLM_article-title">The Hippo Signaling Pathway in Development and Cancer</span>. <i>Dev. Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">491</span>– <span class="NLM_lpage">505</span>, <span class="refDoi"> DOI: 10.1016/j.devcel.2010.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.devcel.2010.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=20951342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSmurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=491-505&author=D.+Pan&title=The+Hippo+Signaling+Pathway+in+Development+and+Cancer&doi=10.1016%2Fj.devcel.2010.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The Hippo Signaling Pathway in Development and Cancer</span></div><div class="casAuthors">Pan, Duojia</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">491-505</span>CODEN:
                <span class="NLM_cas:coden">DCEEBE</span>;
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  First discovered in Drosophila, the Hippo signaling pathway is a conserved regulator of organ size.  Central to this pathway is a kinase cascade leading from the tumor suppressor Hippo (Mst1 and Mst2 in mammals) to the oncoprotein Yki (YAP and TAZ in mammals), a transcriptional coactivator of target genes involved in cell proliferation and survival.  Here, I review recent progress in elucidating the mol. mechanism and physiol. function of Hippo signaling in Drosophila and mammals.  These studies suggest that the core Hippo kinase cascade integrates multiple upstream inputs, enabling dynamic regulation of tissue homeostasis in animal development and physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk3dwAozrlLrVg90H21EOLACvtfcHk0ljjEnZe_Ogr5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSmurjK&md5=67e7f188b5669d7e1432d28ea57a2c90</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2010.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2010.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DD.%26atitle%3DThe%2520Hippo%2520Signaling%2520Pathway%2520in%2520Development%2520and%2520Cancer%26jtitle%3DDev.%2520Cell%26date%3D2010%26volume%3D19%26spage%3D491%26epage%3D505%26doi%3D10.1016%2Fj.devcel.2010.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comerford, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gayyed, M. F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anders, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, D.</span></span> <span> </span><span class="NLM_article-title">Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">1120</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.07.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.cell.2007.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=17889654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKnurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2007&pages=1120-1133&author=J.+Dongauthor=G.+Feldmannauthor=J.+Huangauthor=S.+Wuauthor=N.+Zhangauthor=S.+A.+Comerfordauthor=M.+F.+F.+Gayyedauthor=R.+A.+Andersauthor=A.+Maitraauthor=D.+Pan&title=Elucidation+of+a+Universal+Size-Control+Mechanism+in+Drosophila+and+Mammals&doi=10.1016%2Fj.cell.2007.07.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of a universal size-control mechanism in Drosophila and mammals</span></div><div class="casAuthors">Dong, Jixin; Feldmann, Georg; Huang, Jianbin; Wu, Shian; Zhang, Nailing; Comerford, Sarah A.; Gayyed, Mariana F.; Anders, Robert A.; Maitra, Anirban; Pan, Duojia</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1120-1133</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Coordination of cell proliferation and cell death is essential to attain proper organ size during development and for maintaining tissue homeostasis throughout postnatal life.  In Drosophila, these two processes are orchestrated by the Hippo kinase cascade, a growth-suppressive pathway that ultimately antagonizes the transcriptional coactivator Yorkie (Yki).  Here we demonstrate that a single phosphorylation site in Yki mediates the growth-suppressive output of the Hippo pathway.  Hippo-mediated phosphorylation inactivates Yki by excluding it from the nucleus, whereas loss of Hippo signaling leads to nuclear accumulation and therefore increased Yki activity.  We further delineate a mammalian Hippo signaling pathway that culminates in the phosphorylation of YAP, the mammalian homolog of Yki.  Using a conditional YAP transgenic mouse model, we demonstrate that the mammalian Hippo pathway is a potent regulator of organ size, and that its dysregulation leads to tumorigenesis.  These results uncover a universal size-control mechanism in metazoan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFVuE0XSnE87Vg90H21EOLACvtfcHk0liVIahe89NMmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKnurjO&md5=c8b5bfffd642be6b1fe2af7d012a1c3e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DFeldmann%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DComerford%26aufirst%3DS.%2BA.%26aulast%3DGayyed%26aufirst%3DM.%2BF.%2BF.%26aulast%3DAnders%26aufirst%3DR.%2BA.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DPan%26aufirst%3DD.%26atitle%3DElucidation%2520of%2520a%2520Universal%2520Size-Control%2520Mechanism%2520in%2520Drosophila%2520and%2520Mammals%26jtitle%3DCell%26date%3D2007%26volume%3D130%26spage%3D1120%26epage%3D1133%26doi%3D10.1016%2Fj.cell.2007.07.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monteverde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthalagu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Port, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D. J.</span></span> <span> </span><span class="NLM_article-title">Evidence of Cancer-Promoting Roles for AMPK and Related Kinases</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">4658</span>– <span class="NLM_lpage">4671</span>, <span class="refDoi"> DOI: 10.1111/febs.13534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1111%2Ffebs.13534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26426570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1yksL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2015&pages=4658-4671&author=T.+Monteverdeauthor=N.+Muthalaguauthor=J.+Portauthor=D.+J.+Murphy&title=Evidence+of+Cancer-Promoting+Roles+for+AMPK+and+Related+Kinases&doi=10.1111%2Ffebs.13534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence of cancer-promoting roles for AMPK and related kinases</span></div><div class="casAuthors">Monteverde, Tiziana; Muthalagu, Nathiya; Port, Jennifer; Murphy, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4658-4671</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The discovery that the 5'AMP-activated protein kinase (AMPK) serves to link the tumor suppressors LKB1 and the tuberous sclerosis complex and functions to slow macromol. synthesis through attenuation of the mechanistic target of rapamycin complex 1 revealed a role for AMPK in tumor suppression.  On the other hand, the well-recognized role of AMPK in maintaining ATP homeostasis, through suppression of anabolism and promotion of catabolism, as well as the role of AMPK in neutralizing reactive oxygen species, via maintenance of NADPH-dependent reductive capacity, point to tumor-protective roles in the context of metabolic stress, which is a key feature of many solid tumors.  A growing no. of studies thus suggest a duality of functions for AMPK that are either pro- or anti-cancer, depending upon context.  Importantly, AMPK is composed of three subunits, and multiple isoforms exist for all three, allowing for different permutations to assemble and the potential for specific AMPK complexes to regulate distinct cellular processes.  Moreover, certain subunits of the AMPK complex are frequently overexpressed in a spectrum of human cancer types, suggesting an outright oncogenic function for specific AMPK complexes.  Adding complexity to this picture, the catalytic AMPK alpha subunits belong to a family of 14 kinases that can all be activated by LKB1 and studies are beginning to reveal a similar duality of roles in cancer for other members of the AMPK-related kinase family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAoIicUX6LvrVg90H21EOLACvtfcHk0liVIahe89NMmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1yksL7P&md5=422a673b8fe147a35efa434691d62377</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13534%26sid%3Dliteratum%253Aachs%26aulast%3DMonteverde%26aufirst%3DT.%26aulast%3DMuthalagu%26aufirst%3DN.%26aulast%3DPort%26aufirst%3DJ.%26aulast%3DMurphy%26aufirst%3DD.%2BJ.%26atitle%3DEvidence%2520of%2520Cancer-Promoting%2520Roles%2520for%2520AMPK%2520and%2520Related%2520Kinases%26jtitle%3DFEBS%2520J.%26date%3D2015%26volume%3D282%26spage%3D4658%26epage%3D4671%26doi%3D10.1111%2Ffebs.13534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakoshi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iida, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ide, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, E.</span></span> <span> </span><span class="NLM_article-title">Mitogenic Signalling and the P16INK4a-Rb Pathway Cooperate to Enforce Irreversible Cellular Senescence</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1291</span>– <span class="NLM_lpage">1297</span>, <span class="refDoi"> DOI: 10.1038/ncb1491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fncb1491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=17028578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFCqu7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=1291-1297&author=A.+Takahashiauthor=N.+Ohtaniauthor=K.+Yamakoshiauthor=S.+I.+Iidaauthor=H.+Taharaauthor=K.+Nakayamaauthor=K.+I.+Nakayamaauthor=T.+Ideauthor=H.+Sayaauthor=E.+Hara&title=Mitogenic+Signalling+and+the+P16INK4a-Rb+Pathway+Cooperate+to+Enforce+Irreversible+Cellular+Senescence&doi=10.1038%2Fncb1491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence</span></div><div class="casAuthors">Takahashi, Akiko; Ohtani, Naoko; Yamakoshi, Kimi; Iida, Shin-ichi; Tahara, Hidetoshi; Nakayama, Keiko; Nakayama, Keiichi I.; Ide, Toshinori; Saya, Hideyuki; Hara, Eiji</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1291-1297</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The p16INK4a cyclin-dependent kinase inhibitor has a key role in establishing stable G1 cell-cycle arrest through activating the retinoblastoma (Rb) tumor suppressor protein pRb in cellular senescence.  Here, we show that the p16INK4a /Rb-pathway also cooperates with mitogenic signals to induce elevated intracellular levels of reactive oxygen species (ROS), thereby activating protein kinase Cδ (PKCδ) in human senescent cells.  Importantly, once activated by ROS, PKCδ promotes further generation of ROS, thus establishing a pos. feedback loop to sustain ROS-PKCδ signalling.  Sustained activation of ROS-PKCδ signalling irreversibly blocks cytokinesis, at least partly through reducing the level of WARTS (also known as LATS1), a mitotic exit network (MEN) kinase required for cytokinesis, in human senescent cells.  This irreversible cytokinetic block is likely to act as a second barrier to cellular immortalization ensuring stable cell-cycle arrest in human senescent cells.  These results uncover an unexpected role for the p16INK4a-Rb pathway and provide a new insight into how senescent cell-cycle arrest is enforced in human cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9sOWCCSf_TbVg90H21EOLACvtfcHk0liVIahe89NMmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFCqu7jE&md5=31f9204e6a71b25e07aeac7c7c4bf702</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fncb1491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1491%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DOhtani%26aufirst%3DN.%26aulast%3DYamakoshi%26aufirst%3DK.%26aulast%3DIida%26aufirst%3DS.%2BI.%26aulast%3DTahara%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DK.%2BI.%26aulast%3DIde%26aufirst%3DT.%26aulast%3DSaya%26aufirst%3DH.%26aulast%3DHara%26aufirst%3DE.%26atitle%3DMitogenic%2520Signalling%2520and%2520the%2520P16INK4a-Rb%2520Pathway%2520Cooperate%2520to%2520Enforce%2520Irreversible%2520Cellular%2520Senescence%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2006%26volume%3D8%26spage%3D1291%26epage%3D1297%26doi%3D10.1038%2Fncb1491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, P. Y.</span></span> <span> </span><span class="NLM_article-title">Overexpression of ARK5 Is Associated with Poor Prognosis in Hepatocellular Carcinoma</span>. <i>Tumor Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1913</span>– <span class="NLM_lpage">1918</span>, <span class="refDoi"> DOI: 10.1007/s13277-013-0735-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1007%2Fs13277-013-0735-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXos1yksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1913-1918&author=J.+Cuiauthor=Y.+Yuauthor=G.+F.+Luauthor=C.+Liuauthor=X.+Liuauthor=Y.+X.+Xuauthor=P.+Y.+Zheng&title=Overexpression+of+ARK5+Is+Associated+with+Poor+Prognosis+in+Hepatocellular+Carcinoma&doi=10.1007%2Fs13277-013-0735-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma</span></div><div class="casAuthors">Cui, Jing; Yu, Yong; Lu, Gao-Feng; Liu, Chao; Liu, Xia; Xu, Yu-Xian; Zheng, Peng-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1913-1918</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">ARK5 overexpression has been reported in a variety of human cancers.  However, the role of ARK5 in hepatocellular carcinoma (HCC) remains unclear.  The aim of the present study is to analyze the ARK5 protein expression in HCC tissue samples and to assess its prognostic significance for HCC.  ARK5 mRNA and protein expression were detd. by real-time quant. reverse transcriptase-polymerase chain reaction and Western blot in 20 pairs of fresh frozen HCC tissues and corresponding non-cancerous tissues.  In addn., ARK5 expression was analyzed by immunohistochem. in 130 clinicopathol. characterized HCC cases.  The correlation of ARK5 expression with patients' survival rate was assessed by Kaplan-Meier and Cox regression.  Our results showed that the expression levels of ARK5 mRNA and protein in HCC tissues were both significantly higher than those in non-cancerous tissues.  Our results showed that the high expression of ARK5 in HCC was related to tumor size (p = 0.005), histol. differentiation (p = 0.047), and tumor stage (p = 0.005).  Kaplan-Meier survival anal. showed that a high expression level of ARK5 resulted in a significantly poor prognosis of HCC patients.  Multivariate anal. revealed that ARK5 expression level was an independent prognostic parameter for the overall survival rate of HCC patients.  In conclusion, ARK5 might play a pos. role in tumor development and could serve as an independent predictor of poor prognosis for HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDxvvtj28zA7Vg90H21EOLACvtfcHk0liZmeMqxRJ_2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXos1yksbo%253D&md5=16a82b0238fa593319dc6d38f357de4b</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2Fs13277-013-0735-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-013-0735-x%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DG.%2BF.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%2BX.%26aulast%3DZheng%26aufirst%3DP.%2BY.%26atitle%3DOverexpression%2520of%2520ARK5%2520Is%2520Associated%2520with%2520Poor%2520Prognosis%2520in%2520Hepatocellular%2520Carcinoma%26jtitle%3DTumor%2520Biol.%26date%3D2013%26volume%3D34%26spage%3D1913%26epage%3D1918%26doi%3D10.1007%2Fs13277-013-0735-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span> <span> </span><span class="NLM_article-title">High NUAK1 Expression Correlates with Poor Prognosis and Involved in NSCLC Cells Migration and Invasion</span>. <i>Exp. Lung Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.3109/01902148.2012.744115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.3109%2F01902148.2012.744115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23215946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1CitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2013&pages=9-17&author=P.+Chenauthor=K.+Liauthor=Y.+Liangauthor=L.+Liauthor=X.+Zhu&title=High+NUAK1+Expression+Correlates+with+Poor+Prognosis+and+Involved+in+NSCLC+Cells+Migration+and+Invasion&doi=10.3109%2F01902148.2012.744115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">High NUAK1 expression correlates with poor prognosis and involved in NSCLC cells migration and invasion</span></div><div class="casAuthors">Chen, Peng; Li, Kai; Liang, Yan; Li, Liqing; Zhu, Xiaolin</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Lung Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-17</span>CODEN:
                <span class="NLM_cas:coden">EXLRDA</span>;
        ISSN:<span class="NLM_cas:issn">0190-2148</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Novel (nua) kinase family 1 (NUAK1) is a member of the human adenosine monophosphate (AMP)-activated protein kinase family that has been identified as a key tumor cell survival factor.  In the present study, we investigated the role of NUAK1 in the migration and invasion of human nonsmall cell lung cancer (NSCLC) cells.  Immunohistochem. staining showed that the expression of NUAK1 correlated with the differentiation and stage of the carcinoma, as well as with lymph node metastasis.  Inhibition of NUAK1 expression by small interference RNA severely impaired migration and invasion in A549 cells.  In addn., we found that the knockdown of NUAK1 suppressed the expression of MMP-2 and MMP-9 and the activation of NF-kB, which can regulate the transcription of MMP-2 and MMP-9.  Correspondingly, NUAK1 knockdown reduced lung metastasis in a xenograft mouse model of NSCLC.  Taken together, our results suggest that NUAK1 plays an important role in NSCLC cell migration and invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCk3CvE2xsjLVg90H21EOLACvtfcHk0liZmeMqxRJ_2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1CitbY%253D&md5=72aeac4004140a3d4ce62a66627ec92f</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.3109%2F01902148.2012.744115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01902148.2012.744115%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DHigh%2520NUAK1%2520Expression%2520Correlates%2520with%2520Poor%2520Prognosis%2520and%2520Involved%2520in%2520NSCLC%2520Cells%2520Migration%2520and%2520Invasion%26jtitle%3DExp.%2520Lung%2520Res.%26date%3D2013%26volume%3D39%26spage%3D9%26epage%3D17%26doi%3D10.3109%2F01902148.2012.744115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carvajal, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manfredi, J. J.</span></span> <span> </span><span class="NLM_article-title">Another Fork in the Road - Life or Death Decisions by the Tumour Suppressor P53</span>. <i>EMBO Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.1038/embor.2013.25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fembor.2013.25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23588418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvV2kur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=414-421&author=L.+A.+Carvajalauthor=J.+J.+Manfredi&title=Another+Fork+in+the+Road+-+Life+or+Death+Decisions+by+the+Tumour+Suppressor+P53&doi=10.1038%2Fembor.2013.25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Another fork in the road-life or death decisions by the tumour suppressor p53</span></div><div class="casAuthors">Carvajal, Luis A.; Manfredi, James J.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">414-421</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In response to cellular stress signals, the tumor suppressor p53 accumulates and triggers a host of antineoplastic responses.  For instance, DNA damage activates two main p53-dependent responses: cell cycle arrest and attendant DNA repair or apoptosis (cell death).  It is broadly accepted that, in response to DNA damage, the function of p53 as a sequence-specific transcription factor is crucial for tumor suppression.  The mol. determinants, however, that favor the initiation of either a p53-dependent cell cycle arrest (life) or apoptotic (death) transcriptional program remain elusive.  Gaining a clear understanding of the mechanisms controlling cell fate detn. by p53 could lead to the identification of mol. targets for therapy, which could selectively sensitize cancer cells to apoptosis.  This review summarizes the literature addressing this important question in the field.  Special emphasis is given to the role of the p53 response element, post-translational modifications and protein-protein interactions on cell fate decisions made by p53 in response to DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-Yed0JJ0hu7Vg90H21EOLACvtfcHk0lgW07FFzyD6hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvV2kur0%253D&md5=4aac635e231f9183128ea4cdfec2a1dd</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fembor.2013.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fembor.2013.25%26sid%3Dliteratum%253Aachs%26aulast%3DCarvajal%26aufirst%3DL.%2BA.%26aulast%3DManfredi%26aufirst%3DJ.%2BJ.%26atitle%3DAnother%2520Fork%2520in%2520the%2520Road%2520-%2520Life%2520or%2520Death%2520Decisions%2520by%2520the%2520Tumour%2520Suppressor%2520P53%26jtitle%3DEMBO%2520Rep.%26date%3D2013%26volume%3D14%26spage%3D414%26epage%3D421%26doi%3D10.1038%2Fembor.2013.25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohseni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frazier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camargo, F. D.</span></span> <span> </span><span class="NLM_article-title">A Genetic Screen Identifies an LKB1-MARK Signalling Axis Controlling the Hippo-YAP Pathway</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1038/ncb2884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fncb2884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=24362629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOls7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=108-117&author=M.+Mohseniauthor=J.+Sunauthor=A.+Lauauthor=S.+Curtisauthor=J.+Goldsmithauthor=V.+L.+Foxauthor=C.+Weiauthor=M.+Frazierauthor=O.+Samsonauthor=K.-K.+Wongauthor=C.+Kimauthor=F.+D.+Camargo&title=A+Genetic+Screen+Identifies+an+LKB1-MARK+Signalling+Axis+Controlling+the+Hippo-YAP+Pathway&doi=10.1038%2Fncb2884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A genetic screen identifies an LKB1-MARK signalling axis controlling the Hippo-YAP pathway</span></div><div class="casAuthors">Mohseni, Morvarid; Sun, Jianlong; Lau, Allison; Curtis, Stephen; Goldsmith, Jeffrey; Fox, Victor L.; Wei, Chongjuan; Frazier, Marsha; Samson, Owen; Wong, Kwok-Kin; Kim, Carla; Camargo, Fernando D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">108-117</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Hippo-YAP pathway is an emerging signalling cascade involved in the regulation of stem cell activity and organ size.  To identify components of this pathway, we performed an RNAi-based kinome screen in human cells.  Our screen identified several kinases not previously assocd. with Hippo signalling that control multiple cellular processes.  One of the hits, LKB1, is a common tumor suppressor whose mechanism of action is only partially understood.  We demonstrate that LKB1 acts through its substrates of the microtubule affinity-regulating kinase family to regulate the localization of the polarity determinant Scribble and the activity of the core Hippo kinases.  Our data also indicate that YAP is functionally important for the tumor suppressive effects of LKB1.  Our results identify a signalling axis that links YAP activation with LKB1 mutations, and have implications for the treatment of LKB1-mutant human malignancies.  In addn., our findings provide insight into upstream signals of the Hippo-YAP signalling cascade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8AfFxEgo6irVg90H21EOLACvtfcHk0lgW07FFzyD6hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOls7zI&md5=4c1289d2cb5c8f99f2040faa2bb7593c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fncb2884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2884%26sid%3Dliteratum%253Aachs%26aulast%3DMohseni%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DCurtis%26aufirst%3DS.%26aulast%3DGoldsmith%26aufirst%3DJ.%26aulast%3DFox%26aufirst%3DV.%2BL.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DFrazier%26aufirst%3DM.%26aulast%3DSamson%26aufirst%3DO.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DCamargo%26aufirst%3DF.%2BD.%26atitle%3DA%2520Genetic%2520Screen%2520Identifies%2520an%2520LKB1-MARK%2520Signalling%2520Axis%2520Controlling%2520the%2520Hippo-YAP%2520Pathway%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2014%26volume%3D16%26spage%3D108%26epage%3D117%26doi%3D10.1038%2Fncb2884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mo, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, K. L.</span></span> <span> </span><span class="NLM_article-title">Cellular Energy Stress Induces AMPK-Mediated Regulation of YAP and the Hippo Pathway</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">500</span>– <span class="NLM_lpage">510</span>, <span class="refDoi"> DOI: 10.1038/ncb3111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fncb3111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=25751140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=500-510&author=J.+S.+Moauthor=Z.+Mengauthor=Y.+C.+Kimauthor=H.+W.+Parkauthor=C.+G.+Hansenauthor=S.+Kimauthor=D.+S.+Limauthor=K.+L.+Guan&title=Cellular+Energy+Stress+Induces+AMPK-Mediated+Regulation+of+YAP+and+the+Hippo+Pathway&doi=10.1038%2Fncb3111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway</span></div><div class="casAuthors">Mo, Jung-Soon; Meng, Zhipeng; Kim, Young Chul; Park, Hyun Woo; Hansen, Carsten Gram; Kim, Soohyun; Lim, Dae-Sik; Guan, Kun-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">500-510</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">YAP (Yes-assocd. protein) is a transcription co-activator in the Hippo tumor suppressor pathway and controls cell growth, tissue homeostasis and organ size.  YAP is inhibited by the kinase Lats, which phosphorylates YAP to induce its cytoplasmic localization and proteasomal degrdn.  YAP induces gene expression by binding to the TEAD family transcription factors.  Dysregulation of the Hippo-YAP pathway is frequently obsd. in human cancers.  Here we show that cellular energy stress induces YAP phosphorylation, in part due to AMPK-dependent Lats activation, thereby inhibiting YAP activity.  Moreover, AMPK directly phosphorylates YAP Ser 94, a residue essential for the interaction with TEAD, thus disrupting the YAP-TEAD interaction.  AMPK-induced YAP inhibition can suppress oncogenic transformation of Lats-null cells with high YAP activity.  Our study establishes a mol. mechanism and functional significance of AMPK in linking cellular energy status to the Hippo-YAP pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMNzjxfE8hbbVg90H21EOLACvtfcHk0lgW07FFzyD6hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsrc%253D&md5=2b790417cf799fd937a201506ed5b32a</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fncb3111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb3111%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DJ.%2BS.%26aulast%3DMeng%26aufirst%3DZ.%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DPark%26aufirst%3DH.%2BW.%26aulast%3DHansen%26aufirst%3DC.%2BG.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DLim%26aufirst%3DD.%2BS.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26atitle%3DCellular%2520Energy%2520Stress%2520Induces%2520AMPK-Mediated%2520Regulation%2520of%2520YAP%2520and%2520the%2520Hippo%2520Pathway%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2015%26volume%3D17%26spage%3D500%26epage%3D510%26doi%3D10.1038%2Fncb3111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aziz, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">AMPK Modulates Hippo Pathway Activity to Regulate Energy Homeostasis</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">490</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1038/ncb3113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fncb3113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=25751139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=490-499&author=W.+Wangauthor=Z.+D.+Xiaoauthor=X.+Liauthor=K.+E.+Azizauthor=B.+Ganauthor=R.+L.+Johnsonauthor=J.+Chen&title=AMPK+Modulates+Hippo+Pathway+Activity+to+Regulate+Energy+Homeostasis&doi=10.1038%2Fncb3113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK modulates Hippo pathway activity to regulate energy homeostasis</span></div><div class="casAuthors">Wang, Wenqi; Xiao, Zhen-Dong; Li, Xu; Aziz, Kathryn E.; Gan, Boyi; Johnson, Randy L.; Chen, Junjie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">490-499</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Hippo pathway was discovered as a conserved tumor suppressor pathway restricting cell proliferation and apoptosis.  However, the upstream signals that regulate the Hippo pathway in the context of organ size control and cancer prevention are largely unknown.  Here, we report that glucose, the ubiquitous energy source used for ATP generation, regulates the Hippo pathway downstream effector YAP.  We show that both the Hippo pathway and AMP-activated protein kinase (AMPK) were activated during glucose starvation, resulting in phosphorylation of YAP and contributing to its inactivation.  We also identified glucose-transporter 3 (GLUT3) as a YAP-regulated gene involved in glucose metab.  Together, these results demonstrate that glucose-mediated energy homeostasis is an upstream event involved in regulation of the Hippo pathway and, potentially, an oncogenic function of YAP in promoting glycolysis, thereby providing an exciting link between glucose metab. and the Hippo pathway in tissue maintenance and cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9EQSGm1lcGbVg90H21EOLACvtfcHk0lghZmCQfqPQwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsrY%253D&md5=2b676165cc29546c981774bf2301216c</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1038%2Fncb3113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb3113%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DZ.%2BD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DAziz%26aufirst%3DK.%2BE.%26aulast%3DGan%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DR.%2BL.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DAMPK%2520Modulates%2520Hippo%2520Pathway%2520Activity%2520to%2520Regulate%2520Energy%2520Homeostasis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2015%26volume%3D17%26spage%3D490%26epage%3D499%26doi%3D10.1038%2Fncb3113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeRan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitamant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asara, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardeesy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span> <span> </span><span class="NLM_article-title">Energy Stress Regulates Hippo-YAP Signaling Involving AMPK-Mediated Regulation of Angiomotin-like 1 Protein</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2014.09.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.celrep.2014.09.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=25373897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOrtLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=495-503&author=M.+DeRanauthor=J.+Yangauthor=C.-H.+Shenauthor=E.+C.+Petersauthor=J.+Fitamantauthor=P.+Chanauthor=M.+Hsiehauthor=S.+Zhuauthor=J.+M.+Asaraauthor=B.+Zhengauthor=N.+Bardeesyauthor=J.+Liuauthor=X.+Wu&title=Energy+Stress+Regulates+Hippo-YAP+Signaling+Involving+AMPK-Mediated+Regulation+of+Angiomotin-like+1+Protein&doi=10.1016%2Fj.celrep.2014.09.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Energy Stress Regulates Hippo-YAP Signaling Involving AMPK-Mediated Regulation of Angiomotin-like 1 Protein</span></div><div class="casAuthors">DeRan, Michael; Yang, Jiayi; Shen, Che-Hung; Peters, Eric C.; Fitamant, Julien; Chan, Puiyee; Hsieh, Mindy; Zhu, Shunying; Asara, John M.; Zheng, Bin; Bardeesy, Nabeel; Liu, Jun; Wu, Xu</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">495-503</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Hippo signaling is a tumor-suppressor pathway involved in organ size control and tumorigenesis through the inhibition of YAP and TAZ.  Here, we show that energy stress induces YAP cytoplasmic retention and S127 phosphorylation and inhibits YAP transcriptional activity and YAP-dependent transformation.  These effects require the central metabolic sensor AMP-activated protein kinase (AMPK) and the upstream Hippo pathway components Lats1/Lats2 and angiomotin-like 1 (AMOTL1).  Furthermore, we show that AMPK directly phosphorylates S793 of AMOTL1.  AMPK activation stabilizes and increases AMOTL1 steady-state protein levels, contributing to YAP inhibition.  The phosphorylation-deficient S793Ala mutant of AMOTL1 showed a shorter half-life and conferred resistance to energy-stress-induced YAP inhibition.  Our findings link energy sensing to the Hippo-YAP pathway and suggest that YAP may integrate spatial (contact inhibition), mech., and metabolic signals to control cellular proliferation and survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdF9CsZGTzKLVg90H21EOLACvtfcHk0lghZmCQfqPQwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOrtLrP&md5=2d8692460302f95f7402a72728413293</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.09.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.09.036%26sid%3Dliteratum%253Aachs%26aulast%3DDeRan%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DC.-H.%26aulast%3DPeters%26aufirst%3DE.%2BC.%26aulast%3DFitamant%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DP.%26aulast%3DHsieh%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DAsara%26aufirst%3DJ.%2BM.%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DBardeesy%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26atitle%3DEnergy%2520Stress%2520Regulates%2520Hippo-YAP%2520Signaling%2520Involving%2520AMPK-Mediated%2520Regulation%2520of%2520Angiomotin-like%25201%2520Protein%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D9%26spage%3D495%26epage%3D503%26doi%3D10.1016%2Fj.celrep.2014.09.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babcock, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quilliam, L. A.</span></span> <span> </span><span class="NLM_article-title">LKB1 Tumor Suppressor Regulates AMP Kinase/MTOR-Independent Cell Growth and Proliferation via the Phosphorylation of Yap</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">4100</span>– <span class="NLM_lpage">4109</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fonc.2012.431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23027127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaqtLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=4100-4109&author=H.+B.+Nguyenauthor=J.+T.+Babcockauthor=C.+D.+Wellsauthor=L.+A.+Quilliam&title=LKB1+Tumor+Suppressor+Regulates+AMP+Kinase%2FMTOR-Independent+Cell+Growth+and+Proliferation+via+the+Phosphorylation+of+Yap&doi=10.1038%2Fonc.2012.431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap</span></div><div class="casAuthors">Nguyen, H. B.; Babcock, J. T.; Wells, C. D.; Quilliam, L. A.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">4100-4109</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The liver kinase B1 (LKB1) tumor suppressor inhibits cell growth through its regulation of cellular metab. and apical-basal polarity.  The best understood mechanism whereby LKB1 limits cell growth is through activation of the AMP-activated-protein-kinase/mammalian-target-of-rapamycin (AMPK/mTOR) pathway to control metab.  As LKB1 is also required for polarized epithelial cells to resist hyperplasia, it is anticipated to function through addnl. mechanisms.  Recently, Yes-assocd. protein (Yap) has emerged as a transcriptional co-activator that modulates tissue homeostasis in response to cell-cell contact.  Thus this study examd. a possible connection between Yap and LKB1.  Restoration of LKB1 expression in HeLa cells, which lack this tumor suppressor, or short-hairpin RNA knockdown of LKB1 in NTERT immortalized keratinocytes, demonstrated that LKB1 promotes Yap phosphorylation, nuclear exclusion and proteasomal degrdn.  The ability of phosphorylation-defective Yap mutants to rescue LKB1 phenotypes, such as reduced cell proliferation and cell size, suggest that Yap inhibition contributes to LKB1 tumor suppressor function(s).  However, failure of Lats1/2 knockdown to suppress LKB1-mediated Yap regulation suggested that LKB1 signals to Yap via a non-canonical pathway.  Addnl., LKB1 inhibited Yap independently of either AMPK or mTOR activation.  These findings reveal a novel mechanism whereby LKB1 may restrict cancer cell growth via the inhibition of Yap.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Su5GJ17jSrVg90H21EOLACvtfcHk0ljHBzT_BqUGiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaqtLzP&md5=bfbba5ae755b3e2f10900abb49cfec0e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.431%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DH.%2BB.%26aulast%3DBabcock%26aufirst%3DJ.%2BT.%26aulast%3DWells%26aufirst%3DC.%2BD.%26aulast%3DQuilliam%26aufirst%3DL.%2BA.%26atitle%3DLKB1%2520Tumor%2520Suppressor%2520Regulates%2520AMP%2520Kinase%252FMTOR-Independent%2520Cell%2520Growth%2520and%2520Proliferation%2520via%2520the%2520Phosphorylation%2520of%2520Yap%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D4100%26epage%3D4109%26doi%3D10.1038%2Fonc.2012.431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gill, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregorieff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narimatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couzens, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlotta, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Kwast, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingras, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicheri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrana, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attisano, L.</span></span> <span> </span><span class="NLM_article-title">A Feed Forward Loop Enforces YAP/TAZ Signaling during Tumorigenesis</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-05939-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fs41467-018-05939-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=29317637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVakt7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1-13&author=M.+K.+Gillauthor=T.+Christovaauthor=Y.+Y.+Zhangauthor=A.+Gregorieffauthor=L.+Zhangauthor=M.+Narimatsuauthor=S.+Songauthor=S.+Xiongauthor=A.+L.+Couzensauthor=J.+Tongauthor=J.+R.+Kriegerauthor=M.+F.+Moranauthor=A.+R.+Zlottaauthor=T.+H.+van+der%0AKwastauthor=A.-C.+Gingrasauthor=F.+Sicheriauthor=J.+L.+Wranaauthor=L.+Attisano&title=A+Feed+Forward+Loop+Enforces+YAP%2FTAZ+Signaling+during+Tumorigenesis&doi=10.1038%2Fs41467-018-05939-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling</span></div><div class="casAuthors">Pinho, Andreia V.; Van Bulck, Mathias; Chantrill, Lorraine; Arshi, Mehreen; Sklyarova, Tatyana; Herrmann, David; Vennin, Claire; Gallego-Ortega, David; Mawson, Amanda; Giry-Laterriere, Marc; Magenau, Astrid; Leuckx, Gunther; Baeyens, Luc; Gill, Anthony J.; Phillips, Phoebe; Timpson, Paul; Biankin, Andrew V.; Wu, Jianmin; Rooman, Ilse</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Whereas genomic aberrations in the SLIT-ROBO pathway are frequent in pancreatic ductal adenocarcinoma (PDAC), their function in the pancreas is unclear.  Here we report that in pancreatitis and PDAC mouse models, epithelial Robo2 expression is lost while Robo1 expression becomes most prominent in the stroma.  Cell cultures of mice with loss of epithelial Robo2 (Pdx1Cre;Robo2F/F) show increased activation of Robo1+ myofibroblasts and induction of TGF-β and Wnt pathways.  During pancreatitis, Pdx1Cre;Robo2F/F mice present enhanced myofibroblast activation, collagen crosslinking, T-cell infiltration and tumorigenic immune markers.  The TGF-β inhibitor galunisertib suppresses these effects.  In PDAC patients, ROBO2 expression is overall low while ROBO1 is variably expressed in epithelium and high in stroma.  ROBO2low;ROBO1high patients present the poorest survival.  In conclusion, Robo2 acts non-autonomously as a stroma suppressor gene by restraining myofibroblast activation and T-cell infiltration.  ROBO1/2 expression in PDAC patients may guide therapy with TGF-β inhibitors or other stroma /immune modulating agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog2FcnvCa0hrVg90H21EOLACvtfcHk0ljHBzT_BqUGiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVakt7zK&md5=21f49d6a8fcbc35ad00d983065b67f79</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-05939-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-05939-2%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DM.%2BK.%26aulast%3DChristova%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DY.%2BY.%26aulast%3DGregorieff%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DNarimatsu%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DS.%26aulast%3DXiong%26aufirst%3DS.%26aulast%3DCouzens%26aufirst%3DA.%2BL.%26aulast%3DTong%26aufirst%3DJ.%26aulast%3DKrieger%26aufirst%3DJ.%2BR.%26aulast%3DMoran%26aufirst%3DM.%2BF.%26aulast%3DZlotta%26aufirst%3DA.%2BR.%26aulast%3Dvan%2Bder%2BKwast%26aufirst%3DT.%2BH.%26aulast%3DGingras%26aufirst%3DA.-C.%26aulast%3DSicheri%26aufirst%3DF.%26aulast%3DWrana%26aufirst%3DJ.%2BL.%26aulast%3DAttisano%26aufirst%3DL.%26atitle%3DA%2520Feed%2520Forward%2520Loop%2520Enforces%2520YAP%252FTAZ%2520Signaling%2520during%2520Tumorigenesis%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D1%26epage%3D13%26doi%3D10.1038%2Fs41467-018-05939-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pepe-Mooney, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dill, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calogero, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camargo, F. D.</span></span> <span> </span><span class="NLM_article-title">NUAK2 Is a Critical YAP Target in Liver Cancer</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-07394-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fs41467-018-07394-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=29317637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1Krsr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1-12&author=W.+C.+Yuanauthor=B.+Pepe-Mooneyauthor=G.+G.+Galliauthor=M.+T.+Dillauthor=H.+T.+Huangauthor=M.+Haoauthor=Y.+Wangauthor=H.+Liangauthor=R.+A.+Calogeroauthor=F.+D.+Camargo&title=NUAK2+Is+a+Critical+YAP+Target+in+Liver+Cancer&doi=10.1038%2Fs41467-018-07394-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Interconvertible vanadium-seamed hexameric pyrogallol[4]arene nanocapsules</span></div><div class="casAuthors">Su, Kongzhao; Wu, Mingyan; Yuan, Daqiang; Hong, Maochun</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Research into stimuli-responsive controlled self-assembly and reversible transformation of mol. architectures has received much attention recently, because it is important to understand and reproduce this natural self-assembly behavior.  Here, we report two coordination nanocapsules with variable cavities: a contracted octahedral V24 capsule and an expanded ball-shaped V24 capsule, both of which are constructed from the same no. of subcomponents.  The assemblies of these two V24 capsules are solvent-controlled, and capable of reversible conversion between contracted and expanded forms via control of the geometries of the metal centers by assocn. and dissocn. with axial water mols.  Following such structural interconversions, the magnetic properties are significantly changed.  This work not only provides a strategy for the design and prepn. of coordination nanocapsules with adaptable cavities, but also a unique example with which to understand the transformation process and their structure-property relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouiQ3aHNwvKbVg90H21EOLACvtfcHk0ljHBzT_BqUGiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1Krsr%252FN&md5=825fc76fb3d34ff4703c226af4b5dea4</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-07394-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-07394-5%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DW.%2BC.%26aulast%3DPepe-Mooney%26aufirst%3DB.%26aulast%3DGalli%26aufirst%3DG.%2BG.%26aulast%3DDill%26aufirst%3DM.%2BT.%26aulast%3DHuang%26aufirst%3DH.%2BT.%26aulast%3DHao%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DCalogero%26aufirst%3DR.%2BA.%26aulast%3DCamargo%26aufirst%3DF.%2BD.%26atitle%3DNUAK2%2520Is%2520a%2520Critical%2520YAP%2520Target%2520in%2520Liver%2520Cancer%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D1%26epage%3D12%26doi%3D10.1038%2Fs41467-018-07394-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lessard, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivas, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Queiroz, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirshman, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fielding, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodyear, L. J.</span></span> <span> </span><span class="NLM_article-title">The AMPK-Related Kinase SNARK Regulates Muscle Mass and Myocyte Survival</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1172/JCI79197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1172%2FJCI79197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26690705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BC28rjsFWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2016&pages=560-570&author=S.+J.+Lessardauthor=D.+A.+Rivasauthor=K.+Soauthor=H.+J.+Kohauthor=A.+L.+Queirozauthor=M.+F.+Hirshmanauthor=R.+A.+Fieldingauthor=L.+J.+Goodyear&title=The+AMPK-Related+Kinase+SNARK+Regulates+Muscle+Mass+and+Myocyte+Survival&doi=10.1172%2FJCI79197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The AMPK-related kinase SNARK regulates muscle  mass and myocyte survival</span></div><div class="casAuthors">Lessard Sarah J; Rivas Donato A; So Kawai; Koh Ho-Jin; Queiroz Andre Lima; Hirshman Michael F; Fielding Roger A; Goodyear Laurie J</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">560-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The maintenance of skeletal muscle mass is critical for sustaining health; however, the mechanisms responsible for muscle loss with aging and chronic diseases, such as diabetes and obesity, are poorly understood.  We found that expression of a member of the AMPK-related kinase family, the SNF1-AMPK-related kinase (SNARK, also known as NUAK2), increased with muscle cell differentiation.  SNARK expression increased in skeletal muscles from young mice exposed to metabolic stress and in muscles from healthy older human subjects.  The regulation of SNARK expression in muscle with differentiation and physiological stress suggests that SNARK may function in the maintenance of muscle mass.  Consistent with this hypothesis, decreased endogenous SNARK expression (using siRNA) in cultured muscle cells resulted in increased apoptosis and decreased cell survival under conditions of metabolic stress.  Likewise, muscle-specific transgenic animals expressing a SNARK dominant-negative inactive mutant (SDN) had increased myonuclear apoptosis and activation of apoptotic mediators in muscle.  Moreover, animals expressing SDN had severe, age-accelerated muscle atrophy and increased adiposity, consistent with sarcopenic obesity.  Reduced SNARK activity, in vivo and in vitro, caused downregulation of the Rho kinase signaling pathway, a key mediator of cell survival.  These findings reveal a critical role for SNARK in myocyte survival and the maintenance of muscle mass with age.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTTzGnLnD_mpzslzEEsg76ufW6udTcc2eajwl6v0Wxz2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rjsFWnsg%253D%253D&md5=78fff98098d48a1fcc8550df5074413f</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1172%2FJCI79197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI79197%26sid%3Dliteratum%253Aachs%26aulast%3DLessard%26aufirst%3DS.%2BJ.%26aulast%3DRivas%26aufirst%3DD.%2BA.%26aulast%3DSo%26aufirst%3DK.%26aulast%3DKoh%26aufirst%3DH.%2BJ.%26aulast%3DQueiroz%26aufirst%3DA.%2BL.%26aulast%3DHirshman%26aufirst%3DM.%2BF.%26aulast%3DFielding%26aufirst%3DR.%2BA.%26aulast%3DGoodyear%26aufirst%3DL.%2BJ.%26atitle%3DThe%2520AMPK-Related%2520Kinase%2520SNARK%2520Regulates%2520Muscle%2520Mass%2520and%2520Myocyte%2520Survival%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2016%26volume%3D126%26spage%3D560%26epage%3D570%26doi%3D10.1172%2FJCI79197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Street, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, B. A.</span></span> <span> </span><span class="NLM_article-title">Rho Kinase Proteins-Pleiotropic Modulators of Cell Survival and Apoptosis</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">3645</span>– <span class="NLM_lpage">3657</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22110183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1GktrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=3645-3657&author=C.+A.+Streetauthor=B.+A.+Bryan&title=Rho+Kinase+Proteins-Pleiotropic+Modulators+of+Cell+Survival+and+Apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Rho kinase proteins-pleiotropic modulators of cell survival and apoptosis</span></div><div class="casAuthors">Street, Catharine A.; Bryan, Brad A.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3645-3657</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">A review.  Rho kinase (ROCK) proteins are Rho-GTPase activated serine/threonine kinases that function as modulators of actin-myosin cytoskeletal dynamics via regulation of Lin11, Isl-1 & Mec-3 domain (LIM) kinase, myosin light chain (MLC), and MLC phosphatase.  A strong correlation between cytoskeletal rearrangements and tumor cell invasion, metastasis, and deregulated microenvironment interaction has been reported in the literature, and the utilization of pharmacol. inhibitors of ROCK signaling for the treatment of cancer is actively being pursued by a no. of pharmaceutical companies.  Indeed, in many preclin. models ROCK inhibitors have shown remarkable efficacy in reducing tumor growth and metastasis.  Interestingly, ROCK signaling has been shown to be either pro-apoptotic or pro-survival in a cell type and context dependent manner, though the mol. mechanisms controlling ROCK-mediated cell fate decisions are unknown.  This review summarizes the many pleiotropic roles of ROCK signaling in survival and apoptosis, and suggests that controlled modulation of ROCK activity in tumor cells has the potential to significantly affect tumor survival and patient outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRMSOOGeK1y7Vg90H21EOLACvtfcHk0lgTEBLfAmALxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1GktrfP&md5=bebf4fdaba6da6faa35a9a6d07ac878c</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStreet%26aufirst%3DC.%2BA.%26aulast%3DBryan%26aufirst%3DB.%2BA.%26atitle%3DRho%2520Kinase%2520Proteins-Pleiotropic%2520Modulators%2520of%2520Cell%2520Survival%2520and%2520Apoptosis%26jtitle%3DAnticancer%2520Res.%26date%3D2011%26volume%3D31%26spage%3D3645%26epage%3D3657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Legembre, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schickel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnhart, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, M. E.</span></span> <span> </span><span class="NLM_article-title">Identification of SNF1/AMP Kinase-Related Kinase as an NF-KB- Regulated Anti-Apoptotic Kinase Involved in CD95-Induced Motility and Invasiveness</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">46742</span>– <span class="NLM_lpage">46747</span>, <span class="refDoi"> DOI: 10.1074/jbc.M404334200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M404334200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15345718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFaqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=46742-46747&author=P.+Legembreauthor=R.+Schickelauthor=B.+C.+Barnhartauthor=M.+E.+Peter&title=Identification+of+SNF1%2FAMP+Kinase-Related+Kinase+as+an+NF-KB-+Regulated+Anti-Apoptotic+Kinase+Involved+in+CD95-Induced+Motility+and+Invasiveness&doi=10.1074%2Fjbc.M404334200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of SNF1/AMP Kinase-related Kinase as an NF-κB-regulated Anti-apoptotic Kinase Involved in CD95-induced Motility and Invasiveness</span></div><div class="casAuthors">Legembre, Patrick; Schickel, Robert; Barnhart, Bryan C.; Peter, Marcus E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">46742-46747</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The death receptor CD95 (APO-1/Fas) induces apoptosis in many tissues.  However, in apoptosis-resistant tumor cells, stimulation of CD95 induces up-regulation of a defined no. of mostly anti-apoptotic genes, resulting in increased motility and invasiveness of tumor cells.  The majority of these genes are known NF-κB target genes.  The authors have identified one of the CD95-regulated genes as the serine/threonine kinase [SNF1/AMP kinase-related kinase (SNARK)], which is induced in response to various forms of metabolic stress.  The authors demonstrate that up-regulation of SNARK in response to CD95 ligand and tumor necrosis factor α depends on activation of NF-κB.  Overexpression of SNARK rendered tumor cells more resistant, whereas a kinase-inactive mutant of SNARK sensitized cells to CD95-mediated apoptosis.  Furthermore, small interfering RNA-mediated knockdown of SNARK increased the sensitivity of tumor cells to CD95 ligand- and TRAIL-induced apoptosis.  Importantly, cells with reduced expression of SNARK also showed reduced motility and invasiveness in response to CD95 engagement.  SNARK thus represents an NF-κB-regulated anti-apoptotic gene that contributes to the tumor-promoting activity of CD95 in apoptosis-resistant tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp-W5JNqJ1b7Vg90H21EOLACvtfcHk0lgTEBLfAmALxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFaqurc%253D&md5=cf96de8036781e2d5a96c6f6707d2bfd</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M404334200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M404334200%26sid%3Dliteratum%253Aachs%26aulast%3DLegembre%26aufirst%3DP.%26aulast%3DSchickel%26aufirst%3DR.%26aulast%3DBarnhart%26aufirst%3DB.%2BC.%26aulast%3DPeter%26aufirst%3DM.%2BE.%26atitle%3DIdentification%2520of%2520SNF1%252FAMP%2520Kinase-Related%2520Kinase%2520as%2520an%2520NF-KB-%2520Regulated%2520Anti-Apoptotic%2520Kinase%2520Involved%2520in%2520CD95-Induced%2520Motility%2520and%2520Invasiveness%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D46742%26epage%3D46747%26doi%3D10.1074%2Fjbc.M404334200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monteverde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tait-Mulder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansom, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D. J.</span></span> <span> </span><span class="NLM_article-title">Calcium Signalling Links MYC to NUAK1</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">982</span>– <span class="NLM_lpage">992</span>, <span class="refDoi"> DOI: 10.1038/onc.2017.394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fonc.2017.394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=29106388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslKntb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=982-992&author=T.+Monteverdeauthor=J.+Tait-Mulderauthor=A.+Hedleyauthor=J.+R.+Knightauthor=O.+J.+Sansomauthor=D.+J.+Murphy&title=Calcium+Signalling+Links+MYC+to+NUAK1&doi=10.1038%2Fonc.2017.394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium signalling links MYC to NUAK1</span></div><div class="casAuthors">Monteverde, T.; Tait-Mulder, J.; Hedley, A.; Knight, J. R.; Sansom, O. J.; Murphy, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">982-992</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">NUAK1 is a member of the AMPK-related family of kinases.  Recent evidence suggests that NUAK1 is an important regulator of cell adhesion and migration, cellular and organismal metab., and regulation of TAU stability.  As such, NUAK1 may play key roles in multiple diseases ranging from neurodegeneration to diabetes and metastatic cancer.  Previous work revealed a crucial role for NUAK1 in supporting viability of tumor cells specifically when MYC is overexpressed.  This role is surprising, given that NUAK1 is activated by the tumor suppressor LKB1.  Here we show that, in tumor cells lacking LKB1, NUAK1 activity is maintained by an alternative pathway involving calcium-dependent activation of PKCα.  Calcium/PKCα-dependent activation of NUAK1 supports engagement of the AMPK-TORC1 metabolic checkpoint, thereby protecting tumor cells from MYC-driven cell death, and indeed, MYC selects for this pathway in part via transcriptional regulation of PKCα and ITPR.  Our data point to a novel role for calcium in supporting tumor cell viability and clarify the synthetic lethal interaction between NUAK1 and MYC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKWKiv-P540LVg90H21EOLACvtfcHk0lgTEBLfAmALxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslKntb%252FP&md5=6217c8adcebcc2504f6e89c84fc5e133</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fonc.2017.394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2017.394%26sid%3Dliteratum%253Aachs%26aulast%3DMonteverde%26aufirst%3DT.%26aulast%3DTait-Mulder%26aufirst%3DJ.%26aulast%3DHedley%26aufirst%3DA.%26aulast%3DKnight%26aufirst%3DJ.%2BR.%26aulast%3DSansom%26aufirst%3DO.%2BJ.%26aulast%3DMurphy%26aufirst%3DD.%2BJ.%26atitle%3DCalcium%2520Signalling%2520Links%2520MYC%2520to%2520NUAK1%26jtitle%3DOncogene%26date%3D2018%26volume%3D37%26spage%3D982%26epage%3D992%26doi%3D10.1038%2Fonc.2017.394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cossa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roeschert, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baluapuri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silveira Vidal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulein-Volk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ade, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mastrobuoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luhrmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuster, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilers, M.</span></span> <span> </span><span class="NLM_article-title">Localized Inhibition of Protein Phosphatase 1 by NUAK1 Promotes Spliceosome Activity and Reveals a MYC-Sensitive Feedback Control of Transcription</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1322</span>– <span class="NLM_lpage">1339</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2020.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.molcel.2020.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=32006464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFCmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2020&pages=1322-1339&author=G.+Cossaauthor=I.+Roeschertauthor=F.+Prinzauthor=A.+Baluapuriauthor=R.+Silveira+Vidalauthor=C.+Schulein-Volkauthor=Y.-C.+Changauthor=C.+P.+Adeauthor=G.+Mastrobuoniauthor=C.+Girardauthor=L.+Wortmannauthor=S.+Walzauthor=R.+Luhrmannauthor=S.+Kempaauthor=B.+Kusterauthor=E.+Wolfauthor=D.+Mumbergauthor=M.+Eilers&title=Localized+Inhibition+of+Protein+Phosphatase+1+by+NUAK1+Promotes+Spliceosome+Activity+and+Reveals+a+MYC-Sensitive+Feedback+Control+of+Transcription&doi=10.1016%2Fj.molcel.2020.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Localized Inhibition of Protein Phosphatase 1 by NUAK1 Promotes Spliceosome Activity and Reveals a MYC-Sensitive Feedback Control of Transcription</span></div><div class="casAuthors">Cossa, Giacomo; Roeschert, Isabelle; Prinz, Florian; Baluapuri, Apoorva; Silveira Vidal, Raphael; Schuelein-Voelk, Christina; Chang, Yun-Chien; Ade, Carsten Patrick; Mastrobuoni, Guido; Girard, Cyrille; Wortmann, Lars; Walz, Susanne; Luehrmann, Reinhard; Kempa, Stefan; Kuster, Bernhard; Wolf, Elmar; Mumberg, Dominik; Eilers, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1322-1339.e11</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Deregulated expression of MYC induces a dependence on the NUAK1 kinase, but the mol. mechanisms underlying this dependence have not been fully clarified.  Here, we show that NUAK1 is a predominantly nuclear protein that assocs. with a network of nuclear protein phosphatase 1 (PP1) interactors and that PNUTS, a nuclear regulatory subunit of PP1, is phosphorylated by NUAK1.  Both NUAK1 and PNUTS assoc. with the splicing machinery.  Inhibition of NUAK1 abolishes chromatin assocn. of PNUTS, reduces spliceosome activity, and suppresses nascent RNA synthesis.  Activation of MYC does not bypass the requirement for NUAK1 for spliceosome activity but significantly attenuates transcription inhibition.  Consequently, NUAK1 inhibition in MYC-transformed cells induces global accumulation of RNAPII both at the pause site and at the first exon-intron boundary but does not increase mRNA synthesis.  We suggest that NUAK1 inhibition in the presence of deregulated MYC traps non-productive RNAPII because of the absence of correctly assembled spliceosomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoysNS09sAcLrVg90H21EOLACvtfcHk0ljyrE3zuDb5_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFCmt7s%253D&md5=48f29ed7b439ae84d5c344e50ff1c495</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2020.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2020.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DCossa%26aufirst%3DG.%26aulast%3DRoeschert%26aufirst%3DI.%26aulast%3DPrinz%26aufirst%3DF.%26aulast%3DBaluapuri%26aufirst%3DA.%26aulast%3DSilveira%2BVidal%26aufirst%3DR.%26aulast%3DSchulein-Volk%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DY.-C.%26aulast%3DAde%26aufirst%3DC.%2BP.%26aulast%3DMastrobuoni%26aufirst%3DG.%26aulast%3DGirard%26aufirst%3DC.%26aulast%3DWortmann%26aufirst%3DL.%26aulast%3DWalz%26aufirst%3DS.%26aulast%3DLuhrmann%26aufirst%3DR.%26aulast%3DKempa%26aufirst%3DS.%26aulast%3DKuster%26aufirst%3DB.%26aulast%3DWolf%26aufirst%3DE.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3DEilers%26aufirst%3DM.%26atitle%3DLocalized%2520Inhibition%2520of%2520Protein%2520Phosphatase%25201%2520by%2520NUAK1%2520Promotes%2520Spliceosome%2520Activity%2520and%2520Reveals%2520a%2520MYC-Sensitive%2520Feedback%2520Control%2520of%2520Transcription%26jtitle%3DMol.%2520Cell%26date%3D2020%26volume%3D77%26spage%3D1322%26epage%3D1339%26doi%3D10.1016%2Fj.molcel.2020.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kreisberg, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh-Choudhury, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radnik, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, M. A.</span></span> <span> </span><span class="NLM_article-title">Role of Rho and Myosin Phosphorylation in Actin Stress Fiber Assembly in Mesangial Cells</span>. <i>Am. J. Physiol. - Ren. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">F283</span>– <span class="NLM_lpage">F288</span>, <span class="refDoi"> DOI: 10.1152/ajprenal.1997.273.2.F283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1152%2Fajprenal.1997.273.2.F283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=9277589" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1997&pages=F283-F288&author=J.+I.+Kreisbergauthor=N.+Ghosh-Choudhuryauthor=R.+A.+Radnikauthor=M.+A.+Schwartz&title=Role+of+Rho+and+Myosin+Phosphorylation+in+Actin+Stress+Fiber+Assembly+in+Mesangial+Cells&doi=10.1152%2Fajprenal.1997.273.2.F283"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.1997.273.2.F283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.1997.273.2.F283%26sid%3Dliteratum%253Aachs%26aulast%3DKreisberg%26aufirst%3DJ.%2BI.%26aulast%3DGhosh-Choudhury%26aufirst%3DN.%26aulast%3DRadnik%26aufirst%3DR.%2BA.%26aulast%3DSchwartz%26aufirst%3DM.%2BA.%26atitle%3DRole%2520of%2520Rho%2520and%2520Myosin%2520Phosphorylation%2520in%2520Actin%2520Stress%2520Fiber%2520Assembly%2520in%2520Mesangial%2520Cells%26jtitle%3DAm.%2520J.%2520Physiol.%2520-%2520Ren.%2520Physiol.%26date%3D1997%26volume%3D273%26spage%3DF283%26epage%3DF288%26doi%3D10.1152%2Fajprenal.1997.273.2.F283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Surks, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddick, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtani, K. I.</span></span> <span> </span><span class="NLM_article-title">M-RIP Targets Myosin Phosphatase to Stress Fibers to Regulate Myosin Light Chain Phosphorylation in Vascular Smooth Muscle Cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">42543</span>– <span class="NLM_lpage">42551</span>, <span class="refDoi"> DOI: 10.1074/jbc.M506863200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M506863200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=16257966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCmsLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=42543-42551&author=H.+K.+Surksauthor=N.+Riddickauthor=K.+I.+Ohtani&title=M-RIP+Targets+Myosin+Phosphatase+to+Stress+Fibers+to+Regulate+Myosin+Light+Chain+Phosphorylation+in+Vascular+Smooth+Muscle+Cells&doi=10.1074%2Fjbc.M506863200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">M-RIP Targets Myosin Phosphatase to Stress Fibers to Regulate Myosin Light Chain Phosphorylation in Vascular Smooth Muscle Cells</span></div><div class="casAuthors">Surks, Howard K.; Riddick, Nadeene; Ohtani, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">42543-42551</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Vascular smooth muscle cell contraction and relaxation are directly related to the phosphorylation state of the regulatory myosin light chain.  Myosin light chains are dephosphorylated by myosin phosphatase, leading to vascular smooth muscle relaxation.  Myosin phosphatase is localized not only at actin-myosin stress fibers, where it dephosphorylates myosin light chains, but also in the cytoplasm and at the cell membrane.  The mechanisms by which myosin phosphatase is targeted to these loci are incompletely understood.  We recently identified myosin phosphatase-Rho interacting protein (M-RIP) as a member of the myosin phosphatase complex that directly binds both the myosin-binding subunit of myosin phosphatase and RhoA and is localized to actin-myosin stress fibers.  We hypothesized that M-RIP targets myosin phosphatase to the contractile app. to dephosphorylate myosin light chains.  We used RNA interference to silence the expression of M-RIP in human vascular smooth muscle cells.  M-RIP silencing reduced the localization of the myosin-binding subunit to stress fibers.  This redn. in stress fiber M-RIP and myosin-binding subunit increased basal and lysophosphatidic acid-stimulated myosin light chain phosphorylation.  Neither cellular myosin phosphatase, myosin light chain kinase, nor RhoA activities were changed by M-RIP silencing.  Furthermore, M-RIP silencing resulted in marked phenotypic changes in vascular smooth muscle cells, including increased nos. of stress fibers, increased cell area, and reduced stress fiber inhibition in response to a Rho kinase inhibitor.  These data support the importance of M-RIP-dependent targeting of myosin phosphatase to stress fibers for regulating myosin light chain phosphorylation state and morphol. in human vascular smooth muscle cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruIc5kpnoxT7Vg90H21EOLACvtfcHk0ljyrE3zuDb5_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCmsLvL&md5=026511c96f6990da7300dc8d92a2afbd</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M506863200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M506863200%26sid%3Dliteratum%253Aachs%26aulast%3DSurks%26aufirst%3DH.%2BK.%26aulast%3DRiddick%26aufirst%3DN.%26aulast%3DOhtani%26aufirst%3DK.%2BI.%26atitle%3DM-RIP%2520Targets%2520Myosin%2520Phosphatase%2520to%2520Stress%2520Fibers%2520to%2520Regulate%2520Myosin%2520Light%2520Chain%2520Phosphorylation%2520in%2520Vascular%2520Smooth%2520Muscle%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D42543%26epage%3D42551%26doi%3D10.1074%2Fjbc.M506863200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koga, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikebe, M.</span></span> <span> </span><span class="NLM_article-title">A Novel Regulatory Mechanism of Myosin Light Chain Phosphorylation via Binding of 14–3-3 to Myosin Phosphatase</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1062</span>– <span class="NLM_lpage">1071</span>, <span class="refDoi"> DOI: 10.1091/mbc.e07-07-0668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1091%2Fmbc.e07-07-0668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=18094049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslemsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=1062-1071&author=Y.+Kogaauthor=M.+Ikebe&title=A+Novel+Regulatory+Mechanism+of+Myosin+Light+Chain+Phosphorylation+via+Binding+of+14%E2%80%933-3+to+Myosin+Phosphatase&doi=10.1091%2Fmbc.e07-07-0668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">A novel regulatory mechanism of myosin light chain phosphorylation via binding of 14-3-3 to myosin phosphatase</span></div><div class="casAuthors">Koga, Yasuhiko; Ikebe, Mitsuo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1062-1071</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Myosin II phosphorylation-dependent cell motile events are regulated by myosin light-chain (MLC) kinase and MLC phosphatase (MLCP).  Recent studies have revealed myosin phosphatase targeting subunit (MYPT1), a myosin-binding subunit of MLCP, plays a crit. role in MLCP regulation.  Here we report the new regulatory mechanism of MLCP via the interaction between 14-3-3 and MYPT1.  The binding of 14-3-3β to MYPT1 diminished the direct binding between MYPT1 and myosin II, and 14-3-3β overexpression abolished MYPT1 localization at stress fiber.  Furthermore, 14-3-3β inhibited MLCP holoenzyme activity via the interaction with MYPT1.  Consistently, 14-3-3β overexpression increased myosin II phosphorylation in cells.  We found that MYPT1 phosphorylation at Ser472 was crit. for the binding to 14-3-3.  Epidermal growth factor (EGF) stimulation increased both Ser472 phosphorylation and the binding of MYPT1-14-3-3.  Rho-kinase inhibitor inhibited the EGF-induced Ser472 phosphorylation and the binding of MYPT1-14-3-3.  Rho-kinase specific siRNA also decreased EGF-induced Ser472 phosphorylation correlated with the decrease in MLC phosphorylation.  The present study revealed a new RhoA/Rho-kinase-dependent regulatory mechanism of myosin II phosphorylation by 14-3-3 that dissocs. MLCP from myosin II and attenuates MLCP activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg0xg8XTwdyLVg90H21EOLACvtfcHk0ljyrE3zuDb5_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslemsLw%253D&md5=d5fd0e7e2da45ea22d2538535a016d4f</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e07-07-0668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e07-07-0668%26sid%3Dliteratum%253Aachs%26aulast%3DKoga%26aufirst%3DY.%26aulast%3DIkebe%26aufirst%3DM.%26atitle%3DA%2520Novel%2520Regulatory%2520Mechanism%2520of%2520Myosin%2520Light%2520Chain%2520Phosphorylation%2520via%2520Binding%2520of%252014%25E2%2580%25933-3%2520to%2520Myosin%2520Phosphatase%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2008%26volume%3D19%26spage%3D1062%26epage%3D1071%26doi%3D10.1091%2Fmbc.e07-07-0668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddick, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baur, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surks, H. K.</span></span> <span> </span><span class="NLM_article-title">ROCk Isoform Regulation of Myosin Phosphatase and Contractility in Vascular Smooth Muscle Cells</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.108.188524</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1161%2FCIRCRESAHA.108.188524" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=19131646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFejtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2009&pages=531-540&author=Y.+Wangauthor=X.+R.+Zhengauthor=N.+Riddickauthor=M.+Brydenauthor=W.+Baurauthor=X.+Zhangauthor=H.+K.+Surks&title=ROCk+Isoform+Regulation+of+Myosin+Phosphatase+and+Contractility+in+Vascular+Smooth+Muscle+Cells&doi=10.1161%2FCIRCRESAHA.108.188524"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">ROCK Isoform Regulation of Myosin Phosphatase and Contractility in Vascular Smooth Muscle Cells</span></div><div class="casAuthors">Wang, Yuepeng; Zheng, Xiaoyu Rayne; Riddick, Nadeene; Bryden, Meredith; Baur, Wendy; Zhang, Xin; Surks, Howard K.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">531-540</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Abnormal vascular smooth muscle cell (VSMC) contraction plays an important role in vascular diseases.  The RhoA/ROCK signaling pathway is now well recognized to mediate vascular smooth muscle contraction in response to vasoconstrictors by inhibiting myosin phosphatase (MLCP) activity and increasing myosin light chain phosphorylation.  Two ROCK isoforms, ROCK1 and ROCK2, are expressed in many tissues, yet the isoform-specific roles of ROCK1 and ROCK2 in vascular smooth muscle and the mechanism of ROCK-mediated regulation of MLCP are not well understood.  In this study, ROCK2, but not ROCK1, bound directly to the myosin binding subunit of MLCP, yet both ROCK isoforms regulated MLCP and myosin light chain phosphorylation.  Despite that both ROCK1 and ROCK2 regulated MLCP, the ROCK isoforms had distinct and opposing effects on VSMC morphol. and ROCK2, but not ROCK1, had a predominant role in VSMC contractility.  These data support that although the ROCK isoforms both regulate MLCP and myosin light chain phosphorylation through different mechanisms, they have distinct roles in VSMC function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz6-nW8A7CLrVg90H21EOLACvtfcHk0lhK4Y4HiBxQWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFejtLs%253D&md5=3c80a758fa7f959b49ba67e25447a562</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.108.188524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.108.188524%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DX.%2BR.%26aulast%3DRiddick%26aufirst%3DN.%26aulast%3DBryden%26aufirst%3DM.%26aulast%3DBaur%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSurks%26aufirst%3DH.%2BK.%26atitle%3DROCk%2520Isoform%2520Regulation%2520of%2520Myosin%2520Phosphatase%2520and%2520Contractility%2520in%2520Vascular%2520Smooth%2520Muscle%2520Cells%26jtitle%3DCirc.%2520Res.%26date%3D2009%26volume%3D104%26spage%3D531%26epage%3D540%26doi%3D10.1161%2FCIRCRESAHA.108.188524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakai, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishimoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minegichi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">Induction of Cell-Cell Detachment during Glucose Starvation through F-Actin Conversion by SNARK, the Fourth Member of the AMP-Activated Protein Kinase Catalytic Subunit Family</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>311</i></span>,  <span class="NLM_fpage">156</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2003.09.184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.bbrc.2003.09.184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=14575707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot1Glt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2003&pages=156-161&author=A.+Suzukiauthor=G.+I.+Kusakaiauthor=A.+Kishimotoauthor=Y.+Minegichiauthor=T.+Oguraauthor=H.+Esumi&title=Induction+of+Cell-Cell+Detachment+during+Glucose+Starvation+through+F-Actin+Conversion+by+SNARK%2C+the+Fourth+Member+of+the+AMP-Activated+Protein+Kinase+Catalytic+Subunit+Family&doi=10.1016%2Fj.bbrc.2003.09.184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of cell-cell detachment during glucose starvation through F-actin conversion by SNARK, the fourth member of the AMP-activated protein kinase catalytic subunit family</span></div><div class="casAuthors">Suzuki, Atsushi; Kusakai, Gen-Ichi; Kishimoto, Atsuhiro; Minegichi, Yuji; Ogura, Tsutomu; Esumi, Hiroyasu</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">156-161</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">SNARK, the fourth member of the AMPK catalytic subunit family, was originally identified in a rat kidney cDNA library, and in this study we isolated its human homolog.  A BLAST search anal. using rat SNARK protein yielded a single high homol. clone, DKFZp434J037, isolated from human testis, and since its hypothetical protein showed 84% homol. to rat SNARK protein, we assumed DKFZp434J037 to be the human SNARK cDNA.  The human SNARK cDNA is 3443 bp long and encodes a 628 amino acid protein having an estd. mol. wt. of 69 kDa, and its chromosomal localization had been assigned to 1q32.1.  The same as other members of AMPK catalytic subunit family, human SNARK showed AMP-dependent GST-SAMS phosphorylation activity and enhanced HepG2 cell survival during glucose starvation.  Human SNARK-overexpressing HepG2 cells (H/SNK) showed acute cell-cell detachment when exposed to glucose-free medium and the cell-cell detachment correlated well with the detection of G-actin.  Deletion mutant anal. strongly suggested that the putative catalytic domain of SNARK is necessary for the cell-cell detachment, and Western blotting anal. showed that phosphorylation of FAK and PKC, which were dramatically increased by glucose starvation in HepG2 cells, was markedly suppressed by SNARK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTp76LNaR2OLVg90H21EOLACvtfcHk0lhK4Y4HiBxQWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot1Glt78%253D&md5=c9fd91ab869e07f8546c57e636f41b45</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2003.09.184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2003.09.184%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DKusakai%26aufirst%3DG.%2BI.%26aulast%3DKishimoto%26aufirst%3DA.%26aulast%3DMinegichi%26aufirst%3DY.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DInduction%2520of%2520Cell-Cell%2520Detachment%2520during%2520Glucose%2520Starvation%2520through%2520F-Actin%2520Conversion%2520by%2520SNARK%252C%2520the%2520Fourth%2520Member%2520of%2520the%2520AMP-Activated%2520Protein%2520Kinase%2520Catalytic%2520Subunit%2520Family%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D311%26spage%3D156%26epage%3D161%26doi%3D10.1016%2Fj.bbrc.2003.09.184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mason, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawahare, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voytik-Harbin, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorlutuna, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoder, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boerckel, J. D.</span></span> <span> </span><span class="NLM_article-title">YAP and TAZ Limit Cytoskeletal and Focal Adhesion Maturation to Enable Persistent Cell Motility</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>218</i></span>,  <span class="NLM_fpage">1369</span>– <span class="NLM_lpage">1389</span>, <span class="refDoi"> DOI: 10.1083/jcb.201806065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1083%2Fjcb.201806065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=30737263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1MXps1art74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=218&publication_year=2019&pages=1369-1389&author=D.+E.+Masonauthor=J.+M.+Collinsauthor=J.+H.+Dawahareauthor=T.+D.+Nguyenauthor=Y.+Linauthor=S.+L.+Voytik-Harbinauthor=P.+Zorlutunaauthor=M.+C.+Yoderauthor=J.+D.+Boerckel&title=YAP+and+TAZ+Limit+Cytoskeletal+and+Focal+Adhesion+Maturation+to+Enable+Persistent+Cell+Motility&doi=10.1083%2Fjcb.201806065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">YAP and TAZ limit cytoskeletal and focal adhesion maturation to enable persistent cell motility</span></div><div class="casAuthors">Mason, Devon E.; Collins, Joseph M.; Dawahare, James H.; Nguyen, Trung Dung; Lin, Yang; Voytik-Harbin, Sherry L.; Zorlutuna, Pinar; Yoder, Mervin C.; Boerckel, Joel D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">218</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1369-1389</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">1540-8140</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Cell migration initiates by traction generation through reciprocal actomyosin tension and focal adhesion reinforcement, but continued motility requires adaptive cytoskeletal remodeling and adhesion release.  Here, we asked whether de novo gene expression contributes to this cytoskeletal feedback.  We found that global inhibition of transcription or translation does not impair initial cell polarization or migration initiation, but causes eventual migratory arrest through excessive cytoskeletal tension and over-maturation of focal adhesions, tethering cells to their matrix.  The transcriptional coactivators YAP and TAZ mediate this feedback response, modulating cell mechanics by limiting cytoskeletal and focal adhesion maturation to enable persistent cell motility and 3D vasculogenesis.  Motile arrest after YAP/TAZ ablation was partially rescued by depletion of the YAP/TAZ-dependent myosin phosphatase regulator, NUAK2, or by inhibition of Rho-ROCK-myosin II.  Together, these data establish a transcriptional feedback axis necessary to maintain a responsive cytoskeletal equil. and persistent migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmkEFplI1c37Vg90H21EOLACvtfcHk0lhK4Y4HiBxQWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXps1art74%253D&md5=c52059f6aa9f6ca96e8a175814aaf575</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201806065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201806065%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DD.%2BE.%26aulast%3DCollins%26aufirst%3DJ.%2BM.%26aulast%3DDawahare%26aufirst%3DJ.%2BH.%26aulast%3DNguyen%26aufirst%3DT.%2BD.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DVoytik-Harbin%26aufirst%3DS.%2BL.%26aulast%3DZorlutuna%26aufirst%3DP.%26aulast%3DYoder%26aufirst%3DM.%2BC.%26aulast%3DBoerckel%26aufirst%3DJ.%2BD.%26atitle%3DYAP%2520and%2520TAZ%2520Limit%2520Cytoskeletal%2520and%2520Focal%2520Adhesion%2520Maturation%2520to%2520Enable%2520Persistent%2520Cell%2520Motility%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2019%26volume%3D218%26spage%3D1369%26epage%3D1389%26doi%3D10.1083%2Fjcb.201806065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Courchet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer-Dilhet, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Carmine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polleux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courchet, J.</span></span> <span> </span><span class="NLM_article-title">Haploinsufficiency of Autism Spectrum Disorder Candidate Gene NUAK1 Impairs Cortical Development and Behavior in Mice</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">4289</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-06584-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fs41467-018-06584-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=30327473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BB3czpvFOjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=4289&author=V.+Courchetauthor=A.+J.+Robertsauthor=G.+Meyer-Dilhetauthor=P.+Del+Carmineauthor=T.+L.+Lewisauthor=F.+Polleuxauthor=J.+Courchet&title=Haploinsufficiency+of+Autism+Spectrum+Disorder+Candidate+Gene+NUAK1+Impairs+Cortical+Development+and+Behavior+in+Mice&doi=10.1038%2Fs41467-018-06584-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Haploinsufficiency of autism spectrum disorder candidate gene NUAK1 impairs cortical development and behavior in mice</span></div><div class="casAuthors">Courchet Virginie; Meyer-Dilhet Geraldine; Del Carmine Peggy; Courchet Julien; Roberts Amanda J; Lewis Tommy L Jr; Polleux Franck</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4289</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recently, numerous rare de novo mutations have been identified in patients diagnosed with autism spectrum disorders (ASD).  However, despite the predicted loss-of-function nature of some of these de novo mutations, the affected individuals are heterozygous carriers, which would suggest that most of these candidate genes are haploinsufficient and/or lead to expression of dominant-negative forms of the protein.  Here, we tested this hypothesis with the candidate ASD gene Nuak1 that we previously identified for its role in the development of cortical connectivity.  We report that Nuak1 is haploinsufficient in mice with regard to its function in cortical development.  Furthermore Nuak1(+/-) mice show a combination of abnormal behavioral traits ranging from defective spatial memory consolidation, defects in social novelty (but not social preference) and abnormal sensorimotor gating.  Overall, our results demonstrate that Nuak1 haploinsufficiency leads to defects in the development of cortical connectivity and a complex array of behavorial deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQDaeM-kystWMNIRw0GKUoEfW6udTcc2eYzNPXzPuwmALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czpvFOjuw%253D%253D&md5=d1dc48f19151b17c8d96e24bcb747b3e</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06584-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06584-5%26sid%3Dliteratum%253Aachs%26aulast%3DCourchet%26aufirst%3DV.%26aulast%3DRoberts%26aufirst%3DA.%2BJ.%26aulast%3DMeyer-Dilhet%26aufirst%3DG.%26aulast%3DDel%2BCarmine%26aufirst%3DP.%26aulast%3DLewis%26aufirst%3DT.%2BL.%26aulast%3DPolleux%26aufirst%3DF.%26aulast%3DCourchet%26aufirst%3DJ.%26atitle%3DHaploinsufficiency%2520of%2520Autism%2520Spectrum%2520Disorder%2520Candidate%2520Gene%2520NUAK1%2520Impairs%2520Cortical%2520Development%2520and%2520Behavior%2520in%2520Mice%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D4289%26doi%3D10.1038%2Fs41467-018-06584-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Windelinckx, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mars, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huygens, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peeters, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijmenga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambrechts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aerssens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlietinck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beunen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomis, M. A.</span></span> <span> </span><span class="NLM_article-title">Identification and Prioritization of NUAK1 and PPP1CC as Positional Candidate Loci for Skeletal Muscle Strength Phenotypes</span>. <i>Physiol. Genomics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">981</span>– <span class="NLM_lpage">992</span>, <span class="refDoi"> DOI: 10.1152/physiolgenomics.00200.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1152%2Fphysiolgenomics.00200.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=21750233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFGrtbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=981-992&author=A.+Windelinckxauthor=G.+de+Marsauthor=W.+Huygensauthor=M.+W.+Peetersauthor=B.+Vincentauthor=C.+Wijmengaauthor=D.+Lambrechtsauthor=J.+Aerssensauthor=R.+Vlietinckauthor=G.+Beunenauthor=M.+A.+Thomis&title=Identification+and+Prioritization+of+NUAK1+and+PPP1CC+as+Positional+Candidate+Loci+for+Skeletal+Muscle+Strength+Phenotypes&doi=10.1152%2Fphysiolgenomics.00200.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and prioritization of NUAK1 and PPP1CC as positional candidate loci for skeletal muscle strength phenotypes</span></div><div class="casAuthors">Windelinckx, An; De Mars, Gunther; Huygens, Wim; Peeters, Maarten W.; Vincent, Barbara; Wijmenga, Cisca; Lambrechts, Diether; Aerssens, Jeroen; Vlietinck, Robert; Beunen, Gaston; Thomis, Martine A. I.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Genomics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">981-992</span>CODEN:
                <span class="NLM_cas:coden">PHGEFP</span>;
        ISSN:<span class="NLM_cas:issn">1094-8341</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Muscle strength is an important determinant in elite sports performance as well as in the activities of daily living.  Muscle metab. also plays a role in the genesis, and therefore prevention, of common pathol. conditions and chronic diseases.  Even though heritability ests. between 31 and 78% suggest a significant genetic component in muscle strength, only a limited no. of genes influencing muscle strength have been identified.  This study aimed to identify and prioritize positional candidate genes within a skeletal muscle strength quant. trait locus on chromosome 12q22-23 for follow-up.  A two-staged gene-centered fine-mapping approach using 122 single nucleotide polymorphisms (SNPs) in stage 1 identified a family-based assocn. (n = 500) between several tagSNPs located in the ATPase, Ca2+ transporting, cardiac muscle, slow twitch 2 (ATP2A2; rs3026468), the NUAK family, SNF1-like kinase, 1 (NUAK1: rs10861553 and rs3741886), and the protein phosphatase 1, catalytic subunit, gamma isoform (PPP1CC: rs1050587 and rs7901769) genes and knee torque prodn. (P values up to 0.00092).  In stage 2, family-based assocn. tests on addnl. putatively functional SNPs (e.g., exonic SNPs, SNPs in transcription factor binding sites or in conserved regions) in an enlarged sample (n = 536; 464 individuals overlap with stage 1) did not identify addnl. assocns. with muscle strength characteristics.  Further in-depth analyses will be necessary to elucidate the exact role of ATP2A2, PPP1CC, and NUAK1 in muscle strength and to find out which functional polymorphisms are at the base of the interindividual strength differences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUN-Jxspb3p7Vg90H21EOLACvtfcHk0lj78i7OgSoqlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFGrtbnO&md5=012ed48ec690f376c9987fe283a7b8d1</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1152%2Fphysiolgenomics.00200.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysiolgenomics.00200.2010%26sid%3Dliteratum%253Aachs%26aulast%3DWindelinckx%26aufirst%3DA.%26aulast%3Dde%2BMars%26aufirst%3DG.%26aulast%3DHuygens%26aufirst%3DW.%26aulast%3DPeeters%26aufirst%3DM.%2BW.%26aulast%3DVincent%26aufirst%3DB.%26aulast%3DWijmenga%26aufirst%3DC.%26aulast%3DLambrechts%26aufirst%3DD.%26aulast%3DAerssens%26aufirst%3DJ.%26aulast%3DVlietinck%26aufirst%3DR.%26aulast%3DBeunen%26aufirst%3DG.%26aulast%3DThomis%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520and%2520Prioritization%2520of%2520NUAK1%2520and%2520PPP1CC%2520as%2520Positional%2520Candidate%2520Loci%2520for%2520Skeletal%2520Muscle%2520Strength%2520Phenotypes%26jtitle%3DPhysiol.%2520Genomics%26date%3D2011%26volume%3D43%26spage%3D981%26epage%3D992%26doi%3D10.1152%2Fphysiolgenomics.00200.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lasagna-Reeves, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Haro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousseaux, M. W.C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Ramahi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafar-Nejad, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilanova-Velez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">See, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitschke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troncoso, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbrook, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, H. Y.</span></span> <span> </span><span class="NLM_article-title">Reduction of Nuak1 Decreases Tau and Reverses Phenotypes in a Tauopathy Mouse Model</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2016.09.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.neuron.2016.09.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=27720485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1CltrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2016&pages=407-418&author=C.+A.+Lasagna-Reevesauthor=M.+de+Haroauthor=S.+Haoauthor=J.+Parkauthor=M.+W.C.+Rousseauxauthor=I.+Al-Ramahiauthor=P.+Jafar-Nejadauthor=L.+Vilanova-Velezauthor=L.+Seeauthor=A.+De+Maioauthor=L.+Nitschkeauthor=Z.+Wuauthor=J.+C.+Troncosoauthor=T.+F.+Westbrookauthor=J.+Tangauthor=J.+Botasauthor=H.+Y.+Zoghbi&title=Reduction+of+Nuak1+Decreases+Tau+and+Reverses+Phenotypes+in+a+Tauopathy+Mouse+Model&doi=10.1016%2Fj.neuron.2016.09.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of Nuak1 Decreases Tau and Reverses Phenotypes in a Tauopathy Mouse Model</span></div><div class="casAuthors">Lasagna-Reeves, Cristian A.; de Haro, Maria; Hao, Shuang; Park, Jeehye; Rousseaux, Maxime W. C.; Al-Ramahi, Ismael; Jafar-Nejad, Paymaan; Vilanova-Velez, Luis; See, Lauren; De Maio, Antonia; Nitschke, Larissa; Wu, Zhenyu; Troncoso, Juan C.; Westbrook, Thomas F.; Tang, Jianrong; Botas, Juan; Zoghbi, Huda Y.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">407-418</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Many neurodegenerative proteinopathies share a common pathogenic mechanism: the abnormal accumulation of disease-related proteins.  As growing evidence indicates that reducing the steady-state levels of disease-causing proteins mitigates neurodegeneration in animal models, we developed a strategy to screen for genes that decrease the levels of tau, whose accumulation contributes to the pathol. of both Alzheimer disease (AD) and progressive supranuclear palsy (PSP).  Integrating parallel cell-based and Drosophila genetic screens, we discovered that tau levels are regulated by Nuak1, an AMPK-related kinase.  Nuak1 stabilizes tau by phosphorylation specifically at Ser356.  Inhibition of Nuak1 in fruit flies suppressed neurodegeneration in tau-expressing Drosophila, and Nuak1 haploinsufficiency rescued the phenotypes of a tauopathy mouse model.  These results demonstrate that decreasing total tau levels is a valid strategy for mitigating tau-related neurodegeneration and reveal Nuak1 to be a novel therapeutic entry point for tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-pG3UQBaku7Vg90H21EOLACvtfcHk0liqT2dE1r-Ypg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1CltrfN&md5=b0feedddbe769c972974036876f8f6bf</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2016.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2016.09.022%26sid%3Dliteratum%253Aachs%26aulast%3DLasagna-Reeves%26aufirst%3DC.%2BA.%26aulast%3Dde%2BHaro%26aufirst%3DM.%26aulast%3DHao%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DRousseaux%26aufirst%3DM.%2BW.C.%26aulast%3DAl-Ramahi%26aufirst%3DI.%26aulast%3DJafar-Nejad%26aufirst%3DP.%26aulast%3DVilanova-Velez%26aufirst%3DL.%26aulast%3DSee%26aufirst%3DL.%26aulast%3DDe%2BMaio%26aufirst%3DA.%26aulast%3DNitschke%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DTroncoso%26aufirst%3DJ.%2BC.%26aulast%3DWestbrook%26aufirst%3DT.%2BF.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DBotas%26aufirst%3DJ.%26aulast%3DZoghbi%26aufirst%3DH.%2BY.%26atitle%3DReduction%2520of%2520Nuak1%2520Decreases%2520Tau%2520and%2520Reverses%2520Phenotypes%2520in%2520a%2520Tauopathy%2520Mouse%2520Model%26jtitle%3DNeuron%26date%3D2016%26volume%3D92%26spage%3D407%26epage%3D418%26doi%3D10.1016%2Fj.neuron.2016.09.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kusakai, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">ARK5 Expression in Colorectal Cancer and Its Implications for Tumor Progression</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">987</span>– <span class="NLM_lpage">995</span>, <span class="refDoi"> DOI: 10.1016/S0002-9440(10)63186-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2FS0002-9440%2810%2963186-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=14982852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitl2jt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2004&pages=987-995&author=G.+I.+Kusakaiauthor=A.+Suzukiauthor=T.+Oguraauthor=S.+Miyamotoauthor=A.+Ochiaiauthor=M.+Kaminishiauthor=H.+Esumi&title=ARK5+Expression+in+Colorectal+Cancer+and+Its+Implications+for+Tumor+Progression&doi=10.1016%2FS0002-9440%2810%2963186-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">ARK5 expression in colorectal cancer and its implications for tumor progression</span></div><div class="casAuthors">Kusakai, Gen-ichi; Suzuki, Atsushi; Ogura, Tsutomu; Miyamoto, Sin'ichi; Ochiai, Atsushi; Kaminishi, Michio; Esumi, Hiroyasu</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">987-995</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">A novel member of the human AMPK family, ARK5, was recently discovered to be a key mol. in mediating cancer cell migration activity in human pancreas cancer cell line PANC-1, and its activation was found to be induced by Akt-dependent phosphorylation at Ser 600.  DNA array anal. with 241 paired cDNAs from 13 different types of tumors and corresponding normal tissues derived from cancer patients revealed ARK5 overexpression in the samples of colorectal cancer.  ARK5 expression was measured and an in vitro invasion assay was performed in 6 human colorectal cancer cell lines, WiDr, HCT-15, DLD-1, SW620, LoVo, and SW480, and since high invasion activity was concordant with higher ARK5 expression, ARK5 expression was examd. in relation to tumor progression and metastatic activity in clin. samples.  In 56 clin. samples of primary colorectal cancers and their liver metastases, higher ARK5 expression was obsd. in the samples from more advanced cases, and much higher expression was obsd. in the liver metastases.  In situ hybridization anal. showed ARK5 overexpression in tumor cells.  Based on these findings, the authors propose that ARK5 overexpression is involved in tumor progression of colon cancer clin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDUbZD-Ft3Q7Vg90H21EOLACvtfcHk0liqT2dE1r-Ypg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitl2jt7g%253D&md5=428847d8dee834b18407dbc722144f44</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2963186-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252963186-0%26sid%3Dliteratum%253Aachs%26aulast%3DKusakai%26aufirst%3DG.%2BI.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DS.%26aulast%3DOchiai%26aufirst%3DA.%26aulast%3DKaminishi%26aufirst%3DM.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DARK5%2520Expression%2520in%2520Colorectal%2520Cancer%2520and%2520Its%2520Implications%2520for%2520Tumor%2520Progression%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2004%26volume%3D164%26spage%3D987%26epage%3D995%26doi%3D10.1016%2FS0002-9440%2810%2963186-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Port, J. L. F.</span></span> <i>Investigating the Therapeutic Potential of NUAK1 for the Treatment of Colorectal Cancer</i>. <span class="NLM_publisher-name">University of Glasgow</span>, Ph.D. Thesis, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+L.+F.+Port&title=Investigating+the+Therapeutic+Potential+of+NUAK1+for+the+Treatment+of+Colorectal+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPort%26aufirst%3DJ.%2BL.%2BF.%26jtitle%3DInvestigating%2520the%2520Therapeutic%2520Potential%2520of%2520NUAK1%2520for%2520the%2520Treatment%2520of%2520Colorectal%2520Cancer%26pub%3DUniversity%2520of%2520Glasgow%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, X.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, R.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.-C.</span></span> <span> </span><span class="NLM_article-title">ARK5 Is Associated with the Invasive and Metastatic Potential of Human Breast Cancer Cells</span>. <i>J. Cancer Res. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1007/s00432-011-1102-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1007%2Fs00432-011-1102-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22105900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XpslOlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2012&pages=247-254&author=X.-Z.+Changauthor=J.+Yuauthor=H.-Y.+Liuauthor=R.-H.+Dongauthor=X.-C.+Cao&title=ARK5+Is+Associated+with+the+Invasive+and+Metastatic+Potential+of+Human+Breast+Cancer+Cells&doi=10.1007%2Fs00432-011-1102-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">ARK5 is associated with the invasive and metastatic potential of human breast cancer cells</span></div><div class="casAuthors">Chang, Xin-Zhong; Yu, Jie; Liu, Hai-Yin; Dong, Rui-Hua; Cao, Xu-Chen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Research and Clinical Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-254</span>CODEN:
                <span class="NLM_cas:coden">JCROD7</span>;
        ISSN:<span class="NLM_cas:issn">0171-5216</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The aim was to investigate the effects of Akt/ARK5 pathways on the metastatic potential of human breast cancer cells.  The human ARK5 gene was transfected into MDA-MB-231 cells.  Effects of ARK5 on MDA-MB-231 cells were investigated in vitro.  The tumorigenicity and spontaneously metastatic capability regulated by ARK5 were detd. using an orthotopic xenograft tumor model.  ARK5 enhanced the invasive and metastatic potential of MDA-MB-231 cells under regulation by Akt.  The enhancement was assocd. with increasing MMP-2, MMP-9, and MT1-MMP expression.  The results were further demonstrated by RNA interference expt.  In an in vivo study, we also demonstrated that ARK5-transfected breast cancer cells grew faster and had more pulmonary metastases than its parental counterparts.  ARK5 led to a more invasive phenotype and metastatic potential in human breast cancer dependent on Akt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWDPURHxop5bVg90H21EOLACvtfcHk0liqT2dE1r-Ypg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpslOlsw%253D%253D&md5=7cb1b5e0f6d5ae13656f76d81f3df423</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1007%2Fs00432-011-1102-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00432-011-1102-1%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DX.-Z.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.-Y.%26aulast%3DDong%26aufirst%3DR.-H.%26aulast%3DCao%26aufirst%3DX.-C.%26atitle%3DARK5%2520Is%2520Associated%2520with%2520the%2520Invasive%2520and%2520Metastatic%2520Potential%2520of%2520Human%2520Breast%2520Cancer%2520Cells%26jtitle%3DJ.%2520Cancer%2520Res.%2520Clin.%2520Oncol.%26date%3D2012%26volume%3D138%26spage%3D247%26epage%3D254%26doi%3D10.1007%2Fs00432-011-1102-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.-R.</span></span> <span> </span><span class="NLM_article-title">Activation of ARK5/MiR-1181/HOXA10 Axis Promotes Epithelial-Mesenchymal Transition in Ovarian Cancer</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1193</span>– <span class="NLM_lpage">1202</span>, <span class="refDoi"> DOI: 10.3892/or.2015.4113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.3892%2For.2015.4113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26151663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=1193-1202&author=H.-Y.+Zhangauthor=J.-H.+Liauthor=G.+Liauthor=S.-R.+Wang&title=Activation+of+ARK5%2FMiR-1181%2FHOXA10+Axis+Promotes+Epithelial-Mesenchymal+Transition+in+Ovarian+Cancer&doi=10.3892%2For.2015.4113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of ARK5/miR-1181/HOXA10 axis promotes epithelial-mesenchymal transition in ovarian cancer</span></div><div class="casAuthors">Zhang, Hai-Yan; Li, Jian-Hua; Li, Guang; Wang, Su-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1193-1202</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1791-2431</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Epithelial ovarian cancer (EOC) is the sixth most common cancer in females worldwide and, although advances have been made in the detection, diagnosis and therapies for EOC, it remains the most lethal gynecol. malignancy in advanced countries.  Nevertheless, relatively little is known concerning the mol. events that lead to the development of this highly aggressive disease.  Elucidating the mol. mechanism involved in this disease may prove useful to understand the pathogenesis and progression of the disease, and to identify new targets for effective therapies.  In the present study, we examd. the role of ARK5 in ovarian cancer and normal matched tissues using western blot anal. and migration and invasion, and wound-healing assays.  The results showed that ARK5 was upregulated in ovarian cancer tissues, compared with adjacent normal tissues.  Moreover, it promoted epithelial-mesenchymal transition (EMT) and inhibited miR-1181 expression in ovarian cancer cells.  Subsequent investigations showed that miR-1181 promoted mesenchymal-epithelial transition (MET) in ovarian cancer cells.  Downstream target genes of miR-1181 were searched, and it was identified that miR-1181 degraded HOXA10 by targeting its 3' untranslated region (3'UTR) in ovarian cancer cells.  The results confirmed that HOXA10 promoted EMT in ovarian cancer cells.  Thus, activation of the ARK5/miR-1181/HOXA10 axis may be pos. assocd. with EMT in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5JfPtn9dt3LVg90H21EOLACvtfcHk0lgkDMR8t90rog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSltQ%253D%253D&md5=9acf4208e27ec4d9e085f479374e1cfa</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.3892%2For.2015.4113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2015.4113%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-Y.%26aulast%3DLi%26aufirst%3DJ.-H.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DS.-R.%26atitle%3DActivation%2520of%2520ARK5%252FMiR-1181%252FHOXA10%2520Axis%2520Promotes%2520Epithelial-Mesenchymal%2520Transition%2520in%2520Ovarian%2520Cancer%26jtitle%3DOncol.%2520Rep.%26date%3D2015%26volume%3D34%26spage%3D1193%26epage%3D1202%26doi%3D10.3892%2For.2015.4113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span> <span> </span><span class="NLM_article-title">Inhibition of AMPK-Related Kinase 5 (ARK5) Enhances Cisplatin Cytotoxicity in Non-Small Cell Lung Cancer Cells through Regulation of Epithelial-Mesenchymal Transition</span>. <i>Am. J. Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1708</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=28469776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1KqsLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1708&author=M.+Liauthor=C.+Zhengauthor=H.+Xuauthor=W.+Heauthor=Y.+Ruanauthor=J.+Maauthor=J.+Zhengauthor=C.+Yeauthor=W.+Li&title=Inhibition+of+AMPK-Related+Kinase+5+%28ARK5%29+Enhances+Cisplatin+Cytotoxicity+in+Non-Small+Cell+Lung+Cancer+Cells+through+Regulation+of+Epithelial-Mesenchymal+Transition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of AMPK-related kinase 5 (ARK5) enhances cisplatin cytotoxicity in non-small cell lung cancer cells through regulation of epithelial-mesenchymal transition</span></div><div class="casAuthors">Li, Minghui; Zheng, Chengfei; Xu, Hongfei; He, Wei; Ruan, Yongchun; Ma, Jianyong; Zheng, Junnan; Ye, Chengmeng; Li, Weidong</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Translational Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1708-1719</span>CODEN:
                <span class="NLM_cas:coden">AJTRA7</span>;
        ISSN:<span class="NLM_cas:issn">1943-8141</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Lung cancer incidence and mortality rates are amongst the highest of all malignant tumors worldwide.  ARK5 is a member of the human AMP-activated protein kinase (AMPK) family which is implicated in tumor survival and progression.  The current study was designed to explore the role of ARK5 in resistance of non-small cell lung cancer (NSCLC) to cisplatin.  We studied the sensitivity of two NSCLC cell lines, NCI-H1229 and A549, to cisplatin by using proliferation and cell viability assays.  We then examd. expression of ARK5, Twist, and the epithelial to mesenchymal transition (EMT) biomarkers, E-cadherin and Vimentin, by Western blot and immunofluorescence.  We found that ARK5 downregulation significantly increased the cisplatin chemosensitivity of NSCLC cells, and that NCI-H1299 cells, which express high levels of ARK5 and possess a mesenchymal phenotype, were more resistant to cisplatin than A549 cells, which show low expression ARK5.  Furthermore, siRNA-mediated silencing of ARK5 resulted in altered EMT patterns in NSCLC cells.  These data support a role for ARK5 in regulating EMT in NSCLC cells.  Together, our findings suggest that ARK5 is a potential drug target for combating drug resistance and regulating EMT in NSCLC cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYs7DlKGZmD7Vg90H21EOLACvtfcHk0lgkDMR8t90rog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1KqsLjE&md5=48081e62bcafb95747bdcff0da7e56c6</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DRuan%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DW.%26atitle%3DInhibition%2520of%2520AMPK-Related%2520Kinase%25205%2520%2528ARK5%2529%2520Enhances%2520Cisplatin%2520Cytotoxicity%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520Cells%2520through%2520Regulation%2520of%2520Epithelial-Mesenchymal%2520Transition%26jtitle%3DAm.%2520J.%2520Transl.%2520Res.%26date%3D2017%26volume%3D9%26spage%3D1708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, T.</span></span> <span> </span><span class="NLM_article-title">ARK5 Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Epithelial-Mesenchymal Transition</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>377</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.canlet.2016.04.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=27126361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVOmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2016&pages=140-148&author=T.+Xuauthor=J.+Zhangauthor=W.+Chenauthor=S.+Panauthor=X.+Zhiauthor=L.+Wenauthor=Y.+Zhouauthor=B.+W.+Chenauthor=J.+Qiuauthor=Y.+Zhangauthor=Q.+Yangauthor=X.+Fengauthor=X.+Baiauthor=T.+Liang&title=ARK5+Promotes+Doxorubicin+Resistance+in+Hepatocellular+Carcinoma+via+Epithelial-Mesenchymal+Transition&doi=10.1016%2Fj.canlet.2016.04.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">ARK5 promotes doxorubicin resistance in hepatocellular carcinoma via epithelial-mesenchymal transition</span></div><div class="casAuthors">Xu, Tao; Zhang, Jian; Chen, Wei; Pan, Shengjing; Zhi, Xiao; Wen, Liang; Zhou, Yue; Chen, Bryan Wei; Qiu, Junyu; Zhang, Yun; Yang, Qi; Feng, Xinhua; Bai, Xueli; Liang, Tingbo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-148</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">AMP-activated protein kinase family member 5 (ARK5) overexpression has been reported in many human cancers, and ARK5 is assocd. with poor prognosis in hepatocellular carcinoma (HCC).  However, whether ARK5 is involved in HCC chemoresistance is unclear.  The present study aimed to investigate the role of ARK5 in HCC chemoresistance and the underlying mechanism.  In this study, we found that SNU387 and SNU449 HCC cell lines overexpressing ARK5 displayed low doxorubicin sensitivity compared to Huh7 and Hep3B HCC cell lines with ARK5 low-expression.  And knockdown of ARK5 increased the doxorubicin sensitivity in all HCC cell lines in the manner of inhibiting cell proliferation.  Western blotting and immunofluorescence both showed that ARK5 knockdown upregulated E-cadherin and downregulated vimentin, which was consistent with the knockdown of TWIST, indicating ARK5 was involved in epithelial-mesenchymal transition (EMT).  Moreover, suppressing ARK5 by siRNA restored E-cadherin and vimentin expression induced by doxorubicin treatment or hypoxia culture.  Our results indicated ARK5 confers doxorubicin resistance in HCC via inducing EMT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCbePFNCwvLrVg90H21EOLACvtfcHk0lgkDMR8t90rog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVOmtr8%253D&md5=c217d228a652420ebc780ce7fc76d56f</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DZhi%26aufirst%3DX.%26aulast%3DWen%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DB.%2BW.%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DT.%26atitle%3DARK5%2520Promotes%2520Doxorubicin%2520Resistance%2520in%2520Hepatocellular%2520Carcinoma%2520via%2520Epithelial-Mesenchymal%2520Transition%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D377%26spage%3D140%26epage%3D148%26doi%3D10.1016%2Fj.canlet.2016.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, D.</span></span> <span> </span><span class="NLM_article-title">MiR-96 Functions as a Tumor Suppressor Gene by Targeting NUAK1 in Pancreatic Cancer</span>. <i>Int. J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1599</span>– <span class="NLM_lpage">1605</span>, <span class="refDoi"> DOI: 10.3892/ijmm.2014.1940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.3892%2Fijmm.2014.1940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=25242509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislCksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=1599-1605&author=X.+Huangauthor=W.+Lvauthor=J.+Zhangauthor=D.+Lu&title=MiR-96+Functions+as+a+Tumor+Suppressor+Gene+by+Targeting+NUAK1+in+Pancreatic+Cancer&doi=10.3892%2Fijmm.2014.1940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">miR-96 functions as a tumor suppressor gene by targeting NUAK1 in pancreatic cancer</span></div><div class="casAuthors">Huang, Xuan; Lv, Wei; Zhang, Jian-Hua; Lu, Da-Lin</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1599-1605</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">MicroRNA-96 (miR-96) is known to be down-regulated in pancreatic cancer.  The overexpression of miR-96 in MIA PaCa-2 pancreatic cancer cells has been shown to inhibit cell proliferation, migration and invasion; however, the mechanisms involved have not yet been fully elucidated.  Novel (nua) kinase family 1 (NUAK1) functions as an oncogene in non-small cell lung cancer (NSCLC), melanoma, glioma, breast cancer, hepatocellular carcinoma and pancreatic cancer.  In this study, firstly, we demonstrate that NUAK1 expression is specifically upregulated in pancreatic cancer and that it promotes the proliferation, migration and invasion of MIA PaCa-2 pancreatic cancer cells.  Secondly, we performed an anal. of potential microRNA (miRNA) target sites using three commonly used prediction algorithms: miRanda, TargetScan and PicTar.  All three algorithms predicted that miR-96 targets the 3' untranslated region (3' UTR) of NUAK1.  Further expts. confirmed this prediction, namely that miR-96 suppresses the expression of NUAK1 by targeting its 3' UTR.  Finally, we demonstrate that the introduction of NUAK1 cDNA lacking predicted sites of the 3' UTR abrogates miR-96 cellular function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuwd_IWfG51bVg90H21EOLACvtfcHk0lhjTp9GwtS_Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislCksA%253D%253D&md5=bab2232a47e5154c220541146d23a32b</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.3892%2Fijmm.2014.1940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.2014.1940%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DD.%26atitle%3DMiR-96%2520Functions%2520as%2520a%2520Tumor%2520Suppressor%2520Gene%2520by%2520Targeting%2520NUAK1%2520in%2520Pancreatic%2520Cancer%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2014%26volume%3D34%26spage%3D1599%26epage%3D1605%26doi%3D10.3892%2Fijmm.2014.1940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, F.</span></span> <span> </span><span class="NLM_article-title">MIR-145 Functions as a Tumor Suppressor Targeting NUAK1 in Human Intrahepatic Cholangiocarcinoma</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>465</i></span>,  <span class="NLM_fpage">262</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2015.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.bbrc.2015.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26255969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCis77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2015&pages=262-269&author=X.+Xiongauthor=D.+Sunauthor=H.+Chaiauthor=W.+Shanauthor=Y.+Yuauthor=L.+Puauthor=F.+Cheng&title=MIR-145+Functions+as+a+Tumor+Suppressor+Targeting+NUAK1+in+Human+Intrahepatic+Cholangiocarcinoma&doi=10.1016%2Fj.bbrc.2015.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma</span></div><div class="casAuthors">Xiong, Xinkui; Sun, Daoyi; Chai, Hao; Shan, Wengang; Yu, Yue; Pu, Liyong; Cheng, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">262-269</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The dysregulation of micro (mi)RNAs is assocd. with cancer development.  The miRNA miR-145 is downregulated in intrahepatic cholangiocarcinoma (ICC); however, its precise role in tumor progression has not yet been elucidated.  Novel (nua) kinase family (NUAK)1 functions as an oncogene in various cancers and is a putative target of miR-145 regulation.  In this study, we investigated the regulation of NUAK1 by miR-145 in ICC.  We found that miR-145 level was significantly decreased in ICC tissue and cell lines, which corresponded with an increase in NUAK1 expression.  NUAK1 was found to be a direct target of miR-145 regulation.  The overexpression of miR-145 in ICC cell lines inhibited proliferation, growth, and invasion by suppressing NUAK1 expression, which was assocd. with a decrease in Akt signaling and matrix metalloproteinase protein expression.  Similar results were obsd. by inhibiting NUAK1 expression.  These results demonstrate that miR-145 can prevent ICC progression by targeting NUAK1 and its downstream effectors, and can therefore be useful for clin. diagnosis and targeted therapy of ICC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnV3igieYepLVg90H21EOLACvtfcHk0lhjTp9GwtS_Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCis77L&md5=b98b0eaadfb6662ef58790db65b14bf5</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2015.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2015.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DChai%26aufirst%3DH.%26aulast%3DShan%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DPu%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DF.%26atitle%3DMIR-145%2520Functions%2520as%2520a%2520Tumor%2520Suppressor%2520Targeting%2520NUAK1%2520in%2520Human%2520Intrahepatic%2520Cholangiocarcinoma%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2015%26volume%3D465%26spage%3D262%26epage%3D269%26doi%3D10.1016%2Fj.bbrc.2015.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunematsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasahira, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuniyasu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imoto, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abiko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukunaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takata, T.</span></span> <span> </span><span class="NLM_article-title">MicroRNA-203 Suppresses Invasion and Epithelial-Mesenchymal Transition Induction via Targeting NUAK1 in Head and Neck Cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">8223</span>– <span class="NLM_lpage">8239</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.6972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.18632%2Foncotarget.6972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26882562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BC28jht1yqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=8223-8239&author=M.+Obayashiauthor=M.+Yoshidaauthor=T.+Tsunematsuauthor=I.+Ogawaauthor=T.+Sasahiraauthor=H.+Kuniyasuauthor=I.+Imotoauthor=Y.+Abikoauthor=D.+Xuauthor=S.+Fukunagaauthor=H.+Taharaauthor=Y.+Kudoauthor=T.+Nagaoauthor=T.+Takata&title=MicroRNA-203+Suppresses+Invasion+and+Epithelial-Mesenchymal+Transition+Induction+via+Targeting+NUAK1+in+Head+and+Neck+Cancer&doi=10.18632%2Foncotarget.6972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer</span></div><div class="casAuthors">Obayashi Mariko; Yoshida Maki; Takata Takashi; Yoshida Maki; Nagao Toshitaka; Tsunematsu Takaaki; Kudo Yasusei; Ogawa Ikuko; Sasahira Tomonori; Kuniyasu Hiroki; Imoto Issei; Abiko Yoshimitsu; Xu Dan; Fukunaga Saori; Tahara Hidetoshi; Xu Dan</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">8223-39</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Head and neck squamous cell carcinoma (HNSCC) has a high capacity for invasion.  To identify microRNAs (miRNAs) that regulate HNSCC invasion, we compared miRNA expression profiles between a parent HNSCC cell line and a highly invasive clone.  The miR-200 family and miR-203 were downregulated in the clone.  Here we focused on the role of miR-203 in invasion and epithelial-mesenchymal transition (EMT) induction in HNSCC. miR-203 was downregulated during EMT induction.  Moreover, ectopic overexpression of miR-203 suppressed the invasion and induced mesenchymal-epithelial transition (MET) in HNSCC cells.  Interestingly, we identified NUAK family SNF1-like kinase 1 (NUAK1) as a novel target gene of miR-203 by cyclopedic analysis using anti-Ago2 antibody.  Increased expression of NUAK1 was observed during EMT induction, and ectopic expression of miR-203 delayed EMT induction by suppressing NUAK1 expression.  Moreover, NUAK1 overexpression promoted the invasion of HNSCC cells.  Importantly, NUAK1 expression was well correlated with poor differentiation, invasiveness, and lymph node metastasis in HNSCC cases.  Overall, miR-203 has a tumor-suppressing role in invasion and EMT induction by targeting NUAK1 in HNSCC, suggesting miR-203 as a potential new diagnostic and therapeutic target for the treatment of HNSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSTbbS-qxbrUloaUqgkFHkfW6udTcc2eY8qJvPKP_dCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jht1yqtw%253D%253D&md5=61b7abfb81c4b1037ec51d2692b2c3bc</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.6972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.6972%26sid%3Dliteratum%253Aachs%26aulast%3DObayashi%26aufirst%3DM.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DTsunematsu%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DI.%26aulast%3DSasahira%26aufirst%3DT.%26aulast%3DKuniyasu%26aufirst%3DH.%26aulast%3DImoto%26aufirst%3DI.%26aulast%3DAbiko%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DFukunaga%26aufirst%3DS.%26aulast%3DTahara%26aufirst%3DH.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DNagao%26aufirst%3DT.%26aulast%3DTakata%26aufirst%3DT.%26atitle%3DMicroRNA-203%2520Suppresses%2520Invasion%2520and%2520Epithelial-Mesenchymal%2520Transition%2520Induction%2520via%2520Targeting%2520NUAK1%2520in%2520Head%2520and%2520Neck%2520Cancer%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D8223%26epage%3D8239%26doi%3D10.18632%2Foncotarget.6972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">LncRNA SNHG1 Functions as a CeRNA to Antagonize the Effect of MiR-145a-5p on the Down-regulation of NUAK1 in Nasopharyngeal Carcinoma Cell</span>. <i>J. Cell. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2351</span>– <span class="NLM_lpage">2361</span>, <span class="refDoi"> DOI: 10.1111/jcmm.13497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1111%2Fjcmm.13497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=29575772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtlWhtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2019&pages=2351-2361&author=X.+Lanauthor=X.+Liu&title=LncRNA+SNHG1+Functions+as+a+CeRNA+to+Antagonize+the+Effect+of+MiR-145a-5p+on+the+Down-regulation+of+NUAK1+in+Nasopharyngeal+Carcinoma+Cell&doi=10.1111%2Fjcmm.13497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">LncRNA SNHG1 functions as a ceRNA to antagonize the effect of miR-145a-5p on the down-regulation of NUAK1 in nasopharyngeal carcinoma cell</span></div><div class="casAuthors">Lan, Xintang; Liu, Xiuling</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2351-2361</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-4934</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">How lncRNA SNHG1 influences the aggressiveness of nasopharyngeal carcinoma cells as well as the underlying mechanism was studied.  Transfection was conducted to construct nasopharyngeal carcinoma cells with different expressions of SNHG1, miR-145-5p and NUAK1.  Dual-luciferase reporter assay was performed to explore the relationship between SNHG1, miR-145-5p and NUAK1.  Wound-healing assay and transwell invasion expts. were employed to study changes in cell migration capacity and cell invasion, resp.  Tumor xenografts were performed to observe lung metastasis of nude mice inoculated with transfected CNE cells.  SNHG1 is highly expressed in nasopharyngeal carcinoma tissues and in cell lines.  Down-regulation of SNHG1 facilitated the expression of miR-145-5p and further suppressed the level of NAUK1 in CNE and HNE-1 cells.  Silencing of SNHG1, up-regulation of miR-145-5p and inhibition of NAUK1 by relative transfection all attenuated the aggressiveness of CNE and HNE-1 cells both in vivo and in vitro.  Moreover, the impaired cell migration and invasion by SNHG1 siRNA could be rescued by cotransfection of miR-145-5p in CNE and HNE-1 cells.  LncRNA SNHG1 promoted the expression of NUAK1 by down-regulating miR-145-5p and thus promoted the aggressiveness of nasopharyngeal carcinoma cells through AKT signalling pathway and induced epithelial-mesenchymal transition (EMT).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozgQUUlW4ITbVg90H21EOLACvtfcHk0liamyLYcUuH-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtlWhtbg%253D&md5=62fbd273bfeec3a3e3934911222453ff</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1111%2Fjcmm.13497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjcmm.13497%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DLncRNA%2520SNHG1%2520Functions%2520as%2520a%2520CeRNA%2520to%2520Antagonize%2520the%2520Effect%2520of%2520MiR-145a-5p%2520on%2520the%2520Down-regulation%2520of%2520NUAK1%2520in%2520Nasopharyngeal%2520Carcinoma%2520Cell%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2019%26volume%3D23%26spage%3D2351%26epage%3D2361%26doi%3D10.1111%2Fjcmm.13497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span> <span> </span><span class="NLM_article-title">Expression Level of NUAK1 in Human Nasopharyngeal Carcinoma and Its Prognostic Significance</span>. <i>Eur. Arch. Oto-Rhino-Laryngology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">2563</span>– <span class="NLM_lpage">2573</span>, <span class="refDoi"> DOI: 10.1007/s00405-018-5095-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1007%2Fs00405-018-5095-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=30121842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BB3c7psFWjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2018&pages=2563-2573&author=J.+Liuauthor=G.+Tangauthor=H.+Huangauthor=H.+Liauthor=P.+Zhangauthor=L.+Xu&title=Expression+Level+of+NUAK1+in+Human+Nasopharyngeal+Carcinoma+and+Its+Prognostic+Significance&doi=10.1007%2Fs00405-018-5095-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Expression level of NUAK1 in human nasopharyngeal carcinoma and its prognostic significance</span></div><div class="casAuthors">Liu Jiaoyang; Tang Guoyan; Xu Lihua; Huang He; Li Huan; Zhang Peng; Xu Lihua</div><div class="citationInfo"><span class="NLM_cas:title">European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2563-2573</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Nasopharyngeal carcinoma (NPC) is notable for its high incidence rates in select geographic and ethnic populations, especially among Chinese and Malay populations in Southeastern Asia.  However, relevant biomarkers for the development and prognosis of NPC are not yet clear; therefore, discovering novel biomarkers will facilitate prediction of prognosis and development of targeted therapeutic tactics.  This study aims to quest the potential prognostic value of NUAK1 (a downstream member of Akt) in NPC.  METHODS:  Immunohistochemistry was performed to measure the expression of NUAK1 in paraffin-embedded NPC samples.  Statistical analysis, encompassing chi-square tests and Student's t test, was also employed to evaluate the association between the expression of NUAK1 and clinicopathologic features.  In addition, the survival analysis was used to detect the prognostic significance of NUAK1 in NPC.  RESULTS:  Excessive expression of NUAK1 was found in NPC tissues at mRNA levels.  Statistical analysis revealed a correlation of NUAK1 expression with maximum neck lymph node diameter (p = 0.025) and WHO histological type (p = 0.021).  Furthermore, according to survival analysis, there was clinical relevance between the upregulation of NUAK1 in NPC and DFS.  Subgroup analysis indicated that the expression of NUAK1 was strongly associated with DFS (p = 0.027) and OS (p = 0.026) duration in the patients of N1-3 tumors, but not in patients with N0 tumors.  The expression of NUAK1 was also strongly associated with OS (p = 0.044) and DFS (p = 0.007) in patients of late stage tumour (UICC3-5), but not in patients of early stage tumour (UICC1-2).  In addition, COX regression illustrated that N classification and NUAK1 expression were independent prognostic factors for disease-free survival.  CONCLUSION:  Our study postulated that NUAK1 is excessively expressed in NPC and may serve as a potential predictor of prognosis for NPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvMHlyzNebeA5nADWVYHg1fW6udTcc2eY8qJvPKP_dCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7psFWjsQ%253D%253D&md5=0fd34df410e2160d64bb0d82bf5d2b0f</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1007%2Fs00405-018-5095-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00405-018-5095-0%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DL.%26atitle%3DExpression%2520Level%2520of%2520NUAK1%2520in%2520Human%2520Nasopharyngeal%2520Carcinoma%2520and%2520Its%2520Prognostic%2520Significance%26jtitle%3DEur.%2520Arch.%2520Oto-Rhino-Laryngology%26date%3D2018%26volume%3D275%26spage%3D2563%26epage%3D2573%26doi%3D10.1007%2Fs00405-018-5095-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span> <span> </span><span class="NLM_article-title">Upregulation of LncRNA SnoRNA Host Gene 6 Regulates NUAK Family SnF1-like Kinase-1 Expression by Competitively Binding MicroRNA-125b and Interacting with Snail1/2 in Bladder Cancer</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1002/jcb.27387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1002%2Fjcb.27387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=30168179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Wmt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2019&pages=357-367&author=C.+Wangauthor=W.+Taoauthor=S.+Niauthor=Q.+Chen&title=Upregulation+of+LncRNA+SnoRNA+Host+Gene+6+Regulates+NUAK+Family+SnF1-like+Kinase-1+Expression+by+Competitively+Binding+MicroRNA-125b+and+Interacting+with+Snail1%2F2+in+Bladder+Cancer&doi=10.1002%2Fjcb.27387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Upregulation of lncRNA snoRNA host gene 6 regulates NUAK family SnF1-like kinase-1 expression by competitively binding microRNA-125b and interacting with Snail1/2 in bladder cancer</span></div><div class="casAuthors">Wang, Chunyang; Tao, Weiyang; Ni, Shaobin; Chen, Qiyin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">357-367</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Backgrounds/aims : Numerous studies have reported that long noncoding RNAs (lncRNAs) play crit. roles in the development and progression of bladder cancer (BC).  LncRNA snoRNA host gene 6 (SNHG6) is ectopically expressed in tumor tissues of patients with BC and BC cell lines.  However, little is known about the mol. mechanism of SNHG6-mediated bladder urothelial carcinoma cell migration and invasion.  Methods : We detected the SNHG6 levels in human BC specimens and cell lines by quant. real-time polymerase chain reaction and Western blot, and investigated its role in BC using in vitro assays.  Results : We showed that overexpression of SNHG6 induced epithelial-mesenchymal transition (EMT) and promoted the migration and invasion capabilities of BC cells.  Mechanistically, SNHG6 induced EMT of BC cells by upregulating the expression levels of Snail1/2 and regulated BC cell migration and invasion by tumor suppressive hsa-miR-125b and its target gene NUAK Family Kinase 1 (NUAK1).  Furthermore, we found that SNHG6 was pos. correlated with Snail1/2 expression, and neg. correlated with hsa-miR-125b expression in BC specimens.  Further study showed that SNHG6 repressed hsa-miR-125b expression to upregulate Snail1/2.  Conversely, hsa-miR-125b knockdown augmented SNHG6 expression in BC cells.  Conclusion : Overall, our study demonstrated that SNHG6 promotes BC cell migration and invasion partly via the hsa-miR-125b/Snail1/2/NUAK1 pathway.  Therefore, SNHG6 may be a potential prognostic biomarker in BC, and targeting hsa-miR-125b/Snail1/2/NUAK1 axis may be a promising therapeutic approach for BC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_iOKRgiHibrVg90H21EOLACvtfcHk0lg3xotXFb6O5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Wmt7fP&md5=267cd78dfebde61b8aeaa5b4f7be3627</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1002%2Fjcb.27387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.27387%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DNi%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DQ.%26atitle%3DUpregulation%2520of%2520LncRNA%2520SnoRNA%2520Host%2520Gene%25206%2520Regulates%2520NUAK%2520Family%2520SnF1-like%2520Kinase-1%2520Expression%2520by%2520Competitively%2520Binding%2520MicroRNA-125b%2520and%2520Interacting%2520with%2520Snail1%252F2%2520in%2520Bladder%2520Cancer%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2019%26volume%3D120%26spage%3D357%26epage%3D367%26doi%3D10.1002%2Fjcb.27387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span> <span> </span><span class="NLM_article-title">Knockdown of ARK5 Expression Suppresses Invasion and Metastasis of Gastric Cancer</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1025</span>– <span class="NLM_lpage">1036</span>, <span class="refDoi"> DOI: 10.1159/000478685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1159%2F000478685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=28662499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs12rs7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=1025-1036&author=D.+Chenauthor=G.+Liuauthor=N.+Xuauthor=X.+Youauthor=H.+Zhouauthor=X.+Zhaoauthor=Q.+Liu&title=Knockdown+of+ARK5+Expression+Suppresses+Invasion+and+Metastasis+of+Gastric+Cancer&doi=10.1159%2F000478685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Knockdown of ARK5 Expression Suppresses Invasion and Metastasis of Gastric Cancer</span></div><div class="casAuthors">Chen, Dehu; Liu, Guiyuan; Xu, Ning; You, Xiaolan; Zhou, Haihua; Zhao, Xiaojun; Liu, Qinghong</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1025-1036</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: Gastric cancer (GC) is a common and lethal malignancy, and AMP-activated protein kinase-related kinase 5 (ARK5) has been discovered to promote cancer metastasis in certain types of cancer.  In this study, we explored the role of ARK5 in GC invasion and metastasis.  Methods: ARK5 and epithelial-mesenchymal transition (EMT)-related markers were detd. by immunohistochem. and western blot in GC specimens.  Other methods including stably transfected against ARK5 into SGC7901 and AGS cells, western blot, migration and invasion assays in vitro and nude mice tumorigenicity in vivo were also employed.  Results: The results demonstrated that ARK5 expression was increased and pos. correlated with metastasis, EMT-related markers and poor prognosis in patients with GC.  Knockdown of ARK5 expression remarkably suppressed GC cells invasion and metastasis via regulating EMT, rather than proliferation in vitro and in vivo.  And knockdown of ARK5 expression in GC cells resulted in the down-regulation of the mTOR/p70S6k signals, Slug and SIP1.  Conclusion: The elevated ARK5 expression was closely assocd. with cancer metastasis and patient survival, and it seemed to function in GC cells migration and invasion via EMT alteration, together with the alteration of the mTOR/p70S6k signals, Slug and SIP1, thus providing a potential therapeutic target for GC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrneOQpYQJ-eLVg90H21EOLACvtfcHk0lg3xotXFb6O5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs12rs7bE&md5=56ceba2a329a9d655bb1653a1487f3fb</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1159%2F000478685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000478685%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DN.%26aulast%3DYou%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DQ.%26atitle%3DKnockdown%2520of%2520ARK5%2520Expression%2520Suppresses%2520Invasion%2520and%2520Metastasis%2520of%2520Gastric%2520Cancer%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2017%26volume%3D42%26spage%3D1025%26epage%3D1036%26doi%3D10.1159%2F000478685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. C.</span></span> <span> </span><span class="NLM_article-title">Overexpression of NUAK1 Is Associated with Disease-Free Survival and Overall Survival in Patients with Gastric Cancer</span>. <i>Med. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">61</span>, <span class="refDoi"> DOI: 10.1007/s12032-014-0061-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1007%2Fs12032-014-0061-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=24943992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BC2cfjvFyhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=61&author=X.+T.+Yeauthor=A.+J.+Guoauthor=P.+F.+Yinauthor=X.+D.+Caoauthor=J.+C.+Chang&title=Overexpression+of+NUAK1+Is+Associated+with+Disease-Free+Survival+and+Overall+Survival+in+Patients+with+Gastric+Cancer&doi=10.1007%2Fs12032-014-0061-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of NUAK1 is associated with disease-free survival and overall survival in patients with gastric cancer</span></div><div class="casAuthors">Ye Xiao-tian; Guo Ai-jun; Yin Peng-fei; Cao Xian-dong; Chang Jia-cong</div><div class="citationInfo"><span class="NLM_cas:title">Medical oncology (Northwood, London, England)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">61</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Novel (nua) kinase family 1 (NUAK1) is a member of the human adenosine monophosphate-activated protein kinases family, which is overexpressed in multiple human malignancies and thought to be involved in tumor invasion and metastasis ability.  Our study is to investigate the association of NUAK1 expression with clinicopathological parameters and prognostic significance of patients with gastric cancer.  The expression patterns of the NUAK1 protein in 117 primary archival gastric cancer specimens and 46 adjacent normal epithelial tissues from patients were detected by immunohistochemistry assay.  Staining evaluation results were analyzed statistically in relation to various clinicopathological characters, recurrence-free survival and overall survival.  High level of NUAK1 expression was detected in gastric cancer, significantly more than in adjacent normal epithelial cells.  In gastric cancer, NUAK1 was positively correlated with depth of invasion, lymph node metastasis, pathological stage, surgical resection and histological differentiation.  However, no correlations between NUAK1 expression and patients' age, sex, tumor size, location, CA19-9 or CEA were detected.  The recurrence-free survival and overall survival were significantly shorter for patients with NUAK1 higher scores than those with NUAK1 lower scores.  Multivariate analysis identified NUAK1 was an independent prognostic factor for both recurrence-free survival and overall survival.  Our findings provided convincing evidence for NUAK1 overexpression, which was tightly associated with more aggressive tumor behavior and a poor prognosis, indicating that NUAK1 is a valuable molecular biomarker for gastric cancer progression.  It might also act as a promising target for both prognostic prediction and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcShV0-YwFOzpJ6KlWarZTAzfW6udTcc2eZThFsN9EYESLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfjvFyhtw%253D%253D&md5=73b9e8010dfdad1f17b90d2eab2e10d2</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1007%2Fs12032-014-0061-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12032-014-0061-1%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DX.%2BT.%26aulast%3DGuo%26aufirst%3DA.%2BJ.%26aulast%3DYin%26aufirst%3DP.%2BF.%26aulast%3DCao%26aufirst%3DX.%2BD.%26aulast%3DChang%26aufirst%3DJ.%2BC.%26atitle%3DOverexpression%2520of%2520NUAK1%2520Is%2520Associated%2520with%2520Disease-Free%2520Survival%2520and%2520Overall%2520Survival%2520in%2520Patients%2520with%2520Gastric%2520Cancer%26jtitle%3DMed.%2520Oncol.%26date%3D2014%26volume%3D31%26spage%3D61%26doi%3D10.1007%2Fs12032-014-0061-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Port, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthalagu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceteci, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteverde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruspig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalna, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neilson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brucoli, M.</span></span> <span> </span><span class="NLM_article-title">Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">632</span>– <span class="NLM_lpage">647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1158%2F2159-8290.CD-17-0533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=29500295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1cXos1SjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=632-647&author=J.+Portauthor=N.+Muthalaguauthor=M.+Rajaauthor=F.+Ceteciauthor=T.+Monteverdeauthor=B.+Kruspigauthor=A.+Hedleyauthor=G.+Kalnaauthor=S.+Lillaauthor=L.+Neilsonauthor=M.+Brucoli&title=Colorectal+Tumors+Require+NUAK1+for+Protection+from+Oxidative+Stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress</span></div><div class="casAuthors">Port, Jennifer; Muthalagu, Nathiya; Raja, Meera; Ceteci, Fatih; Monteverde, Tiziana; Kruspig, Bjorn; Hedley, Ann; Kalna, Gabriela; Lilla, Sergio; Neilson, Lisa; Brucoli, Martina; Gyuraszova, Katarina; Tait-Mulder, Jacqueline; Mezna, Mokdad; Svambaryte, Silvija; Bryson, Amy; Sumpton, David; McVie, Allan; Nixon, Colin; Drysdale, Martin; Esumi, Hiroyasu; Murray, Graeme I.; Sansom, Owen J.; Zanivan, Sara R.; Murphy, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">632-647</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Exploiting oxidative stress has recently emerged as a plausible strategy for treatment of human cancer, and antioxidant defenses are implicated in resistance to chemotherapy and radiotherapy.  Targeted suppression of antioxidant defenses could thus broadly improve therapeutic outcomes.  Here, we identify the AMPK-related kinase NUAK1 as a key component of the antioxidant stress response pathway and reveal a specific requirement for this role of NUAK1 in colorectal cancer.  We show that NUAK1 is activated by oxidative stress and that this activation is required to facilitate nuclear import of the antioxidant master regulator NRF2: Activation of NUAK1 coordinates PP1β inhibition with AKT activation in order to suppress GSK3β-dependent inhibition of NRF2 nuclear import.  Deletion of NUAK1 suppresses formation of colorectal tumors, whereas acute depletion of NUAK1 induces regression of preexisting autochthonous tumors.  Importantly, elevated expression of NUAK1 in human colorectal cancer is assocd. with more aggressive disease and reduced overall survival.  This work identifies NUAK1 as a key facilitator of the adaptive antioxidant response that is assocd. with aggressive disease and worse outcome in human colorectal cancer.  Our data suggest that transient NUAK1 inhibition may provide a safe and effective means for treatment of human colorectal cancer via disruption of intrinsic antioxidant defenses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro4vE7jlxJIbVg90H21EOLACvtfcHk0lg3xotXFb6O5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXos1SjtrY%253D&md5=9daed7a74b5f189cac705961ce406373</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-17-0533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-17-0533%26sid%3Dliteratum%253Aachs%26aulast%3DPort%26aufirst%3DJ.%26aulast%3DMuthalagu%26aufirst%3DN.%26aulast%3DRaja%26aufirst%3DM.%26aulast%3DCeteci%26aufirst%3DF.%26aulast%3DMonteverde%26aufirst%3DT.%26aulast%3DKruspig%26aufirst%3DB.%26aulast%3DHedley%26aufirst%3DA.%26aulast%3DKalna%26aufirst%3DG.%26aulast%3DLilla%26aufirst%3DS.%26aulast%3DNeilson%26aufirst%3DL.%26aulast%3DBrucoli%26aufirst%3DM.%26atitle%3DColorectal%2520Tumors%2520Require%2520NUAK1%2520for%2520Protection%2520from%2520Oxidative%2520Stress%26jtitle%3DCancer%2520Discovery%26date%3D2018%26volume%3D8%26spage%3D632%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carninci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasukawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katayama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frith, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravasi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenhard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, C.</span></span> <span> </span><span class="NLM_article-title">The Transcriptional Landscape of the Mammalian Genome</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>309</i></span>,  <span class="NLM_fpage">1559</span>– <span class="NLM_lpage">1563</span>, <span class="refDoi"> DOI: 10.1126/science.1112014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1126%2Fscience.1112014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=16141072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFWju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2005&pages=1559-1563&author=P.+Carninciauthor=T.+Kasukawaauthor=S.+Katayamaauthor=J.+Goughauthor=M.+C.+Frithauthor=N.+Maedaauthor=R.+Oyamaauthor=T.+Ravasiauthor=B.+Lenhardauthor=C.+Wells&title=The+Transcriptional+Landscape+of+the+Mammalian+Genome&doi=10.1126%2Fscience.1112014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">The transcriptional landscape of the mammalian genome</span></div><div class="casAuthors">Carninci, P.; Kasukawa, T.; Katayama, S.; Gough, J.; Frith, M. C.; Maeda, N.; Oyama, R.; Ravasi, T.; Lenhard, B.; Wells, C.; Kodzius, R.; Shimokawa, K.; Bajic, V. B.; Brenner, S. E.; Batalov, S.; Forrest, A. R. R.; Zavolan, M.; Davis, M. J.; Wilming, L. G.; Aidinis, V.; Allen, J. E.; Ambesi-Impiombato, A.; Apweiler, R.; Aturaliya, R. N.; Bailey, T. L.; Bansal, M.; Baxter, L.; Beisel, K. W.; Bersano, T.; Bono, H.; Chalk, A. M.; Chiu, K. P.; Choudhary, V.; Christoffels, A.; Clutterbuck, D. R.; Crowe, L.; Dalla, E.; Dalrymple, B. P.; de Bono, B.; Della Gatta, G.; di Bernardo, D.; Down, T.; Engstrom, P.; Fagiolini, M.; Faulkner, G.; Fletcher, C. F.; Fukushima, T.; Furuno, M.; Futaki, S.; Gariboldi, M.; Georgii-Hemming, P.; Gingeras, T. R.; Gojobori, Y.; Green, R. E.; Gustincich, S.; Harbers, M.; Hayashi, Y.; Hensch, T. K.; Hirokawa, N.; Hill, D.; Huminiecki, L.; Iacono, M.; Ikeo, K.; Iwama, A.; Ishikawa, T.; Jakt, M.; Kanapin, A.; Katoh, M.; Kawasawa, Y.; Kelso, J.; Kitamura, H.; Kitano, H.; Kollias, G.; Krishnan, S. P. T.; Kruger, A.; Kummerfeld, S. K.; Kurochkin, I. V.; Lareau, L. F.; Lazarevic, D.; Lipovich, L.; Liu, J.; Liuni, S.; McWilliam, S.; Mada Babu, M.; Madera, M.; Marchionni, L.; Matsuda, H.; Matsuzawa, S.; Miki, H.; Miyake, S.; Morris, K.; Mottagui-Tabar, S.; Mulder, N.; Nakano, N.; Nakauchi, H.; Ng, P.; Nilsson, R.; Nishiguchi, S.; Nishikawa, S.; Nori, F.; Ohara, O.; Okazaki, Y.; Orlando, V.; Pang, K. C.; Pavan, W. J.; Pavesi, G.; Pesole, G.; Petrovsky, N.; Piazza, S.; Reed, J.; Reid, J. F.; Ring, B. Z.; Ringwald, M.; Rost, B.; Ruan, Y.; Salzberg, S. L.; Sandelin, A.; Schneider, C.; Schooenbach, C.; Sekiguchi, K.; Semple, C. A. M.; Seno, S.; Sessa, L.; Sheng, Y.; Shibata, Y.; Shimada, H.; Shimada, K.; Silva, D.; Sinclair, B.; Sperling, S.; Stupka, E.; Sugiura, K.; Sultana, R.; Takenaka, Y.; Taki, K.; Tammoja, K.; Tan, S. L.; Tang, S.; Tayloor, M. S.; Tegner, J.; Teichmann, S. A.; Ueda, H. R.; van Nimwegen, E.; Verado, R.; Wei, C. L.; Yagi, K.; Yamanishi, H.; Zabarovsky, E.; Zhu, S.; Zimmer, A.; Hide, W.; Bult, C.; Grimmond, S. M.; Teasdale, R. D.; Liu, E. T.; Brusic, V.; Quackenbush, J.; Wahlestedt, C.; Mattick, J. S.; Hume, D. A.; Kai, C.; Sasaki, D.; Tomaru, Y.; Fukuda, S.; Kanamori-Katayama, M.; Suzuki, M.; Aoki, J.; Arakawa, T.; Iida, J.; Imamura, K.; Itoh, M.; Kato, T.; Kawaji, H.; Kawagashira, N.; Kawashima, T.; Kojima, M.; Kondon, S.; Konno, H.; Nakano, K.; Ninomiya, N.; Nishio, T.; Okada, M.; Plessy, C.; Shibata, K.; Shiraki, T.; Suzuki, S.; Tagami, M.; Waki, K.; Watahiki, A.; Okamura-Oho, Y.; Suzuki, H.; Kawai, J.; Hayashizaki, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">5740</span>),
    <span class="NLM_cas:pages">1559-1563</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">This study describes comprehensive polling of transcription start and termination sites and anal. of previously unidentified full-length cDNAs derived from the mouse genome.  The 5' and 3' boundaries of 181,047 transcripts were identified, with extensive variation in transcripts arising from alternative promoter usage, splicing, and polyadenylation.  There were 16,247 new mouse protein-coding transcripts, including 5154 encoding previously unidentified proteins.  Genomic mapping of the transcriptome reveals transcriptional forests, with overlapping transcription on both strands, sepd. by deserts in which few transcripts are obsd.  The data provide a comprehensive platform for the comparative anal. of mammalian transcriptional regulation in differentiation and development.  The authors deposited 284,372 expressed sequence tags in GenBank/EMBL/DDBJ with accession nos. CJ039836-CJ326805 as well as 101,789 high-throughput cDNA sequences deposited with accession nos. AK002213-AK172723.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT0WgTu5-dUrVg90H21EOLACvtfcHk0lhoGnV1oxtUCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFWju7o%253D&md5=46a88549d94e9dd403e277e698f5635e</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1126%2Fscience.1112014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1112014%26sid%3Dliteratum%253Aachs%26aulast%3DCarninci%26aufirst%3DP.%26aulast%3DKasukawa%26aufirst%3DT.%26aulast%3DKatayama%26aufirst%3DS.%26aulast%3DGough%26aufirst%3DJ.%26aulast%3DFrith%26aufirst%3DM.%2BC.%26aulast%3DMaeda%26aufirst%3DN.%26aulast%3DOyama%26aufirst%3DR.%26aulast%3DRavasi%26aufirst%3DT.%26aulast%3DLenhard%26aufirst%3DB.%26aulast%3DWells%26aufirst%3DC.%26atitle%3DThe%2520Transcriptional%2520Landscape%2520of%2520the%2520Mammalian%2520Genome%26jtitle%3DScience%26date%3D2005%26volume%3D309%26spage%3D1559%26epage%3D1563%26doi%3D10.1126%2Fscience.1112014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, T.</span></span> <span> </span><span class="NLM_article-title">Finally, a Sense of Closure? Animal Models of Human Ventral Body Wall Defects</span>. <i>BioEssays</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1307</span>– <span class="NLM_lpage">1321</span>, <span class="refDoi"> DOI: 10.1002/bies.20137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1002%2Fbies.20137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15551266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BD2croslyjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2004&pages=1307-1321&author=S.+Brewerauthor=T.+Williams&title=Finally%2C+a+Sense+of+Closure%3F+Animal+Models+of+Human+Ventral+Body+Wall+Defects&doi=10.1002%2Fbies.20137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Finally, a sense of closure? Animal models of human ventral body wall defects</span></div><div class="casAuthors">Brewer Stephanie; Williams Trevor</div><div class="citationInfo"><span class="NLM_cas:title">BioEssays : news and reviews in molecular, cellular and developmental biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1307-21</span>
        ISSN:<span class="NLM_cas:issn">0265-9247</span>.
    </div><div class="casAbstract">Malformations concerning the ventral body wall constitute one of the leading categories of human birth defects and are present in about one out of every 2000 live births.  Although the occurrence of these defects is relatively common, few detailed experimental studies exist on the development and closure of the ventral body wall in mouse and human.  This field is further complicated by the array of theories on the pathogenesis of body wall defects and the likelihood that there is no single cause for these abnormalities.  In this review, we summarize what is known concerning the mechanisms of normal ventral body wall closure in humans and mice.  We then outline the theories that have been proposed concerning human body wall closure abnormalities and examine the growing number of mouse mutations that impact normal ventral body wall closure.  Finally, we speculate how studies in animal models such as mouse and Drosophila are beginning to provide a much-needed mechanistic framework with which to identify and characterize the genes and tissues required for this vital aspect of human embryogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-668qJqWD93WEEzDrymxmfW6udTcc2ebhISdpm6hZTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2croslyjtw%253D%253D&md5=88aa0d381a6acc56858b91e63c9b869b</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1002%2Fbies.20137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbies.20137%26sid%3Dliteratum%253Aachs%26aulast%3DBrewer%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DT.%26atitle%3DFinally%252C%2520a%2520Sense%2520of%2520Closure%253F%2520Animal%2520Models%2520of%2520Human%2520Ventral%2520Body%2520Wall%2520Defects%26jtitle%3DBioEssays%26date%3D2004%26volume%3D26%26spage%3D1307%26epage%3D1321%26doi%3D10.1002%2Fbies.20137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yatsenko, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Londono, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmont, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, L. G.</span></span> <span> </span><span class="NLM_article-title">Omphalocele in Trisomy 3q: Further Delineation of Phenotype</span>. <i>Clin. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">404</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1034/j.1399-0004.2003.00159.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1034%2Fj.1399-0004.2003.00159.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=14616763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BD3srks1yktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=404-413&author=S.+A.+Yatsenkoauthor=R.+Mendoza-Londonoauthor=J.+W.+Belmontauthor=L.+G.+Shaffer&title=Omphalocele+in+Trisomy+3q%3A+Further+Delineation+of+Phenotype&doi=10.1034%2Fj.1399-0004.2003.00159.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Omphalocele in trisomy 3q: further delineation of phenotype</span></div><div class="casAuthors">Yatsenko S A; Mendoza-Londono R; Belmont J W; Shaffer L G</div><div class="citationInfo"><span class="NLM_cas:title">Clinical genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">404-13</span>
        ISSN:<span class="NLM_cas:issn">0009-9163</span>.
    </div><div class="casAbstract">We report a case of a patient with omphalocele, dysmorphic features, and mild developmental delay associated with a chromosomal aberration.  Chromosome studies showed that the propositus carries a maternally derived unbalanced translocation der(4)t(3;4)(q27.3;q32.3), resulting in trisomy for region 3q27.3-->qter and monosomy for 4q32.3-->qter.  Because the association between dup3q and omphalocele has been reported in several cases, we analyzed the data on 93 previously reported patients with partial trisomy of the long arm of chromosome 3 and compared the clinical features between the cases.  The imbalance of chromosome 3 in the patient was further defined by fluorescence in situ hybridization (FISH) studies using bacterial artificial chromosome (BAC) clones.  BAC clone RP11-171N2 was identified as a breakpoint-spanning clone in the patient and his mother.  Based on our comparative analysis, we have delineated that the smallest region of overlap (SRO) associated with omphalocele is from BAC 171N2 to 3qter.  We hypothesize that the SRO contains a gene(s) important in normal abdominal wall development and is of potential interest for further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlwdlUP_XxQz0SWnHPWbmmfW6udTcc2ebhISdpm6hZTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srks1yktQ%253D%253D&md5=531a2fb0cf771c3825b82581fb912661</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1034%2Fj.1399-0004.2003.00159.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1399-0004.2003.00159.x%26sid%3Dliteratum%253Aachs%26aulast%3DYatsenko%26aufirst%3DS.%2BA.%26aulast%3DMendoza-Londono%26aufirst%3DR.%26aulast%3DBelmont%26aufirst%3DJ.%2BW.%26aulast%3DShaffer%26aufirst%3DL.%2BG.%26atitle%3DOmphalocele%2520in%2520Trisomy%25203q%253A%2520Further%2520Delineation%2520of%2520Phenotype%26jtitle%3DClin.%2520Genet.%26date%3D2003%26volume%3D64%26spage%3D404%26epage%3D413%26doi%3D10.1034%2Fj.1399-0004.2003.00159.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kanagawa, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begleiter, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostlie, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holcomb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M. G.</span></span> <span> </span><span class="NLM_article-title">Omphalocele in Three Generations with Autosomal Dominant Transmission</span>. <i>J. Med. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1136/jmg.39.3.184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1136%2Fjmg.39.3.184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=11897819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BD387otFSisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2002&pages=184-185&author=S.+L.+Kanagawaauthor=M.+L.+Begleiterauthor=D.+J.+Ostlieauthor=G.+Holcombauthor=W.+Drakeauthor=M.+G.+Butler&title=Omphalocele+in+Three+Generations+with+Autosomal+Dominant+Transmission&doi=10.1136%2Fjmg.39.3.184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Omphalocele in three generations with autosomal dominant transmission</span></div><div class="casAuthors">Kanagawa S L; Begleiter M L; Ostlie D J; Holcomb G; Drake W; Butler M G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medical genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">184-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We report a family with nine subjects over three generations affected with an omphalocele requiring surgical intervention within the first few days of life.  Because of the vertical transmission and male to male inheritance in our family, we conclude that an autosomal dominant gene caused the omphalocele in the affected family members.  The paternal great grandfather of the proband was not clinically affected but produced two children with omphaloceles with different spouses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRKFp1XBEwBwIFEOhA_Im3cfW6udTcc2eao3sW89XMYybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387otFSisw%253D%253D&md5=5228c5d342e56c0485a7e0385f27ecf0</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1136%2Fjmg.39.3.184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjmg.39.3.184%26sid%3Dliteratum%253Aachs%26aulast%3DKanagawa%26aufirst%3DS.%2BL.%26aulast%3DBegleiter%26aufirst%3DM.%2BL.%26aulast%3DOstlie%26aufirst%3DD.%2BJ.%26aulast%3DHolcomb%26aufirst%3DG.%26aulast%3DDrake%26aufirst%3DW.%26aulast%3DButler%26aufirst%3DM.%2BG.%26atitle%3DOmphalocele%2520in%2520Three%2520Generations%2520with%2520Autosomal%2520Dominant%2520Transmission%26jtitle%3DJ.%2520Med.%2520Genet.%26date%3D2002%26volume%3D39%26spage%3D184%26epage%3D185%26doi%3D10.1136%2Fjmg.39.3.184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thumkeo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narumiya, S.</span></span> <span> </span><span class="NLM_article-title">ROCK-I and ROCK-II Cooperatively Regulate Closure of Eyelid and Ventral Body Wall in Mouse Embryo</span>. <i>Genes Cells</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">825</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2443.2005.00882.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1111%2Fj.1365-2443.2005.00882.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=16098146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFKktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=825-834&author=D.+Thumkeoauthor=Y.+Shimizuauthor=S.+Sakamotoauthor=S.+Yamadaauthor=S.+Narumiya&title=ROCK-I+and+ROCK-II+Cooperatively+Regulate+Closure+of+Eyelid+and+Ventral+Body+Wall+in+Mouse+Embryo&doi=10.1111%2Fj.1365-2443.2005.00882.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">ROCK-I and ROCK-II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo</span></div><div class="casAuthors">Thumkeo, Dean; Shimizu, Yoshihiko; Sakamoto, Satoko; Yamada, Shuichi; Narumiya, Shuh</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">825-834</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Rho-assocd. kinase (ROCK) is a serine/threonine kinase working in the Rho signaling to actin cytoskeleton.  We previously reported that loss of ROCK-I results in the eyelid open at birth (EOB) and omphalocele phenotype in mice, while loss of ROCK-II results in placental dysfunction leading to intrauterine growth retardation and fetal death.  Here, we report that after backcross to the C57BL/6 N genetic background, ROCK-II knockout (KO) neonates are born also with open eyelid and umbilical hernia, a phenotype similar to that of ROCK-I KO mice.  ROCK-II KO embryos show impaired extension of the eyelid epithelial sheet with disorganized actin bundles in the leading edge of the sheet.  These results suggest that ROCK-I and ROCK-II cooperatively regulates the assembly of actin bundles essential for closure of the eyelid and ventral body wall in mouse embryos.  Consistently, ROCK-I+/-ROCK-II+/- double heterozygous mice also show the EOB and omphalocele phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp58JoKdv8tArVg90H21EOLACvtfcHk0ljCTevN3OhJ6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFKktL8%253D&md5=e81d1e34ab18f4615db2e18c45b05bac</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2443.2005.00882.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2443.2005.00882.x%26sid%3Dliteratum%253Aachs%26aulast%3DThumkeo%26aufirst%3DD.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DNarumiya%26aufirst%3DS.%26atitle%3DROCK-I%2520and%2520ROCK-II%2520Cooperatively%2520Regulate%2520Closure%2520of%2520Eyelid%2520and%2520Ventral%2520Body%2520Wall%2520in%2520Mouse%2520Embryo%26jtitle%3DGenes%2520Cells%26date%3D2005%26volume%3D10%26spage%3D825%26epage%3D834%26doi%3D10.1111%2Fj.1365-2443.2005.00882.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani-Koseki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koseki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span> <span> </span><span class="NLM_article-title">Requirement for Mab21l2 during Development of Murine Retina and Ventral Body Wall</span>. <i>Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">307</span>, <span class="refDoi"> DOI: 10.1016/j.ydbio.2004.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.ydbio.2004.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15385160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVyru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=2004&pages=295-307&author=R.+Yamadaauthor=Y.+Mizutani-Kosekiauthor=H.+Kosekiauthor=N.+Takahashi&title=Requirement+for+Mab21l2+during+Development+of+Murine+Retina+and+Ventral+Body+Wall&doi=10.1016%2Fj.ydbio.2004.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for Mab21l2 during development of murine retina and ventral body wall</span></div><div class="casAuthors">Yamada, Ryuichi; Mizutani-Koseki, Yoko; Koseki, Haruhiko; Takahashi, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Biology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-307</span>CODEN:
                <span class="NLM_cas:coden">DEBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0012-1606</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The mab-21 gene was first identified because of its requirement for ray identity specification in Caenorhabditis elegans.  It is now known to constitute a family of genes that are highly conserved from vertebrates to invertebrates, and two homologs Mab21l1 and Mab21l2 have been identified in many species.  Here the authors describe the generation of Mab21l2-deficient mice, which have defects in eye and body wall formation.  The mutant mouse eye has a rudimentary retina, as a result of insufficient invagination of the optic vesicle due to deficient proliferation, causing the absence of lens.  The defects in optic vesicle development correlate with reduced expression of Chx10, which is also required for retina development; Rx, Lhx2, and Pax6 expression is not significantly affected.  The authors conclude that Mab21l2 expression is essential for optic vesicle growth and formation of the optic cup, its absence causing reduced expression of Chx10.  Mutant mice also display abnormal extrusion of abdominal organs, defects in ventral body wall formation, resulting in death in utero at mid-gestational stage.  The authors' results reveal that Mab21l2 plays crucial roles in retina and in ventral body wall formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol8K5T6h8SdbVg90H21EOLACvtfcHk0ljCTevN3OhJ6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVyru7g%253D&md5=9b4db8bc08dcc19b7796378e0415d408</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.ydbio.2004.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ydbio.2004.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DR.%26aulast%3DMizutani-Koseki%26aufirst%3DY.%26aulast%3DKoseki%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DN.%26atitle%3DRequirement%2520for%2520Mab21l2%2520during%2520Development%2520of%2520Murine%2520Retina%2520and%2520Ventral%2520Body%2520Wall%26jtitle%3DDev.%2520Biol.%26date%3D2004%26volume%3D274%26spage%3D295%26epage%3D307%26doi%3D10.1016%2Fj.ydbio.2004.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dünker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krieglstein, K.</span></span> <span> </span><span class="NLM_article-title">Tgfβ2–/–Tgfβ3–/– Double Knockout Mice Display Severe Midline Fusion Defects and Early Embryonic Lethality</span>. <i>Anat. Embryol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>206</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1007/s00429-002-0273-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1007%2Fs00429-002-0273-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=12478370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVSis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2002&pages=73-83&author=N.+D%C3%BCnkerauthor=K.+Krieglstein&title=Tgf%CE%B22%E2%80%93%2F%E2%80%93Tgf%CE%B23%E2%80%93%2F%E2%80%93+Double+Knockout+Mice+Display+Severe+Midline+Fusion+Defects+and+Early+Embryonic+Lethality&doi=10.1007%2Fs00429-002-0273-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Tgfβ2-/-Tgfβ3-/- double knockout mice display severe midline fusion defects and early embryonic lethality</span></div><div class="casAuthors">Duenker, Nicole; Krieglstein, Kerstin</div><div class="citationInfo"><span class="NLM_cas:title">Anatomy and Embryology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">73-83</span>CODEN:
                <span class="NLM_cas:coden">ANEMDG</span>;
        ISSN:<span class="NLM_cas:issn">0340-2061</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Given all known biol. activities, it is anticipated that transforming growth factors beta (TGF-βs) play important roles in many different developmental processes.  As all three TGF-β isoforms display overlapping expression patterns, deletion of one TGF-β isoform might be compensated for by another.  In the present study, targeted disruption of both Tgfβ2 and Tgfβ3 genes was undertaken to circumvent this question and det. the essential roles of TGF-β2 and TGF-β3 in vivo.  Tgfβ2-/-Tgfβ3-/- double knockout mice and their three-allelic Tgfβ2-/-Tgfβ3+/- littermates display a lack of distal parts of the rib, a lack of sternal primordia, and failure in ventral body wall closure, leading to an extrathoracic position of the heart and extrusion of the liver.  In addn., abnormalities in connective tissue compn. and an early embryonic lethality [around embryonic day (E) 15.5] are seen.  In contrast, Tgfβ2+/-Tgfβ3-/- littermates show normal rib and sternum development, normal anterior body wall fusion, and are still alive on E18.5.  TGF-β2 is already known to play a role in skeletal and craniofacial development.  The results presented here show that beyond this: (a) TGF-βs obviously play a fundamental role in midline fusion and (b) the Tgfβ2 gene seems to play a more important role in mediating developmental processes than the Tgfβ3 gene, since Tgfβ2+/-Tgfβ3-/- mutants - in contrast to their Tgfβ2-/-Tgfβ3+/- littermates - do not display severe malformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFIeTONsBVcrVg90H21EOLACvtfcHk0ljOKsD8j4bsaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVSis7c%253D&md5=1c680d577053bbdf23c885103ddb1640</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1007%2Fs00429-002-0273-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00429-002-0273-6%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25BCnker%26aufirst%3DN.%26aulast%3DKrieglstein%26aufirst%3DK.%26atitle%3DTgf%25CE%25B22%25E2%2580%2593%252F%25E2%2580%2593Tgf%25CE%25B23%25E2%2580%2593%252F%25E2%2580%2593%2520Double%2520Knockout%2520Mice%2520Display%2520Severe%2520Midline%2520Fusion%2520Defects%2520and%2520Early%2520Embryonic%2520Lethality%26jtitle%3DAnat.%2520Embryol.%26date%3D2002%26volume%3D206%26spage%3D73%26epage%3D83%26doi%3D10.1007%2Fs00429-002-0273-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manley, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrow, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capecchi, M. R.</span></span> <span> </span><span class="NLM_article-title">Hoxb2 and Hoxb4 Act Together to Specify Ventral Body Wall Formation</span>. <i>Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>237</i></span>,  <span class="NLM_fpage">130</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1006/dbio.2001.0365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1006%2Fdbio.2001.0365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=11518511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtFGgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=2001&pages=130-144&author=N.+R.+Manleyauthor=J.+R.+Barrowauthor=T.+Zhangauthor=M.+R.+Capecchi&title=Hoxb2+and+Hoxb4+Act+Together+to+Specify+Ventral+Body+Wall+Formation&doi=10.1006%2Fdbio.2001.0365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Hoxb2 and Hoxb4 Act Together to Specify Ventral Body Wall Formation</span></div><div class="casAuthors">Manley, Nancy R.; Barrow, Jeffery R.; Zhang, Tianshu; Capecchi, Mario R.</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Biology (Orlando, FL, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">130-144</span>CODEN:
                <span class="NLM_cas:coden">DEBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0012-1606</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Three different alleles of the Hoxb4 locus were generated by gene targeting in mice.  Two alleles contain insertions of a selectable marker in the first exon in either orientation, and, in the third, the selectable marker was removed, resulting in premature termination of the protein.  Presence and orientation of the selectable marker correlated with the severity of the phenotype, indicating that the selectable marker induces cis effects on neighboring genes that influence the phenotype.  Homozygous mutants of all alleles had cervical skeletal defects similar to those previously reported for Hoxb4 mutant mice.  In the most severe allele, Hoxb4PolII, homozygous mutants died either in utero at approx. E15.5 or immediately after birth, with a severe defect in ventral body wall formation.  Anal. of embryos showed thinning of the primary ventral body wall in mutants relative to control animals at E11.5, before secondary body wall formation.  Prior to this defect, both Alx3 and Alx4 were specifically down regulated in the most ventral part of the primary body wall in Hoxb4PolII mutants.  Hoxb4loxp mutants in which the neo gene has been removed did not have body wall or sternum defects.  In contrast, both the Hoxb4PolII and the previously described Hoxb2PolII alleles that have body wall defects have been shown to disrupt the expression of both Hoxb2 and Hoxb4 in cell types that contribute to body wall formation.  Our results are consistent with a model in which defects in ventral body wall formation require the simultaneous loss of at least Hoxb2 and Hoxb4, and may involve Alx3 and Alx4.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLYPqleAxTu7Vg90H21EOLACvtfcHk0ljOKsD8j4bsaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtFGgtr8%253D&md5=131767c3951c39e14bc381661785f738</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1006%2Fdbio.2001.0365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fdbio.2001.0365%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DN.%2BR.%26aulast%3DBarrow%26aufirst%3DJ.%2BR.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DCapecchi%26aufirst%3DM.%2BR.%26atitle%3DHoxb2%2520and%2520Hoxb4%2520Act%2520Together%2520to%2520Specify%2520Ventral%2520Body%2520Wall%2520Formation%26jtitle%3DDev.%2520Biol.%26date%3D2001%26volume%3D237%26spage%3D130%26epage%3D144%26doi%3D10.1006%2Fdbio.2001.0365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, T.</span></span> <span> </span><span class="NLM_article-title">Loss of AP-2α Impacts Multiple Aspects of Ventral Body Wall Development and Closure</span>. <i>Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">417</span>, <span class="refDoi"> DOI: 10.1016/j.ydbio.2003.11.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.ydbio.2003.11.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15013802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvV2hsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2004&pages=399-417&author=S.+Brewerauthor=T.+Williams&title=Loss+of+AP-2%CE%B1+Impacts+Multiple+Aspects+of+Ventral+Body+Wall+Development+and+Closure&doi=10.1016%2Fj.ydbio.2003.11.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of AP-2α impacts multiple aspects of ventral body wall development and closure</span></div><div class="casAuthors">Brewer, Stephanie; Williams, Trevor</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Biology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">399-417</span>CODEN:
                <span class="NLM_cas:coden">DEBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0012-1606</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Human birth defects involving the ventral body wall are common, yet little is known about the mechanism of body wall closure in mammals.  The AP-2α transcription factor knock-out mouse provides an exceptional tool to understand this particular pathol., since it has one of the most severe ventral body wall closure defects, thoracoabdominoschisis.  To gain insight into the complex morphol. events responsible for body wall closure, the authors have studied this developmental process in AP-2α knock-out mice.  Several tissues involved in normal ventral body wall closure are defective in the absence of AP-2α, including those assocd. with the primary body wall, the umbilical ring, and the mesoderm of the secondary body wall.  These defects, coupled with the expression pattern of AP-2α, suggest that AP-2α is involved in multiple developmental mechanisms directing the morphogenesis of the ventral body wall, including cell migration, differentiation, and death.  There is a failure of migration and fusion of the body folds at the umbilical ring, as well as in the formation and migration of the abdominal bands and ventral musculature.  Furthermore, the mechanism of cell deposition at the umbilical ring is disturbed.  Consequently, the mesodermal compartment of the body wall is underdeveloped.  The authors also suggest that AP-2α is required for signaling from the surface ectoderm to the underlying mesoderm for proper development and closure of the ventral body wall.  These findings provide a fundamental understanding of how AP-2α functions in the closure of the ventral body wall, as well as offer insight into related human birth defects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotqGUSVE3aDbVg90H21EOLACvtfcHk0ljOKsD8j4bsaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvV2hsbc%253D&md5=deb67affad1eb2565e9aa2fd280ca44f</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.ydbio.2003.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ydbio.2003.11.021%26sid%3Dliteratum%253Aachs%26aulast%3DBrewer%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DT.%26atitle%3DLoss%2520of%2520AP-2%25CE%25B1%2520Impacts%2520Multiple%2520Aspects%2520of%2520Ventral%2520Body%2520Wall%2520Development%2520and%2520Closure%26jtitle%3DDev.%2520Biol.%26date%3D2004%26volume%3D267%26spage%3D399%26epage%3D417%26doi%3D10.1016%2Fj.ydbio.2003.11.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riester, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culhane, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trippa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-h.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michor, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huttenhower, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmigiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birrer, M. J.</span></span> <span> </span><span class="NLM_article-title">Risk Prediction for Late-Stage Ovarian Cancer by Meta-Analysis of 1525 Patient Samples</span>. <i>JNCI J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>106</i></span>, <span class="NLM_elocation-id">dju048</span> <span class="refDoi"> DOI: 10.1093/jnci/dju048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1093%2Fjnci%2Fdju048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=24700803" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2014&author=M.+Riesterauthor=W.+Weiauthor=L.+Waldronauthor=A.+C.+Culhaneauthor=L.+Trippaauthor=E.+Olivaauthor=S.-h.+Kimauthor=F.+Michorauthor=C.+Huttenhowerauthor=G.+Parmigianiauthor=M.+J.+Birrer&title=Risk+Prediction+for+Late-Stage+Ovarian+Cancer+by+Meta-Analysis+of+1525+Patient+Samples&doi=10.1093%2Fjnci%2Fdju048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdju048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdju048%26sid%3Dliteratum%253Aachs%26aulast%3DRiester%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DWaldron%26aufirst%3DL.%26aulast%3DCulhane%26aufirst%3DA.%2BC.%26aulast%3DTrippa%26aufirst%3DL.%26aulast%3DOliva%26aufirst%3DE.%26aulast%3DKim%26aufirst%3DS.-h.%26aulast%3DMichor%26aufirst%3DF.%26aulast%3DHuttenhower%26aufirst%3DC.%26aulast%3DParmigiani%26aufirst%3DG.%26aulast%3DBirrer%26aufirst%3DM.%2BJ.%26atitle%3DRisk%2520Prediction%2520for%2520Late-Stage%2520Ovarian%2520Cancer%2520by%2520Meta-Analysis%2520of%25201525%2520Patient%2520Samples%26jtitle%3DJNCI%2520J.%2520Natl.%2520Cancer%2520Inst.%26date%3D2014%26volume%3D106%26doi%3D10.1093%2Fjnci%2Fdju048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phippen, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrads, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, P.-n.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litzi, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcy, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrads, T. P.</span></span> <span> </span><span class="NLM_article-title">NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">213</span>, <span class="refDoi"> DOI: 10.3389/fonc.2016.00213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.3389%2Ffonc.2016.00213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=27833898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BC2snltVOisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=213&author=N.+T.+Phippenauthor=N.+W.+Batemanauthor=G.+Wangauthor=K.+A.+Conradsauthor=W.+Aoauthor=P.-n.+Tengauthor=T.+A.+Litziauthor=J.+Oliverauthor=G.+L.+Maxwellauthor=C.+A.+Hamiltonauthor=K.+M.+Darcyauthor=T.+P.+Conrads&title=NUAK1+%28ARK5%29+Is+Associated+with+Poor+Prognosis+in+Ovarian+Cancer&doi=10.3389%2Ffonc.2016.00213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer</span></div><div class="casAuthors">Phippen Neil T; Bateman Nicholas W; Darcy Kathleen M; Wang Guisong; Conrads Kelly A; Ao Wei; Teng Pang-Ning; Litzi Tracy A; Oliver Julie; Maxwell G Larry; Hamilton Chad A; Conrads Thomas P</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">213</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">BACKGROUND AND OBJECTIVE:  Nua kinase 1 (NUAK1) was identified in multigene signatures of survival and suboptimal debulking in high-grade serous ovarian cancer (HGSOC).  This study investigates the individual clinical and biologic contributions of NUAK1 in HGSOC patients and cell lines.  METHODS:  Public transcript expression, clinical, and outcome data were used to interrogate the relationship between NUAK1 and clinicopathologic factors and patient outcomes including progression-free survival (PFS) and molecular subtypes using logistic and Cox modeling.  Analysis of NUAK1 transcript expression was performed in primary tumors from 34 HGSOC patients with < or ≥2 years PFS.  The impact of silencing NUAK1 by RNA interference (RNAi) on the migratory potential and chemosensitivity of SOC cells was assessed in vitro.  RESULTS:  Elevated NUAK1 transcript expression was associated with worse PFS (hazard ratio = 1.134), advanced stage (odds ratio, OR = 1.7), any residual disease (OR = 1.58), and mesenchymal disease subtype (OR = 7.79 ± 5.89).  Elevated NUAK1 transcript expression was observed in HGSOC patients with < vs. ≥2 years PFS (p < 0.045).  RNAi-mediated silencing of NUAK1 expression attenuated migration of OV90 and E3 HGSOC cells in vitro, but did not modulate sensitivity to cisplatin or paclitaxel.  CONCLUSION:  Elevated NUAK1 was associated with poor survival as well as advanced stage, residual disease after cytoreductive surgery and mesenchymal molecular subtype.  NUAK1 impacted migration, but not chemosensitivity, in vitro.  Additional studies are needed to further develop the concept of NUAK1 as a clinically deployable biomarker and therapeutic target in HGSOC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJulYHhsNcnZPlX7E30qdzfW6udTcc2eZ4KYf04Q8xF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snltVOisw%253D%253D&md5=0c85b51bab3368831b39b27f314631a1</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2016.00213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2016.00213%26sid%3Dliteratum%253Aachs%26aulast%3DPhippen%26aufirst%3DN.%2BT.%26aulast%3DBateman%26aufirst%3DN.%2BW.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DConrads%26aufirst%3DK.%2BA.%26aulast%3DAo%26aufirst%3DW.%26aulast%3DTeng%26aufirst%3DP.-n.%26aulast%3DLitzi%26aufirst%3DT.%2BA.%26aulast%3DOliver%26aufirst%3DJ.%26aulast%3DMaxwell%26aufirst%3DG.%2BL.%26aulast%3DHamilton%26aufirst%3DC.%2BA.%26aulast%3DDarcy%26aufirst%3DK.%2BM.%26aulast%3DConrads%26aufirst%3DT.%2BP.%26atitle%3DNUAK1%2520%2528ARK5%2529%2520Is%2520Associated%2520with%2520Poor%2520Prognosis%2520in%2520Ovarian%2520Cancer%26jtitle%3DFront.%2520Oncol.%26date%3D2016%26volume%3D6%26spage%3D213%26doi%3D10.3389%2Ffonc.2016.00213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. R.</span></span> <span> </span><span class="NLM_article-title">Activation of ARK5/MiR-1181/HOXA10 Axis Promotes Epithelial-Mesenchymal Transition in Ovarian Cancer</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1193</span>– <span class="NLM_lpage">1202</span>, <span class="refDoi"> DOI: 10.3892/or.2015.4113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.3892%2For.2015.4113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26151663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=1193-1202&author=H.+Y.+Zhangauthor=J.+H.+Liauthor=G.+Liauthor=S.+R.+Wang&title=Activation+of+ARK5%2FMiR-1181%2FHOXA10+Axis+Promotes+Epithelial-Mesenchymal+Transition+in+Ovarian+Cancer&doi=10.3892%2For.2015.4113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of ARK5/miR-1181/HOXA10 axis promotes epithelial-mesenchymal transition in ovarian cancer</span></div><div class="casAuthors">Zhang, Hai-Yan; Li, Jian-Hua; Li, Guang; Wang, Su-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1193-1202</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1791-2431</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Epithelial ovarian cancer (EOC) is the sixth most common cancer in females worldwide and, although advances have been made in the detection, diagnosis and therapies for EOC, it remains the most lethal gynecol. malignancy in advanced countries.  Nevertheless, relatively little is known concerning the mol. events that lead to the development of this highly aggressive disease.  Elucidating the mol. mechanism involved in this disease may prove useful to understand the pathogenesis and progression of the disease, and to identify new targets for effective therapies.  In the present study, we examd. the role of ARK5 in ovarian cancer and normal matched tissues using western blot anal. and migration and invasion, and wound-healing assays.  The results showed that ARK5 was upregulated in ovarian cancer tissues, compared with adjacent normal tissues.  Moreover, it promoted epithelial-mesenchymal transition (EMT) and inhibited miR-1181 expression in ovarian cancer cells.  Subsequent investigations showed that miR-1181 promoted mesenchymal-epithelial transition (MET) in ovarian cancer cells.  Downstream target genes of miR-1181 were searched, and it was identified that miR-1181 degraded HOXA10 by targeting its 3' untranslated region (3'UTR) in ovarian cancer cells.  The results confirmed that HOXA10 promoted EMT in ovarian cancer cells.  Thus, activation of the ARK5/miR-1181/HOXA10 axis may be pos. assocd. with EMT in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5JfPtn9dt3LVg90H21EOLACvtfcHk0lgzWFEa1r4DLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSltQ%253D%253D&md5=9acf4208e27ec4d9e085f479374e1cfa</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.3892%2For.2015.4113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2015.4113%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DS.%2BR.%26atitle%3DActivation%2520of%2520ARK5%252FMiR-1181%252FHOXA10%2520Axis%2520Promotes%2520Epithelial-Mesenchymal%2520Transition%2520in%2520Ovarian%2520Cancer%26jtitle%3DOncol.%2520Rep.%26date%3D2015%26volume%3D34%26spage%3D1193%26epage%3D1202%26doi%3D10.3892%2For.2015.4113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, M. H.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Kinase Inhibitors: An Analysis of FDA-Approved Drugs</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.drudis.2015.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26210956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Gru73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=5-10&author=P.+Wuauthor=T.+E.+Nielsenauthor=M.+H.+Clausen&title=Small-Molecule+Kinase+Inhibitors%3A+An+Analysis+of+FDA-Approved+Drugs&doi=10.1016%2Fj.drudis.2015.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule kinase inhibitors: an analysis of FDA-approved drugs</span></div><div class="casAuthors">Wu, Peng; Nielsen, Thomas E.; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-10</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Small-mol. kinase inhibitors (SMKIs), 28 of which are approved by the US Food and Drug Administration (FDA), have been actively pursued as promising targeted therapeutics.  Here, we assess the key structural and physicochem. properties, target selectivity and mechanism of function, and therapeutic indications of these approved inhibitors.  Our anal. showed that >30% of approved SMKIs have a mol. wt. (MW) exceeding 500 and all have a total ring count of between three and five.  The assumption that type II inhibitors tend to be more selective than type I inhibitors has been proved to be unreliable.  Although previous SMKI research was concd. on tyrosine kinase inhibitors for cancer treatment, recent progress indicates diversification of SMKI research in terms of new targets, mechanistic types, and therapeutic indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZrY68ZOI2xLVg90H21EOLACvtfcHk0lgzWFEa1r4DLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Gru73P&md5=228524fa464393053ecbfac19e994929</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DNielsen%26aufirst%3DT.%2BE.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DSmall-Molecule%2520Kinase%2520Inhibitors%253A%2520An%2520Analysis%2520of%2520FDA-Approved%2520Drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26spage%3D5%26epage%3D10%26doi%3D10.1016%2Fj.drudis.2015.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, J. F.</span></span> <span> </span><span class="NLM_article-title">Assay Development for Protein Kinase Enzymes</span>. <i>Nat. Center for Adv. Trans. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">19</span>, <a href="https://www.ncbi.nlm.nih.gov/books/NBK91991/" class="extLink">https://www.ncbi.nlm.nih.gov/books/NBK91991/</a> (accessed Oct 10, 2012)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=1-19&author=J.+F.+Glickman&title=Assay+Development+for+Protein+Kinase+Enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlickman%26aufirst%3DJ.%2BF.%26atitle%3DAssay%2520Development%2520for%2520Protein%2520Kinase%2520Enzymes%26jtitle%3DNat.%2520Center%2520for%2520Adv.%2520Trans.%2520Sci.%26date%3D2012%26volume%3D1%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallares, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span> <span> </span><span class="NLM_article-title">Comprehensive Analysis of Kinase Inhibitor Selectivity</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1046</span>– <span class="NLM_lpage">1051</span>, <span class="refDoi"> DOI: 10.1038/nbt.1990</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+Analysis+of+Kinase+Inhibitor+Selectivity&doi=10.1038%2Fnbt.1990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0ljaJdtGk1cfSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520Analysis%2520of%2520Kinase%2520Inhibitor%2520Selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051%26doi%3D10.1038%2Fnbt.1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhrlage, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prescott, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Characterization of WZ4003 and HTH-01–015 as Selective Inhibitors of the LKB1-Tumour-Suppressor-Activated NUAK Kinases</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>457</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1042/BJ20131152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1042%2FBJ20131152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=24171924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSlur7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2014&pages=215-225&author=S.+Banerjeeauthor=S.+J.+Buhrlageauthor=H.-T.+Huangauthor=X.+Dengauthor=W.+Zhouauthor=J.+Wangauthor=R.+Traynorauthor=A.+R.+Prescottauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+WZ4003+and+HTH-01%E2%80%93015+as+Selective+Inhibitors+of+the+LKB1-Tumour-Suppressor-Activated+NUAK+Kinases&doi=10.1042%2FBJ20131152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of WZ4003 and HTH-01-015 as selective inhibitors of the LKB1-tumour-suppressor-activated NUAK kinases</span></div><div class="casAuthors">Banerjee, Sourav; Buhrlage, Sara J.; Huang, Hai-Tsang; Deng, Xianming; Zhou, Wenjun; Wang, Jinhua; Traynor, Ryan; Prescott, Alan R.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">457</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">215-225</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The related NUAK1 and NUAK2 are members of the AMPK (AMP-activated protein kinase) family of protein kinases that are activated by the LKB1 (liver kinase B1) tumor suppressor kinase.  Recent work suggests they play important roles in regulating key biol. processes including Myc-driven tumorigenesis, senescence, cell adhesion and neuronal polarity.  In the present paper we describe the first highly specific protein kinase inhibitors of NUAK kinases namely WZ4003 and HTH-01-015.  WZ4003 inhibits both NUAK isoforms (IC50 for NUAK1 is 20 nM and for NUAK2 is 100 nM), whereas HTH-01-015 inhibits only NUAK1 (IC50 is 100 nM).  These compds. display extreme selectivity and do not significantly inhibit the activity of 139 other kinases that were tested including ten AMPK family members.  In all cell lines tested, WZ4003 and HTH-01-015 inhibit the phosphorylation of the only well-characterized substrate, MYPT1 (myosin phosphate-targeting subunit 1) that is phosphorylated by NUAK1 at Ser445.  We also identify a mutation (A195T) that does not affect basal NUAK1 activity, but renders it ~ 50-fold resistant to both WZ4003 and HTH-01-015.  Consistent with NUAK1 mediating the phosphorylation of MYPT1 we find that in cells overexpressing drug-resistant NUAK1[A195T], but not wild-type NUAK1, phosphorylation of MYPT1 at Ser445 is no longer suppressed by WZ4003 or HTH-01-015.  We also demonstrate that administration of WZ4003 and HTH-01-015 to MEFs (mouse embryonic fibroblasts) significantly inhibits migration in a wound-healing assay to a similar extent as NUAK1-knockout.  WZ4003 and HTH-01-015 also inhibit proliferation of MEFs to the same extent as NUAK1 knockout and U2OS cells to the same extent as NUAK1 shRNA knockdown.  We find that WZ4003 and HTH-01-015 impaired the invasive potential of U2OS cells in a 3D cell invasion assay to the same extent as NUAK1 knockdown.  The results of the present study indicate that WZ4003 and HTH-01-015 will serve as useful chem. probes to delineate the biol. roles of the NUAK kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Au6CwHtFALVg90H21EOLACvtfcHk0ljaJdtGk1cfSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSlur7K&md5=feab58d16169f39a2d136016328cc0f6</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1042%2FBJ20131152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20131152%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DHuang%26aufirst%3DH.-T.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTraynor%26aufirst%3DR.%26aulast%3DPrescott%26aufirst%3DA.%2BR.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520WZ4003%2520and%2520HTH-01%25E2%2580%2593015%2520as%2520Selective%2520Inhibitors%2520of%2520the%2520LKB1-Tumour-Suppressor-Activated%2520NUAK%2520Kinases%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D457%26spage%3D215%26epage%3D225%26doi%3D10.1042%2FBJ20131152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span> <i>Phosphorylation, Ubiquitylation and Characterisation of Specific Inhibitors of AMPK-Related Kinase NUAK1/ARK5</i>. Ph.D. Thesis, <span class="NLM_publisher-name">University of Dundee</span>, <span class="NLM_publisher-loc">United Kingdom</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+Banerjee&title=Phosphorylation%2C+Ubiquitylation+and+Characterisation+of+Specific+Inhibitors+of+AMPK-Related+Kinase+NUAK1%2FARK5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26jtitle%3DPhosphorylation%252C%2520Ubiquitylation%2520and%2520Characterisation%2520of%2520Specific%2520Inhibitors%2520of%2520AMPK-Related%2520Kinase%2520NUAK1%252FARK5%26pub%3DUniversity%2520of%2520Dundee%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzamko, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prescott, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patricelli, M. P</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomanbhoy, T. K</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S</span></span> <span> </span><span class="NLM_article-title">Characterization of a Selective Inhibitor of the Parkinson’s Disease Kinase LRRK2</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">203</span>, <span class="refDoi"> DOI: 10.1038/nchembio.538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fnchembio.538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=21378983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=203&author=X.+Dengauthor=N.+Dzamkoauthor=A.+Prescottauthor=P.+Daviesauthor=Q.+Liuauthor=Q.+Yangauthor=J.-D.+Leeauthor=M.+P+Patricelliauthor=T.+K+Nomanbhoyauthor=D.+R+Alessiauthor=N.+S+Gray&title=Characterization+of+a+Selective+Inhibitor+of+the+Parkinson%E2%80%99s+Disease+Kinase+LRRK2&doi=10.1038%2Fnchembio.538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2</span></div><div class="casAuthors">Deng, Xianming; Dzamko, Nicolas; Prescott, Alan; Davies, Paul; Liu, Qingsong; Yang, Qingkai; Lee, Jiing-Dwan; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly assocd. with late-onset autosomal dominant Parkinson's disease.  We employed a new, parallel, compd.-centric approach to identify a potent and selective LRRK2 inhibitor, LRRK2-IN-1, and demonstrated that inhibition of LRRK2 induces dephosphorylation of Ser910 and Ser935 and accumulation of LRRK2 within aggregate structures.  LRRK2-IN-1 will serve as a versatile tool to pharmacol. interrogate LRRK2 biol. and study its role in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwLpGURHqDULVg90H21EOLACvtfcHk0lgP8CZLFpERHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D&md5=9f48f74cad9988e3ea8bb7af280473c1</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.538%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DPrescott%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.-D.%26aulast%3DPatricelli%26aufirst%3DM.%2BP%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK%26aulast%3DAlessi%26aufirst%3DD.%2BR%26aulast%3DGray%26aufirst%3DN.%2BS%26atitle%3DCharacterization%2520of%2520a%2520Selective%2520Inhibitor%2520of%2520the%2520Parkinson%25E2%2580%2599s%2520Disease%2520Kinase%2520LRRK2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D203%26doi%3D10.1038%2Fnchembio.538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J. J.</span>; <span class="NLM_string-name">Rogers, E.</span>; <span class="NLM_string-name">Zhai, D.</span>; <span class="NLM_string-name">Deng, W.</span>; <span class="NLM_string-name">Huang, Z.</span>; <span class="NLM_string-name">Whitten, J.</span>; <span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Ending the Endless Acquired Tyrosine Kinase Resistance Mutations—Design of TPX-0005, a Multi-Target ALK/ROS1/TRK Inhibitor with Broad Spectrum Activity against Wild-Type and Mutants Including ALK G1202R, ROS1 G2032R and TRKA G595R</span>.  <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume">76</span>, Supplement: Abstract 2133. <span class="NLM_fpage">2133</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2016-2133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1158%2F1538-7445.AM2016-2133" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=2133&author=J.+J.+Cui&author=E.+Rogers&author=D.+Zhai&author=W.+Deng&author=Z.+Huang&author=J.+Whitten&author=Y.+Li&title=Ending+the+Endless+Acquired+Tyrosine+Kinase+Resistance+Mutations%E2%80%94Design+of+TPX-0005%2C+a+Multi-Target+ALK%2FROS1%2FTRK+Inhibitor+with+Broad+Spectrum+Activity+against+Wild-Type+and+Mutants+Including+ALK+G1202R%2C+ROS1+G2032R+and+TRKA+G595R&doi=10.1158%2F1538-7445.AM2016-2133"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2016-2133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2016-2133%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26atitle%3DEnding%2520the%2520Endless%2520Acquired%2520Tyrosine%2520Kinase%2520Resistance%2520Mutations%25E2%2580%2594Design%2520of%2520TPX-0005%252C%2520a%2520Multi-Target%2520ALK%252FROS1%252FTRK%2520Inhibitor%2520with%2520Broad%2520Spectrum%2520Activity%2520against%2520Wild-Type%2520and%2520Mutants%2520Including%2520ALK%2520G1202R%252C%2520ROS1%2520G2032R%2520and%2520TRKA%2520G595R%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D2133%26doi%3D10.1158%2F1538-7445.AM2016-2133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRyckere, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stashko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaros, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sather, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kireev, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janzen, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earp, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7031</span>– <span class="NLM_lpage">7041</span>, <span class="refDoi"> DOI: 10.1021/jm500749d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500749d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1agu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7031-7041&author=W.+Zhangauthor=D.+DeRyckereauthor=D.+Hunterauthor=J.+Liuauthor=M.+A.+Stashkoauthor=K.+A.+Minsonauthor=C.+T.+Cummingsauthor=M.+Leeauthor=T.+G.+Glarosauthor=D.+L.+Newtonauthor=S.+Satherauthor=D.+Zhangauthor=D.+Kireevauthor=W.+P.+Janzenauthor=H.+S.+Earpauthor=D.+K.+Grahamauthor=S.+V.+Fryeauthor=X.+Wang&title=UNC2025%2C+a+Potent+and+Orally+Bioavailable+MER%2FFLT3+Dual+Inhibitor&doi=10.1021%2Fjm500749d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor</span></div><div class="casAuthors">Zhang, Weihe; DeRyckere, Deborah; Hunter, Debra; Liu, Jing; Stashko, Michael A.; Minson, Katherine A.; Cummings, Christopher T.; Lee, Minjung; Glaros, Trevor G.; Newton, Dianne L.; Sather, Susan; Zhang, Dehui; Kireev, Dmitri; Janzen, William P.; Earp, H. Shelton; Graham, Douglas K.; Frye, Stephen V.; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7031-7041</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We previously reported a potent small mol. Mer tyrosine kinase inhibitor UNC1062.  However, its poor PK properties prevented further assessment in vivo.  We report here the sequential modification of UNC1062 to address DMPK properties and yield a new potent and highly orally bioavailable Mer inhibitor, 11, capable of inhibiting Mer phosphorylation in vivo, following oral dosing as demonstrated by pharmaco-dynamic (PD) studies examg. phospho-Mer in leukemic blasts from mouse bone marrow.  Kinome profiling vs. more than 300 kinases in vitro and cellular selectivity assessments demonstrate that 11 has similar subnanomolar activity against Flt3, an addnl. important target in acute myelogenous leukemia (AML), with pharmacol. useful selectivity vs. other kinases examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIu8sRwBmPqrVg90H21EOLACvtfcHk0lgP8CZLFpERHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1agu7bN&md5=b3be89f194e6f5ea853d82aa67aea939</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fjm500749d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500749d%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DDeRyckere%26aufirst%3DD.%26aulast%3DHunter%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DStashko%26aufirst%3DM.%2BA.%26aulast%3DMinson%26aufirst%3DK.%2BA.%26aulast%3DCummings%26aufirst%3DC.%2BT.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DGlaros%26aufirst%3DT.%2BG.%26aulast%3DNewton%26aufirst%3DD.%2BL.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DKireev%26aufirst%3DD.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DUNC2025%252C%2520a%2520Potent%2520and%2520Orally%2520Bioavailable%2520MER%252FFLT3%2520Dual%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7031%26epage%3D7041%26doi%3D10.1021%2Fjm500749d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khodjaniyazov, K. U.</span></span> <span> </span><span class="NLM_article-title">Synthesis and NMR Spectral Characterization of Novel 2, 3-Polymethylenepyrido [2, 3-d] Pyrimidin-4-Ones</span>. <i>J. J. Adv. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3873</span>– <span class="NLM_lpage">3875</span>, <span class="refDoi"> DOI: 10.24297/jac.v11i8.2193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.24297%2Fjac.v11i8.2193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOnu77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=3873-3875&author=K.+U.+Khodjaniyazov&title=Synthesis+and+NMR+Spectral+Characterization+of+Novel+2%2C+3-Polymethylenepyrido+%5B2%2C+3-d%5D+Pyrimidin-4-Ones&doi=10.24297%2Fjac.v11i8.2193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and NMR spectral characterization of novel 2,3-polymethylenepyrido[2,3-d]pyrimidin-4-ones</span></div><div class="casAuthors">Khodjaniyazov, Khamid U.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Advances in Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3873-3875</span>CODEN:
                <span class="NLM_cas:coden">JACOHO</span>;
        ISSN:<span class="NLM_cas:issn">2321-807X</span>.
    
            (<span class="NLM_cas:orgname">Council for Innovative Research</span>)
        </div><div class="casAbstract">A novel 2,3-polymethylenepyrido[2,3-d]pyrimidine-4-ones I [X = (CH2)n; n = 1, 2, 3] were synthesized via condensation of the 2-aminonicotinic acid together with lactams in the presence of phosphorus oxychloride.  The structures of the newly synthesized pyrido[2,3-d]pyrimidines were confirmed by 1H and 13C NMR spectral data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5FNRBfZB-47Vg90H21EOLACvtfcHk0lgOkFyWM2XAbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOnu77K&md5=79a73a61fd4bd866c2055c652ef80ced</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.24297%2Fjac.v11i8.2193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.24297%252Fjac.v11i8.2193%26sid%3Dliteratum%253Aachs%26aulast%3DKhodjaniyazov%26aufirst%3DK.%2BU.%26atitle%3DSynthesis%2520and%2520NMR%2520Spectral%2520Characterization%2520of%2520Novel%25202%252C%25203-Polymethylenepyrido%2520%255B2%252C%25203-d%255D%2520Pyrimidin-4-Ones%26jtitle%3DJ.%2520J.%2520Adv.%2520Chem.%26date%3D2015%26volume%3D11%26spage%3D3873%26epage%3D3875%26doi%3D10.24297%2Fjac.v11i8.2193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zinchenko, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzychka, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biletskiy, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smolii, O. B.</span></span> <span> </span><span class="NLM_article-title">The Study of the Interaction of 4, 6-Dichloropyrimidine-5-Carbaldehyde with Glycine Esters</span>. <i>Zh. Org. Farm. Khim.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.24959/ophcj.18.935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.24959%2Fophcj.18.935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslSqsb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=42-48&author=H.+M.+Zinchenkoauthor=L.+V.+Muzychkaauthor=I.+I.+Biletskiyauthor=O.+B.+Smolii&title=The+Study+of+the+Interaction+of+4%2C+6-Dichloropyrimidine-5-Carbaldehyde+with+Glycine+Esters&doi=10.24959%2Fophcj.18.935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">The study of the interaction of 4,6-dichloropyrimidine-5-carbaldehyde with glycine esters</span></div><div class="casAuthors">Zinchenko, H. M.; Muzychka, L. V.; Biletskiy, I. I.; Smolii, O. B.</div><div class="citationInfo"><span class="NLM_cas:title">Zhurnal Organichnoi ta Farmatsevtichnoi Khimii</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-48</span>CODEN:
                <span class="NLM_cas:coden">ZOFKAM</span>;
        ISSN:<span class="NLM_cas:issn">2518-1548</span>.
    
            (<span class="NLM_cas:orgname">Natsional'nii Farmatsevtichnii Universitet</span>)
        </div><div class="casAbstract">The aim is to study the interaction of 4,6-dichloropyrimidine-5-carbaldehyde with methyl- and with tert-butylglycinate depending on the reaction conditions.  It has been found that the reaction of 4,6-dichloro-5-formylpyrimidine with hydrochlorides of glycine esters in the presence of triethylamine leads to obtaining derivs. of N-(5-formylpyrimidin-4-yl)glycinate and cyclization products: pyrrolo[2,3-d]pyrimidine and pyrido[2,3-d]pyrimidine.  The interaction of 4,6-dichloropyrimidine-5-carbaldehyde with Me or tert-Bu glycinate in methanol in the presence of triethylamine depending on the molar ratio gives the mixt. of 5-hydroxy-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine and 6-amino-4-chloro-7-oxopyrido[2,3-d]pyrimidine-8(7H)-yl)acetate.  The compn. and structure of the compds. synthesized have been confirmed by NMR-spectroscopy, chromatog. mass-spectrometry and elemental anal.  The previously unknown derivs. of pyrrolo[2,3-d]pyrimidine and pyrido[2,3-d]pyrimidine have been obtained as a result of the interaction of 4,6-dichloro-5-formylpyrimidine with Me and tert-butylglycinate.  The reaction features depending on the reactants ratio have been studied.  The prospects for the synthesis of potential biol. active compds. from 6-amino-4-chloro-7-oxopyrido[2,3-d]pyrimidine-8(7H)-yl)acetate have been described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY_uyzJAY6a7Vg90H21EOLACvtfcHk0lgOkFyWM2XAbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslSqsb3P&md5=54d94a9cdecf30ec471e12f066898dc1</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.24959%2Fophcj.18.935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.24959%252Fophcj.18.935%26sid%3Dliteratum%253Aachs%26aulast%3DZinchenko%26aufirst%3DH.%2BM.%26aulast%3DMuzychka%26aufirst%3DL.%2BV.%26aulast%3DBiletskiy%26aufirst%3DI.%2BI.%26aulast%3DSmolii%26aufirst%3DO.%2BB.%26atitle%3DThe%2520Study%2520of%2520the%2520Interaction%2520of%25204%252C%25206-Dichloropyrimidine-5-Carbaldehyde%2520with%2520Glycine%2520Esters%26jtitle%3DZh.%2520Org.%2520Farm.%2520Khim.%26date%3D2018%26volume%3D16%26spage%3D42%26epage%3D48%26doi%3D10.24959%2Fophcj.18.935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M. V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akula, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosenza, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Athuluridivakar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallireddigari, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallela, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billa, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subbaiah, D. R. C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharathi, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasquez-Del Carpio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgaonkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, E. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of 8-Cyclopentyl-2-[4-(4-Methyl-Piperazin-1-Yl)-Phenylamino]-7-Oxo-7, 8-Dihydro-Pyrido [2, 3-d] Pyrimidine-6-Carbonitrile (7x) as a Potent Inhibitor of Cyclin-Dependent Kinase 4 (CDK4) and AMPK-Related Kinase 5 (ARK5)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">599</span>, <span class="refDoi"> DOI: 10.1021/jm401073p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401073p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=578-599&author=M.+V.+R.+Reddyauthor=B.+Akulaauthor=S.+C.+Cosenzaauthor=S.+Athuluridivakarauthor=M.+R.+Mallireddigariauthor=V.+R.+Pallelaauthor=V.+K.+Billaauthor=D.+R.+C.+V.+Subbaiahauthor=E.+V.+Bharathiauthor=R.+Vasquez-Del+Carpioauthor=A.+Padgaonkarauthor=S.+J.+Bakerauthor=E.+P.+Reddy&title=Discovery+of+8-Cyclopentyl-2-%5B4-%284-Methyl-Piperazin-1-Yl%29-Phenylamino%5D-7-Oxo-7%2C+8-Dihydro-Pyrido+%5B2%2C+3-d%5D+Pyrimidine-6-Carbonitrile+%287x%29+as+a+Potent+Inhibitor+of+Cyclin-Dependent+Kinase+4+%28CDK4%29+and+AMPK-Related+Kinase+5+%28ARK5%29&doi=10.1021%2Fjm401073p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 8-Cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile as a Potent Inhibitor of Cyclin-Dependent Kinase 4 (CDK4) and AMPK-Related Kinase 5 (ARK5)</span></div><div class="casAuthors">Reddy, M. V. Ramana; Akula, Balireddy; Cosenza, Stephen C.; Athuluridivakar, Saikrishna; Mallireddigari, Muralidhar R.; Pallela, Venkat R.; Billa, Vinay K.; Subbaiah, D. R. C. Venkata; Bharathi, E. Vijaya; Vasquez-Del Carpio, Rodrigo; Padgaonkar, Amol; Baker, Stacey J.; Reddy, E. Premkumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">578-599</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The success of imatinib, a BCR-ABL inhibitor for the treatment of chronic myelogenous leukemia, has created a great impetus for the development of addnl. kinase inhibitors as therapeutic agents.  However, the complexity of cancer has led to recent interest in polypharmacol. approaches for developing multikinase inhibitors with low toxicity profiles.  With this goal in mind, the authors analyzed more than 150 novel cyano pyridopyrimidine compds. and identified structure-activity relationship trends that can be exploited in the design of potent kinase inhibitors.  One compd., 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile, was found to be the most active, inducing apoptosis of tumor cells at a concn. of approx. 30-100 nM.  In vitro kinase profiling revealed that 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile is a multikinase inhibitor with potent inhibitory activity against the CDK4/CYCLIN D1 and ARK5 kinases.  Here, the authors report the synthesis, structure-activity relationship, kinase inhibitory profile, in vitro cytotoxicity, and in vivo tumor regression studies by this lead compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMG0fEjk1mb7Vg90H21EOLACvtfcHk0lgOkFyWM2XAbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVKisw%253D%253D&md5=da18d602b1ec793832db5f04813e18d6</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjm401073p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401073p%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DM.%2BV.%2BR.%26aulast%3DAkula%26aufirst%3DB.%26aulast%3DCosenza%26aufirst%3DS.%2BC.%26aulast%3DAthuluridivakar%26aufirst%3DS.%26aulast%3DMallireddigari%26aufirst%3DM.%2BR.%26aulast%3DPallela%26aufirst%3DV.%2BR.%26aulast%3DBilla%26aufirst%3DV.%2BK.%26aulast%3DSubbaiah%26aufirst%3DD.%2BR.%2BC.%2BV.%26aulast%3DBharathi%26aufirst%3DE.%2BV.%26aulast%3DVasquez-Del%2BCarpio%26aufirst%3DR.%26aulast%3DPadgaonkar%26aufirst%3DA.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26atitle%3DDiscovery%2520of%25208-Cyclopentyl-2-%255B4-%25284-Methyl-Piperazin-1-Yl%2529-Phenylamino%255D-7-Oxo-7%252C%25208-Dihydro-Pyrido%2520%255B2%252C%25203-d%255D%2520Pyrimidine-6-Carbonitrile%2520%25287x%2529%2520as%2520a%2520Potent%2520Inhibitor%2520of%2520Cyclin-Dependent%2520Kinase%25204%2520%2528CDK4%2529%2520and%2520AMPK-Related%2520Kinase%25205%2520%2528ARK5%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D578%26epage%3D599%26doi%3D10.1021%2Fjm401073p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkholi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chipuk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M. V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, J. M.</span></span> <span> </span><span class="NLM_article-title">Preclinical Pharmacological Evaluation of a Novel Multiple Kinase Inhibitor, ON123300, in Brain Tumor Models</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1105</span>– <span class="NLM_lpage">1116</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1158%2F1535-7163.MCT-13-0847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=24568969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFWjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=1105-1116&author=X.+Zhangauthor=H.+Lvauthor=Q.+Zhouauthor=R.+Elkholiauthor=J.+E.+Chipukauthor=M.+V.+R.+Reddyauthor=E.+P.+Reddyauthor=J.+M.+Gallo&title=Preclinical+Pharmacological+Evaluation+of+a+Novel+Multiple+Kinase+Inhibitor%2C+ON123300%2C+in+Brain+Tumor+Models&doi=10.1158%2F1535-7163.MCT-13-0847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Pharmacological Evaluation of a Novel Multiple Kinase Inhibitor, ON123300, in Brain Tumor Models</span></div><div class="casAuthors">Zhang, Xiaoping; Lv, Hua; Zhou, Qingyu; Elkholi, Rana; Chipuk, Jerry E.; Reddy, M. V. Ramana; Reddy, E. Premkumar; Gallo, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1105-1116</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">ON123300 is a low mol. wt. multikinase inhibitor identified through a series of screens that supported further analyses for brain tumor chemotherapy.  Biochem. assays indicated that ON123300 was a strong inhibitor of Ark5 and CDK4, as well as growth factor receptor tyrosine kinases such as β-type platelet-derived growth factor receptor (PDGFRβ).  ON123300 inhibited U87 glioma cell proliferation with an IC50 3.4 ± 0.1 μmol/L and reduced phosphorylation of Akt, yet it also unexpectedly induced Erk activation, both in a dose- and time-dependent manner that subsequently was attributed to relieving Akt-mediated C-Raf S259 inactivation and activating a p70S6K-initiated PI3K-neg. feedback loop.  Cotreatment with the EGFR inhibitor gefitinib produced synergistic cytotoxic effects.  Pursuant to the in vitro studies, in vivo pharmacokinetic and pharmacodynamic studies of ON123300 were completed in mice bearing intracerebral U87 tumors following i.v. doses of 5 and 25 mg/kg alone, and also at the higher dose concurrently with gefitinib.  ON123300 showed high brain and brain tumor accumulation based on brain partition coeff. values of at least 2.5.  Consistent with the in vitro studies, single agent ON123300 caused a dose-dependent suppression of phosphorylation of Akt as well as activation of Erk in brain tumors, whereas addn. of gefitinib to the ON123300 regimen significantly enhanced p-Akt inhibition and prevented Erk activation.  In summary, ON123300 demonstrated favorable pharmacokinetic characteristics, and future development for brain tumor therapy would require use of combinations, such as gefitinib, that mitigate its Erk activation and enhance its activity.  Mol Cancer Ther; 13(5); 1105-16. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr457UjL6oAnrVg90H21EOLACvtfcHk0lifIwRi_Jw_xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFWjsLY%253D&md5=04d7383c3bb723978e1b5776af188497</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0847%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DElkholi%26aufirst%3DR.%26aulast%3DChipuk%26aufirst%3DJ.%2BE.%26aulast%3DReddy%26aufirst%3DM.%2BV.%2BR.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26atitle%3DPreclinical%2520Pharmacological%2520Evaluation%2520of%2520a%2520Novel%2520Multiple%2520Kinase%2520Inhibitor%252C%2520ON123300%252C%2520in%2520Brain%2520Tumor%2520Models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26spage%3D1105%26epage%3D1116%26doi%3D10.1158%2F1535-7163.MCT-13-0847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siemeister, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lücking, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wengner, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schatz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegelbauer, K.</span></span> <span> </span><span class="NLM_article-title">BAY 1000394, a Novel Cyclin-Dependent Kinase Inhibitor, with Potent Antitumor Activity in Mono- and in Combination Treatment upon Oral Application</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2265</span>– <span class="NLM_lpage">2273</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-12-0286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1158%2F1535-7163.MCT-12-0286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22821149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVyksrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=2265-2273&author=G.+Siemeisterauthor=U.+L%C3%BCckingauthor=A.+M.+Wengnerauthor=P.+Lienauauthor=W.+Steinkeauthor=C.+Schatzauthor=D.+Mumbergauthor=K.+Ziegelbauer&title=BAY+1000394%2C+a+Novel+Cyclin-Dependent+Kinase+Inhibitor%2C+with+Potent+Antitumor+Activity+in+Mono-+and+in+Combination+Treatment+upon+Oral+Application&doi=10.1158%2F1535-7163.MCT-12-0286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">BAY 1000394, a Novel Cyclin-Dependent Kinase Inhibitor, with Potent Antitumor Activity in Mono- and in Combination Treatment upon Oral Application</span></div><div class="casAuthors">Siemeister, Gerhard; Luecking, Ulrich; Wengner, Antje M.; Lienau, Philip; Steinke, Wolfram; Schatz, Christoph; Mumberg, Dominik; Ziegelbauer, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2265-2273</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Deregulated activity of cyclin-dependent kinases (CDK) results in loss of cell-cycle checkpoint function and increased expression of antiapoptotic proteins, which has been directly linked to the mol. pathol. of cancer.  BAY 1000394 inhibits the activity of cell-cycle CDKs CDK1, CDK2, CDK3, CDK4, and of transcriptional CDKs CDK7 and CDK9 with IC50 values in the range between 5 and 25 nmol/L.  Cell proliferation was inhibited at low nanomolar concn. in a broad spectrum of human cancer cell lines.  In cell-based assays, the inhibition of phosphorylation of the CDK substrates retinoblastoma protein, nucleophosmin, and RNA polymerase II was shown.  Cell-cycle profiles were consistent with inhibition of CDK 1, 2, and 4 as shown in cell-cycle block and release expts.  The physicochem. and pharmacokinetic properties of BAY 1000394 facilitate rapid absorption and moderate oral bioavailability.  The compd. potently inhibits growth of various human tumor xenografts on athymic mice including models of chemotherapy resistance upon oral dosing.  Furthermore, BAY 1000394 shows more than additive efficacy when combined with cisplatin and etoposide.  These results suggest that BAY 1000394 is a potent pan-CDK inhibitor and a novel oral cytotoxic agent currently in phase I clin. trials.  Mol Cancer Ther; 11(10); 2265-73. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBMnyCrxDjqbVg90H21EOLACvtfcHk0lifIwRi_Jw_xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVyksrvK&md5=c175eacd5440b59b113a78a61a89a4b5</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0286%26sid%3Dliteratum%253Aachs%26aulast%3DSiemeister%26aufirst%3DG.%26aulast%3DL%25C3%25BCcking%26aufirst%3DU.%26aulast%3DWengner%26aufirst%3DA.%2BM.%26aulast%3DLienau%26aufirst%3DP.%26aulast%3DSteinke%26aufirst%3DW.%26aulast%3DSchatz%26aufirst%3DC.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3DZiegelbauer%26aufirst%3DK.%26atitle%3DBAY%25201000394%252C%2520a%2520Novel%2520Cyclin-Dependent%2520Kinase%2520Inhibitor%252C%2520with%2520Potent%2520Antitumor%2520Activity%2520in%2520Mono-%2520and%2520in%2520Combination%2520Treatment%2520upon%2520Oral%2520Application%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D2265%26epage%3D2273%26doi%3D10.1158%2F1535-7163.MCT-12-0286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polokoff, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochanny, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biroc, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alicke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckman, B. O.</span></span> <span> </span><span class="NLM_article-title">Novel Small Molecule Inhibitors of 3-Phosphoinositide-Dependent Kinase-1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">19867</span>– <span class="NLM_lpage">19874</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M501367200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15772071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFylsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=19867-19874&author=R.+I.+Feldmanauthor=J.+M.+Wuauthor=M.+A.+Polokoffauthor=M.+J.+Kochannyauthor=H.+Dinterauthor=D.+Zhuauthor=S.+L.+Birocauthor=B.+Alickeauthor=J.+Bryantauthor=S.+Yuanauthor=B.+O.+Buckman&title=Novel+Small+Molecule+Inhibitors+of+3-Phosphoinositide-Dependent+Kinase-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Small Molecule Inhibitors of 3-Phosphoinositide-dependent Kinase-1</span></div><div class="casAuthors">Feldman, Richard I.; Wu, James M.; Polokoff, Mark A.; Kochanny, Monica J.; Dinter, Harald; Zhu, Daguang; Biroc, Sandra L.; Alicke, Bruno; Bryant, Judi; Yuan, Shendong; Buckman, Brad O.; Lentz, Dao; Ferrer, Mike; Whitlow, Marc; Adler, Marc; Finster, Silke; Chang, Zheng; Arnaiz, Damian O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">19867-19874</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The phosphoinositide 3-kinase/3-phosphoinositide-dependent kinase 1 (PDK1)/Akt signaling pathway plays a key role in cancer cell growth, survival, and tumor angiogenesis and represents a promising target for anticancer drugs.  Here, the authors describe three potent PDK1 inhibitors, BX-795, BX-912, and BX-320 (IC50 = 11-30 nM) and their initial biol. characterization.  The inhibitors blocked PDK1/Akt signaling in tumor cells and inhibited the anchorage-dependent growth of a variety of tumor cell lines in culture or induced apoptosis.  A no. of cancer cell lines with elevated Akt activity were >30-fold more sensitive to growth inhibition by PDK1 inhibitors in soft agar than on tissue culture plastic, consistent with the cell survival function of the PDK1/Akt signaling pathway, which is particularly important for unattached cells.  BX-320 inhibited the growth of LOX melanoma tumors in the lungs of nude mice after injection of tumor cells into the tail vein.  The effect of BX-320 on cancer cell growth in vitro and in vivo indicates that PDK1 inhibitors may have clin. utility as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh1M4rgv4qKbVg90H21EOLACvtfcHk0lifIwRi_Jw_xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFylsLc%253D&md5=839db36e331b6a8f4c1335ae5df39226</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M501367200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M501367200%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DR.%2BI.%26aulast%3DWu%26aufirst%3DJ.%2BM.%26aulast%3DPolokoff%26aufirst%3DM.%2BA.%26aulast%3DKochanny%26aufirst%3DM.%2BJ.%26aulast%3DDinter%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DBiroc%26aufirst%3DS.%2BL.%26aulast%3DAlicke%26aufirst%3DB.%26aulast%3DBryant%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DBuckman%26aufirst%3DB.%2BO.%26atitle%3DNovel%2520Small%2520Molecule%2520Inhibitors%2520of%25203-Phosphoinositide-Dependent%2520Kinase-1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D19867%26epage%3D19874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plater, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peggie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">Use of the Pharmacological Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and IκB Kinase ∈:A Distinct Upstream Kinase Mediates Ser-172 Phosphorylation and Activation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">14136</span>– <span class="NLM_lpage">14146</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.000414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M109.000414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=19307177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvV2jtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=14136-14146&author=K.+Clarkauthor=L.+Platerauthor=M.+Peggieauthor=P.+Cohen&title=Use+of+the+Pharmacological+Inhibitor+BX795+to+Study+the+Regulation+and+Physiological+Roles+of+TBK1+and+I%CE%BAB+Kinase+%E2%88%88%3AA+Distinct+Upstream+Kinase+Mediates+Ser-172+Phosphorylation+and+Activation&doi=10.1074%2Fjbc.M109.000414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Use of the Pharmacological Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and IκB Kinase ε: a distinct upstream kinase mediates SER-172 phosphorylation and activation</span></div><div class="casAuthors">Clark, Kristopher; Plater, Lorna; Peggie, Mark; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">14136-14146</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">TANK-binding kinase 1 (TBK1) and IκB kinase ε (IKKε) regulate the prodn. of Type 1 interferons during bacterial and viral infection, but the lack of useful pharmacol. inhibitors has hampered progress in identifying addnl. physiol. roles of these protein kinases and how they are regulated.  Here we demonstrate that BX795, a potent and relatively specific inhibitor of TBK1 and IKKε, blocked the phosphorylation, nuclear translocation, and transcriptional activity of interferon regulatory factor 3 and, hence, the prodn. of interferon-β in macrophages stimulated with poly(I:C) or lipopolysaccharide (LPS).  In contrast, BX795 had no effect on the canonical NFκB signaling pathway.  Although BX795 blocked the autophosphorylation of overexpressed TBK1 and IKKε at Ser-172 and, hence, the autoactivation of these protein kinases, it did not inhibit the phosphorylation of endogenous TBK1 and IKKε at Ser-172 in response to LPS, poly(I:C), interleukin-1α (IL-1α), or tumor necrosis factor α and actually enhanced the LPS, poly(I:C), and IL-1α-stimulated phosphorylation of this residue.  These results demonstrate that the phosphorylation of Ser-172 and the activation of TBK1 and IKKε are catalyzed by a distinct protein kinase(s) in vivo and that TBK1 and IKKε control a feedback loop that limits their activation by LPS, poly(I:C) and IL-1α (but not tumor necrosis factor α) to prevent the hyperactivation of these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9ZqG2gYcFnLVg90H21EOLACvtfcHk0lgqJsXkc5rK5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvV2jtbw%253D&md5=dd663b2022a4c832518cac557143799d</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.000414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.000414%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DK.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DPeggie%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DUse%2520of%2520the%2520Pharmacological%2520Inhibitor%2520BX795%2520to%2520Study%2520the%2520Regulation%2520and%2520Physiological%2520Roles%2520of%2520TBK1%2520and%2520I%25CE%25BAB%2520Kinase%2520%25E2%2588%2588%253AA%2520Distinct%2520Upstream%2520Kinase%2520Mediates%2520Ser-172%2520Phosphorylation%2520and%2520Activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D14136%26epage%3D14146%26doi%3D10.1074%2Fjbc.M109.000414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgeon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caflisch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hantschel, O.</span></span> <span> </span><span class="NLM_article-title">Specificity and Mechanism-of-Action of the JAK2 Tyrosine Kinase Inhibitors Ruxolitinib and SAR302503 (TG101348)</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">404</span>– <span class="NLM_lpage">407</span>, <span class="refDoi"> DOI: 10.1038/leu.2013.205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fleu.2013.205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23823659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsl2gtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=404-407&author=T.+Zhouauthor=S.+Georgeonauthor=R.+Moserauthor=D.+J.+Mooreauthor=A.+Caflischauthor=O.+Hantschel&title=Specificity+and+Mechanism-of-Action+of+the+JAK2+Tyrosine+Kinase+Inhibitors+Ruxolitinib+and+SAR302503+%28TG101348%29&doi=10.1038%2Fleu.2013.205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348)</span></div><div class="casAuthors">Zhou, T.; Georgeon, S.; Moser, R.; Moore, D. J.; Caflisch, A.; Hantschel, O.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">404-407</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-3vjA0n7DlLVg90H21EOLACvtfcHk0lgqJsXkc5rK5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsl2gtbk%253D&md5=7dbebd3eac60c3dd19026c9e3d3d3204</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1038%2Fleu.2013.205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2013.205%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DGeorgeon%26aufirst%3DS.%26aulast%3DMoser%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26aulast%3DCaflisch%26aufirst%3DA.%26aulast%3DHantschel%26aufirst%3DO.%26atitle%3DSpecificity%2520and%2520Mechanism-of-Action%2520of%2520the%2520JAK2%2520Tyrosine%2520Kinase%2520Inhibitors%2520Ruxolitinib%2520and%2520SAR302503%2520%2528TG101348%2529%26jtitle%3DLeukemia%26date%3D2014%26volume%3D28%26spage%3D404%26epage%3D407%26doi%3D10.1038%2Fleu.2013.205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGuzman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pak, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inagaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbach, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, U.</span></span> <span> </span><span class="NLM_article-title">The Novel Kinase Inhibitor PRT062070 (Cerdulatinib) Demonstrates Efficacy in Models of Autoimmunity and B-Cell Cancer</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">538</span>– <span class="NLM_lpage">548</span>, <span class="refDoi"> DOI: 10.1124/jpet.114.218164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1124%2Fjpet.114.218164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=25253883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyhsbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2014&pages=538-548&author=G.+Coffeyauthor=A.+Betzauthor=F.+DeGuzmanauthor=Y.+Pakauthor=M.+Inagakiauthor=D.+C.+Bakerauthor=S.+J.+Hollenbachauthor=A.+Pandeyauthor=U.+Sinha&title=The+Novel+Kinase+Inhibitor+PRT062070+%28Cerdulatinib%29+Demonstrates+Efficacy+in+Models+of+Autoimmunity+and+B-Cell+Cancer&doi=10.1124%2Fjpet.114.218164"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">The novel kinase inhibitor PRT062070 (Cerdulatinib) demonstrates efficacy in models of autoimmunity and B-cell cancer</span></div><div class="casAuthors">Coffey, Greg; Betz, Andreas; DeGuzman, Francis; Pak, Yvonne; Inagaki, Mayuko; Baker, Dale C.; Hollenbach, Stanley J.; Pandey, Anjali; Sinha, Uma</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">538-548, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The heterogeneity and severity of certain autoimmune diseases and B-cell malignancies warrant simultaneous targeting of multiple disease-relevant signaling pathways.  Dual inhibition of spleen tyrosine kinase (SYK) and Janus kinase (JAK) represents such a strategy and may elicit several benefits relative to selective kinase inhibition, such as gaining control over a broader array of disease etiologies, reducing probability of selection for bypass disease mechanisms, and the potential that an overall lower level suppression of individual targets may be sufficient to modulate disease activity.  To this end, we provide data on the discovery and preclin. development of PRT062070 [4-(cyclopropylamino)-2-({4-[4-(ethylsulfonyl)piperazin-1-yl]phenyl}amino)pyrimidine-5-carboxamide hydrochloride], an orally active kinase inhibitor that demonstrates activity against SYK and JAK.  Cellular assays demonstrated specific inhibitory activity against signaling pathways that use SYK and JAK1/3.  Limited inhibition of JAK2 was obsd., and PRT062070 did not inhibit phorbol 12-myristate 13-acetate-mediated signaling or activation in B and T cells nor T-cell antigen receptor-mediated signaling in T cells, providing evidence for selectivity of action.  Potent antitumor activity was obsd. in a subset of B-cell lymphoma cell lines.  After oral dosing, PRT062070 suppressed inflammation and autoantibody generation in a rat collagen-induced arthritis model and blocked B-cell activation and splenomegaly in a mouse model of chronic B-cell antigen receptor stimulation.  PRT062070 is currently under evaluation in a phase I dose escalation study in patients with B-cell leukemia and lymphoma (NCT01994382), with proof-of-concept studies in humans planned to assess therapeutic potential in autoimmune and malignant diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoblL0zhusaV7Vg90H21EOLACvtfcHk0lgqJsXkc5rK5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyhsbbF&md5=caed39628d643e4087ba88f7eaa51326</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.218164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.218164%26sid%3Dliteratum%253Aachs%26aulast%3DCoffey%26aufirst%3DG.%26aulast%3DBetz%26aufirst%3DA.%26aulast%3DDeGuzman%26aufirst%3DF.%26aulast%3DPak%26aufirst%3DY.%26aulast%3DInagaki%26aufirst%3DM.%26aulast%3DBaker%26aufirst%3DD.%2BC.%26aulast%3DHollenbach%26aufirst%3DS.%2BJ.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DSinha%26aufirst%3DU.%26atitle%3DThe%2520Novel%2520Kinase%2520Inhibitor%2520PRT062070%2520%2528Cerdulatinib%2529%2520Demonstrates%2520Efficacy%2520in%2520Models%2520of%2520Autoimmunity%2520and%2520B-Cell%2520Cancer%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D351%26spage%3D538%26epage%3D548%26doi%3D10.1124%2Fjpet.114.218164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGuzman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbach, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, U.</span></span> <span> </span><span class="NLM_article-title">PRT062070: A Dual Syk/JAK Inhibitor with Potent Immune Regulatory Capacity in Rodent Models of Inflammation and Cancer</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">2764</span>, <span class="refDoi"> DOI: 10.1182/blood.V120.21.2764.2764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1182%2Fblood.V120.21.2764.2764" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=2764&author=G.+Coffeyauthor=F.+DeGuzmanauthor=G.+Leeauthor=L.+Kamenauthor=D.+Bakerauthor=S.+J.+Hollenbachauthor=A.+Pandeyauthor=U.+Sinha&title=PRT062070%3A+A+Dual+Syk%2FJAK+Inhibitor+with+Potent+Immune+Regulatory+Capacity+in+Rodent+Models+of+Inflammation+and+Cancer&doi=10.1182%2Fblood.V120.21.2764.2764"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1182%2Fblood.V120.21.2764.2764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V120.21.2764.2764%26sid%3Dliteratum%253Aachs%26aulast%3DCoffey%26aufirst%3DG.%26aulast%3DDeGuzman%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DKamen%26aufirst%3DL.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DHollenbach%26aufirst%3DS.%2BJ.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DSinha%26aufirst%3DU.%26atitle%3DPRT062070%253A%2520A%2520Dual%2520Syk%252FJAK%2520Inhibitor%2520with%2520Potent%2520Immune%2520Regulatory%2520Capacity%2520in%2520Rodent%2520Models%2520of%2520Inflammation%2520and%2520Cancer%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D2764%26doi%3D10.1182%2Fblood.V120.21.2764.2764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, A.</span>; <span class="NLM_string-name">Coffey, G.</span>; <span class="NLM_string-name">Leeds, J.</span></span> <span> </span><span class="NLM_article-title">Cerdulatinib for the Treatment of B-Cell Malignancies</span>. WO<span class="NLM_patent">2016/196385 A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Pandey&author=G.+Coffey&author=J.+Leeds&title=Cerdulatinib+for+the+Treatment+of+B-Cell+Malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DA.%26atitle%3DCerdulatinib%2520for%2520the%2520Treatment%2520of%2520B-Cell%2520Malignancies%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dugo, M.</span></span> <i>Dissecting Melanoma Heterogeneity by Integrative Genomic Analysis for Tailored Anti-Cancer Therapy</i>. Ph.D. Thesis, <span class="NLM_publisher-name">The Open University</span>, <span class="NLM_publisher-loc">United Kingdom</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+Dugo&title=Dissecting+Melanoma+Heterogeneity+by+Integrative+Genomic+Analysis+for+Tailored+Anti-Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDugo%26aufirst%3DM.%26jtitle%3DDissecting%2520Melanoma%2520Heterogeneity%2520by%2520Integrative%2520Genomic%2520Analysis%2520for%2520Tailored%2520Anti-Cancer%2520Therapy%26pub%3DThe%2520Open%2520University%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gingrich, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisko, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albom, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeles, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aimone, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haltiwanger, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells-Knecht, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ator, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, B. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of an Orally Efficacious Inhibitor of Anaplastic Lymphoma Kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4580</span>– <span class="NLM_lpage">4593</span>, <span class="refDoi"> DOI: 10.1021/jm201550q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201550q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms1Sks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4580-4593&author=D.+E.+Gingrichauthor=J.+G.+Liskoauthor=M.+A.+Curryauthor=M.+Chengauthor=M.+Quailauthor=L.+Luauthor=W.+Wanauthor=M.+S.+Albomauthor=T.+S.+Angelesauthor=L.+D.+Aimoneauthor=R.+C.+Haltiwangerauthor=K.+Wells-Knechtauthor=G.+R.+Ottauthor=A.+K.+Ghoseauthor=M.+A.+Atorauthor=B.+Ruggeriauthor=B.+D.+Dorsey&title=Discovery+of+an+Orally+Efficacious+Inhibitor+of+Anaplastic+Lymphoma+Kinase&doi=10.1021%2Fjm201550q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an orally efficacious inhibitor of anaplastic lymphoma kinase</span></div><div class="casAuthors">Gingrich, Diane E.; Lisko, Joseph G.; Curry, Matthew A.; Cheng, Mangeng; Quail, Matthew; Lu, Lihui; Wan, Weihua; Albom, Mark S.; Angeles, Thelma S.; Aimone, Lisa D.; Haltiwanger, R. Curtis; Wells-Knecht, Kevin; Ott, Gregory R.; Ghose, Arup K.; Ator, Mark A.; Ruggeri, Bruce; Dorsey, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4580-4593</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Anaplastic lymphoma kinase (ALK) is a promising therapeutic target for the treatment of cancer, supported by considerable favorable preclin. and clin. activities over the past several years and culminating in the recent FDA approval of the ALK inhibitor crizotinib.  Through a series of targeted modifications on an ALK inhibitor diaminopyrimidine scaffold, our research group has driven improvements in ALK potency, kinase selectivity, and overall pharmaceutical properties.  Optimization of this scaffold has led to the identification of a potent and efficacious inhibitor of ALK, I.  A striking feature of I over previously described ALK inhibitors is its >600-fold selectivity over insulin receptor (IR), a closely related kinase family member.  Most importantly, I exhibited dose proportional escalation in rat compared to compd. 3 which suffered dose limiting absorption preventing further advancement.  Compd. I exhibited significant in vivo antitumor efficacy when dosed orally in an ALK-pos. ALCL tumor xenograft model in SCID mice, warranting further assessment in advanced preclin. models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX3rG4B6V3Y7Vg90H21EOLACvtfcHk0ljhsMXl80usnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms1Sks7s%253D&md5=f0592f6eb9d22a5b8e70ab5d3499f821</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Fjm201550q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201550q%26sid%3Dliteratum%253Aachs%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26aulast%3DLisko%26aufirst%3DJ.%2BG.%26aulast%3DCurry%26aufirst%3DM.%2BA.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DQuail%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DWan%26aufirst%3DW.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DHaltiwanger%26aufirst%3DR.%2BC.%26aulast%3DWells-Knecht%26aufirst%3DK.%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3DDiscovery%2520of%2520an%2520Orally%2520Efficacious%2520Inhibitor%2520of%2520Anaplastic%2520Lymphoma%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4580%26epage%3D4593%26doi%3D10.1021%2Fjm201550q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katayama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lifshits, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakespeare, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iafrate, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A. T.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Strategies to Overcome Crizotinib Resistance in Non-Small Cell Lung Cancers Harboring the Fusion Oncogene EML4-ALK</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">7535</span>– <span class="NLM_lpage">7540</span>, <span class="refDoi"> DOI: 10.1073/pnas.1019559108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1073%2Fpnas.1019559108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=21502504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFSrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=7535-7540&author=R.+Katayamaauthor=T.+M.+Khanauthor=C.+Benesauthor=E.+Lifshitsauthor=H.+Ebiauthor=V.+M.+Riveraauthor=W.+C.+Shakespeareauthor=A.+J.+Iafrateauthor=J.+A.+Engelmanauthor=A.+T.+Shaw&title=Therapeutic+Strategies+to+Overcome+Crizotinib+Resistance+in+Non-Small+Cell+Lung+Cancers+Harboring+the+Fusion+Oncogene+EML4-ALK&doi=10.1073%2Fpnas.1019559108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK</span></div><div class="casAuthors">Katayama, Ryohei; Khan, Tahsin M.; Benes, Cyril; Lifshits, Eugene; Ebi, Hiromichi; Rivera, Victor M.; Shakespeare, William C.; Iafrate, A. John; Engelman, Jeffrey A.; Shaw, Alice T.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7535-7540, S7535/1-S7535/17</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The echinoderm microtubule-assocd. protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) fusion oncogene represents a mol. target in a small subset of non-small cell lung cancers (NSCLCs).  This fusion leads to constitutive ALK activation with potent transforming activity.  In a pivotal phase 1 clin. trial, the ALK tyrosine kinase inhibitor (TKI) crizotinib (PF-02341066) demonstrated impressive antitumor activity in the majority of patients with NSCLC harboring ALK fusions.  However, despite these remarkable initial responses, cancers eventually develop resistance to crizotinib, usually within 1 y, thereby limiting the potential clin. benefit.  To det. how cancers acquire resistance to ALK inhibitors, we established a model of acquired resistance to crizotinib by exposing a highly sensitive EML4-ALK-pos. NSCLC cell line to increasing doses of crizotinib until resistance emerged.  We found that cells resistant to intermediate doses of crizotinib developed amplification of the EML4-ALK gene.  Cells resistant to higher doses (1 μM) also developed a gatekeeper mutation, L1196M, within the kinase domain, rendering EML4-ALK insensitive to crizotinib.  This gatekeeper mutation was readily detected using a unique and highly sensitive allele-specific PCR assay.  Although crizotinib was ineffectual against EML4-ALK harboring the gatekeeper mutation, we obsd. that two structurally different ALK inhibitors, NVPTAE684 and AP26113, were highly active against the resistant cancer cells in vitro and in vivo.  Furthermore, these resistant cells remained highly sensitive to the Hsp90 inhibitor 17-AAG.  Thus, we have developed a model of acquired resistance to ALK inhibitors and have shown that second-generation ALK TKIs or Hsp90 inhibitors are effective in treating crizotinib-resistant tumors harboring secondary gatekeeper mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPbiLG5xpg0LVg90H21EOLACvtfcHk0ljVCM-HC9YF4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFSrsbY%253D&md5=82f47736429e6f71f9fd5852e4df64cb</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1019559108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1019559108%26sid%3Dliteratum%253Aachs%26aulast%3DKatayama%26aufirst%3DR.%26aulast%3DKhan%26aufirst%3DT.%2BM.%26aulast%3DBenes%26aufirst%3DC.%26aulast%3DLifshits%26aufirst%3DE.%26aulast%3DEbi%26aufirst%3DH.%26aulast%3DRivera%26aufirst%3DV.%2BM.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26atitle%3DTherapeutic%2520Strategies%2520to%2520Overcome%2520Crizotinib%2520Resistance%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancers%2520Harboring%2520the%2520Fusion%2520Oncogene%2520EML4-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D7535%26epage%3D7540%26doi%3D10.1073%2Fpnas.1019559108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edupuganti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taliaferro, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidhu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anslyn, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartholomeusz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalby, K. N.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potent Inhibitor of MELK That Inhibits Expression of the Anti-Apoptotic Protein Mcl-1 and TNBC Cell Growth</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2609</span>– <span class="NLM_lpage">2616</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.bmc.2017.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=28351607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltVajtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=2609-2616&author=R.+Edupugantiauthor=J.+M.+Taliaferroauthor=Q.+Wangauthor=X.+Xieauthor=E.+J.+Choauthor=F.+Vidhuauthor=P.+Renauthor=E.+V.+Anslynauthor=C.+Bartholomeuszauthor=K.+N.+Dalby&title=Discovery+of+a+Potent+Inhibitor+of+MELK+That+Inhibits+Expression+of+the+Anti-Apoptotic+Protein+Mcl-1+and+TNBC+Cell+Growth&doi=10.1016%2Fj.bmc.2017.03.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent inhibitor of MELK that inhibits expression of the anti-apoptotic protein Mcl-1 and TNBC cell growth</span></div><div class="casAuthors">Edupuganti, Ramakrishna; Taliaferro, Juliana M.; Wang, Qiantao; Xie, Xuemei; Cho, Eun Jeong; Vidhu, Fnu; Ren, Pengyu; Anslyn, Eric V.; Bartholomeusz, Chandra; Dalby, Kevin N.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2609-2616</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Despite recent advances in molecularly directed therapy, triple neg. breast cancer (TNBC) remains one of the most aggressive forms of breast cancer, still without a suitable target for specific inhibitors.  Maternal embryonic leucine zipper kinase (MELK) is highly expressed in TNBC, where level of overexpression correlates with poor prognosis and an aggressive disease course.  Herein, the authors describe the discovery through targeted kinase inhibitor library screening, and structure-guided design of a series of ATP-competitive indolinone derivs. with subnanomolar inhibition consts. towards MELK.  The most potent compd., I, inhibits the expression of the antiapoptotic protein Mcl-1 and proliferation of TNBC cells exhibiting selectivity for cells expressing high levels of MELK.  These studies suggest that further elaboration of I will furnish MELK-selective inhibitors with potential for development in preclin. models of TNBC and other cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp3HNGNHlJNbVg90H21EOLACvtfcHk0ljVCM-HC9YF4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltVajtLs%253D&md5=acfe499443cf870620959e83ff7fe037</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DEdupuganti%26aufirst%3DR.%26aulast%3DTaliaferro%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DCho%26aufirst%3DE.%2BJ.%26aulast%3DVidhu%26aufirst%3DF.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DAnslyn%26aufirst%3DE.%2BV.%26aulast%3DBartholomeusz%26aufirst%3DC.%26aulast%3DDalby%26aufirst%3DK.%2BN.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520Inhibitor%2520of%2520MELK%2520That%2520Inhibits%2520Expression%2520of%2520the%2520Anti-Apoptotic%2520Protein%2520Mcl-1%2520and%2520TNBC%2520Cell%2520Growth%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D2609%26epage%3D2616%26doi%3D10.1016%2Fj.bmc.2017.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karaman, M. W</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallant, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atteridge, C. E</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, B. T</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. W</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edeen, P. T</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faraoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. P</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, D. J</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milanov, Z. V</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, M. J</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallares, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. K</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritchard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P</span></span> <span> </span><span class="NLM_article-title">A Quantitative Analysis of Kinase Inhibitor Selectivity</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1038/nbt1358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W+Karamanauthor=S.+Herrgardauthor=D.+K+Treiberauthor=P.+Gallantauthor=C.+E+Atteridgeauthor=B.+T+Campbellauthor=K.+W+Chanauthor=P.+Ciceriauthor=M.+I+Davisauthor=P.+T+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P+Huntauthor=D.+J+Lockhartauthor=Z.+V+Milanovauthor=M.+J+Morrisonauthor=G.+Pallaresauthor=H.+K+Patelauthor=S.+Pritchardauthor=L.+M+Wodickaauthor=P.+P+Zarrinkar&title=A+Quantitative+Analysis+of+Kinase+Inhibitor+Selectivity&doi=10.1038%2Fnbt1358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0ljVCM-HC9YF4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE%26aulast%3DCampbell%26aufirst%3DB.%2BT%26aulast%3DChan%26aufirst%3DK.%2BW%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI%26aulast%3DEdeen%26aufirst%3DP.%2BT%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP%26aulast%3DLockhart%26aufirst%3DD.%2BJ%26aulast%3DMilanov%26aufirst%3DZ.%2BV%26aulast%3DMorrison%26aufirst%3DM.%2BJ%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM%26aulast%3DZarrinkar%26aufirst%3DP.%2BP%26atitle%3DA%2520Quantitative%2520Analysis%2520of%2520Kinase%2520Inhibitor%2520Selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132%26doi%3D10.1038%2Fnbt1358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">N’guyen, C.-H.</span>; <span class="NLM_string-name">Molla, A.</span></span> <span> </span><span class="NLM_article-title">Amino-Substituted-Alkyloxy-Benzo [e] Pyrido [4, 3-b] Indole Derivatives as New Potent Kinase Inhibitors</span>. US<span class="NLM_patent">2014073637</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.-H.+N%E2%80%99guyen&author=A.+Molla&title=Amino-Substituted-Alkyloxy-Benzo+%5Be%5D+Pyrido+%5B4%2C+3-b%5D+Indole+Derivatives+as+New+Potent+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DN%25E2%2580%2599guyen%26aufirst%3DC.-H.%26atitle%3DAmino-Substituted-Alkyloxy-Benzo%2520%255Be%255D%2520Pyrido%2520%255B4%252C%25203-b%255D%2520Indole%2520Derivatives%2520as%2520New%2520Potent%2520Kinase%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matuszkiewicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoshino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halkowycz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teratani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimshaw, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paraselli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, R.</span></span> <span> </span><span class="NLM_article-title">Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase Inhibitor</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-12-0657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1158%2F1535-7163.MCT-12-0657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23358665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXls12qs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=460-470&author=P.+Farrellauthor=L.+Shiauthor=J.+Matuszkiewiczauthor=D.+Balakrishnaauthor=T.+Hoshinoauthor=L.+Zhangauthor=S.+Elliottauthor=R.+Fabreyauthor=B.+Leeauthor=P.+Halkowyczauthor=B.+Sangauthor=S.+Ishinoauthor=T.+Nomuraauthor=M.+Terataniauthor=Y.+Ohtaauthor=C.+Grimshawauthor=B.+Paraselliauthor=T.+Satouauthor=R.+de+Jong&title=Biological+Characterization+of+TAK-901%2C+an+Investigational%2C+Novel%2C+Multitargeted+Aurora+B+Kinase+Inhibitor&doi=10.1158%2F1535-7163.MCT-12-0657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase Inhibitor</span></div><div class="casAuthors">Farrell, Pamela; Shi, Lihong; Matuszkiewicz, Jennifer; Balakrishna, Deepika; Hoshino, Takashi; Zhang, Lilly; Elliott, Sarah; Fabrey, Robyn; Lee, Bumsup; Halkowycz, Petro; Sang, BiChing; Ishino, Seigo; Nomura, Toshiyuki; Teratani, Mika; Ohta, Yoshikazu; Grimshaw, Charles; Paraselli, Bheema; Satou, Takashi; de Jong, Ron</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">460-470</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Protein kinases Aurora A, B, and C play essential roles during mitosis and cell division, are frequently elevated in cancer, and represent attractive targets for therapeutic intervention.  TAK-901 is an investigational, multitargeted Aurora B kinase inhibitor derived from a novel azacarboline kinase hinge-binder chemotype.  TAK-901 exhibited time-dependent, tight-binding inhibition of Aurora B, but not Aurora A. Consistent with Aurora B inhibition, TAK-901 suppressed cellular histone H3 phosphorylation and induced polyploidy.  In various human cancer cell lines, TAK-901 inhibited cell proliferation with effective concn. values from 40 to 500 nmol/L.  Examn. of a broad panel of kinases in biochem. assays revealed inhibition of multiple kinases.  However, TAK-901 potently inhibited only a few kinases other than Aurora B in intact cells, including FLT3 and FGFR2.  In rodent xenografts, TAK-901 exhibited potent activity against multiple human solid tumor types, and complete regression was obsd. in the ovarian cancer A2780 model.  TAK-901 also displayed potent activity against several leukemia models.  In vivo biomarker studies showed that TAK-901 induced pharmacodynamic responses consistent with Aurora B inhibition and correlating with retention of TAK-901 in tumor tissue.  These preclin. data highlight the therapeutic potential of TAK-901, which has entered phase I clin. trials in patients within a diverse range of cancers.  Mol Cancer Ther; 12(4); 460-70. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Jmz5iJm_9bVg90H21EOLACvtfcHk0lj02lfWZKyFOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXls12qs78%253D&md5=b91ec09d97e96f2612b10e3c419c5682</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0657%26sid%3Dliteratum%253Aachs%26aulast%3DFarrell%26aufirst%3DP.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DMatuszkiewicz%26aufirst%3DJ.%26aulast%3DBalakrishna%26aufirst%3DD.%26aulast%3DHoshino%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DS.%26aulast%3DFabrey%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DHalkowycz%26aufirst%3DP.%26aulast%3DSang%26aufirst%3DB.%26aulast%3DIshino%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DTeratani%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DY.%26aulast%3DGrimshaw%26aufirst%3DC.%26aulast%3DParaselli%26aufirst%3DB.%26aulast%3DSatou%26aufirst%3DT.%26aulast%3Dde%2BJong%26aufirst%3DR.%26atitle%3DBiological%2520Characterization%2520of%2520TAK-901%252C%2520an%2520Investigational%252C%2520Novel%252C%2520Multitargeted%2520Aurora%2520B%2520Kinase%2520Inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D460%26epage%3D470%26doi%3D10.1158%2F1535-7163.MCT-12-0657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le, L. T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couvet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coll, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Benzo[e]Pyridoindolones as Kinase Inhibitors That Disrupt Mitosis Exit While Erasing AMPK-Thr172 Phosphorylation on the Spindle</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">22152</span>– <span class="NLM_lpage">22166</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.4158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.18632%2Foncotarget.4158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26247630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BC287gtlOjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=22152-22166&author=L.+T.+T.+Leauthor=M.+Couvetauthor=B.+Favierauthor=J.+L.+Collauthor=C.+H.+Nguyenauthor=A.+Molla&title=Discovery+of+Benzo%5Be%5DPyridoindolones+as+Kinase+Inhibitors+That+Disrupt+Mitosis+Exit+While+Erasing+AMPK-Thr172+Phosphorylation+on+the+Spindle&doi=10.18632%2Foncotarget.4158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of benzo[e]pyridoindolones as kinase inhibitors that disrupt mitosis exit while erasing AMPK-Thr172 phosphorylation on the spindle</span></div><div class="casAuthors">Le Ly-Thuy-Tram; Couvet Morgane; Coll Jean-Luc; Molla Annie; Le Ly-Thuy-Tram; Favier Bertrand; Nguyen Chi-Hung</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">22152-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aurora kinases play an essential role in mitotic progression and are attractive targets in cancer therapy.  The first generation of benzo[e]pyridoindole exhibited powerful aurora kinase inhibition but their low solubility limited further development.  Grafting a pyperidine-ethoxy group gives rise to a hydrosoluble inhibitor: compound C5M.C5M could efficiently inhibit the proliferation of cells from different origins.  C5M prevented cell cycling, induced a strong mitotic arrest then, cells became polyploid and finally died.  C5M did not impair the spindle checkpoint, the separation of the sister chromatids and the transfer of aurora B on the mid-zone.  C5M prevented histone H3 phosphorylation at mitotic entry and erased AMPK-Thr172 phosphorylation in late mitosis.  With this unique profile of inhibition, C5M could be useful for understanding the role of phospho-Thr172-AMPK in abscission and the relationship between the chromosomal complex and the energy sensing machinery.C5M is a multikinase inhibitor with interesting preclinical characteristics: high hydro-solubility and a good stability in plasma.  A single dose prevents the expansion of multicellular spheroids.  C5M can safely be injected to mice and reduces significantly the development of xenograft.  The next step will be to define the protocol of treatment and the cancer therapeutic field of this new anti-proliferative drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpml7l8mkX0A20zIbnCCI3fW6udTcc2eb_P05-33KCALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287gtlOjsA%253D%253D&md5=43dd810d96e3d9583f49d053b48771f4</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.4158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.4158%26sid%3Dliteratum%253Aachs%26aulast%3DLe%26aufirst%3DL.%2BT.%2BT.%26aulast%3DCouvet%26aufirst%3DM.%26aulast%3DFavier%26aufirst%3DB.%26aulast%3DColl%26aufirst%3DJ.%2BL.%26aulast%3DNguyen%26aufirst%3DC.%2BH.%26aulast%3DMolla%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520Benzo%255Be%255DPyridoindolones%2520as%2520Kinase%2520Inhibitors%2520That%2520Disrupt%2520Mitosis%2520Exit%2520While%2520Erasing%2520AMPK-Thr172%2520Phosphorylation%2520on%2520the%2520Spindle%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D22152%26epage%3D22166%26doi%3D10.18632%2Foncotarget.4158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, T.</span>; <span class="NLM_string-name">Koolman, H.</span></span> <span> </span><span class="NLM_article-title">Thiazole Derivatives for the Treatment of Diseases Such as Cancer</span>. US<span class="NLM_patent">8703961 B2</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+Heinrich&author=H.+Koolman&title=Thiazole+Derivatives+for+the+Treatment+of+Diseases+Such+as+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DT.%26atitle%3DThiazole%2520Derivatives%2520for%2520the%2520Treatment%2520of%2520Diseases%2520Such%2520as%2520Cancer%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeely, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dempsey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blosser, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, M. S.</span></span> <span> </span><span class="NLM_article-title">LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2004</span>– <span class="NLM_lpage">2013</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-1037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1158%2F1535-7163.MCT-14-1037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26141948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVegs7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=2004-2013&author=C.+Kingauthor=H.+B.+Diazauthor=S.+McNeelyauthor=D.+Barnardauthor=J.+Dempseyauthor=W.+Blosserauthor=R.+Beckmannauthor=D.+Bardaauthor=M.+S.+Marshall&title=LY2606368+Causes+Replication+Catastrophe+and+Antitumor+Effects+through+CHK1-Dependent+Mechanisms&doi=10.1158%2F1535-7163.MCT-14-1037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms</span></div><div class="casAuthors">King, Constance; Diaz, H. Bruce; McNeely, Samuel; Barnard, Darlene; Dempsey, Jack; Blosser, Wayne; Beckmann, Richard; Barda, David; Marshall, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2004-2013</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">CHK1 is a multifunctional protein kinase integral to both the cellular response to DNA damage and control of the no. of active replication forks.  CHK1 inhibitors are currently under investigation as chemopotentiating agents due to CHK1's role in establishing DNA damage checkpoints in the cell cycle.  Here, we describe the characterization of a novel CHK1 inhibitor, LY2606368, which as a single agent causes double-stranded DNA breakage while simultaneously removing the protection of the DNA damage checkpoints.  The action of LY2606368 is dependent upon inhibition of CHK1 and the corresponding increase in CDC25A activation of CDK2, which increases the no. of replication forks while reducing their stability.  Treatment of cells with LY2606368 results in the rapid appearance of TUNEL and pH2AX-pos. double-stranded DNA breaks in the S-phase cell population.  Loss of the CHK1-dependent DNA damage checkpoints permits cells with damaged DNA to proceed into early mitosis and die.  The majority of treated mitotic nuclei consist of extensively fragmented chromosomes.  Inhibition of apoptosis by the caspase inhibitor Z-VAD-FMK had no effect on chromosome fragmentation, indicating that LY2606368 causes replication catastrophe.  Changes in the ratio of RPA2 to phosphorylated H2AX following LY2606368 treatment further support replication catastrophe as the mechanism of DNA damage.  LY2606368 shows similar activity in xenograft tumor models, which results in significant tumor growth inhibition.  LY2606368 is a potent representative of a novel class of drugs for the treatment of cancer that acts through replication catastrophe.  Mol Cancer Ther; 14(9); 2004-13. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSZ3pHCHoj6LVg90H21EOLACvtfcHk0li8OSxSPnQmlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVegs7vK&md5=ae5d36fc1ac012bdbb5228e38001db38</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-1037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-1037%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DC.%26aulast%3DDiaz%26aufirst%3DH.%2BB.%26aulast%3DMcNeely%26aufirst%3DS.%26aulast%3DBarnard%26aufirst%3DD.%26aulast%3DDempsey%26aufirst%3DJ.%26aulast%3DBlosser%26aufirst%3DW.%26aulast%3DBeckmann%26aufirst%3DR.%26aulast%3DBarda%26aufirst%3DD.%26aulast%3DMarshall%26aufirst%3DM.%2BS.%26atitle%3DLY2606368%2520Causes%2520Replication%2520Catastrophe%2520and%2520Antitumor%2520Effects%2520through%2520CHK1-Dependent%2520Mechanisms%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D2004%26epage%3D2013%26doi%3D10.1158%2F1535-7163.MCT-14-1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shpiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S. C.</span></span> <span> </span><span class="NLM_article-title">Comparison of the Specificity of Trk Inhibitors in Recombinant and Neuronal Assays</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2011.03.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.neuropharm.2011.03.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=21466816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslynsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=148-155&author=K.+J.+Martinauthor=N.+Shpiroauthor=R.+Traynorauthor=M.+Elliottauthor=J.+S.+C.+Arthur&title=Comparison+of+the+Specificity+of+Trk+Inhibitors+in+Recombinant+and+Neuronal+Assays&doi=10.1016%2Fj.neuropharm.2011.03.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the specificity of Trk inhibitors in recombinant and neuronal assays</span></div><div class="casAuthors">Martin, Kirsty J.; Shpiro, Natalia; Traynor, Ryan; Elliott, Matthew; Arthur, J. Simon C.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">148-155</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurotrophins are important mediators of neuronal development, survival and plasticity.  They act via binding to Trk receptors, which results in the stimulation of the intracellular tyrosine kinase domain of the receptor leading to autophosphorylation of this domain.  This in turn creates a scaffold that recruits various adapter proteins allowing the activation of intracellular signaling cascades including the PLCγ, MAPK and PI3K pathways.  Compds. that specifically block the activity of the tyrosine kinase domain of Trk receptors would provide a powerful tool to study the role of these receptors in cells.  K252a has previously been used for this purpose, however the authors show here that it can inhibit many tyrosine and serine/threonine kinases in vitro.  Profiling of 3 newer inhibitors, referred to here as SHN-753, SHN-722 and GSK-Trk, demonstrate that they have significantly improved specificity for the kinase activity of TrkA in vitro compared to K252a.  In addn. these compds. were found to block the TrkB mediated activation of ERK1/2 by BDNF, but did not affect NMDA induced ERK1/2 activation.  These compds., while still not completely specific for Trk receptor kinase activity, do represent a considerable improvement over K252a and should prove valuable in the study of neurotrophin-mediated actions in the nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcrkOys9w847Vg90H21EOLACvtfcHk0li8OSxSPnQmlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslynsL4%253D&md5=27a8a1b990598241d5914a51d3965d0c</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2011.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2011.03.021%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DK.%2BJ.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DTraynor%26aufirst%3DR.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26atitle%3DComparison%2520of%2520the%2520Specificity%2520of%2520Trk%2520Inhibitors%2520in%2520Recombinant%2520and%2520Neuronal%2520Assays%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D61%26spage%3D148%26epage%3D155%26doi%3D10.1016%2Fj.neuropharm.2011.03.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gozgit, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bebernitz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huszar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinda, M.</span></span> <span> </span><span class="NLM_article-title">Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-XL Survival Signaling in the Human JAK2 V617F Cell Line SET-2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">32334</span>– <span class="NLM_lpage">32343</span>, <span class="refDoi"> DOI: 10.1074/jbc.M803813200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M803813200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=18775810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOjtL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=32334-32343&author=J.+M.+Gozgitauthor=G.+Bebernitzauthor=P.+Patilauthor=M.+Yeauthor=J.+Parmentierauthor=J.+Wuauthor=N.+Suauthor=T.+Wangauthor=S.+Ioannidisauthor=A.+Daviesauthor=D.+Huszarauthor=M.+Zinda&title=Effects+of+the+JAK2+Inhibitor%2C+AZ960%2C+on+Pim%2FBAD%2FBCL-XL+Survival+Signaling+in+the+Human+JAK2+V617F+Cell+Line+SET-2&doi=10.1074%2Fjbc.M803813200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-xL Survival Signaling in the Human JAK2 V617F Cell Line SET-2</span></div><div class="casAuthors">Gozgit, Joseph M.; Bebernitz, Geraldine; Patil, Pankaj; Ye, Minwei; Parmentier, Julie; Wu, Jiaquan; Su, Nancy; Wang, Tao; Ioannidis, Stephanos; Davies, Audrey; Huszar, Dennis; Zinda, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">32334-32343</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The Janus-assocd. kinase 2 (JAK2) V617F mutation is believed to play a crit. role in the pathogenesis of polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis.  We have characterized a novel small mol. JAK2 inhibitor, AZ960, and used it as a tool to investigate the consequences of JAK2 V617F inhibition in the SET-2 cell line.  AZ960 inhibits JAK2 kinase with a Ki of 0.00045 μM in vitro and treatment of TEL-JAK2 driven Ba/F3 cells with AZ960 blocked STAT5 phosphorylation and potently inhibited cell proliferation (GI50 = 0.025 μM).  AZ960 demonstrated selectivity for TEL-JAK2-driven STAT5 phosphorylation and cell proliferation when compared with cell lines driven by similar fusions of the other JAK kinase family members.  In the SET-2 human megakaryoblastic cell line, heterozygous for the JAK2 V617F allele, inhibition of JAK2 resulted in decreased STAT3/5 phosphorylation and inhibition of cell proliferation (GI50 = 0.033 μM) predominately through the induction of mitochondrial-mediated apoptosis.  We provide evidence that JAK2 inhibition induces apoptosis by direct and indirect regulation of the anti-apoptotic protein BCL-xL.  Inhibition of JAK2 blocked BCL-XL mRNA expression resulting in a redn. of BCL-xL protein levels.  Addnl., inhibition of JAK2 resulted in decreased PIM1 and PIM2 mRNA expression.  Decreased PIM1 mRNA corresponded with a decrease in Pim1 protein levels and inhibition of BAD phosphorylation at Ser112.  Finally, small interfering RNA-mediated suppression of BCL-xL resulted in apoptotic cell death similar to the phenotype obsd. following JAK2 inhibition.  These results suggest a model in which JAK2 promotes cell survival by signaling through the Pim/BAD/BCL-xL pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSkGcqoxCVmrVg90H21EOLACvtfcHk0li8OSxSPnQmlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOjtL%252FE&md5=c06798f302c0c0b50d4c763ae5c731c3</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M803813200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M803813200%26sid%3Dliteratum%253Aachs%26aulast%3DGozgit%26aufirst%3DJ.%2BM.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DPatil%26aufirst%3DP.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DParmentier%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DA.%26aulast%3DHuszar%26aufirst%3DD.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DEffects%2520of%2520the%2520JAK2%2520Inhibitor%252C%2520AZ960%252C%2520on%2520Pim%252FBAD%252FBCL-XL%2520Survival%2520Signaling%2520in%2520the%2520Human%2520JAK2%2520V617F%2520Cell%2520Line%2520SET-2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D32334%26epage%3D32343%26doi%3D10.1074%2Fjbc.M803813200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinsmore, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elwood, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibeau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraybill, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapointe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. R.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design and Development of (Benz)Imidazole Pyridones as JAK1-Selective Kinase Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1803</span>– <span class="NLM_lpage">1808</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.02.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.bmcl.2016.02.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26927423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt12mtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1803-1808&author=V.+Simovauthor=S.+V.+Deshmukhauthor=C.+J.+Dinsmoreauthor=F.+Elwoodauthor=R.+B.+Fernandezauthor=Y.+Garciaauthor=C.+Gibeauauthor=H.+Gunaydinauthor=J.+Jungauthor=J.+D.+Katzauthor=B.+Kraybillauthor=B.+Lapointeauthor=S.+B.+Patelauthor=T.+Siuauthor=H.+Suauthor=J.+R.+Young&title=Structure-Based+Design+and+Development+of+%28Benz%29Imidazole+Pyridones+as+JAK1-Selective+Kinase+Inhibitors&doi=10.1016%2Fj.bmcl.2016.02.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design and development of (benz)imidazole pyridones as JAK1-selective kinase inhibitors</span></div><div class="casAuthors">Simov, Vladimir; Deshmukh, Sujal V.; Dinsmore, Christopher J.; Elwood, Fiona; Fernandez, Rafael B.; Garcia, Yudith; Gibeau, Craig; Gunaydin, Hakan; Jung, Joon; Katz, Jason D.; Kraybill, Brian; Lapointe, Blair; Patel, Sangita B.; Siu, Tony; Su, Hua; Young, Jonathan R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1803-1808</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The mammalian Janus Kinases (JAK1, JAK2, JAK3 and TYK2) are intracellular, nonreceptor tyrosine kinases whose activities have been assocd. in the literature and the clinic with a variety of hyperproliferative diseases and immunol. disorders.  At the onset of the program, it was hypothesized that a JAK1 selective compd. over JAK2 could lead to an improved therapeutic index relative to marketed nonselective JAK inhibitors by avoiding the clin. AEs, such as anemia, presumably assocd. with JAK2 inhibition.  During the course of the JAK1 program, a no. of diverse chem. scaffolds were identified from both uHTS campaigns and de novo scaffold design.  As part of this effort, a (benz)imidazole scaffold evolved via a scaffold-hopping exercise from a mature chem. series.  Concurrent crystallog.-driven exploration of the ribose pocket and the solvent front led to analogs with optimized kinome and JAK1 selectivities over the JAK2 isoform by targeting several residues unique to JAK1, such as Arg-879 and Glu-966.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeRwubYziKxrVg90H21EOLACvtfcHk0liV6kDQwS-dzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt12mtLo%253D&md5=f863ad973f0f86993bb7f796821b5059</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DSimov%26aufirst%3DV.%26aulast%3DDeshmukh%26aufirst%3DS.%2BV.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DElwood%26aufirst%3DF.%26aulast%3DFernandez%26aufirst%3DR.%2BB.%26aulast%3DGarcia%26aufirst%3DY.%26aulast%3DGibeau%26aufirst%3DC.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DKatz%26aufirst%3DJ.%2BD.%26aulast%3DKraybill%26aufirst%3DB.%26aulast%3DLapointe%26aufirst%3DB.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DSiu%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DYoung%26aufirst%3DJ.%2BR.%26atitle%3DStructure-Based%2520Design%2520and%2520Development%2520of%2520%2528Benz%2529Imidazole%2520Pyridones%2520as%2520JAK1-Selective%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1803%26epage%3D1808%26doi%3D10.1016%2Fj.bmcl.2016.02.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J. J.</span>; <span class="NLM_string-name">Li, Y.</span>; <span class="NLM_string-name">Rogers, E. W.</span>; <span class="NLM_string-name">Zhai, D.</span>; <span class="NLM_string-name">Deng, W.</span>; <span class="NLM_string-name">Huang, Z.</span></span> <span> </span><span class="NLM_article-title">Chiral Diaryl Macrocycles and Uses Thereof</span>. WO<span class="NLM_patent">2017015367A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+J.+Cui&author=Y.+Li&author=E.+W.+Rogers&author=D.+Zhai&author=W.+Deng&author=Z.+Huang&title=Chiral+Diaryl+Macrocycles+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26atitle%3DChiral%2520Diaryl%2520Macrocycles%2520and%2520Uses%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apgar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garin-Chesa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savchenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaaf, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahn, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoephel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haaksma, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adolf, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraut, N.</span></span> <span> </span><span class="NLM_article-title">BI 885578, a Novel IGF1R/INSR Tyrosine Kinase Inhibitor with Pharmacokinetic Properties That Dissociate Antitumor Efficacy and Perturbation of Glucose Homeostasis</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2762</span>– <span class="NLM_lpage">2772</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-15-0539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1158%2F1535-7163.MCT-15-0539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26438154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKlu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=2762-2772&author=M.+P.+Sandersonauthor=J.+Apgarauthor=P.+Garin-Chesaauthor=M.+H.+Hofmannauthor=D.+Kesslerauthor=J.+Quantauthor=A.+Savchenkoauthor=O.+Schaafauthor=M.+Treuauthor=H.+Tyeauthor=S.+K.+Zahnauthor=A.+Zoephelauthor=E.+Haaksmaauthor=G.+R.+Adolfauthor=N.+Kraut&title=BI+885578%2C+a+Novel+IGF1R%2FINSR+Tyrosine+Kinase+Inhibitor+with+Pharmacokinetic+Properties+That+Dissociate+Antitumor+Efficacy+and+Perturbation+of+Glucose+Homeostasis&doi=10.1158%2F1535-7163.MCT-15-0539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">BI 885578, a Novel IGF1R/INSR Tyrosine Kinase Inhibitor with Pharmacokinetic Properties That Dissociate Antitumor Efficacy and Perturbation of Glucose Homeostasis</span></div><div class="casAuthors">Sanderson, Michael P.; Apgar, Joshua; Garin-Chesa, Pilar; Hofmann, Marco H.; Kessler, Dirk; Quant, Jens; Savchenko, Alexander; Schaaf, Otmar; Treu, Matthias; Tye, Heather; Zahn, Stephan K.; Zoephel, Andreas; Haaksma, Eric; Adolf, Guenther R.; Kraut, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2762-2772</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibition of the IGF1R, INSRA, and INSRB receptor tyrosine kinases represents an attractive approach of pharmacol. intervention in cancer, owing to the roles of the IGF1R and INSRA in promoting cell proliferation and survival.  However, the central role of the INSRB isoform in glucose homeostasis suggests that prolonged inhibition of this kinase could result in metabolic toxicity.  We describe here the profile of the novel compd. BI 885578, a potent and selective ATP-competitive IGF1R/INSR tyrosine kinase inhibitor distinguished by rapid intestinal absorption and a short in vivo half-life as a result of rapid metabolic clearance.  BI 885578, administered daily per os, displayed an acceptable tolerability profile in mice at doses that significantly reduced the growth of xenografted human GEO and CL-14 colon carcinoma tumors.  We found that treatment with BI 885578 is accompanied by increases in circulating glucose and insulin levels, which in turn leads to compensatory hyperphosphorylation of muscle INSRs and subsequent normalization of blood glucose within a few hours.  In contrast, the normalization of IGF1R and INSR phosphorylation in GEO tumors occurs at a much slower rate.  In accordance with this, BI 885578 led to a prolonged inhibition of cell proliferation and induction of apoptosis in GEO tumors.  We propose that the remarkable therapeutic window obsd. for BI 885578 is achieved by virtue of the distinctive pharmacokinetic properties of the compd., capitalizing on the physiol. mechanisms of glucose homeostasis and differential levels of IGF1R and INSR expression in tumors and normal tissues.  Mol Cancer Ther; 14(12); 2762-72. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo1q7ZLdPL7rVg90H21EOLACvtfcHk0liV6kDQwS-dzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKlu73E&md5=3683e0ac329ddabba6786976cf5d7860</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-15-0539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-15-0539%26sid%3Dliteratum%253Aachs%26aulast%3DSanderson%26aufirst%3DM.%2BP.%26aulast%3DApgar%26aufirst%3DJ.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DHofmann%26aufirst%3DM.%2BH.%26aulast%3DKessler%26aufirst%3DD.%26aulast%3DQuant%26aufirst%3DJ.%26aulast%3DSavchenko%26aufirst%3DA.%26aulast%3DSchaaf%26aufirst%3DO.%26aulast%3DTreu%26aufirst%3DM.%26aulast%3DTye%26aufirst%3DH.%26aulast%3DZahn%26aufirst%3DS.%2BK.%26aulast%3DZoephel%26aufirst%3DA.%26aulast%3DHaaksma%26aufirst%3DE.%26aulast%3DAdolf%26aufirst%3DG.%2BR.%26aulast%3DKraut%26aufirst%3DN.%26atitle%3DBI%2520885578%252C%2520a%2520Novel%2520IGF1R%252FINSR%2520Tyrosine%2520Kinase%2520Inhibitor%2520with%2520Pharmacokinetic%2520Properties%2520That%2520Dissociate%2520Antitumor%2520Efficacy%2520and%2520Perturbation%2520of%2520Glucose%2520Homeostasis%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D2762%26epage%3D2772%26doi%3D10.1158%2F1535-7163.MCT-15-0539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deacon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horiuchi, K.</span></span> <span> </span><span class="NLM_article-title">The Challenge of Selecting Protein Kinase Assays for Lead Discovery Optimization</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">607</span>– <span class="NLM_lpage">621</span>, <span class="refDoi"> DOI: 10.1517/17460441.3.6.607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1517%2F17460441.3.6.607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=19662101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotVyrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=607-621&author=H.+Maauthor=S.+Deaconauthor=K.+Horiuchi&title=The+Challenge+of+Selecting+Protein+Kinase+Assays+for+Lead+Discovery+Optimization&doi=10.1517%2F17460441.3.6.607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">The challenge of selecting protein kinase assays for lead discovery optimization</span></div><div class="casAuthors">Ma, Haiching; Deacon, Sean; Horiuchi, Kurumi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">607-621</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Protein kinases represent one of the most promising groups of drug targets owing to their involvement in such pathol. conditions as cancer, inflammatory diseases, neural disorders, and metab. problems.  In the last few years, numerous pharmaceutical and biotech companies have established kinase high-throughput screening (HTS) programs, and the reagent and service industries for kinase assay platforms, kits, and profiling services have begun to thrive.  Objective: The plethora of different assay formats available today poses a great challenge to scientists who want to select a technol. that will be cost efficient, convenient to use, and have low false pos. and false neg. rates.  Methods: In the current review, we summarize the most commonly used kinase assay methods in the drug discovery process, present the advantages and disadvantages of each of these methods, and discuss the challenges of discovering kinase inhibitors by using these technologies.  Conclusions: The decision of selecting the assay formats for HTS or service platform for profiling should take into account not only the final goals of the screens but also the limitation of resources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL-z-puxv_a7Vg90H21EOLACvtfcHk0lgncwCvYNH9Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotVyrt70%253D&md5=d01a65a4560c5edb357f02c788631c69</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1517%2F17460441.3.6.607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.3.6.607%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DH.%26aulast%3DDeacon%26aufirst%3DS.%26aulast%3DHoriuchi%26aufirst%3DK.%26atitle%3DThe%2520Challenge%2520of%2520Selecting%2520Protein%2520Kinase%2520Assays%2520for%2520Lead%2520Discovery%2520Optimization%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26spage%3D607%26epage%3D621%26doi%3D10.1517%2F17460441.3.6.607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naeem, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stetsiv, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetting, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashirullah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisbrecht, E. R.</span></span> <span> </span><span class="NLM_article-title">Drosophila NUAK functions with Starvin/BAG3 in autophagic protein turnover</span>. <i>PLoS Genet.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>16</i></span>, <span class="NLM_elocation-id">e1008700</span> <span class="refDoi"> DOI: 10.1371/journal.pgen.1008700</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1371%2Fjournal.pgen.1008700" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=32320396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFSjs7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2020&author=D.+Brooksauthor=F.+Naeemauthor=M.+Stetsivauthor=S.+C.+Goettingauthor=S.+Bawaauthor=N.+Greenauthor=C.+Clarkauthor=A.+Bashirullahauthor=E.+R.+Geisbrecht&title=Drosophila+NUAK+functions+with+Starvin%2FBAG3+in+autophagic+protein+turnover&doi=10.1371%2Fjournal.pgen.1008700"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Drosophila NUAK functions with Starvin/BAG3 in autophagic protein turnover</span></div><div class="casAuthors">Brooks, David; Naeem, Fawwaz; Stetsiv, Marta; Goetting, Samantha C.; Bawa, Simranjot; Green, Nicole; Clark, Cheryl; Bashirullah, Arash; Geisbrecht, Erika R.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Genetics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e1008700</span>CODEN:
                <span class="NLM_cas:coden">PGLEB5</span>;
        ISSN:<span class="NLM_cas:issn">1553-7404</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The inability to remove protein aggregates in post-mitotic cells such as muscles or neurons is a cellular hallmark of aging cells and is a key factor in the initiation and progression of protein misfolding diseases.  While protein aggregate disorders share common features, the mol. level events that culminate in abnormal protein accumulation cannot be explained by a single mechanism.  Here we show that loss of the serine/threonine kinase NUAK causes cellular degeneration resulting from the incomplete clearance of protein aggregates in Drosophila larval muscles.  In NUAK mutant muscles, regions that lack the myofibrillar proteins F-actin and Myosin heavy chain (MHC) instead contain damaged organelles and the accumulation of select proteins, including Filamin (Fil) and CryAB.  NUAK biochem. and genetically interacts with Drosophila Starvin (Stv), the ortholog of mammalian Bcl-2-assocd. athanogene 3 (BAG3).  Consistent with a known role for the co-chaperone BAG3 and the Heat shock cognate 71 kDa (HSC70)/HSPA8 ATPase in the autophagic clearance of proteins, RNA interference (RNAi) of Drosophila Stv, Hsc70-4, or autophagy-related 8a (Atg8a) all exhibit muscle degeneration and muscle contraction defects that phenocopy NUAK mutants.  We further demonstrate that Fil is a target of NUAK kinase activity and abnormally accumulates upon loss of the BAG3-Hsc70-4 complex.  In addn., Ubiquitin (Ub), ref(2)p/p62, and Atg8a are increased in regions of protein aggregation, consistent with a block in autophagy upon loss of NUAK.  Collectively, our results establish a novel role for NUAK with the Stv-Hsc70-4 complex in the autophagic clearance of proteins that may eventually lead to treatment options for protein aggregate diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1M6WtUolRVbVg90H21EOLACvtfcHk0lgncwCvYNH9Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFSjs7bI&md5=2f648643d3fc5668fb63cee16f4c8ad3</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.1008700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.1008700%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DD.%26aulast%3DNaeem%26aufirst%3DF.%26aulast%3DStetsiv%26aufirst%3DM.%26aulast%3DGoetting%26aufirst%3DS.%2BC.%26aulast%3DBawa%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DN.%26aulast%3DClark%26aufirst%3DC.%26aulast%3DBashirullah%26aufirst%3DA.%26aulast%3DGeisbrecht%26aufirst%3DE.%2BR.%26atitle%3DDrosophila%2520NUAK%2520functions%2520with%2520Starvin%252FBAG3%2520in%2520autophagic%2520protein%2520turnover%26jtitle%3DPLoS%2520Genet.%26date%3D2020%26volume%3D16%26doi%3D10.1371%2Fjournal.pgen.1008700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Homology of NUAK1 in several species and ARKs sequence homology of the kinase domain. (A) Schematic representation of NUAK1 gene products in each animal. Red designates Ser/Thr kinase domain conserved throughout NUAK1 gene products (number shows the amino acid identity with the domain in mouse NUAK1). The Ser/Thr kinase domain is highly conserved among human, mouse and zebrafish NUAK1 genes. (B) Alignment and dendogram of the T-loop sequences of the AMPK-related kinases. Conserved residues are marked in yellow, whereas identical residues are marked in red. An asterisk indicates the Ser and Thr phosphorylation sites of STK11. S, N, G, and A indicate preferences for Ser, Asn, Gly, and Ala, respectively; ϕ represents a large hydrophobic residue; and X stands for any amino acid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic illustration of NUAK1 mechanism in controlling cell adhesion. After activation and phosphorylation by STK11, NUAK1 forms a complex with MYPT1 and PP1β. Subsequently, NUAK1 phosphorylates MYPT1 at Ser<sup>910</sup>, Ser<sup>472</sup>, and Ser<sup>445</sup> to enhance binding between MYPT1 and 14-3-3 protein and to inhibit the phosphatase capacity of PP1β. The overall result demonstrated in the figure illustrates that increased MLC2 phosphorylation enhances cell detachment and myosin II activation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic illustration of ubiquitylation and degradation of NUAK1 and mechanisms of PTEN-NUAK1 and PTEN-STK11 synthetic sickness/lethality. (A) NUAK1 binds and phosphorylates PP1β<sup>MYPT1</sup> myosin phosphatase complex at Ser<sup>472</sup> and Ser<sup>445</sup>, promoting 14-3-3 binding. In the S/G<sub>2</sub>-phase of the cell cycle, MYPT1 and NUAK1 are primed by CDKs, which in turn creates a docking site for PLK. PLK1 binds with MYPT1 at Ser<sup>473</sup>, leading to inactivation of PLK1 upon PP1β<sup>MYPT1</sup>-based dephosphorylation of Thr<sup>210</sup> at the PLK1 activation loop. PLK docking on to NUAK1 at Ser<sup>445</sup> results in phosphorylation of NUAK1 at Ser<sup>480</sup> and Ser<sup>476</sup>. This would in turn assists SCF<sup>βTrCP</sup> binding and therefore leads to ubiquitylation and degradation of NUAK1. (B) Effects of losing function of NUAK1 and STK11 on progression of cell cycle (top models) and DNA damage repair (bottom models) in PTEN-cells. (i) Function of selected genes in PTEN+cells for comparing. (ii) PKB signaling is not inactivated by PTEN in PTEN-cells, resulting in enhanced NUAK1 activation, and improved progression of cell cycle. The PTEN participation to DNA damage repair is suppressed. (iii) Progression of cell cycle is furthermore accelerated in PTEN-cells without STK11, attributed to absence of STK11-NUAK1 inhibition. DNA damage repair is more suppressed as compared to PTEN-cells with STK11 potency attributed to absence of NUAK1activation by STK11. (iv) Progression of cell cycle is arrested in PTEN cells without NUAK1. Owing to loss of NUAK activity, DNA damage repair is lost as compared to PTEN-cells having NUAK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hippo pathway. The Hippo pathway is a growth regulating signaling pathway. Dashed lines designate possible interactions recognized by the homology from the Drosophila pathway. Solid lines indicate known direct interactions. Proteins in direct contact with each other also show known direct interactions. Phosphorylating the transcriptional activators TAZ and YAP by LATS1/2 results in cytosolic sequestration, thus suppressing TEAD-target gene transcription. LATS1 and LATS2 are negatively regulated by NUAK isoforms but activated directly by AMPK and indirectly by MARK1 and MARK1 kinases, downstream of STK11. AMPK directly phosphorylates YAP, which prevents its interaction with TEAD transcription parameters.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Schematic illustration of calcium signaling relations MYC to NUAK1 and model depicting pre-mRNA splicing machinery. (A) Despite the lack of STK11, NUAK1 is active in HeLa cells. Like AMPK, basal activity of NUAK1 is regulated via tonic calcium signaling and activity enhances as a result of calcium mobilization. Opposite to AMPK, CamKK2 does not appear to regulate NUAK1, but rather PKCα participates in activation of NUAK1 in response to calcium signaling. Calcium-mediated activation of the mTORC1-AMPK metabolic checkpoint demands both NUAK1 and PKCα, and suppression of either leads to MYC-dependent cell death, suggesting a positive function for this pathway in maintaining tumor. (B) NUAK1 binds with PP1 and phosphorylates its targeting subunit PNUTS. Consequently, PNUTS, PP1, and NUAK1 develop a trimer that is associated with the splicing machinery. Inhibiting NUAK1 decreases activity of spliceosome and synthesis of nascent RNA. Inhibition of NUAK1 traps RNAPII at the exon–intron boundary when MYC is deregulated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Model of NUAK2 mechanism in the development of actin stress fibers and of the transcriptional negative feedback system that modulates intracellular tension. (A) Dotted arrows show phosphorylation occasion. Myosin heads are shown in light green, whereas actin filaments are shown in dark pink (MLC in dark green). NUAKs enhance the assembly of actin stress fibers by inhibiting MLC phosphatase complex composed of PP1 and MYPT1 subunits. NUAK2 inhibits the MLC phosphatase complex by direct MYPT1 phosphorylation, which is likely to be negative allosteric modulation for MRIP binding (designated by blunted arrow). Also, NUAK1 directly interacts with phosphorylate MYPT1 and PP1 species. MYPT1 phosphorylation by ROCK kinases or by NUAKs recruits 14-3-3 proteins, which keep the myosin phosphatase away from actin stress fibers, enhancing the formation of stress fibers. MRIP and MYPT1 are currently the only two identified protein–protein interactions with NUAK2. (B) ROCK activation of myosin II increases cytoskeletal tension, which causes TAZ and YAP localization. Active TAZ and YAP inhibit ROCK-based MLC phosphorylation through transcriptional control of NUAK2 and ARHGAP 29 and 28 expression, which in turn prevent overactivation of myosin II.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Model showing NUAKs as a key regulator of protein degradation. (A) Autophagic protein clearance of filamin (Fil) in <i>WT</i> muscle tissue. NUAK phosphorylates Fil either for incorporation into the Z-disc (i) or/and upon protein damage owing to unfolding and folding of the protein (ii). CryAB (alpha B-crystallin) is generally bound to Fil at the Z-disc and the Stv-Hsc70-4 protein complex detects damaged Fil protein. The addition of lysine-63 (K63)-linked polyubiquitin chains on Fil recruits sequestosome 1 (SQSTM1; <i>aka</i>. p62) and autophagy-related 8a (Atg8a) for autophagosome biogenesis. Autophagosomes fuse with lysosomes to form the autolyosome for eventual protein degradation. (B) Fil phosphorylation is lost in <i>NUAK–/–</i>. Unincorporated and/or damaged Fil protein at the Z-disc bound to CryAB. Atg8a, p62, and PolyUb proteins are still recruited to CryAB-Fil complexes. The absence of lysosomes in regions of protein accumulation prevents autophagic protein clearance.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Chemical structures of doxorubicin and ON-123300.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structure of seven-membered ring fused pyrimidine inhibitors of NUAK isoforms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structure of five- and six-membered ring fused pyrimidine inhibitors of NUAK isoforms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structure of inhibitors of <i>N</i>-phenylpyrimidin-2-amine series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures of highly functionalized pyrimidine-2,4-diamine NUAKs inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structure of highly functionalized indole-based inhibitors of NUAK isoforms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structure of thiazole-cored inhibitors of NUAK isoforms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/medium/jm0c00533_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structure of pyrazole- and imidazole-containing inhibitors of NUAK isoforms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c00533/20210107/images/large/jm0c00533_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00533&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i53">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71777" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71777" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 148 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krupa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, N.</span></span> <span> </span><span class="NLM_article-title">The Repertoire of Protein Kinases Encoded in the Draft Version of the Human Genome: Atypical Variations and Uncommon Domain Combinations</span>. <i>Genome Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">research0066–1</span> <span class="refDoi"> DOI: 10.1186/gb-2002-3-12-research0066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1186%2Fgb-2002-3-12-research0066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&author=A.+Krupaauthor=N.+Srinivasan&title=The+Repertoire+of+Protein+Kinases+Encoded+in+the+Draft+Version+of+the+Human+Genome%3A+Atypical+Variations+and+Uncommon+Domain+Combinations&doi=10.1186%2Fgb-2002-3-12-research0066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1186%2Fgb-2002-3-12-research0066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2002-3-12-research0066%26sid%3Dliteratum%253Aachs%26aulast%3DKrupa%26aufirst%3DA.%26aulast%3DSrinivasan%26aufirst%3DN.%26atitle%3DThe%2520Repertoire%2520of%2520Protein%2520Kinases%2520Encoded%2520in%2520the%2520Draft%2520Version%2520of%2520the%2520Human%2520Genome%253A%2520Atypical%2520Variations%2520and%2520Uncommon%2520Domain%2520Combinations%26jtitle%3DGenome%2520Biol.%26date%3D2002%26volume%3D3%26doi%3D10.1186%2Fgb-2002-3-12-research0066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kennelly, P. J.</span></span> <span> </span><span class="NLM_article-title">Protein Kinases and Protein Phosphatases in Prokaryotes: A Genomic Perspective</span>. <i>FEMS Microbiol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>206</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1111/j.1574-6968.2002.tb10978.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1111%2Fj.1574-6968.2002.tb10978.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=11786249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFaisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2002&pages=1-8&author=P.+J.+Kennelly&title=Protein+Kinases+and+Protein+Phosphatases+in+Prokaryotes%3A+A+Genomic+Perspective&doi=10.1111%2Fj.1574-6968.2002.tb10978.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinases and protein phosphatases in prokaryotes: a genomic perspective</span></div><div class="casAuthors">Kennelly, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">FEMS Microbiology Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">FMLED7</span>;
        ISSN:<span class="NLM_cas:issn">0378-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  For many years, the regulation of protein structure and function by phosphorylation and dephosphorylation was considered a relatively recent invention that arose independently in each phylogenetic domain.  Over time, however, incidents of apparent domain trespass involving the presence of 'eukaryotic' protein kinases or protein phosphatases in prokaryotic organisms were reported with increasing frequency.  Today, genomics has provided the means to examine the phylogenetic distribution of 'eukaryotic' protein kinases and protein phosphatases in a comprehensive and systematic manner.  The results of these genome searches challenge previous conceptions concerning the origins and evolution of this versatile regulatory mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSlBclTsrsGrVg90H21EOLACvtfcHk0lhnK6UHxzQa3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFaisw%253D%253D&md5=2587d78ea9f0a5541752791c8fa94374</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1574-6968.2002.tb10978.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1574-6968.2002.tb10978.x%26sid%3Dliteratum%253Aachs%26aulast%3DKennelly%26aufirst%3DP.%2BJ.%26atitle%3DProtein%2520Kinases%2520and%2520Protein%2520Phosphatases%2520in%2520Prokaryotes%253A%2520A%2520Genomic%2520Perspective%26jtitle%3DFEMS%2520Microbiol.%2520Lett.%26date%3D2002%26volume%3D206%26spage%3D1%26epage%3D8%26doi%3D10.1111%2Fj.1574-6968.2002.tb10978.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moustakas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardali, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heldin, C.-H.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of TGF-β Signaling in Regulation of Cell Growth and Differentiation</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/S0165-2478(02)00023-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2FS0165-2478%2802%2900023-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=12008039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsVSqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=85-91&author=A.+Moustakasauthor=K.+Pardaliauthor=A.+Gaalauthor=C.-H.+Heldin&title=Mechanisms+of+TGF-%CE%B2+Signaling+in+Regulation+of+Cell+Growth+and+Differentiation&doi=10.1016%2FS0165-2478%2802%2900023-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of TGF-β signaling in regulation of cell growth and differentiation</span></div><div class="casAuthors">Moustakas, Aristidis; Pardali, Katerina; Gaal, Annamaria; Heldin, Carl-Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">85-91</span>CODEN:
                <span class="NLM_cas:coden">IMLED6</span>;
        ISSN:<span class="NLM_cas:issn">0165-2478</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Transforming growth factor β (TGF-β) is a secreted protein that regulates proliferation, differentiation, and death of various cell types.  All immune cell lineages, including B, T, and dendritic cells as well as macrophages, secrete TGF-β, which neg. regulates their proliferation, differentiation, and activation by other cytokines.  Thus, TGF-β is a potent immunosuppressant and perturbation of TGF-β signaling is linked to autoimmunity, inflammation, and cancer.  Here, the authors summarize their work on the growth inhibitory pathway downstream of TGF-β, which is triggered by receptor serine/threonine kinases at the cell surface and downstream effectors of the Smad family.  Activated Smads regulate transcription of target genes, including cell cycle inhibitors such as p21, which mediate the anti-proliferative response and partially explain the tumor suppressive action of the TGF-β pathway.  The authors have described a mol. mechanism of regulation of the p21 gene by Smads and transcription factor Sp1.  At late stages of tumor progression, TGF-β promotes tumorigenesis via suppression of the immune system and changes in cell differentiation of epithelial tumor cells, a phenomenon termed epithelial to mesenchymal transdifferentiation (EMT).  The authors review their work on the role of the Smad pathway in controlling EMT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqwoFaLN0-TrVg90H21EOLACvtfcHk0lgaCdckw-hk9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsVSqu7w%253D&md5=cd931827d83c97836e320c31a96e258f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0165-2478%2802%2900023-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-2478%252802%252900023-8%26sid%3Dliteratum%253Aachs%26aulast%3DMoustakas%26aufirst%3DA.%26aulast%3DPardali%26aufirst%3DK.%26aulast%3DGaal%26aufirst%3DA.%26aulast%3DHeldin%26aufirst%3DC.-H.%26atitle%3DMechanisms%2520of%2520TGF-%25CE%25B2%2520Signaling%2520in%2520Regulation%2520of%2520Cell%2520Growth%2520and%2520Differentiation%26jtitle%3DImmunol.%2520Lett.%26date%3D2002%26volume%3D82%26spage%3D85%26epage%3D91%26doi%3D10.1016%2FS0165-2478%2802%2900023-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanks, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span> <span> </span><span class="NLM_article-title">The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>241</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1126/science.3291115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1126%2Fscience.3291115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=3291115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADyaL1cXlt1Cqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=1988&pages=42-52&author=S.+K.+Hanksauthor=A.+M.+Quinnauthor=T.+Hunter&title=The+Protein+Kinase+Family%3A+Conserved+Features+and+Deduced+Phylogeny+of+the+Catalytic+Domains&doi=10.1126%2Fscience.3291115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The protein kinase family:  conserved features and deduced phylogeny of the catalytic domains</span></div><div class="casAuthors">Hanks, Steven K.; Quinn, Anne Marie; Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue">4861</span>),
    <span class="NLM_cas:pages">42-52</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">An alignment of catalytic domain amino acid sequences from 65 different members of the protein kinase family, including many putative protein kinase sequences recently deduced from nucleotide sequence data, is presented.  Based on this alignment, conserved features of the catalytic domains are identified and discussed, and a visual display of the various intersequence relations is provided through construction of a catalytic domain phylogenetic tree.  Catalytic domains from protein kinases having similar modes of regulation or substrate specificities cluster together within the tree.  Clustering appears predictive of the properties and function of novel protein kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2wvmHwUOA1rVg90H21EOLACvtfcHk0lgaCdckw-hk9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXlt1Cqtbw%253D&md5=5130b76aafb7e479ebf7ac83ec7ca701</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.3291115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.3291115%26sid%3Dliteratum%253Aachs%26aulast%3DHanks%26aufirst%3DS.%2BK.%26aulast%3DQuinn%26aufirst%3DA.%2BM.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DThe%2520Protein%2520Kinase%2520Family%253A%2520Conserved%2520Features%2520and%2520Deduced%2520Phylogeny%2520of%2520the%2520Catalytic%2520Domains%26jtitle%3DScience%26date%3D1988%26volume%3D241%26spage%3D42%26epage%3D52%26doi%3D10.1126%2Fscience.3291115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petkevicius, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristariyanto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peggie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plater, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedrioli, P. G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIver, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of CRTC3 by the Salt-Inducible Kinases Controls the Interconversion of Classically Activated and Regulatory Macrophages</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">16986</span>– <span class="NLM_lpage">16991</span>, <span class="refDoi"> DOI: 10.1073/pnas.1215450109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1073%2Fpnas.1215450109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23033494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1WksLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=16986-16991&author=K.+Clarkauthor=K.+F.+MacKenzieauthor=K.+Petkeviciusauthor=Y.+Kristariyantoauthor=J.+Zhangauthor=H.+G.+Choiauthor=M.+Peggieauthor=L.+Platerauthor=P.+G.+A.+Pedrioliauthor=E.+McIverauthor=N.+S.+Grayauthor=J.+S.+C.+Arthurauthor=P.+Cohen&title=Phosphorylation+of+CRTC3+by+the+Salt-Inducible+Kinases+Controls+the+Interconversion+of+Classically+Activated+and+Regulatory+Macrophages&doi=10.1073%2Fpnas.1215450109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages</span></div><div class="casAuthors">Clark, Kristopher; MacKenzie, Kirsty F.; Petkevicius, Kasparas; Kristariyanto, Yosua; Zhang, Jiazhen; Choi, Hwan Geun; Peggie, Mark; Plater, Lorna; Pedrioli, Patrick G. A.; McIver, Ed; Gray, Nathanael S.; Arthur, J. Simon C.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">16986-16991, S16986/1-S16986/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Macrophages acquire strikingly different properties that enable them to play key roles during the initiation, propagation, and resoln. of inflammation.  Classically activated (M1) macrophages produce proinflammatory mediators to combat invading pathogens and respond to tissue damage in the host, whereas regulatory macrophages (M2b) produce high levels of anti-inflammatory mols., such as IL-10, and low levels of proinflammatory cytokines, like IL-12, and are important for the resoln. of inflammatory responses.  A central problem in this area is to understand how the formation of regulatory macrophages can be promoted at sites of inflammation to prevent and/or alleviate chronic inflammatory and autoimmune diseases.  Here, we demonstrate that the salt-inducible kinases (SIKs) restrict the formation of regulatory macrophages and that their inhibition induces striking increases in many of the characteristic markers of regulatory macrophages, greatly stimulating the prodn. of IL-10 and other anti-inflammatory mols.  We show that SIK inhibitors elevate IL-10 prodn. by inducing the dephosphorylation of cAMP response element-binding protein (CREB)-regulated transcriptional coactivator (CRTC) 3, its dissocn. from 14-3-3 proteins and its translocation to the nucleus where it enhances a gene transcription program controlled by CREB.  Importantly, the effects of SIK inhibitors on IL-10 prodn. are lost in macrophages that express a drug-resistant mutant of SIK2.  These findings identify SIKs as a key mol. switch whose inhibition reprograms macrophages to an anti-inflammatory phenotype.  The remarkable effects of SIK inhibitors on macrophage function suggest that drugs that target these protein kinases may have therapeutic potential for the treatment of inflammatory and autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ5CpfkhhodrVg90H21EOLACvtfcHk0lgaCdckw-hk9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1WksLzE&md5=cd6fcd9a04957488d2d37bf912621a63</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1215450109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1215450109%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DK.%26aulast%3DMacKenzie%26aufirst%3DK.%2BF.%26aulast%3DPetkevicius%26aufirst%3DK.%26aulast%3DKristariyanto%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DPeggie%26aufirst%3DM.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DPedrioli%26aufirst%3DP.%2BG.%2BA.%26aulast%3DMcIver%26aufirst%3DE.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DPhosphorylation%2520of%2520CRTC3%2520by%2520the%2520Salt-Inducible%2520Kinases%2520Controls%2520the%2520Interconversion%2520of%2520Classically%2520Activated%2520and%2520Regulatory%2520Macrophages%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D16986%26epage%3D16991%26doi%3D10.1073%2Fpnas.1215450109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Screaton, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conkright, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Best, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canettieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffries, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takemori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montminy, M.</span></span> <span> </span><span class="NLM_article-title">The CREB Coactivator TORC2 Functions as a Calcium- and CAMP-Sensitive Coincidence Detector</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2004.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.cell.2004.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15454081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlyqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2004&pages=61-74&author=R.+A.+Screatonauthor=M.+D.+Conkrightauthor=Y.+Katohauthor=J.+L.+Bestauthor=G.+Canettieriauthor=S.+Jeffriesauthor=E.+Guzmanauthor=S.+Niessenauthor=J.+R.+Yatesauthor=H.+Takemoriauthor=M.+Okamotoauthor=M.+Montminy&title=The+CREB+Coactivator+TORC2+Functions+as+a+Calcium-+and+CAMP-Sensitive+Coincidence+Detector&doi=10.1016%2Fj.cell.2004.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector</span></div><div class="casAuthors">Screaton, Robert A.; Conkright, Michael D.; Katoh, Yoshiko; Best, Jennifer L.; Canettieri, Gianluca; Jeffries, Shawn; Guzman, Ernesto; Niessen, Sherry; Yates, John R., III; Takemori, Hiroshi; Okamoto, Mitsuhiro; Montminy, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-74</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Elevations in circulating glucose and gut hormones during feeding promote pancreatic islet cell viability in part via the calcium- and cAMP-dependent activation of the transcription factor CREB.  Here, we describe a signaling module that mediates the synergistic effects of these pathways on cellular gene expression by stimulating the dephosphorylation and nuclear entry of TORC2, a CREB coactivator.  This module consists of the calcium-regulated phosphatase calcineurin and the Ser/Thr kinase SIK2, both of which assoc. with TORC2.  Under resting conditions, TORC2 is sequestered in the cytoplasm via a phosphorylation-dependent interaction with 14-3-3 proteins.  Triggering of the calcium and cAMP second messenger pathways by glucose and gut hormones disrupts TORC2:14-3-3 complexes via complementary effects on TORC2 dephosphorylation; calcium influx increases calcineurin activity, whereas cAMP inhibits SIK2 kinase activity.  Our results illustrate how a phosphatase/kinase module connects two signaling pathways in response to nutrient and hormonal cues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2vwAHAe13oLVg90H21EOLACvtfcHk0lhnrUfSFmeSPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlyqu74%253D&md5=18b3093acf60cb2d7480db191e2c14e4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2004.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2004.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DScreaton%26aufirst%3DR.%2BA.%26aulast%3DConkright%26aufirst%3DM.%2BD.%26aulast%3DKatoh%26aufirst%3DY.%26aulast%3DBest%26aufirst%3DJ.%2BL.%26aulast%3DCanettieri%26aufirst%3DG.%26aulast%3DJeffries%26aufirst%3DS.%26aulast%3DGuzman%26aufirst%3DE.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DYates%26aufirst%3DJ.%2BR.%26aulast%3DTakemori%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DM.%26aulast%3DMontminy%26aufirst%3DM.%26atitle%3DThe%2520CREB%2520Coactivator%2520TORC2%2520Functions%2520as%2520a%2520Calcium-%2520and%2520CAMP-Sensitive%2520Coincidence%2520Detector%26jtitle%3DCell%26date%3D2004%26volume%3D119%26spage%3D61%26epage%3D74%26doi%3D10.1016%2Fj.cell.2004.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matenia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E. M.</span></span> <span> </span><span class="NLM_article-title">The Tau of MARK: A Polarized View of the Cytoskeleton</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">342</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2009.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.tibs.2009.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=19559622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVylsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=332-342&author=D.+Mateniaauthor=E.+M.+Mandelkow&title=The+Tau+of+MARK%3A+A+Polarized+View+of+the+Cytoskeleton&doi=10.1016%2Fj.tibs.2009.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The tau of MARK: a polarized view of the cytoskeleton</span></div><div class="casAuthors">Matenia, Dorthe; Mandelkow, Eva-Maria</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">332-342</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Microtubule-affinity regulating kinases (MARKs) were originally discovered by their ability to phosphorylate tau protein and related microtubule-assocd. proteins (MAPs), and thereby to regulate microtubule dynamics in neurons.  Members of the MARK (also known as partition-defective [Par]-1 kinase) family were subsequently found to be highly conserved and to have key roles in cell processes such as detn. of polarity, cell-cycle control, intracellular signal transduction, transport, and cytoskeleton.  This is important for neuronal differentiation, but is also prominent in neurodegenerative 'tauopathies' such as Alzheimer's disease.  The identified functions of MARK/Par-1 are diverse and require accurate regulation.  Recent discoveries including the x-ray structure of human MARKs have contributed to an increased understanding of the mechanisms that control the kinase activity and, thus, the actin and microtubule cytoskeleton.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwzIeIjkyHRLVg90H21EOLACvtfcHk0lhnrUfSFmeSPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVylsrk%253D&md5=e752082afc70186927284aeb7f872648</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2009.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2009.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DMatenia%26aufirst%3DD.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26atitle%3DThe%2520Tau%2520of%2520MARK%253A%2520A%2520Polarized%2520View%2520of%2520the%2520Cytoskeleton%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2009%26volume%3D34%26spage%3D332%26epage%3D342%26doi%3D10.1016%2Fj.tibs.2009.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crump, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanes, J. R.</span></span> <span> </span><span class="NLM_article-title">Mammalian SAD Kinases Are Required for Neuronal Polarization</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1126/science.1107403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1126%2Fscience.1107403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15705853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2005&pages=929-932&author=M.+Kishiauthor=Y.+A.+Panauthor=J.+G.+Crumpauthor=J.+R.+Sanes&title=Mammalian+SAD+Kinases+Are+Required+for+Neuronal+Polarization&doi=10.1126%2Fscience.1107403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian SAD Kinases Are Required for Neuronal Polarization</span></div><div class="casAuthors">Kishi, Masashi; Pan, Y. Albert; Crump, Justin Gage; Sanes, Joshua R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">5711</span>),
    <span class="NLM_cas:pages">929-932</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Elec. activity in neurons is generally initiated in dendritic processes then propagated along axons to synapses, where it is passed to other neurons.  Major structural features of neurons-their dendrites and axons-are thus related to their fundamental functions: the receipt and transmission of information.  The acquisition of these distinct properties by dendrites and axons, called polarization, is a crit. step in neuronal differentiation.  We show here that SAD-A and SAD-B, mammalian orthologs of a kinase needed for presynaptic differentiation in Caenorhabditis elegans, are required for neuronal polarization.  These kinases will provide entry points for unraveling signaling mechanisms that polarize neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqefz9PBjkY5bVg90H21EOLACvtfcHk0lhnrUfSFmeSPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWms7c%253D&md5=ce57d6d8dba8c417ce1bf6826e70252d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1107403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1107403%26sid%3Dliteratum%253Aachs%26aulast%3DKishi%26aufirst%3DM.%26aulast%3DPan%26aufirst%3DY.%2BA.%26aulast%3DCrump%26aufirst%3DJ.%2BG.%26aulast%3DSanes%26aufirst%3DJ.%2BR.%26atitle%3DMammalian%2520SAD%2520Kinases%2520Are%2520Required%2520for%2520Neuronal%2520Polarization%26jtitle%3DScience%26date%3D2005%26volume%3D307%26spage%3D929%26epage%3D932%26doi%3D10.1126%2Fscience.1107403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardie, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawley, S. A.</span></span> <span> </span><span class="NLM_article-title">AMPK: A Nutrient and Energy Sensor That Maintains Energy Homeostasis</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1038/nrm3311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fnrm3311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22436748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVenu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=251-262&author=D.+G.+Hardieauthor=F.+A.+Rossauthor=S.+A.+Hawley&title=AMPK%3A+A+Nutrient+and+Energy+Sensor+That+Maintains+Energy+Homeostasis&doi=10.1038%2Fnrm3311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK: A nutrient and energy sensor that maintains energy homeostasis</span></div><div class="casAuthors">Hardie, D. Grahame; Ross, Fiona A.; Hawley, Simon A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">251-262</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  AMP-activated protein kinase (AMPK) is a crucial cellular energy sensor.  Once activated by falling energy status, it promotes ATP prodn. by increasing the activity or expression of proteins involved in catabolism while conserving ATP by switching off biosynthetic pathways.  AMPK also regulates metabolic energy balance at the whole-body level.  For example, it mediates the effects of agents acting on the hypothalamus that promote feeding and entrains circadian rhythms of metab. and feeding behavior.  Finally, recent studies reveal that AMPK conserves ATP levels through the regulation of processes other than metab., such as the cell cycle and neuronal membrane excitability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEnrOEhtMBFbVg90H21EOLACvtfcHk0liNoAin1YuzOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVenu7w%253D&md5=1f5378d191c69af099e70c4c8bf3229e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrm3311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3311%26sid%3Dliteratum%253Aachs%26aulast%3DHardie%26aufirst%3DD.%2BG.%26aulast%3DRoss%26aufirst%3DF.%2BA.%26aulast%3DHawley%26aufirst%3DS.%2BA.%26atitle%3DAMPK%253A%2520A%2520Nutrient%2520and%2520Energy%2520Sensor%2520That%2520Maintains%2520Energy%2520Homeostasis%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2012%26volume%3D13%26spage%3D251%26epage%3D262%26doi%3D10.1038%2Fnrm3311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhrlage, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prescott, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Characterization of WZ4003 and HTH-01–015 as Selective Inhibitors of the LKB1-Tumour-Suppressor-Activated NUAK Kinases</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>457</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1042/BJ20131152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1042%2FBJ20131152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=24171924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSlur7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2014&pages=215-225&author=S.+Banerjeeauthor=S.+J.+Buhrlageauthor=H.+T.+Huangauthor=X.+Dengauthor=W.+Zhouauthor=J.+Wangauthor=R.+Traynorauthor=A.+R.+Prescottauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+WZ4003+and+HTH-01%E2%80%93015+as+Selective+Inhibitors+of+the+LKB1-Tumour-Suppressor-Activated+NUAK+Kinases&doi=10.1042%2FBJ20131152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of WZ4003 and HTH-01-015 as selective inhibitors of the LKB1-tumour-suppressor-activated NUAK kinases</span></div><div class="casAuthors">Banerjee, Sourav; Buhrlage, Sara J.; Huang, Hai-Tsang; Deng, Xianming; Zhou, Wenjun; Wang, Jinhua; Traynor, Ryan; Prescott, Alan R.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">457</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">215-225</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The related NUAK1 and NUAK2 are members of the AMPK (AMP-activated protein kinase) family of protein kinases that are activated by the LKB1 (liver kinase B1) tumor suppressor kinase.  Recent work suggests they play important roles in regulating key biol. processes including Myc-driven tumorigenesis, senescence, cell adhesion and neuronal polarity.  In the present paper we describe the first highly specific protein kinase inhibitors of NUAK kinases namely WZ4003 and HTH-01-015.  WZ4003 inhibits both NUAK isoforms (IC50 for NUAK1 is 20 nM and for NUAK2 is 100 nM), whereas HTH-01-015 inhibits only NUAK1 (IC50 is 100 nM).  These compds. display extreme selectivity and do not significantly inhibit the activity of 139 other kinases that were tested including ten AMPK family members.  In all cell lines tested, WZ4003 and HTH-01-015 inhibit the phosphorylation of the only well-characterized substrate, MYPT1 (myosin phosphate-targeting subunit 1) that is phosphorylated by NUAK1 at Ser445.  We also identify a mutation (A195T) that does not affect basal NUAK1 activity, but renders it ~ 50-fold resistant to both WZ4003 and HTH-01-015.  Consistent with NUAK1 mediating the phosphorylation of MYPT1 we find that in cells overexpressing drug-resistant NUAK1[A195T], but not wild-type NUAK1, phosphorylation of MYPT1 at Ser445 is no longer suppressed by WZ4003 or HTH-01-015.  We also demonstrate that administration of WZ4003 and HTH-01-015 to MEFs (mouse embryonic fibroblasts) significantly inhibits migration in a wound-healing assay to a similar extent as NUAK1-knockout.  WZ4003 and HTH-01-015 also inhibit proliferation of MEFs to the same extent as NUAK1 knockout and U2OS cells to the same extent as NUAK1 shRNA knockdown.  We find that WZ4003 and HTH-01-015 impaired the invasive potential of U2OS cells in a 3D cell invasion assay to the same extent as NUAK1 knockdown.  The results of the present study indicate that WZ4003 and HTH-01-015 will serve as useful chem. probes to delineate the biol. roles of the NUAK kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Au6CwHtFALVg90H21EOLACvtfcHk0liNoAin1YuzOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSlur7K&md5=feab58d16169f39a2d136016328cc0f6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1042%2FBJ20131152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20131152%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DHuang%26aufirst%3DH.%2BT.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTraynor%26aufirst%3DR.%26aulast%3DPrescott%26aufirst%3DA.%2BR.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520WZ4003%2520and%2520HTH-01%25E2%2580%2593015%2520as%2520Selective%2520Inhibitors%2520of%2520the%2520LKB1-Tumour-Suppressor-Activated%2520NUAK%2520Kinases%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D457%26spage%3D215%26epage%3D225%26doi%3D10.1042%2FBJ20131152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Courchet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courchet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polleux, F.</span></span> <span> </span><span class="NLM_article-title">XTerminal Axon Branching Is Regulated by the LKB1-NUAK1 Kinase Pathway via Presynaptic Mitochondrial Capture</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">1510</span>– <span class="NLM_lpage">1525</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2013.05.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.cell.2013.05.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23791179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVWnsrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2013&pages=1510-1525&author=J.+Courchetauthor=T.+L.+Lewisauthor=S.+Leeauthor=V.+Courchetauthor=D.+Y.+Liouauthor=S.+Aizawaauthor=F.+Polleux&title=XTerminal+Axon+Branching+Is+Regulated+by+the+LKB1-NUAK1+Kinase+Pathway+via+Presynaptic+Mitochondrial+Capture&doi=10.1016%2Fj.cell.2013.05.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Terminal Axon Branching Is Regulated by the LKB1-NUAK1 Kinase Pathway via Presynaptic Mitochondrial Capture</span></div><div class="casAuthors">Courchet, Julien; Lewis, Tommy L., Jr.; Lee, Sohyon; Courchet, Virginie; Liou, Deng-Yuan; Aizawa, Shinichi; Polleux, Franck</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1510-1525</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mol. mechanisms underlying the axon arborization of mammalian neurons are poorly understood but are crit. for the establishment of functional neural circuits.  We identified a pathway defined by two kinases, LKB1 and NUAK1, required for cortical axon branching in vivo.  Conditional deletion of LKB1 after axon specification or knockdown of NUAK1 drastically reduced axon branching in vivo, whereas their overexpression was sufficient to increase axon branching.  The LKB1-NUAK1 pathway controls mitochondria immobilization in axons.  Using manipulation of Syntaphilin, a protein necessary and sufficient to arrest mitochondrial transport specifically in the axon, we demonstrate that the LKB1-NUAK1 kinase pathway regulates axon branching by promoting mitochondria immobilization.  Finally, we show that LKB1 and NUAK1 are necessary and sufficient to immobilize mitochondria specifically at nascent presynaptic sites.  Our results unravel a link between presynaptic mitochondrial capture and axon branching.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxc7_I338GRrVg90H21EOLACvtfcHk0liNoAin1YuzOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVWnsrvO&md5=ccc07f566665c4cc691361347f23e05c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2013.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2013.05.021%26sid%3Dliteratum%253Aachs%26aulast%3DCourchet%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DT.%2BL.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DCourchet%26aufirst%3DV.%26aulast%3DLiou%26aufirst%3DD.%2BY.%26aulast%3DAizawa%26aufirst%3DS.%26aulast%3DPolleux%26aufirst%3DF.%26atitle%3DXTerminal%2520Axon%2520Branching%2520Is%2520Regulated%2520by%2520the%2520LKB1-NUAK1%2520Kinase%2520Pathway%2520via%2520Presynaptic%2520Mitochondrial%2520Capture%26jtitle%3DCell%26date%3D2013%26volume%3D153%26spage%3D1510%26epage%3D1525%26doi%3D10.1016%2Fj.cell.2013.05.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Humbert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navaratnam, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Costa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martien, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbadie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Launoit, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, D.</span></span> <span> </span><span class="NLM_article-title">Regulation of Ploidy and Senescence by the AMPK-Related Kinase NUAK1</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">376</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1038/emboj.2009.342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Femboj.2009.342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=19927127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSmu7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=376-386&author=N.+Humbertauthor=N.+Navaratnamauthor=A.+Augertauthor=M.+Da+Costaauthor=S.+Martienauthor=J.+Wangauthor=D.+Martinezauthor=C.+Abbadieauthor=D.+Carlingauthor=Y.+de+Launoitauthor=J.+Gilauthor=D.+Bernard&title=Regulation+of+Ploidy+and+Senescence+by+the+AMPK-Related+Kinase+NUAK1&doi=10.1038%2Femboj.2009.342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of ploidy and senescence by the AMPK-related kinase NUAK1</span></div><div class="casAuthors">Humbert, Nicolas; Navaratnam, Naveenan; Augert, Arnaud; Da Costa, Marco; Martien, Sebastien; Wang, Jing; Martinez, Dolores; Abbadie, Corinne; Carling, David; de Launoit, Yvan; Gil, Jesus; Bernard, David</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">376-386</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Senescence is an irreversible cell-cycle arrest that is elicited by a wide range of factors, including replicative exhaustion.  Emerging evidences suggest that cellular senescence contributes to aging and acts as a tumor suppressor mechanism.  To identify novel genes regulating senescence, we performed a loss-of-function screen on normal human diploid fibroblasts.  Downregulation of the AMPK-related protein kinase 5 (ARK5 or NUAK1) results in extension of the cellular replicative lifespan.  Interestingly, the levels of NUAK1 are upregulated during senescence whereas its ectopic expression triggers a premature senescence.  Cells that constitutively express NUAK1 suffer gross aneuploidies and show diminished expression of the genomic stability regulator LATS1, whereas depletion of NUAK1 with shRNA exerts opposite effects.  Interestingly, a dominant-neg. form of LATS1 phenocopies NUAK1 effects.  Moreover, we show that NUAK1 phosphorylates LATS1 at S464 and this has a role in controlling its stability.  In summary, our work highlights a novel role for NUAK1 in the control of cellular senescence and cellular ploidy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS28reOUWITLVg90H21EOLACvtfcHk0lgEDhIxHgPlrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSmu7rO&md5=b11a0a6a81ae940636af2a38dd6d609c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Femboj.2009.342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2009.342%26sid%3Dliteratum%253Aachs%26aulast%3DHumbert%26aufirst%3DN.%26aulast%3DNavaratnam%26aufirst%3DN.%26aulast%3DAugert%26aufirst%3DA.%26aulast%3DDa%2BCosta%26aufirst%3DM.%26aulast%3DMartien%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DD.%26aulast%3DAbbadie%26aufirst%3DC.%26aulast%3DCarling%26aufirst%3DD.%26aulast%3Dde%2BLaunoit%26aufirst%3DY.%26aulast%3DGil%26aufirst%3DJ.%26aulast%3DBernard%26aufirst%3DD.%26atitle%3DRegulation%2520of%2520Ploidy%2520and%2520Senescence%2520by%2520the%2520AMPK-Related%2520Kinase%2520NUAK1%26jtitle%3DEMBO%2520J.%26date%3D2010%26volume%3D29%26spage%3D376%26epage%3D386%26doi%3D10.1038%2Femboj.2009.342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vallenius, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaahtomeri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovac, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osiceanu, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viljanen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mäkelä, T. P.</span></span> <span> </span><span class="NLM_article-title">An Association between NUAK2 and MRIP Reveals a Novel Mechanism for Regulation of Actin Stress Fibers</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">384</span>– <span class="NLM_lpage">393</span>, <span class="refDoi"> DOI: 10.1242/jcs.072660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1242%2Fjcs.072660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=21242312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFOqu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2011&pages=384-393&author=T.+Valleniusauthor=K.+Vaahtomeriauthor=B.+Kovacauthor=A.+M.+Osiceanuauthor=M.+Viljanenauthor=T.+P.+M%C3%A4kel%C3%A4&title=An+Association+between+NUAK2+and+MRIP+Reveals+a+Novel+Mechanism+for+Regulation+of+Actin+Stress+Fibers&doi=10.1242%2Fjcs.072660"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">An association between NUAK2 and MRIP reveals a novel mechanism for regulation of actin stress fibers</span></div><div class="casAuthors">Vallenius, Tea; Vaahtomeri, Kari; Kovac, Bianca; Osiceanu, Ana-Maria; Viljanen, Martta; Makela, Tomi P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">384-393</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Actin stress fiber assembly and contractility in nonmuscle motile cells requires phosphorylation of myosin regulatory light chain (MLC).  Dephosphorylation and disassembly are mediated by MLC phosphatase, which is targeted to actin fibers by the assocn. of its regulatory subunit MYPT1 with myosin phosphatase Rho-interacting protein (MRIP).  In the present study, we identify the kinase NUAK2 as a second protein targeted by MRIP to actin fibers.  Assocn. of NUAK2 with MRIP increases MLC phosphorylation and promotes formation of stress fibers.  This activity does not require the kinase activity of NUAK2 but is dependent on both MRIP and MYPT1, indicating that the NUAK2-MRIP assocn. inhibits fiber disassembly and MYPT1-mediated MLC dephosphorylation.  NUAK2 levels are strongly induced by stimuli increasing actomyosin fiber formation, and NUAK2 is required for fiber maintenance in exponentially growing cells, implicating NUAK2 in a pos.-feedback loop regulating actin stress fibers independently of the MLC kinase Rho-assocd. protein kinase (ROCK).  The identified MRIP-NUAK2 assocn. reveals a novel mechanism for the maintenance of actin stress fibers through counteracting MYPT1 and, together with recent results, implicates the NUAK proteins as important regulators of the MLC phosphatase acting in both a kinase-dependent and kinase-independent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1NEleHDviObVg90H21EOLACvtfcHk0lgEDhIxHgPlrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFOqu7Y%253D&md5=4796fab6b93cf7b28dadd26292c245a6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1242%2Fjcs.072660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.072660%26sid%3Dliteratum%253Aachs%26aulast%3DVallenius%26aufirst%3DT.%26aulast%3DVaahtomeri%26aufirst%3DK.%26aulast%3DKovac%26aufirst%3DB.%26aulast%3DOsiceanu%26aufirst%3DA.%2BM.%26aulast%3DViljanen%26aufirst%3DM.%26aulast%3DM%25C3%25A4kel%25C3%25A4%26aufirst%3DT.%2BP.%26atitle%3DAn%2520Association%2520between%2520NUAK2%2520and%2520MRIP%2520Reveals%2520a%2520Novel%2520Mechanism%2520for%2520Regulation%2520of%2520Actin%2520Stress%2520Fibers%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2011%26volume%3D124%26spage%3D384%26epage%3D393%26doi%3D10.1242%2Fjcs.072660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zagórska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prescott, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span> <span> </span><span class="NLM_article-title">New Roles for the LKB1-NUAK Pathway in Controlling Myosin Phosphatase Complexes and Cell Adhesion</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">ra25</span> <span class="refDoi"> DOI: 10.1126/scisignal.2000616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1126%2Fscisignal.2000616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=20354225" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&author=A.+Zag%C3%B3rskaauthor=M.+Deakauthor=D.+G.+Campbellauthor=S.+Banerjeeauthor=M.+Hiranoauthor=S.+Aizawaauthor=A.+R.+Prescottauthor=D.+R.+Alessi&title=New+Roles+for+the+LKB1-NUAK+Pathway+in+Controlling+Myosin+Phosphatase+Complexes+and+Cell+Adhesion&doi=10.1126%2Fscisignal.2000616"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2000616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2000616%26sid%3Dliteratum%253Aachs%26aulast%3DZag%25C3%25B3rska%26aufirst%3DA.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DD.%2BG.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DHirano%26aufirst%3DM.%26aulast%3DAizawa%26aufirst%3DS.%26aulast%3DPrescott%26aufirst%3DA.%2BR.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DNew%2520Roles%2520for%2520the%2520LKB1-NUAK%2520Pathway%2520in%2520Controlling%2520Myosin%2520Phosphatase%2520Complexes%2520and%2520Cell%2520Adhesion%26jtitle%3DSci.%2520Signaling%26date%3D2010%26volume%3D3%26doi%3D10.1126%2Fscisignal.2000616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyonari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furushima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizawa, S.</span></span> <span> </span><span class="NLM_article-title">A New Serine/Threonine Protein Kinase, Omphk1, Essential to Ventral Body Wall Formation</span>. <i>Dev. Dyn.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>235</i></span>,  <span class="NLM_fpage">2229</span>– <span class="NLM_lpage">2237</span>, <span class="refDoi"> DOI: 10.1002/dvdy.20823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1002%2Fdvdy.20823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=16715502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVeisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=2006&pages=2229-2237&author=M.+Hiranoauthor=H.+Kiyonariauthor=A.+Inoueauthor=K.+Furushimaauthor=T.+Murataauthor=Y.+Sudaauthor=S.+Aizawa&title=A+New+Serine%2FThreonine+Protein+Kinase%2C+Omphk1%2C+Essential+to+Ventral+Body+Wall+Formation&doi=10.1002%2Fdvdy.20823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A new serine/threonine protein kinase, Omphk1, essential to ventral body wall formation</span></div><div class="casAuthors">Hirano, Mariko; Kiyonari, Hiroshi; Inoue, Ai; Furushima, Kenryo; Murata, Takuya; Suda, Yoko; Aizawa, Schinichi</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Dynamics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">235</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2229-2237</span>CODEN:
                <span class="NLM_cas:coden">DEDYEI</span>;
        ISSN:<span class="NLM_cas:issn">1058-8388</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Here, we report a new serine/threonine protein kinase of the SNF1 subfamily Omphk1.  Two Omphk homologues exist in each vertebrate species, and one homolog exists in Drosophila and Caenorhabditis elegans; the kinase domain is highly conserved among these homologues, and several domains are conserved among vertebrate Omphk.  Omphk1 expression dynamically changes in the developing central nervous system, is found ubiquitously in epidermis, and is present uniquely in several other tissues.  Its expression is also found in each tissue assocd. with the ventral body wall closure: the primary body wall composed of primitive ectoderm and each component of the secondary body wall.  Concomitantly, its null mutant exhibits omphalocele with a failure in closure of the secondary body wall.  There are no apparent gross morphol. defects in brain, however, despite the unique Omphk1 expression in this tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZHWRrkcxnS7Vg90H21EOLACvtfcHk0lh_O9TnCWDCwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVeisbg%253D&md5=87f08700859e6049a3919a93e170271b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fdvdy.20823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdvdy.20823%26sid%3Dliteratum%253Aachs%26aulast%3DHirano%26aufirst%3DM.%26aulast%3DKiyonari%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DFurushima%26aufirst%3DK.%26aulast%3DMurata%26aufirst%3DT.%26aulast%3DSuda%26aufirst%3DY.%26aulast%3DAizawa%26aufirst%3DS.%26atitle%3DA%2520New%2520Serine%252FThreonine%2520Protein%2520Kinase%252C%2520Omphk1%252C%2520Essential%2520to%2520Ventral%2520Body%2520Wall%2520Formation%26jtitle%3DDev.%2520Dyn.%26date%3D2006%26volume%3D235%26spage%3D2229%26epage%3D2237%26doi%3D10.1002%2Fdvdy.20823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohmura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shioi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizawa, S.</span></span> <span> </span><span class="NLM_article-title">Neural Tube Defects by NUAK1 and NUAK2 Double Mutation</span>. <i>Dev. Dyn.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>241</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1364</span>, <span class="refDoi"> DOI: 10.1002/dvdy.23816</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1002%2Fdvdy.23816" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22689267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVCjs7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=2012&pages=1350-1364&author=T.+Ohmuraauthor=G.+Shioiauthor=M.+Hiranoauthor=S.+Aizawa&title=Neural+Tube+Defects+by+NUAK1+and+NUAK2+Double+Mutation&doi=10.1002%2Fdvdy.23816"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Neural tube defects by NUAK1 and NUAK2 double mutation</span></div><div class="casAuthors">Ohmura, Tomomi; Shioi, Go; Hirano, Mariko; Aizawa, Shinichi</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Dynamics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1350-1364</span>CODEN:
                <span class="NLM_cas:coden">DEDYEI</span>;
        ISSN:<span class="NLM_cas:issn">1058-8388</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Background: NUAK1 and NUAK2, members of the AMP-activated protein kinase family of serine/threonine kinases, are prominently expressed in neuroectoderm, but their functions in neurulation have not been elucidated.  Results: NUAK1 and NUAK2 double mutants exhibited exencephaly, facial clefting, and spina bifida.  Median hinge point was formed, but dorsolateral hinge point formation was not apparent in cranial neural plate; neither apical constriction nor apico-basal elongation took place efficiently in the double mutants during the 5-10-somite stages.  Concomitantly, the apical concn. of phosphorylated myosin light chain 2, F-actin, and cortactin was insignificant, and development of acetylated α-tubulin-pos. microtubules was poor.  However, the distribution of F-actin, cortactin, Shroom3, Rho, myosin heavy chain IIB, phosphorylated myosin light chain 2, α-tubulin, γ-tubulin, or acetylated α-tubulin was apparently normal in the double mutant neuroepithelia at the 5-somite stage.  Conclusions: NUAK1 and NUAK2 complementarily function in the apical constriction and apico-basal elongation that assoc. with the dorsolateral hinge point formation in cephalic neural plate during the 5- to 10-somite stages.  In the double mutant neural plate, phosphorylated myosin light chain 2, F-actin, and cortactin did not conc. efficiently in apical surfaces, and acetylated α-tubulin-pos. microtubules did not develop significantly.  Developmental Dynamics 241:1350-1364, 2012. © 2012 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYQ8OxUKQi9bVg90H21EOLACvtfcHk0lh_O9TnCWDCwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVCjs7nI&md5=13fb6332eab4620fd4f2325f23af8221</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fdvdy.23816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdvdy.23816%26sid%3Dliteratum%253Aachs%26aulast%3DOhmura%26aufirst%3DT.%26aulast%3DShioi%26aufirst%3DG.%26aulast%3DHirano%26aufirst%3DM.%26aulast%3DAizawa%26aufirst%3DS.%26atitle%3DNeural%2520Tube%2520Defects%2520by%2520NUAK1%2520and%2520NUAK2%2520Double%2520Mutation%26jtitle%3DDev.%2520Dyn.%26date%3D2012%26volume%3D241%26spage%3D1350%26epage%3D1364%26doi%3D10.1002%2Fdvdy.23816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulbrich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wustefeld, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aeberhard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kress, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthalagu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rycak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudalska, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zender, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D. J.</span></span> <span> </span><span class="NLM_article-title">Deregulated MYC Expression Induces Dependence upon AMPK-Related Kinase 5</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>483</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">612</span>, <span class="refDoi"> DOI: 10.1038/nature10927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fnature10927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22460906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtVertbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=608-612&author=L.+Liuauthor=J.+Ulbrichauthor=J.+Mullerauthor=T.+Wustefeldauthor=L.+Aeberhardauthor=T.+R.+Kressauthor=N.+Muthalaguauthor=L.+Rycakauthor=R.+Rudalskaauthor=R.+Mollauthor=S.+Kempaauthor=L.+Zenderauthor=M.+Eilersauthor=D.+J.+Murphy&title=Deregulated+MYC+Expression+Induces+Dependence+upon+AMPK-Related+Kinase+5&doi=10.1038%2Fnature10927"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Deregulated MYC expression induces dependence upon AMPK-related kinase 5</span></div><div class="casAuthors">Liu, Lidan; Ulbrich, Jannes; Mueller, Judith; Wuestefeld, Torsten; Aeberhard, Lukas; Kress, Theresia R.; Muthalagu, Nathiya; Rycak, Lukas; Rudalska, Ramona; Moll, Roland; Kempa, Stefan; Zender, Lars; Eilers, Martin; Murphy, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">7391</span>),
    <span class="NLM_cas:pages">608-612</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deregulated expression of the MYC oncoprotein contributes to the genesis of many human tumors, yet strategies to exploit this for a rational tumor therapy are scarce.  MYC promotes cell growth and proliferation, and alters cellular metab. to enhance the provision of precursors for phospholipids and cellular macromols.  Here we show in human and murine cell lines that oncogenic levels of MYC establish a dependence on AMPK-related kinase 5 (ARK5; also known as NUAK1) for maintaining metabolic homeostasis and for cell survival.  ARK5 is an upstream regulator of AMPK and limits protein synthesis via inhibition of the mammalian target of rapamycin 1 (mTORC1) signaling pathway.  ARK5 also maintains expression of mitochondrial respiratory chain complexes and respiratory capacity, which is required for efficient glutamine metab.  Inhibition of ARK5 leads to a collapse of cellular ATP levels in cells expressing deregulated MYC, inducing multiple pro-apoptotic responses as a secondary consequence.  Depletion of ARK5 prolongs survival in MYC-driven mouse models of hepatocellular carcinoma, demonstrating that targeting cellular energy homeostasis is a valid therapeutic strategy to eliminate tumor cells that express deregulated MYC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWeNMQX50Id7Vg90H21EOLACvtfcHk0lh_O9TnCWDCwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtVertbk%253D&md5=ca6d9a40456878557f1c4a9cfb5e85f4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature10927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10927%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DUlbrich%26aufirst%3DJ.%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DWustefeld%26aufirst%3DT.%26aulast%3DAeberhard%26aufirst%3DL.%26aulast%3DKress%26aufirst%3DT.%2BR.%26aulast%3DMuthalagu%26aufirst%3DN.%26aulast%3DRycak%26aufirst%3DL.%26aulast%3DRudalska%26aufirst%3DR.%26aulast%3DMoll%26aufirst%3DR.%26aulast%3DKempa%26aufirst%3DS.%26aulast%3DZender%26aufirst%3DL.%26aulast%3DEilers%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DD.%2BJ.%26atitle%3DDeregulated%2520MYC%2520Expression%2520Induces%2520Dependence%2520upon%2520AMPK-Related%2520Kinase%25205%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D608%26epage%3D612%26doi%3D10.1038%2Fnature10927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaled, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netanely, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buxbaum, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janas, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postolsky, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, C.</span></span> <span> </span><span class="NLM_article-title">Transcription Factor/MicroRNA Axis Blocks Melanoma Invasion Program by MiR-211 Targeting NUAK1</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1038/jid.2013.340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fjid.2013.340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23934065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOns7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2014&pages=441-451&author=R.+E.+Bellauthor=M.+Khaledauthor=D.+Netanelyauthor=S.+Schubertauthor=T.+Golanauthor=A.+Buxbaumauthor=M.+M.+Janasauthor=B.+Postolskyauthor=M.+S.+Goldbergauthor=R.+Shamirauthor=C.+Levy&title=Transcription+Factor%2FMicroRNA+Axis+Blocks+Melanoma+Invasion+Program+by+MiR-211+Targeting+NUAK1&doi=10.1038%2Fjid.2013.340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Transcription Factor/microRNA Axis Blocks Melanoma Invasion Program by miR-211 Targeting NUAK1</span></div><div class="casAuthors">Bell, Rachel E.; Khaled, Mehdi; Netanely, Dvir; Schubert, Steffen; Golan, Tamar; Buxbaum, Amir; Janas, Maja M.; Postolsky, Benny; Goldberg, Michael S.; Shamir, Ron; Levy, Carmit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441-451</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanoma is one of the deadliest human cancers, responsible for approx. 80% of skin cancer mortalities.  The aggressiveness of melanoma is due to its capacity to proliferate and rapidly invade surrounding tissues, leading to metastases.  A recent model suggests melanoma progresses by reversibly switching between proliferation and invasion transcriptional signatures.  Recent studies show that cancer cells are more sensitive to microRNA (miRNA) perturbation than are non-cancer cells; however, the roles of miRNAs in melanoma plasticity remain unexplored.  Here, we use the gene expression profiles of melanoma and normal melanocytes to characterize the transcription factor-miRNA relationship that modulates the proliferative and invasive programs of melanoma.  We identified two sets of miRNAs that likely regulate these programs.  Interestingly, one of the miRNAs involved in melanoma invasion is miR-211, a known target of the master regulator microphthalmia-assocd. transcription factor (MITF).  We demonstrate that miR-211 contributes to melanoma adhesion by directly targeting a gene, NUAK1.  Inhibition of miR-211 increases NUAK1 expression and decreases melanoma adhesion, whereas upregulation of miR-211 restores adhesion through NUAK1 repression.  This study defines the MITF/miR-211 axis that inhibits the invasive program by blocking adhesion.  Furthermore, we have identified NUAK1 as a potential target for the treatment of metastatic melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWuaHHq7d3f7Vg90H21EOLACvtfcHk0lgY0sXrkDPZ8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOns7nL&md5=02bc20bb2808c189cf5bcb6d10d83319</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fjid.2013.340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjid.2013.340%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DR.%2BE.%26aulast%3DKhaled%26aufirst%3DM.%26aulast%3DNetanely%26aufirst%3DD.%26aulast%3DSchubert%26aufirst%3DS.%26aulast%3DGolan%26aufirst%3DT.%26aulast%3DBuxbaum%26aufirst%3DA.%26aulast%3DJanas%26aufirst%3DM.%2BM.%26aulast%3DPostolsky%26aufirst%3DB.%26aulast%3DGoldberg%26aufirst%3DM.%2BS.%26aulast%3DShamir%26aufirst%3DR.%26aulast%3DLevy%26aufirst%3DC.%26atitle%3DTranscription%2520Factor%252FMicroRNA%2520Axis%2520Blocks%2520Melanoma%2520Invasion%2520Program%2520by%2520MiR-211%2520Targeting%2520NUAK1%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2014%26volume%3D134%26spage%3D441%26epage%3D451%26doi%3D10.1038%2Fjid.2013.340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kusakai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">Strong Association of ARK5 with Tumor Invasion and Metastasis</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15354411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXms1Kjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=263-268&author=G.+Kusakaiauthor=A.+Suzukiauthor=T.+Oguraauthor=M.+Kaminishiauthor=H.+Esumi&title=Strong+Association+of+ARK5+with+Tumor+Invasion+and+Metastasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Strong association of ARK5 with tumor invasion and metastasis</span></div><div class="casAuthors">Kusakai, G.; Suzuki, A.; Ogura, T.; Kaminishi, M.; Esumi, H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">263-268</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">0392-9078</span>.
    
            (<span class="NLM_cas:orgname">Regina Elena Institute for Cancer Research</span>)
        </div><div class="casAbstract">The authors recently identified a novel human AMPK family member, ARK5, and discovered that it is a major factor in Akt-dependent cancer cell survival and migration activity through activation of MT1-MMPs in vitro.  The mRNA expression of other AMPK family members and ARK5 was measured using RT-PCR in human colorectal carcinoma cell lines DLD-1, WiDr, HCT-15, SW620, LoVo, SW480, and mRNA expression of AMPK-α1, SNARK, MELK and ARK5, but not AMPK-α2, was detected in every line.  Quant.-PCR (Q-PCR) to est. the amt. of ARK5 mRNA expression in the cell lines showed that there is a variety of ARK5 expressions among the cell lines and high expression was obsd. in a cell line derived from the metastatic lesion, LoVo.  To det. the effect of ARK5 overexpression on metastasis in vivo, the authors established human pancreas cancer cell line PANC-1 stably transfected with ARK5 full-length expression vector (P/ARK) and DLD-1 stably transfected with the same vector (D/ARK).  Migration assay showed a remarkable increase in the activity both in P/ARK and D/ARK, and an in vivo metastasis assay showed a marked increase of P/ARK in liver metastasis.  Based on these observations, it is suggested that ARK5 expression is involved in cancer invasion and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjb82P4k4HYrVg90H21EOLACvtfcHk0lgY0sXrkDPZ8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXms1Kjtbk%253D&md5=398d15306b52cfdb1e68016240821743</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKusakai%26aufirst%3DG.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DKaminishi%26aufirst%3DM.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DStrong%2520Association%2520of%2520ARK5%2520with%2520Tumor%2520Invasion%2520and%2520Metastasis%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D23%26spage%3D263%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span> <span> </span><span class="NLM_article-title">ARK5 Promotes Glioma Cell Invasion, and Its Elevated Expression Is Correlated with Poor Clinical Outcome</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">752</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2012.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.ejca.2012.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23063350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFSntbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=752-763&author=S.+Luauthor=N.+Niuauthor=H.+Guoauthor=J.+Tangauthor=W.+Guoauthor=Z.+Liuauthor=L.+Shiauthor=T.+Sunauthor=F.+Zhouauthor=H.+Liauthor=J.+Zhangauthor=B.+Zhang&title=ARK5+Promotes+Glioma+Cell+Invasion%2C+and+Its+Elevated+Expression+Is+Correlated+with+Poor+Clinical+Outcome&doi=10.1016%2Fj.ejca.2012.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">ARK5 promotes glioma cell invasion, and its elevated expression is correlated with poor clinical outcome</span></div><div class="casAuthors">Lu, Shijun; Niu, Na; Guo, Hua; Tang, Jinbao; Guo, Wenjun; Liu, Zhijun; Shi, Lihong; Sun, Tongyi; Zhou, Fenghua; Li, Hongli; Zhang, Jin; Zhang, Baogang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">752-763</span>CODEN:
                <span class="NLM_cas:coden">EJCAEL</span>;
        ISSN:<span class="NLM_cas:issn">0959-8049</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Poor prognosis of malignant gliomas is primarily attributed to their highly invasive nature.  Despite the identification of new biomarkers and mol. targets for the improvement of the diagnosis, prognosis and treatment of glioma, the overall prognosis of the disease remains poor.  This study is the first to show the significant upregulation of ARK5 paraffin-embedded archival glioma biopsies compared with those in adjacent non-cancerous brain tissues.  Statistical anal. suggests that the upregulation of ARK5 correlates with the World Health Organization grade of glioma (P < 0.001) and that patients with a high ARK5 level exhibit shorter survival time (P < 0.01).  In addn., ARK5 can promote glioma cell invasion by regulating cytoskeleton rearrangement and matrix metalloproteinase activation.  ARK5 knockdown was found to reduce brain invasion in a glioma xenograft mouse model.  Our results strongly suggest that ARK5 represents a novel and valuable biomarker to aid in the prediction of patient prognosis and is a potential therapeutic target against glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5qpZul5r0vrVg90H21EOLACvtfcHk0lgY0sXrkDPZ8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFSntbfM&md5=4c925e50ea022837261e763553ca1fd5</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2012.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2012.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DS.%26aulast%3DNiu%26aufirst%3DN.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DB.%26atitle%3DARK5%2520Promotes%2520Glioma%2520Cell%2520Invasion%252C%2520and%2520Its%2520Elevated%2520Expression%2520Is%2520Correlated%2520with%2520Poor%2520Clinical%2520Outcome%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2013%26volume%3D49%26spage%3D752%26epage%3D763%26doi%3D10.1016%2Fj.ejca.2012.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z. Y.</span></span> <span> </span><span class="NLM_article-title">A New Role of NUAK1: Directly Phosphorylating P53 and Regulating Cell Proliferation</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2933</span>– <span class="NLM_lpage">2942</span>, <span class="refDoi"> DOI: 10.1038/onc.2011.19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fonc.2011.19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=21317932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVGjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=2933-2942&author=X.+Houauthor=J.+E.+Liuauthor=W.+Liuauthor=C.+Y.+Liuauthor=Z.+Y.+Liuauthor=Z.+Y.+Sun&title=A+New+Role+of+NUAK1%3A+Directly+Phosphorylating+P53+and+Regulating+Cell+Proliferation&doi=10.1038%2Fonc.2011.19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A new role of NUAK1: Directly phosphorylating p53 and regulating cell proliferation</span></div><div class="casAuthors">Hou, X.; Liu, J.-E.; Liu, W.; Liu, C.-Y.; Liu, Z.-Y.; Sun, Z.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2933-2942</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">It has been suggested that adenosine monophosphate-activated protein kinase (AMPK) and 12 AMPK-related kinases (ARK), including novel (nua) kinase family 1 (NUAK1), are activated by master kinase LKB1, a major tumor suppressor.  Apart from evidence to suggest that NUAK1 participates in induction of tumor survival, invasion and p53-independent cellular senescence, its detailed biol. functions remain unclear.  Here we showed that in the presence of wild-type LKB1, NUAK1 directly interacts with and phosphorylates p53 in vitro and in vivo.  The phosphorylation of p53 induced by LKB1 required the kinase activity of NUAK1 and phosphorylation of NUAK1 at Thr211 by LKB1 was essential for its kinase activity, which leads to the conclusion that LKB1 activates NUAK1 and regulates phosphorylation of p53 through the NUAK1 kinase, at least partially.  LKB1/NUAK1 activation leads to cell cycle arrest at the G1/S border by inducing expression of p21/WAF1.  Under the regulation of LKB1, NUAK1 interacts with p53 in the nucleus and binds to the p53-responsive element of p21/WAF1 promoter.  These findings have highlighted a novel role for NUAK1 in LKB1-related signaling pathways; NUAK1 can regulate cell proliferation and exert tumor suppression through direct interaction with p53.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKoSQTxnlahbVg90H21EOLACvtfcHk0lgY0sXrkDPZ8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVGjsbk%253D&md5=b10697d03763efb757233f54b8b5a85b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fonc.2011.19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2011.19%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%2BE.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DC.%2BY.%26aulast%3DLiu%26aufirst%3DZ.%2BY.%26aulast%3DSun%26aufirst%3DZ.%2BY.%26atitle%3DA%2520New%2520Role%2520of%2520NUAK1%253A%2520Directly%2520Phosphorylating%2520P53%2520and%2520Regulating%2520Cell%2520Proliferation%26jtitle%3DOncogene%26date%3D2011%26volume%3D30%26spage%3D2933%26epage%3D2942%26doi%3D10.1038%2Fonc.2011.19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kläger, S.</span></span> <i>Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors</i>. Ph.D. Thesis, <span class="NLM_publisher-name">Technische Universität München</span>, <span class="NLM_publisher-loc">Germany</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=S.+Kl%C3%A4ger&title=Chemical+Proteomics+Reveals+the+Target+Landscape+of+Clinical+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKl%25C3%25A4ger%26aufirst%3DS.%26jtitle%3DChemical%2520Proteomics%2520Reveals%2520the%2520Target%2520Landscape%2520of%2520Clinical%2520Kinase%2520Inhibitors%26pub%3DTechnische%2520Universit%25C3%25A4t%2520M%25C3%25BCnchen%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishimoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavin, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">Identification of a Novel Protein Kinase Mediating Akt Survival Signaling to the ATM Protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1074/jbc.M206025200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M206025200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=12409306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD38XpvVWgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=48-53&author=A.+Suzukiauthor=G.+Kusakaiauthor=A.+Kishimotoauthor=J.+Luauthor=T.+Oguraauthor=M.+F.+Lavinauthor=H.+Esumi&title=Identification+of+a+Novel+Protein+Kinase+Mediating+Akt+Survival+Signaling+to+the+ATM+Protein&doi=10.1074%2Fjbc.M206025200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Protein Kinase Mediating Akt Survival Signaling to the ATM Protein</span></div><div class="casAuthors">Suzuki, Atsushi; Kusakai, Gen-ichi; Kishimoto, Atsuhiro; Lu, Jie; Ogura, Tsutomu; Lavin, Martin F.; Esumi, Hiroyasu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-53</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">We identified a novel human AMP-activated protein kinase (AMPK) family member, designated ARK5, encoding 661 amino acids with an estd. mol. mass of 74 kDa.  The putative amino acid sequence reveals 47, 45.8, 42.4, and 55% homol. to AMPK-α1, AMPK-α2, MELK, and SNARK, resp., suggesting that it is a new member of the AMPK family.  It has a putative Akt phosphorylation motif at amino acids 595-600, and Ser600 was found to be phosphorylated by active Akt resulting in the activation of kinase activity toward the SAMS peptide, a consensus AMPK substrate.  During nutrient starvation, ARK5 supported the survival of cells in an Akt-dependent manner.  In addn., we also demonstrated that ARK5, when activated by Akt, phosphorylated the ATM protein that is mutated in the human genetic disorder ataxia-telangiectasia and also induced the phosphorylation of p53.  On the basis of our current findings, we propose that a novel AMPK family member, ARK5, is the tumor cell survival factor activated by Akt and acts as an ATM kinase under the conditions of nutrient starvation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuT-kNwBTkPbVg90H21EOLACvtfcHk0liyvdJ9fuEIQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpvVWgu70%253D&md5=a52ad90eac8f2a45b62d8c25545338d9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M206025200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M206025200%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DKusakai%26aufirst%3DG.%26aulast%3DKishimoto%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DLavin%26aufirst%3DM.%2BF.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520a%2520Novel%2520Protein%2520Kinase%2520Mediating%2520Akt%2520Survival%2520Signaling%2520to%2520the%2520ATM%2520Protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D48%26epage%3D53%26doi%3D10.1074%2Fjbc.M206025200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishimoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">ARK5 Suppresses the Cell Death Induced by Nutrient Starvation and Death Receptors via Inhibition of Caspase 8 Activation, but Not by Chemotherapeutic Agents or UV Irradiation</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">6177</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1206899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fsj.onc.1206899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=13679856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlWhtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=6177&author=A.+Suzukiauthor=G.+Kusakaiauthor=A.+Kishimotoauthor=J.+Luauthor=T.+Oguraauthor=H.+Esumi&title=ARK5+Suppresses+the+Cell+Death+Induced+by+Nutrient+Starvation+and+Death+Receptors+via+Inhibition+of+Caspase+8+Activation%2C+but+Not+by+Chemotherapeutic+Agents+or+UV+Irradiation&doi=10.1038%2Fsj.onc.1206899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiation</span></div><div class="casAuthors">Suzuki, Atsushi; Kusakai, Gen-ichi; Kishimoto, Atsuhiro; Lu, Jie; Ogura, Tsutomu; Esumi, Hiroyasu</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">6177-6182</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">AMPK is a serine/threonine protein kinase family and we recently identified a novel member, ARK5.  The activation of ARK5 is triggered by Akt, and ARK5 induces tumor cell survival during nutrient starvation.  In the current study, we investigated the mechanisms of induction of cell survival by ARK5.  Human hepatoma HepG2 cells undergo necrotic cell death within 24 h after the start of glucose starvation, and the cell death signaling has been mediated by death-receptor-independent activation of caspase 8.  When HepG2 cells were transfected with ARK5 expression vector and subjected to several cell death stimuli, ARK5 was found to suppress cell death by glucose starvation, TRAIL, and TNF-α, but not by UV irradn., camptothecin, or doxorubicin.  Western blotting anal. revealed that both TRAIL and glucose starvation induced Bid cleavage and FLIP degrdn. following caspase 8 activation in a time-dependent manner, and ARK5 overexpression clearly delayed Bid cleavage, FLIP degrdn., and caspase 8 activation.  On the basis of the results of this study, we report that cell survival induced by ARK5 is, at least in part, due to inhibition of caspase 8 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon5dK8QZhTcrVg90H21EOLACvtfcHk0liyvdJ9fuEIQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlWhtbs%253D&md5=b575aaf1f9ce19b969f54f72fa62bcf9</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1206899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1206899%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DKusakai%26aufirst%3DG.%26aulast%3DKishimoto%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DARK5%2520Suppresses%2520the%2520Cell%2520Death%2520Induced%2520by%2520Nutrient%2520Starvation%2520and%2520Death%2520Receptors%2520via%2520Inhibition%2520of%2520Caspase%25208%2520Activation%252C%2520but%2520Not%2520by%2520Chemotherapeutic%2520Agents%2520or%2520UV%2520Irradiation%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D6177%26doi%3D10.1038%2Fsj.onc.1206899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paudel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H. J.</span></span> <span> </span><span class="NLM_article-title">Regulation and Function of Protein Kinases and Phosphatases</span>. <i>Enzyme Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2011</i></span>,  <span class="NLM_fpage">794089</span>, <span class="refDoi"> DOI: 10.4061/2011/794089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.4061%2F2011%2F794089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22195276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BC38%252Fps1ynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=794089&author=H.+C.+Chengauthor=R.+Z.+Qiauthor=H.+Paudelauthor=H.+J.+Zhu&title=Regulation+and+Function+of+Protein+Kinases+and+Phosphatases&doi=10.4061%2F2011%2F794089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation and function of protein kinases and phosphatases</span></div><div class="casAuthors">Cheng Heung-Chin; Qi Robert Z; Paudel Hemant; Zhu Hong-Jian</div><div class="citationInfo"><span class="NLM_cas:title">Enzyme research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">794089</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4A6JSV6MuoP6xYuD7tu2XfW6udTcc2eZjORJX0l2bi7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252Fps1ynsg%253D%253D&md5=54e052a7549da369d492bfac0e0d25ce</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.4061%2F2011%2F794089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4061%252F2011%252F794089%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%2BC.%26aulast%3DQi%26aufirst%3DR.%2BZ.%26aulast%3DPaudel%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DH.%2BJ.%26atitle%3DRegulation%2520and%2520Function%2520of%2520Protein%2520Kinases%2520and%2520Phosphatases%26jtitle%3DEnzyme%2520Res.%26date%3D2011%26volume%3D2011%26spage%3D794089%26doi%3D10.4061%2F2011%2F794089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Domenech Moreno, E.</span></span> <i>Identification of New Protein-Protein Interactions with NUAK2 by Proximity-Dependent Biotin Labeling</i>, Master’s Thesis, <span class="NLM_publisher-name">Helsingin yliopisto</span>, <span class="NLM_publisher-loc">Finland</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=E.+Domenech+Moreno&title=Identification+of+New+Protein-Protein+Interactions+with+NUAK2+by+Proximity-Dependent+Biotin+Labeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDomenech%2BMoreno%26aufirst%3DE.%26jtitle%3DIdentification%2520of%2520New%2520Protein-Protein%2520Interactions%2520with%2520NUAK2%2520by%2520Proximity-Dependent%2520Biotin%2520Labeling%26pub%3DHelsingin%2520yliopisto%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lizcano, J. M</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goransson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrice, N. A</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boudeau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawley, S. A</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udd, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makela, T. P</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardie, D G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R</span></span> <span> </span><span class="NLM_article-title">LKB1 Is a Master Kinase That Activates 13 Kinases of the AMPK Subfamily, Including MARK/PAR-1</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">843</span>, <span class="refDoi"> DOI: 10.1038/sj.emboj.7600110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fsj.emboj.7600110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=14976552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFCjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=833-843&author=J.+M+Lizcanoauthor=O.+Goranssonauthor=R.+Tothauthor=M.+Deakauthor=N.+A+Morriceauthor=J.+Boudeauauthor=S.+A+Hawleyauthor=L.+Uddauthor=T.+P+Makelaauthor=D+G.+Hardieauthor=D.+R+Alessi&title=LKB1+Is+a+Master+Kinase+That+Activates+13+Kinases+of+the+AMPK+Subfamily%2C+Including+MARK%2FPAR-1&doi=10.1038%2Fsj.emboj.7600110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1</span></div><div class="casAuthors">Lizcano, Jose M.; Goeransson, Olga; Toth, Rachel; Deak, Maria; Morrice, Nick A.; Boudeau, Jerome; Hawley, Simon A.; Udd, Lina; Maekelae, Tomi P.; Hardie, D. Grahame; Alessi, Dario R.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">833-843</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We recently demonstrated that the LKB1 tumor suppressor kinase, in complex with the pseudokinase STRAD and the scaffolding protein MO25, phosphorylates and activates AMP-activated protein kinase (AMPK).  A total of 12 human kinases (NUAK1, NUAK2, BRSK1, BRSK2, QIK, QSK, SIK, MARK1, MARK2, MARK3, MARK4 and MELK) are related to AMPK.  Here we demonstrate that LKB1 can phosphorylate the T-loop of all the members of this subfamily, apart from MELK, increasing their activity >50-fold.  LKB1 catalytic activity and the presence of MO25 and STRAD are required for activation.  Mutation of the T-loop Thr phosphorylated by LKB1 to Ala prevented activation, while mutation to glutamate produced active forms of many of the AMPK-related kinases.  Activities of endogenous NUAK2, QIK, QSK, SIK, MARK1, MARK2/3 and MARK4 were markedly reduced in LKB1-deficient cells.  Neither LKB1 activity nor that of AMPK-related kinases was stimulated by phenformin or AICAR, which activate AMPK.  Our results show that LKB1 functions as a master upstream protein kinase, regulating AMPK-related kinases as well as AMPK.  Between them, these kinases may mediate the physiol. effects of LKB1, including its tumor suppressor function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzr93XYu3yFbVg90H21EOLACvtfcHk0liZcVs89hBoCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFCjtbs%253D&md5=1aab7e4182fae41b3597b73baa5f0b7d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7600110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7600110%26sid%3Dliteratum%253Aachs%26aulast%3DLizcano%26aufirst%3DJ.%2BM%26aulast%3DGoransson%26aufirst%3DO.%26aulast%3DToth%26aufirst%3DR.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DMorrice%26aufirst%3DN.%2BA%26aulast%3DBoudeau%26aufirst%3DJ.%26aulast%3DHawley%26aufirst%3DS.%2BA%26aulast%3DUdd%26aufirst%3DL.%26aulast%3DMakela%26aufirst%3DT.%2BP%26aulast%3DHardie%26aufirst%3DD%2BG.%26aulast%3DAlessi%26aufirst%3DD.%2BR%26atitle%3DLKB1%2520Is%2520a%2520Master%2520Kinase%2520That%2520Activates%252013%2520Kinases%2520of%2520the%2520AMPK%2520Subfamily%252C%2520Including%2520MARK%252FPAR-1%26jtitle%3DEMBO%2520J.%26date%3D2004%26volume%3D23%26spage%3D833%26epage%3D843%26doi%3D10.1038%2Fsj.emboj.7600110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakai, G. -i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishimoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">ARK5 Is a Tumor Invasion-Associated Factor Downstream of Akt Signaling</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3526</span>– <span class="NLM_lpage">3535</span>, <span class="refDoi"> DOI: 10.1128/MCB.24.8.3526-3535.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1128%2FMCB.24.8.3526-3535.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15060171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFKjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=3526-3535&author=A.+Suzukiauthor=J.+Luauthor=G.+-i.+Kusakaiauthor=A.+Kishimotoauthor=T.+Oguraauthor=H.+Esumi&title=ARK5+Is+a+Tumor+Invasion-Associated+Factor+Downstream+of+Akt+Signaling&doi=10.1128%2FMCB.24.8.3526-3535.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">ARK5 is a tumor invasion-associated factor downstream of Akt signaling</span></div><div class="casAuthors">Suzuki, Atsushi; Lu, Jie; Kusakai, Gen-ichi; Kishimoto, Atsuhiro; Ogura, Tsutomu; Esumi, Hiroyasu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3526-3535</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">AMP-activated protein kinases (AMPKs) are a class of serine/threonine protein kinases that are activated by an increase in intracellular AMP concn.  They are a sensitive indicator of cellular energy status and have been found to promote tumor cell survival during nutrient starvation.  We recently identified a novel AMPK catalytic subunit family member, ARK5, whose activation is directly regulated by Akt, which, in turn, has been reported to be a key player in tumor malignancy.  In this study, we attempted to det. whether ARK5 is involved in tumor malignancy under regulation by Akt.  Matrigel invasion assays demonstrated that both overexpressed and endogenous ARK5 showed strong activity dependent on Akt.  In addn., ARK5 expression induced activation of matrix metalloproteinase 2 (MMP-2) and MMP-9 following new expression of membrane type 1 MMP (MT1-MMP), and the MT1-MMP expression induced by ARK5 was initiated by rapamycin-sensitive signaling.  In nude mice, ARK5 expression was assocd. with a significant increase in tumor growth and significant suppression of necrosis in tumor tissue.  Interestingly, only the ARK5-overexpressing PANC-1 cell line (P/ARK) tumor showed invasion and metastasis in nude mice, although Akt was activated in tumors derived from both P/ARK and its parental cell line.  We report that a novel AMPK catalytic subunit family member, ARK5, plays a key role in tumor malignancy downstream of Akt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp2pQK3k2_uLVg90H21EOLACvtfcHk0liZcVs89hBoCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFKjtLk%253D&md5=cf805bd959892c2da70eebd31559ce3b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.8.3526-3535.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.8.3526-3535.2004%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DKusakai%26aufirst%3DG.%2B-i.%26aulast%3DKishimoto%26aufirst%3DA.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DARK5%2520Is%2520a%2520Tumor%2520Invasion-Associated%2520Factor%2520Downstream%2520of%2520Akt%2520Signaling%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D3526%26epage%3D3535%26doi%3D10.1128%2FMCB.24.8.3526-3535.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marx, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugoor, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panneerselvam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelkow, E.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of Polarity-Inducing Kinase Family MARK/Par-1 within the Branch of AMPK/Snf1-Related Kinases</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1637</span>– <span class="NLM_lpage">1648</span>, <span class="refDoi"> DOI: 10.1096/fj.09-148064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1096%2Ffj.09-148064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=20071654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnt1Ojtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=1637-1648&author=A.+Marxauthor=C.+Nugoorauthor=S.+Panneerselvamauthor=E.+Mandelkow&title=Structure+and+Function+of+Polarity-Inducing+Kinase+Family+MARK%2FPar-1+within+the+Branch+of+AMPK%2FSnf1-Related+Kinases&doi=10.1096%2Ffj.09-148064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of polarity-inducing kinase family MARK/Par-1 within the branch of AMPK/Snf1-related kinases</span></div><div class="casAuthors">Marx, A.; Nugoor, C.; Panneerselvam, S.; Mandelkow, E.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1637-1648, 10.1096/fj.09-148064</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review.  Kinases of the MARK/Par-1 family of S/T protein kinases are regulators of diverse cellular processes in Caenorhabditis elegans, Drosophila, yeast, and mammalian cells.  They are involved in nematode embryogenesis, epithelial cell polarization, cell signaling, and neuronal differentiation.  MARK phosphorylates microtubule-assocd. proteins such as tau and is a key regulator of microtubule-based intracellular transport.  Hyperphosphorylation of tau causes defects in neuronal transport and may induce abnormal aggregation of tau in Alzheimer disease and other tauopathies.  Recent high-resoln. structure anal. of MARK fragments covering the kinase domain and accessory regulatory domains has revealed important details regarding the autoregulation of MARK, but their interpretation has remained controversial.  Here, the authors focus on the structural aspects of MARK activity and autoregulation.  Comparison of the available MARK structures with related kinases of the AMPK family and with new structures of MARK isoforms (MARK2 and MARK3) reveals unexpected structural similarities between these kinases that may help to resolve the existing controversies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGEBJF7HxdZ7Vg90H21EOLACvtfcHk0lhO_f6hznFLug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnt1Ojtbs%253D&md5=ab8f0ca6a38b55ee99e7b74f265e08c1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1096%2Ffj.09-148064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.09-148064%26sid%3Dliteratum%253Aachs%26aulast%3DMarx%26aufirst%3DA.%26aulast%3DNugoor%26aufirst%3DC.%26aulast%3DPanneerselvam%26aufirst%3DS.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DStructure%2520and%2520Function%2520of%2520Polarity-Inducing%2520Kinase%2520Family%2520MARK%252FPar-1%2520within%2520the%2520Branch%2520of%2520AMPK%252FSnf1-Related%2520Kinases%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26spage%3D1637%26epage%3D1648%26doi%3D10.1096%2Ffj.09-148064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardie, D. G.</span></span> <span> </span><span class="NLM_article-title">AMP-Activated/SNF1 Protein Kinases: Conserved Guardians of Cellular Energy</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">774</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1038/nrm2249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fnrm2249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=17712357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKmt7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=774-785&author=D.+G.+Hardie&title=AMP-Activated%2FSNF1+Protein+Kinases%3A+Conserved+Guardians+of+Cellular+Energy&doi=10.1038%2Fnrm2249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy</span></div><div class="casAuthors">Hardie, D. Grahame</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">774-785</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The SNF1/AMP-activated protein kinase (AMPK) family maintains the balance between ATP prodn. and consumption in all eukaryotic cells.  The kinases are heterotrimers that comprise a catalytic subunit and regulatory subunits that sense cellular energy levels.  When energy status is compromised, the system activates catabolic pathways and switches off protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation.  Surprisingly, recent results indicate that the AMPK system is also important in functions that go beyond the regulation of energy homeostasis, such as the maintenance of cell polarity in epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpQCBXuVk2N7Vg90H21EOLACvtfcHk0lhO_f6hznFLug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKmt7vP&md5=ebf155462b8d49227514227561cf90a9</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrm2249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2249%26sid%3Dliteratum%253Aachs%26aulast%3DHardie%26aufirst%3DD.%2BG.%26atitle%3DAMP-Activated%252FSNF1%2520Protein%2520Kinases%253A%2520Conserved%2520Guardians%2520of%2520Cellular%2520Energy%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D774%26epage%3D785%26doi%3D10.1038%2Fnrm2249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. H.</span></span> <span> </span><span class="NLM_article-title">Cross-Talk between AMPK and MTOR in Regulating Energy Balance</span>. <i>Crit. Rev. Food Sci. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1080/10408398.2010.500245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1080%2F10408398.2010.500245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22369257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms1WgtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=373-381&author=J.+Xuauthor=J.+Jiauthor=X.+H.+Yan&title=Cross-Talk+between+AMPK+and+MTOR+in+Regulating+Energy+Balance&doi=10.1080%2F10408398.2010.500245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-Talk between AMPK and mTOR in Regulating Energy Balance</span></div><div class="casAuthors">Xu, Jia; Ji, Jian; Yan, Xiang-Hua</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Food Science and Nutrition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">373-381</span>CODEN:
                <span class="NLM_cas:coden">CRFND6</span>;
        ISSN:<span class="NLM_cas:issn">1040-8398</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  Energy balance is maintained by a complex homeostatic system involving some signaling pathways and "nutrient sensors" in multiple tissues and organs.  Any defect assocd. with the pathways can lead to metabolic disorders including obesity, type 2 diabetes, and the metabolic syndrome.  The 5'-adenosine monophosphate-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) appear to play a significant role in the intermediary metab. of these diseases.  AMPK is involved in the fundamental regulation of energy balance at the whole body level by responding to hormonal and nutrient signals in the central nervous system and peripheral tissues that modulate food intake and energy expenditure.  Mammalian target of rapamycin (mTOR),is one of the downstream targets of AMPK functions as an intracellular nutrient sensor to control protein synthesis, cell growth, and metab.  Recent research demonstrated the possible interplay between mTOR and AMPK signaling pathways.  In this review, we will present current knowledge of AMPK and mTOR pathways in regulating energy balance and demonstrate the convergence between these two pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnS4N5k5NH6LVg90H21EOLACvtfcHk0lhO_f6hznFLug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms1WgtLw%253D&md5=0232b59ccadfd284f612a5089c9e0ed3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1080%2F10408398.2010.500245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408398.2010.500245%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DX.%2BH.%26atitle%3DCross-Talk%2520between%2520AMPK%2520and%2520MTOR%2520in%2520Regulating%2520Energy%2520Balance%26jtitle%3DCrit.%2520Rev.%2520Food%2520Sci.%2520Nutr.%26date%3D2012%26volume%3D52%26spage%3D373%26epage%3D381%26doi%3D10.1080%2F10408398.2010.500245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bull, D.</span></span> <i>Investigating the Role and Regulation of the AMPK-Related Kinase NUAK1</i>, Ph.D. Thesis, <span class="NLM_publisher-name">Imperial College London</span>, <span class="NLM_publisher-loc">United Kingdom</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=D.+Bull&title=Investigating+the+Role+and+Regulation+of+the+AMPK-Related+Kinase+NUAK1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBull%26aufirst%3DD.%26jtitle%3DInvestigating%2520the%2520Role%2520and%2520Regulation%2520of%2520the%2520AMPK-Related%2520Kinase%2520NUAK1%26pub%3DImperial%2520College%2520London%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppelt, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">Muscle Contractions, AICAR, and Insulin Cause Phosphorylation of an AMPK-Related Kinase</span>. <i>Am. J. Physiol. - Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">E986</span>– <span class="NLM_lpage">E992</span>, <span class="refDoi"> DOI: 10.1152/ajpendo.00335.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1152%2Fajpendo.00335.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=16030062" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2005&pages=E986-E992&author=J.+S.+Fisherauthor=J.+S.+Juauthor=P.+J.+Oppeltauthor=J.+L.+Smithauthor=A.+Suzukiauthor=H.+Esumi&title=Muscle+Contractions%2C+AICAR%2C+and+Insulin+Cause+Phosphorylation+of+an+AMPK-Related+Kinase&doi=10.1152%2Fajpendo.00335.2004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.00335.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.00335.2004%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DJ.%2BS.%26aulast%3DJu%26aufirst%3DJ.%2BS.%26aulast%3DOppelt%26aufirst%3DP.%2BJ.%26aulast%3DSmith%26aufirst%3DJ.%2BL.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DMuscle%2520Contractions%252C%2520AICAR%252C%2520and%2520Insulin%2520Cause%2520Phosphorylation%2520of%2520an%2520AMPK-Related%2520Kinase%26jtitle%3DAm.%2520J.%2520Physiol.%2520-%2520Endocrinol.%2520Metab.%26date%3D2005%26volume%3D289%26spage%3DE986%26epage%3DE992%26doi%3D10.1152%2Fajpendo.00335.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lefebvre, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahmolky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drucker, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, C. F.</span></span> <span> </span><span class="NLM_article-title">Identification and Characterization of a Novel Sucrose-Non-Fermenting Protein Kinase/AMP-Activated Protein Kinase-Related Protein Kinase, SNARK</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1042/0264-6021:3550297</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1042%2Fbj3550297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=11284715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsValur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2001&pages=297-305&author=D.+L.+Lefebvreauthor=Y.+Baiauthor=N.+Shahmolkyauthor=M.+Sharmaauthor=R.+Poonauthor=D.+J.+Druckerauthor=C.+F.+Rosen&title=Identification+and+Characterization+of+a+Novel+Sucrose-Non-Fermenting+Protein+Kinase%2FAMP-Activated+Protein+Kinase-Related+Protein+Kinase%2C+SNARK&doi=10.1042%2F0264-6021%3A3550297"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of a novel sucrose-non-fermenting protein kinase/AMP-activated protein kinase-related protein kinase, SNARK</span></div><div class="casAuthors">Lefebvre, Diana L.; Bai, Yahong; Shahmolky, Nazanin; Sharma, Monika; Poon, Raymond; Drucker, Daniel J.; Rosen, Cheryl F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">297-305</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Subtraction hybridization after the exposure of keratinocytes to UV radiation identified a differentially expressed cDNA that encodes a protein of 630 amino acid residues possessing significant similarity to the catalytic domain of the sucrose-non-fermenting protein kinase (SNF1)/AMP-activated protein kinase (AMPK) family of serine/threonine protein kinases.  Northern blotting and reverse-transcriptase-mediated PCR demonstrated that mRNA transcripts for the SNF1/AMPK-related kinase (SNARK) were widely expressed in rodent tissues.  The SNARK gene was localized to human chromosome 1q32 by fluorescent in situ hybridization.  SNARK was translated in vitro to yield a single protein band of approx. 76 kDa; Western anal. of transfected baby hamster kidney (BHK) cells detected two SNARK-immunoreactive bands of approx. 76-80 kDa.  SNARK was capable of autophosphorylation in vitro; immunopptd. SNARK exhibited phosphotransferase activity with the synthetic peptide substrate HMRSAMSGLHLVKRR (SAMS) as a kinase substrate.  SNARK activity was significantly increased by AMP and 5-amino-4-imidazolecarboxamide riboside (AICAriboside) in rat keratinocyte cells, implying that SNARK might be activated by an AMPK kinase-dependent pathway.  Furthermore, glucose deprivation increased SNARK activity 3-fold in BHK fibroblasts.  These findings identify SNARK as a glucose- and AICAriboside-regulated member of the AMPK-related gene family that represents a new candidate mediator of the cellular response to metabolic stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquvJv0tlxC17Vg90H21EOLACvtfcHk0ljplAD6QHx50Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsValur8%253D&md5=c3d75be60fe8b24fcf5c5f0589b1fc36</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1042%2Fbj3550297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3550297%26sid%3Dliteratum%253Aachs%26aulast%3DLefebvre%26aufirst%3DD.%2BL.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DShahmolky%26aufirst%3DN.%26aulast%3DSharma%26aufirst%3DM.%26aulast%3DPoon%26aufirst%3DR.%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26aulast%3DRosen%26aufirst%3DC.%2BF.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520a%2520Novel%2520Sucrose-Non-Fermenting%2520Protein%2520Kinase%252FAMP-Activated%2520Protein%2520Kinase-Related%2520Protein%2520Kinase%252C%2520SNARK%26jtitle%3DBiochem.%2520J.%26date%3D2001%26volume%3D355%26spage%3D297%26epage%3D305%26doi%3D10.1042%2F0264-6021%3A3550297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katajisto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallenius, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaahtomeri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udd, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiainen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mäkelä, T. P.</span></span> <span> </span><span class="NLM_article-title">The LKB1 Tumor Suppressor Kinase in Human Disease</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1775</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.bbcan.2006.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.bbcan.2006.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=17010524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlaltr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1775&publication_year=2007&pages=63-75&author=P.+Katajistoauthor=T.+Valleniusauthor=K.+Vaahtomeriauthor=N.+Ekmanauthor=L.+Uddauthor=M.+Tiainenauthor=T.+P.+M%C3%A4kel%C3%A4&title=The+LKB1+Tumor+Suppressor+Kinase+in+Human+Disease&doi=10.1016%2Fj.bbcan.2006.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The LKB1 tumor suppressor kinase in human disease</span></div><div class="casAuthors">Katajisto, Pekka; Vallenius, Tea; Vaahtomeri, Kari; Ekman, Niklas; Udd, Lina; Tiainen, Marianne; Maekelae, Tomi P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1775</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-75</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Inactivating germline mutations in the LKB1 gene underlie Peutz-Jeghers syndrome characterized by hamartomatous polyps and an elevated risk for cancer.  Recent studies suggest the involvement of LKB1 also in more common human disorders including diabetes and in a significant fraction of lung adenocarcinomas.  These observations have increased the interest towards signaling pathways of this tumor suppressor kinase.  The recent breakthroughs in understanding the mol. functions of the LKB1 indicate its contribution as a regulator of cell polarity, energy metab. and cell proliferation.  Here we review how the substrates and cellular functions of LKB1 may be linked to Peutz-Jeghers syndrome and other diseases, and discuss how some of the mol. changes assocd. with altered LKB1 signaling might be used in therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgGAfGU1gOV7Vg90H21EOLACvtfcHk0ljplAD6QHx50Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlaltr%252FI&md5=936e91dd7e160b0b01db7253d9141763</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2006.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2006.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DKatajisto%26aufirst%3DP.%26aulast%3DVallenius%26aufirst%3DT.%26aulast%3DVaahtomeri%26aufirst%3DK.%26aulast%3DEkman%26aufirst%3DN.%26aulast%3DUdd%26aufirst%3DL.%26aulast%3DTiainen%26aufirst%3DM.%26aulast%3DM%25C3%25A4kel%25C3%25A4%26aufirst%3DT.%2BP.%26atitle%3DThe%2520LKB1%2520Tumor%2520Suppressor%2520Kinase%2520in%2520Human%2520Disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2007%26volume%3D1775%26spage%3D63%26epage%3D75%26doi%3D10.1016%2Fj.bbcan.2006.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoppe, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reedy, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schriefer, L. A.</span></span> <span> </span><span class="NLM_article-title">Caenorhabditis Elegans Unc-82 Encodes a Serine/Threonine Kinase Important for Myosin Filament Organization in Muscle during Growth</span>. <i>Genetics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1534/genetics.109.110189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1534%2Fgenetics.109.110189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=19901071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOntbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2010&pages=79-90&author=P.+E.+Hoppeauthor=J.+Chauauthor=K.+A.+Flanaganauthor=A.+R.+Reedyauthor=L.+A.+Schriefer&title=Caenorhabditis+Elegans+Unc-82+Encodes+a+Serine%2FThreonine+Kinase+Important+for+Myosin+Filament+Organization+in+Muscle+during+Growth&doi=10.1534%2Fgenetics.109.110189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Caenorhabditis elegans unc-82 encodes a serine/threonine kinase important for myosin filament organization in muscle during growth</span></div><div class="casAuthors">Hoppe, Pamela E.; Chau, Johnnie; Flanagan, Kelly A.; Reedy, April R.; Schriefer, Lawrence A.</div><div class="citationInfo"><span class="NLM_cas:title">Genetics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-90</span>CODEN:
                <span class="NLM_cas:coden">GENTAE</span>;
        ISSN:<span class="NLM_cas:issn">0016-6731</span>.
    
            (<span class="NLM_cas:orgname">Genetics Society of America</span>)
        </div><div class="casAbstract">Mutations in the unc-82 locus of Caenorhabditis elegans were previously identified by screening for disrupted muscle cytoskeleton in otherwise apparently normal mutagenized animals.  Here we demonstrate that the locus encodes a serine/threonine kinase orthologous to human ARK5/SNARK (NUAK1/NUAK2) and related to the PAR-1 and SNF1/AMP-Activated kinase (AMPK) families.  The predicted 1600-amino-acid polypeptide contains an N-terminal catalytic domain and noncomplex repetitive sequence in the remainder of the mol.  Phenotypic analyses indicate that unc-82 is required for maintaining the organization of myosin filaments and internal components of the M-line during cell-shape changes.  Mutants exhibit normal patterning of cytoskeletal elements during early embryogenesis.  Defects in localization of thick filament and M-line components arise during embryonic elongation and become progressively more severe as development proceeds.  The phenotype is independent of contractile activity, consistent with unc-82 mutations preventing proper cytoskeletal reorganization during growth, rather than undermining structural integrity of the M-line.  This is the first report establishing a role for the UNC-82/ARK5/SNARK kinases in normal development.  We propose that activation of UNC-82 kinase during cell elongation regulates thick filament attachment or growth, perhaps through phosphorylation of myosin and paramyosin.  We speculate that regulation of myosin is an ancestral characteristic of kinases in this region of the kinome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppMaV_9tMnq7Vg90H21EOLACvtfcHk0ljplAD6QHx50Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOntbfF&md5=4755cc0e022e9581b08b16fc98dd1c93</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1534%2Fgenetics.109.110189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1534%252Fgenetics.109.110189%26sid%3Dliteratum%253Aachs%26aulast%3DHoppe%26aufirst%3DP.%2BE.%26aulast%3DChau%26aufirst%3DJ.%26aulast%3DFlanagan%26aufirst%3DK.%2BA.%26aulast%3DReedy%26aufirst%3DA.%2BR.%26aulast%3DSchriefer%26aufirst%3DL.%2BA.%26atitle%3DCaenorhabditis%2520Elegans%2520Unc-82%2520Encodes%2520a%2520Serine%252FThreonine%2520Kinase%2520Important%2520for%2520Myosin%2520Filament%2520Organization%2520in%2520Muscle%2520during%2520Growth%26jtitle%3DGenetics%26date%3D2010%26volume%3D184%26spage%3D79%26epage%3D90%26doi%3D10.1534%2Fgenetics.109.110189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lefebvre, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, C. F.</span></span> <span> </span><span class="NLM_article-title">Regulation of SNARK Activity in Response to Cellular Stresses</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1724</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2005.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.bbagen.2005.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFGisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1724&publication_year=2005&pages=71-85&author=D.+L.+Lefebvreauthor=C.+F.+Rosen&title=Regulation+of+SNARK+Activity+in+Response+to+Cellular+Stresses&doi=10.1016%2Fj.bbagen.2005.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of SNARK activity in response to cellular stresses</span></div><div class="casAuthors">Lefebvre, Diana L.; Rosen, Cheryl F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1724</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">71-85</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">SNARK is a member of the AMPK subfamily of serine/threonine protein kinases.  In this study, we examd. the regulation of SNARK activity in kidney (BHK, HEK293), pancreatic β-cell insulinoma (INS-1), hepatocarcinoma (H4IIE) and keratinocyte (NRKC)-derived cell lines in response to diverse cellular stresses.  We show that SNARK activity is regulated by glucose- or glutamine-deprivation, induction of endoplasmic reticulum stress by homocysteine or DTT, elevation of cellular AMP and/or depletion of ATP, hyperosmotic stress, salt stress, UV B radiation and oxidative stress caused by hydrogen peroxide.  Moreover, the regulation of SNARK activity in response to cellular stresses depends greatly upon cell type.  Furthermore, SNARK activity is downregulated by metformin in a dose- and time-dependent manner in H4IIE cells.  These observations support a role for SNARK as a mol. component of the cellular stress response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZKW01TW42ArVg90H21EOLACvtfcHk0ljplAD6QHx50Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFGisb8%253D&md5=800ac654b9fc04021efe53bcf97c2e31</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2005.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2005.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DLefebvre%26aufirst%3DD.%2BL.%26aulast%3DRosen%26aufirst%3DC.%2BF.%26atitle%3DRegulation%2520of%2520SNARK%2520Activity%2520in%2520Response%2520to%2520Cellular%2520Stresses%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2005%26volume%3D1724%26spage%3D71%26epage%3D85%26doi%3D10.1016%2Fj.bbagen.2005.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rune, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osler, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zierath, J. R.</span></span> <span> </span><span class="NLM_article-title">Regulation of Skeletal Muscle Sucrose, Non-Fermenting 1/AMP-Activated Protein Kinase-Related Kinase (SNARK) by Metabolic Stress and Diabetes</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2182</span>– <span class="NLM_lpage">2189</span>, <span class="refDoi"> DOI: 10.1007/s00125-009-1465-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1007%2Fs00125-009-1465-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=19652946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVygtLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2182-2189&author=A.+Runeauthor=M.+E.+Oslerauthor=T.+Fritzauthor=J.+R.+Zierath&title=Regulation+of+Skeletal+Muscle+Sucrose%2C+Non-Fermenting+1%2FAMP-Activated+Protein+Kinase-Related+Kinase+%28SNARK%29+by+Metabolic+Stress+and+Diabetes&doi=10.1007%2Fs00125-009-1465-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of skeletal muscle sucrose, non-fermenting 1/AMP-activated protein kinase-related kinase (SNARK) by metabolic stress and diabetes</span></div><div class="casAuthors">Rune, A.; Osler, M. E.; Fritz, T.; Zierath, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2182-2189</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aims/hypothesis: Sucrose, non-fermenting 1/AMP-activated protein kinase-related kinase (SNARK) is involved in cellular stress responses linked to obesity and type 2 diabetes.  We detd. the role of SNARK in response to metabolic stress and insulin action on glucose and lipid metab. in skeletal muscle.  Methods: Vastus lateralis skeletal muscle biopsies were obtained from normal glucose tolerant (n = 35) and type 2 diabetic (n = 31) men and women for SNARK expression studies.  Primary myotube cultures were derived from biopsies obtained from normal glucose tolerant individuals for metabolic studies.  Results: SNARK (also known as NUAK2) mRNA expression was unaltered between normal glucose tolerant individuals and type 2 diabetic patients.  SNARK expression was increased in skeletal muscle from obese (BMI >31 kg/m2) normal glucose tolerant individuals and type 2 diabetic patients (1.4- and 1.4-fold, resp., p < 0.05) vs overweight (BMI <28 kg/m2) normal glucose tolerant individuals and type 2 diabetic patients.  SNARK mRNA was increased in myotubes exposed to palmitate (12-fold; p < 0.01), or TNF-α (25-fold, p < 0.05), but not to oleate, glucose or IL-6, whereas expression of the AMP-activated protein kinase α2 subunit was unaltered.  Small interfering (si)RNA against SNARK reduced mRNA and protein in myotubes by 61% and 60%, resp. (p < 0.05).  SNARK siRNA was without effect on basal or insulin-stimulated glucose uptake or lipid oxidn., and insufficient to rescue TNF-α- or palmitate-induced insulin resistance.  Conclusions/interpretation: Skeletal muscle SNARK expression is increased in human obesity, and in response to metabolic stressors, but not type 2 diabetes.  Partial SNARK depletion failed to modify either glucose or lipid metab., or protect against TNF-α- or palmitate-induced insulin resistance in primary human myotubes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXp2SjR73Ad7Vg90H21EOLACvtfcHk0lg4x64_fPFgig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVygtLbN&md5=022f689d4333704ad2819014bf4e13e5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs00125-009-1465-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-009-1465-x%26sid%3Dliteratum%253Aachs%26aulast%3DRune%26aufirst%3DA.%26aulast%3DOsler%26aufirst%3DM.%2BE.%26aulast%3DFritz%26aufirst%3DT.%26aulast%3DZierath%26aufirst%3DJ.%2BR.%26atitle%3DRegulation%2520of%2520Skeletal%2520Muscle%2520Sucrose%252C%2520Non-Fermenting%25201%252FAMP-Activated%2520Protein%2520Kinase-Related%2520Kinase%2520%2528SNARK%2529%2520by%2520Metabolic%2520Stress%2520and%2520Diabetes%26jtitle%3DDiabetologia%26date%3D2009%26volume%3D52%26spage%3D2182%26epage%3D2189%26doi%3D10.1007%2Fs00125-009-1465-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koh, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathod, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middelbeek, R. J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lessard, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treebak, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtaszewski, J. F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirshman, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodyear, L. J.</span></span> <span> </span><span class="NLM_article-title">Sucrose Nonfermenting AMPK-Related Kinase (SNARK) Mediates Contraction-Stimulated Glucose Transport in Mouse Skeletal Muscle</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">15541</span>– <span class="NLM_lpage">15546</span>, <span class="refDoi"> DOI: 10.1073/pnas.1008131107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1073%2Fpnas.1008131107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=20713714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaqu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=15541-15546&author=H.-J.+Kohauthor=T.+Toyodaauthor=N.+Fujiiauthor=M.+M.+Jungauthor=A.+Rathodauthor=R.+J.-W.+Middelbeekauthor=S.+J.+Lessardauthor=J.+T.+Treebakauthor=K.+Tsuchiharaauthor=H.+Esumiauthor=E.+A.+Richterauthor=J.+F.+P.+Wojtaszewskiauthor=M.+F.+Hirshmanauthor=L.+J.+Goodyear&title=Sucrose+Nonfermenting+AMPK-Related+Kinase+%28SNARK%29+Mediates+Contraction-Stimulated+Glucose+Transport+in+Mouse+Skeletal+Muscle&doi=10.1073%2Fpnas.1008131107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Sucrose nonfermenting AMPK-related kinase (SNARK) mediates contraction-stimulated glucose transport in mouse skeletal muscle</span></div><div class="casAuthors">Koh, Ho-Jin; Toyoda, Taro; Fujii, Nobuharu; Jung, Michelle M.; Rathod, Amee; Middelbeek, R. Jan-Willem; Lessard, Sarah J.; Treebak, Jonas T.; Tsuchihara, Katsuya; Esumi, Hiroyasu; Richter, Erik A.; Wojtaszewski, Jorgen F. P.; Hirshman, Michael F.; Goodyear, Laurie J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">15541-15546, S15541/1-S15541/8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The signaling mechanisms that mediate the important effects of contraction to increase glucose transport in skeletal muscle are not well understood, but are known to occur through an insulin-independent mechanism.  Muscle-specific knockout of LKB1, an upstream kinase for AMPK and AMPK-related protein kinases, significantly inhibited contraction-stimulated glucose transport.  This finding, in conjunction with previous studies of ablated AMPKα2 activity showing no effect on contraction-stimulated glucose transport, suggests that one or more AMPK-related protein kinases are important for this process.  Muscle contraction increased sucrose nonfermenting AMPK-related kinase (SNARK) activity, an effect blunted in the muscle-specific LKB1 knockout mice.  Expression of a mutant SNARK in mouse tibialis anterior muscle impaired contraction-stimulated, but not insulin-stimulated, glucose transport.  Whole-body SNARK heterozygotic knockout mice also had impaired contraction-stimulated glucose transport in skeletal muscle, and knockdown of SNARK in C2C12 muscle cells impaired sorbitol-stimulated glucose transport.  SNARK is activated by muscle contraction and is a unique mediator of contraction-stimulated glucose transport in skeletal muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-xuJlbFtRuLVg90H21EOLACvtfcHk0lg4x64_fPFgig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaqu7%252FO&md5=719969b715141ae60f4664438b55534d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1008131107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1008131107%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DH.-J.%26aulast%3DToyoda%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DJung%26aufirst%3DM.%2BM.%26aulast%3DRathod%26aufirst%3DA.%26aulast%3DMiddelbeek%26aufirst%3DR.%2BJ.-W.%26aulast%3DLessard%26aufirst%3DS.%2BJ.%26aulast%3DTreebak%26aufirst%3DJ.%2BT.%26aulast%3DTsuchihara%26aufirst%3DK.%26aulast%3DEsumi%26aufirst%3DH.%26aulast%3DRichter%26aufirst%3DE.%2BA.%26aulast%3DWojtaszewski%26aufirst%3DJ.%2BF.%2BP.%26aulast%3DHirshman%26aufirst%3DM.%2BF.%26aulast%3DGoodyear%26aufirst%3DL.%2BJ.%26atitle%3DSucrose%2520Nonfermenting%2520AMPK-Related%2520Kinase%2520%2528SNARK%2529%2520Mediates%2520Contraction-Stimulated%2520Glucose%2520Transport%2520in%2520Mouse%2520Skeletal%2520Muscle%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D15541%26epage%3D15546%26doi%3D10.1073%2Fpnas.1008131107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X. C.</span></span> <span> </span><span class="NLM_article-title">ARK5 Is Associated with the Invasive and Metastatic Potential of Human Breast Cancer Cells</span>. <i>J. Cancer Res. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1007/s00432-011-1102-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1007%2Fs00432-011-1102-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22105900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XpslOlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2012&pages=247-254&author=X.+Z.+Changauthor=J.+Yuauthor=H.+Y.+Liuauthor=R.+H.+Dongauthor=X.+C.+Cao&title=ARK5+Is+Associated+with+the+Invasive+and+Metastatic+Potential+of+Human+Breast+Cancer+Cells&doi=10.1007%2Fs00432-011-1102-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">ARK5 is associated with the invasive and metastatic potential of human breast cancer cells</span></div><div class="casAuthors">Chang, Xin-Zhong; Yu, Jie; Liu, Hai-Yin; Dong, Rui-Hua; Cao, Xu-Chen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Research and Clinical Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-254</span>CODEN:
                <span class="NLM_cas:coden">JCROD7</span>;
        ISSN:<span class="NLM_cas:issn">0171-5216</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The aim was to investigate the effects of Akt/ARK5 pathways on the metastatic potential of human breast cancer cells.  The human ARK5 gene was transfected into MDA-MB-231 cells.  Effects of ARK5 on MDA-MB-231 cells were investigated in vitro.  The tumorigenicity and spontaneously metastatic capability regulated by ARK5 were detd. using an orthotopic xenograft tumor model.  ARK5 enhanced the invasive and metastatic potential of MDA-MB-231 cells under regulation by Akt.  The enhancement was assocd. with increasing MMP-2, MMP-9, and MT1-MMP expression.  The results were further demonstrated by RNA interference expt.  In an in vivo study, we also demonstrated that ARK5-transfected breast cancer cells grew faster and had more pulmonary metastases than its parental counterparts.  ARK5 led to a more invasive phenotype and metastatic potential in human breast cancer dependent on Akt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWDPURHxop5bVg90H21EOLACvtfcHk0lg4x64_fPFgig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpslOlsw%253D%253D&md5=7cb1b5e0f6d5ae13656f76d81f3df423</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2Fs00432-011-1102-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00432-011-1102-1%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DX.%2BZ.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.%2BY.%26aulast%3DDong%26aufirst%3DR.%2BH.%26aulast%3DCao%26aufirst%3DX.%2BC.%26atitle%3DARK5%2520Is%2520Associated%2520with%2520the%2520Invasive%2520and%2520Metastatic%2520Potential%2520of%2520Human%2520Breast%2520Cancer%2520Cells%26jtitle%3DJ.%2520Cancer%2520Res.%2520Clin.%2520Oncol.%26date%3D2012%26volume%3D138%26spage%3D247%26epage%3D254%26doi%3D10.1007%2Fs00432-011-1102-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span> <span> </span><span class="NLM_article-title">MiR-204 Inhibits Human NSCLC Metastasis through Suppression of NUAK1</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">2316</span>, <span class="refDoi"> DOI: 10.1038/bjc.2014.580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fbjc.2014.580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=25412236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGltL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=2316&author=L.+Shiauthor=B.+Zhangauthor=X.+Sunauthor=S.+Luauthor=Z.+Liuauthor=Y.+Liuauthor=H.+Liauthor=L.+Wangauthor=X.+Wangauthor=C.+Zhao&title=MiR-204+Inhibits+Human+NSCLC+Metastasis+through+Suppression+of+NUAK1&doi=10.1038%2Fbjc.2014.580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1</span></div><div class="casAuthors">Shi, L.; Zhang, B.; Sun, X.; Lu, S.; Liu, Z.; Liu, Y.; Li, H.; Wang, L.; Wang, X.; Zhao, C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2316-2327</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Lung cancer is a leading cause of cancer-related mortality worldwide and non-small-cell lung carcinoma (NSCLC) is responsible for almost 80% of lung cancer-related deaths.  Identifying novel mols. that can repress the invasiveness and metastasis of lung cancer will facilitate the development of new antilung cancer strategies.  The aim of this study is to det. the roles of NUAK1 (a downstream of Akt) and miR-204 in the invasiveness and metastasis of NSCLC and to reveal the correlation between NUAK1 and miR-204.  Methods: The expression of NUAK1 in primary human NSCLC tissues was evaluated by immunohistochem.  Real-time PCR was employed to measure the expression level of miR-204.  The effect of NUAK1 and miR204 on the prognosis of NSCLC patients was evaluated by log-rank test.  The siRNA transfection was used to manipulate the expression levels of NUAK1 and miR204 in cancer cells.  Chemotaxis assay, Scratch assay, and Matrigel invasion assay were performed to evaluate the migration and invasion of cells.  Cellular F-actin measurement was used to measure F-actin polymn. in lung cancer cells.  Western blot was used to detect the expression levels of corresponding proteins.  The Luciferase assay and RNA immunopptn. were used to confirm the actual binding site of miR-204 to 3'UTR of NUAK1.  Results: Increased expression of NUAK1 is correlated with the invasiveness and metastasis of human NSCLC.  Knockdown of NUAK1 inhibited cell migration and invasion.  In addn., this study showed that NUAK1 influenced mTOR phosphorylation and induced the phosphorylation of p70S6K1 and eukaryotic initiation factor 4E-binding protein1 (4E-BP1), two downstream targets of mTOR in NSCLC cells.  At the same time, decreased expression of miR-204 promoted NSCLC progression and, contrarily, manipulated upregulation of miR-204-inhibited cell migration and invasion.  There is clin. relevance between miR-204 downregulation and NUAK1 upregulation in human NSCLC.  Furthermore, we found that miR-204 inhibited NSCLC tumor invasion by directly targeting and downregulating NUAK1 expression.  Finally, our data suggested that the downregulation of miR-204 was due to hypermethylation of its promoter region.  Conclusions: Our results indicate that NUAK1 is excessively expressed in NSCLC and plays important roles in NSCLC invasion.  The miR-204 acts as a tumor suppressor by inhibiting NUAK1 expression in NSCLC.  Both NUAK1 and miR-204 may serve as potential targets of NSCLC therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_HXqvYexXfrVg90H21EOLACvtfcHk0ljaTmmee9o2Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGltL7P&md5=497c30171ec912fac145c81b6b1c7942</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2014.580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2014.580%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DC.%26atitle%3DMiR-204%2520Inhibits%2520Human%2520NSCLC%2520Metastasis%2520through%2520Suppression%2520of%2520NUAK1%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2014%26volume%3D111%26spage%3D2316%26doi%3D10.1038%2Fbjc.2014.580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monteverde, T.</span></span> <i>Investigating the Function and Regulation of NUAK1 and Its Role in Non-Small Cell Lung Cancer</i>. Ph.D. Thesis, <span class="NLM_publisher-name">University of Glasgow</span>, <span class="NLM_publisher-loc">United Kingdom</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=T.+Monteverde&title=Investigating+the+Function+and+Regulation+of+NUAK1+and+Its+Role+in+Non-Small+Cell+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonteverde%26aufirst%3DT.%26jtitle%3DInvestigating%2520the%2520Function%2520and%2520Regulation%2520of%2520NUAK1%2520and%2520Its%2520Role%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%26pub%3DUniversity%2520of%2520Glasgow%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, J.</span></span> <span> </span><span class="NLM_article-title">TGF-β Signaling: A Complex Role in Tumorigenesis (Review)</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">704</span>, <span class="refDoi"> DOI: 10.3892/mmr.2017.7970</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.3892%2Fmmr.2017.7970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=29115550" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=699-704&author=S.+Liuauthor=S.+Chenauthor=J.+Zeng&title=TGF-%CE%B2+Signaling%3A+A+Complex+Role+in+Tumorigenesis+%28Review%29&doi=10.3892%2Fmmr.2017.7970"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2017.7970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2017.7970%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZeng%26aufirst%3DJ.%26atitle%3DTGF-%25CE%25B2%2520Signaling%253A%2520A%2520Complex%2520Role%2520in%2520Tumorigenesis%2520%2528Review%2529%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2017%26volume%3D17%26spage%3D699%26epage%3D704%26doi%3D10.3892%2Fmmr.2017.7970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolliopoulos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raja, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Razmara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heldin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heldin, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moustakas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Heide, L. P.</span></span> <span> </span><span class="NLM_article-title">Transforming Growth Factor (TGF) Induces NUAK Kinase Expression to Fine-Tune Its Signaling Output</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">4119</span>– <span class="NLM_lpage">4136</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA118.004984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.RA118.004984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=30622137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvFSmsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=4119-4136&author=C.+Kolliopoulosauthor=E.+Rajaauthor=M.+Razmaraauthor=P.+Heldinauthor=C.+H.+Heldinauthor=A.+Moustakasauthor=L.+P.+Van+Der+Heide&title=Transforming+Growth+Factor+%28TGF%29+Induces+NUAK+Kinase+Expression+to+Fine-Tune+Its+Signaling+Output&doi=10.1074%2Fjbc.RA118.004984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Transforming growth factor β (TGFβ) induces NUAK kinase expression to fine-tune its signaling output</span></div><div class="casAuthors">Kolliopoulos, Constantinos; Raja, Erna; Razmara, Masoud; Heldin, Paraskevi; Heldin, Carl-Henrik; Moustakas, Aristidis; van der Heide, Lars P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4119-4136</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">TGFβ signaling via SMAD proteins and protein kinase pathways up- or down-regulates the expression of many genes and thus affects physiol. processes, such as differentiation, migration, cell cycle arrest, and apoptosis, during developmental or adult tissue homeostasis.  We here report that NUAK family kinase 1 (NUAK1) and NUAK2 are two TGFβ target genes.  NUAK1/2 belong to the AMP-activated protein kinase (AMPK) family, whose members control central and protein metab., polarity, and overall cellular homeostasis.  We found that TGFβ-mediated transcriptional induction of NUAK1 and NUAK2 requires SMAD family members 2, 3, and 4 (SMAD2/3/4) and mitogen-activated protein kinase (MAPK) activities, which provided immediate and early signals for the transient expression of these two kinases.  Genomic mapping identified an enhancer element within the first intron of the NUAK2 gene that can recruit SMAD proteins, which, when cloned, could confer induction by TGFβ.  Furthermore, NUAK2 formed protein complexes with SMAD3 and the TGFβ type I receptor.  Functionally, NUAK1 suppressed and NUAK2 induced TGFβ signaling.  This was evident during TGFβ-induced epithelial cytostasis, mesenchymal differentiation, and myofibroblast contractility, in which NUAK1 or NUAK2 silencing enhanced or inhibited these responses, resp.  In conclusion, we have identified a bifurcating loop during TGFβ signaling, whereby transcriptional induction of NUAK1 serves as a neg. checkpoint and NUAK2 induction pos. contributes to signaling and terminal differentiation responses to TGFβ activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomkmMV7cd_V7Vg90H21EOLACvtfcHk0ljaTmmee9o2Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvFSmsb8%253D&md5=7cede483273b178a0354350fcbf42a46</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA118.004984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA118.004984%26sid%3Dliteratum%253Aachs%26aulast%3DKolliopoulos%26aufirst%3DC.%26aulast%3DRaja%26aufirst%3DE.%26aulast%3DRazmara%26aufirst%3DM.%26aulast%3DHeldin%26aufirst%3DP.%26aulast%3DHeldin%26aufirst%3DC.%2BH.%26aulast%3DMoustakas%26aufirst%3DA.%26aulast%3DVan%2BDer%2BHeide%26aufirst%3DL.%2BP.%26atitle%3DTransforming%2520Growth%2520Factor%2520%2528TGF%2529%2520Induces%2520NUAK%2520Kinase%2520Expression%2520to%2520Fine-Tune%2520Its%2520Signaling%2520Output%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D4119%26epage%3D4136%26doi%3D10.1074%2Fjbc.RA118.004984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shintani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seguchi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minamino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitakaze, M.</span></span> <span> </span><span class="NLM_article-title">Identification of a Novel Substrate for TNFα-Induced Kinase NUAK2</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2007.11.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.bbrc.2007.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=18023418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlyrsbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2008&pages=541-547&author=H.+Yamamotoauthor=S.+Takashimaauthor=Y.+Shintaniauthor=S.+Yamazakiauthor=O.+Seguchiauthor=A.+Nakanoauthor=S.+Higoauthor=H.+Katoauthor=Y.+Liaoauthor=Y.+Asanoauthor=T.+Minaminoauthor=Y.+Matsumuraauthor=H.+Takedaauthor=M.+Kitakaze&title=Identification+of+a+Novel+Substrate+for+TNF%CE%B1-Induced+Kinase+NUAK2&doi=10.1016%2Fj.bbrc.2007.11.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel substrate for TNFα-induced kinase NUAK2</span></div><div class="casAuthors">Yamamoto, Hiroyuki; Takashima, Seiji; Shintani, Yasunori; Yamazaki, Satoru; Seguchi, Osamu; Nakano, Atsushi; Higo, Shuichiro; Kato, Hisakazu; Liao, Yulin; Asano, Yoshihiro; Minamino, Tetsuo; Matsumura, Yasushi; Takeda, Hiroshi; Kitakaze, Masafumi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">541-547</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">TNFα has multiple important cellular functions both in normal cells and in tumor cells.  To explore the role of TNFα, we identified NUAK family, SNF1-like kinase 2 (NUAK2), as a TNFα-induced kinase by gene chip anal.  NUAK2 is known to be induced by various cellular stresses and involved in cell mortality, however, its substrate has never been identified.  We developed original protocol of de novo screening for kinase substrates using an in vitro kinase assay and high performance liq. chromatog. (HPLC).  Using this procedure, we identified myosin phosphatase target subunit 1 (MYPT1) as a specific substrate for NUAK2.  MYPT1 was phosphorylated at another site(s) by NUAK2, other than known Rho-kinase phosphorylation sites (Thr696 or Thr853) responsible for inhibition of myosin phosphatase activity.  These data suggest different phosphorylation and regulation of MYPT1 activity by NUAK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj-LLt2R1BPbVg90H21EOLACvtfcHk0ljaTmmee9o2Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlyrsbjI&md5=d823034d0a75749d87579f17893d9063</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2007.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2007.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DTakashima%26aufirst%3DS.%26aulast%3DShintani%26aufirst%3DY.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DSeguchi%26aufirst%3DO.%26aulast%3DNakano%26aufirst%3DA.%26aulast%3DHigo%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DH.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DAsano%26aufirst%3DY.%26aulast%3DMinamino%26aufirst%3DT.%26aulast%3DMatsumura%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DH.%26aulast%3DKitakaze%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520a%2520Novel%2520Substrate%2520for%2520TNF%25CE%25B1-Induced%2520Kinase%2520NUAK2%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D365%26spage%3D541%26epage%3D547%26doi%3D10.1016%2Fj.bbrc.2007.11.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagórska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prescott, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span> <span> </span><span class="NLM_article-title">Interplay between Polo Kinase, LKB1-Activated NUAK1 Kinase, PP1βMYPT1 Phosphatase Complex and the SCβTrCP E3 Ubiquitin Ligase</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1042/BJ20140408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1042%2FBJ20140408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=24785407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVGhtbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2014&pages=233-245&author=S.+Banerjeeauthor=A.+Zag%C3%B3rskaauthor=M.+Deakauthor=D.+G.+Campbellauthor=A.+R.+Prescottauthor=D.+R.+Alessi&title=Interplay+between+Polo+Kinase%2C+LKB1-Activated+NUAK1+Kinase%2C+PP1%CE%B2MYPT1+Phosphatase+Complex+and+the+SC%CE%B2TrCP+E3+Ubiquitin+Ligase&doi=10.1042%2FBJ20140408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Interplay between Polo kinase, LKB1-activated NUAK1 kinase, PP1βMYPT1 phosphatase complex and the SCFβTrCP E3 ubiquitin ligase</span></div><div class="casAuthors">Banerjee, Sourav; Zagorska, Anna; Deak, Maria; Campbell, David G.; Prescott, Alan R.; Alessi, Dario R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-245</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">NUAK1 (NUAK family SnF1-like kinase-1) and NUAK2 protein kinases are activated by the LKB1 tumor suppressor and have been implicated in regulating multiple processes such as cell survival, senescence, adhesion and polarity.  In the present paper we present evidence that expression of NUAK1 is controlled by CDK (cyclin-dependent kinase), PLK (Polo kinase) and the SCFβTrCP (Skp, Cullin and F-boxβTrCP) E3 ubiquitin ligase complex.  Our data indicate that CDK phosphorylates NUAK1 at Ser445, triggering binding to PLK, which subsequently phosphorylates NUAK1 at two conserved non-catalytic serine residues (Ser476 and Ser480).  This induces binding of NUAK1 to βTrCP, the substrate-recognition subunit of the SCFβTrCP E3 ligase, resulting in NUAK1 becoming ubiquitylated and degraded.  We also show that NUAK1 and PLK1 are reciprocally controlled in the cell cycle.  In G2-M-phase, when PLK1 is most active, NUAK1 levels are low and vice versa in S-phase, when PLK1 expression is low, NUAK1 is more highly expressed.  Moreover, NUAK1 inhibitors (WZ4003 or HTH-01-015) suppress proliferation by reducing the population of cells in S-phase and mitosis, an effect that can be rescued by overexpression of a NUAK1 mutant in which Ser476 and Ser480 are mutated to alanine.  Finally, previous work has suggested that NUAK1 phosphorylates and inhibits PP1βMYPT1 (where PP1 is protein phosphatase 1) and that a major role for the PP1βMYPT1 complex is to inhibit PLK1 by dephosphorylating its T-loop (Thr210).  We demonstrate that activation of NUAK1 leads to a striking increase in phosphorylation of PLK1 at Thr210, an effect that is suppressed by NUAK1 inhibitors.  Our data link NUAK1 to important cell-cycle signalling components (CDK, PLK and SCFβTrCP) and suggest that NUAK1 plays a role in stimulating S-phase, as well as PLK1 activity via its ability to regulate the PP1βMYPT1 phosphatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraMe19to0IkLVg90H21EOLACvtfcHk0ljhUxegGz10cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVGhtbrK&md5=44c41ed44716228341c8d3d97a99283a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1042%2FBJ20140408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20140408%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DZag%25C3%25B3rska%26aufirst%3DA.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DD.%2BG.%26aulast%3DPrescott%26aufirst%3DA.%2BR.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DInterplay%2520between%2520Polo%2520Kinase%252C%2520LKB1-Activated%2520NUAK1%2520Kinase%252C%2520PP1%25CE%25B2MYPT1%2520Phosphatase%2520Complex%2520and%2520the%2520SC%25CE%25B2TrCP%2520E3%2520Ubiquitin%2520Ligase%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D461%26spage%3D233%26epage%3D245%26doi%3D10.1042%2FBJ20140408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanford, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodyear, L. J.</span></span> <span> </span><span class="NLM_article-title">Exercise and Type 2 Diabetes: Molecular Mechanisms Regulating Glucose Uptake in Skeletal Muscle</span>. <i>Adv. Physiol. Educ.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1152/advan.00080.2014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1152%2Fadvan.00080.2014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=25434013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BC2MzhvVarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=308-314&author=K.+I.+Stanfordauthor=L.+J.+Goodyear&title=Exercise+and+Type+2+Diabetes%3A+Molecular+Mechanisms+Regulating+Glucose+Uptake+in+Skeletal+Muscle&doi=10.1152%2Fadvan.00080.2014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal muscle</span></div><div class="casAuthors">Stanford Kristin I; Goodyear Laurie J</div><div class="citationInfo"><span class="NLM_cas:title">Advances in physiology education</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">308-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Exercise is a well-established tool to prevent and combat type 2 diabetes.  Exercise improves whole body metabolic health in people with type 2 diabetes, and adaptations to skeletal muscle are essential for this improvement.  An acute bout of exercise increases skeletal muscle glucose uptake, while chronic exercise training improves mitochondrial function, increases mitochondrial biogenesis, and increases the expression of glucose transporter proteins and numerous metabolic genes.  This review focuses on the molecular mechanisms that mediate the effects of exercise to increase glucose uptake in skeletal muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQEqKsXbBpWjfcsfMJQC1ZdfW6udTcc2eaSqbxwFueF7Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzhvVarsw%253D%253D&md5=b345c6129113e1472e77f1fac850169d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1152%2Fadvan.00080.2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fadvan.00080.2014%26sid%3Dliteratum%253Aachs%26aulast%3DStanford%26aufirst%3DK.%2BI.%26aulast%3DGoodyear%26aufirst%3DL.%2BJ.%26atitle%3DExercise%2520and%2520Type%25202%2520Diabetes%253A%2520Molecular%2520Mechanisms%2520Regulating%2520Glucose%2520Uptake%2520in%2520Skeletal%2520Muscle%26jtitle%3DAdv.%2520Physiol.%2520Educ.%26date%3D2014%26volume%3D38%26spage%3D308%26epage%3D314%26doi%3D10.1152%2Fadvan.00080.2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodyear, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, B. B.</span></span> <span> </span><span class="NLM_article-title">Exercise, Glucose Transport, and Insulin Sensitivity</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1146/annurev.med.49.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1146%2Fannurev.med.49.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=9509261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADyaK1cXhtFKqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1998&pages=235-261&author=L.+J.+Goodyearauthor=B.+B.+Kahn&title=Exercise%2C+Glucose+Transport%2C+and+Insulin+Sensitivity&doi=10.1146%2Fannurev.med.49.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Exercise, glucose transport, and insulin sensitivity</span></div><div class="casAuthors">Goodyear, Laurie J.; Kahn, Barbara B.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">235-261</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review, with 168 refs.  Phys. exercise can be an important adjunct in the treatment of both non-insulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus.  Over the past several years, considerable progress has been made in understanding the mol. basis for these clin. important effects of phys. exercise.  Similarly to insulin, a single bout of exercise increases the rate of glucose uptake into the contracting skeletal muscles, a process that is regulated by the translocation of GLUT4 glucose transporters to the plasma membrane and transverse tubules.  Exercise and insulin utilize different signaling pathways, both of which lead to the activation of glucose transport, which perhaps explains why humans with insulin resistance can increase muscle glucose transport in response to an acute bout of exercise.  Exercise training in humans results in numerous beneficial adaptations in skeletal muscles, including an increase in GLUT4 expression.  The increase in muscle GLUT4 in trained individuals contributes to an increase in the responsiveness of muscle glucose uptake to insulin, although not all studies show that exercise training in patients with diabetes improves overall glucose control.  However, there is now extensive epidemiol. evidence demonstrating that long-term regular phys. exercise can significantly reduce the risk of developing non-insulin-dependent diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSKuS8WPmVjbVg90H21EOLACvtfcHk0ljhUxegGz10cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtFKqs74%253D&md5=316cb103463a5112abfa56712bc73d8e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1146%2Fannurev.med.49.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.med.49.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DGoodyear%26aufirst%3DL.%2BJ.%26aulast%3DKahn%26aufirst%3DB.%2BB.%26atitle%3DExercise%252C%2520Glucose%2520Transport%252C%2520and%2520Insulin%2520Sensitivity%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D1998%26volume%3D49%26spage%3D235%26epage%3D261%26doi%3D10.1146%2Fannurev.med.49.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koh, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnolds, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liew, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirshman, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodyear, L. J.</span></span> <span> </span><span class="NLM_article-title">Skeletal Muscle-Selective Knockout of LKB1 Increases Insulin Sensitivity, Improves Glucose Homeostasis, and Decreases TRB3</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">8217</span>– <span class="NLM_lpage">8227</span>, <span class="refDoi"> DOI: 10.1128/MCB.00979-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1128%2FMCB.00979-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=16966378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1aksbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=8217-8227&author=H.-J.+Kohauthor=D.+E.+Arnoldsauthor=N.+Fujiiauthor=T.+T.+Tranauthor=M.+J.+Rogersauthor=N.+Jessenauthor=Y.+Liauthor=C.+W.+Liewauthor=R.+C.+Hoauthor=M.+F.+Hirshmanauthor=R.+N.+Kulkarniauthor=C.+R.+Kahnauthor=L.+J.+Goodyear&title=Skeletal+Muscle-Selective+Knockout+of+LKB1+Increases+Insulin+Sensitivity%2C+Improves+Glucose+Homeostasis%2C+and+Decreases+TRB3&doi=10.1128%2FMCB.00979-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3</span></div><div class="casAuthors">Koh, Ho-Jin; Arnolds, David E.; Fujii, Nobuharu; Tran, Thien T.; Rogers, Marc J.; Jessen, Niels; Li, Yangfeng; Liew, Chong Wee; Ho, Richard C.; Hirshman, Michael F.; Kulkarni, Rohit N.; Kahn, C. Ronald; Goodyear, Laurie J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8217-8227</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">LKB1 is a tumor suppressor that may also be fundamental to cell metab., since LKB1 phosphorylates and activates the energy sensing enzyme AMPK.  We generated muscle-specific LKB1 knockout (MLKB1KO) mice, and surprisingly, found that a lack of LKB1 in skeletal muscle enhanced insulin sensitivity, as evidenced by decreased fasting glucose and insulin concns., improved glucose tolerance, increased muscle glucose uptake in vivo, and increased glucose utilization during a hyperinsulinemic-euglycemic clamp.  MLKB1KO mice had increased insulin-stimulated Akt phosphorylation and a >80% decrease in muscle expression of TRB3, a recently identified Akt inhibitor.  Akt/TRB3 binding was present in skeletal muscle, and overexpression of TRB3 in C2C12 myoblasts significantly reduced Akt phosphorylation.  These results demonstrate that skeletal muscle LKB1 is a neg. regulator of insulin sensitivity and glucose homeostasis.  LKB1-mediated TRB3 expression provides a novel link between LKB1 and Akt, crit. kinases involved in both tumor genesis and cell metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSp_xYvILbV7Vg90H21EOLACvtfcHk0liG9w-bQrT7MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1aksbfJ&md5=b568eb6b6a1c8a5243b2645b270f3de6</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1128%2FMCB.00979-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00979-06%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DH.-J.%26aulast%3DArnolds%26aufirst%3DD.%2BE.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DTran%26aufirst%3DT.%2BT.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26aulast%3DJessen%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiew%26aufirst%3DC.%2BW.%26aulast%3DHo%26aufirst%3DR.%2BC.%26aulast%3DHirshman%26aufirst%3DM.%2BF.%26aulast%3DKulkarni%26aufirst%3DR.%2BN.%26aulast%3DKahn%26aufirst%3DC.%2BR.%26aulast%3DGoodyear%26aufirst%3DL.%2BJ.%26atitle%3DSkeletal%2520Muscle-Selective%2520Knockout%2520of%2520LKB1%2520Increases%2520Insulin%2520Sensitivity%252C%2520Improves%2520Glucose%2520Homeostasis%252C%2520and%2520Decreases%2520TRB3%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D8217%26epage%3D8227%26doi%3D10.1128%2FMCB.00979-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeppesen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maarbjerg, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordy, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritzen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pehmoller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sylow, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serup, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prats, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qvortrup, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyck, J. R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schjerling, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtaszewski, J. F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiens, B.</span></span> <span> </span><span class="NLM_article-title">LKB1 Regulates Lipid Oxidation during Exercise Independently of AMPK</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1490</span>– <span class="NLM_lpage">1499</span>, <span class="refDoi"> DOI: 10.2337/db12-1160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.2337%2Fdb12-1160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23349504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVSnurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=1490-1499&author=J.+Jeppesenauthor=S.+J.+Maarbjergauthor=A.+B.+Jordyauthor=A.+M.+Fritzenauthor=C.+Pehmollerauthor=L.+Sylowauthor=A.+K.+Serupauthor=N.+Jessenauthor=K.+Thorsenauthor=C.+Pratsauthor=K.+Qvortrupauthor=J.+R.+B.+Dyckauthor=R.+W.+Hunterauthor=K.+Sakamotoauthor=D.+M.+Thomsonauthor=P.+Schjerlingauthor=J.+F.+P.+Wojtaszewskiauthor=E.+A.+Richterauthor=B.+Kiens&title=LKB1+Regulates+Lipid+Oxidation+during+Exercise+Independently+of+AMPK&doi=10.2337%2Fdb12-1160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">LKB1 regulates lipid oxidation during exercise independently of AMPK</span></div><div class="casAuthors">Jeppesen, Jacob; Maarbjerg, Stine J.; Jordy, Andreas B.; Fritzen, Andreas M.; Pehmoeller, Christian; Sylow, Lykke; Serup, Annette Karen; Jessen, Niels; Thorsen, Kasper; Prats, Clara; Qvortrup, Klaus; Dyck, Jason R. B.; Hunter, Roger W.; Sakamoto, Kei; Thomson, David M.; Schjerling, Peter; Wojtaszewski, Joergen F. P.; Richter, Erik A.; Kiens, Bente</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1490-1499</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Lipid metab. is important for health and insulin action, yet the fundamental process of regulating lipid metab. during muscle contraction is incompletely understood.  Here, we show that liver kinase B1 (LKB1) muscle-specific knockout (LKB1 MKO) mice display decreased fatty acid (FA) oxidn. during treadmill exercise.  LKB1 MKO mice also show decreased muscle SIK3 activity, increased histone deacetylase 4 expression, decreased NAD+ concn. and SIRT1 activity, and decreased expression of genes involved in FA oxidn.  In AMP-activated protein kinase (AMPK)α2 KO mice, substrate use was similar to that in WT mice, which excluded that decreased FA oxidn. in LKB1 MKO mice was due to decreased AMPKα2 activity.  Addnl., LKB1 MKO muscle demonstrated decreased FA oxidn. in vitro.  A markedly decreased phosphorylation of TBC1D1, a proposed regulator of FA transport, and a low CoA content could contribute to the low FA oxidn. in LKB1 MKO.  LKB1 deficiency did not reduce muscle glucose uptake or oxidn. during exercise in vivo, excluding a general impairment of substrate use during exercise in LKB1 MKO mice.  Our findings demonstrate that LKB1 is a novel mol. regulator of major importance for FA oxidn. but not glucose uptake in muscle during exercise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB3p2JmgcFkbVg90H21EOLACvtfcHk0liG9w-bQrT7MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVSnurnO&md5=67c373632edf4610dda4fb35e80ea3d2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.2337%2Fdb12-1160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb12-1160%26sid%3Dliteratum%253Aachs%26aulast%3DJeppesen%26aufirst%3DJ.%26aulast%3DMaarbjerg%26aufirst%3DS.%2BJ.%26aulast%3DJordy%26aufirst%3DA.%2BB.%26aulast%3DFritzen%26aufirst%3DA.%2BM.%26aulast%3DPehmoller%26aufirst%3DC.%26aulast%3DSylow%26aufirst%3DL.%26aulast%3DSerup%26aufirst%3DA.%2BK.%26aulast%3DJessen%26aufirst%3DN.%26aulast%3DThorsen%26aufirst%3DK.%26aulast%3DPrats%26aufirst%3DC.%26aulast%3DQvortrup%26aufirst%3DK.%26aulast%3DDyck%26aufirst%3DJ.%2BR.%2BB.%26aulast%3DHunter%26aufirst%3DR.%2BW.%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DThomson%26aufirst%3DD.%2BM.%26aulast%3DSchjerling%26aufirst%3DP.%26aulast%3DWojtaszewski%26aufirst%3DJ.%2BF.%2BP.%26aulast%3DRichter%26aufirst%3DE.%2BA.%26aulast%3DKiens%26aufirst%3DB.%26atitle%3DLKB1%2520Regulates%2520Lipid%2520Oxidation%2520during%2520Exercise%2520Independently%2520of%2520AMPK%26jtitle%3DDiabetes%26date%3D2013%26volume%3D62%26spage%3D1490%26epage%3D1499%26doi%3D10.2337%2Fdb12-1160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jørgensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viollet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frøsig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birk, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schjerling, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaulont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtaszewski, J. F. P.</span></span> <span> </span><span class="NLM_article-title">Knockout of the A2 but Not A1 5′-AMP-Activated Protein Kinase Isoform Abolishes 5-Aminoimidazole-4-Carboxamide-1-β-4-Ribofuranosidebut Not Contraction-Induced Glucose Uptake in Skeletal Muscle</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">1070</span>– <span class="NLM_lpage">1079</span>, <span class="refDoi"> DOI: 10.1074/jbc.M306205200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M306205200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=14573616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVyltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=1070-1079&author=S.+B.+J%C3%B8rgensenauthor=B.+Violletauthor=F.+Andreelliauthor=C.+Fr%C3%B8sigauthor=J.+B.+Birkauthor=P.+Schjerlingauthor=S.+Vaulontauthor=E.+A.+Richterauthor=J.+F.+P.+Wojtaszewski&title=Knockout+of+the+A2+but+Not+A1+5%E2%80%B2-AMP-Activated+Protein+Kinase+Isoform+Abolishes+5-Aminoimidazole-4-Carboxamide-1-%CE%B2-4-Ribofuranosidebut+Not+Contraction-Induced+Glucose+Uptake+in+Skeletal+Muscle&doi=10.1074%2Fjbc.M306205200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Knockout of the α2 but Not α1 5'-AMP-activated Protein Kinase Isoform Abolishes 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranoside- but Not Contraction-induced Glucose Uptake in Skeletal Muscle</span></div><div class="casAuthors">Jorgensen, Sebastian B.; Viollet, Benoit; Andreelli, Fabrizio; Frosig, Christian; Birk, Jesper B.; Schjerling, Peter; Vaulont, Sophie; Richter, Erik A.; Wojtaszewski, Jorgen F. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1070-1079</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">We investigated the importance of the two catalytic α-isoforms of the 5'-AMP-activated protein kinase (AMPK) in 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) and contraction-induced glucose uptake in skeletal muscle.  Incubated soleus and EDL muscle from whole-body α2- or α1-AMPK knockout (KO) and wild type (WT) mice were incubated with 2.0 mM AICAR or elec. stimulated to contraction.  Both AICAR and contraction increased 2DG uptake in WT muscles.  KO of α2, but not α1, abolished AICAR-induced glucose uptake, whereas neither KO affected contraction-induced glucose uptake.  AICAR and contraction increased α2- and α1-AMPK activity in wild type (WT) muscles.  During AICAR stimulation, the remaining AMPK activity in KO muscles increased to the same level as in WT.  During contraction, the remaining AMPK activity in α2-KO muscles was elevated by 100% probably explained by a 2-3-fold increase in α1-protein.  In α1-KO muscles, α2-AMPK activity increased to similar levels as in WT.  Both interventions increased total AMPK activity, as expressed by AMPK-P and ACCβ-P, in WT muscles.  During AICAR stimulation, this was dramatically reduced in α2-KO but not in α1-KO, whereas during contraction, both measurements were essentially similar to WT in both KO-muscles.  The results show that α2-AMPK is the main donor of basal and AICAR-stimulated AMPK activity and is responsible for AICAR-induced glucose uptake.  In contrast, during contraction, the two α-isoforms seem to substitute for each other in terms of activity, which may explain the normal glucose uptake despite the lack of either α2- or α1-AMPK.  Alternatively, neither α-isoform of AMPK is involved in contraction-induced muscle glucose uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtl68JqWYfMLVg90H21EOLACvtfcHk0liG9w-bQrT7MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVyltw%253D%253D&md5=21a703c390363be00bca0f94f502a093</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M306205200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M306205200%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DS.%2BB.%26aulast%3DViollet%26aufirst%3DB.%26aulast%3DAndreelli%26aufirst%3DF.%26aulast%3DFr%25C3%25B8sig%26aufirst%3DC.%26aulast%3DBirk%26aufirst%3DJ.%2BB.%26aulast%3DSchjerling%26aufirst%3DP.%26aulast%3DVaulont%26aufirst%3DS.%26aulast%3DRichter%26aufirst%3DE.%2BA.%26aulast%3DWojtaszewski%26aufirst%3DJ.%2BF.%2BP.%26atitle%3DKnockout%2520of%2520the%2520A2%2520but%2520Not%2520A1%25205%25E2%2580%25B2-AMP-Activated%2520Protein%2520Kinase%2520Isoform%2520Abolishes%25205-Aminoimidazole-4-Carboxamide-1-%25CE%25B2-4-Ribofuranosidebut%2520Not%2520Contraction-Induced%2520Glucose%2520Uptake%2520in%2520Skeletal%2520Muscle%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D1070%26epage%3D1079%26doi%3D10.1074%2Fjbc.M306205200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirshman, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kane, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodyear, L. J.</span></span> <span> </span><span class="NLM_article-title">AMP-Activated Protein Kinase A2 Activity Is Not Essential for Contraction-and Hyperosmolarity-Induced Glucose Transport in Skeletal Muscle</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">39033</span>– <span class="NLM_lpage">39041</span>, <span class="refDoi"> DOI: 10.1074/jbc.M504208200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M504208200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=16186119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1emsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=39033-39041&author=N.+Fujiiauthor=M.+F.+Hirshmanauthor=E.+M.+Kaneauthor=R.+C.+Hoauthor=L.+E.+Peterauthor=M.+M.+Seifertauthor=L.+J.+Goodyear&title=AMP-Activated+Protein+Kinase+A2+Activity+Is+Not+Essential+for+Contraction-and+Hyperosmolarity-Induced+Glucose+Transport+in+Skeletal+Muscle&doi=10.1074%2Fjbc.M504208200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">AMP-activated Protein Kinase α2 Activity Is Not Essential for Contraction- and Hyperosmolarity-induced Glucose Transport in Skeletal Muscle</span></div><div class="casAuthors">Fujii, Nobuharu; Hirshman, Michael F.; Kane, Erin M.; Ho, Richard C.; Peter, Lauren E.; Seifert, Matthew M.; Goodyear, Laurie J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">39033-39041</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">To examine the role of AMP-activated protein kinase (AMPK) in muscle glucose transport, we generated muscle-specific transgenic mice (TG) carrying cDNAs of inactive α2 (α2i TG) and α1 (α1i TG) catalytic subunits.  Extensor digitorum longus (EDL) muscles from wild type and TG mice were isolated and subjected to a series of in vitro incubation expts.  In α2i TG mice basal α2 activity was barely detectable, whereas basal α1 activity was only partially reduced.  Known AMPK stimuli including 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR), rotenone (a Complex I inhibitor), dinitrophenol (a mitochondrial uncoupler), muscle contraction, and sorbitol (producing hyperosmolar shock) did not increase AMPK α2 activity in α2i TG mice, whereas α1 activation was attenuated by only 30-50%.  Glucose transport was measured in vitro using isolated EDL muscles from α2i TG mice.  AICAR- and rotenone-stimulated glucose transport was fully inhibited in α2i TG mice; however, the lack of AMPK α2 activity had no effect on contraction- or sorbitol-induced glucose transport.  Similar to these observations in vitro, contraction-stimulated glucose transport, assessed in vivo by 2-deoxy-D-[3H]glucose incorporation into EDL, tibialis anterior, and gastrocnemius muscles, was normal in α2i TG mice.  Thus, AMPK α2 activation is essential for some, but not all, insulin-independent glucose transport.  Muscle contraction- and hyperosmolarity-induced glucose transport may be regulated by a redundant mechanism in which AMPK α2 is one of multiple signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWy5Ns2U3E2rVg90H21EOLACvtfcHk0lja4kJJXWUnmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1emsrrL&md5=8f280e5c01adabf5a3531f069572f795</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M504208200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M504208200%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DHirshman%26aufirst%3DM.%2BF.%26aulast%3DKane%26aufirst%3DE.%2BM.%26aulast%3DHo%26aufirst%3DR.%2BC.%26aulast%3DPeter%26aufirst%3DL.%2BE.%26aulast%3DSeifert%26aufirst%3DM.%2BM.%26aulast%3DGoodyear%26aufirst%3DL.%2BJ.%26atitle%3DAMP-Activated%2520Protein%2520Kinase%2520A2%2520Activity%2520Is%2520Not%2520Essential%2520for%2520Contraction-and%2520Hyperosmolarity-Induced%2520Glucose%2520Transport%2520in%2520Skeletal%2520Muscle%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D39033%26epage%3D39041%26doi%3D10.1074%2Fjbc.M504208200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujioka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuga, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">Susceptibility of Snark-deficient Mice to Azoxymethane-induced Colorectal Tumorigenesis and the Formation of Aberrant Crypt Foci</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">682</span>, <span class="refDoi"> DOI: 10.1111/j.1349-7006.2008.00734.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1111%2Fj.1349-7006.2008.00734.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=18307533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsFGqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=677-682&author=K.+Tsuchiharaauthor=T.+Oguraauthor=R.+Fujiokaauthor=S.+Fujiiauthor=W.+Kugaauthor=M.+Saitoauthor=T.+Ochiyaauthor=A.+Ochiaiauthor=H.+Esumi&title=Susceptibility+of+Snark-deficient+Mice+to+Azoxymethane-induced+Colorectal+Tumorigenesis+and+the+Formation+of+Aberrant+Crypt+Foci&doi=10.1111%2Fj.1349-7006.2008.00734.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Susceptibility of Snark-deficient mice to azoxymethane-induced colorectal tumorigenesis and the formation of aberrant crypt foci</span></div><div class="casAuthors">Tsuchihara, Katsuya; Ogura, Tsutomu; Fujioka, Rumi; Fujii, Satoshi; Kuga, Wataru; Saito, Marie; Ochiya, Takahiro; Ochiai, Atsushi; Esumi, Hiroyasu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">677-682</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">SNF-1/5'-AMP-activated kinase (AMPK)-related kinase (SNARK) is a member of the AMPK-related kinases.  Snark+/- mice exhibited mature-onset obesity and related metabolic disorders.  Obesity is regarded as a risk factor for colorectal cancer.  To investigate whether Snark deficiency is involved in tumorigenesis in the large intestine, obese Snark+/- mice were treated with a chem. carcinogen, azoxymethane (AOM).  The incidences of both adenomas and aberrant crypt foci (ACF) were significantly higher in Snark+/- mice than in their wild-type counterparts 28 wk after the completion of AOM treatment (10 mg/kg/wk for 8 wk).  Furthermore, ACF formation was enhanced in Snark+/- mice treated with AOM for 2 wk, suggesting that Snark deficiency contributed to the early phase of tumorigenesis.  The total no. of ACF was correlated with bodyweight in Snark+/- and Snark+/+ mice, suggesting that obesity was a risk factor for colorectal tumorigenesis in this model.  However, the correlation coeff. was higher in Snark+/- mice.  Moreover, AOM-induced ACF formation was also enhanced in preobese Snark+/- mice.  Together, these findings suggest that AOM-induced tumorigenesis in Snark+/- mice was enhanced via obesity-dependent and -independent mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNomKK31XXT7Vg90H21EOLACvtfcHk0lja4kJJXWUnmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsFGqt78%253D&md5=b9b95c566fd8f1d5e0a7534c216cbf4d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2008.00734.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2008.00734.x%26sid%3Dliteratum%253Aachs%26aulast%3DTsuchihara%26aufirst%3DK.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DFujioka%26aufirst%3DR.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DKuga%26aufirst%3DW.%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DOchiya%26aufirst%3DT.%26aulast%3DOchiai%26aufirst%3DA.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DSusceptibility%2520of%2520Snark-deficient%2520Mice%2520to%2520Azoxymethane-induced%2520Colorectal%2520Tumorigenesis%2520and%2520the%2520Formation%2520of%2520Aberrant%2520Crypt%2520Foci%26jtitle%3DCancer%2520Sci.%26date%3D2008%26volume%3D99%26spage%3D677%26epage%3D682%26doi%3D10.1111%2Fj.1349-7006.2008.00734.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inazuka, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shioi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">Muscle-Specific Knock-out of NUAK Family SNF1-like Kinase 1 (NUAK1) Prevents High Fat Diet-Induced Glucose Intolerance</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">16379</span>– <span class="NLM_lpage">16389</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.302687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M111.302687" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22418434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvVKgtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=16379-16389&author=F.+Inazukaauthor=N.+Sugiyamaauthor=M.+Tomitaauthor=T.+Abeauthor=G.+Shioiauthor=H.+Esumi&title=Muscle-Specific+Knock-out+of+NUAK+Family+SNF1-like+Kinase+1+%28NUAK1%29+Prevents+High+Fat+Diet-Induced+Glucose+Intolerance&doi=10.1074%2Fjbc.M111.302687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Muscle-specific Knock-out of NUAK Family SNF1-like Kinase 1 (NUAK1) Prevents High Fat Diet-induced Glucose Intolerance</span></div><div class="casAuthors">Inazuka, Fumika; Sugiyama, Naoyuki; Tomita, Masaru; Abe, Takaya; Shioi, Go; Esumi, Hiroyasu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">16379-16389</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">NUAK1 is a member of the AMP-activated protein kinase-related kinase family.  Recent studies have shown that NUAK1 is involved in cellular senescence and motility in epithelial cells and fibroblasts.  However, the physiol. roles of NUAK1 are poorly understood because of embryonic lethality in NUAK1 null mice.  The purpose of this study was to elucidate the roles of NUAK1 in adult tissues.  We detd. the tissue distribution of NUAK1 and generated muscle-specific NUAK1 knock-out (MNUAK1KO) mice.  For phenotypic anal., whole body glucose homeostasis and muscle glucose metab. were examd.  Quant. phosphoproteome anal. of soleus muscle was performed to understand the mol. mechanisms underlying the knock-out phenotype.  Nuak1 mRNA was preferentially expressed in highly oxidative tissues such as brain, heart, and soleus muscle.  On a high fat diet, MNUAK1KO mice had a lower fasting blood glucose level, greater glucose tolerance, higher insulin sensitivity, and higher concn. of muscle glycogen than control mice.  Phosphoproteome anal. revealed that phosphorylation of IRS1 Ser-1097 was markedly decreased in NUAK1-deficient muscle.  Consistent with this, insulin signaling was enhanced in the soleus muscle of MNUAK1KO mice, as evidenced by increased phosphorylation of IRS1 Tyr-608, AKT Thr-308, and TBC1D4 Thr-649.  These observations suggest that a physiol. role of NUAK1 is to suppress glucose uptake through neg. regulation of insulin signaling in oxidative muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6cPulwikhIrVg90H21EOLACvtfcHk0lja4kJJXWUnmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvVKgtL8%253D&md5=bdbbf947d37653c83b09c8197e4a4bc0</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.302687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.302687%26sid%3Dliteratum%253Aachs%26aulast%3DInazuka%26aufirst%3DF.%26aulast%3DSugiyama%26aufirst%3DN.%26aulast%3DTomita%26aufirst%3DM.%26aulast%3DAbe%26aufirst%3DT.%26aulast%3DShioi%26aufirst%3DG.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DMuscle-Specific%2520Knock-out%2520of%2520NUAK%2520Family%2520SNF1-like%2520Kinase%25201%2520%2528NUAK1%2529%2520Prevents%2520High%2520Fat%2520Diet-Induced%2520Glucose%2520Intolerance%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D16379%26epage%3D16389%26doi%3D10.1074%2Fjbc.M111.302687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perumal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leshchenko, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Divakar, S. K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brody, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M. V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagannath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parekh, S.</span></span> <span> </span><span class="NLM_article-title">Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1236</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-2934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1158%2F0008-5472.CAN-15-2934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26873845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslCltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=1225-1236&author=D.+Perumalauthor=P.-Y.+Kuoauthor=V.+V.+Leshchenkoauthor=Z.+Jiangauthor=S.+K.+A.+Divakarauthor=H.+J.+Choauthor=A.+Chariauthor=J.+Brodyauthor=M.+V.+R.+Reddyauthor=W.+Zhangauthor=E.+P.+Reddyauthor=S.+Jagannathauthor=S.+Parekh&title=Dual+Targeting+of+CDK4+and+ARK5+Using+a+Novel+Kinase+Inhibitor+ON123300+Exerts+Potent+Anticancer+Activity+against+Multiple+Myeloma&doi=10.1158%2F0008-5472.CAN-15-2934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma</span></div><div class="casAuthors">Perumal, Deepak; Kuo, Pei-Yu; Leshchenko, Violetta V.; Jiang, Zewei; Divakar, Sai Krishna Athaluri; Cho, Hearn Jay; Chari, Ajai; Brody, Joshua; Reddy, M. V. Ramana; Zhang, Weijia; Reddy, E. Premkumar; Jagannath, Sundar; Parekh, Samir</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1225-1236</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Multiple myeloma is a fatal plasma cell neoplasm accounting for over 10,000 deaths in the United States each year.  Despite new therapies, multiple myeloma remains incurable, and patients ultimately develop drug resistance and succumb to the disease.  The response to selective CDK4/6 inhibitors has been modest in multiple myeloma, potentially because of incomplete targeting of other crit. myeloma oncogenic kinases.  As a substantial no. of multiple myeloma cell lines and primary samples were found to express AMPK-related protein kinase 5(ARK5), a member of the AMPK family assocd. with tumor growth and invasion, we examd. whether dual inhibition of CDK4 and ARK5 kinases using ON123300 results in a better therapeutic outcome.  Treatment of multiple myeloma cell lines and primary samples with ON123300 in vitro resulted in rapid induction of cell-cycle arrest followed by apoptosis.  ON123300-mediated ARK5 inhibition or ARK5-specific siRNAs resulted in the inhibition of the mTOR/S6K pathway and upregulation of the AMPK kinase cascade.  AMPK upregulation resulted in increased SIRT1 levels and destabilization of steady-state MYC protein.  Furthermore, ON123300 was very effective in inhibiting tumor growth in mouse xenograft assays.  In addn., multiple myeloma cells sensitive to ON123300 were found to have a unique genomic signature that can guide the clin. development of ON123300.  Our study provides preclin. evidence that ON123300 is unique in simultaneously inhibiting key oncogenic pathways in multiple myeloma and supports further development of ARK5 inhibition as a therapeutic approach in multiple myeloma.  Cancer Res; 76(5); 1225-36. 2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtWO_AVb9ttrVg90H21EOLACvtfcHk0lgKWST-yqwIHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslCltbc%253D&md5=82a0f15235151765215f18d43506c6c3</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-2934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-2934%26sid%3Dliteratum%253Aachs%26aulast%3DPerumal%26aufirst%3DD.%26aulast%3DKuo%26aufirst%3DP.-Y.%26aulast%3DLeshchenko%26aufirst%3DV.%2BV.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DDivakar%26aufirst%3DS.%2BK.%2BA.%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DChari%26aufirst%3DA.%26aulast%3DBrody%26aufirst%3DJ.%26aulast%3DReddy%26aufirst%3DM.%2BV.%2BR.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DParekh%26aufirst%3DS.%26atitle%3DDual%2520Targeting%2520of%2520CDK4%2520and%2520ARK5%2520Using%2520a%2520Novel%2520Kinase%2520Inhibitor%2520ON123300%2520Exerts%2520Potent%2520Anticancer%2520Activity%2520against%2520Multiple%2520Myeloma%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D1225%26epage%3D1236%26doi%3D10.1158%2F0008-5472.CAN-15-2934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, D. L.</span></span> <span> </span><span class="NLM_article-title">MiR-96 Functions as a Tumor Suppressor Gene by Targeting NUAK1 in Pancreatic Cancer</span>. <i>Int. J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1599</span>– <span class="NLM_lpage">1605</span>, <span class="refDoi"> DOI: 10.3892/ijmm.2014.1940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.3892%2Fijmm.2014.1940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=25242509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislCksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=1599-1605&author=X.+Huangauthor=W.+Lvauthor=J.+H.+Zhangauthor=D.+L.+Lu&title=MiR-96+Functions+as+a+Tumor+Suppressor+Gene+by+Targeting+NUAK1+in+Pancreatic+Cancer&doi=10.3892%2Fijmm.2014.1940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">miR-96 functions as a tumor suppressor gene by targeting NUAK1 in pancreatic cancer</span></div><div class="casAuthors">Huang, Xuan; Lv, Wei; Zhang, Jian-Hua; Lu, Da-Lin</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1599-1605</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">MicroRNA-96 (miR-96) is known to be down-regulated in pancreatic cancer.  The overexpression of miR-96 in MIA PaCa-2 pancreatic cancer cells has been shown to inhibit cell proliferation, migration and invasion; however, the mechanisms involved have not yet been fully elucidated.  Novel (nua) kinase family 1 (NUAK1) functions as an oncogene in non-small cell lung cancer (NSCLC), melanoma, glioma, breast cancer, hepatocellular carcinoma and pancreatic cancer.  In this study, firstly, we demonstrate that NUAK1 expression is specifically upregulated in pancreatic cancer and that it promotes the proliferation, migration and invasion of MIA PaCa-2 pancreatic cancer cells.  Secondly, we performed an anal. of potential microRNA (miRNA) target sites using three commonly used prediction algorithms: miRanda, TargetScan and PicTar.  All three algorithms predicted that miR-96 targets the 3' untranslated region (3' UTR) of NUAK1.  Further expts. confirmed this prediction, namely that miR-96 suppresses the expression of NUAK1 by targeting its 3' UTR.  Finally, we demonstrate that the introduction of NUAK1 cDNA lacking predicted sites of the 3' UTR abrogates miR-96 cellular function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuwd_IWfG51bVg90H21EOLACvtfcHk0lgKWST-yqwIHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislCksA%253D%253D&md5=bab2232a47e5154c220541146d23a32b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.3892%2Fijmm.2014.1940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.2014.1940%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%2BH.%26aulast%3DLu%26aufirst%3DD.%2BL.%26atitle%3DMiR-96%2520Functions%2520as%2520a%2520Tumor%2520Suppressor%2520Gene%2520by%2520Targeting%2520NUAK1%2520in%2520Pancreatic%2520Cancer%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2014%26volume%3D34%26spage%3D1599%26epage%3D1605%26doi%3D10.3892%2Fijmm.2014.1940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A. W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, G. Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teh, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozen, S. G.</span></span> <span> </span><span class="NLM_article-title">Functional Genomics Identifies Specific Vulnerabilities in PTEN-Deficient Breast Cancer</span>. <i>Breast Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1186/s13058-018-0949-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1186%2Fs13058-018-0949-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=29291743" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=1-16&author=Y.+C.+Tangauthor=S.+C.+Hoauthor=E.+Tanauthor=A.+W.+T.+Ngauthor=J.+R.+McPhersonauthor=G.+Y.+L.+Gohauthor=B.+T.+Tehauthor=F.+Bardauthor=S.+G.+Rozen&title=Functional+Genomics+Identifies+Specific+Vulnerabilities+in+PTEN-Deficient+Breast+Cancer&doi=10.1186%2Fs13058-018-0949-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1186%2Fs13058-018-0949-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13058-018-0949-3%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DY.%2BC.%26aulast%3DHo%26aufirst%3DS.%2BC.%26aulast%3DTan%26aufirst%3DE.%26aulast%3DNg%26aufirst%3DA.%2BW.%2BT.%26aulast%3DMcPherson%26aufirst%3DJ.%2BR.%26aulast%3DGoh%26aufirst%3DG.%2BY.%2BL.%26aulast%3DTeh%26aufirst%3DB.%2BT.%26aulast%3DBard%26aufirst%3DF.%26aulast%3DRozen%26aufirst%3DS.%2BG.%26atitle%3DFunctional%2520Genomics%2520Identifies%2520Specific%2520Vulnerabilities%2520in%2520PTEN-Deficient%2520Breast%2520Cancer%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2018%26volume%3D20%26spage%3D1%26epage%3D16%26doi%3D10.1186%2Fs13058-018-0949-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, D.</span></span> <span> </span><span class="NLM_article-title">The Hippo Signaling Pathway in Development and Cancer</span>. <i>Dev. Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">491</span>– <span class="NLM_lpage">505</span>, <span class="refDoi"> DOI: 10.1016/j.devcel.2010.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.devcel.2010.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=20951342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSmurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=491-505&author=D.+Pan&title=The+Hippo+Signaling+Pathway+in+Development+and+Cancer&doi=10.1016%2Fj.devcel.2010.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The Hippo Signaling Pathway in Development and Cancer</span></div><div class="casAuthors">Pan, Duojia</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">491-505</span>CODEN:
                <span class="NLM_cas:coden">DCEEBE</span>;
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  First discovered in Drosophila, the Hippo signaling pathway is a conserved regulator of organ size.  Central to this pathway is a kinase cascade leading from the tumor suppressor Hippo (Mst1 and Mst2 in mammals) to the oncoprotein Yki (YAP and TAZ in mammals), a transcriptional coactivator of target genes involved in cell proliferation and survival.  Here, I review recent progress in elucidating the mol. mechanism and physiol. function of Hippo signaling in Drosophila and mammals.  These studies suggest that the core Hippo kinase cascade integrates multiple upstream inputs, enabling dynamic regulation of tissue homeostasis in animal development and physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk3dwAozrlLrVg90H21EOLACvtfcHk0lgBVjLi0uRQzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSmurjK&md5=67e7f188b5669d7e1432d28ea57a2c90</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2010.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2010.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DD.%26atitle%3DThe%2520Hippo%2520Signaling%2520Pathway%2520in%2520Development%2520and%2520Cancer%26jtitle%3DDev.%2520Cell%26date%3D2010%26volume%3D19%26spage%3D491%26epage%3D505%26doi%3D10.1016%2Fj.devcel.2010.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comerford, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gayyed, M. F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anders, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, D.</span></span> <span> </span><span class="NLM_article-title">Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">1120</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.07.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.cell.2007.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=17889654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKnurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2007&pages=1120-1133&author=J.+Dongauthor=G.+Feldmannauthor=J.+Huangauthor=S.+Wuauthor=N.+Zhangauthor=S.+A.+Comerfordauthor=M.+F.+F.+Gayyedauthor=R.+A.+Andersauthor=A.+Maitraauthor=D.+Pan&title=Elucidation+of+a+Universal+Size-Control+Mechanism+in+Drosophila+and+Mammals&doi=10.1016%2Fj.cell.2007.07.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of a universal size-control mechanism in Drosophila and mammals</span></div><div class="casAuthors">Dong, Jixin; Feldmann, Georg; Huang, Jianbin; Wu, Shian; Zhang, Nailing; Comerford, Sarah A.; Gayyed, Mariana F.; Anders, Robert A.; Maitra, Anirban; Pan, Duojia</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1120-1133</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Coordination of cell proliferation and cell death is essential to attain proper organ size during development and for maintaining tissue homeostasis throughout postnatal life.  In Drosophila, these two processes are orchestrated by the Hippo kinase cascade, a growth-suppressive pathway that ultimately antagonizes the transcriptional coactivator Yorkie (Yki).  Here we demonstrate that a single phosphorylation site in Yki mediates the growth-suppressive output of the Hippo pathway.  Hippo-mediated phosphorylation inactivates Yki by excluding it from the nucleus, whereas loss of Hippo signaling leads to nuclear accumulation and therefore increased Yki activity.  We further delineate a mammalian Hippo signaling pathway that culminates in the phosphorylation of YAP, the mammalian homolog of Yki.  Using a conditional YAP transgenic mouse model, we demonstrate that the mammalian Hippo pathway is a potent regulator of organ size, and that its dysregulation leads to tumorigenesis.  These results uncover a universal size-control mechanism in metazoan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFVuE0XSnE87Vg90H21EOLACvtfcHk0lgBVjLi0uRQzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKnurjO&md5=c8b5bfffd642be6b1fe2af7d012a1c3e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DFeldmann%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DComerford%26aufirst%3DS.%2BA.%26aulast%3DGayyed%26aufirst%3DM.%2BF.%2BF.%26aulast%3DAnders%26aufirst%3DR.%2BA.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DPan%26aufirst%3DD.%26atitle%3DElucidation%2520of%2520a%2520Universal%2520Size-Control%2520Mechanism%2520in%2520Drosophila%2520and%2520Mammals%26jtitle%3DCell%26date%3D2007%26volume%3D130%26spage%3D1120%26epage%3D1133%26doi%3D10.1016%2Fj.cell.2007.07.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monteverde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthalagu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Port, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D. J.</span></span> <span> </span><span class="NLM_article-title">Evidence of Cancer-Promoting Roles for AMPK and Related Kinases</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">4658</span>– <span class="NLM_lpage">4671</span>, <span class="refDoi"> DOI: 10.1111/febs.13534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1111%2Ffebs.13534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26426570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1yksL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2015&pages=4658-4671&author=T.+Monteverdeauthor=N.+Muthalaguauthor=J.+Portauthor=D.+J.+Murphy&title=Evidence+of+Cancer-Promoting+Roles+for+AMPK+and+Related+Kinases&doi=10.1111%2Ffebs.13534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence of cancer-promoting roles for AMPK and related kinases</span></div><div class="casAuthors">Monteverde, Tiziana; Muthalagu, Nathiya; Port, Jennifer; Murphy, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4658-4671</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The discovery that the 5'AMP-activated protein kinase (AMPK) serves to link the tumor suppressors LKB1 and the tuberous sclerosis complex and functions to slow macromol. synthesis through attenuation of the mechanistic target of rapamycin complex 1 revealed a role for AMPK in tumor suppression.  On the other hand, the well-recognized role of AMPK in maintaining ATP homeostasis, through suppression of anabolism and promotion of catabolism, as well as the role of AMPK in neutralizing reactive oxygen species, via maintenance of NADPH-dependent reductive capacity, point to tumor-protective roles in the context of metabolic stress, which is a key feature of many solid tumors.  A growing no. of studies thus suggest a duality of functions for AMPK that are either pro- or anti-cancer, depending upon context.  Importantly, AMPK is composed of three subunits, and multiple isoforms exist for all three, allowing for different permutations to assemble and the potential for specific AMPK complexes to regulate distinct cellular processes.  Moreover, certain subunits of the AMPK complex are frequently overexpressed in a spectrum of human cancer types, suggesting an outright oncogenic function for specific AMPK complexes.  Adding complexity to this picture, the catalytic AMPK alpha subunits belong to a family of 14 kinases that can all be activated by LKB1 and studies are beginning to reveal a similar duality of roles in cancer for other members of the AMPK-related kinase family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAoIicUX6LvrVg90H21EOLACvtfcHk0lgBVjLi0uRQzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1yksL7P&md5=422a673b8fe147a35efa434691d62377</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13534%26sid%3Dliteratum%253Aachs%26aulast%3DMonteverde%26aufirst%3DT.%26aulast%3DMuthalagu%26aufirst%3DN.%26aulast%3DPort%26aufirst%3DJ.%26aulast%3DMurphy%26aufirst%3DD.%2BJ.%26atitle%3DEvidence%2520of%2520Cancer-Promoting%2520Roles%2520for%2520AMPK%2520and%2520Related%2520Kinases%26jtitle%3DFEBS%2520J.%26date%3D2015%26volume%3D282%26spage%3D4658%26epage%3D4671%26doi%3D10.1111%2Ffebs.13534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakoshi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iida, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ide, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, E.</span></span> <span> </span><span class="NLM_article-title">Mitogenic Signalling and the P16INK4a-Rb Pathway Cooperate to Enforce Irreversible Cellular Senescence</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1291</span>– <span class="NLM_lpage">1297</span>, <span class="refDoi"> DOI: 10.1038/ncb1491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fncb1491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=17028578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFCqu7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=1291-1297&author=A.+Takahashiauthor=N.+Ohtaniauthor=K.+Yamakoshiauthor=S.+I.+Iidaauthor=H.+Taharaauthor=K.+Nakayamaauthor=K.+I.+Nakayamaauthor=T.+Ideauthor=H.+Sayaauthor=E.+Hara&title=Mitogenic+Signalling+and+the+P16INK4a-Rb+Pathway+Cooperate+to+Enforce+Irreversible+Cellular+Senescence&doi=10.1038%2Fncb1491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence</span></div><div class="casAuthors">Takahashi, Akiko; Ohtani, Naoko; Yamakoshi, Kimi; Iida, Shin-ichi; Tahara, Hidetoshi; Nakayama, Keiko; Nakayama, Keiichi I.; Ide, Toshinori; Saya, Hideyuki; Hara, Eiji</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1291-1297</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The p16INK4a cyclin-dependent kinase inhibitor has a key role in establishing stable G1 cell-cycle arrest through activating the retinoblastoma (Rb) tumor suppressor protein pRb in cellular senescence.  Here, we show that the p16INK4a /Rb-pathway also cooperates with mitogenic signals to induce elevated intracellular levels of reactive oxygen species (ROS), thereby activating protein kinase Cδ (PKCδ) in human senescent cells.  Importantly, once activated by ROS, PKCδ promotes further generation of ROS, thus establishing a pos. feedback loop to sustain ROS-PKCδ signalling.  Sustained activation of ROS-PKCδ signalling irreversibly blocks cytokinesis, at least partly through reducing the level of WARTS (also known as LATS1), a mitotic exit network (MEN) kinase required for cytokinesis, in human senescent cells.  This irreversible cytokinetic block is likely to act as a second barrier to cellular immortalization ensuring stable cell-cycle arrest in human senescent cells.  These results uncover an unexpected role for the p16INK4a-Rb pathway and provide a new insight into how senescent cell-cycle arrest is enforced in human cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9sOWCCSf_TbVg90H21EOLACvtfcHk0lg6V4HkAbjjgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFCqu7jE&md5=31f9204e6a71b25e07aeac7c7c4bf702</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fncb1491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1491%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DOhtani%26aufirst%3DN.%26aulast%3DYamakoshi%26aufirst%3DK.%26aulast%3DIida%26aufirst%3DS.%2BI.%26aulast%3DTahara%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DK.%2BI.%26aulast%3DIde%26aufirst%3DT.%26aulast%3DSaya%26aufirst%3DH.%26aulast%3DHara%26aufirst%3DE.%26atitle%3DMitogenic%2520Signalling%2520and%2520the%2520P16INK4a-Rb%2520Pathway%2520Cooperate%2520to%2520Enforce%2520Irreversible%2520Cellular%2520Senescence%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2006%26volume%3D8%26spage%3D1291%26epage%3D1297%26doi%3D10.1038%2Fncb1491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, P. Y.</span></span> <span> </span><span class="NLM_article-title">Overexpression of ARK5 Is Associated with Poor Prognosis in Hepatocellular Carcinoma</span>. <i>Tumor Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1913</span>– <span class="NLM_lpage">1918</span>, <span class="refDoi"> DOI: 10.1007/s13277-013-0735-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1007%2Fs13277-013-0735-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXos1yksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1913-1918&author=J.+Cuiauthor=Y.+Yuauthor=G.+F.+Luauthor=C.+Liuauthor=X.+Liuauthor=Y.+X.+Xuauthor=P.+Y.+Zheng&title=Overexpression+of+ARK5+Is+Associated+with+Poor+Prognosis+in+Hepatocellular+Carcinoma&doi=10.1007%2Fs13277-013-0735-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma</span></div><div class="casAuthors">Cui, Jing; Yu, Yong; Lu, Gao-Feng; Liu, Chao; Liu, Xia; Xu, Yu-Xian; Zheng, Peng-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1913-1918</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">ARK5 overexpression has been reported in a variety of human cancers.  However, the role of ARK5 in hepatocellular carcinoma (HCC) remains unclear.  The aim of the present study is to analyze the ARK5 protein expression in HCC tissue samples and to assess its prognostic significance for HCC.  ARK5 mRNA and protein expression were detd. by real-time quant. reverse transcriptase-polymerase chain reaction and Western blot in 20 pairs of fresh frozen HCC tissues and corresponding non-cancerous tissues.  In addn., ARK5 expression was analyzed by immunohistochem. in 130 clinicopathol. characterized HCC cases.  The correlation of ARK5 expression with patients' survival rate was assessed by Kaplan-Meier and Cox regression.  Our results showed that the expression levels of ARK5 mRNA and protein in HCC tissues were both significantly higher than those in non-cancerous tissues.  Our results showed that the high expression of ARK5 in HCC was related to tumor size (p = 0.005), histol. differentiation (p = 0.047), and tumor stage (p = 0.005).  Kaplan-Meier survival anal. showed that a high expression level of ARK5 resulted in a significantly poor prognosis of HCC patients.  Multivariate anal. revealed that ARK5 expression level was an independent prognostic parameter for the overall survival rate of HCC patients.  In conclusion, ARK5 might play a pos. role in tumor development and could serve as an independent predictor of poor prognosis for HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDxvvtj28zA7Vg90H21EOLACvtfcHk0lg6V4HkAbjjgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXos1yksbo%253D&md5=16a82b0238fa593319dc6d38f357de4b</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2Fs13277-013-0735-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-013-0735-x%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DG.%2BF.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%2BX.%26aulast%3DZheng%26aufirst%3DP.%2BY.%26atitle%3DOverexpression%2520of%2520ARK5%2520Is%2520Associated%2520with%2520Poor%2520Prognosis%2520in%2520Hepatocellular%2520Carcinoma%26jtitle%3DTumor%2520Biol.%26date%3D2013%26volume%3D34%26spage%3D1913%26epage%3D1918%26doi%3D10.1007%2Fs13277-013-0735-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span> <span> </span><span class="NLM_article-title">High NUAK1 Expression Correlates with Poor Prognosis and Involved in NSCLC Cells Migration and Invasion</span>. <i>Exp. Lung Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.3109/01902148.2012.744115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.3109%2F01902148.2012.744115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23215946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1CitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2013&pages=9-17&author=P.+Chenauthor=K.+Liauthor=Y.+Liangauthor=L.+Liauthor=X.+Zhu&title=High+NUAK1+Expression+Correlates+with+Poor+Prognosis+and+Involved+in+NSCLC+Cells+Migration+and+Invasion&doi=10.3109%2F01902148.2012.744115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">High NUAK1 expression correlates with poor prognosis and involved in NSCLC cells migration and invasion</span></div><div class="casAuthors">Chen, Peng; Li, Kai; Liang, Yan; Li, Liqing; Zhu, Xiaolin</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Lung Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-17</span>CODEN:
                <span class="NLM_cas:coden">EXLRDA</span>;
        ISSN:<span class="NLM_cas:issn">0190-2148</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Novel (nua) kinase family 1 (NUAK1) is a member of the human adenosine monophosphate (AMP)-activated protein kinase family that has been identified as a key tumor cell survival factor.  In the present study, we investigated the role of NUAK1 in the migration and invasion of human nonsmall cell lung cancer (NSCLC) cells.  Immunohistochem. staining showed that the expression of NUAK1 correlated with the differentiation and stage of the carcinoma, as well as with lymph node metastasis.  Inhibition of NUAK1 expression by small interference RNA severely impaired migration and invasion in A549 cells.  In addn., we found that the knockdown of NUAK1 suppressed the expression of MMP-2 and MMP-9 and the activation of NF-kB, which can regulate the transcription of MMP-2 and MMP-9.  Correspondingly, NUAK1 knockdown reduced lung metastasis in a xenograft mouse model of NSCLC.  Taken together, our results suggest that NUAK1 plays an important role in NSCLC cell migration and invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCk3CvE2xsjLVg90H21EOLACvtfcHk0lg6V4HkAbjjgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1CitbY%253D&md5=72aeac4004140a3d4ce62a66627ec92f</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.3109%2F01902148.2012.744115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01902148.2012.744115%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DHigh%2520NUAK1%2520Expression%2520Correlates%2520with%2520Poor%2520Prognosis%2520and%2520Involved%2520in%2520NSCLC%2520Cells%2520Migration%2520and%2520Invasion%26jtitle%3DExp.%2520Lung%2520Res.%26date%3D2013%26volume%3D39%26spage%3D9%26epage%3D17%26doi%3D10.3109%2F01902148.2012.744115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carvajal, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manfredi, J. J.</span></span> <span> </span><span class="NLM_article-title">Another Fork in the Road - Life or Death Decisions by the Tumour Suppressor P53</span>. <i>EMBO Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.1038/embor.2013.25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fembor.2013.25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23588418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvV2kur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=414-421&author=L.+A.+Carvajalauthor=J.+J.+Manfredi&title=Another+Fork+in+the+Road+-+Life+or+Death+Decisions+by+the+Tumour+Suppressor+P53&doi=10.1038%2Fembor.2013.25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Another fork in the road-life or death decisions by the tumour suppressor p53</span></div><div class="casAuthors">Carvajal, Luis A.; Manfredi, James J.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">414-421</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In response to cellular stress signals, the tumor suppressor p53 accumulates and triggers a host of antineoplastic responses.  For instance, DNA damage activates two main p53-dependent responses: cell cycle arrest and attendant DNA repair or apoptosis (cell death).  It is broadly accepted that, in response to DNA damage, the function of p53 as a sequence-specific transcription factor is crucial for tumor suppression.  The mol. determinants, however, that favor the initiation of either a p53-dependent cell cycle arrest (life) or apoptotic (death) transcriptional program remain elusive.  Gaining a clear understanding of the mechanisms controlling cell fate detn. by p53 could lead to the identification of mol. targets for therapy, which could selectively sensitize cancer cells to apoptosis.  This review summarizes the literature addressing this important question in the field.  Special emphasis is given to the role of the p53 response element, post-translational modifications and protein-protein interactions on cell fate decisions made by p53 in response to DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-Yed0JJ0hu7Vg90H21EOLACvtfcHk0lg6V4HkAbjjgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvV2kur0%253D&md5=4aac635e231f9183128ea4cdfec2a1dd</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fembor.2013.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fembor.2013.25%26sid%3Dliteratum%253Aachs%26aulast%3DCarvajal%26aufirst%3DL.%2BA.%26aulast%3DManfredi%26aufirst%3DJ.%2BJ.%26atitle%3DAnother%2520Fork%2520in%2520the%2520Road%2520-%2520Life%2520or%2520Death%2520Decisions%2520by%2520the%2520Tumour%2520Suppressor%2520P53%26jtitle%3DEMBO%2520Rep.%26date%3D2013%26volume%3D14%26spage%3D414%26epage%3D421%26doi%3D10.1038%2Fembor.2013.25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohseni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frazier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camargo, F. D.</span></span> <span> </span><span class="NLM_article-title">A Genetic Screen Identifies an LKB1-MARK Signalling Axis Controlling the Hippo-YAP Pathway</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1038/ncb2884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fncb2884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=24362629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOls7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=108-117&author=M.+Mohseniauthor=J.+Sunauthor=A.+Lauauthor=S.+Curtisauthor=J.+Goldsmithauthor=V.+L.+Foxauthor=C.+Weiauthor=M.+Frazierauthor=O.+Samsonauthor=K.-K.+Wongauthor=C.+Kimauthor=F.+D.+Camargo&title=A+Genetic+Screen+Identifies+an+LKB1-MARK+Signalling+Axis+Controlling+the+Hippo-YAP+Pathway&doi=10.1038%2Fncb2884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A genetic screen identifies an LKB1-MARK signalling axis controlling the Hippo-YAP pathway</span></div><div class="casAuthors">Mohseni, Morvarid; Sun, Jianlong; Lau, Allison; Curtis, Stephen; Goldsmith, Jeffrey; Fox, Victor L.; Wei, Chongjuan; Frazier, Marsha; Samson, Owen; Wong, Kwok-Kin; Kim, Carla; Camargo, Fernando D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">108-117</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Hippo-YAP pathway is an emerging signalling cascade involved in the regulation of stem cell activity and organ size.  To identify components of this pathway, we performed an RNAi-based kinome screen in human cells.  Our screen identified several kinases not previously assocd. with Hippo signalling that control multiple cellular processes.  One of the hits, LKB1, is a common tumor suppressor whose mechanism of action is only partially understood.  We demonstrate that LKB1 acts through its substrates of the microtubule affinity-regulating kinase family to regulate the localization of the polarity determinant Scribble and the activity of the core Hippo kinases.  Our data also indicate that YAP is functionally important for the tumor suppressive effects of LKB1.  Our results identify a signalling axis that links YAP activation with LKB1 mutations, and have implications for the treatment of LKB1-mutant human malignancies.  In addn., our findings provide insight into upstream signals of the Hippo-YAP signalling cascade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8AfFxEgo6irVg90H21EOLACvtfcHk0liLu6YO_X_mpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOls7zI&md5=4c1289d2cb5c8f99f2040faa2bb7593c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fncb2884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2884%26sid%3Dliteratum%253Aachs%26aulast%3DMohseni%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DCurtis%26aufirst%3DS.%26aulast%3DGoldsmith%26aufirst%3DJ.%26aulast%3DFox%26aufirst%3DV.%2BL.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DFrazier%26aufirst%3DM.%26aulast%3DSamson%26aufirst%3DO.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DCamargo%26aufirst%3DF.%2BD.%26atitle%3DA%2520Genetic%2520Screen%2520Identifies%2520an%2520LKB1-MARK%2520Signalling%2520Axis%2520Controlling%2520the%2520Hippo-YAP%2520Pathway%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2014%26volume%3D16%26spage%3D108%26epage%3D117%26doi%3D10.1038%2Fncb2884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mo, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, K. L.</span></span> <span> </span><span class="NLM_article-title">Cellular Energy Stress Induces AMPK-Mediated Regulation of YAP and the Hippo Pathway</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">500</span>– <span class="NLM_lpage">510</span>, <span class="refDoi"> DOI: 10.1038/ncb3111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fncb3111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=25751140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=500-510&author=J.+S.+Moauthor=Z.+Mengauthor=Y.+C.+Kimauthor=H.+W.+Parkauthor=C.+G.+Hansenauthor=S.+Kimauthor=D.+S.+Limauthor=K.+L.+Guan&title=Cellular+Energy+Stress+Induces+AMPK-Mediated+Regulation+of+YAP+and+the+Hippo+Pathway&doi=10.1038%2Fncb3111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway</span></div><div class="casAuthors">Mo, Jung-Soon; Meng, Zhipeng; Kim, Young Chul; Park, Hyun Woo; Hansen, Carsten Gram; Kim, Soohyun; Lim, Dae-Sik; Guan, Kun-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">500-510</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">YAP (Yes-assocd. protein) is a transcription co-activator in the Hippo tumor suppressor pathway and controls cell growth, tissue homeostasis and organ size.  YAP is inhibited by the kinase Lats, which phosphorylates YAP to induce its cytoplasmic localization and proteasomal degrdn.  YAP induces gene expression by binding to the TEAD family transcription factors.  Dysregulation of the Hippo-YAP pathway is frequently obsd. in human cancers.  Here we show that cellular energy stress induces YAP phosphorylation, in part due to AMPK-dependent Lats activation, thereby inhibiting YAP activity.  Moreover, AMPK directly phosphorylates YAP Ser 94, a residue essential for the interaction with TEAD, thus disrupting the YAP-TEAD interaction.  AMPK-induced YAP inhibition can suppress oncogenic transformation of Lats-null cells with high YAP activity.  Our study establishes a mol. mechanism and functional significance of AMPK in linking cellular energy status to the Hippo-YAP pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMNzjxfE8hbbVg90H21EOLACvtfcHk0liLu6YO_X_mpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsrc%253D&md5=2b790417cf799fd937a201506ed5b32a</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fncb3111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb3111%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DJ.%2BS.%26aulast%3DMeng%26aufirst%3DZ.%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DPark%26aufirst%3DH.%2BW.%26aulast%3DHansen%26aufirst%3DC.%2BG.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DLim%26aufirst%3DD.%2BS.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26atitle%3DCellular%2520Energy%2520Stress%2520Induces%2520AMPK-Mediated%2520Regulation%2520of%2520YAP%2520and%2520the%2520Hippo%2520Pathway%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2015%26volume%3D17%26spage%3D500%26epage%3D510%26doi%3D10.1038%2Fncb3111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aziz, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">AMPK Modulates Hippo Pathway Activity to Regulate Energy Homeostasis</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">490</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1038/ncb3113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fncb3113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=25751139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=490-499&author=W.+Wangauthor=Z.+D.+Xiaoauthor=X.+Liauthor=K.+E.+Azizauthor=B.+Ganauthor=R.+L.+Johnsonauthor=J.+Chen&title=AMPK+Modulates+Hippo+Pathway+Activity+to+Regulate+Energy+Homeostasis&doi=10.1038%2Fncb3113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK modulates Hippo pathway activity to regulate energy homeostasis</span></div><div class="casAuthors">Wang, Wenqi; Xiao, Zhen-Dong; Li, Xu; Aziz, Kathryn E.; Gan, Boyi; Johnson, Randy L.; Chen, Junjie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">490-499</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Hippo pathway was discovered as a conserved tumor suppressor pathway restricting cell proliferation and apoptosis.  However, the upstream signals that regulate the Hippo pathway in the context of organ size control and cancer prevention are largely unknown.  Here, we report that glucose, the ubiquitous energy source used for ATP generation, regulates the Hippo pathway downstream effector YAP.  We show that both the Hippo pathway and AMP-activated protein kinase (AMPK) were activated during glucose starvation, resulting in phosphorylation of YAP and contributing to its inactivation.  We also identified glucose-transporter 3 (GLUT3) as a YAP-regulated gene involved in glucose metab.  Together, these results demonstrate that glucose-mediated energy homeostasis is an upstream event involved in regulation of the Hippo pathway and, potentially, an oncogenic function of YAP in promoting glycolysis, thereby providing an exciting link between glucose metab. and the Hippo pathway in tissue maintenance and cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9EQSGm1lcGbVg90H21EOLACvtfcHk0liLu6YO_X_mpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsrY%253D&md5=2b676165cc29546c981774bf2301216c</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1038%2Fncb3113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb3113%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DZ.%2BD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DAziz%26aufirst%3DK.%2BE.%26aulast%3DGan%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DR.%2BL.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DAMPK%2520Modulates%2520Hippo%2520Pathway%2520Activity%2520to%2520Regulate%2520Energy%2520Homeostasis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2015%26volume%3D17%26spage%3D490%26epage%3D499%26doi%3D10.1038%2Fncb3113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeRan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitamant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asara, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardeesy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span> <span> </span><span class="NLM_article-title">Energy Stress Regulates Hippo-YAP Signaling Involving AMPK-Mediated Regulation of Angiomotin-like 1 Protein</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2014.09.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.celrep.2014.09.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=25373897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOrtLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=495-503&author=M.+DeRanauthor=J.+Yangauthor=C.-H.+Shenauthor=E.+C.+Petersauthor=J.+Fitamantauthor=P.+Chanauthor=M.+Hsiehauthor=S.+Zhuauthor=J.+M.+Asaraauthor=B.+Zhengauthor=N.+Bardeesyauthor=J.+Liuauthor=X.+Wu&title=Energy+Stress+Regulates+Hippo-YAP+Signaling+Involving+AMPK-Mediated+Regulation+of+Angiomotin-like+1+Protein&doi=10.1016%2Fj.celrep.2014.09.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Energy Stress Regulates Hippo-YAP Signaling Involving AMPK-Mediated Regulation of Angiomotin-like 1 Protein</span></div><div class="casAuthors">DeRan, Michael; Yang, Jiayi; Shen, Che-Hung; Peters, Eric C.; Fitamant, Julien; Chan, Puiyee; Hsieh, Mindy; Zhu, Shunying; Asara, John M.; Zheng, Bin; Bardeesy, Nabeel; Liu, Jun; Wu, Xu</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">495-503</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Hippo signaling is a tumor-suppressor pathway involved in organ size control and tumorigenesis through the inhibition of YAP and TAZ.  Here, we show that energy stress induces YAP cytoplasmic retention and S127 phosphorylation and inhibits YAP transcriptional activity and YAP-dependent transformation.  These effects require the central metabolic sensor AMP-activated protein kinase (AMPK) and the upstream Hippo pathway components Lats1/Lats2 and angiomotin-like 1 (AMOTL1).  Furthermore, we show that AMPK directly phosphorylates S793 of AMOTL1.  AMPK activation stabilizes and increases AMOTL1 steady-state protein levels, contributing to YAP inhibition.  The phosphorylation-deficient S793Ala mutant of AMOTL1 showed a shorter half-life and conferred resistance to energy-stress-induced YAP inhibition.  Our findings link energy sensing to the Hippo-YAP pathway and suggest that YAP may integrate spatial (contact inhibition), mech., and metabolic signals to control cellular proliferation and survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdF9CsZGTzKLVg90H21EOLACvtfcHk0lh8VD-1fi70xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOrtLrP&md5=2d8692460302f95f7402a72728413293</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.09.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.09.036%26sid%3Dliteratum%253Aachs%26aulast%3DDeRan%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DC.-H.%26aulast%3DPeters%26aufirst%3DE.%2BC.%26aulast%3DFitamant%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DP.%26aulast%3DHsieh%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DAsara%26aufirst%3DJ.%2BM.%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DBardeesy%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26atitle%3DEnergy%2520Stress%2520Regulates%2520Hippo-YAP%2520Signaling%2520Involving%2520AMPK-Mediated%2520Regulation%2520of%2520Angiomotin-like%25201%2520Protein%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D9%26spage%3D495%26epage%3D503%26doi%3D10.1016%2Fj.celrep.2014.09.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babcock, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quilliam, L. A.</span></span> <span> </span><span class="NLM_article-title">LKB1 Tumor Suppressor Regulates AMP Kinase/MTOR-Independent Cell Growth and Proliferation via the Phosphorylation of Yap</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">4100</span>– <span class="NLM_lpage">4109</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fonc.2012.431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23027127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaqtLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=4100-4109&author=H.+B.+Nguyenauthor=J.+T.+Babcockauthor=C.+D.+Wellsauthor=L.+A.+Quilliam&title=LKB1+Tumor+Suppressor+Regulates+AMP+Kinase%2FMTOR-Independent+Cell+Growth+and+Proliferation+via+the+Phosphorylation+of+Yap&doi=10.1038%2Fonc.2012.431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap</span></div><div class="casAuthors">Nguyen, H. B.; Babcock, J. T.; Wells, C. D.; Quilliam, L. A.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">4100-4109</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The liver kinase B1 (LKB1) tumor suppressor inhibits cell growth through its regulation of cellular metab. and apical-basal polarity.  The best understood mechanism whereby LKB1 limits cell growth is through activation of the AMP-activated-protein-kinase/mammalian-target-of-rapamycin (AMPK/mTOR) pathway to control metab.  As LKB1 is also required for polarized epithelial cells to resist hyperplasia, it is anticipated to function through addnl. mechanisms.  Recently, Yes-assocd. protein (Yap) has emerged as a transcriptional co-activator that modulates tissue homeostasis in response to cell-cell contact.  Thus this study examd. a possible connection between Yap and LKB1.  Restoration of LKB1 expression in HeLa cells, which lack this tumor suppressor, or short-hairpin RNA knockdown of LKB1 in NTERT immortalized keratinocytes, demonstrated that LKB1 promotes Yap phosphorylation, nuclear exclusion and proteasomal degrdn.  The ability of phosphorylation-defective Yap mutants to rescue LKB1 phenotypes, such as reduced cell proliferation and cell size, suggest that Yap inhibition contributes to LKB1 tumor suppressor function(s).  However, failure of Lats1/2 knockdown to suppress LKB1-mediated Yap regulation suggested that LKB1 signals to Yap via a non-canonical pathway.  Addnl., LKB1 inhibited Yap independently of either AMPK or mTOR activation.  These findings reveal a novel mechanism whereby LKB1 may restrict cancer cell growth via the inhibition of Yap.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Su5GJ17jSrVg90H21EOLACvtfcHk0lh8VD-1fi70xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaqtLzP&md5=bfbba5ae755b3e2f10900abb49cfec0e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.431%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DH.%2BB.%26aulast%3DBabcock%26aufirst%3DJ.%2BT.%26aulast%3DWells%26aufirst%3DC.%2BD.%26aulast%3DQuilliam%26aufirst%3DL.%2BA.%26atitle%3DLKB1%2520Tumor%2520Suppressor%2520Regulates%2520AMP%2520Kinase%252FMTOR-Independent%2520Cell%2520Growth%2520and%2520Proliferation%2520via%2520the%2520Phosphorylation%2520of%2520Yap%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D4100%26epage%3D4109%26doi%3D10.1038%2Fonc.2012.431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gill, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregorieff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narimatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couzens, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlotta, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Kwast, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingras, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicheri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrana, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attisano, L.</span></span> <span> </span><span class="NLM_article-title">A Feed Forward Loop Enforces YAP/TAZ Signaling during Tumorigenesis</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-05939-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fs41467-018-05939-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=29317637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVakt7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1-13&author=M.+K.+Gillauthor=T.+Christovaauthor=Y.+Y.+Zhangauthor=A.+Gregorieffauthor=L.+Zhangauthor=M.+Narimatsuauthor=S.+Songauthor=S.+Xiongauthor=A.+L.+Couzensauthor=J.+Tongauthor=J.+R.+Kriegerauthor=M.+F.+Moranauthor=A.+R.+Zlottaauthor=T.+H.+van+der%0AKwastauthor=A.-C.+Gingrasauthor=F.+Sicheriauthor=J.+L.+Wranaauthor=L.+Attisano&title=A+Feed+Forward+Loop+Enforces+YAP%2FTAZ+Signaling+during+Tumorigenesis&doi=10.1038%2Fs41467-018-05939-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling</span></div><div class="casAuthors">Pinho, Andreia V.; Van Bulck, Mathias; Chantrill, Lorraine; Arshi, Mehreen; Sklyarova, Tatyana; Herrmann, David; Vennin, Claire; Gallego-Ortega, David; Mawson, Amanda; Giry-Laterriere, Marc; Magenau, Astrid; Leuckx, Gunther; Baeyens, Luc; Gill, Anthony J.; Phillips, Phoebe; Timpson, Paul; Biankin, Andrew V.; Wu, Jianmin; Rooman, Ilse</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Whereas genomic aberrations in the SLIT-ROBO pathway are frequent in pancreatic ductal adenocarcinoma (PDAC), their function in the pancreas is unclear.  Here we report that in pancreatitis and PDAC mouse models, epithelial Robo2 expression is lost while Robo1 expression becomes most prominent in the stroma.  Cell cultures of mice with loss of epithelial Robo2 (Pdx1Cre;Robo2F/F) show increased activation of Robo1+ myofibroblasts and induction of TGF-β and Wnt pathways.  During pancreatitis, Pdx1Cre;Robo2F/F mice present enhanced myofibroblast activation, collagen crosslinking, T-cell infiltration and tumorigenic immune markers.  The TGF-β inhibitor galunisertib suppresses these effects.  In PDAC patients, ROBO2 expression is overall low while ROBO1 is variably expressed in epithelium and high in stroma.  ROBO2low;ROBO1high patients present the poorest survival.  In conclusion, Robo2 acts non-autonomously as a stroma suppressor gene by restraining myofibroblast activation and T-cell infiltration.  ROBO1/2 expression in PDAC patients may guide therapy with TGF-β inhibitors or other stroma /immune modulating agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog2FcnvCa0hrVg90H21EOLACvtfcHk0lh8VD-1fi70xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVakt7zK&md5=21f49d6a8fcbc35ad00d983065b67f79</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-05939-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-05939-2%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DM.%2BK.%26aulast%3DChristova%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DY.%2BY.%26aulast%3DGregorieff%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DNarimatsu%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DS.%26aulast%3DXiong%26aufirst%3DS.%26aulast%3DCouzens%26aufirst%3DA.%2BL.%26aulast%3DTong%26aufirst%3DJ.%26aulast%3DKrieger%26aufirst%3DJ.%2BR.%26aulast%3DMoran%26aufirst%3DM.%2BF.%26aulast%3DZlotta%26aufirst%3DA.%2BR.%26aulast%3Dvan%2Bder%2BKwast%26aufirst%3DT.%2BH.%26aulast%3DGingras%26aufirst%3DA.-C.%26aulast%3DSicheri%26aufirst%3DF.%26aulast%3DWrana%26aufirst%3DJ.%2BL.%26aulast%3DAttisano%26aufirst%3DL.%26atitle%3DA%2520Feed%2520Forward%2520Loop%2520Enforces%2520YAP%252FTAZ%2520Signaling%2520during%2520Tumorigenesis%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D1%26epage%3D13%26doi%3D10.1038%2Fs41467-018-05939-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pepe-Mooney, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dill, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calogero, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camargo, F. D.</span></span> <span> </span><span class="NLM_article-title">NUAK2 Is a Critical YAP Target in Liver Cancer</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-07394-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fs41467-018-07394-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=29317637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1Krsr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1-12&author=W.+C.+Yuanauthor=B.+Pepe-Mooneyauthor=G.+G.+Galliauthor=M.+T.+Dillauthor=H.+T.+Huangauthor=M.+Haoauthor=Y.+Wangauthor=H.+Liangauthor=R.+A.+Calogeroauthor=F.+D.+Camargo&title=NUAK2+Is+a+Critical+YAP+Target+in+Liver+Cancer&doi=10.1038%2Fs41467-018-07394-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Interconvertible vanadium-seamed hexameric pyrogallol[4]arene nanocapsules</span></div><div class="casAuthors">Su, Kongzhao; Wu, Mingyan; Yuan, Daqiang; Hong, Maochun</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Research into stimuli-responsive controlled self-assembly and reversible transformation of mol. architectures has received much attention recently, because it is important to understand and reproduce this natural self-assembly behavior.  Here, we report two coordination nanocapsules with variable cavities: a contracted octahedral V24 capsule and an expanded ball-shaped V24 capsule, both of which are constructed from the same no. of subcomponents.  The assemblies of these two V24 capsules are solvent-controlled, and capable of reversible conversion between contracted and expanded forms via control of the geometries of the metal centers by assocn. and dissocn. with axial water mols.  Following such structural interconversions, the magnetic properties are significantly changed.  This work not only provides a strategy for the design and prepn. of coordination nanocapsules with adaptable cavities, but also a unique example with which to understand the transformation process and their structure-property relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouiQ3aHNwvKbVg90H21EOLACvtfcHk0lhoO0CCLJ_95A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1Krsr%252FN&md5=825fc76fb3d34ff4703c226af4b5dea4</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-07394-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-07394-5%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DW.%2BC.%26aulast%3DPepe-Mooney%26aufirst%3DB.%26aulast%3DGalli%26aufirst%3DG.%2BG.%26aulast%3DDill%26aufirst%3DM.%2BT.%26aulast%3DHuang%26aufirst%3DH.%2BT.%26aulast%3DHao%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DCalogero%26aufirst%3DR.%2BA.%26aulast%3DCamargo%26aufirst%3DF.%2BD.%26atitle%3DNUAK2%2520Is%2520a%2520Critical%2520YAP%2520Target%2520in%2520Liver%2520Cancer%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D1%26epage%3D12%26doi%3D10.1038%2Fs41467-018-07394-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lessard, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivas, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Queiroz, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirshman, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fielding, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodyear, L. J.</span></span> <span> </span><span class="NLM_article-title">The AMPK-Related Kinase SNARK Regulates Muscle Mass and Myocyte Survival</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1172/JCI79197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1172%2FJCI79197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26690705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BC28rjsFWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2016&pages=560-570&author=S.+J.+Lessardauthor=D.+A.+Rivasauthor=K.+Soauthor=H.+J.+Kohauthor=A.+L.+Queirozauthor=M.+F.+Hirshmanauthor=R.+A.+Fieldingauthor=L.+J.+Goodyear&title=The+AMPK-Related+Kinase+SNARK+Regulates+Muscle+Mass+and+Myocyte+Survival&doi=10.1172%2FJCI79197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The AMPK-related kinase SNARK regulates muscle  mass and myocyte survival</span></div><div class="casAuthors">Lessard Sarah J; Rivas Donato A; So Kawai; Koh Ho-Jin; Queiroz Andre Lima; Hirshman Michael F; Fielding Roger A; Goodyear Laurie J</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">560-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The maintenance of skeletal muscle mass is critical for sustaining health; however, the mechanisms responsible for muscle loss with aging and chronic diseases, such as diabetes and obesity, are poorly understood.  We found that expression of a member of the AMPK-related kinase family, the SNF1-AMPK-related kinase (SNARK, also known as NUAK2), increased with muscle cell differentiation.  SNARK expression increased in skeletal muscles from young mice exposed to metabolic stress and in muscles from healthy older human subjects.  The regulation of SNARK expression in muscle with differentiation and physiological stress suggests that SNARK may function in the maintenance of muscle mass.  Consistent with this hypothesis, decreased endogenous SNARK expression (using siRNA) in cultured muscle cells resulted in increased apoptosis and decreased cell survival under conditions of metabolic stress.  Likewise, muscle-specific transgenic animals expressing a SNARK dominant-negative inactive mutant (SDN) had increased myonuclear apoptosis and activation of apoptotic mediators in muscle.  Moreover, animals expressing SDN had severe, age-accelerated muscle atrophy and increased adiposity, consistent with sarcopenic obesity.  Reduced SNARK activity, in vivo and in vitro, caused downregulation of the Rho kinase signaling pathway, a key mediator of cell survival.  These findings reveal a critical role for SNARK in myocyte survival and the maintenance of muscle mass with age.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTTzGnLnD_mpzslzEEsg76ufW6udTcc2eYKFnntEq1DY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rjsFWnsg%253D%253D&md5=78fff98098d48a1fcc8550df5074413f</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1172%2FJCI79197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI79197%26sid%3Dliteratum%253Aachs%26aulast%3DLessard%26aufirst%3DS.%2BJ.%26aulast%3DRivas%26aufirst%3DD.%2BA.%26aulast%3DSo%26aufirst%3DK.%26aulast%3DKoh%26aufirst%3DH.%2BJ.%26aulast%3DQueiroz%26aufirst%3DA.%2BL.%26aulast%3DHirshman%26aufirst%3DM.%2BF.%26aulast%3DFielding%26aufirst%3DR.%2BA.%26aulast%3DGoodyear%26aufirst%3DL.%2BJ.%26atitle%3DThe%2520AMPK-Related%2520Kinase%2520SNARK%2520Regulates%2520Muscle%2520Mass%2520and%2520Myocyte%2520Survival%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2016%26volume%3D126%26spage%3D560%26epage%3D570%26doi%3D10.1172%2FJCI79197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Street, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, B. A.</span></span> <span> </span><span class="NLM_article-title">Rho Kinase Proteins-Pleiotropic Modulators of Cell Survival and Apoptosis</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">3645</span>– <span class="NLM_lpage">3657</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22110183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1GktrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=3645-3657&author=C.+A.+Streetauthor=B.+A.+Bryan&title=Rho+Kinase+Proteins-Pleiotropic+Modulators+of+Cell+Survival+and+Apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Rho kinase proteins-pleiotropic modulators of cell survival and apoptosis</span></div><div class="casAuthors">Street, Catharine A.; Bryan, Brad A.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3645-3657</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">A review.  Rho kinase (ROCK) proteins are Rho-GTPase activated serine/threonine kinases that function as modulators of actin-myosin cytoskeletal dynamics via regulation of Lin11, Isl-1 & Mec-3 domain (LIM) kinase, myosin light chain (MLC), and MLC phosphatase.  A strong correlation between cytoskeletal rearrangements and tumor cell invasion, metastasis, and deregulated microenvironment interaction has been reported in the literature, and the utilization of pharmacol. inhibitors of ROCK signaling for the treatment of cancer is actively being pursued by a no. of pharmaceutical companies.  Indeed, in many preclin. models ROCK inhibitors have shown remarkable efficacy in reducing tumor growth and metastasis.  Interestingly, ROCK signaling has been shown to be either pro-apoptotic or pro-survival in a cell type and context dependent manner, though the mol. mechanisms controlling ROCK-mediated cell fate decisions are unknown.  This review summarizes the many pleiotropic roles of ROCK signaling in survival and apoptosis, and suggests that controlled modulation of ROCK activity in tumor cells has the potential to significantly affect tumor survival and patient outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRMSOOGeK1y7Vg90H21EOLACvtfcHk0lhoO0CCLJ_95A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1GktrfP&md5=bebf4fdaba6da6faa35a9a6d07ac878c</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStreet%26aufirst%3DC.%2BA.%26aulast%3DBryan%26aufirst%3DB.%2BA.%26atitle%3DRho%2520Kinase%2520Proteins-Pleiotropic%2520Modulators%2520of%2520Cell%2520Survival%2520and%2520Apoptosis%26jtitle%3DAnticancer%2520Res.%26date%3D2011%26volume%3D31%26spage%3D3645%26epage%3D3657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Legembre, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schickel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnhart, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, M. E.</span></span> <span> </span><span class="NLM_article-title">Identification of SNF1/AMP Kinase-Related Kinase as an NF-KB- Regulated Anti-Apoptotic Kinase Involved in CD95-Induced Motility and Invasiveness</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">46742</span>– <span class="NLM_lpage">46747</span>, <span class="refDoi"> DOI: 10.1074/jbc.M404334200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M404334200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15345718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFaqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=46742-46747&author=P.+Legembreauthor=R.+Schickelauthor=B.+C.+Barnhartauthor=M.+E.+Peter&title=Identification+of+SNF1%2FAMP+Kinase-Related+Kinase+as+an+NF-KB-+Regulated+Anti-Apoptotic+Kinase+Involved+in+CD95-Induced+Motility+and+Invasiveness&doi=10.1074%2Fjbc.M404334200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of SNF1/AMP Kinase-related Kinase as an NF-κB-regulated Anti-apoptotic Kinase Involved in CD95-induced Motility and Invasiveness</span></div><div class="casAuthors">Legembre, Patrick; Schickel, Robert; Barnhart, Bryan C.; Peter, Marcus E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">46742-46747</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The death receptor CD95 (APO-1/Fas) induces apoptosis in many tissues.  However, in apoptosis-resistant tumor cells, stimulation of CD95 induces up-regulation of a defined no. of mostly anti-apoptotic genes, resulting in increased motility and invasiveness of tumor cells.  The majority of these genes are known NF-κB target genes.  The authors have identified one of the CD95-regulated genes as the serine/threonine kinase [SNF1/AMP kinase-related kinase (SNARK)], which is induced in response to various forms of metabolic stress.  The authors demonstrate that up-regulation of SNARK in response to CD95 ligand and tumor necrosis factor α depends on activation of NF-κB.  Overexpression of SNARK rendered tumor cells more resistant, whereas a kinase-inactive mutant of SNARK sensitized cells to CD95-mediated apoptosis.  Furthermore, small interfering RNA-mediated knockdown of SNARK increased the sensitivity of tumor cells to CD95 ligand- and TRAIL-induced apoptosis.  Importantly, cells with reduced expression of SNARK also showed reduced motility and invasiveness in response to CD95 engagement.  SNARK thus represents an NF-κB-regulated anti-apoptotic gene that contributes to the tumor-promoting activity of CD95 in apoptosis-resistant tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp-W5JNqJ1b7Vg90H21EOLACvtfcHk0ljpEQ96W7PuTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFaqurc%253D&md5=cf96de8036781e2d5a96c6f6707d2bfd</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M404334200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M404334200%26sid%3Dliteratum%253Aachs%26aulast%3DLegembre%26aufirst%3DP.%26aulast%3DSchickel%26aufirst%3DR.%26aulast%3DBarnhart%26aufirst%3DB.%2BC.%26aulast%3DPeter%26aufirst%3DM.%2BE.%26atitle%3DIdentification%2520of%2520SNF1%252FAMP%2520Kinase-Related%2520Kinase%2520as%2520an%2520NF-KB-%2520Regulated%2520Anti-Apoptotic%2520Kinase%2520Involved%2520in%2520CD95-Induced%2520Motility%2520and%2520Invasiveness%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D46742%26epage%3D46747%26doi%3D10.1074%2Fjbc.M404334200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monteverde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tait-Mulder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansom, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D. J.</span></span> <span> </span><span class="NLM_article-title">Calcium Signalling Links MYC to NUAK1</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">982</span>– <span class="NLM_lpage">992</span>, <span class="refDoi"> DOI: 10.1038/onc.2017.394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fonc.2017.394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=29106388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslKntb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=982-992&author=T.+Monteverdeauthor=J.+Tait-Mulderauthor=A.+Hedleyauthor=J.+R.+Knightauthor=O.+J.+Sansomauthor=D.+J.+Murphy&title=Calcium+Signalling+Links+MYC+to+NUAK1&doi=10.1038%2Fonc.2017.394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium signalling links MYC to NUAK1</span></div><div class="casAuthors">Monteverde, T.; Tait-Mulder, J.; Hedley, A.; Knight, J. R.; Sansom, O. J.; Murphy, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">982-992</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">NUAK1 is a member of the AMPK-related family of kinases.  Recent evidence suggests that NUAK1 is an important regulator of cell adhesion and migration, cellular and organismal metab., and regulation of TAU stability.  As such, NUAK1 may play key roles in multiple diseases ranging from neurodegeneration to diabetes and metastatic cancer.  Previous work revealed a crucial role for NUAK1 in supporting viability of tumor cells specifically when MYC is overexpressed.  This role is surprising, given that NUAK1 is activated by the tumor suppressor LKB1.  Here we show that, in tumor cells lacking LKB1, NUAK1 activity is maintained by an alternative pathway involving calcium-dependent activation of PKCα.  Calcium/PKCα-dependent activation of NUAK1 supports engagement of the AMPK-TORC1 metabolic checkpoint, thereby protecting tumor cells from MYC-driven cell death, and indeed, MYC selects for this pathway in part via transcriptional regulation of PKCα and ITPR.  Our data point to a novel role for calcium in supporting tumor cell viability and clarify the synthetic lethal interaction between NUAK1 and MYC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKWKiv-P540LVg90H21EOLACvtfcHk0ljpEQ96W7PuTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslKntb%252FP&md5=6217c8adcebcc2504f6e89c84fc5e133</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fonc.2017.394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2017.394%26sid%3Dliteratum%253Aachs%26aulast%3DMonteverde%26aufirst%3DT.%26aulast%3DTait-Mulder%26aufirst%3DJ.%26aulast%3DHedley%26aufirst%3DA.%26aulast%3DKnight%26aufirst%3DJ.%2BR.%26aulast%3DSansom%26aufirst%3DO.%2BJ.%26aulast%3DMurphy%26aufirst%3DD.%2BJ.%26atitle%3DCalcium%2520Signalling%2520Links%2520MYC%2520to%2520NUAK1%26jtitle%3DOncogene%26date%3D2018%26volume%3D37%26spage%3D982%26epage%3D992%26doi%3D10.1038%2Fonc.2017.394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cossa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roeschert, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baluapuri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silveira Vidal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulein-Volk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ade, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mastrobuoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luhrmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuster, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilers, M.</span></span> <span> </span><span class="NLM_article-title">Localized Inhibition of Protein Phosphatase 1 by NUAK1 Promotes Spliceosome Activity and Reveals a MYC-Sensitive Feedback Control of Transcription</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1322</span>– <span class="NLM_lpage">1339</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2020.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.molcel.2020.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=32006464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFCmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2020&pages=1322-1339&author=G.+Cossaauthor=I.+Roeschertauthor=F.+Prinzauthor=A.+Baluapuriauthor=R.+Silveira+Vidalauthor=C.+Schulein-Volkauthor=Y.-C.+Changauthor=C.+P.+Adeauthor=G.+Mastrobuoniauthor=C.+Girardauthor=L.+Wortmannauthor=S.+Walzauthor=R.+Luhrmannauthor=S.+Kempaauthor=B.+Kusterauthor=E.+Wolfauthor=D.+Mumbergauthor=M.+Eilers&title=Localized+Inhibition+of+Protein+Phosphatase+1+by+NUAK1+Promotes+Spliceosome+Activity+and+Reveals+a+MYC-Sensitive+Feedback+Control+of+Transcription&doi=10.1016%2Fj.molcel.2020.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Localized Inhibition of Protein Phosphatase 1 by NUAK1 Promotes Spliceosome Activity and Reveals a MYC-Sensitive Feedback Control of Transcription</span></div><div class="casAuthors">Cossa, Giacomo; Roeschert, Isabelle; Prinz, Florian; Baluapuri, Apoorva; Silveira Vidal, Raphael; Schuelein-Voelk, Christina; Chang, Yun-Chien; Ade, Carsten Patrick; Mastrobuoni, Guido; Girard, Cyrille; Wortmann, Lars; Walz, Susanne; Luehrmann, Reinhard; Kempa, Stefan; Kuster, Bernhard; Wolf, Elmar; Mumberg, Dominik; Eilers, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1322-1339.e11</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Deregulated expression of MYC induces a dependence on the NUAK1 kinase, but the mol. mechanisms underlying this dependence have not been fully clarified.  Here, we show that NUAK1 is a predominantly nuclear protein that assocs. with a network of nuclear protein phosphatase 1 (PP1) interactors and that PNUTS, a nuclear regulatory subunit of PP1, is phosphorylated by NUAK1.  Both NUAK1 and PNUTS assoc. with the splicing machinery.  Inhibition of NUAK1 abolishes chromatin assocn. of PNUTS, reduces spliceosome activity, and suppresses nascent RNA synthesis.  Activation of MYC does not bypass the requirement for NUAK1 for spliceosome activity but significantly attenuates transcription inhibition.  Consequently, NUAK1 inhibition in MYC-transformed cells induces global accumulation of RNAPII both at the pause site and at the first exon-intron boundary but does not increase mRNA synthesis.  We suggest that NUAK1 inhibition in the presence of deregulated MYC traps non-productive RNAPII because of the absence of correctly assembled spliceosomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoysNS09sAcLrVg90H21EOLACvtfcHk0ljpEQ96W7PuTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFCmt7s%253D&md5=48f29ed7b439ae84d5c344e50ff1c495</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2020.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2020.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DCossa%26aufirst%3DG.%26aulast%3DRoeschert%26aufirst%3DI.%26aulast%3DPrinz%26aufirst%3DF.%26aulast%3DBaluapuri%26aufirst%3DA.%26aulast%3DSilveira%2BVidal%26aufirst%3DR.%26aulast%3DSchulein-Volk%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DY.-C.%26aulast%3DAde%26aufirst%3DC.%2BP.%26aulast%3DMastrobuoni%26aufirst%3DG.%26aulast%3DGirard%26aufirst%3DC.%26aulast%3DWortmann%26aufirst%3DL.%26aulast%3DWalz%26aufirst%3DS.%26aulast%3DLuhrmann%26aufirst%3DR.%26aulast%3DKempa%26aufirst%3DS.%26aulast%3DKuster%26aufirst%3DB.%26aulast%3DWolf%26aufirst%3DE.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3DEilers%26aufirst%3DM.%26atitle%3DLocalized%2520Inhibition%2520of%2520Protein%2520Phosphatase%25201%2520by%2520NUAK1%2520Promotes%2520Spliceosome%2520Activity%2520and%2520Reveals%2520a%2520MYC-Sensitive%2520Feedback%2520Control%2520of%2520Transcription%26jtitle%3DMol.%2520Cell%26date%3D2020%26volume%3D77%26spage%3D1322%26epage%3D1339%26doi%3D10.1016%2Fj.molcel.2020.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kreisberg, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh-Choudhury, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radnik, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, M. A.</span></span> <span> </span><span class="NLM_article-title">Role of Rho and Myosin Phosphorylation in Actin Stress Fiber Assembly in Mesangial Cells</span>. <i>Am. J. Physiol. - Ren. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">F283</span>– <span class="NLM_lpage">F288</span>, <span class="refDoi"> DOI: 10.1152/ajprenal.1997.273.2.F283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1152%2Fajprenal.1997.273.2.F283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=9277589" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1997&pages=F283-F288&author=J.+I.+Kreisbergauthor=N.+Ghosh-Choudhuryauthor=R.+A.+Radnikauthor=M.+A.+Schwartz&title=Role+of+Rho+and+Myosin+Phosphorylation+in+Actin+Stress+Fiber+Assembly+in+Mesangial+Cells&doi=10.1152%2Fajprenal.1997.273.2.F283"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.1997.273.2.F283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.1997.273.2.F283%26sid%3Dliteratum%253Aachs%26aulast%3DKreisberg%26aufirst%3DJ.%2BI.%26aulast%3DGhosh-Choudhury%26aufirst%3DN.%26aulast%3DRadnik%26aufirst%3DR.%2BA.%26aulast%3DSchwartz%26aufirst%3DM.%2BA.%26atitle%3DRole%2520of%2520Rho%2520and%2520Myosin%2520Phosphorylation%2520in%2520Actin%2520Stress%2520Fiber%2520Assembly%2520in%2520Mesangial%2520Cells%26jtitle%3DAm.%2520J.%2520Physiol.%2520-%2520Ren.%2520Physiol.%26date%3D1997%26volume%3D273%26spage%3DF283%26epage%3DF288%26doi%3D10.1152%2Fajprenal.1997.273.2.F283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Surks, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddick, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtani, K. I.</span></span> <span> </span><span class="NLM_article-title">M-RIP Targets Myosin Phosphatase to Stress Fibers to Regulate Myosin Light Chain Phosphorylation in Vascular Smooth Muscle Cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">42543</span>– <span class="NLM_lpage">42551</span>, <span class="refDoi"> DOI: 10.1074/jbc.M506863200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M506863200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=16257966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCmsLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=42543-42551&author=H.+K.+Surksauthor=N.+Riddickauthor=K.+I.+Ohtani&title=M-RIP+Targets+Myosin+Phosphatase+to+Stress+Fibers+to+Regulate+Myosin+Light+Chain+Phosphorylation+in+Vascular+Smooth+Muscle+Cells&doi=10.1074%2Fjbc.M506863200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">M-RIP Targets Myosin Phosphatase to Stress Fibers to Regulate Myosin Light Chain Phosphorylation in Vascular Smooth Muscle Cells</span></div><div class="casAuthors">Surks, Howard K.; Riddick, Nadeene; Ohtani, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">42543-42551</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Vascular smooth muscle cell contraction and relaxation are directly related to the phosphorylation state of the regulatory myosin light chain.  Myosin light chains are dephosphorylated by myosin phosphatase, leading to vascular smooth muscle relaxation.  Myosin phosphatase is localized not only at actin-myosin stress fibers, where it dephosphorylates myosin light chains, but also in the cytoplasm and at the cell membrane.  The mechanisms by which myosin phosphatase is targeted to these loci are incompletely understood.  We recently identified myosin phosphatase-Rho interacting protein (M-RIP) as a member of the myosin phosphatase complex that directly binds both the myosin-binding subunit of myosin phosphatase and RhoA and is localized to actin-myosin stress fibers.  We hypothesized that M-RIP targets myosin phosphatase to the contractile app. to dephosphorylate myosin light chains.  We used RNA interference to silence the expression of M-RIP in human vascular smooth muscle cells.  M-RIP silencing reduced the localization of the myosin-binding subunit to stress fibers.  This redn. in stress fiber M-RIP and myosin-binding subunit increased basal and lysophosphatidic acid-stimulated myosin light chain phosphorylation.  Neither cellular myosin phosphatase, myosin light chain kinase, nor RhoA activities were changed by M-RIP silencing.  Furthermore, M-RIP silencing resulted in marked phenotypic changes in vascular smooth muscle cells, including increased nos. of stress fibers, increased cell area, and reduced stress fiber inhibition in response to a Rho kinase inhibitor.  These data support the importance of M-RIP-dependent targeting of myosin phosphatase to stress fibers for regulating myosin light chain phosphorylation state and morphol. in human vascular smooth muscle cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruIc5kpnoxT7Vg90H21EOLACvtfcHk0lhFQPj4FukmXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCmsLvL&md5=026511c96f6990da7300dc8d92a2afbd</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M506863200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M506863200%26sid%3Dliteratum%253Aachs%26aulast%3DSurks%26aufirst%3DH.%2BK.%26aulast%3DRiddick%26aufirst%3DN.%26aulast%3DOhtani%26aufirst%3DK.%2BI.%26atitle%3DM-RIP%2520Targets%2520Myosin%2520Phosphatase%2520to%2520Stress%2520Fibers%2520to%2520Regulate%2520Myosin%2520Light%2520Chain%2520Phosphorylation%2520in%2520Vascular%2520Smooth%2520Muscle%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D42543%26epage%3D42551%26doi%3D10.1074%2Fjbc.M506863200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koga, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikebe, M.</span></span> <span> </span><span class="NLM_article-title">A Novel Regulatory Mechanism of Myosin Light Chain Phosphorylation via Binding of 14–3-3 to Myosin Phosphatase</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1062</span>– <span class="NLM_lpage">1071</span>, <span class="refDoi"> DOI: 10.1091/mbc.e07-07-0668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1091%2Fmbc.e07-07-0668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=18094049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslemsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=1062-1071&author=Y.+Kogaauthor=M.+Ikebe&title=A+Novel+Regulatory+Mechanism+of+Myosin+Light+Chain+Phosphorylation+via+Binding+of+14%E2%80%933-3+to+Myosin+Phosphatase&doi=10.1091%2Fmbc.e07-07-0668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">A novel regulatory mechanism of myosin light chain phosphorylation via binding of 14-3-3 to myosin phosphatase</span></div><div class="casAuthors">Koga, Yasuhiko; Ikebe, Mitsuo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1062-1071</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Myosin II phosphorylation-dependent cell motile events are regulated by myosin light-chain (MLC) kinase and MLC phosphatase (MLCP).  Recent studies have revealed myosin phosphatase targeting subunit (MYPT1), a myosin-binding subunit of MLCP, plays a crit. role in MLCP regulation.  Here we report the new regulatory mechanism of MLCP via the interaction between 14-3-3 and MYPT1.  The binding of 14-3-3β to MYPT1 diminished the direct binding between MYPT1 and myosin II, and 14-3-3β overexpression abolished MYPT1 localization at stress fiber.  Furthermore, 14-3-3β inhibited MLCP holoenzyme activity via the interaction with MYPT1.  Consistently, 14-3-3β overexpression increased myosin II phosphorylation in cells.  We found that MYPT1 phosphorylation at Ser472 was crit. for the binding to 14-3-3.  Epidermal growth factor (EGF) stimulation increased both Ser472 phosphorylation and the binding of MYPT1-14-3-3.  Rho-kinase inhibitor inhibited the EGF-induced Ser472 phosphorylation and the binding of MYPT1-14-3-3.  Rho-kinase specific siRNA also decreased EGF-induced Ser472 phosphorylation correlated with the decrease in MLC phosphorylation.  The present study revealed a new RhoA/Rho-kinase-dependent regulatory mechanism of myosin II phosphorylation by 14-3-3 that dissocs. MLCP from myosin II and attenuates MLCP activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg0xg8XTwdyLVg90H21EOLACvtfcHk0lhFQPj4FukmXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslemsLw%253D&md5=d5fd0e7e2da45ea22d2538535a016d4f</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e07-07-0668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e07-07-0668%26sid%3Dliteratum%253Aachs%26aulast%3DKoga%26aufirst%3DY.%26aulast%3DIkebe%26aufirst%3DM.%26atitle%3DA%2520Novel%2520Regulatory%2520Mechanism%2520of%2520Myosin%2520Light%2520Chain%2520Phosphorylation%2520via%2520Binding%2520of%252014%25E2%2580%25933-3%2520to%2520Myosin%2520Phosphatase%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2008%26volume%3D19%26spage%3D1062%26epage%3D1071%26doi%3D10.1091%2Fmbc.e07-07-0668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddick, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baur, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surks, H. K.</span></span> <span> </span><span class="NLM_article-title">ROCk Isoform Regulation of Myosin Phosphatase and Contractility in Vascular Smooth Muscle Cells</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1161/CIRCRESAHA.108.188524</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1161%2FCIRCRESAHA.108.188524" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=19131646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFejtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2009&pages=531-540&author=Y.+Wangauthor=X.+R.+Zhengauthor=N.+Riddickauthor=M.+Brydenauthor=W.+Baurauthor=X.+Zhangauthor=H.+K.+Surks&title=ROCk+Isoform+Regulation+of+Myosin+Phosphatase+and+Contractility+in+Vascular+Smooth+Muscle+Cells&doi=10.1161%2FCIRCRESAHA.108.188524"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">ROCK Isoform Regulation of Myosin Phosphatase and Contractility in Vascular Smooth Muscle Cells</span></div><div class="casAuthors">Wang, Yuepeng; Zheng, Xiaoyu Rayne; Riddick, Nadeene; Bryden, Meredith; Baur, Wendy; Zhang, Xin; Surks, Howard K.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">531-540</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Abnormal vascular smooth muscle cell (VSMC) contraction plays an important role in vascular diseases.  The RhoA/ROCK signaling pathway is now well recognized to mediate vascular smooth muscle contraction in response to vasoconstrictors by inhibiting myosin phosphatase (MLCP) activity and increasing myosin light chain phosphorylation.  Two ROCK isoforms, ROCK1 and ROCK2, are expressed in many tissues, yet the isoform-specific roles of ROCK1 and ROCK2 in vascular smooth muscle and the mechanism of ROCK-mediated regulation of MLCP are not well understood.  In this study, ROCK2, but not ROCK1, bound directly to the myosin binding subunit of MLCP, yet both ROCK isoforms regulated MLCP and myosin light chain phosphorylation.  Despite that both ROCK1 and ROCK2 regulated MLCP, the ROCK isoforms had distinct and opposing effects on VSMC morphol. and ROCK2, but not ROCK1, had a predominant role in VSMC contractility.  These data support that although the ROCK isoforms both regulate MLCP and myosin light chain phosphorylation through different mechanisms, they have distinct roles in VSMC function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz6-nW8A7CLrVg90H21EOLACvtfcHk0lhFQPj4FukmXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFejtLs%253D&md5=3c80a758fa7f959b49ba67e25447a562</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1161%2FCIRCRESAHA.108.188524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCRESAHA.108.188524%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DX.%2BR.%26aulast%3DRiddick%26aufirst%3DN.%26aulast%3DBryden%26aufirst%3DM.%26aulast%3DBaur%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSurks%26aufirst%3DH.%2BK.%26atitle%3DROCk%2520Isoform%2520Regulation%2520of%2520Myosin%2520Phosphatase%2520and%2520Contractility%2520in%2520Vascular%2520Smooth%2520Muscle%2520Cells%26jtitle%3DCirc.%2520Res.%26date%3D2009%26volume%3D104%26spage%3D531%26epage%3D540%26doi%3D10.1161%2FCIRCRESAHA.108.188524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakai, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishimoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minegichi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">Induction of Cell-Cell Detachment during Glucose Starvation through F-Actin Conversion by SNARK, the Fourth Member of the AMP-Activated Protein Kinase Catalytic Subunit Family</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>311</i></span>,  <span class="NLM_fpage">156</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2003.09.184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.bbrc.2003.09.184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=14575707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot1Glt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2003&pages=156-161&author=A.+Suzukiauthor=G.+I.+Kusakaiauthor=A.+Kishimotoauthor=Y.+Minegichiauthor=T.+Oguraauthor=H.+Esumi&title=Induction+of+Cell-Cell+Detachment+during+Glucose+Starvation+through+F-Actin+Conversion+by+SNARK%2C+the+Fourth+Member+of+the+AMP-Activated+Protein+Kinase+Catalytic+Subunit+Family&doi=10.1016%2Fj.bbrc.2003.09.184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of cell-cell detachment during glucose starvation through F-actin conversion by SNARK, the fourth member of the AMP-activated protein kinase catalytic subunit family</span></div><div class="casAuthors">Suzuki, Atsushi; Kusakai, Gen-Ichi; Kishimoto, Atsuhiro; Minegichi, Yuji; Ogura, Tsutomu; Esumi, Hiroyasu</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">156-161</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">SNARK, the fourth member of the AMPK catalytic subunit family, was originally identified in a rat kidney cDNA library, and in this study we isolated its human homolog.  A BLAST search anal. using rat SNARK protein yielded a single high homol. clone, DKFZp434J037, isolated from human testis, and since its hypothetical protein showed 84% homol. to rat SNARK protein, we assumed DKFZp434J037 to be the human SNARK cDNA.  The human SNARK cDNA is 3443 bp long and encodes a 628 amino acid protein having an estd. mol. wt. of 69 kDa, and its chromosomal localization had been assigned to 1q32.1.  The same as other members of AMPK catalytic subunit family, human SNARK showed AMP-dependent GST-SAMS phosphorylation activity and enhanced HepG2 cell survival during glucose starvation.  Human SNARK-overexpressing HepG2 cells (H/SNK) showed acute cell-cell detachment when exposed to glucose-free medium and the cell-cell detachment correlated well with the detection of G-actin.  Deletion mutant anal. strongly suggested that the putative catalytic domain of SNARK is necessary for the cell-cell detachment, and Western blotting anal. showed that phosphorylation of FAK and PKC, which were dramatically increased by glucose starvation in HepG2 cells, was markedly suppressed by SNARK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTp76LNaR2OLVg90H21EOLACvtfcHk0lhsVPMs3SMtkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot1Glt78%253D&md5=c9fd91ab869e07f8546c57e636f41b45</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2003.09.184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2003.09.184%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DKusakai%26aufirst%3DG.%2BI.%26aulast%3DKishimoto%26aufirst%3DA.%26aulast%3DMinegichi%26aufirst%3DY.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DInduction%2520of%2520Cell-Cell%2520Detachment%2520during%2520Glucose%2520Starvation%2520through%2520F-Actin%2520Conversion%2520by%2520SNARK%252C%2520the%2520Fourth%2520Member%2520of%2520the%2520AMP-Activated%2520Protein%2520Kinase%2520Catalytic%2520Subunit%2520Family%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D311%26spage%3D156%26epage%3D161%26doi%3D10.1016%2Fj.bbrc.2003.09.184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mason, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawahare, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voytik-Harbin, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorlutuna, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoder, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boerckel, J. D.</span></span> <span> </span><span class="NLM_article-title">YAP and TAZ Limit Cytoskeletal and Focal Adhesion Maturation to Enable Persistent Cell Motility</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>218</i></span>,  <span class="NLM_fpage">1369</span>– <span class="NLM_lpage">1389</span>, <span class="refDoi"> DOI: 10.1083/jcb.201806065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1083%2Fjcb.201806065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=30737263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1MXps1art74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=218&publication_year=2019&pages=1369-1389&author=D.+E.+Masonauthor=J.+M.+Collinsauthor=J.+H.+Dawahareauthor=T.+D.+Nguyenauthor=Y.+Linauthor=S.+L.+Voytik-Harbinauthor=P.+Zorlutunaauthor=M.+C.+Yoderauthor=J.+D.+Boerckel&title=YAP+and+TAZ+Limit+Cytoskeletal+and+Focal+Adhesion+Maturation+to+Enable+Persistent+Cell+Motility&doi=10.1083%2Fjcb.201806065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">YAP and TAZ limit cytoskeletal and focal adhesion maturation to enable persistent cell motility</span></div><div class="casAuthors">Mason, Devon E.; Collins, Joseph M.; Dawahare, James H.; Nguyen, Trung Dung; Lin, Yang; Voytik-Harbin, Sherry L.; Zorlutuna, Pinar; Yoder, Mervin C.; Boerckel, Joel D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">218</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1369-1389</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">1540-8140</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Cell migration initiates by traction generation through reciprocal actomyosin tension and focal adhesion reinforcement, but continued motility requires adaptive cytoskeletal remodeling and adhesion release.  Here, we asked whether de novo gene expression contributes to this cytoskeletal feedback.  We found that global inhibition of transcription or translation does not impair initial cell polarization or migration initiation, but causes eventual migratory arrest through excessive cytoskeletal tension and over-maturation of focal adhesions, tethering cells to their matrix.  The transcriptional coactivators YAP and TAZ mediate this feedback response, modulating cell mechanics by limiting cytoskeletal and focal adhesion maturation to enable persistent cell motility and 3D vasculogenesis.  Motile arrest after YAP/TAZ ablation was partially rescued by depletion of the YAP/TAZ-dependent myosin phosphatase regulator, NUAK2, or by inhibition of Rho-ROCK-myosin II.  Together, these data establish a transcriptional feedback axis necessary to maintain a responsive cytoskeletal equil. and persistent migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmkEFplI1c37Vg90H21EOLACvtfcHk0lhsVPMs3SMtkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXps1art74%253D&md5=c52059f6aa9f6ca96e8a175814aaf575</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201806065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201806065%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DD.%2BE.%26aulast%3DCollins%26aufirst%3DJ.%2BM.%26aulast%3DDawahare%26aufirst%3DJ.%2BH.%26aulast%3DNguyen%26aufirst%3DT.%2BD.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DVoytik-Harbin%26aufirst%3DS.%2BL.%26aulast%3DZorlutuna%26aufirst%3DP.%26aulast%3DYoder%26aufirst%3DM.%2BC.%26aulast%3DBoerckel%26aufirst%3DJ.%2BD.%26atitle%3DYAP%2520and%2520TAZ%2520Limit%2520Cytoskeletal%2520and%2520Focal%2520Adhesion%2520Maturation%2520to%2520Enable%2520Persistent%2520Cell%2520Motility%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2019%26volume%3D218%26spage%3D1369%26epage%3D1389%26doi%3D10.1083%2Fjcb.201806065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Courchet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer-Dilhet, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Carmine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polleux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courchet, J.</span></span> <span> </span><span class="NLM_article-title">Haploinsufficiency of Autism Spectrum Disorder Candidate Gene NUAK1 Impairs Cortical Development and Behavior in Mice</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">4289</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-06584-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fs41467-018-06584-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=30327473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BB3czpvFOjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=4289&author=V.+Courchetauthor=A.+J.+Robertsauthor=G.+Meyer-Dilhetauthor=P.+Del+Carmineauthor=T.+L.+Lewisauthor=F.+Polleuxauthor=J.+Courchet&title=Haploinsufficiency+of+Autism+Spectrum+Disorder+Candidate+Gene+NUAK1+Impairs+Cortical+Development+and+Behavior+in+Mice&doi=10.1038%2Fs41467-018-06584-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Haploinsufficiency of autism spectrum disorder candidate gene NUAK1 impairs cortical development and behavior in mice</span></div><div class="casAuthors">Courchet Virginie; Meyer-Dilhet Geraldine; Del Carmine Peggy; Courchet Julien; Roberts Amanda J; Lewis Tommy L Jr; Polleux Franck</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4289</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recently, numerous rare de novo mutations have been identified in patients diagnosed with autism spectrum disorders (ASD).  However, despite the predicted loss-of-function nature of some of these de novo mutations, the affected individuals are heterozygous carriers, which would suggest that most of these candidate genes are haploinsufficient and/or lead to expression of dominant-negative forms of the protein.  Here, we tested this hypothesis with the candidate ASD gene Nuak1 that we previously identified for its role in the development of cortical connectivity.  We report that Nuak1 is haploinsufficient in mice with regard to its function in cortical development.  Furthermore Nuak1(+/-) mice show a combination of abnormal behavioral traits ranging from defective spatial memory consolidation, defects in social novelty (but not social preference) and abnormal sensorimotor gating.  Overall, our results demonstrate that Nuak1 haploinsufficiency leads to defects in the development of cortical connectivity and a complex array of behavorial deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQDaeM-kystWMNIRw0GKUoEfW6udTcc2ebbYVikIx3ld7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3czpvFOjuw%253D%253D&md5=d1dc48f19151b17c8d96e24bcb747b3e</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06584-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06584-5%26sid%3Dliteratum%253Aachs%26aulast%3DCourchet%26aufirst%3DV.%26aulast%3DRoberts%26aufirst%3DA.%2BJ.%26aulast%3DMeyer-Dilhet%26aufirst%3DG.%26aulast%3DDel%2BCarmine%26aufirst%3DP.%26aulast%3DLewis%26aufirst%3DT.%2BL.%26aulast%3DPolleux%26aufirst%3DF.%26aulast%3DCourchet%26aufirst%3DJ.%26atitle%3DHaploinsufficiency%2520of%2520Autism%2520Spectrum%2520Disorder%2520Candidate%2520Gene%2520NUAK1%2520Impairs%2520Cortical%2520Development%2520and%2520Behavior%2520in%2520Mice%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D4289%26doi%3D10.1038%2Fs41467-018-06584-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Windelinckx, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mars, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huygens, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peeters, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijmenga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambrechts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aerssens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlietinck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beunen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomis, M. A.</span></span> <span> </span><span class="NLM_article-title">Identification and Prioritization of NUAK1 and PPP1CC as Positional Candidate Loci for Skeletal Muscle Strength Phenotypes</span>. <i>Physiol. Genomics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">981</span>– <span class="NLM_lpage">992</span>, <span class="refDoi"> DOI: 10.1152/physiolgenomics.00200.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1152%2Fphysiolgenomics.00200.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=21750233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFGrtbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=981-992&author=A.+Windelinckxauthor=G.+de+Marsauthor=W.+Huygensauthor=M.+W.+Peetersauthor=B.+Vincentauthor=C.+Wijmengaauthor=D.+Lambrechtsauthor=J.+Aerssensauthor=R.+Vlietinckauthor=G.+Beunenauthor=M.+A.+Thomis&title=Identification+and+Prioritization+of+NUAK1+and+PPP1CC+as+Positional+Candidate+Loci+for+Skeletal+Muscle+Strength+Phenotypes&doi=10.1152%2Fphysiolgenomics.00200.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and prioritization of NUAK1 and PPP1CC as positional candidate loci for skeletal muscle strength phenotypes</span></div><div class="casAuthors">Windelinckx, An; De Mars, Gunther; Huygens, Wim; Peeters, Maarten W.; Vincent, Barbara; Wijmenga, Cisca; Lambrechts, Diether; Aerssens, Jeroen; Vlietinck, Robert; Beunen, Gaston; Thomis, Martine A. I.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Genomics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">981-992</span>CODEN:
                <span class="NLM_cas:coden">PHGEFP</span>;
        ISSN:<span class="NLM_cas:issn">1094-8341</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Muscle strength is an important determinant in elite sports performance as well as in the activities of daily living.  Muscle metab. also plays a role in the genesis, and therefore prevention, of common pathol. conditions and chronic diseases.  Even though heritability ests. between 31 and 78% suggest a significant genetic component in muscle strength, only a limited no. of genes influencing muscle strength have been identified.  This study aimed to identify and prioritize positional candidate genes within a skeletal muscle strength quant. trait locus on chromosome 12q22-23 for follow-up.  A two-staged gene-centered fine-mapping approach using 122 single nucleotide polymorphisms (SNPs) in stage 1 identified a family-based assocn. (n = 500) between several tagSNPs located in the ATPase, Ca2+ transporting, cardiac muscle, slow twitch 2 (ATP2A2; rs3026468), the NUAK family, SNF1-like kinase, 1 (NUAK1: rs10861553 and rs3741886), and the protein phosphatase 1, catalytic subunit, gamma isoform (PPP1CC: rs1050587 and rs7901769) genes and knee torque prodn. (P values up to 0.00092).  In stage 2, family-based assocn. tests on addnl. putatively functional SNPs (e.g., exonic SNPs, SNPs in transcription factor binding sites or in conserved regions) in an enlarged sample (n = 536; 464 individuals overlap with stage 1) did not identify addnl. assocns. with muscle strength characteristics.  Further in-depth analyses will be necessary to elucidate the exact role of ATP2A2, PPP1CC, and NUAK1 in muscle strength and to find out which functional polymorphisms are at the base of the interindividual strength differences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUN-Jxspb3p7Vg90H21EOLACvtfcHk0liST1sgeC0U2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFGrtbnO&md5=012ed48ec690f376c9987fe283a7b8d1</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1152%2Fphysiolgenomics.00200.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysiolgenomics.00200.2010%26sid%3Dliteratum%253Aachs%26aulast%3DWindelinckx%26aufirst%3DA.%26aulast%3Dde%2BMars%26aufirst%3DG.%26aulast%3DHuygens%26aufirst%3DW.%26aulast%3DPeeters%26aufirst%3DM.%2BW.%26aulast%3DVincent%26aufirst%3DB.%26aulast%3DWijmenga%26aufirst%3DC.%26aulast%3DLambrechts%26aufirst%3DD.%26aulast%3DAerssens%26aufirst%3DJ.%26aulast%3DVlietinck%26aufirst%3DR.%26aulast%3DBeunen%26aufirst%3DG.%26aulast%3DThomis%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520and%2520Prioritization%2520of%2520NUAK1%2520and%2520PPP1CC%2520as%2520Positional%2520Candidate%2520Loci%2520for%2520Skeletal%2520Muscle%2520Strength%2520Phenotypes%26jtitle%3DPhysiol.%2520Genomics%26date%3D2011%26volume%3D43%26spage%3D981%26epage%3D992%26doi%3D10.1152%2Fphysiolgenomics.00200.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lasagna-Reeves, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Haro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousseaux, M. W.C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Ramahi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafar-Nejad, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilanova-Velez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">See, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitschke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troncoso, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbrook, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, H. Y.</span></span> <span> </span><span class="NLM_article-title">Reduction of Nuak1 Decreases Tau and Reverses Phenotypes in a Tauopathy Mouse Model</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2016.09.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.neuron.2016.09.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=27720485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1CltrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2016&pages=407-418&author=C.+A.+Lasagna-Reevesauthor=M.+de+Haroauthor=S.+Haoauthor=J.+Parkauthor=M.+W.C.+Rousseauxauthor=I.+Al-Ramahiauthor=P.+Jafar-Nejadauthor=L.+Vilanova-Velezauthor=L.+Seeauthor=A.+De+Maioauthor=L.+Nitschkeauthor=Z.+Wuauthor=J.+C.+Troncosoauthor=T.+F.+Westbrookauthor=J.+Tangauthor=J.+Botasauthor=H.+Y.+Zoghbi&title=Reduction+of+Nuak1+Decreases+Tau+and+Reverses+Phenotypes+in+a+Tauopathy+Mouse+Model&doi=10.1016%2Fj.neuron.2016.09.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of Nuak1 Decreases Tau and Reverses Phenotypes in a Tauopathy Mouse Model</span></div><div class="casAuthors">Lasagna-Reeves, Cristian A.; de Haro, Maria; Hao, Shuang; Park, Jeehye; Rousseaux, Maxime W. C.; Al-Ramahi, Ismael; Jafar-Nejad, Paymaan; Vilanova-Velez, Luis; See, Lauren; De Maio, Antonia; Nitschke, Larissa; Wu, Zhenyu; Troncoso, Juan C.; Westbrook, Thomas F.; Tang, Jianrong; Botas, Juan; Zoghbi, Huda Y.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">407-418</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Many neurodegenerative proteinopathies share a common pathogenic mechanism: the abnormal accumulation of disease-related proteins.  As growing evidence indicates that reducing the steady-state levels of disease-causing proteins mitigates neurodegeneration in animal models, we developed a strategy to screen for genes that decrease the levels of tau, whose accumulation contributes to the pathol. of both Alzheimer disease (AD) and progressive supranuclear palsy (PSP).  Integrating parallel cell-based and Drosophila genetic screens, we discovered that tau levels are regulated by Nuak1, an AMPK-related kinase.  Nuak1 stabilizes tau by phosphorylation specifically at Ser356.  Inhibition of Nuak1 in fruit flies suppressed neurodegeneration in tau-expressing Drosophila, and Nuak1 haploinsufficiency rescued the phenotypes of a tauopathy mouse model.  These results demonstrate that decreasing total tau levels is a valid strategy for mitigating tau-related neurodegeneration and reveal Nuak1 to be a novel therapeutic entry point for tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-pG3UQBaku7Vg90H21EOLACvtfcHk0liST1sgeC0U2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1CltrfN&md5=b0feedddbe769c972974036876f8f6bf</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2016.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2016.09.022%26sid%3Dliteratum%253Aachs%26aulast%3DLasagna-Reeves%26aufirst%3DC.%2BA.%26aulast%3Dde%2BHaro%26aufirst%3DM.%26aulast%3DHao%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DRousseaux%26aufirst%3DM.%2BW.C.%26aulast%3DAl-Ramahi%26aufirst%3DI.%26aulast%3DJafar-Nejad%26aufirst%3DP.%26aulast%3DVilanova-Velez%26aufirst%3DL.%26aulast%3DSee%26aufirst%3DL.%26aulast%3DDe%2BMaio%26aufirst%3DA.%26aulast%3DNitschke%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DTroncoso%26aufirst%3DJ.%2BC.%26aulast%3DWestbrook%26aufirst%3DT.%2BF.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DBotas%26aufirst%3DJ.%26aulast%3DZoghbi%26aufirst%3DH.%2BY.%26atitle%3DReduction%2520of%2520Nuak1%2520Decreases%2520Tau%2520and%2520Reverses%2520Phenotypes%2520in%2520a%2520Tauopathy%2520Mouse%2520Model%26jtitle%3DNeuron%26date%3D2016%26volume%3D92%26spage%3D407%26epage%3D418%26doi%3D10.1016%2Fj.neuron.2016.09.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kusakai, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochiai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esumi, H.</span></span> <span> </span><span class="NLM_article-title">ARK5 Expression in Colorectal Cancer and Its Implications for Tumor Progression</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">987</span>– <span class="NLM_lpage">995</span>, <span class="refDoi"> DOI: 10.1016/S0002-9440(10)63186-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2FS0002-9440%2810%2963186-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=14982852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitl2jt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2004&pages=987-995&author=G.+I.+Kusakaiauthor=A.+Suzukiauthor=T.+Oguraauthor=S.+Miyamotoauthor=A.+Ochiaiauthor=M.+Kaminishiauthor=H.+Esumi&title=ARK5+Expression+in+Colorectal+Cancer+and+Its+Implications+for+Tumor+Progression&doi=10.1016%2FS0002-9440%2810%2963186-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">ARK5 expression in colorectal cancer and its implications for tumor progression</span></div><div class="casAuthors">Kusakai, Gen-ichi; Suzuki, Atsushi; Ogura, Tsutomu; Miyamoto, Sin'ichi; Ochiai, Atsushi; Kaminishi, Michio; Esumi, Hiroyasu</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">987-995</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">A novel member of the human AMPK family, ARK5, was recently discovered to be a key mol. in mediating cancer cell migration activity in human pancreas cancer cell line PANC-1, and its activation was found to be induced by Akt-dependent phosphorylation at Ser 600.  DNA array anal. with 241 paired cDNAs from 13 different types of tumors and corresponding normal tissues derived from cancer patients revealed ARK5 overexpression in the samples of colorectal cancer.  ARK5 expression was measured and an in vitro invasion assay was performed in 6 human colorectal cancer cell lines, WiDr, HCT-15, DLD-1, SW620, LoVo, and SW480, and since high invasion activity was concordant with higher ARK5 expression, ARK5 expression was examd. in relation to tumor progression and metastatic activity in clin. samples.  In 56 clin. samples of primary colorectal cancers and their liver metastases, higher ARK5 expression was obsd. in the samples from more advanced cases, and much higher expression was obsd. in the liver metastases.  In situ hybridization anal. showed ARK5 overexpression in tumor cells.  Based on these findings, the authors propose that ARK5 overexpression is involved in tumor progression of colon cancer clin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDUbZD-Ft3Q7Vg90H21EOLACvtfcHk0liST1sgeC0U2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitl2jt7g%253D&md5=428847d8dee834b18407dbc722144f44</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2963186-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252963186-0%26sid%3Dliteratum%253Aachs%26aulast%3DKusakai%26aufirst%3DG.%2BI.%26aulast%3DSuzuki%26aufirst%3DA.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DS.%26aulast%3DOchiai%26aufirst%3DA.%26aulast%3DKaminishi%26aufirst%3DM.%26aulast%3DEsumi%26aufirst%3DH.%26atitle%3DARK5%2520Expression%2520in%2520Colorectal%2520Cancer%2520and%2520Its%2520Implications%2520for%2520Tumor%2520Progression%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2004%26volume%3D164%26spage%3D987%26epage%3D995%26doi%3D10.1016%2FS0002-9440%2810%2963186-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Port, J. L. F.</span></span> <i>Investigating the Therapeutic Potential of NUAK1 for the Treatment of Colorectal Cancer</i>. <span class="NLM_publisher-name">University of Glasgow</span>, Ph.D. Thesis, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+L.+F.+Port&title=Investigating+the+Therapeutic+Potential+of+NUAK1+for+the+Treatment+of+Colorectal+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPort%26aufirst%3DJ.%2BL.%2BF.%26jtitle%3DInvestigating%2520the%2520Therapeutic%2520Potential%2520of%2520NUAK1%2520for%2520the%2520Treatment%2520of%2520Colorectal%2520Cancer%26pub%3DUniversity%2520of%2520Glasgow%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, X.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, R.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.-C.</span></span> <span> </span><span class="NLM_article-title">ARK5 Is Associated with the Invasive and Metastatic Potential of Human Breast Cancer Cells</span>. <i>J. Cancer Res. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1007/s00432-011-1102-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1007%2Fs00432-011-1102-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22105900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XpslOlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2012&pages=247-254&author=X.-Z.+Changauthor=J.+Yuauthor=H.-Y.+Liuauthor=R.-H.+Dongauthor=X.-C.+Cao&title=ARK5+Is+Associated+with+the+Invasive+and+Metastatic+Potential+of+Human+Breast+Cancer+Cells&doi=10.1007%2Fs00432-011-1102-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">ARK5 is associated with the invasive and metastatic potential of human breast cancer cells</span></div><div class="casAuthors">Chang, Xin-Zhong; Yu, Jie; Liu, Hai-Yin; Dong, Rui-Hua; Cao, Xu-Chen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Research and Clinical Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-254</span>CODEN:
                <span class="NLM_cas:coden">JCROD7</span>;
        ISSN:<span class="NLM_cas:issn">0171-5216</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The aim was to investigate the effects of Akt/ARK5 pathways on the metastatic potential of human breast cancer cells.  The human ARK5 gene was transfected into MDA-MB-231 cells.  Effects of ARK5 on MDA-MB-231 cells were investigated in vitro.  The tumorigenicity and spontaneously metastatic capability regulated by ARK5 were detd. using an orthotopic xenograft tumor model.  ARK5 enhanced the invasive and metastatic potential of MDA-MB-231 cells under regulation by Akt.  The enhancement was assocd. with increasing MMP-2, MMP-9, and MT1-MMP expression.  The results were further demonstrated by RNA interference expt.  In an in vivo study, we also demonstrated that ARK5-transfected breast cancer cells grew faster and had more pulmonary metastases than its parental counterparts.  ARK5 led to a more invasive phenotype and metastatic potential in human breast cancer dependent on Akt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWDPURHxop5bVg90H21EOLACvtfcHk0lhzNouUWdmZkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpslOlsw%253D%253D&md5=7cb1b5e0f6d5ae13656f76d81f3df423</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1007%2Fs00432-011-1102-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00432-011-1102-1%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DX.-Z.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.-Y.%26aulast%3DDong%26aufirst%3DR.-H.%26aulast%3DCao%26aufirst%3DX.-C.%26atitle%3DARK5%2520Is%2520Associated%2520with%2520the%2520Invasive%2520and%2520Metastatic%2520Potential%2520of%2520Human%2520Breast%2520Cancer%2520Cells%26jtitle%3DJ.%2520Cancer%2520Res.%2520Clin.%2520Oncol.%26date%3D2012%26volume%3D138%26spage%3D247%26epage%3D254%26doi%3D10.1007%2Fs00432-011-1102-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.-R.</span></span> <span> </span><span class="NLM_article-title">Activation of ARK5/MiR-1181/HOXA10 Axis Promotes Epithelial-Mesenchymal Transition in Ovarian Cancer</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1193</span>– <span class="NLM_lpage">1202</span>, <span class="refDoi"> DOI: 10.3892/or.2015.4113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.3892%2For.2015.4113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26151663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=1193-1202&author=H.-Y.+Zhangauthor=J.-H.+Liauthor=G.+Liauthor=S.-R.+Wang&title=Activation+of+ARK5%2FMiR-1181%2FHOXA10+Axis+Promotes+Epithelial-Mesenchymal+Transition+in+Ovarian+Cancer&doi=10.3892%2For.2015.4113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of ARK5/miR-1181/HOXA10 axis promotes epithelial-mesenchymal transition in ovarian cancer</span></div><div class="casAuthors">Zhang, Hai-Yan; Li, Jian-Hua; Li, Guang; Wang, Su-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1193-1202</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1791-2431</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Epithelial ovarian cancer (EOC) is the sixth most common cancer in females worldwide and, although advances have been made in the detection, diagnosis and therapies for EOC, it remains the most lethal gynecol. malignancy in advanced countries.  Nevertheless, relatively little is known concerning the mol. events that lead to the development of this highly aggressive disease.  Elucidating the mol. mechanism involved in this disease may prove useful to understand the pathogenesis and progression of the disease, and to identify new targets for effective therapies.  In the present study, we examd. the role of ARK5 in ovarian cancer and normal matched tissues using western blot anal. and migration and invasion, and wound-healing assays.  The results showed that ARK5 was upregulated in ovarian cancer tissues, compared with adjacent normal tissues.  Moreover, it promoted epithelial-mesenchymal transition (EMT) and inhibited miR-1181 expression in ovarian cancer cells.  Subsequent investigations showed that miR-1181 promoted mesenchymal-epithelial transition (MET) in ovarian cancer cells.  Downstream target genes of miR-1181 were searched, and it was identified that miR-1181 degraded HOXA10 by targeting its 3' untranslated region (3'UTR) in ovarian cancer cells.  The results confirmed that HOXA10 promoted EMT in ovarian cancer cells.  Thus, activation of the ARK5/miR-1181/HOXA10 axis may be pos. assocd. with EMT in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5JfPtn9dt3LVg90H21EOLACvtfcHk0lhzNouUWdmZkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSltQ%253D%253D&md5=9acf4208e27ec4d9e085f479374e1cfa</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.3892%2For.2015.4113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2015.4113%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-Y.%26aulast%3DLi%26aufirst%3DJ.-H.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DS.-R.%26atitle%3DActivation%2520of%2520ARK5%252FMiR-1181%252FHOXA10%2520Axis%2520Promotes%2520Epithelial-Mesenchymal%2520Transition%2520in%2520Ovarian%2520Cancer%26jtitle%3DOncol.%2520Rep.%26date%3D2015%26volume%3D34%26spage%3D1193%26epage%3D1202%26doi%3D10.3892%2For.2015.4113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span> <span> </span><span class="NLM_article-title">Inhibition of AMPK-Related Kinase 5 (ARK5) Enhances Cisplatin Cytotoxicity in Non-Small Cell Lung Cancer Cells through Regulation of Epithelial-Mesenchymal Transition</span>. <i>Am. J. Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1708</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=28469776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1KqsLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1708&author=M.+Liauthor=C.+Zhengauthor=H.+Xuauthor=W.+Heauthor=Y.+Ruanauthor=J.+Maauthor=J.+Zhengauthor=C.+Yeauthor=W.+Li&title=Inhibition+of+AMPK-Related+Kinase+5+%28ARK5%29+Enhances+Cisplatin+Cytotoxicity+in+Non-Small+Cell+Lung+Cancer+Cells+through+Regulation+of+Epithelial-Mesenchymal+Transition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of AMPK-related kinase 5 (ARK5) enhances cisplatin cytotoxicity in non-small cell lung cancer cells through regulation of epithelial-mesenchymal transition</span></div><div class="casAuthors">Li, Minghui; Zheng, Chengfei; Xu, Hongfei; He, Wei; Ruan, Yongchun; Ma, Jianyong; Zheng, Junnan; Ye, Chengmeng; Li, Weidong</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Translational Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1708-1719</span>CODEN:
                <span class="NLM_cas:coden">AJTRA7</span>;
        ISSN:<span class="NLM_cas:issn">1943-8141</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Lung cancer incidence and mortality rates are amongst the highest of all malignant tumors worldwide.  ARK5 is a member of the human AMP-activated protein kinase (AMPK) family which is implicated in tumor survival and progression.  The current study was designed to explore the role of ARK5 in resistance of non-small cell lung cancer (NSCLC) to cisplatin.  We studied the sensitivity of two NSCLC cell lines, NCI-H1229 and A549, to cisplatin by using proliferation and cell viability assays.  We then examd. expression of ARK5, Twist, and the epithelial to mesenchymal transition (EMT) biomarkers, E-cadherin and Vimentin, by Western blot and immunofluorescence.  We found that ARK5 downregulation significantly increased the cisplatin chemosensitivity of NSCLC cells, and that NCI-H1299 cells, which express high levels of ARK5 and possess a mesenchymal phenotype, were more resistant to cisplatin than A549 cells, which show low expression ARK5.  Furthermore, siRNA-mediated silencing of ARK5 resulted in altered EMT patterns in NSCLC cells.  These data support a role for ARK5 in regulating EMT in NSCLC cells.  Together, our findings suggest that ARK5 is a potential drug target for combating drug resistance and regulating EMT in NSCLC cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYs7DlKGZmD7Vg90H21EOLACvtfcHk0lhzNouUWdmZkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1KqsLjE&md5=48081e62bcafb95747bdcff0da7e56c6</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DRuan%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DW.%26atitle%3DInhibition%2520of%2520AMPK-Related%2520Kinase%25205%2520%2528ARK5%2529%2520Enhances%2520Cisplatin%2520Cytotoxicity%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520Cells%2520through%2520Regulation%2520of%2520Epithelial-Mesenchymal%2520Transition%26jtitle%3DAm.%2520J.%2520Transl.%2520Res.%26date%3D2017%26volume%3D9%26spage%3D1708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, T.</span></span> <span> </span><span class="NLM_article-title">ARK5 Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Epithelial-Mesenchymal Transition</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>377</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2016.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.canlet.2016.04.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=27126361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVOmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2016&pages=140-148&author=T.+Xuauthor=J.+Zhangauthor=W.+Chenauthor=S.+Panauthor=X.+Zhiauthor=L.+Wenauthor=Y.+Zhouauthor=B.+W.+Chenauthor=J.+Qiuauthor=Y.+Zhangauthor=Q.+Yangauthor=X.+Fengauthor=X.+Baiauthor=T.+Liang&title=ARK5+Promotes+Doxorubicin+Resistance+in+Hepatocellular+Carcinoma+via+Epithelial-Mesenchymal+Transition&doi=10.1016%2Fj.canlet.2016.04.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">ARK5 promotes doxorubicin resistance in hepatocellular carcinoma via epithelial-mesenchymal transition</span></div><div class="casAuthors">Xu, Tao; Zhang, Jian; Chen, Wei; Pan, Shengjing; Zhi, Xiao; Wen, Liang; Zhou, Yue; Chen, Bryan Wei; Qiu, Junyu; Zhang, Yun; Yang, Qi; Feng, Xinhua; Bai, Xueli; Liang, Tingbo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-148</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">AMP-activated protein kinase family member 5 (ARK5) overexpression has been reported in many human cancers, and ARK5 is assocd. with poor prognosis in hepatocellular carcinoma (HCC).  However, whether ARK5 is involved in HCC chemoresistance is unclear.  The present study aimed to investigate the role of ARK5 in HCC chemoresistance and the underlying mechanism.  In this study, we found that SNU387 and SNU449 HCC cell lines overexpressing ARK5 displayed low doxorubicin sensitivity compared to Huh7 and Hep3B HCC cell lines with ARK5 low-expression.  And knockdown of ARK5 increased the doxorubicin sensitivity in all HCC cell lines in the manner of inhibiting cell proliferation.  Western blotting and immunofluorescence both showed that ARK5 knockdown upregulated E-cadherin and downregulated vimentin, which was consistent with the knockdown of TWIST, indicating ARK5 was involved in epithelial-mesenchymal transition (EMT).  Moreover, suppressing ARK5 by siRNA restored E-cadherin and vimentin expression induced by doxorubicin treatment or hypoxia culture.  Our results indicated ARK5 confers doxorubicin resistance in HCC via inducing EMT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCbePFNCwvLrVg90H21EOLACvtfcHk0liEr56gCwwfvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVOmtr8%253D&md5=c217d228a652420ebc780ce7fc76d56f</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2016.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2016.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DZhi%26aufirst%3DX.%26aulast%3DWen%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DB.%2BW.%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DT.%26atitle%3DARK5%2520Promotes%2520Doxorubicin%2520Resistance%2520in%2520Hepatocellular%2520Carcinoma%2520via%2520Epithelial-Mesenchymal%2520Transition%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D377%26spage%3D140%26epage%3D148%26doi%3D10.1016%2Fj.canlet.2016.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, D.</span></span> <span> </span><span class="NLM_article-title">MiR-96 Functions as a Tumor Suppressor Gene by Targeting NUAK1 in Pancreatic Cancer</span>. <i>Int. J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1599</span>– <span class="NLM_lpage">1605</span>, <span class="refDoi"> DOI: 10.3892/ijmm.2014.1940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.3892%2Fijmm.2014.1940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=25242509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislCksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=1599-1605&author=X.+Huangauthor=W.+Lvauthor=J.+Zhangauthor=D.+Lu&title=MiR-96+Functions+as+a+Tumor+Suppressor+Gene+by+Targeting+NUAK1+in+Pancreatic+Cancer&doi=10.3892%2Fijmm.2014.1940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">miR-96 functions as a tumor suppressor gene by targeting NUAK1 in pancreatic cancer</span></div><div class="casAuthors">Huang, Xuan; Lv, Wei; Zhang, Jian-Hua; Lu, Da-Lin</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1599-1605</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">MicroRNA-96 (miR-96) is known to be down-regulated in pancreatic cancer.  The overexpression of miR-96 in MIA PaCa-2 pancreatic cancer cells has been shown to inhibit cell proliferation, migration and invasion; however, the mechanisms involved have not yet been fully elucidated.  Novel (nua) kinase family 1 (NUAK1) functions as an oncogene in non-small cell lung cancer (NSCLC), melanoma, glioma, breast cancer, hepatocellular carcinoma and pancreatic cancer.  In this study, firstly, we demonstrate that NUAK1 expression is specifically upregulated in pancreatic cancer and that it promotes the proliferation, migration and invasion of MIA PaCa-2 pancreatic cancer cells.  Secondly, we performed an anal. of potential microRNA (miRNA) target sites using three commonly used prediction algorithms: miRanda, TargetScan and PicTar.  All three algorithms predicted that miR-96 targets the 3' untranslated region (3' UTR) of NUAK1.  Further expts. confirmed this prediction, namely that miR-96 suppresses the expression of NUAK1 by targeting its 3' UTR.  Finally, we demonstrate that the introduction of NUAK1 cDNA lacking predicted sites of the 3' UTR abrogates miR-96 cellular function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuwd_IWfG51bVg90H21EOLACvtfcHk0liEr56gCwwfvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislCksA%253D%253D&md5=bab2232a47e5154c220541146d23a32b</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.3892%2Fijmm.2014.1940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.2014.1940%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DD.%26atitle%3DMiR-96%2520Functions%2520as%2520a%2520Tumor%2520Suppressor%2520Gene%2520by%2520Targeting%2520NUAK1%2520in%2520Pancreatic%2520Cancer%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2014%26volume%3D34%26spage%3D1599%26epage%3D1605%26doi%3D10.3892%2Fijmm.2014.1940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, F.</span></span> <span> </span><span class="NLM_article-title">MIR-145 Functions as a Tumor Suppressor Targeting NUAK1 in Human Intrahepatic Cholangiocarcinoma</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>465</i></span>,  <span class="NLM_fpage">262</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2015.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.bbrc.2015.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26255969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCis77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2015&pages=262-269&author=X.+Xiongauthor=D.+Sunauthor=H.+Chaiauthor=W.+Shanauthor=Y.+Yuauthor=L.+Puauthor=F.+Cheng&title=MIR-145+Functions+as+a+Tumor+Suppressor+Targeting+NUAK1+in+Human+Intrahepatic+Cholangiocarcinoma&doi=10.1016%2Fj.bbrc.2015.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma</span></div><div class="casAuthors">Xiong, Xinkui; Sun, Daoyi; Chai, Hao; Shan, Wengang; Yu, Yue; Pu, Liyong; Cheng, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">262-269</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The dysregulation of micro (mi)RNAs is assocd. with cancer development.  The miRNA miR-145 is downregulated in intrahepatic cholangiocarcinoma (ICC); however, its precise role in tumor progression has not yet been elucidated.  Novel (nua) kinase family (NUAK)1 functions as an oncogene in various cancers and is a putative target of miR-145 regulation.  In this study, we investigated the regulation of NUAK1 by miR-145 in ICC.  We found that miR-145 level was significantly decreased in ICC tissue and cell lines, which corresponded with an increase in NUAK1 expression.  NUAK1 was found to be a direct target of miR-145 regulation.  The overexpression of miR-145 in ICC cell lines inhibited proliferation, growth, and invasion by suppressing NUAK1 expression, which was assocd. with a decrease in Akt signaling and matrix metalloproteinase protein expression.  Similar results were obsd. by inhibiting NUAK1 expression.  These results demonstrate that miR-145 can prevent ICC progression by targeting NUAK1 and its downstream effectors, and can therefore be useful for clin. diagnosis and targeted therapy of ICC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnV3igieYepLVg90H21EOLACvtfcHk0liEr56gCwwfvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCis77L&md5=b98b0eaadfb6662ef58790db65b14bf5</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2015.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2015.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DChai%26aufirst%3DH.%26aulast%3DShan%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DPu%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DF.%26atitle%3DMIR-145%2520Functions%2520as%2520a%2520Tumor%2520Suppressor%2520Targeting%2520NUAK1%2520in%2520Human%2520Intrahepatic%2520Cholangiocarcinoma%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2015%26volume%3D465%26spage%3D262%26epage%3D269%26doi%3D10.1016%2Fj.bbrc.2015.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunematsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasahira, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuniyasu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imoto, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abiko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukunaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takata, T.</span></span> <span> </span><span class="NLM_article-title">MicroRNA-203 Suppresses Invasion and Epithelial-Mesenchymal Transition Induction via Targeting NUAK1 in Head and Neck Cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">8223</span>– <span class="NLM_lpage">8239</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.6972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.18632%2Foncotarget.6972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26882562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BC28jht1yqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=8223-8239&author=M.+Obayashiauthor=M.+Yoshidaauthor=T.+Tsunematsuauthor=I.+Ogawaauthor=T.+Sasahiraauthor=H.+Kuniyasuauthor=I.+Imotoauthor=Y.+Abikoauthor=D.+Xuauthor=S.+Fukunagaauthor=H.+Taharaauthor=Y.+Kudoauthor=T.+Nagaoauthor=T.+Takata&title=MicroRNA-203+Suppresses+Invasion+and+Epithelial-Mesenchymal+Transition+Induction+via+Targeting+NUAK1+in+Head+and+Neck+Cancer&doi=10.18632%2Foncotarget.6972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer</span></div><div class="casAuthors">Obayashi Mariko; Yoshida Maki; Takata Takashi; Yoshida Maki; Nagao Toshitaka; Tsunematsu Takaaki; Kudo Yasusei; Ogawa Ikuko; Sasahira Tomonori; Kuniyasu Hiroki; Imoto Issei; Abiko Yoshimitsu; Xu Dan; Fukunaga Saori; Tahara Hidetoshi; Xu Dan</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">8223-39</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Head and neck squamous cell carcinoma (HNSCC) has a high capacity for invasion.  To identify microRNAs (miRNAs) that regulate HNSCC invasion, we compared miRNA expression profiles between a parent HNSCC cell line and a highly invasive clone.  The miR-200 family and miR-203 were downregulated in the clone.  Here we focused on the role of miR-203 in invasion and epithelial-mesenchymal transition (EMT) induction in HNSCC. miR-203 was downregulated during EMT induction.  Moreover, ectopic overexpression of miR-203 suppressed the invasion and induced mesenchymal-epithelial transition (MET) in HNSCC cells.  Interestingly, we identified NUAK family SNF1-like kinase 1 (NUAK1) as a novel target gene of miR-203 by cyclopedic analysis using anti-Ago2 antibody.  Increased expression of NUAK1 was observed during EMT induction, and ectopic expression of miR-203 delayed EMT induction by suppressing NUAK1 expression.  Moreover, NUAK1 overexpression promoted the invasion of HNSCC cells.  Importantly, NUAK1 expression was well correlated with poor differentiation, invasiveness, and lymph node metastasis in HNSCC cases.  Overall, miR-203 has a tumor-suppressing role in invasion and EMT induction by targeting NUAK1 in HNSCC, suggesting miR-203 as a potential new diagnostic and therapeutic target for the treatment of HNSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSTbbS-qxbrUloaUqgkFHkfW6udTcc2eZE5tsJiqkQPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jht1yqtw%253D%253D&md5=61b7abfb81c4b1037ec51d2692b2c3bc</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.6972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.6972%26sid%3Dliteratum%253Aachs%26aulast%3DObayashi%26aufirst%3DM.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DTsunematsu%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DI.%26aulast%3DSasahira%26aufirst%3DT.%26aulast%3DKuniyasu%26aufirst%3DH.%26aulast%3DImoto%26aufirst%3DI.%26aulast%3DAbiko%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DFukunaga%26aufirst%3DS.%26aulast%3DTahara%26aufirst%3DH.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DNagao%26aufirst%3DT.%26aulast%3DTakata%26aufirst%3DT.%26atitle%3DMicroRNA-203%2520Suppresses%2520Invasion%2520and%2520Epithelial-Mesenchymal%2520Transition%2520Induction%2520via%2520Targeting%2520NUAK1%2520in%2520Head%2520and%2520Neck%2520Cancer%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D8223%26epage%3D8239%26doi%3D10.18632%2Foncotarget.6972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">LncRNA SNHG1 Functions as a CeRNA to Antagonize the Effect of MiR-145a-5p on the Down-regulation of NUAK1 in Nasopharyngeal Carcinoma Cell</span>. <i>J. Cell. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2351</span>– <span class="NLM_lpage">2361</span>, <span class="refDoi"> DOI: 10.1111/jcmm.13497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1111%2Fjcmm.13497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=29575772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtlWhtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2019&pages=2351-2361&author=X.+Lanauthor=X.+Liu&title=LncRNA+SNHG1+Functions+as+a+CeRNA+to+Antagonize+the+Effect+of+MiR-145a-5p+on+the+Down-regulation+of+NUAK1+in+Nasopharyngeal+Carcinoma+Cell&doi=10.1111%2Fjcmm.13497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">LncRNA SNHG1 functions as a ceRNA to antagonize the effect of miR-145a-5p on the down-regulation of NUAK1 in nasopharyngeal carcinoma cell</span></div><div class="casAuthors">Lan, Xintang; Liu, Xiuling</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2351-2361</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-4934</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">How lncRNA SNHG1 influences the aggressiveness of nasopharyngeal carcinoma cells as well as the underlying mechanism was studied.  Transfection was conducted to construct nasopharyngeal carcinoma cells with different expressions of SNHG1, miR-145-5p and NUAK1.  Dual-luciferase reporter assay was performed to explore the relationship between SNHG1, miR-145-5p and NUAK1.  Wound-healing assay and transwell invasion expts. were employed to study changes in cell migration capacity and cell invasion, resp.  Tumor xenografts were performed to observe lung metastasis of nude mice inoculated with transfected CNE cells.  SNHG1 is highly expressed in nasopharyngeal carcinoma tissues and in cell lines.  Down-regulation of SNHG1 facilitated the expression of miR-145-5p and further suppressed the level of NAUK1 in CNE and HNE-1 cells.  Silencing of SNHG1, up-regulation of miR-145-5p and inhibition of NAUK1 by relative transfection all attenuated the aggressiveness of CNE and HNE-1 cells both in vivo and in vitro.  Moreover, the impaired cell migration and invasion by SNHG1 siRNA could be rescued by cotransfection of miR-145-5p in CNE and HNE-1 cells.  LncRNA SNHG1 promoted the expression of NUAK1 by down-regulating miR-145-5p and thus promoted the aggressiveness of nasopharyngeal carcinoma cells through AKT signalling pathway and induced epithelial-mesenchymal transition (EMT).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozgQUUlW4ITbVg90H21EOLACvtfcHk0lg9_63wNli9HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtlWhtbg%253D&md5=62fbd273bfeec3a3e3934911222453ff</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1111%2Fjcmm.13497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjcmm.13497%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DLncRNA%2520SNHG1%2520Functions%2520as%2520a%2520CeRNA%2520to%2520Antagonize%2520the%2520Effect%2520of%2520MiR-145a-5p%2520on%2520the%2520Down-regulation%2520of%2520NUAK1%2520in%2520Nasopharyngeal%2520Carcinoma%2520Cell%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2019%26volume%3D23%26spage%3D2351%26epage%3D2361%26doi%3D10.1111%2Fjcmm.13497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span> <span> </span><span class="NLM_article-title">Expression Level of NUAK1 in Human Nasopharyngeal Carcinoma and Its Prognostic Significance</span>. <i>Eur. Arch. Oto-Rhino-Laryngology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">2563</span>– <span class="NLM_lpage">2573</span>, <span class="refDoi"> DOI: 10.1007/s00405-018-5095-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1007%2Fs00405-018-5095-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=30121842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BB3c7psFWjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2018&pages=2563-2573&author=J.+Liuauthor=G.+Tangauthor=H.+Huangauthor=H.+Liauthor=P.+Zhangauthor=L.+Xu&title=Expression+Level+of+NUAK1+in+Human+Nasopharyngeal+Carcinoma+and+Its+Prognostic+Significance&doi=10.1007%2Fs00405-018-5095-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Expression level of NUAK1 in human nasopharyngeal carcinoma and its prognostic significance</span></div><div class="casAuthors">Liu Jiaoyang; Tang Guoyan; Xu Lihua; Huang He; Li Huan; Zhang Peng; Xu Lihua</div><div class="citationInfo"><span class="NLM_cas:title">European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2563-2573</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Nasopharyngeal carcinoma (NPC) is notable for its high incidence rates in select geographic and ethnic populations, especially among Chinese and Malay populations in Southeastern Asia.  However, relevant biomarkers for the development and prognosis of NPC are not yet clear; therefore, discovering novel biomarkers will facilitate prediction of prognosis and development of targeted therapeutic tactics.  This study aims to quest the potential prognostic value of NUAK1 (a downstream member of Akt) in NPC.  METHODS:  Immunohistochemistry was performed to measure the expression of NUAK1 in paraffin-embedded NPC samples.  Statistical analysis, encompassing chi-square tests and Student's t test, was also employed to evaluate the association between the expression of NUAK1 and clinicopathologic features.  In addition, the survival analysis was used to detect the prognostic significance of NUAK1 in NPC.  RESULTS:  Excessive expression of NUAK1 was found in NPC tissues at mRNA levels.  Statistical analysis revealed a correlation of NUAK1 expression with maximum neck lymph node diameter (p = 0.025) and WHO histological type (p = 0.021).  Furthermore, according to survival analysis, there was clinical relevance between the upregulation of NUAK1 in NPC and DFS.  Subgroup analysis indicated that the expression of NUAK1 was strongly associated with DFS (p = 0.027) and OS (p = 0.026) duration in the patients of N1-3 tumors, but not in patients with N0 tumors.  The expression of NUAK1 was also strongly associated with OS (p = 0.044) and DFS (p = 0.007) in patients of late stage tumour (UICC3-5), but not in patients of early stage tumour (UICC1-2).  In addition, COX regression illustrated that N classification and NUAK1 expression were independent prognostic factors for disease-free survival.  CONCLUSION:  Our study postulated that NUAK1 is excessively expressed in NPC and may serve as a potential predictor of prognosis for NPC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvMHlyzNebeA5nADWVYHg1fW6udTcc2eZE5tsJiqkQPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7psFWjsQ%253D%253D&md5=0fd34df410e2160d64bb0d82bf5d2b0f</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1007%2Fs00405-018-5095-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00405-018-5095-0%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DL.%26atitle%3DExpression%2520Level%2520of%2520NUAK1%2520in%2520Human%2520Nasopharyngeal%2520Carcinoma%2520and%2520Its%2520Prognostic%2520Significance%26jtitle%3DEur.%2520Arch.%2520Oto-Rhino-Laryngology%26date%3D2018%26volume%3D275%26spage%3D2563%26epage%3D2573%26doi%3D10.1007%2Fs00405-018-5095-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span> <span> </span><span class="NLM_article-title">Upregulation of LncRNA SnoRNA Host Gene 6 Regulates NUAK Family SnF1-like Kinase-1 Expression by Competitively Binding MicroRNA-125b and Interacting with Snail1/2 in Bladder Cancer</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1002/jcb.27387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1002%2Fjcb.27387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=30168179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Wmt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2019&pages=357-367&author=C.+Wangauthor=W.+Taoauthor=S.+Niauthor=Q.+Chen&title=Upregulation+of+LncRNA+SnoRNA+Host+Gene+6+Regulates+NUAK+Family+SnF1-like+Kinase-1+Expression+by+Competitively+Binding+MicroRNA-125b+and+Interacting+with+Snail1%2F2+in+Bladder+Cancer&doi=10.1002%2Fjcb.27387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Upregulation of lncRNA snoRNA host gene 6 regulates NUAK family SnF1-like kinase-1 expression by competitively binding microRNA-125b and interacting with Snail1/2 in bladder cancer</span></div><div class="casAuthors">Wang, Chunyang; Tao, Weiyang; Ni, Shaobin; Chen, Qiyin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">357-367</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Backgrounds/aims : Numerous studies have reported that long noncoding RNAs (lncRNAs) play crit. roles in the development and progression of bladder cancer (BC).  LncRNA snoRNA host gene 6 (SNHG6) is ectopically expressed in tumor tissues of patients with BC and BC cell lines.  However, little is known about the mol. mechanism of SNHG6-mediated bladder urothelial carcinoma cell migration and invasion.  Methods : We detected the SNHG6 levels in human BC specimens and cell lines by quant. real-time polymerase chain reaction and Western blot, and investigated its role in BC using in vitro assays.  Results : We showed that overexpression of SNHG6 induced epithelial-mesenchymal transition (EMT) and promoted the migration and invasion capabilities of BC cells.  Mechanistically, SNHG6 induced EMT of BC cells by upregulating the expression levels of Snail1/2 and regulated BC cell migration and invasion by tumor suppressive hsa-miR-125b and its target gene NUAK Family Kinase 1 (NUAK1).  Furthermore, we found that SNHG6 was pos. correlated with Snail1/2 expression, and neg. correlated with hsa-miR-125b expression in BC specimens.  Further study showed that SNHG6 repressed hsa-miR-125b expression to upregulate Snail1/2.  Conversely, hsa-miR-125b knockdown augmented SNHG6 expression in BC cells.  Conclusion : Overall, our study demonstrated that SNHG6 promotes BC cell migration and invasion partly via the hsa-miR-125b/Snail1/2/NUAK1 pathway.  Therefore, SNHG6 may be a potential prognostic biomarker in BC, and targeting hsa-miR-125b/Snail1/2/NUAK1 axis may be a promising therapeutic approach for BC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_iOKRgiHibrVg90H21EOLACvtfcHk0lg8XTJyfE6lQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Wmt7fP&md5=267cd78dfebde61b8aeaa5b4f7be3627</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1002%2Fjcb.27387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.27387%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DNi%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DQ.%26atitle%3DUpregulation%2520of%2520LncRNA%2520SnoRNA%2520Host%2520Gene%25206%2520Regulates%2520NUAK%2520Family%2520SnF1-like%2520Kinase-1%2520Expression%2520by%2520Competitively%2520Binding%2520MicroRNA-125b%2520and%2520Interacting%2520with%2520Snail1%252F2%2520in%2520Bladder%2520Cancer%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2019%26volume%3D120%26spage%3D357%26epage%3D367%26doi%3D10.1002%2Fjcb.27387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span> <span> </span><span class="NLM_article-title">Knockdown of ARK5 Expression Suppresses Invasion and Metastasis of Gastric Cancer</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1025</span>– <span class="NLM_lpage">1036</span>, <span class="refDoi"> DOI: 10.1159/000478685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1159%2F000478685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=28662499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs12rs7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=1025-1036&author=D.+Chenauthor=G.+Liuauthor=N.+Xuauthor=X.+Youauthor=H.+Zhouauthor=X.+Zhaoauthor=Q.+Liu&title=Knockdown+of+ARK5+Expression+Suppresses+Invasion+and+Metastasis+of+Gastric+Cancer&doi=10.1159%2F000478685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Knockdown of ARK5 Expression Suppresses Invasion and Metastasis of Gastric Cancer</span></div><div class="casAuthors">Chen, Dehu; Liu, Guiyuan; Xu, Ning; You, Xiaolan; Zhou, Haihua; Zhao, Xiaojun; Liu, Qinghong</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1025-1036</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: Gastric cancer (GC) is a common and lethal malignancy, and AMP-activated protein kinase-related kinase 5 (ARK5) has been discovered to promote cancer metastasis in certain types of cancer.  In this study, we explored the role of ARK5 in GC invasion and metastasis.  Methods: ARK5 and epithelial-mesenchymal transition (EMT)-related markers were detd. by immunohistochem. and western blot in GC specimens.  Other methods including stably transfected against ARK5 into SGC7901 and AGS cells, western blot, migration and invasion assays in vitro and nude mice tumorigenicity in vivo were also employed.  Results: The results demonstrated that ARK5 expression was increased and pos. correlated with metastasis, EMT-related markers and poor prognosis in patients with GC.  Knockdown of ARK5 expression remarkably suppressed GC cells invasion and metastasis via regulating EMT, rather than proliferation in vitro and in vivo.  And knockdown of ARK5 expression in GC cells resulted in the down-regulation of the mTOR/p70S6k signals, Slug and SIP1.  Conclusion: The elevated ARK5 expression was closely assocd. with cancer metastasis and patient survival, and it seemed to function in GC cells migration and invasion via EMT alteration, together with the alteration of the mTOR/p70S6k signals, Slug and SIP1, thus providing a potential therapeutic target for GC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrneOQpYQJ-eLVg90H21EOLACvtfcHk0lg8XTJyfE6lQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs12rs7bE&md5=56ceba2a329a9d655bb1653a1487f3fb</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1159%2F000478685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000478685%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DN.%26aulast%3DYou%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DQ.%26atitle%3DKnockdown%2520of%2520ARK5%2520Expression%2520Suppresses%2520Invasion%2520and%2520Metastasis%2520of%2520Gastric%2520Cancer%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2017%26volume%3D42%26spage%3D1025%26epage%3D1036%26doi%3D10.1159%2F000478685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. C.</span></span> <span> </span><span class="NLM_article-title">Overexpression of NUAK1 Is Associated with Disease-Free Survival and Overall Survival in Patients with Gastric Cancer</span>. <i>Med. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">61</span>, <span class="refDoi"> DOI: 10.1007/s12032-014-0061-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1007%2Fs12032-014-0061-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=24943992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BC2cfjvFyhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=61&author=X.+T.+Yeauthor=A.+J.+Guoauthor=P.+F.+Yinauthor=X.+D.+Caoauthor=J.+C.+Chang&title=Overexpression+of+NUAK1+Is+Associated+with+Disease-Free+Survival+and+Overall+Survival+in+Patients+with+Gastric+Cancer&doi=10.1007%2Fs12032-014-0061-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of NUAK1 is associated with disease-free survival and overall survival in patients with gastric cancer</span></div><div class="casAuthors">Ye Xiao-tian; Guo Ai-jun; Yin Peng-fei; Cao Xian-dong; Chang Jia-cong</div><div class="citationInfo"><span class="NLM_cas:title">Medical oncology (Northwood, London, England)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">61</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Novel (nua) kinase family 1 (NUAK1) is a member of the human adenosine monophosphate-activated protein kinases family, which is overexpressed in multiple human malignancies and thought to be involved in tumor invasion and metastasis ability.  Our study is to investigate the association of NUAK1 expression with clinicopathological parameters and prognostic significance of patients with gastric cancer.  The expression patterns of the NUAK1 protein in 117 primary archival gastric cancer specimens and 46 adjacent normal epithelial tissues from patients were detected by immunohistochemistry assay.  Staining evaluation results were analyzed statistically in relation to various clinicopathological characters, recurrence-free survival and overall survival.  High level of NUAK1 expression was detected in gastric cancer, significantly more than in adjacent normal epithelial cells.  In gastric cancer, NUAK1 was positively correlated with depth of invasion, lymph node metastasis, pathological stage, surgical resection and histological differentiation.  However, no correlations between NUAK1 expression and patients' age, sex, tumor size, location, CA19-9 or CEA were detected.  The recurrence-free survival and overall survival were significantly shorter for patients with NUAK1 higher scores than those with NUAK1 lower scores.  Multivariate analysis identified NUAK1 was an independent prognostic factor for both recurrence-free survival and overall survival.  Our findings provided convincing evidence for NUAK1 overexpression, which was tightly associated with more aggressive tumor behavior and a poor prognosis, indicating that NUAK1 is a valuable molecular biomarker for gastric cancer progression.  It might also act as a promising target for both prognostic prediction and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcShV0-YwFOzpJ6KlWarZTAzfW6udTcc2eY0Ojg7xeT23bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfjvFyhtw%253D%253D&md5=73b9e8010dfdad1f17b90d2eab2e10d2</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1007%2Fs12032-014-0061-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12032-014-0061-1%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DX.%2BT.%26aulast%3DGuo%26aufirst%3DA.%2BJ.%26aulast%3DYin%26aufirst%3DP.%2BF.%26aulast%3DCao%26aufirst%3DX.%2BD.%26aulast%3DChang%26aufirst%3DJ.%2BC.%26atitle%3DOverexpression%2520of%2520NUAK1%2520Is%2520Associated%2520with%2520Disease-Free%2520Survival%2520and%2520Overall%2520Survival%2520in%2520Patients%2520with%2520Gastric%2520Cancer%26jtitle%3DMed.%2520Oncol.%26date%3D2014%26volume%3D31%26spage%3D61%26doi%3D10.1007%2Fs12032-014-0061-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Port, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthalagu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceteci, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteverde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruspig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalna, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neilson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brucoli, M.</span></span> <span> </span><span class="NLM_article-title">Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">632</span>– <span class="NLM_lpage">647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1158%2F2159-8290.CD-17-0533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=29500295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1cXos1SjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=632-647&author=J.+Portauthor=N.+Muthalaguauthor=M.+Rajaauthor=F.+Ceteciauthor=T.+Monteverdeauthor=B.+Kruspigauthor=A.+Hedleyauthor=G.+Kalnaauthor=S.+Lillaauthor=L.+Neilsonauthor=M.+Brucoli&title=Colorectal+Tumors+Require+NUAK1+for+Protection+from+Oxidative+Stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress</span></div><div class="casAuthors">Port, Jennifer; Muthalagu, Nathiya; Raja, Meera; Ceteci, Fatih; Monteverde, Tiziana; Kruspig, Bjorn; Hedley, Ann; Kalna, Gabriela; Lilla, Sergio; Neilson, Lisa; Brucoli, Martina; Gyuraszova, Katarina; Tait-Mulder, Jacqueline; Mezna, Mokdad; Svambaryte, Silvija; Bryson, Amy; Sumpton, David; McVie, Allan; Nixon, Colin; Drysdale, Martin; Esumi, Hiroyasu; Murray, Graeme I.; Sansom, Owen J.; Zanivan, Sara R.; Murphy, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">632-647</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Exploiting oxidative stress has recently emerged as a plausible strategy for treatment of human cancer, and antioxidant defenses are implicated in resistance to chemotherapy and radiotherapy.  Targeted suppression of antioxidant defenses could thus broadly improve therapeutic outcomes.  Here, we identify the AMPK-related kinase NUAK1 as a key component of the antioxidant stress response pathway and reveal a specific requirement for this role of NUAK1 in colorectal cancer.  We show that NUAK1 is activated by oxidative stress and that this activation is required to facilitate nuclear import of the antioxidant master regulator NRF2: Activation of NUAK1 coordinates PP1β inhibition with AKT activation in order to suppress GSK3β-dependent inhibition of NRF2 nuclear import.  Deletion of NUAK1 suppresses formation of colorectal tumors, whereas acute depletion of NUAK1 induces regression of preexisting autochthonous tumors.  Importantly, elevated expression of NUAK1 in human colorectal cancer is assocd. with more aggressive disease and reduced overall survival.  This work identifies NUAK1 as a key facilitator of the adaptive antioxidant response that is assocd. with aggressive disease and worse outcome in human colorectal cancer.  Our data suggest that transient NUAK1 inhibition may provide a safe and effective means for treatment of human colorectal cancer via disruption of intrinsic antioxidant defenses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro4vE7jlxJIbVg90H21EOLACvtfcHk0lhncU0PvhOzNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXos1SjtrY%253D&md5=9daed7a74b5f189cac705961ce406373</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-17-0533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-17-0533%26sid%3Dliteratum%253Aachs%26aulast%3DPort%26aufirst%3DJ.%26aulast%3DMuthalagu%26aufirst%3DN.%26aulast%3DRaja%26aufirst%3DM.%26aulast%3DCeteci%26aufirst%3DF.%26aulast%3DMonteverde%26aufirst%3DT.%26aulast%3DKruspig%26aufirst%3DB.%26aulast%3DHedley%26aufirst%3DA.%26aulast%3DKalna%26aufirst%3DG.%26aulast%3DLilla%26aufirst%3DS.%26aulast%3DNeilson%26aufirst%3DL.%26aulast%3DBrucoli%26aufirst%3DM.%26atitle%3DColorectal%2520Tumors%2520Require%2520NUAK1%2520for%2520Protection%2520from%2520Oxidative%2520Stress%26jtitle%3DCancer%2520Discovery%26date%3D2018%26volume%3D8%26spage%3D632%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carninci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasukawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katayama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frith, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravasi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenhard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, C.</span></span> <span> </span><span class="NLM_article-title">The Transcriptional Landscape of the Mammalian Genome</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>309</i></span>,  <span class="NLM_fpage">1559</span>– <span class="NLM_lpage">1563</span>, <span class="refDoi"> DOI: 10.1126/science.1112014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1126%2Fscience.1112014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=16141072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFWju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2005&pages=1559-1563&author=P.+Carninciauthor=T.+Kasukawaauthor=S.+Katayamaauthor=J.+Goughauthor=M.+C.+Frithauthor=N.+Maedaauthor=R.+Oyamaauthor=T.+Ravasiauthor=B.+Lenhardauthor=C.+Wells&title=The+Transcriptional+Landscape+of+the+Mammalian+Genome&doi=10.1126%2Fscience.1112014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">The transcriptional landscape of the mammalian genome</span></div><div class="casAuthors">Carninci, P.; Kasukawa, T.; Katayama, S.; Gough, J.; Frith, M. C.; Maeda, N.; Oyama, R.; Ravasi, T.; Lenhard, B.; Wells, C.; Kodzius, R.; Shimokawa, K.; Bajic, V. B.; Brenner, S. E.; Batalov, S.; Forrest, A. R. R.; Zavolan, M.; Davis, M. J.; Wilming, L. G.; Aidinis, V.; Allen, J. E.; Ambesi-Impiombato, A.; Apweiler, R.; Aturaliya, R. N.; Bailey, T. L.; Bansal, M.; Baxter, L.; Beisel, K. W.; Bersano, T.; Bono, H.; Chalk, A. M.; Chiu, K. P.; Choudhary, V.; Christoffels, A.; Clutterbuck, D. R.; Crowe, L.; Dalla, E.; Dalrymple, B. P.; de Bono, B.; Della Gatta, G.; di Bernardo, D.; Down, T.; Engstrom, P.; Fagiolini, M.; Faulkner, G.; Fletcher, C. F.; Fukushima, T.; Furuno, M.; Futaki, S.; Gariboldi, M.; Georgii-Hemming, P.; Gingeras, T. R.; Gojobori, Y.; Green, R. E.; Gustincich, S.; Harbers, M.; Hayashi, Y.; Hensch, T. K.; Hirokawa, N.; Hill, D.; Huminiecki, L.; Iacono, M.; Ikeo, K.; Iwama, A.; Ishikawa, T.; Jakt, M.; Kanapin, A.; Katoh, M.; Kawasawa, Y.; Kelso, J.; Kitamura, H.; Kitano, H.; Kollias, G.; Krishnan, S. P. T.; Kruger, A.; Kummerfeld, S. K.; Kurochkin, I. V.; Lareau, L. F.; Lazarevic, D.; Lipovich, L.; Liu, J.; Liuni, S.; McWilliam, S.; Mada Babu, M.; Madera, M.; Marchionni, L.; Matsuda, H.; Matsuzawa, S.; Miki, H.; Miyake, S.; Morris, K.; Mottagui-Tabar, S.; Mulder, N.; Nakano, N.; Nakauchi, H.; Ng, P.; Nilsson, R.; Nishiguchi, S.; Nishikawa, S.; Nori, F.; Ohara, O.; Okazaki, Y.; Orlando, V.; Pang, K. C.; Pavan, W. J.; Pavesi, G.; Pesole, G.; Petrovsky, N.; Piazza, S.; Reed, J.; Reid, J. F.; Ring, B. Z.; Ringwald, M.; Rost, B.; Ruan, Y.; Salzberg, S. L.; Sandelin, A.; Schneider, C.; Schooenbach, C.; Sekiguchi, K.; Semple, C. A. M.; Seno, S.; Sessa, L.; Sheng, Y.; Shibata, Y.; Shimada, H.; Shimada, K.; Silva, D.; Sinclair, B.; Sperling, S.; Stupka, E.; Sugiura, K.; Sultana, R.; Takenaka, Y.; Taki, K.; Tammoja, K.; Tan, S. L.; Tang, S.; Tayloor, M. S.; Tegner, J.; Teichmann, S. A.; Ueda, H. R.; van Nimwegen, E.; Verado, R.; Wei, C. L.; Yagi, K.; Yamanishi, H.; Zabarovsky, E.; Zhu, S.; Zimmer, A.; Hide, W.; Bult, C.; Grimmond, S. M.; Teasdale, R. D.; Liu, E. T.; Brusic, V.; Quackenbush, J.; Wahlestedt, C.; Mattick, J. S.; Hume, D. A.; Kai, C.; Sasaki, D.; Tomaru, Y.; Fukuda, S.; Kanamori-Katayama, M.; Suzuki, M.; Aoki, J.; Arakawa, T.; Iida, J.; Imamura, K.; Itoh, M.; Kato, T.; Kawaji, H.; Kawagashira, N.; Kawashima, T.; Kojima, M.; Kondon, S.; Konno, H.; Nakano, K.; Ninomiya, N.; Nishio, T.; Okada, M.; Plessy, C.; Shibata, K.; Shiraki, T.; Suzuki, S.; Tagami, M.; Waki, K.; Watahiki, A.; Okamura-Oho, Y.; Suzuki, H.; Kawai, J.; Hayashizaki, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">5740</span>),
    <span class="NLM_cas:pages">1559-1563</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">This study describes comprehensive polling of transcription start and termination sites and anal. of previously unidentified full-length cDNAs derived from the mouse genome.  The 5' and 3' boundaries of 181,047 transcripts were identified, with extensive variation in transcripts arising from alternative promoter usage, splicing, and polyadenylation.  There were 16,247 new mouse protein-coding transcripts, including 5154 encoding previously unidentified proteins.  Genomic mapping of the transcriptome reveals transcriptional forests, with overlapping transcription on both strands, sepd. by deserts in which few transcripts are obsd.  The data provide a comprehensive platform for the comparative anal. of mammalian transcriptional regulation in differentiation and development.  The authors deposited 284,372 expressed sequence tags in GenBank/EMBL/DDBJ with accession nos. CJ039836-CJ326805 as well as 101,789 high-throughput cDNA sequences deposited with accession nos. AK002213-AK172723.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT0WgTu5-dUrVg90H21EOLACvtfcHk0lhncU0PvhOzNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFWju7o%253D&md5=46a88549d94e9dd403e277e698f5635e</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1126%2Fscience.1112014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1112014%26sid%3Dliteratum%253Aachs%26aulast%3DCarninci%26aufirst%3DP.%26aulast%3DKasukawa%26aufirst%3DT.%26aulast%3DKatayama%26aufirst%3DS.%26aulast%3DGough%26aufirst%3DJ.%26aulast%3DFrith%26aufirst%3DM.%2BC.%26aulast%3DMaeda%26aufirst%3DN.%26aulast%3DOyama%26aufirst%3DR.%26aulast%3DRavasi%26aufirst%3DT.%26aulast%3DLenhard%26aufirst%3DB.%26aulast%3DWells%26aufirst%3DC.%26atitle%3DThe%2520Transcriptional%2520Landscape%2520of%2520the%2520Mammalian%2520Genome%26jtitle%3DScience%26date%3D2005%26volume%3D309%26spage%3D1559%26epage%3D1563%26doi%3D10.1126%2Fscience.1112014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, T.</span></span> <span> </span><span class="NLM_article-title">Finally, a Sense of Closure? Animal Models of Human Ventral Body Wall Defects</span>. <i>BioEssays</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1307</span>– <span class="NLM_lpage">1321</span>, <span class="refDoi"> DOI: 10.1002/bies.20137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1002%2Fbies.20137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15551266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BD2croslyjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2004&pages=1307-1321&author=S.+Brewerauthor=T.+Williams&title=Finally%2C+a+Sense+of+Closure%3F+Animal+Models+of+Human+Ventral+Body+Wall+Defects&doi=10.1002%2Fbies.20137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Finally, a sense of closure? Animal models of human ventral body wall defects</span></div><div class="casAuthors">Brewer Stephanie; Williams Trevor</div><div class="citationInfo"><span class="NLM_cas:title">BioEssays : news and reviews in molecular, cellular and developmental biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1307-21</span>
        ISSN:<span class="NLM_cas:issn">0265-9247</span>.
    </div><div class="casAbstract">Malformations concerning the ventral body wall constitute one of the leading categories of human birth defects and are present in about one out of every 2000 live births.  Although the occurrence of these defects is relatively common, few detailed experimental studies exist on the development and closure of the ventral body wall in mouse and human.  This field is further complicated by the array of theories on the pathogenesis of body wall defects and the likelihood that there is no single cause for these abnormalities.  In this review, we summarize what is known concerning the mechanisms of normal ventral body wall closure in humans and mice.  We then outline the theories that have been proposed concerning human body wall closure abnormalities and examine the growing number of mouse mutations that impact normal ventral body wall closure.  Finally, we speculate how studies in animal models such as mouse and Drosophila are beginning to provide a much-needed mechanistic framework with which to identify and characterize the genes and tissues required for this vital aspect of human embryogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-668qJqWD93WEEzDrymxmfW6udTcc2earZGkyo8KwMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2croslyjtw%253D%253D&md5=88aa0d381a6acc56858b91e63c9b869b</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1002%2Fbies.20137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbies.20137%26sid%3Dliteratum%253Aachs%26aulast%3DBrewer%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DT.%26atitle%3DFinally%252C%2520a%2520Sense%2520of%2520Closure%253F%2520Animal%2520Models%2520of%2520Human%2520Ventral%2520Body%2520Wall%2520Defects%26jtitle%3DBioEssays%26date%3D2004%26volume%3D26%26spage%3D1307%26epage%3D1321%26doi%3D10.1002%2Fbies.20137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yatsenko, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Londono, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmont, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, L. G.</span></span> <span> </span><span class="NLM_article-title">Omphalocele in Trisomy 3q: Further Delineation of Phenotype</span>. <i>Clin. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">404</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1034/j.1399-0004.2003.00159.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1034%2Fj.1399-0004.2003.00159.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=14616763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BD3srks1yktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=404-413&author=S.+A.+Yatsenkoauthor=R.+Mendoza-Londonoauthor=J.+W.+Belmontauthor=L.+G.+Shaffer&title=Omphalocele+in+Trisomy+3q%3A+Further+Delineation+of+Phenotype&doi=10.1034%2Fj.1399-0004.2003.00159.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Omphalocele in trisomy 3q: further delineation of phenotype</span></div><div class="casAuthors">Yatsenko S A; Mendoza-Londono R; Belmont J W; Shaffer L G</div><div class="citationInfo"><span class="NLM_cas:title">Clinical genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">404-13</span>
        ISSN:<span class="NLM_cas:issn">0009-9163</span>.
    </div><div class="casAbstract">We report a case of a patient with omphalocele, dysmorphic features, and mild developmental delay associated with a chromosomal aberration.  Chromosome studies showed that the propositus carries a maternally derived unbalanced translocation der(4)t(3;4)(q27.3;q32.3), resulting in trisomy for region 3q27.3-->qter and monosomy for 4q32.3-->qter.  Because the association between dup3q and omphalocele has been reported in several cases, we analyzed the data on 93 previously reported patients with partial trisomy of the long arm of chromosome 3 and compared the clinical features between the cases.  The imbalance of chromosome 3 in the patient was further defined by fluorescence in situ hybridization (FISH) studies using bacterial artificial chromosome (BAC) clones.  BAC clone RP11-171N2 was identified as a breakpoint-spanning clone in the patient and his mother.  Based on our comparative analysis, we have delineated that the smallest region of overlap (SRO) associated with omphalocele is from BAC 171N2 to 3qter.  We hypothesize that the SRO contains a gene(s) important in normal abdominal wall development and is of potential interest for further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlwdlUP_XxQz0SWnHPWbmmfW6udTcc2earZGkyo8KwMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srks1yktQ%253D%253D&md5=531a2fb0cf771c3825b82581fb912661</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1034%2Fj.1399-0004.2003.00159.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1399-0004.2003.00159.x%26sid%3Dliteratum%253Aachs%26aulast%3DYatsenko%26aufirst%3DS.%2BA.%26aulast%3DMendoza-Londono%26aufirst%3DR.%26aulast%3DBelmont%26aufirst%3DJ.%2BW.%26aulast%3DShaffer%26aufirst%3DL.%2BG.%26atitle%3DOmphalocele%2520in%2520Trisomy%25203q%253A%2520Further%2520Delineation%2520of%2520Phenotype%26jtitle%3DClin.%2520Genet.%26date%3D2003%26volume%3D64%26spage%3D404%26epage%3D413%26doi%3D10.1034%2Fj.1399-0004.2003.00159.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kanagawa, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begleiter, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostlie, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holcomb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M. G.</span></span> <span> </span><span class="NLM_article-title">Omphalocele in Three Generations with Autosomal Dominant Transmission</span>. <i>J. Med. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1136/jmg.39.3.184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1136%2Fjmg.39.3.184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=11897819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BD387otFSisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2002&pages=184-185&author=S.+L.+Kanagawaauthor=M.+L.+Begleiterauthor=D.+J.+Ostlieauthor=G.+Holcombauthor=W.+Drakeauthor=M.+G.+Butler&title=Omphalocele+in+Three+Generations+with+Autosomal+Dominant+Transmission&doi=10.1136%2Fjmg.39.3.184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Omphalocele in three generations with autosomal dominant transmission</span></div><div class="casAuthors">Kanagawa S L; Begleiter M L; Ostlie D J; Holcomb G; Drake W; Butler M G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medical genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">184-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We report a family with nine subjects over three generations affected with an omphalocele requiring surgical intervention within the first few days of life.  Because of the vertical transmission and male to male inheritance in our family, we conclude that an autosomal dominant gene caused the omphalocele in the affected family members.  The paternal great grandfather of the proband was not clinically affected but produced two children with omphaloceles with different spouses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRKFp1XBEwBwIFEOhA_Im3cfW6udTcc2ebm5WKfHPLqu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387otFSisw%253D%253D&md5=5228c5d342e56c0485a7e0385f27ecf0</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1136%2Fjmg.39.3.184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjmg.39.3.184%26sid%3Dliteratum%253Aachs%26aulast%3DKanagawa%26aufirst%3DS.%2BL.%26aulast%3DBegleiter%26aufirst%3DM.%2BL.%26aulast%3DOstlie%26aufirst%3DD.%2BJ.%26aulast%3DHolcomb%26aufirst%3DG.%26aulast%3DDrake%26aufirst%3DW.%26aulast%3DButler%26aufirst%3DM.%2BG.%26atitle%3DOmphalocele%2520in%2520Three%2520Generations%2520with%2520Autosomal%2520Dominant%2520Transmission%26jtitle%3DJ.%2520Med.%2520Genet.%26date%3D2002%26volume%3D39%26spage%3D184%26epage%3D185%26doi%3D10.1136%2Fjmg.39.3.184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thumkeo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narumiya, S.</span></span> <span> </span><span class="NLM_article-title">ROCK-I and ROCK-II Cooperatively Regulate Closure of Eyelid and Ventral Body Wall in Mouse Embryo</span>. <i>Genes Cells</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">825</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2443.2005.00882.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1111%2Fj.1365-2443.2005.00882.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=16098146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFKktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=825-834&author=D.+Thumkeoauthor=Y.+Shimizuauthor=S.+Sakamotoauthor=S.+Yamadaauthor=S.+Narumiya&title=ROCK-I+and+ROCK-II+Cooperatively+Regulate+Closure+of+Eyelid+and+Ventral+Body+Wall+in+Mouse+Embryo&doi=10.1111%2Fj.1365-2443.2005.00882.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">ROCK-I and ROCK-II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo</span></div><div class="casAuthors">Thumkeo, Dean; Shimizu, Yoshihiko; Sakamoto, Satoko; Yamada, Shuichi; Narumiya, Shuh</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">825-834</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Rho-assocd. kinase (ROCK) is a serine/threonine kinase working in the Rho signaling to actin cytoskeleton.  We previously reported that loss of ROCK-I results in the eyelid open at birth (EOB) and omphalocele phenotype in mice, while loss of ROCK-II results in placental dysfunction leading to intrauterine growth retardation and fetal death.  Here, we report that after backcross to the C57BL/6 N genetic background, ROCK-II knockout (KO) neonates are born also with open eyelid and umbilical hernia, a phenotype similar to that of ROCK-I KO mice.  ROCK-II KO embryos show impaired extension of the eyelid epithelial sheet with disorganized actin bundles in the leading edge of the sheet.  These results suggest that ROCK-I and ROCK-II cooperatively regulates the assembly of actin bundles essential for closure of the eyelid and ventral body wall in mouse embryos.  Consistently, ROCK-I+/-ROCK-II+/- double heterozygous mice also show the EOB and omphalocele phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp58JoKdv8tArVg90H21EOLACvtfcHk0lj8NlzAMXP6WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFKktL8%253D&md5=e81d1e34ab18f4615db2e18c45b05bac</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2443.2005.00882.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2443.2005.00882.x%26sid%3Dliteratum%253Aachs%26aulast%3DThumkeo%26aufirst%3DD.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DNarumiya%26aufirst%3DS.%26atitle%3DROCK-I%2520and%2520ROCK-II%2520Cooperatively%2520Regulate%2520Closure%2520of%2520Eyelid%2520and%2520Ventral%2520Body%2520Wall%2520in%2520Mouse%2520Embryo%26jtitle%3DGenes%2520Cells%26date%3D2005%26volume%3D10%26spage%3D825%26epage%3D834%26doi%3D10.1111%2Fj.1365-2443.2005.00882.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani-Koseki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koseki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span> <span> </span><span class="NLM_article-title">Requirement for Mab21l2 during Development of Murine Retina and Ventral Body Wall</span>. <i>Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">307</span>, <span class="refDoi"> DOI: 10.1016/j.ydbio.2004.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.ydbio.2004.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15385160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVyru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=2004&pages=295-307&author=R.+Yamadaauthor=Y.+Mizutani-Kosekiauthor=H.+Kosekiauthor=N.+Takahashi&title=Requirement+for+Mab21l2+during+Development+of+Murine+Retina+and+Ventral+Body+Wall&doi=10.1016%2Fj.ydbio.2004.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for Mab21l2 during development of murine retina and ventral body wall</span></div><div class="casAuthors">Yamada, Ryuichi; Mizutani-Koseki, Yoko; Koseki, Haruhiko; Takahashi, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Biology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-307</span>CODEN:
                <span class="NLM_cas:coden">DEBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0012-1606</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The mab-21 gene was first identified because of its requirement for ray identity specification in Caenorhabditis elegans.  It is now known to constitute a family of genes that are highly conserved from vertebrates to invertebrates, and two homologs Mab21l1 and Mab21l2 have been identified in many species.  Here the authors describe the generation of Mab21l2-deficient mice, which have defects in eye and body wall formation.  The mutant mouse eye has a rudimentary retina, as a result of insufficient invagination of the optic vesicle due to deficient proliferation, causing the absence of lens.  The defects in optic vesicle development correlate with reduced expression of Chx10, which is also required for retina development; Rx, Lhx2, and Pax6 expression is not significantly affected.  The authors conclude that Mab21l2 expression is essential for optic vesicle growth and formation of the optic cup, its absence causing reduced expression of Chx10.  Mutant mice also display abnormal extrusion of abdominal organs, defects in ventral body wall formation, resulting in death in utero at mid-gestational stage.  The authors' results reveal that Mab21l2 plays crucial roles in retina and in ventral body wall formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol8K5T6h8SdbVg90H21EOLACvtfcHk0lj8NlzAMXP6WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVyru7g%253D&md5=9b4db8bc08dcc19b7796378e0415d408</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.ydbio.2004.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ydbio.2004.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DR.%26aulast%3DMizutani-Koseki%26aufirst%3DY.%26aulast%3DKoseki%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DN.%26atitle%3DRequirement%2520for%2520Mab21l2%2520during%2520Development%2520of%2520Murine%2520Retina%2520and%2520Ventral%2520Body%2520Wall%26jtitle%3DDev.%2520Biol.%26date%3D2004%26volume%3D274%26spage%3D295%26epage%3D307%26doi%3D10.1016%2Fj.ydbio.2004.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dünker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krieglstein, K.</span></span> <span> </span><span class="NLM_article-title">Tgfβ2–/–Tgfβ3–/– Double Knockout Mice Display Severe Midline Fusion Defects and Early Embryonic Lethality</span>. <i>Anat. Embryol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>206</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1007/s00429-002-0273-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1007%2Fs00429-002-0273-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=12478370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVSis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2002&pages=73-83&author=N.+D%C3%BCnkerauthor=K.+Krieglstein&title=Tgf%CE%B22%E2%80%93%2F%E2%80%93Tgf%CE%B23%E2%80%93%2F%E2%80%93+Double+Knockout+Mice+Display+Severe+Midline+Fusion+Defects+and+Early+Embryonic+Lethality&doi=10.1007%2Fs00429-002-0273-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Tgfβ2-/-Tgfβ3-/- double knockout mice display severe midline fusion defects and early embryonic lethality</span></div><div class="casAuthors">Duenker, Nicole; Krieglstein, Kerstin</div><div class="citationInfo"><span class="NLM_cas:title">Anatomy and Embryology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">73-83</span>CODEN:
                <span class="NLM_cas:coden">ANEMDG</span>;
        ISSN:<span class="NLM_cas:issn">0340-2061</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Given all known biol. activities, it is anticipated that transforming growth factors beta (TGF-βs) play important roles in many different developmental processes.  As all three TGF-β isoforms display overlapping expression patterns, deletion of one TGF-β isoform might be compensated for by another.  In the present study, targeted disruption of both Tgfβ2 and Tgfβ3 genes was undertaken to circumvent this question and det. the essential roles of TGF-β2 and TGF-β3 in vivo.  Tgfβ2-/-Tgfβ3-/- double knockout mice and their three-allelic Tgfβ2-/-Tgfβ3+/- littermates display a lack of distal parts of the rib, a lack of sternal primordia, and failure in ventral body wall closure, leading to an extrathoracic position of the heart and extrusion of the liver.  In addn., abnormalities in connective tissue compn. and an early embryonic lethality [around embryonic day (E) 15.5] are seen.  In contrast, Tgfβ2+/-Tgfβ3-/- littermates show normal rib and sternum development, normal anterior body wall fusion, and are still alive on E18.5.  TGF-β2 is already known to play a role in skeletal and craniofacial development.  The results presented here show that beyond this: (a) TGF-βs obviously play a fundamental role in midline fusion and (b) the Tgfβ2 gene seems to play a more important role in mediating developmental processes than the Tgfβ3 gene, since Tgfβ2+/-Tgfβ3-/- mutants - in contrast to their Tgfβ2-/-Tgfβ3+/- littermates - do not display severe malformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFIeTONsBVcrVg90H21EOLACvtfcHk0lhIQEyGasYZSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVSis7c%253D&md5=1c680d577053bbdf23c885103ddb1640</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1007%2Fs00429-002-0273-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00429-002-0273-6%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25BCnker%26aufirst%3DN.%26aulast%3DKrieglstein%26aufirst%3DK.%26atitle%3DTgf%25CE%25B22%25E2%2580%2593%252F%25E2%2580%2593Tgf%25CE%25B23%25E2%2580%2593%252F%25E2%2580%2593%2520Double%2520Knockout%2520Mice%2520Display%2520Severe%2520Midline%2520Fusion%2520Defects%2520and%2520Early%2520Embryonic%2520Lethality%26jtitle%3DAnat.%2520Embryol.%26date%3D2002%26volume%3D206%26spage%3D73%26epage%3D83%26doi%3D10.1007%2Fs00429-002-0273-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manley, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrow, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capecchi, M. R.</span></span> <span> </span><span class="NLM_article-title">Hoxb2 and Hoxb4 Act Together to Specify Ventral Body Wall Formation</span>. <i>Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>237</i></span>,  <span class="NLM_fpage">130</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1006/dbio.2001.0365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1006%2Fdbio.2001.0365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=11518511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtFGgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=2001&pages=130-144&author=N.+R.+Manleyauthor=J.+R.+Barrowauthor=T.+Zhangauthor=M.+R.+Capecchi&title=Hoxb2+and+Hoxb4+Act+Together+to+Specify+Ventral+Body+Wall+Formation&doi=10.1006%2Fdbio.2001.0365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Hoxb2 and Hoxb4 Act Together to Specify Ventral Body Wall Formation</span></div><div class="casAuthors">Manley, Nancy R.; Barrow, Jeffery R.; Zhang, Tianshu; Capecchi, Mario R.</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Biology (Orlando, FL, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">130-144</span>CODEN:
                <span class="NLM_cas:coden">DEBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0012-1606</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Three different alleles of the Hoxb4 locus were generated by gene targeting in mice.  Two alleles contain insertions of a selectable marker in the first exon in either orientation, and, in the third, the selectable marker was removed, resulting in premature termination of the protein.  Presence and orientation of the selectable marker correlated with the severity of the phenotype, indicating that the selectable marker induces cis effects on neighboring genes that influence the phenotype.  Homozygous mutants of all alleles had cervical skeletal defects similar to those previously reported for Hoxb4 mutant mice.  In the most severe allele, Hoxb4PolII, homozygous mutants died either in utero at approx. E15.5 or immediately after birth, with a severe defect in ventral body wall formation.  Anal. of embryos showed thinning of the primary ventral body wall in mutants relative to control animals at E11.5, before secondary body wall formation.  Prior to this defect, both Alx3 and Alx4 were specifically down regulated in the most ventral part of the primary body wall in Hoxb4PolII mutants.  Hoxb4loxp mutants in which the neo gene has been removed did not have body wall or sternum defects.  In contrast, both the Hoxb4PolII and the previously described Hoxb2PolII alleles that have body wall defects have been shown to disrupt the expression of both Hoxb2 and Hoxb4 in cell types that contribute to body wall formation.  Our results are consistent with a model in which defects in ventral body wall formation require the simultaneous loss of at least Hoxb2 and Hoxb4, and may involve Alx3 and Alx4.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLYPqleAxTu7Vg90H21EOLACvtfcHk0lhIQEyGasYZSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtFGgtr8%253D&md5=131767c3951c39e14bc381661785f738</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1006%2Fdbio.2001.0365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fdbio.2001.0365%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DN.%2BR.%26aulast%3DBarrow%26aufirst%3DJ.%2BR.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DCapecchi%26aufirst%3DM.%2BR.%26atitle%3DHoxb2%2520and%2520Hoxb4%2520Act%2520Together%2520to%2520Specify%2520Ventral%2520Body%2520Wall%2520Formation%26jtitle%3DDev.%2520Biol.%26date%3D2001%26volume%3D237%26spage%3D130%26epage%3D144%26doi%3D10.1006%2Fdbio.2001.0365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, T.</span></span> <span> </span><span class="NLM_article-title">Loss of AP-2α Impacts Multiple Aspects of Ventral Body Wall Development and Closure</span>. <i>Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">417</span>, <span class="refDoi"> DOI: 10.1016/j.ydbio.2003.11.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.ydbio.2003.11.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15013802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvV2hsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2004&pages=399-417&author=S.+Brewerauthor=T.+Williams&title=Loss+of+AP-2%CE%B1+Impacts+Multiple+Aspects+of+Ventral+Body+Wall+Development+and+Closure&doi=10.1016%2Fj.ydbio.2003.11.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of AP-2α impacts multiple aspects of ventral body wall development and closure</span></div><div class="casAuthors">Brewer, Stephanie; Williams, Trevor</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Biology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">399-417</span>CODEN:
                <span class="NLM_cas:coden">DEBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0012-1606</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Human birth defects involving the ventral body wall are common, yet little is known about the mechanism of body wall closure in mammals.  The AP-2α transcription factor knock-out mouse provides an exceptional tool to understand this particular pathol., since it has one of the most severe ventral body wall closure defects, thoracoabdominoschisis.  To gain insight into the complex morphol. events responsible for body wall closure, the authors have studied this developmental process in AP-2α knock-out mice.  Several tissues involved in normal ventral body wall closure are defective in the absence of AP-2α, including those assocd. with the primary body wall, the umbilical ring, and the mesoderm of the secondary body wall.  These defects, coupled with the expression pattern of AP-2α, suggest that AP-2α is involved in multiple developmental mechanisms directing the morphogenesis of the ventral body wall, including cell migration, differentiation, and death.  There is a failure of migration and fusion of the body folds at the umbilical ring, as well as in the formation and migration of the abdominal bands and ventral musculature.  Furthermore, the mechanism of cell deposition at the umbilical ring is disturbed.  Consequently, the mesodermal compartment of the body wall is underdeveloped.  The authors also suggest that AP-2α is required for signaling from the surface ectoderm to the underlying mesoderm for proper development and closure of the ventral body wall.  These findings provide a fundamental understanding of how AP-2α functions in the closure of the ventral body wall, as well as offer insight into related human birth defects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotqGUSVE3aDbVg90H21EOLACvtfcHk0lhIQEyGasYZSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvV2hsbc%253D&md5=deb67affad1eb2565e9aa2fd280ca44f</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.ydbio.2003.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ydbio.2003.11.021%26sid%3Dliteratum%253Aachs%26aulast%3DBrewer%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DT.%26atitle%3DLoss%2520of%2520AP-2%25CE%25B1%2520Impacts%2520Multiple%2520Aspects%2520of%2520Ventral%2520Body%2520Wall%2520Development%2520and%2520Closure%26jtitle%3DDev.%2520Biol.%26date%3D2004%26volume%3D267%26spage%3D399%26epage%3D417%26doi%3D10.1016%2Fj.ydbio.2003.11.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riester, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culhane, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trippa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-h.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michor, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huttenhower, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmigiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birrer, M. J.</span></span> <span> </span><span class="NLM_article-title">Risk Prediction for Late-Stage Ovarian Cancer by Meta-Analysis of 1525 Patient Samples</span>. <i>JNCI J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>106</i></span>, <span class="NLM_elocation-id">dju048</span> <span class="refDoi"> DOI: 10.1093/jnci/dju048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1093%2Fjnci%2Fdju048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=24700803" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2014&author=M.+Riesterauthor=W.+Weiauthor=L.+Waldronauthor=A.+C.+Culhaneauthor=L.+Trippaauthor=E.+Olivaauthor=S.-h.+Kimauthor=F.+Michorauthor=C.+Huttenhowerauthor=G.+Parmigianiauthor=M.+J.+Birrer&title=Risk+Prediction+for+Late-Stage+Ovarian+Cancer+by+Meta-Analysis+of+1525+Patient+Samples&doi=10.1093%2Fjnci%2Fdju048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdju048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdju048%26sid%3Dliteratum%253Aachs%26aulast%3DRiester%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DWaldron%26aufirst%3DL.%26aulast%3DCulhane%26aufirst%3DA.%2BC.%26aulast%3DTrippa%26aufirst%3DL.%26aulast%3DOliva%26aufirst%3DE.%26aulast%3DKim%26aufirst%3DS.-h.%26aulast%3DMichor%26aufirst%3DF.%26aulast%3DHuttenhower%26aufirst%3DC.%26aulast%3DParmigiani%26aufirst%3DG.%26aulast%3DBirrer%26aufirst%3DM.%2BJ.%26atitle%3DRisk%2520Prediction%2520for%2520Late-Stage%2520Ovarian%2520Cancer%2520by%2520Meta-Analysis%2520of%25201525%2520Patient%2520Samples%26jtitle%3DJNCI%2520J.%2520Natl.%2520Cancer%2520Inst.%26date%3D2014%26volume%3D106%26doi%3D10.1093%2Fjnci%2Fdju048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phippen, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrads, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, P.-n.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litzi, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darcy, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrads, T. P.</span></span> <span> </span><span class="NLM_article-title">NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">213</span>, <span class="refDoi"> DOI: 10.3389/fonc.2016.00213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.3389%2Ffonc.2016.00213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=27833898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BC2snltVOisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=213&author=N.+T.+Phippenauthor=N.+W.+Batemanauthor=G.+Wangauthor=K.+A.+Conradsauthor=W.+Aoauthor=P.-n.+Tengauthor=T.+A.+Litziauthor=J.+Oliverauthor=G.+L.+Maxwellauthor=C.+A.+Hamiltonauthor=K.+M.+Darcyauthor=T.+P.+Conrads&title=NUAK1+%28ARK5%29+Is+Associated+with+Poor+Prognosis+in+Ovarian+Cancer&doi=10.3389%2Ffonc.2016.00213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer</span></div><div class="casAuthors">Phippen Neil T; Bateman Nicholas W; Darcy Kathleen M; Wang Guisong; Conrads Kelly A; Ao Wei; Teng Pang-Ning; Litzi Tracy A; Oliver Julie; Maxwell G Larry; Hamilton Chad A; Conrads Thomas P</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">213</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">BACKGROUND AND OBJECTIVE:  Nua kinase 1 (NUAK1) was identified in multigene signatures of survival and suboptimal debulking in high-grade serous ovarian cancer (HGSOC).  This study investigates the individual clinical and biologic contributions of NUAK1 in HGSOC patients and cell lines.  METHODS:  Public transcript expression, clinical, and outcome data were used to interrogate the relationship between NUAK1 and clinicopathologic factors and patient outcomes including progression-free survival (PFS) and molecular subtypes using logistic and Cox modeling.  Analysis of NUAK1 transcript expression was performed in primary tumors from 34 HGSOC patients with < or ≥2 years PFS.  The impact of silencing NUAK1 by RNA interference (RNAi) on the migratory potential and chemosensitivity of SOC cells was assessed in vitro.  RESULTS:  Elevated NUAK1 transcript expression was associated with worse PFS (hazard ratio = 1.134), advanced stage (odds ratio, OR = 1.7), any residual disease (OR = 1.58), and mesenchymal disease subtype (OR = 7.79 ± 5.89).  Elevated NUAK1 transcript expression was observed in HGSOC patients with < vs. ≥2 years PFS (p < 0.045).  RNAi-mediated silencing of NUAK1 expression attenuated migration of OV90 and E3 HGSOC cells in vitro, but did not modulate sensitivity to cisplatin or paclitaxel.  CONCLUSION:  Elevated NUAK1 was associated with poor survival as well as advanced stage, residual disease after cytoreductive surgery and mesenchymal molecular subtype.  NUAK1 impacted migration, but not chemosensitivity, in vitro.  Additional studies are needed to further develop the concept of NUAK1 as a clinically deployable biomarker and therapeutic target in HGSOC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJulYHhsNcnZPlX7E30qdzfW6udTcc2eYHlms-tulAMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snltVOisw%253D%253D&md5=0c85b51bab3368831b39b27f314631a1</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2016.00213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2016.00213%26sid%3Dliteratum%253Aachs%26aulast%3DPhippen%26aufirst%3DN.%2BT.%26aulast%3DBateman%26aufirst%3DN.%2BW.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DConrads%26aufirst%3DK.%2BA.%26aulast%3DAo%26aufirst%3DW.%26aulast%3DTeng%26aufirst%3DP.-n.%26aulast%3DLitzi%26aufirst%3DT.%2BA.%26aulast%3DOliver%26aufirst%3DJ.%26aulast%3DMaxwell%26aufirst%3DG.%2BL.%26aulast%3DHamilton%26aufirst%3DC.%2BA.%26aulast%3DDarcy%26aufirst%3DK.%2BM.%26aulast%3DConrads%26aufirst%3DT.%2BP.%26atitle%3DNUAK1%2520%2528ARK5%2529%2520Is%2520Associated%2520with%2520Poor%2520Prognosis%2520in%2520Ovarian%2520Cancer%26jtitle%3DFront.%2520Oncol.%26date%3D2016%26volume%3D6%26spage%3D213%26doi%3D10.3389%2Ffonc.2016.00213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. R.</span></span> <span> </span><span class="NLM_article-title">Activation of ARK5/MiR-1181/HOXA10 Axis Promotes Epithelial-Mesenchymal Transition in Ovarian Cancer</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1193</span>– <span class="NLM_lpage">1202</span>, <span class="refDoi"> DOI: 10.3892/or.2015.4113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.3892%2For.2015.4113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26151663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=1193-1202&author=H.+Y.+Zhangauthor=J.+H.+Liauthor=G.+Liauthor=S.+R.+Wang&title=Activation+of+ARK5%2FMiR-1181%2FHOXA10+Axis+Promotes+Epithelial-Mesenchymal+Transition+in+Ovarian+Cancer&doi=10.3892%2For.2015.4113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of ARK5/miR-1181/HOXA10 axis promotes epithelial-mesenchymal transition in ovarian cancer</span></div><div class="casAuthors">Zhang, Hai-Yan; Li, Jian-Hua; Li, Guang; Wang, Su-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1193-1202</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1791-2431</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Epithelial ovarian cancer (EOC) is the sixth most common cancer in females worldwide and, although advances have been made in the detection, diagnosis and therapies for EOC, it remains the most lethal gynecol. malignancy in advanced countries.  Nevertheless, relatively little is known concerning the mol. events that lead to the development of this highly aggressive disease.  Elucidating the mol. mechanism involved in this disease may prove useful to understand the pathogenesis and progression of the disease, and to identify new targets for effective therapies.  In the present study, we examd. the role of ARK5 in ovarian cancer and normal matched tissues using western blot anal. and migration and invasion, and wound-healing assays.  The results showed that ARK5 was upregulated in ovarian cancer tissues, compared with adjacent normal tissues.  Moreover, it promoted epithelial-mesenchymal transition (EMT) and inhibited miR-1181 expression in ovarian cancer cells.  Subsequent investigations showed that miR-1181 promoted mesenchymal-epithelial transition (MET) in ovarian cancer cells.  Downstream target genes of miR-1181 were searched, and it was identified that miR-1181 degraded HOXA10 by targeting its 3' untranslated region (3'UTR) in ovarian cancer cells.  The results confirmed that HOXA10 promoted EMT in ovarian cancer cells.  Thus, activation of the ARK5/miR-1181/HOXA10 axis may be pos. assocd. with EMT in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5JfPtn9dt3LVg90H21EOLACvtfcHk0lgM9_NNXRdHag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSltQ%253D%253D&md5=9acf4208e27ec4d9e085f479374e1cfa</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.3892%2For.2015.4113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2015.4113%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DS.%2BR.%26atitle%3DActivation%2520of%2520ARK5%252FMiR-1181%252FHOXA10%2520Axis%2520Promotes%2520Epithelial-Mesenchymal%2520Transition%2520in%2520Ovarian%2520Cancer%26jtitle%3DOncol.%2520Rep.%26date%3D2015%26volume%3D34%26spage%3D1193%26epage%3D1202%26doi%3D10.3892%2For.2015.4113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, M. H.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Kinase Inhibitors: An Analysis of FDA-Approved Drugs</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.drudis.2015.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26210956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Gru73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=5-10&author=P.+Wuauthor=T.+E.+Nielsenauthor=M.+H.+Clausen&title=Small-Molecule+Kinase+Inhibitors%3A+An+Analysis+of+FDA-Approved+Drugs&doi=10.1016%2Fj.drudis.2015.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule kinase inhibitors: an analysis of FDA-approved drugs</span></div><div class="casAuthors">Wu, Peng; Nielsen, Thomas E.; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-10</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Small-mol. kinase inhibitors (SMKIs), 28 of which are approved by the US Food and Drug Administration (FDA), have been actively pursued as promising targeted therapeutics.  Here, we assess the key structural and physicochem. properties, target selectivity and mechanism of function, and therapeutic indications of these approved inhibitors.  Our anal. showed that >30% of approved SMKIs have a mol. wt. (MW) exceeding 500 and all have a total ring count of between three and five.  The assumption that type II inhibitors tend to be more selective than type I inhibitors has been proved to be unreliable.  Although previous SMKI research was concd. on tyrosine kinase inhibitors for cancer treatment, recent progress indicates diversification of SMKI research in terms of new targets, mechanistic types, and therapeutic indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZrY68ZOI2xLVg90H21EOLACvtfcHk0lgM9_NNXRdHag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Gru73P&md5=228524fa464393053ecbfac19e994929</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DNielsen%26aufirst%3DT.%2BE.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DSmall-Molecule%2520Kinase%2520Inhibitors%253A%2520An%2520Analysis%2520of%2520FDA-Approved%2520Drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26spage%3D5%26epage%3D10%26doi%3D10.1016%2Fj.drudis.2015.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, J. F.</span></span> <span> </span><span class="NLM_article-title">Assay Development for Protein Kinase Enzymes</span>. <i>Nat. Center for Adv. Trans. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">19</span>, <a href="https://www.ncbi.nlm.nih.gov/books/NBK91991/" class="extLink">https://www.ncbi.nlm.nih.gov/books/NBK91991/</a> (accessed Oct 10, 2012)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=1-19&author=J.+F.+Glickman&title=Assay+Development+for+Protein+Kinase+Enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlickman%26aufirst%3DJ.%2BF.%26atitle%3DAssay%2520Development%2520for%2520Protein%2520Kinase%2520Enzymes%26jtitle%3DNat.%2520Center%2520for%2520Adv.%2520Trans.%2520Sci.%26date%3D2012%26volume%3D1%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallares, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span> <span> </span><span class="NLM_article-title">Comprehensive Analysis of Kinase Inhibitor Selectivity</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1046</span>– <span class="NLM_lpage">1051</span>, <span class="refDoi"> DOI: 10.1038/nbt.1990</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+Analysis+of+Kinase+Inhibitor+Selectivity&doi=10.1038%2Fnbt.1990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0li5E4AxADwjxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520Analysis%2520of%2520Kinase%2520Inhibitor%2520Selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051%26doi%3D10.1038%2Fnbt.1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhrlage, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prescott, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Characterization of WZ4003 and HTH-01–015 as Selective Inhibitors of the LKB1-Tumour-Suppressor-Activated NUAK Kinases</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>457</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1042/BJ20131152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1042%2FBJ20131152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=24171924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSlur7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2014&pages=215-225&author=S.+Banerjeeauthor=S.+J.+Buhrlageauthor=H.-T.+Huangauthor=X.+Dengauthor=W.+Zhouauthor=J.+Wangauthor=R.+Traynorauthor=A.+R.+Prescottauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+WZ4003+and+HTH-01%E2%80%93015+as+Selective+Inhibitors+of+the+LKB1-Tumour-Suppressor-Activated+NUAK+Kinases&doi=10.1042%2FBJ20131152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of WZ4003 and HTH-01-015 as selective inhibitors of the LKB1-tumour-suppressor-activated NUAK kinases</span></div><div class="casAuthors">Banerjee, Sourav; Buhrlage, Sara J.; Huang, Hai-Tsang; Deng, Xianming; Zhou, Wenjun; Wang, Jinhua; Traynor, Ryan; Prescott, Alan R.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">457</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">215-225</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The related NUAK1 and NUAK2 are members of the AMPK (AMP-activated protein kinase) family of protein kinases that are activated by the LKB1 (liver kinase B1) tumor suppressor kinase.  Recent work suggests they play important roles in regulating key biol. processes including Myc-driven tumorigenesis, senescence, cell adhesion and neuronal polarity.  In the present paper we describe the first highly specific protein kinase inhibitors of NUAK kinases namely WZ4003 and HTH-01-015.  WZ4003 inhibits both NUAK isoforms (IC50 for NUAK1 is 20 nM and for NUAK2 is 100 nM), whereas HTH-01-015 inhibits only NUAK1 (IC50 is 100 nM).  These compds. display extreme selectivity and do not significantly inhibit the activity of 139 other kinases that were tested including ten AMPK family members.  In all cell lines tested, WZ4003 and HTH-01-015 inhibit the phosphorylation of the only well-characterized substrate, MYPT1 (myosin phosphate-targeting subunit 1) that is phosphorylated by NUAK1 at Ser445.  We also identify a mutation (A195T) that does not affect basal NUAK1 activity, but renders it ~ 50-fold resistant to both WZ4003 and HTH-01-015.  Consistent with NUAK1 mediating the phosphorylation of MYPT1 we find that in cells overexpressing drug-resistant NUAK1[A195T], but not wild-type NUAK1, phosphorylation of MYPT1 at Ser445 is no longer suppressed by WZ4003 or HTH-01-015.  We also demonstrate that administration of WZ4003 and HTH-01-015 to MEFs (mouse embryonic fibroblasts) significantly inhibits migration in a wound-healing assay to a similar extent as NUAK1-knockout.  WZ4003 and HTH-01-015 also inhibit proliferation of MEFs to the same extent as NUAK1 knockout and U2OS cells to the same extent as NUAK1 shRNA knockdown.  We find that WZ4003 and HTH-01-015 impaired the invasive potential of U2OS cells in a 3D cell invasion assay to the same extent as NUAK1 knockdown.  The results of the present study indicate that WZ4003 and HTH-01-015 will serve as useful chem. probes to delineate the biol. roles of the NUAK kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Au6CwHtFALVg90H21EOLACvtfcHk0li5E4AxADwjxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSlur7K&md5=feab58d16169f39a2d136016328cc0f6</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1042%2FBJ20131152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20131152%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DHuang%26aufirst%3DH.-T.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTraynor%26aufirst%3DR.%26aulast%3DPrescott%26aufirst%3DA.%2BR.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520WZ4003%2520and%2520HTH-01%25E2%2580%2593015%2520as%2520Selective%2520Inhibitors%2520of%2520the%2520LKB1-Tumour-Suppressor-Activated%2520NUAK%2520Kinases%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D457%26spage%3D215%26epage%3D225%26doi%3D10.1042%2FBJ20131152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span> <i>Phosphorylation, Ubiquitylation and Characterisation of Specific Inhibitors of AMPK-Related Kinase NUAK1/ARK5</i>. Ph.D. Thesis, <span class="NLM_publisher-name">University of Dundee</span>, <span class="NLM_publisher-loc">United Kingdom</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+Banerjee&title=Phosphorylation%2C+Ubiquitylation+and+Characterisation+of+Specific+Inhibitors+of+AMPK-Related+Kinase+NUAK1%2FARK5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26jtitle%3DPhosphorylation%252C%2520Ubiquitylation%2520and%2520Characterisation%2520of%2520Specific%2520Inhibitors%2520of%2520AMPK-Related%2520Kinase%2520NUAK1%252FARK5%26pub%3DUniversity%2520of%2520Dundee%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzamko, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prescott, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patricelli, M. P</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomanbhoy, T. K</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S</span></span> <span> </span><span class="NLM_article-title">Characterization of a Selective Inhibitor of the Parkinson’s Disease Kinase LRRK2</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">203</span>, <span class="refDoi"> DOI: 10.1038/nchembio.538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fnchembio.538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=21378983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=203&author=X.+Dengauthor=N.+Dzamkoauthor=A.+Prescottauthor=P.+Daviesauthor=Q.+Liuauthor=Q.+Yangauthor=J.-D.+Leeauthor=M.+P+Patricelliauthor=T.+K+Nomanbhoyauthor=D.+R+Alessiauthor=N.+S+Gray&title=Characterization+of+a+Selective+Inhibitor+of+the+Parkinson%E2%80%99s+Disease+Kinase+LRRK2&doi=10.1038%2Fnchembio.538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2</span></div><div class="casAuthors">Deng, Xianming; Dzamko, Nicolas; Prescott, Alan; Davies, Paul; Liu, Qingsong; Yang, Qingkai; Lee, Jiing-Dwan; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly assocd. with late-onset autosomal dominant Parkinson's disease.  We employed a new, parallel, compd.-centric approach to identify a potent and selective LRRK2 inhibitor, LRRK2-IN-1, and demonstrated that inhibition of LRRK2 induces dephosphorylation of Ser910 and Ser935 and accumulation of LRRK2 within aggregate structures.  LRRK2-IN-1 will serve as a versatile tool to pharmacol. interrogate LRRK2 biol. and study its role in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwLpGURHqDULVg90H21EOLACvtfcHk0li5E4AxADwjxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D&md5=9f48f74cad9988e3ea8bb7af280473c1</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.538%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DPrescott%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.-D.%26aulast%3DPatricelli%26aufirst%3DM.%2BP%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK%26aulast%3DAlessi%26aufirst%3DD.%2BR%26aulast%3DGray%26aufirst%3DN.%2BS%26atitle%3DCharacterization%2520of%2520a%2520Selective%2520Inhibitor%2520of%2520the%2520Parkinson%25E2%2580%2599s%2520Disease%2520Kinase%2520LRRK2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D203%26doi%3D10.1038%2Fnchembio.538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J. J.</span>; <span class="NLM_string-name">Rogers, E.</span>; <span class="NLM_string-name">Zhai, D.</span>; <span class="NLM_string-name">Deng, W.</span>; <span class="NLM_string-name">Huang, Z.</span>; <span class="NLM_string-name">Whitten, J.</span>; <span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Ending the Endless Acquired Tyrosine Kinase Resistance Mutations—Design of TPX-0005, a Multi-Target ALK/ROS1/TRK Inhibitor with Broad Spectrum Activity against Wild-Type and Mutants Including ALK G1202R, ROS1 G2032R and TRKA G595R</span>.  <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume">76</span>, Supplement: Abstract 2133. <span class="NLM_fpage">2133</span><span class="refDoi"> DOI: 10.1158/1538-7445.AM2016-2133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1158%2F1538-7445.AM2016-2133" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=2133&author=J.+J.+Cui&author=E.+Rogers&author=D.+Zhai&author=W.+Deng&author=Z.+Huang&author=J.+Whitten&author=Y.+Li&title=Ending+the+Endless+Acquired+Tyrosine+Kinase+Resistance+Mutations%E2%80%94Design+of+TPX-0005%2C+a+Multi-Target+ALK%2FROS1%2FTRK+Inhibitor+with+Broad+Spectrum+Activity+against+Wild-Type+and+Mutants+Including+ALK+G1202R%2C+ROS1+G2032R+and+TRKA+G595R&doi=10.1158%2F1538-7445.AM2016-2133"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2016-2133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2016-2133%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26atitle%3DEnding%2520the%2520Endless%2520Acquired%2520Tyrosine%2520Kinase%2520Resistance%2520Mutations%25E2%2580%2594Design%2520of%2520TPX-0005%252C%2520a%2520Multi-Target%2520ALK%252FROS1%252FTRK%2520Inhibitor%2520with%2520Broad%2520Spectrum%2520Activity%2520against%2520Wild-Type%2520and%2520Mutants%2520Including%2520ALK%2520G1202R%252C%2520ROS1%2520G2032R%2520and%2520TRKA%2520G595R%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D2133%26doi%3D10.1158%2F1538-7445.AM2016-2133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRyckere, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stashko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaros, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sather, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kireev, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janzen, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earp, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7031</span>– <span class="NLM_lpage">7041</span>, <span class="refDoi"> DOI: 10.1021/jm500749d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500749d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1agu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7031-7041&author=W.+Zhangauthor=D.+DeRyckereauthor=D.+Hunterauthor=J.+Liuauthor=M.+A.+Stashkoauthor=K.+A.+Minsonauthor=C.+T.+Cummingsauthor=M.+Leeauthor=T.+G.+Glarosauthor=D.+L.+Newtonauthor=S.+Satherauthor=D.+Zhangauthor=D.+Kireevauthor=W.+P.+Janzenauthor=H.+S.+Earpauthor=D.+K.+Grahamauthor=S.+V.+Fryeauthor=X.+Wang&title=UNC2025%2C+a+Potent+and+Orally+Bioavailable+MER%2FFLT3+Dual+Inhibitor&doi=10.1021%2Fjm500749d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor</span></div><div class="casAuthors">Zhang, Weihe; DeRyckere, Deborah; Hunter, Debra; Liu, Jing; Stashko, Michael A.; Minson, Katherine A.; Cummings, Christopher T.; Lee, Minjung; Glaros, Trevor G.; Newton, Dianne L.; Sather, Susan; Zhang, Dehui; Kireev, Dmitri; Janzen, William P.; Earp, H. Shelton; Graham, Douglas K.; Frye, Stephen V.; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7031-7041</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We previously reported a potent small mol. Mer tyrosine kinase inhibitor UNC1062.  However, its poor PK properties prevented further assessment in vivo.  We report here the sequential modification of UNC1062 to address DMPK properties and yield a new potent and highly orally bioavailable Mer inhibitor, 11, capable of inhibiting Mer phosphorylation in vivo, following oral dosing as demonstrated by pharmaco-dynamic (PD) studies examg. phospho-Mer in leukemic blasts from mouse bone marrow.  Kinome profiling vs. more than 300 kinases in vitro and cellular selectivity assessments demonstrate that 11 has similar subnanomolar activity against Flt3, an addnl. important target in acute myelogenous leukemia (AML), with pharmacol. useful selectivity vs. other kinases examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIu8sRwBmPqrVg90H21EOLACvtfcHk0lgJSnzIt98MVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1agu7bN&md5=b3be89f194e6f5ea853d82aa67aea939</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fjm500749d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500749d%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DDeRyckere%26aufirst%3DD.%26aulast%3DHunter%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DStashko%26aufirst%3DM.%2BA.%26aulast%3DMinson%26aufirst%3DK.%2BA.%26aulast%3DCummings%26aufirst%3DC.%2BT.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DGlaros%26aufirst%3DT.%2BG.%26aulast%3DNewton%26aufirst%3DD.%2BL.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DKireev%26aufirst%3DD.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DUNC2025%252C%2520a%2520Potent%2520and%2520Orally%2520Bioavailable%2520MER%252FFLT3%2520Dual%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7031%26epage%3D7041%26doi%3D10.1021%2Fjm500749d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khodjaniyazov, K. U.</span></span> <span> </span><span class="NLM_article-title">Synthesis and NMR Spectral Characterization of Novel 2, 3-Polymethylenepyrido [2, 3-d] Pyrimidin-4-Ones</span>. <i>J. J. Adv. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3873</span>– <span class="NLM_lpage">3875</span>, <span class="refDoi"> DOI: 10.24297/jac.v11i8.2193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.24297%2Fjac.v11i8.2193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOnu77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=3873-3875&author=K.+U.+Khodjaniyazov&title=Synthesis+and+NMR+Spectral+Characterization+of+Novel+2%2C+3-Polymethylenepyrido+%5B2%2C+3-d%5D+Pyrimidin-4-Ones&doi=10.24297%2Fjac.v11i8.2193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and NMR spectral characterization of novel 2,3-polymethylenepyrido[2,3-d]pyrimidin-4-ones</span></div><div class="casAuthors">Khodjaniyazov, Khamid U.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Advances in Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3873-3875</span>CODEN:
                <span class="NLM_cas:coden">JACOHO</span>;
        ISSN:<span class="NLM_cas:issn">2321-807X</span>.
    
            (<span class="NLM_cas:orgname">Council for Innovative Research</span>)
        </div><div class="casAbstract">A novel 2,3-polymethylenepyrido[2,3-d]pyrimidine-4-ones I [X = (CH2)n; n = 1, 2, 3] were synthesized via condensation of the 2-aminonicotinic acid together with lactams in the presence of phosphorus oxychloride.  The structures of the newly synthesized pyrido[2,3-d]pyrimidines were confirmed by 1H and 13C NMR spectral data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5FNRBfZB-47Vg90H21EOLACvtfcHk0lgJSnzIt98MVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOnu77K&md5=79a73a61fd4bd866c2055c652ef80ced</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.24297%2Fjac.v11i8.2193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.24297%252Fjac.v11i8.2193%26sid%3Dliteratum%253Aachs%26aulast%3DKhodjaniyazov%26aufirst%3DK.%2BU.%26atitle%3DSynthesis%2520and%2520NMR%2520Spectral%2520Characterization%2520of%2520Novel%25202%252C%25203-Polymethylenepyrido%2520%255B2%252C%25203-d%255D%2520Pyrimidin-4-Ones%26jtitle%3DJ.%2520J.%2520Adv.%2520Chem.%26date%3D2015%26volume%3D11%26spage%3D3873%26epage%3D3875%26doi%3D10.24297%2Fjac.v11i8.2193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zinchenko, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzychka, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biletskiy, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smolii, O. B.</span></span> <span> </span><span class="NLM_article-title">The Study of the Interaction of 4, 6-Dichloropyrimidine-5-Carbaldehyde with Glycine Esters</span>. <i>Zh. Org. Farm. Khim.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.24959/ophcj.18.935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.24959%2Fophcj.18.935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslSqsb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=42-48&author=H.+M.+Zinchenkoauthor=L.+V.+Muzychkaauthor=I.+I.+Biletskiyauthor=O.+B.+Smolii&title=The+Study+of+the+Interaction+of+4%2C+6-Dichloropyrimidine-5-Carbaldehyde+with+Glycine+Esters&doi=10.24959%2Fophcj.18.935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">The study of the interaction of 4,6-dichloropyrimidine-5-carbaldehyde with glycine esters</span></div><div class="casAuthors">Zinchenko, H. M.; Muzychka, L. V.; Biletskiy, I. I.; Smolii, O. B.</div><div class="citationInfo"><span class="NLM_cas:title">Zhurnal Organichnoi ta Farmatsevtichnoi Khimii</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-48</span>CODEN:
                <span class="NLM_cas:coden">ZOFKAM</span>;
        ISSN:<span class="NLM_cas:issn">2518-1548</span>.
    
            (<span class="NLM_cas:orgname">Natsional'nii Farmatsevtichnii Universitet</span>)
        </div><div class="casAbstract">The aim is to study the interaction of 4,6-dichloropyrimidine-5-carbaldehyde with methyl- and with tert-butylglycinate depending on the reaction conditions.  It has been found that the reaction of 4,6-dichloro-5-formylpyrimidine with hydrochlorides of glycine esters in the presence of triethylamine leads to obtaining derivs. of N-(5-formylpyrimidin-4-yl)glycinate and cyclization products: pyrrolo[2,3-d]pyrimidine and pyrido[2,3-d]pyrimidine.  The interaction of 4,6-dichloropyrimidine-5-carbaldehyde with Me or tert-Bu glycinate in methanol in the presence of triethylamine depending on the molar ratio gives the mixt. of 5-hydroxy-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine and 6-amino-4-chloro-7-oxopyrido[2,3-d]pyrimidine-8(7H)-yl)acetate.  The compn. and structure of the compds. synthesized have been confirmed by NMR-spectroscopy, chromatog. mass-spectrometry and elemental anal.  The previously unknown derivs. of pyrrolo[2,3-d]pyrimidine and pyrido[2,3-d]pyrimidine have been obtained as a result of the interaction of 4,6-dichloro-5-formylpyrimidine with Me and tert-butylglycinate.  The reaction features depending on the reactants ratio have been studied.  The prospects for the synthesis of potential biol. active compds. from 6-amino-4-chloro-7-oxopyrido[2,3-d]pyrimidine-8(7H)-yl)acetate have been described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY_uyzJAY6a7Vg90H21EOLACvtfcHk0ljsXQb-Bq9zCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslSqsb3P&md5=54d94a9cdecf30ec471e12f066898dc1</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.24959%2Fophcj.18.935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.24959%252Fophcj.18.935%26sid%3Dliteratum%253Aachs%26aulast%3DZinchenko%26aufirst%3DH.%2BM.%26aulast%3DMuzychka%26aufirst%3DL.%2BV.%26aulast%3DBiletskiy%26aufirst%3DI.%2BI.%26aulast%3DSmolii%26aufirst%3DO.%2BB.%26atitle%3DThe%2520Study%2520of%2520the%2520Interaction%2520of%25204%252C%25206-Dichloropyrimidine-5-Carbaldehyde%2520with%2520Glycine%2520Esters%26jtitle%3DZh.%2520Org.%2520Farm.%2520Khim.%26date%3D2018%26volume%3D16%26spage%3D42%26epage%3D48%26doi%3D10.24959%2Fophcj.18.935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M. V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akula, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosenza, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Athuluridivakar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallireddigari, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallela, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billa, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subbaiah, D. R. C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharathi, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasquez-Del Carpio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padgaonkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, E. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of 8-Cyclopentyl-2-[4-(4-Methyl-Piperazin-1-Yl)-Phenylamino]-7-Oxo-7, 8-Dihydro-Pyrido [2, 3-d] Pyrimidine-6-Carbonitrile (7x) as a Potent Inhibitor of Cyclin-Dependent Kinase 4 (CDK4) and AMPK-Related Kinase 5 (ARK5)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">599</span>, <span class="refDoi"> DOI: 10.1021/jm401073p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401073p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=578-599&author=M.+V.+R.+Reddyauthor=B.+Akulaauthor=S.+C.+Cosenzaauthor=S.+Athuluridivakarauthor=M.+R.+Mallireddigariauthor=V.+R.+Pallelaauthor=V.+K.+Billaauthor=D.+R.+C.+V.+Subbaiahauthor=E.+V.+Bharathiauthor=R.+Vasquez-Del+Carpioauthor=A.+Padgaonkarauthor=S.+J.+Bakerauthor=E.+P.+Reddy&title=Discovery+of+8-Cyclopentyl-2-%5B4-%284-Methyl-Piperazin-1-Yl%29-Phenylamino%5D-7-Oxo-7%2C+8-Dihydro-Pyrido+%5B2%2C+3-d%5D+Pyrimidine-6-Carbonitrile+%287x%29+as+a+Potent+Inhibitor+of+Cyclin-Dependent+Kinase+4+%28CDK4%29+and+AMPK-Related+Kinase+5+%28ARK5%29&doi=10.1021%2Fjm401073p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 8-Cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile as a Potent Inhibitor of Cyclin-Dependent Kinase 4 (CDK4) and AMPK-Related Kinase 5 (ARK5)</span></div><div class="casAuthors">Reddy, M. V. Ramana; Akula, Balireddy; Cosenza, Stephen C.; Athuluridivakar, Saikrishna; Mallireddigari, Muralidhar R.; Pallela, Venkat R.; Billa, Vinay K.; Subbaiah, D. R. C. Venkata; Bharathi, E. Vijaya; Vasquez-Del Carpio, Rodrigo; Padgaonkar, Amol; Baker, Stacey J.; Reddy, E. Premkumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">578-599</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The success of imatinib, a BCR-ABL inhibitor for the treatment of chronic myelogenous leukemia, has created a great impetus for the development of addnl. kinase inhibitors as therapeutic agents.  However, the complexity of cancer has led to recent interest in polypharmacol. approaches for developing multikinase inhibitors with low toxicity profiles.  With this goal in mind, the authors analyzed more than 150 novel cyano pyridopyrimidine compds. and identified structure-activity relationship trends that can be exploited in the design of potent kinase inhibitors.  One compd., 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile, was found to be the most active, inducing apoptosis of tumor cells at a concn. of approx. 30-100 nM.  In vitro kinase profiling revealed that 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile is a multikinase inhibitor with potent inhibitory activity against the CDK4/CYCLIN D1 and ARK5 kinases.  Here, the authors report the synthesis, structure-activity relationship, kinase inhibitory profile, in vitro cytotoxicity, and in vivo tumor regression studies by this lead compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMG0fEjk1mb7Vg90H21EOLACvtfcHk0ljsXQb-Bq9zCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVKisw%253D%253D&md5=da18d602b1ec793832db5f04813e18d6</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjm401073p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401073p%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DM.%2BV.%2BR.%26aulast%3DAkula%26aufirst%3DB.%26aulast%3DCosenza%26aufirst%3DS.%2BC.%26aulast%3DAthuluridivakar%26aufirst%3DS.%26aulast%3DMallireddigari%26aufirst%3DM.%2BR.%26aulast%3DPallela%26aufirst%3DV.%2BR.%26aulast%3DBilla%26aufirst%3DV.%2BK.%26aulast%3DSubbaiah%26aufirst%3DD.%2BR.%2BC.%2BV.%26aulast%3DBharathi%26aufirst%3DE.%2BV.%26aulast%3DVasquez-Del%2BCarpio%26aufirst%3DR.%26aulast%3DPadgaonkar%26aufirst%3DA.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26atitle%3DDiscovery%2520of%25208-Cyclopentyl-2-%255B4-%25284-Methyl-Piperazin-1-Yl%2529-Phenylamino%255D-7-Oxo-7%252C%25208-Dihydro-Pyrido%2520%255B2%252C%25203-d%255D%2520Pyrimidine-6-Carbonitrile%2520%25287x%2529%2520as%2520a%2520Potent%2520Inhibitor%2520of%2520Cyclin-Dependent%2520Kinase%25204%2520%2528CDK4%2529%2520and%2520AMPK-Related%2520Kinase%25205%2520%2528ARK5%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D578%26epage%3D599%26doi%3D10.1021%2Fjm401073p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkholi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chipuk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M. V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, J. M.</span></span> <span> </span><span class="NLM_article-title">Preclinical Pharmacological Evaluation of a Novel Multiple Kinase Inhibitor, ON123300, in Brain Tumor Models</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1105</span>– <span class="NLM_lpage">1116</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1158%2F1535-7163.MCT-13-0847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=24568969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFWjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=1105-1116&author=X.+Zhangauthor=H.+Lvauthor=Q.+Zhouauthor=R.+Elkholiauthor=J.+E.+Chipukauthor=M.+V.+R.+Reddyauthor=E.+P.+Reddyauthor=J.+M.+Gallo&title=Preclinical+Pharmacological+Evaluation+of+a+Novel+Multiple+Kinase+Inhibitor%2C+ON123300%2C+in+Brain+Tumor+Models&doi=10.1158%2F1535-7163.MCT-13-0847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Pharmacological Evaluation of a Novel Multiple Kinase Inhibitor, ON123300, in Brain Tumor Models</span></div><div class="casAuthors">Zhang, Xiaoping; Lv, Hua; Zhou, Qingyu; Elkholi, Rana; Chipuk, Jerry E.; Reddy, M. V. Ramana; Reddy, E. Premkumar; Gallo, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1105-1116</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">ON123300 is a low mol. wt. multikinase inhibitor identified through a series of screens that supported further analyses for brain tumor chemotherapy.  Biochem. assays indicated that ON123300 was a strong inhibitor of Ark5 and CDK4, as well as growth factor receptor tyrosine kinases such as β-type platelet-derived growth factor receptor (PDGFRβ).  ON123300 inhibited U87 glioma cell proliferation with an IC50 3.4 ± 0.1 μmol/L and reduced phosphorylation of Akt, yet it also unexpectedly induced Erk activation, both in a dose- and time-dependent manner that subsequently was attributed to relieving Akt-mediated C-Raf S259 inactivation and activating a p70S6K-initiated PI3K-neg. feedback loop.  Cotreatment with the EGFR inhibitor gefitinib produced synergistic cytotoxic effects.  Pursuant to the in vitro studies, in vivo pharmacokinetic and pharmacodynamic studies of ON123300 were completed in mice bearing intracerebral U87 tumors following i.v. doses of 5 and 25 mg/kg alone, and also at the higher dose concurrently with gefitinib.  ON123300 showed high brain and brain tumor accumulation based on brain partition coeff. values of at least 2.5.  Consistent with the in vitro studies, single agent ON123300 caused a dose-dependent suppression of phosphorylation of Akt as well as activation of Erk in brain tumors, whereas addn. of gefitinib to the ON123300 regimen significantly enhanced p-Akt inhibition and prevented Erk activation.  In summary, ON123300 demonstrated favorable pharmacokinetic characteristics, and future development for brain tumor therapy would require use of combinations, such as gefitinib, that mitigate its Erk activation and enhance its activity.  Mol Cancer Ther; 13(5); 1105-16. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr457UjL6oAnrVg90H21EOLACvtfcHk0ljsXQb-Bq9zCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFWjsLY%253D&md5=04d7383c3bb723978e1b5776af188497</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0847%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DElkholi%26aufirst%3DR.%26aulast%3DChipuk%26aufirst%3DJ.%2BE.%26aulast%3DReddy%26aufirst%3DM.%2BV.%2BR.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26atitle%3DPreclinical%2520Pharmacological%2520Evaluation%2520of%2520a%2520Novel%2520Multiple%2520Kinase%2520Inhibitor%252C%2520ON123300%252C%2520in%2520Brain%2520Tumor%2520Models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26spage%3D1105%26epage%3D1116%26doi%3D10.1158%2F1535-7163.MCT-13-0847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siemeister, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lücking, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wengner, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schatz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegelbauer, K.</span></span> <span> </span><span class="NLM_article-title">BAY 1000394, a Novel Cyclin-Dependent Kinase Inhibitor, with Potent Antitumor Activity in Mono- and in Combination Treatment upon Oral Application</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2265</span>– <span class="NLM_lpage">2273</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-12-0286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1158%2F1535-7163.MCT-12-0286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=22821149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVyksrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=2265-2273&author=G.+Siemeisterauthor=U.+L%C3%BCckingauthor=A.+M.+Wengnerauthor=P.+Lienauauthor=W.+Steinkeauthor=C.+Schatzauthor=D.+Mumbergauthor=K.+Ziegelbauer&title=BAY+1000394%2C+a+Novel+Cyclin-Dependent+Kinase+Inhibitor%2C+with+Potent+Antitumor+Activity+in+Mono-+and+in+Combination+Treatment+upon+Oral+Application&doi=10.1158%2F1535-7163.MCT-12-0286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">BAY 1000394, a Novel Cyclin-Dependent Kinase Inhibitor, with Potent Antitumor Activity in Mono- and in Combination Treatment upon Oral Application</span></div><div class="casAuthors">Siemeister, Gerhard; Luecking, Ulrich; Wengner, Antje M.; Lienau, Philip; Steinke, Wolfram; Schatz, Christoph; Mumberg, Dominik; Ziegelbauer, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2265-2273</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Deregulated activity of cyclin-dependent kinases (CDK) results in loss of cell-cycle checkpoint function and increased expression of antiapoptotic proteins, which has been directly linked to the mol. pathol. of cancer.  BAY 1000394 inhibits the activity of cell-cycle CDKs CDK1, CDK2, CDK3, CDK4, and of transcriptional CDKs CDK7 and CDK9 with IC50 values in the range between 5 and 25 nmol/L.  Cell proliferation was inhibited at low nanomolar concn. in a broad spectrum of human cancer cell lines.  In cell-based assays, the inhibition of phosphorylation of the CDK substrates retinoblastoma protein, nucleophosmin, and RNA polymerase II was shown.  Cell-cycle profiles were consistent with inhibition of CDK 1, 2, and 4 as shown in cell-cycle block and release expts.  The physicochem. and pharmacokinetic properties of BAY 1000394 facilitate rapid absorption and moderate oral bioavailability.  The compd. potently inhibits growth of various human tumor xenografts on athymic mice including models of chemotherapy resistance upon oral dosing.  Furthermore, BAY 1000394 shows more than additive efficacy when combined with cisplatin and etoposide.  These results suggest that BAY 1000394 is a potent pan-CDK inhibitor and a novel oral cytotoxic agent currently in phase I clin. trials.  Mol Cancer Ther; 11(10); 2265-73. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBMnyCrxDjqbVg90H21EOLACvtfcHk0lhqLkAgJraACA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVyksrvK&md5=c175eacd5440b59b113a78a61a89a4b5</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0286%26sid%3Dliteratum%253Aachs%26aulast%3DSiemeister%26aufirst%3DG.%26aulast%3DL%25C3%25BCcking%26aufirst%3DU.%26aulast%3DWengner%26aufirst%3DA.%2BM.%26aulast%3DLienau%26aufirst%3DP.%26aulast%3DSteinke%26aufirst%3DW.%26aulast%3DSchatz%26aufirst%3DC.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3DZiegelbauer%26aufirst%3DK.%26atitle%3DBAY%25201000394%252C%2520a%2520Novel%2520Cyclin-Dependent%2520Kinase%2520Inhibitor%252C%2520with%2520Potent%2520Antitumor%2520Activity%2520in%2520Mono-%2520and%2520in%2520Combination%2520Treatment%2520upon%2520Oral%2520Application%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D2265%26epage%3D2273%26doi%3D10.1158%2F1535-7163.MCT-12-0286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polokoff, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochanny, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biroc, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alicke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckman, B. O.</span></span> <span> </span><span class="NLM_article-title">Novel Small Molecule Inhibitors of 3-Phosphoinositide-Dependent Kinase-1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">19867</span>– <span class="NLM_lpage">19874</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M501367200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=15772071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFylsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=19867-19874&author=R.+I.+Feldmanauthor=J.+M.+Wuauthor=M.+A.+Polokoffauthor=M.+J.+Kochannyauthor=H.+Dinterauthor=D.+Zhuauthor=S.+L.+Birocauthor=B.+Alickeauthor=J.+Bryantauthor=S.+Yuanauthor=B.+O.+Buckman&title=Novel+Small+Molecule+Inhibitors+of+3-Phosphoinositide-Dependent+Kinase-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Small Molecule Inhibitors of 3-Phosphoinositide-dependent Kinase-1</span></div><div class="casAuthors">Feldman, Richard I.; Wu, James M.; Polokoff, Mark A.; Kochanny, Monica J.; Dinter, Harald; Zhu, Daguang; Biroc, Sandra L.; Alicke, Bruno; Bryant, Judi; Yuan, Shendong; Buckman, Brad O.; Lentz, Dao; Ferrer, Mike; Whitlow, Marc; Adler, Marc; Finster, Silke; Chang, Zheng; Arnaiz, Damian O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">19867-19874</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The phosphoinositide 3-kinase/3-phosphoinositide-dependent kinase 1 (PDK1)/Akt signaling pathway plays a key role in cancer cell growth, survival, and tumor angiogenesis and represents a promising target for anticancer drugs.  Here, the authors describe three potent PDK1 inhibitors, BX-795, BX-912, and BX-320 (IC50 = 11-30 nM) and their initial biol. characterization.  The inhibitors blocked PDK1/Akt signaling in tumor cells and inhibited the anchorage-dependent growth of a variety of tumor cell lines in culture or induced apoptosis.  A no. of cancer cell lines with elevated Akt activity were >30-fold more sensitive to growth inhibition by PDK1 inhibitors in soft agar than on tissue culture plastic, consistent with the cell survival function of the PDK1/Akt signaling pathway, which is particularly important for unattached cells.  BX-320 inhibited the growth of LOX melanoma tumors in the lungs of nude mice after injection of tumor cells into the tail vein.  The effect of BX-320 on cancer cell growth in vitro and in vivo indicates that PDK1 inhibitors may have clin. utility as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh1M4rgv4qKbVg90H21EOLACvtfcHk0lhqLkAgJraACA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFylsLc%253D&md5=839db36e331b6a8f4c1335ae5df39226</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M501367200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M501367200%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DR.%2BI.%26aulast%3DWu%26aufirst%3DJ.%2BM.%26aulast%3DPolokoff%26aufirst%3DM.%2BA.%26aulast%3DKochanny%26aufirst%3DM.%2BJ.%26aulast%3DDinter%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DBiroc%26aufirst%3DS.%2BL.%26aulast%3DAlicke%26aufirst%3DB.%26aulast%3DBryant%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DBuckman%26aufirst%3DB.%2BO.%26atitle%3DNovel%2520Small%2520Molecule%2520Inhibitors%2520of%25203-Phosphoinositide-Dependent%2520Kinase-1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D19867%26epage%3D19874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plater, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peggie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">Use of the Pharmacological Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and IκB Kinase ∈:A Distinct Upstream Kinase Mediates Ser-172 Phosphorylation and Activation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">14136</span>– <span class="NLM_lpage">14146</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.000414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M109.000414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=19307177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvV2jtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=14136-14146&author=K.+Clarkauthor=L.+Platerauthor=M.+Peggieauthor=P.+Cohen&title=Use+of+the+Pharmacological+Inhibitor+BX795+to+Study+the+Regulation+and+Physiological+Roles+of+TBK1+and+I%CE%BAB+Kinase+%E2%88%88%3AA+Distinct+Upstream+Kinase+Mediates+Ser-172+Phosphorylation+and+Activation&doi=10.1074%2Fjbc.M109.000414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Use of the Pharmacological Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and IκB Kinase ε: a distinct upstream kinase mediates SER-172 phosphorylation and activation</span></div><div class="casAuthors">Clark, Kristopher; Plater, Lorna; Peggie, Mark; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">14136-14146</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">TANK-binding kinase 1 (TBK1) and IκB kinase ε (IKKε) regulate the prodn. of Type 1 interferons during bacterial and viral infection, but the lack of useful pharmacol. inhibitors has hampered progress in identifying addnl. physiol. roles of these protein kinases and how they are regulated.  Here we demonstrate that BX795, a potent and relatively specific inhibitor of TBK1 and IKKε, blocked the phosphorylation, nuclear translocation, and transcriptional activity of interferon regulatory factor 3 and, hence, the prodn. of interferon-β in macrophages stimulated with poly(I:C) or lipopolysaccharide (LPS).  In contrast, BX795 had no effect on the canonical NFκB signaling pathway.  Although BX795 blocked the autophosphorylation of overexpressed TBK1 and IKKε at Ser-172 and, hence, the autoactivation of these protein kinases, it did not inhibit the phosphorylation of endogenous TBK1 and IKKε at Ser-172 in response to LPS, poly(I:C), interleukin-1α (IL-1α), or tumor necrosis factor α and actually enhanced the LPS, poly(I:C), and IL-1α-stimulated phosphorylation of this residue.  These results demonstrate that the phosphorylation of Ser-172 and the activation of TBK1 and IKKε are catalyzed by a distinct protein kinase(s) in vivo and that TBK1 and IKKε control a feedback loop that limits their activation by LPS, poly(I:C) and IL-1α (but not tumor necrosis factor α) to prevent the hyperactivation of these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9ZqG2gYcFnLVg90H21EOLACvtfcHk0lhqLkAgJraACA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvV2jtbw%253D&md5=dd663b2022a4c832518cac557143799d</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.000414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.000414%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DK.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DPeggie%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DUse%2520of%2520the%2520Pharmacological%2520Inhibitor%2520BX795%2520to%2520Study%2520the%2520Regulation%2520and%2520Physiological%2520Roles%2520of%2520TBK1%2520and%2520I%25CE%25BAB%2520Kinase%2520%25E2%2588%2588%253AA%2520Distinct%2520Upstream%2520Kinase%2520Mediates%2520Ser-172%2520Phosphorylation%2520and%2520Activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D14136%26epage%3D14146%26doi%3D10.1074%2Fjbc.M109.000414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgeon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caflisch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hantschel, O.</span></span> <span> </span><span class="NLM_article-title">Specificity and Mechanism-of-Action of the JAK2 Tyrosine Kinase Inhibitors Ruxolitinib and SAR302503 (TG101348)</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">404</span>– <span class="NLM_lpage">407</span>, <span class="refDoi"> DOI: 10.1038/leu.2013.205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fleu.2013.205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23823659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsl2gtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=404-407&author=T.+Zhouauthor=S.+Georgeonauthor=R.+Moserauthor=D.+J.+Mooreauthor=A.+Caflischauthor=O.+Hantschel&title=Specificity+and+Mechanism-of-Action+of+the+JAK2+Tyrosine+Kinase+Inhibitors+Ruxolitinib+and+SAR302503+%28TG101348%29&doi=10.1038%2Fleu.2013.205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348)</span></div><div class="casAuthors">Zhou, T.; Georgeon, S.; Moser, R.; Moore, D. J.; Caflisch, A.; Hantschel, O.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">404-407</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-3vjA0n7DlLVg90H21EOLACvtfcHk0lgbFtraQ9TBsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsl2gtbk%253D&md5=7dbebd3eac60c3dd19026c9e3d3d3204</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1038%2Fleu.2013.205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2013.205%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DGeorgeon%26aufirst%3DS.%26aulast%3DMoser%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26aulast%3DCaflisch%26aufirst%3DA.%26aulast%3DHantschel%26aufirst%3DO.%26atitle%3DSpecificity%2520and%2520Mechanism-of-Action%2520of%2520the%2520JAK2%2520Tyrosine%2520Kinase%2520Inhibitors%2520Ruxolitinib%2520and%2520SAR302503%2520%2528TG101348%2529%26jtitle%3DLeukemia%26date%3D2014%26volume%3D28%26spage%3D404%26epage%3D407%26doi%3D10.1038%2Fleu.2013.205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGuzman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pak, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inagaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbach, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, U.</span></span> <span> </span><span class="NLM_article-title">The Novel Kinase Inhibitor PRT062070 (Cerdulatinib) Demonstrates Efficacy in Models of Autoimmunity and B-Cell Cancer</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">538</span>– <span class="NLM_lpage">548</span>, <span class="refDoi"> DOI: 10.1124/jpet.114.218164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1124%2Fjpet.114.218164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=25253883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyhsbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2014&pages=538-548&author=G.+Coffeyauthor=A.+Betzauthor=F.+DeGuzmanauthor=Y.+Pakauthor=M.+Inagakiauthor=D.+C.+Bakerauthor=S.+J.+Hollenbachauthor=A.+Pandeyauthor=U.+Sinha&title=The+Novel+Kinase+Inhibitor+PRT062070+%28Cerdulatinib%29+Demonstrates+Efficacy+in+Models+of+Autoimmunity+and+B-Cell+Cancer&doi=10.1124%2Fjpet.114.218164"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">The novel kinase inhibitor PRT062070 (Cerdulatinib) demonstrates efficacy in models of autoimmunity and B-cell cancer</span></div><div class="casAuthors">Coffey, Greg; Betz, Andreas; DeGuzman, Francis; Pak, Yvonne; Inagaki, Mayuko; Baker, Dale C.; Hollenbach, Stanley J.; Pandey, Anjali; Sinha, Uma</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">538-548, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The heterogeneity and severity of certain autoimmune diseases and B-cell malignancies warrant simultaneous targeting of multiple disease-relevant signaling pathways.  Dual inhibition of spleen tyrosine kinase (SYK) and Janus kinase (JAK) represents such a strategy and may elicit several benefits relative to selective kinase inhibition, such as gaining control over a broader array of disease etiologies, reducing probability of selection for bypass disease mechanisms, and the potential that an overall lower level suppression of individual targets may be sufficient to modulate disease activity.  To this end, we provide data on the discovery and preclin. development of PRT062070 [4-(cyclopropylamino)-2-({4-[4-(ethylsulfonyl)piperazin-1-yl]phenyl}amino)pyrimidine-5-carboxamide hydrochloride], an orally active kinase inhibitor that demonstrates activity against SYK and JAK.  Cellular assays demonstrated specific inhibitory activity against signaling pathways that use SYK and JAK1/3.  Limited inhibition of JAK2 was obsd., and PRT062070 did not inhibit phorbol 12-myristate 13-acetate-mediated signaling or activation in B and T cells nor T-cell antigen receptor-mediated signaling in T cells, providing evidence for selectivity of action.  Potent antitumor activity was obsd. in a subset of B-cell lymphoma cell lines.  After oral dosing, PRT062070 suppressed inflammation and autoantibody generation in a rat collagen-induced arthritis model and blocked B-cell activation and splenomegaly in a mouse model of chronic B-cell antigen receptor stimulation.  PRT062070 is currently under evaluation in a phase I dose escalation study in patients with B-cell leukemia and lymphoma (NCT01994382), with proof-of-concept studies in humans planned to assess therapeutic potential in autoimmune and malignant diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoblL0zhusaV7Vg90H21EOLACvtfcHk0lgbFtraQ9TBsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyhsbbF&md5=caed39628d643e4087ba88f7eaa51326</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.218164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.218164%26sid%3Dliteratum%253Aachs%26aulast%3DCoffey%26aufirst%3DG.%26aulast%3DBetz%26aufirst%3DA.%26aulast%3DDeGuzman%26aufirst%3DF.%26aulast%3DPak%26aufirst%3DY.%26aulast%3DInagaki%26aufirst%3DM.%26aulast%3DBaker%26aufirst%3DD.%2BC.%26aulast%3DHollenbach%26aufirst%3DS.%2BJ.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DSinha%26aufirst%3DU.%26atitle%3DThe%2520Novel%2520Kinase%2520Inhibitor%2520PRT062070%2520%2528Cerdulatinib%2529%2520Demonstrates%2520Efficacy%2520in%2520Models%2520of%2520Autoimmunity%2520and%2520B-Cell%2520Cancer%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D351%26spage%3D538%26epage%3D548%26doi%3D10.1124%2Fjpet.114.218164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGuzman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbach, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, U.</span></span> <span> </span><span class="NLM_article-title">PRT062070: A Dual Syk/JAK Inhibitor with Potent Immune Regulatory Capacity in Rodent Models of Inflammation and Cancer</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">2764</span>, <span class="refDoi"> DOI: 10.1182/blood.V120.21.2764.2764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1182%2Fblood.V120.21.2764.2764" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=2764&author=G.+Coffeyauthor=F.+DeGuzmanauthor=G.+Leeauthor=L.+Kamenauthor=D.+Bakerauthor=S.+J.+Hollenbachauthor=A.+Pandeyauthor=U.+Sinha&title=PRT062070%3A+A+Dual+Syk%2FJAK+Inhibitor+with+Potent+Immune+Regulatory+Capacity+in+Rodent+Models+of+Inflammation+and+Cancer&doi=10.1182%2Fblood.V120.21.2764.2764"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1182%2Fblood.V120.21.2764.2764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V120.21.2764.2764%26sid%3Dliteratum%253Aachs%26aulast%3DCoffey%26aufirst%3DG.%26aulast%3DDeGuzman%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DKamen%26aufirst%3DL.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DHollenbach%26aufirst%3DS.%2BJ.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DSinha%26aufirst%3DU.%26atitle%3DPRT062070%253A%2520A%2520Dual%2520Syk%252FJAK%2520Inhibitor%2520with%2520Potent%2520Immune%2520Regulatory%2520Capacity%2520in%2520Rodent%2520Models%2520of%2520Inflammation%2520and%2520Cancer%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D2764%26doi%3D10.1182%2Fblood.V120.21.2764.2764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, A.</span>; <span class="NLM_string-name">Coffey, G.</span>; <span class="NLM_string-name">Leeds, J.</span></span> <span> </span><span class="NLM_article-title">Cerdulatinib for the Treatment of B-Cell Malignancies</span>. WO<span class="NLM_patent">2016/196385 A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Pandey&author=G.+Coffey&author=J.+Leeds&title=Cerdulatinib+for+the+Treatment+of+B-Cell+Malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DA.%26atitle%3DCerdulatinib%2520for%2520the%2520Treatment%2520of%2520B-Cell%2520Malignancies%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dugo, M.</span></span> <i>Dissecting Melanoma Heterogeneity by Integrative Genomic Analysis for Tailored Anti-Cancer Therapy</i>. Ph.D. Thesis, <span class="NLM_publisher-name">The Open University</span>, <span class="NLM_publisher-loc">United Kingdom</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+Dugo&title=Dissecting+Melanoma+Heterogeneity+by+Integrative+Genomic+Analysis+for+Tailored+Anti-Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDugo%26aufirst%3DM.%26jtitle%3DDissecting%2520Melanoma%2520Heterogeneity%2520by%2520Integrative%2520Genomic%2520Analysis%2520for%2520Tailored%2520Anti-Cancer%2520Therapy%26pub%3DThe%2520Open%2520University%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gingrich, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisko, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albom, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeles, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aimone, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haltiwanger, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells-Knecht, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ator, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, B. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of an Orally Efficacious Inhibitor of Anaplastic Lymphoma Kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4580</span>– <span class="NLM_lpage">4593</span>, <span class="refDoi"> DOI: 10.1021/jm201550q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201550q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms1Sks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4580-4593&author=D.+E.+Gingrichauthor=J.+G.+Liskoauthor=M.+A.+Curryauthor=M.+Chengauthor=M.+Quailauthor=L.+Luauthor=W.+Wanauthor=M.+S.+Albomauthor=T.+S.+Angelesauthor=L.+D.+Aimoneauthor=R.+C.+Haltiwangerauthor=K.+Wells-Knechtauthor=G.+R.+Ottauthor=A.+K.+Ghoseauthor=M.+A.+Atorauthor=B.+Ruggeriauthor=B.+D.+Dorsey&title=Discovery+of+an+Orally+Efficacious+Inhibitor+of+Anaplastic+Lymphoma+Kinase&doi=10.1021%2Fjm201550q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an orally efficacious inhibitor of anaplastic lymphoma kinase</span></div><div class="casAuthors">Gingrich, Diane E.; Lisko, Joseph G.; Curry, Matthew A.; Cheng, Mangeng; Quail, Matthew; Lu, Lihui; Wan, Weihua; Albom, Mark S.; Angeles, Thelma S.; Aimone, Lisa D.; Haltiwanger, R. Curtis; Wells-Knecht, Kevin; Ott, Gregory R.; Ghose, Arup K.; Ator, Mark A.; Ruggeri, Bruce; Dorsey, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4580-4593</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Anaplastic lymphoma kinase (ALK) is a promising therapeutic target for the treatment of cancer, supported by considerable favorable preclin. and clin. activities over the past several years and culminating in the recent FDA approval of the ALK inhibitor crizotinib.  Through a series of targeted modifications on an ALK inhibitor diaminopyrimidine scaffold, our research group has driven improvements in ALK potency, kinase selectivity, and overall pharmaceutical properties.  Optimization of this scaffold has led to the identification of a potent and efficacious inhibitor of ALK, I.  A striking feature of I over previously described ALK inhibitors is its >600-fold selectivity over insulin receptor (IR), a closely related kinase family member.  Most importantly, I exhibited dose proportional escalation in rat compared to compd. 3 which suffered dose limiting absorption preventing further advancement.  Compd. I exhibited significant in vivo antitumor efficacy when dosed orally in an ALK-pos. ALCL tumor xenograft model in SCID mice, warranting further assessment in advanced preclin. models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX3rG4B6V3Y7Vg90H21EOLACvtfcHk0liljEJzmtzICQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms1Sks7s%253D&md5=f0592f6eb9d22a5b8e70ab5d3499f821</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Fjm201550q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201550q%26sid%3Dliteratum%253Aachs%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26aulast%3DLisko%26aufirst%3DJ.%2BG.%26aulast%3DCurry%26aufirst%3DM.%2BA.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DQuail%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DWan%26aufirst%3DW.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DHaltiwanger%26aufirst%3DR.%2BC.%26aulast%3DWells-Knecht%26aufirst%3DK.%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3DDiscovery%2520of%2520an%2520Orally%2520Efficacious%2520Inhibitor%2520of%2520Anaplastic%2520Lymphoma%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4580%26epage%3D4593%26doi%3D10.1021%2Fjm201550q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katayama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lifshits, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakespeare, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iafrate, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A. T.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Strategies to Overcome Crizotinib Resistance in Non-Small Cell Lung Cancers Harboring the Fusion Oncogene EML4-ALK</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">7535</span>– <span class="NLM_lpage">7540</span>, <span class="refDoi"> DOI: 10.1073/pnas.1019559108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1073%2Fpnas.1019559108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=21502504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFSrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=7535-7540&author=R.+Katayamaauthor=T.+M.+Khanauthor=C.+Benesauthor=E.+Lifshitsauthor=H.+Ebiauthor=V.+M.+Riveraauthor=W.+C.+Shakespeareauthor=A.+J.+Iafrateauthor=J.+A.+Engelmanauthor=A.+T.+Shaw&title=Therapeutic+Strategies+to+Overcome+Crizotinib+Resistance+in+Non-Small+Cell+Lung+Cancers+Harboring+the+Fusion+Oncogene+EML4-ALK&doi=10.1073%2Fpnas.1019559108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK</span></div><div class="casAuthors">Katayama, Ryohei; Khan, Tahsin M.; Benes, Cyril; Lifshits, Eugene; Ebi, Hiromichi; Rivera, Victor M.; Shakespeare, William C.; Iafrate, A. John; Engelman, Jeffrey A.; Shaw, Alice T.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7535-7540, S7535/1-S7535/17</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The echinoderm microtubule-assocd. protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) fusion oncogene represents a mol. target in a small subset of non-small cell lung cancers (NSCLCs).  This fusion leads to constitutive ALK activation with potent transforming activity.  In a pivotal phase 1 clin. trial, the ALK tyrosine kinase inhibitor (TKI) crizotinib (PF-02341066) demonstrated impressive antitumor activity in the majority of patients with NSCLC harboring ALK fusions.  However, despite these remarkable initial responses, cancers eventually develop resistance to crizotinib, usually within 1 y, thereby limiting the potential clin. benefit.  To det. how cancers acquire resistance to ALK inhibitors, we established a model of acquired resistance to crizotinib by exposing a highly sensitive EML4-ALK-pos. NSCLC cell line to increasing doses of crizotinib until resistance emerged.  We found that cells resistant to intermediate doses of crizotinib developed amplification of the EML4-ALK gene.  Cells resistant to higher doses (1 μM) also developed a gatekeeper mutation, L1196M, within the kinase domain, rendering EML4-ALK insensitive to crizotinib.  This gatekeeper mutation was readily detected using a unique and highly sensitive allele-specific PCR assay.  Although crizotinib was ineffectual against EML4-ALK harboring the gatekeeper mutation, we obsd. that two structurally different ALK inhibitors, NVPTAE684 and AP26113, were highly active against the resistant cancer cells in vitro and in vivo.  Furthermore, these resistant cells remained highly sensitive to the Hsp90 inhibitor 17-AAG.  Thus, we have developed a model of acquired resistance to ALK inhibitors and have shown that second-generation ALK TKIs or Hsp90 inhibitors are effective in treating crizotinib-resistant tumors harboring secondary gatekeeper mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPbiLG5xpg0LVg90H21EOLACvtfcHk0liljEJzmtzICQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFSrsbY%253D&md5=82f47736429e6f71f9fd5852e4df64cb</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1019559108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1019559108%26sid%3Dliteratum%253Aachs%26aulast%3DKatayama%26aufirst%3DR.%26aulast%3DKhan%26aufirst%3DT.%2BM.%26aulast%3DBenes%26aufirst%3DC.%26aulast%3DLifshits%26aufirst%3DE.%26aulast%3DEbi%26aufirst%3DH.%26aulast%3DRivera%26aufirst%3DV.%2BM.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26atitle%3DTherapeutic%2520Strategies%2520to%2520Overcome%2520Crizotinib%2520Resistance%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancers%2520Harboring%2520the%2520Fusion%2520Oncogene%2520EML4-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D7535%26epage%3D7540%26doi%3D10.1073%2Fpnas.1019559108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edupuganti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taliaferro, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidhu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anslyn, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartholomeusz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalby, K. N.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potent Inhibitor of MELK That Inhibits Expression of the Anti-Apoptotic Protein Mcl-1 and TNBC Cell Growth</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2609</span>– <span class="NLM_lpage">2616</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.bmc.2017.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=28351607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltVajtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=2609-2616&author=R.+Edupugantiauthor=J.+M.+Taliaferroauthor=Q.+Wangauthor=X.+Xieauthor=E.+J.+Choauthor=F.+Vidhuauthor=P.+Renauthor=E.+V.+Anslynauthor=C.+Bartholomeuszauthor=K.+N.+Dalby&title=Discovery+of+a+Potent+Inhibitor+of+MELK+That+Inhibits+Expression+of+the+Anti-Apoptotic+Protein+Mcl-1+and+TNBC+Cell+Growth&doi=10.1016%2Fj.bmc.2017.03.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent inhibitor of MELK that inhibits expression of the anti-apoptotic protein Mcl-1 and TNBC cell growth</span></div><div class="casAuthors">Edupuganti, Ramakrishna; Taliaferro, Juliana M.; Wang, Qiantao; Xie, Xuemei; Cho, Eun Jeong; Vidhu, Fnu; Ren, Pengyu; Anslyn, Eric V.; Bartholomeusz, Chandra; Dalby, Kevin N.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2609-2616</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Despite recent advances in molecularly directed therapy, triple neg. breast cancer (TNBC) remains one of the most aggressive forms of breast cancer, still without a suitable target for specific inhibitors.  Maternal embryonic leucine zipper kinase (MELK) is highly expressed in TNBC, where level of overexpression correlates with poor prognosis and an aggressive disease course.  Herein, the authors describe the discovery through targeted kinase inhibitor library screening, and structure-guided design of a series of ATP-competitive indolinone derivs. with subnanomolar inhibition consts. towards MELK.  The most potent compd., I, inhibits the expression of the antiapoptotic protein Mcl-1 and proliferation of TNBC cells exhibiting selectivity for cells expressing high levels of MELK.  These studies suggest that further elaboration of I will furnish MELK-selective inhibitors with potential for development in preclin. models of TNBC and other cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp3HNGNHlJNbVg90H21EOLACvtfcHk0liljEJzmtzICQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltVajtLs%253D&md5=acfe499443cf870620959e83ff7fe037</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DEdupuganti%26aufirst%3DR.%26aulast%3DTaliaferro%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DCho%26aufirst%3DE.%2BJ.%26aulast%3DVidhu%26aufirst%3DF.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DAnslyn%26aufirst%3DE.%2BV.%26aulast%3DBartholomeusz%26aufirst%3DC.%26aulast%3DDalby%26aufirst%3DK.%2BN.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520Inhibitor%2520of%2520MELK%2520That%2520Inhibits%2520Expression%2520of%2520the%2520Anti-Apoptotic%2520Protein%2520Mcl-1%2520and%2520TNBC%2520Cell%2520Growth%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D2609%26epage%3D2616%26doi%3D10.1016%2Fj.bmc.2017.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karaman, M. W</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallant, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atteridge, C. E</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, B. T</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. W</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. I</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edeen, P. T</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faraoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. P</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, D. J</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milanov, Z. V</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, M. J</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallares, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. K</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritchard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P</span></span> <span> </span><span class="NLM_article-title">A Quantitative Analysis of Kinase Inhibitor Selectivity</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1038/nbt1358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W+Karamanauthor=S.+Herrgardauthor=D.+K+Treiberauthor=P.+Gallantauthor=C.+E+Atteridgeauthor=B.+T+Campbellauthor=K.+W+Chanauthor=P.+Ciceriauthor=M.+I+Davisauthor=P.+T+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P+Huntauthor=D.+J+Lockhartauthor=Z.+V+Milanovauthor=M.+J+Morrisonauthor=G.+Pallaresauthor=H.+K+Patelauthor=S.+Pritchardauthor=L.+M+Wodickaauthor=P.+P+Zarrinkar&title=A+Quantitative+Analysis+of+Kinase+Inhibitor+Selectivity&doi=10.1038%2Fnbt1358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0lhHQKdxDZhFgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE%26aulast%3DCampbell%26aufirst%3DB.%2BT%26aulast%3DChan%26aufirst%3DK.%2BW%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI%26aulast%3DEdeen%26aufirst%3DP.%2BT%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP%26aulast%3DLockhart%26aufirst%3DD.%2BJ%26aulast%3DMilanov%26aufirst%3DZ.%2BV%26aulast%3DMorrison%26aufirst%3DM.%2BJ%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM%26aulast%3DZarrinkar%26aufirst%3DP.%2BP%26atitle%3DA%2520Quantitative%2520Analysis%2520of%2520Kinase%2520Inhibitor%2520Selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132%26doi%3D10.1038%2Fnbt1358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">N’guyen, C.-H.</span>; <span class="NLM_string-name">Molla, A.</span></span> <span> </span><span class="NLM_article-title">Amino-Substituted-Alkyloxy-Benzo [e] Pyrido [4, 3-b] Indole Derivatives as New Potent Kinase Inhibitors</span>. US<span class="NLM_patent">2014073637</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.-H.+N%E2%80%99guyen&author=A.+Molla&title=Amino-Substituted-Alkyloxy-Benzo+%5Be%5D+Pyrido+%5B4%2C+3-b%5D+Indole+Derivatives+as+New+Potent+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DN%25E2%2580%2599guyen%26aufirst%3DC.-H.%26atitle%3DAmino-Substituted-Alkyloxy-Benzo%2520%255Be%255D%2520Pyrido%2520%255B4%252C%25203-b%255D%2520Indole%2520Derivatives%2520as%2520New%2520Potent%2520Kinase%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matuszkiewicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoshino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halkowycz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teratani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimshaw, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paraselli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, R.</span></span> <span> </span><span class="NLM_article-title">Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase Inhibitor</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-12-0657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1158%2F1535-7163.MCT-12-0657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=23358665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXls12qs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=460-470&author=P.+Farrellauthor=L.+Shiauthor=J.+Matuszkiewiczauthor=D.+Balakrishnaauthor=T.+Hoshinoauthor=L.+Zhangauthor=S.+Elliottauthor=R.+Fabreyauthor=B.+Leeauthor=P.+Halkowyczauthor=B.+Sangauthor=S.+Ishinoauthor=T.+Nomuraauthor=M.+Terataniauthor=Y.+Ohtaauthor=C.+Grimshawauthor=B.+Paraselliauthor=T.+Satouauthor=R.+de+Jong&title=Biological+Characterization+of+TAK-901%2C+an+Investigational%2C+Novel%2C+Multitargeted+Aurora+B+Kinase+Inhibitor&doi=10.1158%2F1535-7163.MCT-12-0657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase Inhibitor</span></div><div class="casAuthors">Farrell, Pamela; Shi, Lihong; Matuszkiewicz, Jennifer; Balakrishna, Deepika; Hoshino, Takashi; Zhang, Lilly; Elliott, Sarah; Fabrey, Robyn; Lee, Bumsup; Halkowycz, Petro; Sang, BiChing; Ishino, Seigo; Nomura, Toshiyuki; Teratani, Mika; Ohta, Yoshikazu; Grimshaw, Charles; Paraselli, Bheema; Satou, Takashi; de Jong, Ron</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">460-470</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Protein kinases Aurora A, B, and C play essential roles during mitosis and cell division, are frequently elevated in cancer, and represent attractive targets for therapeutic intervention.  TAK-901 is an investigational, multitargeted Aurora B kinase inhibitor derived from a novel azacarboline kinase hinge-binder chemotype.  TAK-901 exhibited time-dependent, tight-binding inhibition of Aurora B, but not Aurora A. Consistent with Aurora B inhibition, TAK-901 suppressed cellular histone H3 phosphorylation and induced polyploidy.  In various human cancer cell lines, TAK-901 inhibited cell proliferation with effective concn. values from 40 to 500 nmol/L.  Examn. of a broad panel of kinases in biochem. assays revealed inhibition of multiple kinases.  However, TAK-901 potently inhibited only a few kinases other than Aurora B in intact cells, including FLT3 and FGFR2.  In rodent xenografts, TAK-901 exhibited potent activity against multiple human solid tumor types, and complete regression was obsd. in the ovarian cancer A2780 model.  TAK-901 also displayed potent activity against several leukemia models.  In vivo biomarker studies showed that TAK-901 induced pharmacodynamic responses consistent with Aurora B inhibition and correlating with retention of TAK-901 in tumor tissue.  These preclin. data highlight the therapeutic potential of TAK-901, which has entered phase I clin. trials in patients within a diverse range of cancers.  Mol Cancer Ther; 12(4); 460-70. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Jmz5iJm_9bVg90H21EOLACvtfcHk0lhHQKdxDZhFgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXls12qs78%253D&md5=b91ec09d97e96f2612b10e3c419c5682</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0657%26sid%3Dliteratum%253Aachs%26aulast%3DFarrell%26aufirst%3DP.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DMatuszkiewicz%26aufirst%3DJ.%26aulast%3DBalakrishna%26aufirst%3DD.%26aulast%3DHoshino%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DS.%26aulast%3DFabrey%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DHalkowycz%26aufirst%3DP.%26aulast%3DSang%26aufirst%3DB.%26aulast%3DIshino%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DTeratani%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DY.%26aulast%3DGrimshaw%26aufirst%3DC.%26aulast%3DParaselli%26aufirst%3DB.%26aulast%3DSatou%26aufirst%3DT.%26aulast%3Dde%2BJong%26aufirst%3DR.%26atitle%3DBiological%2520Characterization%2520of%2520TAK-901%252C%2520an%2520Investigational%252C%2520Novel%252C%2520Multitargeted%2520Aurora%2520B%2520Kinase%2520Inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D460%26epage%3D470%26doi%3D10.1158%2F1535-7163.MCT-12-0657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le, L. T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couvet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coll, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Benzo[e]Pyridoindolones as Kinase Inhibitors That Disrupt Mitosis Exit While Erasing AMPK-Thr172 Phosphorylation on the Spindle</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">22152</span>– <span class="NLM_lpage">22166</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.4158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.18632%2Foncotarget.4158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26247630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A280%3ADC%252BC287gtlOjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=22152-22166&author=L.+T.+T.+Leauthor=M.+Couvetauthor=B.+Favierauthor=J.+L.+Collauthor=C.+H.+Nguyenauthor=A.+Molla&title=Discovery+of+Benzo%5Be%5DPyridoindolones+as+Kinase+Inhibitors+That+Disrupt+Mitosis+Exit+While+Erasing+AMPK-Thr172+Phosphorylation+on+the+Spindle&doi=10.18632%2Foncotarget.4158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of benzo[e]pyridoindolones as kinase inhibitors that disrupt mitosis exit while erasing AMPK-Thr172 phosphorylation on the spindle</span></div><div class="casAuthors">Le Ly-Thuy-Tram; Couvet Morgane; Coll Jean-Luc; Molla Annie; Le Ly-Thuy-Tram; Favier Bertrand; Nguyen Chi-Hung</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">22152-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aurora kinases play an essential role in mitotic progression and are attractive targets in cancer therapy.  The first generation of benzo[e]pyridoindole exhibited powerful aurora kinase inhibition but their low solubility limited further development.  Grafting a pyperidine-ethoxy group gives rise to a hydrosoluble inhibitor: compound C5M.C5M could efficiently inhibit the proliferation of cells from different origins.  C5M prevented cell cycling, induced a strong mitotic arrest then, cells became polyploid and finally died.  C5M did not impair the spindle checkpoint, the separation of the sister chromatids and the transfer of aurora B on the mid-zone.  C5M prevented histone H3 phosphorylation at mitotic entry and erased AMPK-Thr172 phosphorylation in late mitosis.  With this unique profile of inhibition, C5M could be useful for understanding the role of phospho-Thr172-AMPK in abscission and the relationship between the chromosomal complex and the energy sensing machinery.C5M is a multikinase inhibitor with interesting preclinical characteristics: high hydro-solubility and a good stability in plasma.  A single dose prevents the expansion of multicellular spheroids.  C5M can safely be injected to mice and reduces significantly the development of xenograft.  The next step will be to define the protocol of treatment and the cancer therapeutic field of this new anti-proliferative drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpml7l8mkX0A20zIbnCCI3fW6udTcc2eambwQbH1j9RLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287gtlOjsA%253D%253D&md5=43dd810d96e3d9583f49d053b48771f4</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.4158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.4158%26sid%3Dliteratum%253Aachs%26aulast%3DLe%26aufirst%3DL.%2BT.%2BT.%26aulast%3DCouvet%26aufirst%3DM.%26aulast%3DFavier%26aufirst%3DB.%26aulast%3DColl%26aufirst%3DJ.%2BL.%26aulast%3DNguyen%26aufirst%3DC.%2BH.%26aulast%3DMolla%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520Benzo%255Be%255DPyridoindolones%2520as%2520Kinase%2520Inhibitors%2520That%2520Disrupt%2520Mitosis%2520Exit%2520While%2520Erasing%2520AMPK-Thr172%2520Phosphorylation%2520on%2520the%2520Spindle%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D22152%26epage%3D22166%26doi%3D10.18632%2Foncotarget.4158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, T.</span>; <span class="NLM_string-name">Koolman, H.</span></span> <span> </span><span class="NLM_article-title">Thiazole Derivatives for the Treatment of Diseases Such as Cancer</span>. US<span class="NLM_patent">8703961 B2</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+Heinrich&author=H.+Koolman&title=Thiazole+Derivatives+for+the+Treatment+of+Diseases+Such+as+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DT.%26atitle%3DThiazole%2520Derivatives%2520for%2520the%2520Treatment%2520of%2520Diseases%2520Such%2520as%2520Cancer%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeely, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dempsey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blosser, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, M. S.</span></span> <span> </span><span class="NLM_article-title">LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2004</span>– <span class="NLM_lpage">2013</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-1037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1158%2F1535-7163.MCT-14-1037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26141948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVegs7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=2004-2013&author=C.+Kingauthor=H.+B.+Diazauthor=S.+McNeelyauthor=D.+Barnardauthor=J.+Dempseyauthor=W.+Blosserauthor=R.+Beckmannauthor=D.+Bardaauthor=M.+S.+Marshall&title=LY2606368+Causes+Replication+Catastrophe+and+Antitumor+Effects+through+CHK1-Dependent+Mechanisms&doi=10.1158%2F1535-7163.MCT-14-1037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms</span></div><div class="casAuthors">King, Constance; Diaz, H. Bruce; McNeely, Samuel; Barnard, Darlene; Dempsey, Jack; Blosser, Wayne; Beckmann, Richard; Barda, David; Marshall, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2004-2013</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">CHK1 is a multifunctional protein kinase integral to both the cellular response to DNA damage and control of the no. of active replication forks.  CHK1 inhibitors are currently under investigation as chemopotentiating agents due to CHK1's role in establishing DNA damage checkpoints in the cell cycle.  Here, we describe the characterization of a novel CHK1 inhibitor, LY2606368, which as a single agent causes double-stranded DNA breakage while simultaneously removing the protection of the DNA damage checkpoints.  The action of LY2606368 is dependent upon inhibition of CHK1 and the corresponding increase in CDC25A activation of CDK2, which increases the no. of replication forks while reducing their stability.  Treatment of cells with LY2606368 results in the rapid appearance of TUNEL and pH2AX-pos. double-stranded DNA breaks in the S-phase cell population.  Loss of the CHK1-dependent DNA damage checkpoints permits cells with damaged DNA to proceed into early mitosis and die.  The majority of treated mitotic nuclei consist of extensively fragmented chromosomes.  Inhibition of apoptosis by the caspase inhibitor Z-VAD-FMK had no effect on chromosome fragmentation, indicating that LY2606368 causes replication catastrophe.  Changes in the ratio of RPA2 to phosphorylated H2AX following LY2606368 treatment further support replication catastrophe as the mechanism of DNA damage.  LY2606368 shows similar activity in xenograft tumor models, which results in significant tumor growth inhibition.  LY2606368 is a potent representative of a novel class of drugs for the treatment of cancer that acts through replication catastrophe.  Mol Cancer Ther; 14(9); 2004-13. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSZ3pHCHoj6LVg90H21EOLACvtfcHk0ljWNhRLSQ8poQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVegs7vK&md5=ae5d36fc1ac012bdbb5228e38001db38</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-1037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-1037%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DC.%26aulast%3DDiaz%26aufirst%3DH.%2BB.%26aulast%3DMcNeely%26aufirst%3DS.%26aulast%3DBarnard%26aufirst%3DD.%26aulast%3DDempsey%26aufirst%3DJ.%26aulast%3DBlosser%26aufirst%3DW.%26aulast%3DBeckmann%26aufirst%3DR.%26aulast%3DBarda%26aufirst%3DD.%26aulast%3DMarshall%26aufirst%3DM.%2BS.%26atitle%3DLY2606368%2520Causes%2520Replication%2520Catastrophe%2520and%2520Antitumor%2520Effects%2520through%2520CHK1-Dependent%2520Mechanisms%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D2004%26epage%3D2013%26doi%3D10.1158%2F1535-7163.MCT-14-1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shpiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S. C.</span></span> <span> </span><span class="NLM_article-title">Comparison of the Specificity of Trk Inhibitors in Recombinant and Neuronal Assays</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2011.03.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.neuropharm.2011.03.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=21466816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslynsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=148-155&author=K.+J.+Martinauthor=N.+Shpiroauthor=R.+Traynorauthor=M.+Elliottauthor=J.+S.+C.+Arthur&title=Comparison+of+the+Specificity+of+Trk+Inhibitors+in+Recombinant+and+Neuronal+Assays&doi=10.1016%2Fj.neuropharm.2011.03.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the specificity of Trk inhibitors in recombinant and neuronal assays</span></div><div class="casAuthors">Martin, Kirsty J.; Shpiro, Natalia; Traynor, Ryan; Elliott, Matthew; Arthur, J. Simon C.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">148-155</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurotrophins are important mediators of neuronal development, survival and plasticity.  They act via binding to Trk receptors, which results in the stimulation of the intracellular tyrosine kinase domain of the receptor leading to autophosphorylation of this domain.  This in turn creates a scaffold that recruits various adapter proteins allowing the activation of intracellular signaling cascades including the PLCγ, MAPK and PI3K pathways.  Compds. that specifically block the activity of the tyrosine kinase domain of Trk receptors would provide a powerful tool to study the role of these receptors in cells.  K252a has previously been used for this purpose, however the authors show here that it can inhibit many tyrosine and serine/threonine kinases in vitro.  Profiling of 3 newer inhibitors, referred to here as SHN-753, SHN-722 and GSK-Trk, demonstrate that they have significantly improved specificity for the kinase activity of TrkA in vitro compared to K252a.  In addn. these compds. were found to block the TrkB mediated activation of ERK1/2 by BDNF, but did not affect NMDA induced ERK1/2 activation.  These compds., while still not completely specific for Trk receptor kinase activity, do represent a considerable improvement over K252a and should prove valuable in the study of neurotrophin-mediated actions in the nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcrkOys9w847Vg90H21EOLACvtfcHk0ljWNhRLSQ8poQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslynsL4%253D&md5=27a8a1b990598241d5914a51d3965d0c</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2011.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2011.03.021%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DK.%2BJ.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DTraynor%26aufirst%3DR.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26atitle%3DComparison%2520of%2520the%2520Specificity%2520of%2520Trk%2520Inhibitors%2520in%2520Recombinant%2520and%2520Neuronal%2520Assays%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D61%26spage%3D148%26epage%3D155%26doi%3D10.1016%2Fj.neuropharm.2011.03.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gozgit, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bebernitz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huszar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinda, M.</span></span> <span> </span><span class="NLM_article-title">Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-XL Survival Signaling in the Human JAK2 V617F Cell Line SET-2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">32334</span>– <span class="NLM_lpage">32343</span>, <span class="refDoi"> DOI: 10.1074/jbc.M803813200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1074%2Fjbc.M803813200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=18775810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOjtL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=32334-32343&author=J.+M.+Gozgitauthor=G.+Bebernitzauthor=P.+Patilauthor=M.+Yeauthor=J.+Parmentierauthor=J.+Wuauthor=N.+Suauthor=T.+Wangauthor=S.+Ioannidisauthor=A.+Daviesauthor=D.+Huszarauthor=M.+Zinda&title=Effects+of+the+JAK2+Inhibitor%2C+AZ960%2C+on+Pim%2FBAD%2FBCL-XL+Survival+Signaling+in+the+Human+JAK2+V617F+Cell+Line+SET-2&doi=10.1074%2Fjbc.M803813200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-xL Survival Signaling in the Human JAK2 V617F Cell Line SET-2</span></div><div class="casAuthors">Gozgit, Joseph M.; Bebernitz, Geraldine; Patil, Pankaj; Ye, Minwei; Parmentier, Julie; Wu, Jiaquan; Su, Nancy; Wang, Tao; Ioannidis, Stephanos; Davies, Audrey; Huszar, Dennis; Zinda, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">32334-32343</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The Janus-assocd. kinase 2 (JAK2) V617F mutation is believed to play a crit. role in the pathogenesis of polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis.  We have characterized a novel small mol. JAK2 inhibitor, AZ960, and used it as a tool to investigate the consequences of JAK2 V617F inhibition in the SET-2 cell line.  AZ960 inhibits JAK2 kinase with a Ki of 0.00045 μM in vitro and treatment of TEL-JAK2 driven Ba/F3 cells with AZ960 blocked STAT5 phosphorylation and potently inhibited cell proliferation (GI50 = 0.025 μM).  AZ960 demonstrated selectivity for TEL-JAK2-driven STAT5 phosphorylation and cell proliferation when compared with cell lines driven by similar fusions of the other JAK kinase family members.  In the SET-2 human megakaryoblastic cell line, heterozygous for the JAK2 V617F allele, inhibition of JAK2 resulted in decreased STAT3/5 phosphorylation and inhibition of cell proliferation (GI50 = 0.033 μM) predominately through the induction of mitochondrial-mediated apoptosis.  We provide evidence that JAK2 inhibition induces apoptosis by direct and indirect regulation of the anti-apoptotic protein BCL-xL.  Inhibition of JAK2 blocked BCL-XL mRNA expression resulting in a redn. of BCL-xL protein levels.  Addnl., inhibition of JAK2 resulted in decreased PIM1 and PIM2 mRNA expression.  Decreased PIM1 mRNA corresponded with a decrease in Pim1 protein levels and inhibition of BAD phosphorylation at Ser112.  Finally, small interfering RNA-mediated suppression of BCL-xL resulted in apoptotic cell death similar to the phenotype obsd. following JAK2 inhibition.  These results suggest a model in which JAK2 promotes cell survival by signaling through the Pim/BAD/BCL-xL pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSkGcqoxCVmrVg90H21EOLACvtfcHk0lhxA9xDxCRc9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOjtL%252FE&md5=c06798f302c0c0b50d4c763ae5c731c3</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M803813200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M803813200%26sid%3Dliteratum%253Aachs%26aulast%3DGozgit%26aufirst%3DJ.%2BM.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DPatil%26aufirst%3DP.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DParmentier%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DA.%26aulast%3DHuszar%26aufirst%3DD.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DEffects%2520of%2520the%2520JAK2%2520Inhibitor%252C%2520AZ960%252C%2520on%2520Pim%252FBAD%252FBCL-XL%2520Survival%2520Signaling%2520in%2520the%2520Human%2520JAK2%2520V617F%2520Cell%2520Line%2520SET-2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D32334%26epage%3D32343%26doi%3D10.1074%2Fjbc.M803813200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinsmore, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elwood, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibeau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraybill, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapointe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. R.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design and Development of (Benz)Imidazole Pyridones as JAK1-Selective Kinase Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1803</span>– <span class="NLM_lpage">1808</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.02.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1016%2Fj.bmcl.2016.02.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26927423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt12mtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1803-1808&author=V.+Simovauthor=S.+V.+Deshmukhauthor=C.+J.+Dinsmoreauthor=F.+Elwoodauthor=R.+B.+Fernandezauthor=Y.+Garciaauthor=C.+Gibeauauthor=H.+Gunaydinauthor=J.+Jungauthor=J.+D.+Katzauthor=B.+Kraybillauthor=B.+Lapointeauthor=S.+B.+Patelauthor=T.+Siuauthor=H.+Suauthor=J.+R.+Young&title=Structure-Based+Design+and+Development+of+%28Benz%29Imidazole+Pyridones+as+JAK1-Selective+Kinase+Inhibitors&doi=10.1016%2Fj.bmcl.2016.02.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design and development of (benz)imidazole pyridones as JAK1-selective kinase inhibitors</span></div><div class="casAuthors">Simov, Vladimir; Deshmukh, Sujal V.; Dinsmore, Christopher J.; Elwood, Fiona; Fernandez, Rafael B.; Garcia, Yudith; Gibeau, Craig; Gunaydin, Hakan; Jung, Joon; Katz, Jason D.; Kraybill, Brian; Lapointe, Blair; Patel, Sangita B.; Siu, Tony; Su, Hua; Young, Jonathan R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1803-1808</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The mammalian Janus Kinases (JAK1, JAK2, JAK3 and TYK2) are intracellular, nonreceptor tyrosine kinases whose activities have been assocd. in the literature and the clinic with a variety of hyperproliferative diseases and immunol. disorders.  At the onset of the program, it was hypothesized that a JAK1 selective compd. over JAK2 could lead to an improved therapeutic index relative to marketed nonselective JAK inhibitors by avoiding the clin. AEs, such as anemia, presumably assocd. with JAK2 inhibition.  During the course of the JAK1 program, a no. of diverse chem. scaffolds were identified from both uHTS campaigns and de novo scaffold design.  As part of this effort, a (benz)imidazole scaffold evolved via a scaffold-hopping exercise from a mature chem. series.  Concurrent crystallog.-driven exploration of the ribose pocket and the solvent front led to analogs with optimized kinome and JAK1 selectivities over the JAK2 isoform by targeting several residues unique to JAK1, such as Arg-879 and Glu-966.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeRwubYziKxrVg90H21EOLACvtfcHk0lhxA9xDxCRc9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt12mtLo%253D&md5=f863ad973f0f86993bb7f796821b5059</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DSimov%26aufirst%3DV.%26aulast%3DDeshmukh%26aufirst%3DS.%2BV.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DElwood%26aufirst%3DF.%26aulast%3DFernandez%26aufirst%3DR.%2BB.%26aulast%3DGarcia%26aufirst%3DY.%26aulast%3DGibeau%26aufirst%3DC.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DKatz%26aufirst%3DJ.%2BD.%26aulast%3DKraybill%26aufirst%3DB.%26aulast%3DLapointe%26aufirst%3DB.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DSiu%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DYoung%26aufirst%3DJ.%2BR.%26atitle%3DStructure-Based%2520Design%2520and%2520Development%2520of%2520%2528Benz%2529Imidazole%2520Pyridones%2520as%2520JAK1-Selective%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1803%26epage%3D1808%26doi%3D10.1016%2Fj.bmcl.2016.02.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J. J.</span>; <span class="NLM_string-name">Li, Y.</span>; <span class="NLM_string-name">Rogers, E. W.</span>; <span class="NLM_string-name">Zhai, D.</span>; <span class="NLM_string-name">Deng, W.</span>; <span class="NLM_string-name">Huang, Z.</span></span> <span> </span><span class="NLM_article-title">Chiral Diaryl Macrocycles and Uses Thereof</span>. WO<span class="NLM_patent">2017015367A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+J.+Cui&author=Y.+Li&author=E.+W.+Rogers&author=D.+Zhai&author=W.+Deng&author=Z.+Huang&title=Chiral+Diaryl+Macrocycles+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26atitle%3DChiral%2520Diaryl%2520Macrocycles%2520and%2520Uses%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apgar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garin-Chesa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savchenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaaf, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahn, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoephel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haaksma, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adolf, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraut, N.</span></span> <span> </span><span class="NLM_article-title">BI 885578, a Novel IGF1R/INSR Tyrosine Kinase Inhibitor with Pharmacokinetic Properties That Dissociate Antitumor Efficacy and Perturbation of Glucose Homeostasis</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2762</span>– <span class="NLM_lpage">2772</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-15-0539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1158%2F1535-7163.MCT-15-0539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=26438154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKlu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=2762-2772&author=M.+P.+Sandersonauthor=J.+Apgarauthor=P.+Garin-Chesaauthor=M.+H.+Hofmannauthor=D.+Kesslerauthor=J.+Quantauthor=A.+Savchenkoauthor=O.+Schaafauthor=M.+Treuauthor=H.+Tyeauthor=S.+K.+Zahnauthor=A.+Zoephelauthor=E.+Haaksmaauthor=G.+R.+Adolfauthor=N.+Kraut&title=BI+885578%2C+a+Novel+IGF1R%2FINSR+Tyrosine+Kinase+Inhibitor+with+Pharmacokinetic+Properties+That+Dissociate+Antitumor+Efficacy+and+Perturbation+of+Glucose+Homeostasis&doi=10.1158%2F1535-7163.MCT-15-0539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">BI 885578, a Novel IGF1R/INSR Tyrosine Kinase Inhibitor with Pharmacokinetic Properties That Dissociate Antitumor Efficacy and Perturbation of Glucose Homeostasis</span></div><div class="casAuthors">Sanderson, Michael P.; Apgar, Joshua; Garin-Chesa, Pilar; Hofmann, Marco H.; Kessler, Dirk; Quant, Jens; Savchenko, Alexander; Schaaf, Otmar; Treu, Matthias; Tye, Heather; Zahn, Stephan K.; Zoephel, Andreas; Haaksma, Eric; Adolf, Guenther R.; Kraut, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2762-2772</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibition of the IGF1R, INSRA, and INSRB receptor tyrosine kinases represents an attractive approach of pharmacol. intervention in cancer, owing to the roles of the IGF1R and INSRA in promoting cell proliferation and survival.  However, the central role of the INSRB isoform in glucose homeostasis suggests that prolonged inhibition of this kinase could result in metabolic toxicity.  We describe here the profile of the novel compd. BI 885578, a potent and selective ATP-competitive IGF1R/INSR tyrosine kinase inhibitor distinguished by rapid intestinal absorption and a short in vivo half-life as a result of rapid metabolic clearance.  BI 885578, administered daily per os, displayed an acceptable tolerability profile in mice at doses that significantly reduced the growth of xenografted human GEO and CL-14 colon carcinoma tumors.  We found that treatment with BI 885578 is accompanied by increases in circulating glucose and insulin levels, which in turn leads to compensatory hyperphosphorylation of muscle INSRs and subsequent normalization of blood glucose within a few hours.  In contrast, the normalization of IGF1R and INSR phosphorylation in GEO tumors occurs at a much slower rate.  In accordance with this, BI 885578 led to a prolonged inhibition of cell proliferation and induction of apoptosis in GEO tumors.  We propose that the remarkable therapeutic window obsd. for BI 885578 is achieved by virtue of the distinctive pharmacokinetic properties of the compd., capitalizing on the physiol. mechanisms of glucose homeostasis and differential levels of IGF1R and INSR expression in tumors and normal tissues.  Mol Cancer Ther; 14(12); 2762-72. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo1q7ZLdPL7rVg90H21EOLACvtfcHk0lhXDwlSUOQmjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKlu73E&md5=3683e0ac329ddabba6786976cf5d7860</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-15-0539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-15-0539%26sid%3Dliteratum%253Aachs%26aulast%3DSanderson%26aufirst%3DM.%2BP.%26aulast%3DApgar%26aufirst%3DJ.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DHofmann%26aufirst%3DM.%2BH.%26aulast%3DKessler%26aufirst%3DD.%26aulast%3DQuant%26aufirst%3DJ.%26aulast%3DSavchenko%26aufirst%3DA.%26aulast%3DSchaaf%26aufirst%3DO.%26aulast%3DTreu%26aufirst%3DM.%26aulast%3DTye%26aufirst%3DH.%26aulast%3DZahn%26aufirst%3DS.%2BK.%26aulast%3DZoephel%26aufirst%3DA.%26aulast%3DHaaksma%26aufirst%3DE.%26aulast%3DAdolf%26aufirst%3DG.%2BR.%26aulast%3DKraut%26aufirst%3DN.%26atitle%3DBI%2520885578%252C%2520a%2520Novel%2520IGF1R%252FINSR%2520Tyrosine%2520Kinase%2520Inhibitor%2520with%2520Pharmacokinetic%2520Properties%2520That%2520Dissociate%2520Antitumor%2520Efficacy%2520and%2520Perturbation%2520of%2520Glucose%2520Homeostasis%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D2762%26epage%3D2772%26doi%3D10.1158%2F1535-7163.MCT-15-0539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deacon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horiuchi, K.</span></span> <span> </span><span class="NLM_article-title">The Challenge of Selecting Protein Kinase Assays for Lead Discovery Optimization</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">607</span>– <span class="NLM_lpage">621</span>, <span class="refDoi"> DOI: 10.1517/17460441.3.6.607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1517%2F17460441.3.6.607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=19662101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotVyrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=607-621&author=H.+Maauthor=S.+Deaconauthor=K.+Horiuchi&title=The+Challenge+of+Selecting+Protein+Kinase+Assays+for+Lead+Discovery+Optimization&doi=10.1517%2F17460441.3.6.607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">The challenge of selecting protein kinase assays for lead discovery optimization</span></div><div class="casAuthors">Ma, Haiching; Deacon, Sean; Horiuchi, Kurumi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">607-621</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Protein kinases represent one of the most promising groups of drug targets owing to their involvement in such pathol. conditions as cancer, inflammatory diseases, neural disorders, and metab. problems.  In the last few years, numerous pharmaceutical and biotech companies have established kinase high-throughput screening (HTS) programs, and the reagent and service industries for kinase assay platforms, kits, and profiling services have begun to thrive.  Objective: The plethora of different assay formats available today poses a great challenge to scientists who want to select a technol. that will be cost efficient, convenient to use, and have low false pos. and false neg. rates.  Methods: In the current review, we summarize the most commonly used kinase assay methods in the drug discovery process, present the advantages and disadvantages of each of these methods, and discuss the challenges of discovering kinase inhibitors by using these technologies.  Conclusions: The decision of selecting the assay formats for HTS or service platform for profiling should take into account not only the final goals of the screens but also the limitation of resources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL-z-puxv_a7Vg90H21EOLACvtfcHk0lhXDwlSUOQmjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotVyrt70%253D&md5=d01a65a4560c5edb357f02c788631c69</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1517%2F17460441.3.6.607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.3.6.607%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DH.%26aulast%3DDeacon%26aufirst%3DS.%26aulast%3DHoriuchi%26aufirst%3DK.%26atitle%3DThe%2520Challenge%2520of%2520Selecting%2520Protein%2520Kinase%2520Assays%2520for%2520Lead%2520Discovery%2520Optimization%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26spage%3D607%26epage%3D621%26doi%3D10.1517%2F17460441.3.6.607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naeem, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stetsiv, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetting, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashirullah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisbrecht, E. R.</span></span> <span> </span><span class="NLM_article-title">Drosophila NUAK functions with Starvin/BAG3 in autophagic protein turnover</span>. <i>PLoS Genet.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>16</i></span>, <span class="NLM_elocation-id">e1008700</span> <span class="refDoi"> DOI: 10.1371/journal.pgen.1008700</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=10.1371%2Fjournal.pgen.1008700" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=32320396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFSjs7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2020&author=D.+Brooksauthor=F.+Naeemauthor=M.+Stetsivauthor=S.+C.+Goettingauthor=S.+Bawaauthor=N.+Greenauthor=C.+Clarkauthor=A.+Bashirullahauthor=E.+R.+Geisbrecht&title=Drosophila+NUAK+functions+with+Starvin%2FBAG3+in+autophagic+protein+turnover&doi=10.1371%2Fjournal.pgen.1008700"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Drosophila NUAK functions with Starvin/BAG3 in autophagic protein turnover</span></div><div class="casAuthors">Brooks, David; Naeem, Fawwaz; Stetsiv, Marta; Goetting, Samantha C.; Bawa, Simranjot; Green, Nicole; Clark, Cheryl; Bashirullah, Arash; Geisbrecht, Erika R.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Genetics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e1008700</span>CODEN:
                <span class="NLM_cas:coden">PGLEB5</span>;
        ISSN:<span class="NLM_cas:issn">1553-7404</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The inability to remove protein aggregates in post-mitotic cells such as muscles or neurons is a cellular hallmark of aging cells and is a key factor in the initiation and progression of protein misfolding diseases.  While protein aggregate disorders share common features, the mol. level events that culminate in abnormal protein accumulation cannot be explained by a single mechanism.  Here we show that loss of the serine/threonine kinase NUAK causes cellular degeneration resulting from the incomplete clearance of protein aggregates in Drosophila larval muscles.  In NUAK mutant muscles, regions that lack the myofibrillar proteins F-actin and Myosin heavy chain (MHC) instead contain damaged organelles and the accumulation of select proteins, including Filamin (Fil) and CryAB.  NUAK biochem. and genetically interacts with Drosophila Starvin (Stv), the ortholog of mammalian Bcl-2-assocd. athanogene 3 (BAG3).  Consistent with a known role for the co-chaperone BAG3 and the Heat shock cognate 71 kDa (HSC70)/HSPA8 ATPase in the autophagic clearance of proteins, RNA interference (RNAi) of Drosophila Stv, Hsc70-4, or autophagy-related 8a (Atg8a) all exhibit muscle degeneration and muscle contraction defects that phenocopy NUAK mutants.  We further demonstrate that Fil is a target of NUAK kinase activity and abnormally accumulates upon loss of the BAG3-Hsc70-4 complex.  In addn., Ubiquitin (Ub), ref(2)p/p62, and Atg8a are increased in regions of protein aggregation, consistent with a block in autophagy upon loss of NUAK.  Collectively, our results establish a novel role for NUAK with the Stv-Hsc70-4 complex in the autophagic clearance of proteins that may eventually lead to treatment options for protein aggregate diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1M6WtUolRVbVg90H21EOLACvtfcHk0lhXDwlSUOQmjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFSjs7bI&md5=2f648643d3fc5668fb63cee16f4c8ad3</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.1008700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.1008700%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DD.%26aulast%3DNaeem%26aufirst%3DF.%26aulast%3DStetsiv%26aufirst%3DM.%26aulast%3DGoetting%26aufirst%3DS.%2BC.%26aulast%3DBawa%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DN.%26aulast%3DClark%26aufirst%3DC.%26aulast%3DBashirullah%26aufirst%3DA.%26aulast%3DGeisbrecht%26aufirst%3DE.%2BR.%26atitle%3DDrosophila%2520NUAK%2520functions%2520with%2520Starvin%252FBAG3%2520in%2520autophagic%2520protein%2520turnover%26jtitle%3DPLoS%2520Genet.%26date%3D2020%26volume%3D16%26doi%3D10.1371%2Fjournal.pgen.1008700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00533&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-1%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00533" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00533" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6679836bdae91929","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
